cell_line_id,drug_id,response,predictions
DMS 273,9952709,2.373087309160908,2.5326708971073546
NCI-H522,613000,2.2856040748624347,2.674397667749095
YAPC,16038120,1.926562361021756,1.073708986887988
NCI-H292,9935249,3.8808310590786,3.3459385414125338
SNU-449,navitoclax-gemcitabine (1-1 mol-mol),5.117951975418846,-1.2056252886801488
NCI-H522,9908783,5.043768225694569,4.765420321662087
JM-1,11175137,0.9157477453434189,1.6243980337110184
NCI-H522,5287620,-2.19230412457559,-2.0961213542736683
MDA-MB-453,4917,2.8920757434762203,2.7487458687767203
DMS 273,135421197,2.3407622077730035,1.6684144203645612
SNU-449,BRD-K55473186,5.1406225681359174,4.015861892842585
SNU-61,4521392,3.90812104829802,4.028922432026923
G-401,9549297,1.736191202159007,2.072977377689381
NCI-H146,89183176,1.451528120959232,3.362386878069591
LOU-NH91,5287620,-1.52867963951729,-1.8221940979458708
FTC-133,123631,3.8044847524269865,2.4630172284131264
KMRC-1,5291,3.811670367299954,3.5544980581324346
A-673,9823820,4.6435125645675095,3.145330001184005
FU-OV-1,168313047,2.3973799381416208,2.5438189141236482
Panc 04.03,44462760,4.978463894781355,4.365031644900704
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272,3.1325599316735895
OPM-2,445091,3.996829176942573,3.7389407634013803
ONS-76,5746,1.4703359849180313,1.3003836149592345
NCI-H661,3025944,3.908905198351104,4.257121801929736
A4/Fukuda,107970,1.5574682195612295,2.0954603373173883
CAL-51,49850262,3.6300011952383584,3.5408147704714406
NCI-H460,2858523,3.1665522277325575,3.1266838669911077
G-401,6184667,2.5094508901292487,2.558930419459669
NCI-H661,44607531,1.139733733680255,1.6741828836931283
SNU-81,6917907,-6.2756065511253185,-3.852585097366027
MSTO-211H,54678924,1.5146991125566602,2.085434099170727
FTC-133,10127622,5.496386107928154,3.506398879612977
EFO-27,11977753,-1.8189065225127747,-1.122597255214387
SNU-61,selumetinib-decitabine (4-1 mol-mol),0.7791363138333649,2.0212232917852946
MSTO-211H,19582717,3.17062921236116,4.1988461959353796
KMRC-1,53392493,3.2185750963739026,2.6035794163567014
OPM-2,2749,1.7313419667612246,1.0781155077741267
NCI-H460,5351362,3.0809857123464037,1.7282795122876677
SNU-449,56949517,4.374997906660537,4.443698052983972
NCI-H146,1716436,1.8968095332546364,2.6565091371045644
MSTO-211H,9884685,-1.5007126123703023,0.7949903666731807
CA46,46926350,-5.311040218420036,-4.543267402805458
BxPC-3,72193861,-0.2425633398981322,1.728994550688472
NCI-H522,24180719,4.104291025168841,3.506247958447526
NCI-H292,16038120,0.8772093711483475,1.3368961146938168
NCI-H2171,11364421,-5.769988570724398,-3.1684838869482594
LOU-NH91,71304818,3.9209078908272703,2.7062004055611526
NCI-H2009,71466380,3.950405172838994,4.599486513435631
EFO-27,44607530,2.237032971856772,1.9869237930104615
CAL-51,3136844,4.799885860604426,4.442068588643295
MSTO-211H,9936388,-4.464575449065994,-0.1725411427245544
A2780,66577038,2.715796351675557,2.8287773055706333
G-401,24779724,6.361263224396382,3.6257435148207575
OPM-2,5470400,-0.1217933569770787,-0.34837572794511873
HCC1143,36314,1.6197332159913502,-1.690504813874872
SW1463,54143018,1.6932952952144893,0.10815431981220272
JM-1,1317464,3.8125649173872938,2.493971492759684
DMS 273,46907787,0.4735517334159472,0.6390151151546444
MDA-MB-453,46843906,1.4379824902109608,3.2171253794576287
YAPC,6252,1.451992868069142,1.3805378277496174
MDA-MB-157,navitoclax-sorafenib (1-1 mol-mol),-1.4384143120917083,1.645435096299928
CA46,46943432,1.2105530921386296,0.9981547272268889
NCI-H292,24785538,2.1095024536235374,1.9990718198712905
NCI-H292,3038522,3.811290582208577,3.4402257635118834
NCI-H460,54454,2.7807551042334935,2.526922362442616
NCI-H661,9911463,3.595935737335879,4.057177263724251
BT-549,4261,1.9217340769001163,1.9815810170465769
FTC-133,16013152,4.199465293191842,4.292169169339276
MDA-MB-453,54618305,5.448966988850886,4.383032006317418
LOU-NH91,56946209,-2.032751224257796,-4.023987765616838
KMRC-1,16659841,4.161446951047465,3.6217252343408535
LXF 289,66577038,2.7615792990535937,2.9663969588445696
A-673,2871966,-2.1375369153988597,0.174031029326062
EFO-27,4788,6.204062284318603,5.786023297322393
FTC-133,5281321,-2.4880366458953196,-1.3095924970837356
JM-1,613753,2.4959303189076376,2.8785963126465672
CAL-51,168312962,1.4117577594763937,2.0794901129564725
OPM-2,6450551,0.7106995413225735,1.597046089857863
ONS-76,selumetinib-decitabine (4-1 mol-mol),-0.8020302824426914,3.0991255668711104
EFO-27,26596,4.577324640946523,-1.0079912826643311
LoVo,656346,0.766025679375412,0.9292927774654506
NCI-H522,4477,0.4448521837298123,0.037726750380910355
NCI-H727,9936388,1.6432072244848812,-1.319751386677816
FTC-133,104842,-5.8581546696404,-2.5280732096512484
EFO-27,7326481,5.957065585898912,3.117037089172052
NCI-H460,11222830,2.8861636193629323,1.7355260478642769
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245,3.532513676026573
NCI-H460,54618771,1.6853262233131374,1.0762154478162176
JM-1,52947716,1.780956269613054,-3.2773576026999867
OPM-2,9444,2.5095115053941557,3.657117807509193
NCI-H146,60700,-4.723399126949256,-1.1236950496953129
BxPC-3,9911830,2.611582201474507,2.815597427408783
NCI-H146,16038120,1.7989248875403512,0.7058376269120484
LXF 289,51037431,5.679407317259089,3.34319503292822
HCC1143,44589607,1.260451666530297,3.119191237365717
CA46,5281321,-3.5082232289526663,-2.9772199971671
BxPC-3,3815108,3.682439325637505,2.8717373183955215
BT-549,ISOX-bortezomib (250-1 mol-mol),0.1826356805695565,0.9299132964771075
BxPC-3,3552672,2.73628551508051,2.9401026128998367
SCC-9,3081361,1.719146178558617,2.3940456153862053
SCC-9,135875424,4.9754653396039314,4.261416166094445
LoVo,1716436,2.86184708699294,3.083110067158298
MDA-MB-157,9884685,1.398372779004129,0.6378545294411548
NCI-H292,9911463,4.207043029649759,4.007682235826976
G-401,54626689,4.421186382617726,4.432391419020915
NCI-H460,6917907,-4.956095121428261,-4.690435669884923
CA46,25062766,1.483751377697603,1.7323546850309444
LXF 289,44241473,4.688676931788039,4.8638158905222095
EFO-27,71680916,4.9682795090816185,4.950023825593311
SW1463,11152667,-0.1903484351781526,-0.6787269634919834
NCI-H292,73707398,0.96137499748578,1.417089534748133
NCI-H2009,16725315,3.943728055015544,4.413303917510346
SNU-61,135440466,2.760100648324382,2.1925338454967847
A2780,451668,4.676838081876032,1.9059441616126604
JM-1,46191454,-0.7072965876905944,0.189475449142713
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.3918338398665528
SNU-449,2733526,4.280379959685792,3.787005025993722
JM-1,10302451,3.097435274235228,2.7447471212378445
DMS 273,tanespimycin-gemcitabine (1-1 mol-mol),-1.669434491650497,-1.4345870335677486
EFO-27,vorinostat-carboplatin (1-1 mol-mol),2.7861871023454077,3.4636469265133227
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.248867729206212
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.4377861128923997
OPM-2,52912189,-3.1407059889083424,0.28334435770735206
SCC-9,9549297,5.273243325738832,2.7261652664198603
A-673,375860,-0.5094320760358009,-0.38126348839922086
SNU-449,15983966,0.8926749279922188,-0.9138383840162281
SNU-449,135440466,2.7536019754154375,2.4848006142245564
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956,1.3110198860551034
NCI-H522,73707398,0.7434005611154502,1.0447461058680028
NCI-H1623,72376,-0.6301176586270604,-1.6401627619604313
SCC-9,24901704,4.548877009949327,3.418393096043445
HSC-4,448949,2.25928901468022,2.0594068934025604
SCC-9,25102847,2.571358625043281,2.815263573460561
FTC-133,135411,0.6572104898559208,0.8241852266402837
DMS 273,445643,4.452334519038606,3.9094580514214665
HSC-4,24771867,2.9499855440491243,3.224082868176387
BxPC-3,2841722,6.186043735824486,4.323936821585469
MDA-MB-157,52947716,2.709287320485668,-0.6931093651769247
HSC-4,46224516,3.389129888163455,2.5251178438436575
NCI-H146,400769,-1.4971487301951925,-0.6780827309782409
LOU-NH91,387447,-3.4249375140388247,-4.16044165806067
CA46,6610216,4.017162804005507,3.9383321656971244
LoVo,375860,-0.1162329718395109,-0.18498654680325377
FU-OV-1,9911830,2.8434321082933773,2.713078570555174
LoVo,9840324,5.061772266378942,5.794076004770216
MSTO-211H,56649450,2.845391743702004,4.003227210169747
HSC-4,9935249,3.700870290975298,3.3140200724524544
BT-549,44486219,4.179253703467884,4.4324183085352695
SNU-449,24901704,3.9093934632949616,3.5468127528056472
FTC-133,44589607,3.1305768616958085,2.7432179233511005
LOU-NH91,42642645,0.5799169530603235,1.2788148089382125
KYSE-70,51037431,6.2873914521382765,3.2199837796516304
KMRC-1,1566236,3.0378094444517645,2.8197507307648215
Panc 04.03,42642645,1.6619965718360328,1.0705300181334187
CAL-51,3689413,0.5709426612715743,0.07778631032533428
NCI-H522,44487872,5.4176039717063915,4.465285211147034
NCI-H2009,16722836,0.9347693241342916,1.9994511233879027
NCI-H522,11222830,1.4433136379668847,1.2850180000821074
CA46,72193861,0.1338517787347367,0.2663888604246368
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403,0.1799849239959478
LoVo,119607,4.4096130331744865,5.288366721203617
MDA-MB-453,1566236,2.5975650319928434,2.0781692190772425
ONS-76,11152667,-0.1692604119623072,-0.12936657136634294
G-401,24748573,1.6686206591324024,1.9710387800964555
A2780,176870,3.0464675702719655,3.1268613239881864
NCI-H727,vorinostat-navitoclax (4-1 mol-mol),3.0192408076128823,1.2956564574392453
OPM-2,3385,3.5898560550490837,2.7393044385342655
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-0.7751553567094159
NOMO-1,53495165,-0.0338576092201104,-1.7192247369696918
LoVo,46191454,2.275591949439888,1.5747001867132926
A4/Fukuda,4096211,1.2598455852625392,1.4633413009463214
NCI-H522,25126798,3.91575296607237,3.3703835388520424
FU-OV-1,135411,0.8541212220651947,0.8851476789479349
KYSE-70,10113978,1.960067513789881,2.9644900696347207
FU-OV-1,24856436,0.8416503079264269,0.7148692683829675
A-498,10026128,4.231838396167064,3.7393264170379945
JM-1,11626560,-0.1801568688824005,0.7673995656779118
NCI-H460,9911830,3.1326305509826824,2.596253429817361
A-673,9911830,1.9751375507094395,2.124270005593604
Panc 04.03,71751553,4.683117627568525,4.603484065301256
LXF 289,6450551,1.9915066986525345,2.8471703423100423
NCI-H522,156414,0.937566519659893,1.273520554920404
MDA-MB-453,6610355,3.820285868995436,4.384110308853832
FU-OV-1,46843906,0.6915308493256752,3.226225458733331
NCI-H522,42642645,1.4297074042386375,0.23427459599072178
SCC-9,4917,3.683292695011318,3.0779728612008705
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,0.9977434580402044
SBC-5,54649381,4.189343649803657,3.8826956855950248
NCI-H1623,6918837,-3.3974396350468674,-2.894634819554045
KMRC-1,10184653,1.755388017214173,1.1201586484403994
LXF 289,9967941,3.6599941581067057,3.9544603800487086
FTC-133,57519531,1.7209799050566308,2.7936420374030915
NCI-H661,19582717,3.3132894226769056,4.262204754921854
MSTO-211H,selumetinib-PLX-4032 (8-1 mol-mol),2.4533429181840307,3.284003877926022
LoVo,71466578,1.8530080227063717,4.6645272297069615
NCI-H2009,46907787,0.5680124512944033,2.4967312748639983
DMS 273,49793307,-3.720971975288363,-3.621198393802891
NCI-H522,135659046,3.4944475458884012,3.5731872496510935
FTC-133,5351362,2.946320615286136,1.8877344356922248
JM-1,208908,1.8689748302954872,2.2474933178002363
Panc 04.03,216239,3.3806837686851923,2.5246266626193155
NOMO-1,71466445,1.8310961714544176,2.3981655546487017
NCI-H522,71680916,3.6078643166976896,4.334849155072231
EFO-27,2126,5.846579140474247,4.712440310311475
ONS-76,5284616,3.539643222518188,2.2384983438481227
SCC-9,16736978,3.1048488109971664,1.5980601924709408
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485,-3.989316183454426
A4/Fukuda,23582824,-0.7377224087572002,0.7300233380962671
NCI-H661,53325874,4.390083123893945,4.5075369060420885
SNU-61,4096211,1.05462843518756,1.8142786958663384
CAL-51,675434,4.354107922133551,4.606884347796662
NOMO-1,11175137,1.3676050257567425,1.9004462554874346
NCI-H2171,5335621,4.282845813975702,3.9313828503326325
SNU-449,11647372,1.9881649315547345,1.6809938574134347
NCI-H522,3503,2.0960599148243557,2.101571368249599
NCI-H2171,52947716,1.4567314464455066,-1.15642265669043
NOMO-1,5291,3.5817896511091862,3.3692627609148356
NCI-H522,46843906,2.3044802452603967,2.3110239972306785
OPM-2,11494412,0.3054873199299708,0.4739911608237328
A-673,53495165,-1.305348317827654,-1.0041415091284627
KYSE-70,54618771,1.1170424016733127,1.186745923735468
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.2741999757407774
SCC-9,3062316,1.318086870144001,1.0122928558831297
LoVo,387447,-3.727342469020989,-4.116828001076624
MSTO-211H,73707386,2.8647689708389943,3.086685428264433
FTC-133,54613361,1.5430217136639572,0.3116290993400243
SNU-61,12001922,2.043150446887516,1.8695335124053858
DMS 273,374536,2.442253811681885,1.46350926667633
LXF 289,10302451,1.735451917587997,3.45681890301784
CAL-51,2858523,3.1959449804225524,3.0261467146425223
Panc 04.03,23582824,1.118403221753994,1.169851209578993
KMRC-1,6505803,1.455434702084088,-0.5721507768124888
CAL-51,4261,2.4552246887350417,1.7755726184905294
SCC-9,5746,1.774962232755205,1.2121450974481969
NCI-H661,71466578,3.739107690689307,4.71269196927971
ONS-76,54619267,4.0364090976663,4.268312010849697
NCI-H522,100016,6.692385014202011,5.715494245568781
G-401,11719255,3.853695059500007,2.7927297783871667
HSC-4,3815108,3.178044313970192,3.0317812706509493
NCI-H2171,5287620,-0.0573950216422359,-2.3018508148119916
A4/Fukuda,5311,-0.1264358008137528,0.6260611892293649
NCI-H292,387447,-4.003442188855186,-4.042492873600708
OPM-2,148124,-6.3849256320012575,-3.184128974807937
MDA-MB-453,alisertib-navitoclax (2-1 mol-mol),3.3277558601146215,0.2877745570416861
DMS 273,salermide-PLX-4032 (12-1 mol-mol),5.306834954267239,4.677569741838792
CA46,9967941,3.699441503938977,3.2814473299171443
SNU-61,JQ-1-navitoclax (2-1 mol-mol),0.8164075639499123,0.4147969779261257
LXF 289,387447,-4.093727880786265,-3.834350212973602
CAL-51,5113032,4.55807021159329,4.754082863790266
NCI-H727,serdemetan-SCH-529074 (1-1 mol-mol),2.331809225876462,2.0394200203813044
OPM-2,241158,1.7102591321182437,2.593229313098629
ONS-76,16741245,1.9308546797770672,3.9495524058553615
Panc 04.03,322968,5.075488138121087,4.117475574253577
BT-549,135875424,3.804392758634582,3.973558192625491
A-673,54626689,4.6393725921997415,4.418881066956738
SNU-449,navitoclax-birinapant (1-1 mol-mol),3.571225842715355,1.503276088626688
HCC1143,3543504,4.280043771428645,4.566769511461307
BxPC-3,107970,2.2592769610294448,2.4135241385380515
ONS-76,51037431,1.0002101292366832,3.0968177334926095
G-401,24785538,-1.0602782345595374,0.9600464855355287
MDA-MB-453,SNX-2112-bortezomib (250-1 mol-mol),-2.8558068979293383,-1.4959072363575703
FTC-133,676352,3.9949531967924297,2.137480612651496
NOMO-1,53232,3.2414615649348772,2.4958403980382524
LoVo,11625818,2.0848313295223844,4.407368963346501
A4/Fukuda,702558,5.147225783500614,4.241259284864742
NOMO-1,11455910,0.2303469505827257,0.37490578423071325
SNU-81,4096211,1.97800800333133,1.637123647570137
NCI-H522,676352,1.6559488811299496,1.956505660960769
YAPC,60750,-4.781219880342373,-1.5993765359699603
Panc 04.03,11612883,3.751429287253437,2.996201653127593
NCI-H661,67156097,-3.370555704228358,-0.40364983185434794
SNU-449,4705,3.898593282840832,3.4556536707271444
MDA-MB-157,9952709,2.6586157499418444,3.2231449477188274
NCI-H522,16038120,0.9671280612186928,0.8755465653429738
A4/Fukuda,4259181,-0.5702867723998835,-0.21432380097425752
LoVo,135398744,6.330186357549225,6.2326432969137455
OPM-2,637858,0.8070227403937857,1.0366684263873163
SCC-9,3038522,1.9571402343301385,3.240696586148074
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498,-0.2579375830390249
A4/Fukuda,10127622,0.8035335483112384,3.9882435426546623
Panc 04.03,4378219,5.53220646065493,2.5435022500576876
EFO-27,JQ-1-vorinostat (2-1 mol-mol),1.2489296683546294,1.2845696804189939
LOU-NH91,navitoclax-piperlongumine (1-1 mol-mol),-1.482580438049138,2.022382100241169
EFO-27,11396600,3.826824277303455,3.9255944683739106
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283,1.6441946618716485
NCI-H2171,7251185,0.8673768610035957,1.7272617359155291
NCI-H1623,5311281,4.903104817913162,2.778670728519686
OPM-2,11317348,2.0151792351474755,1.3976033335203368
OPM-2,100016,3.804278037815123,5.004762121230999
LoVo,46224516,4.94892102130723,2.6220531935791285
A4/Fukuda,9826308,-1.4955537783248567,-0.32601232174755956
LoVo,15547703,1.4569683263207862,3.142388210021193
LoVo,227681,3.064150517180394,3.575175249127213
NCI-H727,5460769,4.510942150258337,2.8087340286902585
NCI-H292,6918837,-2.538558148903755,-2.3713711200406298
A2780,132971,2.947129832610188,2.378907568679402
FTC-133,4788,5.605324981437421,5.634213463146701
A-498,selumetinib-decitabine (4-1 mol-mol),2.586259947527723,4.1402161938176185
A-498,23582824,2.0595934555669886,1.0714555368996417
SNU-61,8515,5.6731171982359365,3.603727009869675
MDA-MB-453,23582824,0.0198148722876335,0.5401241556623642
DMS 273,5329102,2.038563375095403,1.8342725914591904
NCI-H460,72193861,2.1658883750752844,1.6684028926603995
MDA-MB-157,6610355,3.680589360872168,4.742111742863408
Panc 04.03,56649450,4.182465283011193,3.54016834860225
NCI-H727,124202324,2.79148434895864,2.477029318267914
MSTO-211H,24772860,-3.3585393605141824,-1.6897315326019946
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776,1.6038305609618015
CAL-51,20959075,-3.1196535578382987,-2.7949415868886636
OPM-2,322968,0.7466819505545055,2.1159080984490357
CA46,984333,-2.431082434536014,-0.3527074545453231
JM-1,1242560,2.356943306915098,3.0045906878074278
NOMO-1,25126798,3.9519848152055848,3.2353671400871282
MDA-MB-453,5738263,2.9414099779046934,3.315383273396019
OVISE,10074640,3.3556303567674064,3.267769510843309
SNU-81,JQ-1-MK-0752 (1-1 mol-mol),4.555770786077887,1.1848916474991515
MSTO-211H,159324,-0.971759723426381,3.526924888501624
Panc 04.03,46191454,2.0071895522726377,2.0124695811970406
SBC-5,9826308,0.1778598819423294,0.817268483464881
BxPC-3,1641662,3.0109567862503654,3.5230366150382495
NCI-H460,2708,4.613368759945332,5.099603292450127
MDA-MB-453,2746,1.6853152695376463,2.9554671046473753
NCI-H292,2858523,3.0406792249868633,3.1538933611934725
LoVo,52912189,0.3784309245329977,1.9553883183266547
BxPC-3,navitoclax-gemcitabine (1-1 mol-mol),-2.057283602704844,-0.3041693494468247
NCI-H460,9936388,2.3098343611543415,-0.5800589880754181
A4/Fukuda,176870,1.9874765150136215,2.5872092258980466
LOU-NH91,49793307,0.2442451207819767,-2.028227725147923
MDA-MB-453,2945648,2.145365576847094,2.900632678049921
SNU-449,54596490,5.440438718305218,4.956128475378292
NCI-H2171,9927531,3.1501077196413783,4.074681114576739
CAL-51,25150857,2.2346870378683934,2.5079204006306126
YAPC,navitoclax-sorafenib (1-1 mol-mol),5.55182899322967,1.916153123691234
NCI-H727,9444,4.415864627267573,4.065733591903928
CA46,71466578,1.7711352492213497,2.66188558016787
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.4634230067947267
G-401,11507802,0.4930201538787991,0.9410442493742954
OVISE,11214940,-0.1911189695405239,2.380186111662356
MDA-MB-453,135999136,4.2113637134750395,3.538837477995581
CA46,445455,4.357290874085763,3.9549766966516358
KMRC-1,5335621,6.052276706579308,4.4821545706830985
Panc 04.03,36462,3.526332093717117,2.8009570068043432
SBC-5,56963564,-0.838635946263744,0.5498026677443724
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997,2.362078454575579
NCI-H727,46224516,2.477743379244975,2.4321484570129566
NCI-H292,11222830,1.205012148013641,1.832883067690244
MDA-MB-453,24771867,4.091824937074987,2.2031524017579813
NCI-H460,72376,-0.5460239014371263,-1.4537744978057965
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023,1.2666906057823935
LXF 289,9911830,2.045852319971143,2.6266447178532712
LoVo,1242560,3.2639930925900305,3.6080313344253363
NCI-H292,6918736,3.734181331597608,-1.3616483391370966
G-401,11717001,3.7897150646045863,4.136511387620268
ONS-76,46398810,2.9642978938134004,2.627545234170045
NCI-H522,1242560,4.210520049105227,3.4944870104101597
EFO-27,3081361,2.362036241237279,2.508215491828598
SBC-5,11222830,1.4112085967579189,1.6736213389922137
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.150534278436751
CA46,11213558,2.4131379110887496,1.2819721982557646
FU-OV-1,6918837,-4.1157354170673495,-2.1019511800711643
A4/Fukuda,56946209,-6.395954164738885,-4.829138151181621
NCI-H2171,tanespimycin-gemcitabine (1-1 mol-mol),-2.6967474652224745,-1.3678668183560245
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492,1.25027254522817
OVISE,vorinostat-navitoclax (4-1 mol-mol),1.48951856204489,1.106447237276285
MDA-MB-453,navitoclax-birinapant (1-1 mol-mol),3.002333269444996,1.472707923702927
A4/Fukuda,216239,1.5760740052804734,1.909926118729687
FTC-133,4578,5.173307644971936,4.457015115749856
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304,1.3150727828364068
NCI-H460,54618164,4.49670945938676,4.09100825868164
CAL-51,42642645,0.4324607401831485,0.5339374888709844
BxPC-3,24771867,1.9124988819938955,2.9739277115912905
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335,2.1118838266343714
NCI-H460,15953870,5.00315267734786,3.541959506837261
A2780,24964624,-0.4628922796959323,1.82078514130258
CAL-51,654092,0.82886283906252,-0.1375456663216184
G-401,5281321,-2.57337969869382,-1.6467734314411808
MDA-MB-157,3634881,2.7842407118999852,3.2395243827790345
MDA-MB-453,42642645,1.5292302084545462,0.9432084101534399
BT-549,54618164,4.423974096662665,4.217396429822366
A4/Fukuda,16741245,4.963846947143099,3.67426231042953
BxPC-3,44632017,0.4026385498906549,1.186364172383059
ONS-76,9911830,2.941904202808556,2.6193101514646187
NCI-H146,navitoclax-birinapant (1-1 mol-mol),-2.693365824422348,0.3281392239940379
ONS-76,4477,-0.2351585842599584,0.6508820847015728
JM-1,44493528,3.997956862382446,3.833676076946054
NCI-H146,5702613,3.149923076768629,2.826395688087684
NOMO-1,25150857,2.063048355345986,1.5246051550417987
LoVo,24856436,-0.7244956111709783,0.3979791219117572
OPM-2,53481919,3.0492738202957206,2.9760417722941734
BxPC-3,44507138,1.658490789748868,2.572508006086876
FU-OV-1,2113511,4.466585490981426,5.405365099616993
NCI-H661,2749,0.7713739826565964,2.0027776378069957
NCI-H1623,53495165,-0.5563852526996439,1.211490010042738
NCI-H522,6610216,4.154510920860766,4.094130281846888
BxPC-3,148198,-2.171424706341701,-3.0753731429912334
MSTO-211H,4788,5.119342350142264,5.678068002694156
A-498,1750826,-1.7479882416802337,-1.9266453074816252
HSC-4,136227924,4.2199200707906845,3.0162645957050143
Panc 04.03,selumetinib-UNC0638 (4-1 mol-mol),4.963542223842957,3.102921670577185
LoVo,54618771,0.7060685526757626,1.038990608355615
DMS 273,10322450,3.6367733537116167,3.325059636802006
ONS-76,1750826,-1.6505794475434372,-1.6182925529298948
MDA-MB-157,135440466,3.174924928897617,2.222919403497901
NCI-H727,241158,6.115461447477091,3.865277185046661
HCC1143,46398810,2.1694021244377333,2.6906042902021055
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416,0.9530323530006822
SNU-449,3062316,-1.3612378425924234,1.619360305309974
SNU-449,11977753,-2.005546044599541,-1.224079664491661
JM-1,24771867,-4.48997165682624,-1.2032136715909525
NCI-H2009,11507802,1.1556617167312242,1.9604492942191163
HSC-4,11964036,1.64347500999081,1.343298181051638
Panc 04.03,5479543,4.112837907412102,3.733636145569776
ONS-76,439501,-2.2755976390662163,-2.248279981019064
JM-1,54639126,4.392955654749798,2.5181528393462203
CA46,11167602,1.6890466560929325,1.7684142960577633
CA46,135411,0.0331424760277949,-0.035947985738096065
MDA-MB-453,tretinoin-navitoclax (4-1 mol-mol),3.844804044479517,1.9652539522493548
Panc 04.03,11625818,5.081289492721679,4.721772372790774
NCI-H292,12001922,1.805770236255338,2.159953375578998
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,2.032056433023199
MDA-MB-453,5278396,3.602107220771141,3.434497333721846
NCI-H522,6438330,2.681865372615506,1.9732673317868725
A-673,71466445,2.638210082463498,3.5062606109520296
MDA-MB-453,25105715,3.2581724710849778,3.398464553461879
A2780,17759555,2.3500586644289165,3.5520090389958834
YAPC,124202324,3.68667481758741,2.500910300563056
NCI-H522,25227462,-0.4562280137645088,0.8211299526652168
KYSE-70,10074640,3.109810551584267,3.1142728445374432
HCC1143,5278396,2.995823973274505,3.6720543400368335
HSC-4,5479543,4.052409111099337,3.6204045223304826
NCI-H661,446155,0.1985182541705634,3.0693948008119203
YAPC,53495165,-1.0203233667221312,0.8317510880179029
FU-OV-1,11719255,3.4823701199113097,3.5680349038254384
NCI-H2171,5278396,3.2627520221828115,3.1840970165860365
MDA-MB-157,9911830,0.0801478348660684,2.7953116255704824
OPM-2,9911463,3.091122447781221,3.272092236225751
LoVo,25126798,3.7423562181337338,3.9113067427758574
EFO-27,9911463,4.361076045114702,4.048421733542772
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148,-2.852716455871168
A2780,5280436,2.9198027340920434,3.0626106507444657
SCC-9,5311037,3.6943722712183007,3.9313918343881693
ONS-76,5978,-2.168221630618191,-1.4937114336895636
A-673,44819697,-3.745571155852308,-0.7017234481630902
CA46,24785538,1.2011715151517115,0.17471369149826352
HSC-4,9936388,2.361545024779824,-0.6777515293658353
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.493679797699447
NCI-H460,49793307,0.4479933662320887,-2.4457278060384073
A2780,64971,1.607646338152048,2.177860362804461
JM-1,72193861,0.5763432020354632,0.2564052077218973
NOMO-1,11625818,1.7683333213472852,3.659276530400904
NCI-H522,navitoclax-PLX-4032 (1-1 mol-mol),3.539669986895116,1.6963158911443126
MSTO-211H,11507802,-2.113337212450165,1.9948203946861434
NCI-H661,53232,0.4849867031297817,3.244591005517567
YAPC,16720766,-1.1916244870670316,0.8522321154023796
NCI-H522,208908,1.8410391152152548,2.4764835209983773
MDA-MB-157,5284616,2.798393493195082,2.717061037610748
MSTO-211H,6505803,-0.0669493563910609,-0.5525448036091959
NOMO-1,56649450,3.0749194455734012,2.7748002296317424
NCI-H727,9967941,3.73486297967426,3.903863007382833
SW1463,15547703,3.1824451623977312,2.8697596545634387
FTC-133,24951314,1.987520160616717,1.5032085458366509
MDA-MB-157,24772860,-2.2599749907314175,-1.8292271398010738
G-401,2749,1.3663456978729704,1.492172647613213
BT-549,16065773,1.5788570773866877,2.7705754522766948
OPM-2,11955716,-2.9191891869850015,-1.9340566734334192
NCI-H661,176870,2.3474624932942207,3.5611986143971968
NCI-H292,66577038,2.9683700205355765,3.0759533188738772
MSTO-211H,54143018,-0.309857947329572,0.914296592870473
OPM-2,3634881,2.0291765129520467,2.61550972579379
LOU-NH91,navitoclax-birinapant (1-1 mol-mol),-1.5910791983061243,1.7196444523435594
A-498,44607531,1.7098722083353044,1.6541470499122104
KMRC-1,2749,2.412459730094544,1.8876627506817898
NCI-H292,57519531,1.7489075965122454,2.936305345503207
NCI-H727,11404337,0.8145711342672778,-0.1378556130788977
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379,4.479794794815854
SNU-81,107985,-4.076050447844214,-3.3223610440098894
SNU-61,24785538,1.5668080683488936,0.8963165797287981
SNU-449,56946209,-2.472995255165521,-3.8937395067503275
KYSE-70,452548,2.3575041584151637,0.2523421384953292
BxPC-3,5280436,3.644569175052812,3.818886221345756
JM-1,409805,3.649428990507172,3.783591906705888
SNU-81,17755052,-1.02795410661762,1.2794251129172771
DMS 273,SNX-2112-bortezomib (250-1 mol-mol),0.148208176798338,-1.6286948024747212
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906,2.385791629277882
G-401,54618771,0.8582285882331511,0.846784010421911
LoVo,4788,4.577300245187766,5.776368803873978
A2780,24771867,-2.9740519428749055,0.6223937044332513
NCI-H292,4261,1.3935441456482582,1.9660877067573823
SCC-9,vorinostat-navitoclax (4-1 mol-mol),1.1894462341904075,1.1367884887628605
NCI-H522,2729026,3.0595997973682043,2.5910875525972625
MSTO-211H,448949,1.6774063902575909,2.11319233757374
BxPC-3,9825149,2.348819386499172,2.32246293566575
NCI-H522,44607531,1.4505766804532754,1.4156513751135478
NCI-H292,ISOX-bortezomib (250-1 mol-mol),0.5542499080925709,0.9182540533209749
A-498,1285940,4.242355519484504,3.658072905870486
BT-549,selumetinib-BRD-A02303741 (4-1 mol-mol),5.411757040622344,4.624230595515397
NCI-H661,44543605,4.030509034099432,4.0433701576358025
CAL-51,12003241,-1.2189714227076325,-1.0778537978430236
A4/Fukuda,135411,0.1560078623072997,0.24769948742971365
HCC1143,675434,4.285446752444937,4.553220135930367
CA46,11719255,3.04595311036835,2.347333103798332
BxPC-3,654092,-0.3546902897816355,-0.1813299653204664
NCI-H292,11238147,1.7384499640365698,3.06970575845532
LoVo,285033,-2.045623665035502,-1.7639709538005035
NCI-H1623,136227924,2.959018127447204,2.811291108524458
OPM-2,5329102,0.9197947820907424,1.4314415658232995
OPM-2,208908,1.37961789198716,2.108867999263058
MSTO-211H,124202324,2.766151060695559,2.6779307975367157
LOU-NH91,piperlongumine-MST-312 (1-1 mol-mol),1.9465172211690425,2.036982361185346
SBC-5,selumetinib-piperlongumine (8-1 mol-mol),5.086049517752745,3.359072328523151
SNU-81,55508,3.0035688840672767,2.8437835179781676
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.8750357937529921
A-498,24821094,3.8657770123239574,2.9557733774040065
DMS 273,6918736,-3.620580414510608,-2.33430130974786
JM-1,3062316,-0.5573937765637444,0.73611552377908
JM-1,56649450,3.7062904943567263,3.0863223890025786
SBC-5,24856436,0.2896075356546521,0.4272641974209029
BT-549,285033,-1.3520552126123144,-1.4488479567774375
OPM-2,5746,0.8583790934138843,-0.10570723121095621
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449,4.305957532181001
G-401,6914657,-5.660532663542792,-4.9189564179398015
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-0.8109781954548295
HSC-4,2858523,3.1192513569149245,3.171160814904587
NCI-H522,675434,4.236381328267226,4.368378757351529
CAL-51,25183872,-0.1080661998677032,-0.4873055026360533
BT-549,4259181,2.4625999028961743,0.3395637958808165
NCI-H522,11455910,0.4156799864056491,0.4885870401708881
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893,-0.12795635016429885
EFO-27,JQ-1-UNC0638 (2-1 mol-mol),3.1988831496339536,2.0623085713956057
NCI-H460,3543504,4.388423548450019,4.563113235201346
LOU-NH91,11626560,1.802766880846386,2.138068701789524
NCI-H522,2871966,1.782445654343025,0.397482294394602
G-401,135440466,1.822823734742602,2.290971372705631
A-673,10172275,4.325815901444083,2.795901559094132
LoVo,3385,1.4948122184820352,4.198667635106244
OVISE,BRD-K27188169-navitoclax (2-1 mol-mol),1.3102218056663513,2.3834956432529446
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259,-0.6338573163832312
A-673,637858,0.7164978632133837,1.462359698412265
OPM-2,4915,5.457147549775398,2.9181376917343833
CAL-51,11626560,0.7349282975065881,2.0013886965631844
NCI-H661,2729026,2.3445725854556696,2.6691696247546735
KMRC-1,25126798,3.86147373401716,3.644100829963857
KMRC-1,107970,3.035071998795665,2.609760672863666
MDA-MB-157,16219061,1.3123257474603047,3.4581435838824404
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121,2.7478153391747586
NCI-H292,erlotinib-PLX-4032 (2-1 mol-mol),3.1994790670479,2.8434870981483367
NCI-H2009,24964624,2.271229049936602,2.686792686731107
NCI-H522,7251185,1.2190943442977031,2.2555209274143433
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.3490920721729487
G-401,52912189,0.0594470173160698,1.5360023515363475
OPM-2,vorinostat-carboplatin (1-1 mol-mol),1.8335119611994213,1.8903359416149266
OVISE,702558,5.699669356311473,5.3985148017748665
BxPC-3,selumetinib-navitoclax (8-1 mol-mol),-0.6113329982147029,1.6718597237175978
EFO-27,54678924,2.818156902929417,2.205585042951705
LOU-NH91,44607530,2.1348137775706646,2.001981030514579
EFO-27,24180125,3.663788732934096,3.1430935032176803
NCI-H661,135421197,1.0600684669241136,2.00112067803419
MDA-MB-157,56963564,-0.5852778857487072,0.5918776838778158
OVISE,navitoclax-pluripotin (1-1 mol-mol),-0.9390281108513666,-0.35658628871606873
LXF 289,6505803,-2.367756082461904,-0.026418744815531775
SCC-9,navitoclax-gemcitabine (1-1 mol-mol),1.7873613384947808,-0.9048542844212875
A-673,5278396,3.572368012209165,3.402475168249187
MDA-MB-453,135421197,0.8806711164351635,1.9003865898720285
NCI-H661,11396600,4.301216087095742,3.945585271101321
G-401,148124,-6.018913106580182,-3.452608746596024
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884,2.535156557524749
SNU-61,208908,2.000237947522829,2.0909232306442727
NCI-H661,5329102,2.676948448482624,2.1924713797311908
NCI-H146,148124,-0.9007997951548676,-3.144302691610854
HSC-4,446155,4.1145986724492865,2.8058545067695753
NCI-H661,3825829,3.711058317012711,4.196697038172639
OPM-2,135411,1.0006691045824918,0.2673743157981771
CAL-51,3815108,3.0623029951861396,3.0064529419201524
NCI-H522,2858523,2.9817407099898676,2.9090005277429767
YAPC,2708,5.2324194580289065,5.140098345134073
Panc 04.03,4917,3.7974030923782274,3.217822350188355
KMRC-1,51039095,3.0507646213845008,2.7872862930411966
MDA-MB-157,44632017,-0.0621812067979977,1.2734760825830351
KYSE-70,613753,3.646356391333843,3.0363770886556063
OPM-2,11364421,-7.162542415885671,-4.390541121508787
KYSE-70,11964036,0.6479741930424838,1.2638319404359648
EFO-27,9915743,1.432055126276498,1.4557777058817565
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258,2.9374480448226183
A2780,9935249,1.4583070792637778,2.3079869302372917
NCI-H292,25105715,3.507158893285561,3.422536997294767
JM-1,5566,2.903571956440186,2.855445572180598
NCI-H460,16722836,2.818869820371906,1.8631480440604746
MDA-MB-453,71466380,3.4268898477848784,4.232698215551514
MSTO-211H,24753719,3.2448003358152286,4.357364694257917
JM-1,637858,0.5231851777275447,1.0720543939822842
MDA-MB-453,11152667,-1.4808178636693017,0.6154836439568321
HCC1143,44185566,2.5224843451498273,2.7839996323411937
SBC-5,53481919,4.872311947173971,3.8430000393127766
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834,1.9885736051443774
LoVo,3038522,4.270533501697307,3.416347853174195
OPM-2,5280436,1.5288125622159816,2.9203430132637247
A-673,71680916,4.0499723530429295,4.198100876098861
LOU-NH91,6610355,5.077923698507978,4.688570398385493
SW1463,10127622,-0.1211197806374188,3.4689148078960077
ONS-76,2126,3.999900921085769,4.4428198911700125
NCI-H522,53301938,4.938312106360689,1.5596794418538493
NCI-H2171,3552672,1.63504499488054,2.2638520770291035
SNU-449,375860,2.655390537146391,-0.11630903713398638
MDA-MB-157,54626689,4.568687551235484,4.62800871364758
KMRC-1,5746,2.0919022066371484,1.4019698370987301
CAL-51,24964624,1.6704816041215405,2.544284462992278
EFO-27,46199207,3.7203826311454096,3.3343251635870628
A2780,439501,-2.4090624878410316,-2.3486961833873634
LoVo,89183176,4.107889784939482,4.4890132763270465
NCI-H661,24772860,-4.399665014096174,-1.7483334800619277
NOMO-1,46224516,2.27353152393119,2.152522957894028
NCI-H460,5281672,4.99885948312363,4.497407375602683
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935,1.6065537527874587
OVISE,navitoclax-birinapant (1-1 mol-mol),0.2692297316447783,2.000050538739728
NCI-H460,9967941,4.030885542149613,3.8352451269399888
NCI-H292,44819697,-0.5623825720804246,0.163411359998902
OPM-2,216468,0.7655721379939343,0.9683760231467864
ONS-76,60700,0.0915142349819345,0.06776104497358654
YAPC,17755052,3.2330221121257874,2.0798515752775555
EFO-27,444795,5.488221670965637,4.717780037543361
YAPC,24797083,1.6153709299916277,1.4958425070844976
NCI-H661,51039095,3.3700376717556315,2.9890483972409276
MDA-MB-453,25154868,3.2796937080857296,4.135113327766984
A2780,decitabine-navitoclax (2-1 mol-mol),1.762746087507787,0.8302743808360492
KMRC-1,9911463,4.4126092990485395,3.768251510317027
NCI-H727,JQ-1-vorinostat (2-1 mol-mol),2.062672486797119,0.8266604522557117
G-401,107970,2.0352708529532824,2.1285275066884055
FU-OV-1,25195348,3.3767609447508846,3.5521472475973894
NCI-H1623,11234052,4.315313421055944,4.146538201369723
MDA-MB-157,151289,0.3130009139891556,1.2317163866501792
EFO-27,56973724,4.318199286965652,3.1394936172293835
NCI-H460,5328940,3.322075361136407,1.76892689360341
NCI-H2171,11964036,0.8555185627034467,0.8073468103358133
Panc 04.03,24821094,4.144896314615952,3.2448922247692225
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.4173295137067647
Panc 04.03,selumetinib-MK-2206 (8-1 mol-mol),2.306008489562984,2.4678372599718985
FTC-133,5280436,3.005172717589714,3.5781151171313117
NCI-H292,49766530,5.348764781206105,-0.452203349733142
NCI-H661,selumetinib-decitabine (4-1 mol-mol),5.0553831746033815,4.421596605183613
FTC-133,219104,4.114698267906641,3.783399115125614
A-498,BRD-A02303741-navitoclax (2-1 mol-mol),1.0685247130671895,2.474328131125196
ONS-76,6918736,-1.0728340962982743,-1.5337768371804261
A4/Fukuda,16065773,1.900447949816596,2.2809616235899095
FU-OV-1,25126798,3.715640842708804,3.7643525364083854
NCI-H460,6505803,-0.4074860596498978,-0.6687667971005606
ONS-76,44491742,4.314760532803232,4.396740339058907
MSTO-211H,6914657,-1.9341273237470331,-3.5218856265526597
G-401,136227924,2.3105932180874365,2.4148068618528424
Panc 04.03,148198,-3.912302089259141,-2.9516294815962
CAL-51,23725625,3.781531245600544,4.854391192525328
NCI-H1623,7251185,3.63742147878688,2.690888989744544
A2780,44589607,1.4452328541597397,2.605914041583854
A-673,675434,3.949120496105267,4.374858293611466
KMRC-1,25227462,1.6145893273286742,0.21956952321529846
BxPC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),1.732263513385207,3.646153559920441
HSC-4,2749,1.8453067540575636,2.2891262844009774
DMS 273,6438330,2.6669951536881182,2.053325239491807
KMRC-1,44491742,6.09620831621162,4.229028456576368
MDA-MB-453,3465537,1.8912554302439897,2.3643681327319515
SNU-61,156414,1.6812768260110038,1.295769585534786
YAPC,11625818,4.8006567630911094,4.424201630013543
CAL-51,9911463,4.251278022142156,4.046635011524657
MSTO-211H,68056272,2.8034566103574825,3.6367808464914306
OVISE,9911830,4.830872688345326,2.7782296451290387
MDA-MB-453,6917907,3.1299164846836796,-4.4730447941606295
SNU-449,9444,4.238096768887569,4.14555789037653
SNU-61,3062316,1.255261088163193,1.3138702549203303
A2780,11178236,-3.658526043242797,-3.3493758302388104
MSTO-211H,219104,2.9811404214526136,4.106958814768046
CA46,11364421,-6.636542851208846,-4.833164246615032
NCI-H1623,3689413,0.664737487618683,0.7982596437065463
YAPC,9907093,4.959151627500645,4.305049704299389
ONS-76,19582717,4.438276624405871,4.135348617298036
LoVo,446155,3.732759169917468,2.8407490504276405
G-401,5566,2.967754959970698,2.993118398520002
JM-1,navitoclax-PLX-4032 (1-1 mol-mol),0.5328133860295355,0.04715185716204209
HSC-4,9884685,0.6492053944574516,0.6344835176541677
CA46,4788,4.772802977698259,5.007126781072872
SBC-5,selumetinib-PLX-4032 (8-1 mol-mol),4.703781138829708,3.211751770702149
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.7518116480602428
Panc 04.03,6918837,-2.8853122799888085,-2.089219922247564
NCI-H460,71466380,4.4879606530616725,4.425208010975182
CA46,25183872,-1.226882585953409,-1.9656859913417208
NCI-H146,12001922,1.0892970499924846,1.622591853483571
SBC-5,11625818,4.225517908096314,4.199274526351802
JM-1,vorinostat-navitoclax (4-1 mol-mol),-0.3924776625427159,-0.1683020563081953
LoVo,2708,4.2308362163689415,4.835442341566309
OVISE,72193861,4.281646205908775,2.349203924985649
NCI-H460,16720766,0.8258921674033131,0.7006740619793799
LoVo,4378219,2.040258922351895,2.3232932929076773
MSTO-211H,24901704,1.657456360567008,3.6235064663951135
A4/Fukuda,4477,0.5783674149898913,0.513345135038462
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026,3.356697732101489
CA46,107985,-3.181693098398671,-4.089039090749993
DMS 273,JQ-1-MK-0752 (1-1 mol-mol),0.7328961203568959,1.21881432990528
EFO-27,19582717,3.374407024388894,4.585174200017632
NCI-H1623,15953870,1.9962949386047493,3.692674709187372
FU-OV-1,46199207,3.737847668041784,3.2085337399813443
A2780,11213558,0.737897067491707,1.55284470834858
NCI-H460,9926054,2.081701465030928,2.004436204951788
NCI-H460,11404337,1.7201854837770862,-0.3350039696108346
NCI-H2171,2749,1.9442537074322577,1.3973610722376546
HSC-4,49846579,1.975916395804951,1.5829838939441756
NCI-H2009,56963564,-0.2763231945711286,0.3917195488926105
Panc 04.03,3825829,5.002168928220905,4.214194669210038
HSC-4,5738263,3.918173826320675,3.4582857234461413
MDA-MB-157,9926054,2.0716850398098368,2.1566861084076248
OPM-2,50905018,4.056598853615348,3.458443156907307
BxPC-3,9915743,0.4274244099837221,0.7761843873117614
HSC-4,16725315,4.164866459292326,4.564891394287153
SCC-9,11175137,3.431057653368815,2.690261280981383
A-673,BRD-A02303741-carboplatin (1-1 mol-mol),5.048794854025553,4.089377717619227
NCI-H146,107985,-3.379993708562796,-3.6906141762072644
SNU-61,3689413,-2.128463404187725,-0.4197571055512839
KMRC-1,9903786,4.024109374851969,2.815945566361454
JM-1,BRD-A02303741-navitoclax (2-1 mol-mol),0.7492754152668983,0.7796798122513355
SNU-61,73707386,3.625444775073466,2.814303987317276
ONS-76,11238147,3.0900457426442864,2.607123376542898
KMRC-1,selumetinib-UNC0638 (4-1 mol-mol),3.730844045001738,2.9490303461653706
SBC-5,JQ-1-vorinostat (2-1 mol-mol),1.350348201689009,1.1148365762464936
MDA-MB-157,piperlongumine-MST-312 (1-1 mol-mol),0.2909221181293618,1.9130189747772608
OPM-2,44607531,0.9426576866563848,1.1706874302262051
BT-549,409805,3.826135579342285,4.966859090850505
G-401,6505803,-2.085126737120111,-0.5884339122809653
ONS-76,9866186,2.0020907987509657,0.864329321123184
BT-549,1641662,3.5282995747020514,3.6975253347134736
MSTO-211H,3384730,2.0695323326007387,3.1438144463039923
NCI-H292,439501,-2.469830491210978,-1.962229707741847
NCI-H2009,11964036,0.3874991337590915,1.6977614675869952
Panc 04.03,9840324,5.85151623174837,6.0006320768712635
NCI-H522,5311,1.356899837189567,1.1076423592704627
ONS-76,5311,1.4287655491580966,1.4747961174213444
NCI-H146,JQ-1-navitoclax (2-1 mol-mol),-2.878043275810858,-0.0306830974357207
EFO-27,24775005,4.127014722833266,3.842188834939126
NCI-H460,5278396,3.885794996406102,3.6747230404255675
NCI-H2009,23725625,3.8804106674125713,5.175385143486291
NCI-H146,25102847,3.053262776547781,2.4822157642747955
JM-1,11396600,1.6173586604508372,2.461458504703442
SBC-5,168312962,-2.5718885882949896,2.165371714692502
DMS 273,46215462,1.755765775691153,1.4135353513638784
YAPC,107985,-3.02393363080246,-3.3041072227171147
KYSE-70,5566,3.0340425256076813,2.8320169870247685
G-401,BRD-A02303741-carboplatin (1-1 mol-mol),4.945197636740216,4.256704199793285
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984,1.4005254317022096
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704,0.072947471906625
CAL-51,11404337,-1.4033364127444676,-0.2294034213515112
A4/Fukuda,25183872,-2.565081518812491,-1.7632593124473377
SNU-61,3815108,2.973673139417603,2.777076300099226
KYSE-70,11507802,1.463595053056406,2.0259539446407206
A2780,10296883,3.5268945611299927,3.7480439119877316
FTC-133,24797083,1.5806228477994335,1.4904539844373381
MDA-MB-157,122327,5.563359607134461,4.725311996165448
NCI-H2009,ISOX-bortezomib (250-1 mol-mol),0.5557935848602048,0.7219968421106309
NCI-H146,4378219,1.8118272794434884,2.1751232965920746
SNU-81,54143018,-0.9079963072010888,0.5796833286647654
NCI-H2009,49850262,3.4451640543988233,3.9031282925548614
KMRC-1,54143018,1.481383467839363,0.7186400047472649
NCI-H522,11507802,0.900021964921284,0.902316359960553
A2780,6438330,0.9178294762259074,1.7388977613456675
A-673,selumetinib-piperlongumine (8-1 mol-mol),2.5365769801397,2.6007630681849845
SW1463,82146,3.98984472956996,3.660685902663745
BxPC-3,135984461,1.8776729747018608,4.2984454522369155
NCI-H2171,56946209,-6.55665845628197,-4.586417869681127
KMRC-1,selumetinib-MK-2206 (8-1 mol-mol),2.4382383240498244,2.238870674617384
HCC1143,54619267,5.25191473393144,4.240744453827104
NCI-H2171,46907787,0.7633638606493435,0.8414853104155908
NCI-H1623,216468,3.833399887526913,3.6111270488471616
MDA-MB-453,9803433,3.6839578739817935,4.53257918173595
SCC-9,11955716,-2.333323067647372,-0.9015707847110974
A4/Fukuda,54619267,3.184419267966046,3.7122086279782307
KYSE-70,387447,-2.8804562370412765,-3.4436860302528136
FTC-133,135398744,6.510037604259866,6.485935180172056
CA46,2842253,3.7037662444842696,3.322595453697806
BT-549,12001922,2.460799936977109,2.0532217855234522
LoVo,107970,2.0597080136849795,2.1878970993574995
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.41696040123172
CAL-51,3385,3.064238699960593,4.27290738198279
CAL-51,375860,-0.3577134594482877,0.06222456606013193
OPM-2,3025944,3.8735985412418943,3.9322041133783046
NCI-H522,53325874,4.347038439567835,4.089611633747212
MSTO-211H,216239,0.7405720543436254,2.478938800266064
CAL-51,9868037,3.5441777448678615,3.3843041464212553
A-673,49836020,4.096681472773702,3.3736653272668193
SNU-61,erlotinib-PLX-4032 (2-1 mol-mol),3.033607579022277,3.223917300187578
LoVo,49836020,1.6927786584323,3.530118261362395
OPM-2,5291,3.3293230980723254,3.3562062773662467
LOU-NH91,9884685,4.047485572984955,0.6833896780421088
HSC-4,36462,0.7755986988683452,2.309792724378254
SNU-61,46907787,2.0753699666277936,0.8745665731268456
NCI-H522,5951923,5.621144710124551,3.5928248488694963
SBC-5,445091,4.3721050746953845,4.360818006885201
MSTO-211H,6252,0.7966303392140095,1.2854583232610464
MSTO-211H,6610355,3.5448971464264507,4.460727546066479
DMS 273,selumetinib-MK-2206 (8-1 mol-mol),1.7350778472906083,2.2005003423405634
CAL-51,15953870,3.220977372988981,3.5475412981519368
NCI-H460,25150857,3.536831166282903,2.5540865976593956
DMS 273,3854666,0.530051590236263,1.201109922612893
LXF 289,9825149,1.6285560242869113,2.213700302340736
NCI-H522,67156097,-2.1513446238308656,-1.5191132210794998
MSTO-211H,3062316,0.3213577633457804,1.0666027879810556
LXF 289,11485656,2.2610473771175847,2.5548461991072737
BT-549,4477,0.6326595549350394,0.6460950828686562
NCI-H2009,54454,1.843451372115344,2.580401340708241
SNU-449,16013152,4.866412327860677,4.250107076739192
SBC-5,16115403,-4.662279180425711,-4.044048068574385
A2780,2842253,3.957240977141399,4.052996648437074
MSTO-211H,135398516,-0.6247457561994184,2.002382215773583
NCI-H146,navitoclax-pluripotin (1-1 mol-mol),-2.9432727760472326,-1.0433985893333457
YAPC,702558,5.05880400043124,5.402473901244033
MDA-MB-453,409805,5.496183153122164,4.591860885588975
G-401,25161177,2.410029759496817,3.716582721080121
A4/Fukuda,3025944,3.254701794903189,3.9726388909088355
NOMO-1,126941,-2.339513844414448,-3.3811208726691633
FU-OV-1,159324,3.7929038817112746,3.3692343244850083
MSTO-211H,2113511,3.4014041807223228,5.816081583140528
A4/Fukuda,1242560,1.4412010240031818,3.0615351100168424
OPM-2,327653,2.4944005218311984,2.725886596595576
HCC1143,navitoclax-pluripotin (1-1 mol-mol),0.3469367515592647,-0.6223034008931009
KYSE-70,46398810,2.5990171625416916,2.664170877521201
MSTO-211H,44486219,3.5621328730435216,4.268207069731236
MDA-MB-453,6450551,2.407686053683273,2.460756215517857
A4/Fukuda,24180719,2.900503133545593,3.2391665158165726
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416,1.7161975983311242
A4/Fukuda,11234052,3.83864189929063,3.1420370904109594
ONS-76,10231331,-2.145918525616272,1.8908191513351382
JM-1,11656518,1.5501827619920003,0.3577750755697579
SNU-61,ISOX-bortezomib (250-1 mol-mol),1.4968983788663748,0.7420710464363672
EFO-27,16741245,5.191473652546265,3.8901498244283066
DMS 273,216468,1.1199955960897896,1.2762013962897663
MSTO-211H,3689413,-2.1873545800685865,-0.25778062507457744
NCI-H727,10074640,3.0722260002613697,3.27999858553769
BxPC-3,66577038,2.7392816080167117,3.08174191432688
OPM-2,44489675,4.196628172603179,3.8566569905609525
A-673,1239801,2.654695998337671,3.4931708494064595
G-401,9444,5.739332402240228,3.8109680426496824
NCI-H661,SNX-2112-bortezomib (250-1 mol-mol),0.017075608398325,-1.007496381814161
KYSE-70,71466380,5.08916461895765,4.582749128183474
NCI-H460,3025944,5.476008686130055,4.117252904866053
OPM-2,375860,-0.7230228450862618,-0.4467792867646705
G-401,262093,2.911602765721858,2.4030096920074255
OPM-2,12001922,1.1641343868089369,1.584297198257849
SCC-9,9903786,2.6448761987997917,3.014942365343474
YAPC,1750826,2.252131937951327,-0.37745537399679774
JM-1,9840324,5.823306366003189,5.431513616767303
SNU-61,4705,2.600761934037586,3.1037399461437656
HCC1143,24821094,3.095995819095247,3.053795785163495
A-673,JQ-1-vorinostat (2-1 mol-mol),0.4793000681263289,0.31527684002351253
HSC-4,15983966,0.1445652725334258,-0.6215382001556286
MDA-MB-157,9887053,3.277628039368057,4.168664877767381
KYSE-70,969516,2.5944329315988552,2.9798132182868455
CAL-51,135421197,1.6266864976107616,1.8359869411099594
LOU-NH91,11175137,1.9157928307161511,2.849090349315388
NCI-H661,168313047,3.0111797961595523,2.465863392976391
Panc 04.03,16659841,4.736684370351261,4.072259091100194
KYSE-70,16720766,1.38091635176305,1.2136979832055959
SNU-449,BRD-A02303741-navitoclax (2-1 mol-mol),3.897294679895557,2.6705190744811604
NCI-H2009,9911463,4.220122302208283,3.884959807659717
HCC1143,selumetinib-navitoclax (8-1 mol-mol),3.081871684463836,2.3068222156289777
MDA-MB-157,44491742,3.772080854170876,4.38873327548417
A-673,216239,1.7434495050319987,2.1894682249369235
MSTO-211H,9967941,1.8027522151796112,3.920034416066962
YAPC,3815108,3.3369752363492315,3.0253524555182407
MSTO-211H,73707398,0.6990065379334892,1.6338983976765433
NCI-H727,4788,5.448581481072406,5.620928732591254
A2780,9911830,1.8386970616579583,2.1661267537766276
JM-1,3038522,1.6953465924304043,2.5082098608266143
FTC-133,107985,-2.14591043360211,-3.326156374863009
NCI-H727,3503,3.7902677592538265,2.3969759955676335
ONS-76,selumetinib-navitoclax (8-1 mol-mol),-1.4029292063040089,1.8627936779387735
KMRC-1,24771867,5.5206603877823275,1.7280480226825328
KYSE-70,3634881,3.4536977245329363,3.4287945423374104
SBC-5,119607,3.910029744126627,5.313187837720592
NCI-H292,serdemetan-SCH-529074 (1-1 mol-mol),2.3213297405207083,2.352533113630743
Panc 04.03,5329102,2.9853977590279075,2.202571723309714
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457,2.047705753298654
A2780,9826308,-0.0101157672837292,0.29250923502115184
HSC-4,135440466,2.2202939224472655,2.2740858151658774
NCI-H727,6917907,-5.56846167215282,-4.641204223920095
MDA-MB-157,123631,3.9412563374531864,2.452134399317867
MSTO-211H,11640390,2.078497045728262,3.799396275089154
OVISE,54649381,4.33420809644373,3.7340522905667752
MDA-MB-157,9868037,3.2071579521245823,3.437182139130756
A4/Fukuda,67291369,-0.3870993856905487,0.8115427021885583
A4/Fukuda,10113978,1.900139268592958,2.615910509029382
KMRC-1,doxorubicin-navitoclax (2-1 mol-mol),-0.3990728174038296,-0.7941498333938668
A2780,46199207,2.4758344041689093,3.1796830721124043
NCI-H2009,151289,0.8401149520435854,1.2119503539533012
DMS 273,4477,0.2378478748071137,0.5054564228959488
HCC1143,6852167,2.667487538311212,3.1136808574303423
NCI-H460,5335621,5.645903220513178,4.470136891123392
NCI-H460,54613361,2.8642714411834502,0.006644143747619346
A2780,6852167,1.374383856311773,2.5678068181674973
SCC-9,11707110,2.5707994933885736,0.43605399177100745
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831,1.9229446300044948
MDA-MB-453,BRD9876-MK-1775 (4-1 mol-mol),0.1986827293321165,0.6945976644884602
EFO-27,6610355,3.735872349212987,4.52127532036878
ONS-76,navitoclax-piperlongumine (1-1 mol-mol),2.7557969357291476,1.5328311648777848
OPM-2,16038120,-1.581922980476964,-0.047448667922458894
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622,1.9647357065726558
HCC1143,10410894,4.771687149558392,3.522445965658113
YAPC,54454,3.200830039856186,2.8535444096342086
DMS 273,6252,1.7538621935564394,-0.4904272873261689
SCC-9,doxorubicin-navitoclax (2-1 mol-mol),-1.5026968555435367,-0.644541953994344
G-401,44491742,3.951665256591854,4.072641966332358
DMS 273,11625818,4.382645377089847,3.6847373139098103
LOU-NH91,3503,2.9647844947930397,2.468942979052771
G-401,446155,3.2535633304842144,2.6762274590129453
DMS 273,675434,4.24768091674901,4.273963979036563
Panc 04.03,erlotinib-PLX-4032 (2-1 mol-mol),4.205995552769646,3.137901248630149
YAPC,ISOX-bortezomib (250-1 mol-mol),1.2420544087730638,0.7539261425715865
Panc 04.03,168313016,6.087789512449841,5.033906629746638
NCI-H1623,24856436,0.944997546799197,0.7322251955729088
ONS-76,ISOX-bortezomib (250-1 mol-mol),0.2723721998746015,0.5995581592157432
LoVo,3025986,-0.1762115912359206,-1.0134269734837857
A-673,10184653,1.446453264453446,1.164970699217615
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633,2.2631363782793867
LoVo,66577038,2.852951614414874,3.1084107374313343
NCI-H522,3136844,3.3827652175643577,3.922910153554785
A-673,3676137,4.749608800479587,4.278427292983663
SCC-9,409805,5.497565328609373,4.896024110855493
DMS 273,6918328,-1.955094157059326,-0.43039034087126515
LXF 289,4259181,0.8555931132792622,0.3316838343066422
OVISE,448949,2.233154508177948,2.1590324318881304
JM-1,675434,3.7844228868956296,4.093906010590677
NCI-H292,5566,3.044146869319611,3.0298972962289796
EFO-27,227681,1.958013080406725,3.7150323091729405
EFO-27,65064,5.385038331959097,5.083424373205177
A-498,9907093,3.786767310891997,4.25542312427098
SNU-61,676352,2.4274144006766893,2.2821695922007077
MDA-MB-157,135421197,1.265960780615991,2.0312657632876867
NCI-H460,10074640,3.83137833519258,3.2041338501324876
BxPC-3,46199207,2.8626203608628416,3.1537191726623734
CAL-51,387447,-3.720200693098244,-4.342679993248004
NCI-H146,56946209,-6.937271673290349,-4.231277512652474
EFO-27,46907787,4.067144836646944,2.6727418182901834
NCI-H292,2729026,2.9142630754738037,2.7729450142577345
LOU-NH91,1716436,1.3649900096390022,3.2518127112665827
KMRC-1,8515,4.713762602344707,3.8971741211680335
MDA-MB-453,crizotinib-PLX-4032 (2-1 mol-mol),2.6505270517489596,2.1462309742598613
SNU-449,448949,1.5810053045793695,2.219899386091014
SBC-5,4096211,1.588189246491771,2.3590625081016725
NCI-H661,26596,-0.5563822784391794,-0.8592083111099872
A4/Fukuda,51037431,0.9928208538339424,2.812883382793243
HCC1143,doxorubicin-navitoclax (2-1 mol-mol),-0.0488581620418106,-0.7646823147868761
OVISE,5311,2.608797421965248,1.7232778446293435
A2780,11238147,1.47132390494783,2.528118807000653
NCI-H1623,676352,1.987229853680802,2.0406579215378424
Panc 04.03,126941,-1.1535511280443094,-2.0017354131018674
NCI-H727,9926054,2.0492739470784445,1.947740882346367
LoVo,65064,4.389937632551182,5.082884841339323
SNU-449,52947716,1.9936156354056855,0.4991566276139129
Panc 04.03,5351362,1.307383541492636,1.9819769983071738
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355,1.2601165296719543
NOMO-1,44493952,3.580250185381126,3.250373156928812
A-498,676352,1.77005199556574,2.2304731272075706
Panc 04.03,5280436,1.6844699655115762,3.8007554273394146
CAL-51,16736978,0.375988055286384,1.808108577393011
MDA-MB-157,54618771,3.1146330047846877,1.6257397625398788
NOMO-1,6450551,1.2307950565416117,1.2587625090262877
MDA-MB-157,tretinoin-carboplatin (2-1 mol-mol),3.238516076449109,5.094731180350456
G-401,25105715,3.9034348367564258,3.176885535303091
BxPC-3,151289,0.5689607060021993,1.1427176781077317
NCI-H727,44543605,4.300237824274415,3.7325479760867313
SNU-81,2907,6.641268536629272,2.3070963478373785
SNU-81,613753,2.2388707005796507,2.8939573371209626
JM-1,168312962,1.22629450044224,0.4072120335164472
LOU-NH91,168313200,3.810508485111527,2.9476332352235413
NCI-H146,3854666,1.3221451848305394,1.563396572051395
KYSE-70,322968,3.381611542483835,3.892700933202578
ONS-76,241158,4.846225597872182,3.7096993217690266
SNU-61,selumetinib-PLX-4032 (8-1 mol-mol),1.220990708913243,3.124286576856247
KMRC-1,JQ-1-vorinostat (2-1 mol-mol),1.4567711420543266,0.913588183073759
CAL-51,5291,4.8235616489491635,3.6114359935924347
SNU-61,SNX-2112-bortezomib (250-1 mol-mol),-2.113975984395572,-1.5709838884945488
MDA-MB-453,168313016,4.163913885489913,4.827992162553236
A-498,60700,2.2087582051541257,0.6073403380609617
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609,5.133340089020563
HSC-4,6918878,5.2813290465493505,2.995859526696638
MDA-MB-453,9884685,-1.4419247946131482,0.3201952916080991
A2780,2746,1.939184711313242,2.6148393978905817
NCI-H661,148198,-4.235070372495308,-3.482719172827297
HSC-4,54678924,3.092091974621669,2.1969963704355657
A-673,2113511,4.0082027727586,5.163450034370646
A4/Fukuda,5287620,-3.30087759062066,-2.1849347673780324
SNU-449,selumetinib-MK-2206 (8-1 mol-mol),3.758556004242712,2.7921282095189115
LOU-NH91,6918328,0.1478473020386815,0.37081263287651334
BxPC-3,3385,3.820290029267426,4.3075391134793986
MDA-MB-453,44185566,2.487729821066063,2.2979385276067124
LXF 289,46907787,-0.1426698074457199,2.905742583429065
EFO-27,piperlongumine-MST-312 (1-1 mol-mol),1.300459178940563,2.097452135441716
EFO-27,9887053,4.025142225668377,4.217750821990863
BxPC-3,4259181,0.1397018777458316,0.5593236744997805
SCC-9,10184653,-0.319006591471168,1.3033710833435017
SNU-449,53232,1.6560937312011326,2.6029423628544364
BxPC-3,53232,2.859321527409702,2.7602696642514952
NCI-H460,71304818,2.359856693071434,2.577583549855534
NCI-H2009,11178236,-2.605718631753464,-3.363567742927295
FU-OV-1,400769,0.1189863997269066,-0.2903534385440088
NCI-H292,vorinostat-carboplatin (1-1 mol-mol),3.668554918362719,3.551001399706736
FTC-133,72376,-0.3430893294901544,-1.3209659135337628
LOU-NH91,2858523,2.98680776080117,3.090783366856249
LoVo,6918837,-3.586713596901602,-2.8538856449546905
SNU-449,erlotinib-PLX-4032 (2-1 mol-mol),3.286095103916852,3.2649605351932043
CAL-51,6918837,-3.0563476396929703,-2.8317537212743082
NCI-H292,676352,2.616071543582294,2.259911608186446
NCI-H522,11626560,2.464867345362881,1.4547681379999546
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526,-0.9223067566909997
A-673,11167602,2.442600782118551,2.1451440074208707
OPM-2,11222830,0.0961911151739945,1.4536392965234226
A4/Fukuda,7251185,1.076285820033946,1.7820314609742667
OPM-2,24978538,1.9225155298388676,-0.37318493010930476
CAL-51,135411,0.595745817277345,0.6940980221797717
NCI-H2009,selumetinib-tretinoin (2-1 mol-mol),-1.112372565869968,3.455358176189224
HSC-4,3025986,-1.9523671858491285,-1.0259338818857353
BT-549,54618771,1.4883156908959423,1.7557702465711922
DMS 273,1239801,5.369367906855259,3.2652980118130075
SNU-449,374536,4.370390285639732,2.287998068356481
MDA-MB-157,168313016,4.249309770188466,4.512851907633777
NCI-H522,446155,3.2752737209903504,2.531410974017284
BxPC-3,9935249,3.9268263105803727,3.292904978664246
A2780,16725315,3.2354385253964253,3.8043227502000683
NCI-H522,11647372,2.460433695225771,0.7533153098725142
MDA-MB-157,3689413,-1.567220624306923,-0.217129418317153
NOMO-1,36314,1.6795260413615891,-1.3804638343327298
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.059432900039127004
ONS-76,46199207,3.062888044588984,3.27960134155559
HSC-4,2746,3.845189406581069,3.1708535599189043
A-673,126941,-4.88778992999732,-2.9188021853820745
A4/Fukuda,2874250,4.0164309105299685,4.512158793505225
DMS 273,navitoclax-piperlongumine (1-1 mol-mol),2.7902567268334786,1.002344865865412
Panc 04.03,3136844,4.698465140769799,4.413001190071178
KYSE-70,53232,3.7067207893488017,2.9574114357899592
CAL-51,24180125,2.8082301472193203,3.0800515094915806
Panc 04.03,9884685,1.6842032304446288,1.0497311127704232
NCI-H460,11626560,2.497647926194901,1.9820838613043796
SNU-449,168312962,3.745202246753347,2.2873246872779083
HCC1143,9935249,3.8757786370374303,3.375997435764501
SNU-449,613753,3.229445182846538,3.3572884656201563
OPM-2,44491742,3.727542800888903,4.0072042972266235
KYSE-70,9936388,-4.915846401119174,-0.9439808248196273
CAL-51,654092,0.82886283906252,-0.1375456663216184
SBC-5,448949,2.9920694717704204,2.1326513461406815
OPM-2,46843906,-0.5330027912440064,1.4624534510698433
CAL-51,5566,3.271951139375183,2.96244783468576
KMRC-1,53232,3.79650380515527,2.862831077119412
CAL-51,11228183,3.6770505489909007,2.532895119908106
SW1463,24785538,0.6322996420886741,1.0581042921001602
A4/Fukuda,119182,-4.160589878424858,-1.9957407713708326
A-498,107970,3.0044685679861054,2.335731274635965
CAL-51,11612883,1.9359641259018452,2.7454631107910723
A-498,11317348,4.2355090436144875,3.278487190000453
LoVo,67291369,1.4516021942624118,2.8817725773401754
A2780,11222830,0.6433638933511314,1.357510732209315
BxPC-3,241158,3.755569293331497,3.9235449611932403
SCC-9,6610216,4.4695629784882795,4.309050053928515
CAL-51,374536,3.1977545561189347,2.118465868590985
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296,2.3129058724159033
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942,-0.5205922118129103
SNU-449,72376,1.1438392823146497,-1.0945423178751152
A-673,4259181,-0.6373852614685119,-0.21952005480247205
DMS 273,168313200,2.725135044490621,2.8173515990439655
NCI-H460,9911463,4.421747687015995,3.796283531024344
JM-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.988694058348957,3.9470554404045193
YAPC,119182,-1.6155541294016968,-0.17323508889346637
SBC-5,6184667,2.5027552360756946,3.1082029395354294
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326,1.8856672539122084
G-401,2858523,3.0226653633513,2.931129586075586
MDA-MB-157,10184653,0.5581112583171038,1.3606780694878449
A4/Fukuda,19582717,0.7629696429231957,2.949693827611834
NCI-H460,53392493,4.733063337287369,2.869140764830229
OPM-2,72193861,0.7906161175639799,0.2816967521067664
NCI-H146,44491742,2.6808030102351323,4.210088812032706
NOMO-1,46398810,2.1682472320454504,1.9151020701697048
DMS 273,16736978,0.9096800466601204,1.4112668989646613
NCI-H292,navitoclax-piperlongumine (1-1 mol-mol),2.359221869060842,2.100784321081334
CAL-51,16741245,4.222373420591208,3.924501071717737
MDA-MB-157,10074640,3.629475203970288,3.310426851591213
SNU-449,2828334,6.138780539354761,6.253078391956404
HSC-4,9823820,4.434899642824078,4.003565722060453
A-673,11238147,1.6374380314183412,2.5372176326573164
EFO-27,selumetinib-PLX-4032 (8-1 mol-mol),5.056777545277596,3.884464865314186
A4/Fukuda,4915,4.811112690158961,2.8047143469067355
JM-1,42642645,-0.9084434189288264,-0.1921209480234764
MDA-MB-157,3854666,0.668628762558335,2.2110645169230465
SBC-5,2841722,4.592516057239796,4.2745444801686805
BxPC-3,2742550,6.208235416241253,3.742943077418823
NCI-H2171,168313200,1.615164123973231,2.670895165257085
LOU-NH91,46843906,2.60442098689998,3.2236522640393583
DMS 273,54619267,3.628421853226673,3.8748913182771925
CAL-51,16725315,3.2794500362302,4.0922467132052995
MDA-MB-157,10127622,3.2546864424502076,4.16153968295056
NCI-H2171,16725315,3.053630151756443,3.6000524857266885
SCC-9,9935249,4.690276947265519,3.2405077017456785
NCI-H460,44507138,4.578042897326484,2.5079507265693763
NCI-H1623,5282054,3.865413044747809,3.8989217804975937
HCC1143,984333,-0.0539665216618622,0.7096047557225272
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309,3.573340177363008
MDA-MB-453,9840324,6.873328025428986,5.85703935126524
Panc 04.03,176870,4.897846724128431,3.5348337663587173
NOMO-1,11640390,1.5691640408186416,2.436889858120781
Panc 04.03,409805,5.536204895331733,5.261811898570785
MSTO-211H,71466445,2.2675767772231024,4.185869581886115
NCI-H2171,9915743,0.832341910278816,0.7799678639024876
A4/Fukuda,5281672,3.917758560865086,4.310034119203425
LXF 289,11427553,2.4541082171467368,2.7840722541072056
Panc 04.03,7251185,3.2944683029692237,2.9166636058766215
NCI-H522,9933475,1.020852520604034,1.8738257905076288
JM-1,24180719,3.5833576580940005,3.122381112246369
SCC-9,15953870,4.1491811794097995,3.5360334681120666
Panc 04.03,56946209,-4.443392589569815,-4.0575044691356315
BT-549,6918837,-1.3661230802503712,-2.201904570301731
ONS-76,56946209,-3.559106939272703,-3.7122749723828803
OVISE,44507138,4.185704551553473,2.643292597205903
NCI-H292,441298,3.4530013870499037,2.5865256037964657
EFO-27,374536,3.468329704237433,2.3644928008354533
NCI-H292,568763,1.0095796953036382,0.5064301816925296
NCI-H522,122327,3.7548997428021904,4.536609361009853
FTC-133,409805,6.0297974484260655,4.9360114142589575
KMRC-1,3384730,3.706671423221143,2.879732940510085
HSC-4,5351362,1.6988999536887646,1.435501800445764
BT-549,448949,1.6914375683866394,2.1708579855451258
JM-1,753704,3.307600856766594,3.9344014324557888
CAL-51,25195348,5.6667768045179905,3.326098897211334
CAL-51,3025986,-1.0834382414923172,-0.5622120712167523
HCC1143,15547703,3.062266000318877,3.3635149129556394
EFO-27,navitoclax-PLX-4032 (1-1 mol-mol),3.1574015935029083,2.3062435006758917
CAL-51,135999136,4.2132345103647015,4.1119466044226725
ONS-76,55283,0.3588409196586273,3.0271243294591756
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.2948188113994552
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485,2.240229964271075
SW1463,25262965,-1.5690747748042335,-1.2502159561355897
FTC-133,241158,4.091507154193835,4.094137955687104
KMRC-1,23582824,0.9449566223543509,1.1510206456617547
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086,1.0262769161448924
FU-OV-1,16013152,4.2048953133679765,4.208837041612216
MDA-MB-453,613000,0.0740651651217389,2.4499153874601527
MDA-MB-157,24797083,0.6098010922803769,1.5090182261451215
NCI-H460,10074640,3.83137833519258,3.2041338501324876
CAL-51,16722836,0.8083581946159574,1.5092724758423497
NCI-H146,tretinoin-navitoclax (4-1 mol-mol),-1.851053903762128,1.6207111059180805
G-401,BRD-A02303741-navitoclax (2-1 mol-mol),3.4869097822802915,1.3932413526899166
G-401,10322450,4.220475308231234,3.5156053982323443
G-401,15983966,-4.354524639754001,-2.6933108482102686
CA46,9887053,1.048475441216289,2.242035058991335
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035,4.7009558477809295
NCI-H1623,11152667,-0.7587975819891684,0.12803851791286155
HSC-4,11609586,5.018303752842559,3.03824837154886
OPM-2,67156097,-3.031514601372161,-2.071803981703496
G-401,984333,0.0612358592539302,0.41934408507416715
LXF 289,9908783,5.689655754809611,5.050742493393045
SCC-9,5329102,2.2394800798474677,2.1401388946652182
NCI-H661,17759555,2.3282310316349935,3.6695101253335793
LXF 289,24856436,0.8419130403195528,0.6608037885811946
SBC-5,159324,3.4028835437957112,3.1477990788746557
JM-1,6184667,1.7187669889057045,2.548499465847602
MDA-MB-157,11396600,3.7386973485738424,3.89556931893981
BxPC-3,216239,2.4917493719892274,2.4084363066959105
MDA-MB-453,72193861,1.6700607918257404,1.8002178716052029
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049,2.7268340587246165
KMRC-1,9915743,1.4003501061845525,0.5736068858342035
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863,1.6003767704347962
A-673,12001922,0.9671300191794728,1.6771089125848235
A-673,1323703,5.495685082034704,1.9232002974034073
SCC-9,2729026,3.0647326637868573,2.780304061542777
HCC1143,navitoclax-piperlongumine (1-1 mol-mol),1.8457079169425925,1.9919505149983365
NCI-H2171,3503,1.152076889590999,2.1854555983185406
JM-1,252682,6.042634536055517,6.605412672354781
CA46,44137675,2.206940954689562,2.8613123037447132
CAL-51,11152667,-1.203722258692511,-0.16117819576287082
LXF 289,135984461,4.539632657840611,3.6085341370684585
EFO-27,docetaxel-tanespimycin (2-1 mol-mol),2.492630012164076,-2.642081178096416
SW1463,11507802,1.438199099446833,1.4243286458747888
BxPC-3,25062766,1.590701824067561,2.169853777760369
EFO-27,45279963,4.232301991437958,3.8874447840009156
G-401,selumetinib-MK-2206 (8-1 mol-mol),1.699600486285741,2.0142778421780934
NCI-H2009,42642645,0.1491359953679814,1.0386556542082168
FTC-133,53495165,1.6157050027500164,1.147771586367214
NCI-H292,11640390,3.2514062698758015,3.8190394928444773
A-673,135423438,2.29660224903782,1.5527076323607825
SBC-5,9911830,3.21689826570876,2.6477341627181286
MDA-MB-157,36314,-4.695989096441824,-0.7746440516093148
NCI-H1623,5328940,1.639592653942716,1.725825363442954
SNU-61,135999136,5.618921387112628,3.184542790490633
CAL-51,25102847,1.94226811064499,2.287884855595305
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037,2.633225811084293
A2780,68056272,2.2410901197134923,3.3416133423640972
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814,1.4710611419557074
KYSE-70,24856436,0.5719980221753466,0.5355476023233815
CAL-51,46398810,2.084696284876613,2.625879782339065
NCI-H661,16720766,3.873672796747104,0.505519058483654
LXF 289,11234052,4.719623128458786,4.426900642897512
NCI-H146,selumetinib-PLX-4032 (8-1 mol-mol),4.7955071162055,3.4597459692859722
MSTO-211H,107970,1.929708493397844,2.513752999150735
MDA-MB-453,9929138,5.862527790185705,5.496902746528928
G-401,285033,-4.902412101243927,-2.4125988710328956
OPM-2,6852167,1.7172653102666242,1.9532488134342656
EFO-27,11228183,3.371245966973651,2.7878369195204793
CAL-51,17759555,3.5733302595078182,3.46657978025504
SCC-9,24785538,2.4612574042553432,2.030045321685745
KMRC-1,11364421,1.724167601186248,-2.015655819738054
MDA-MB-453,24748573,1.9919110400088051,2.307145062971465
EFO-27,5460769,4.47484627366887,2.615383303416761
HCC1143,49850262,3.2153342375189533,3.8700451617654426
Panc 04.03,66577038,3.1738099516277667,3.168403270401953
NCI-H661,11238147,3.129195095759777,2.9869766251571037
SNU-61,6623618,1.73773822434396,2.4071217780168093
EFO-27,16720766,3.656433318818957,0.6886321524691961
BxPC-3,969516,1.4378873066513898,2.806745745788626
JM-1,54596558,3.768195826371459,3.94863674667734
LOU-NH91,5738263,3.7277759973822726,3.549350143851263
JM-1,25183872,-4.29494207596009,-1.8304906262853715
NCI-H292,89928392,1.456532385863884,1.757026567144842
NCI-H460,119607,4.735621464768821,5.159179445742001
NCI-H460,322968,5.369771337760045,4.146368042852625
MSTO-211H,navitoclax-sorafenib (1-1 mol-mol),-1.757065878159517,2.119004298399045
CAL-51,9907093,3.7886359098281783,4.1478301409564775
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,5.0474051858179365
LoVo,123631,1.2882244486240189,2.293441547165243
NCI-H661,crizotinib-PLX-4032 (2-1 mol-mol),2.1767708357401188,2.0228218248233722
MDA-MB-453,15983966,1.8434310309669164,-0.5101898033447958
A-673,selumetinib-PLX-4032 (8-1 mol-mol),5.680938960321501,3.6676872417795345
HCC1143,135440466,2.588436572703006,2.55523854534067
NCI-H146,9926054,1.7480459470636802,1.8142396490968726
KMRC-1,5278396,3.6212610119500783,3.7399202130263705
A2780,46191454,-1.192769752942619,1.201881352482832
A4/Fukuda,25062766,1.3929374396347198,1.7547236009062548
NCI-H292,53232,1.814131755875953,2.888443466968235
ONS-76,24771867,4.286887453999452,2.2759840142779297
FU-OV-1,31703,-1.7023718917237094,-0.49412753456697855
A4/Fukuda,66577038,2.118562328013949,2.641550316481577
NOMO-1,445455,4.303833401854377,3.8907907427795565
NCI-H2009,12003241,-1.6852069192913937,-1.1132605857330469
LXF 289,42642645,0.485507292149712,0.8804697073247195
NOMO-1,46199207,2.5514936314753434,2.6639135279503665
NCI-H460,322968,5.369771337760045,4.146368042852625
Panc 04.03,5328940,2.517395347800957,1.8788037336960375
SNU-61,9936388,-6.308071034865157,-2.306948129189786
LoVo,4261,-0.8211989197292223,1.6093694332187802
A2780,136227924,2.141563547945887,2.630639347917437
DMS 273,11175137,1.5448586489611442,2.3802912854415794
LoVo,44202524,1.5416570481285088,1.9501325536085983
HCC1143,9907093,3.794716934303189,4.244717721250391
NCI-H292,6610216,4.846288432835765,4.407789583502435
BxPC-3,11178236,-3.5754762678880567,-2.9785126170089193
MDA-MB-453,5978,-2.563797038396111,-1.6540537712707546
NCI-H146,5460769,1.8747395178404,2.7990680839200404
CA46,11238147,1.5462987380530164,1.8623897417054431
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063,2.5454947486278523
LoVo,2828334,5.515630519838643,6.129640960240145
KMRC-1,5287969,-1.8174868244268352,-1.853862816118164
NCI-H460,676352,2.985829219207002,2.2167135749874256
SNU-61,23635314,-2.2430318809352556,-1.968690707011541
NCI-H460,11612883,2.88158995470921,2.8675088421685673
HCC1143,24951314,0.9489239510798212,1.6131181550621774
OVISE,387447,-4.037756707187744,-3.6588429088934147
JM-1,568763,-0.4685251193741573,-0.2441511019926766
SNU-449,9907093,4.078651849005814,4.388168754497476
BT-549,53392493,1.9491955503491856,2.812721587112853
MSTO-211H,24180719,1.9210037149309027,3.734180133351089
NCI-H1623,23635314,-3.504391783968502,-1.4711078927412897
MDA-MB-157,135875424,2.7117106005077276,3.945959657383516
NCI-H661,54678924,1.9600004323573317,2.182855085410877
DMS 273,25105715,3.6490952941772496,3.2470036123289416
NCI-H1623,216345,4.517328735854535,3.989907434525414
SNU-61,5282054,3.0015154117441996,3.3585963085437256
SNU-61,10302451,2.848073588995495,2.9644157088153444
CAL-51,16720766,0.5416929462446769,0.1316246796921092
ONS-76,BRD-A02303741-navitoclax (2-1 mol-mol),3.993242759783489,2.6012985793402446
OPM-2,selumetinib-decitabine (4-1 mol-mol),0.7585781361547917,0.3881278450415702
NCI-H522,46398810,2.2314734558486053,2.225210287130096
JM-1,67156097,-2.627968736143573,-2.3080301026697536
LXF 289,60700,2.2902498510351528,0.11029864866504396
BxPC-3,2945648,3.219283504871713,3.2024449572573412
A4/Fukuda,65064,3.1077716650538707,4.1720067155317295
NCI-H292,tanespimycin-gemcitabine (1-1 mol-mol),0.0441766051027791,-0.5706987357475518
BxPC-3,10077130,4.243605425717339,3.0555178749156227
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815,0.7879661936067567
NCI-H2171,tretinoin-navitoclax (4-1 mol-mol),-0.4442650177645615,0.7747406553583787
NCI-H292,carboplatin-UNC0638 (2-1 mol-mol),3.385304428653225,3.5515507027626
LoVo,168312962,0.7059894109575258,1.9512937457510637
G-401,65064,5.209946412003188,4.294537670627527
NCI-H146,148198,-5.323171419653744,-3.7667972576734594
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739,-0.06066807975181335
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094,1.0644674462490746
HCC1143,2746,1.9419289545652112,3.25339280407084
NCI-H2009,erlotinib-PLX-4032 (2-1 mol-mol),3.949302222933775,3.32105261379137
JM-1,decitabine-navitoclax (2-1 mol-mol),-3.5626840909623234,-0.5059832476270456
NCI-H2009,10385095,0.2451756361843044,1.4745586923247864
OPM-2,11167602,1.1745103577473592,1.9624225787100975
CAL-51,26596,-1.4638590943230956,-0.8752007689010375
NCI-H460,1716436,4.318712917611328,3.211657609333817
ONS-76,71304818,2.469307822454373,2.3816394084131973
BxPC-3,11626560,1.2674200020854305,1.944779964555754
CAL-51,104842,-3.020036586723177,-3.26186443268448
NCI-H460,49793307,0.4479933662320887,-2.4457278060384073
FTC-133,5284373,3.681008384459256,2.8882721797082125
SBC-5,11455910,0.8715920005264659,1.0383123109507097
MSTO-211H,49850262,3.597717946429448,3.9932144973407953
DMS 273,2871966,0.6484564569530932,0.25230687183769573
OPM-2,2729026,2.502425703285658,2.3965272214513034
KMRC-1,JQ-1-navitoclax (2-1 mol-mol),1.5220385393532236,0.779073828690492
NCI-H292,9840324,5.8141064790381884,5.950147646718214
NCI-H661,375860,0.2037463104187888,-0.06816020162243715
NOMO-1,6918328,-2.206625897840938,-1.0991615208708412
NCI-H522,54143018,0.2801073306793095,0.2493842048300935
OPM-2,23635314,-4.85335222903722,-2.7803216095916623
NCI-H1623,1716436,2.729344651836522,2.994681008586111
CA46,60700,-1.6899904219212585,-2.235275766659405
SNU-81,10077130,-1.1742608263747976,3.4120013040706647
MSTO-211H,9907093,3.5779290533064856,4.3031296396209235
CA46,2126,3.4622152695614767,3.8321151966630134
CAL-51,49766530,0.4609697007955676,-0.006222180748342691
CAL-51,6438330,3.884194225982375,2.398807300680575
KYSE-70,68056272,3.571583007543391,3.8926658385942856
LOU-NH91,vorinostat-navitoclax (4-1 mol-mol),-1.0050592172430175,1.4560547611865666
EFO-27,68056272,3.9995237189063784,3.7675787851748357
SCC-9,241158,3.962823581088113,4.120632194196569
NOMO-1,5746,1.3002002606442051,-0.155660257607082
MSTO-211H,44202524,1.4972222665959742,2.3926636323214305
NCI-H727,49793307,-2.322611372156632,-2.5140252508843624
NCI-H146,4578,4.154543455900732,4.282844775053037
NCI-H522,JQ-1-vorinostat (2-1 mol-mol),-0.7689256810946783,0.8213420209439307
LoVo,107985,-3.583734032756361,-3.492594796895241
YAPC,984333,0.9591784056691972,1.081425164745809
SW1463,1750826,-6.63000221324875,-1.6246520030920037
NCI-H1623,crizotinib-PLX-4032 (2-1 mol-mol),2.4308697458394652,1.9776311732950445
HSC-4,9866186,0.7177643600632182,0.9177721726235676
G-401,navitoclax-pluripotin (1-1 mol-mol),-1.0942323522272883,-1.1348526308853388
ONS-76,135398516,1.9151603507117831,2.0704101911319515
LoVo,11964036,-0.4950100771581299,0.9722035583792326
KMRC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.7808089870084007,1.9623308131748356
CAL-51,11964036,0.7531640395115359,1.277456821841888
SBC-5,5328940,3.016318294707136,1.7731603333376504
SNU-61,9444,4.091366887299019,4.168728771753533
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149,2.336582680417514
A2780,676352,1.788840905955693,1.9457100764277717
FTC-133,JQ-1-vorinostat (2-1 mol-mol),2.666931641938378,1.0497200240416442
JM-1,7251185,0.7253388444333596,1.8113618487572654
Panc 04.03,JQ-1-navitoclax (2-1 mol-mol),4.611253227928805,0.9918083679038986
NCI-H460,52947716,-4.997624319891589,-0.3247394243397397
NCI-H2009,6505803,-0.1719772058921901,-0.1296320222534704
OVISE,25126798,4.262747569123806,3.9703860168818
G-401,54678924,1.6253720221899297,1.7212565477421178
Panc 04.03,tretinoin-navitoclax (4-1 mol-mol),4.366288248143094,2.9256930855336276
A2780,135421197,1.3895584306244824,1.6692402578275218
EFO-27,25126798,3.692256603979053,3.899479848208275
DMS 273,73707398,1.2764695344106731,0.738728524067374
MSTO-211H,10296883,3.6762481855456985,3.9590662555688705
LOU-NH91,60700,-0.2604526525302556,0.06607484274692463
Panc 04.03,8515,4.900392472396633,3.9431433426218656
A4/Fukuda,216345,2.739557201577506,3.2317204656831753
A-673,24978538,2.0217931845087596,0.4119636751196879
SBC-5,11152667,-0.3838978082878119,-0.42828862564005676
NCI-H460,15983966,-0.5601417251503862,-1.9888494825188439
EFO-27,400769,-0.0834796845468066,-0.4629363681726379
YAPC,2858523,3.168058012530131,3.1136293754146602
LOU-NH91,navitoclax-sorafenib (1-1 mol-mol),-0.9074262006529596,1.939818257624374
NCI-H2171,227681,1.8296199533038344,2.782870734109945
NCI-H460,11455910,1.4134750909778395,1.0960077748428918
G-401,44566777,-0.9568944013200004,0.6972027797893309
NCI-H292,5328940,1.2067364026743148,1.927068058225022
G-401,navitoclax-sorafenib (1-1 mol-mol),1.5806960178530294,1.0918536228895104
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.082109662926556
JM-1,25154868,2.919888649987432,3.7380997405117196
LoVo,44185566,1.1715497148164364,2.5434399749241376
ONS-76,54618164,4.167815792355048,4.229652346082553
NOMO-1,151289,1.0922355572005962,0.31413830157132167
G-401,44493528,4.310857122389352,4.237174828145153
KYSE-70,89928392,5.113782206339635,1.921248203645024
NCI-H661,89928392,1.5970967591597882,1.5800958647144427
SCC-9,docetaxel-tanespimycin (2-1 mol-mol),-3.608220129301709,-2.7340185306506357
KMRC-1,3503,2.6706031423305845,2.543265514668944
G-401,11455910,1.3171347053017213,0.5624851368065212
SNU-449,208908,2.01293579360495,2.241305298251241
G-401,57519531,1.5783303012871783,2.1232539735917926
MDA-MB-453,11427553,2.8599395215861567,2.918153949864979
LOU-NH91,241158,4.097895358021133,3.9918766733089712
G-401,24951314,0.7541386929645643,0.7957151527997152
MDA-MB-453,208908,1.869724740513474,1.5957047130359145
YAPC,46398810,3.0625661294812216,2.705594324283864
LOU-NH91,1750826,-0.8784962447018205,-1.9300409815879396
FTC-133,ISOX-bortezomib (250-1 mol-mol),0.3351331605659957,0.5487310247691383
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209,3.1437453313384554
MDA-MB-157,100016,3.517936084480814,6.236960713857009
HCC1143,60750,-4.413462787403808,-1.5979938404533058
NCI-H661,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5299727991020555,4.431662384482533
HCC1143,159324,3.533344711636858,3.375997435764501
JM-1,1750826,-4.271139507623605,-3.26363574442093
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205,-0.2049985000677417
A-673,11396600,2.723776149104898,3.1903525719080004
NCI-H1623,24964624,2.070631930148384,2.747645956737648
MDA-MB-453,104842,-3.389911854354977,-2.9542051439685366
SNU-81,49793307,-4.215972202332142,-2.9214174265529227
A4/Fukuda,54618164,3.3817410387547575,3.7909356168540147
NCI-H2171,26596,-1.7584148860978708,-2.0678152364540363
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155,1.6798986995274938
ONS-76,676352,2.5309673509494535,2.3150840375750583
SCC-9,4378219,1.9931327421657885,2.525083531299822
CAL-51,613753,3.3238399640193177,3.08935476678198
Panc 04.03,49867926,4.237506736984018,4.401396622831253
NCI-H292,salermide-PLX-4032 (12-1 mol-mol),5.437042614590839,5.042688271833988
NCI-H727,selumetinib-navitoclax (8-1 mol-mol),-2.0021206675207885,2.1621132827696967
MSTO-211H,3543504,4.118160915221066,4.464663410556291
NCI-H460,6252,1.4342703041264255,1.301132716860092
OVISE,navitoclax-gemcitabine (1-1 mol-mol),-0.8912301406187855,-0.5165977198347393
NCI-H727,3825829,4.725008182252989,3.794526312764203
OPM-2,119182,-0.8289962289267476,-2.0778020797609527
LoVo,54613361,-1.4267659732177436,0.05199599298144038
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023,2.092859169107363
A4/Fukuda,126941,-4.18863393868508,-2.904103037311968
NCI-H2171,SNX-2112-bortezomib (250-1 mol-mol),-3.076194221484089,-1.7544566039817504
NCI-H460,136227924,3.925006850615035,3.1695322750605626
NCI-H727,3136844,6.195563862298742,4.309564006826913
MDA-MB-453,136227924,2.410345496671846,2.680104458852503
SNU-61,51037431,3.7250627983577513,3.238140973197835
SNU-61,3384730,2.3184170398790154,2.3159776658477553
Panc 04.03,24753719,4.39873379823384,4.327094637393078
SNU-81,5978,-4.726956734092058,-1.605659330086759
SNU-61,9967941,2.1294940171884043,3.381189015832833
SNU-81,selumetinib-piperlongumine (8-1 mol-mol),-0.9226947877098262,2.3214712164222315
ONS-76,5470400,1.68546701619173,0.34774693709172483
JM-1,52912189,-1.1165299764243126,0.1716990917309113
NOMO-1,52947716,-3.339302012338735,-3.006177365919549
JM-1,26596,-2.491901301923365,-2.9183686188712397
NCI-H661,445455,5.2176896422295025,4.717903677807201
SBC-5,216468,3.330480208625043,3.0359483489996677
NCI-H292,5311,1.7806932533505695,1.6157099763418077
Panc 04.03,9935249,3.3873751996630177,3.340007446152595
NCI-H2009,doxorubicin-navitoclax (2-1 mol-mol),-0.756296183538871,-0.8198782873318485
CA46,25262965,-5.196703638661911,-2.9299401158628746
NCI-H460,11626560,2.497647926194901,1.9820838613043796
CAL-51,54686904,4.850424917483252,3.294784718477884
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994,0.9197489122034886
NCI-H2171,6918328,-2.9240080597430813,-0.9766982920062348
CAL-51,3825829,3.9510679995615257,4.013678126142293
SNU-61,65064,4.771880102821997,4.942849424713471
CAL-51,124202324,2.033990287468598,2.62310143727046
NCI-H1623,11494412,1.2552972437851018,1.8841889658684763
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415,0.1870037275290937
JM-1,135398516,1.8505892369708832,1.383972811611603
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708,4.0983338317602325
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327,2.44307531897909
LoVo,1641662,3.111662868893329,3.395520609168595
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142,1.4549226813046738
HCC1143,24856436,0.4052757500096688,0.9764389188212687
YAPC,73707398,1.1307339717786768,1.4668700663875043
FU-OV-1,24771867,2.3744516407985485,3.0508286389994073
NCI-H727,piperlongumine-MST-312 (1-1 mol-mol),1.950169428347768,1.9100170790151518
SNU-61,2749,1.958913212534665,1.5833816162808276
CAL-51,20959075,-3.1196535578382987,-2.7949415868886636
A-673,6918878,1.2344260030899934,1.9400889670774668
LOU-NH91,73707398,1.1540810865513749,1.31098428356988
NCI-H2171,107985,-3.896160678794096,-3.2450449777401382
KYSE-70,12003241,-1.4257688129039825,-0.6081319076269088
MDA-MB-453,10296883,4.2989687155614735,3.9075277535210757
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266,2.953068390055681
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858,1.2371838869166463
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186,1.6219451662267708
NCI-H661,4259181,-1.4326329693308524,0.15149330979222145
JM-1,salermide-PLX-4032 (12-1 mol-mol),5.264877641383212,4.6527667754312905
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086,0.4322567425705523
SCC-9,25183872,-1.5689686359020558,-0.47574753446629586
NCI-H727,6438394,3.7246032061112553,1.6783696579322864
NCI-H1623,selumetinib-navitoclax (8-1 mol-mol),2.5972184822142004,1.963250904163804
Panc 04.03,9911463,4.4327726522455855,3.9562474776214582
ONS-76,2733487,6.718347537986806,5.912661665969381
MDA-MB-453,25062766,1.9156877669914651,2.579042182790124
NCI-H1623,36314,1.7259264714185265,0.15211792791748194
SCC-9,selumetinib-piperlongumine (8-1 mol-mol),4.590174164336879,3.788524057280563
MDA-MB-453,11234052,3.3366002038414493,4.336309503607799
NCI-H661,54143018,-0.94518686271758,0.800274166463481
NOMO-1,72376,-3.881755374018637,-3.343685264780867
NCI-H1623,104842,-3.8091356035642434,-2.713159539552826
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.248867729206212
JM-1,71466445,1.831003524042788,2.331772450714047
EFO-27,49766530,-2.657964166176686,-0.6075866223997722
NCI-H661,753704,5.093119647973415,5.003319984467992
OPM-2,11175137,1.4890519960627426,2.0378374314447525
G-401,carboplatin-etoposide (40-17 mol-mol),0.9786260223785996,1.2216285023998175
A4/Fukuda,5746,-1.1009867615741116,0.42255460772032044
SNU-449,44489675,3.6193477306301927,4.040128283388019
NCI-H661,12001922,2.629031416850278,1.9389855926282318
DMS 273,11640390,3.3173332454053717,2.7559199653533875
SNU-449,4259181,0.6587440570439733,0.23049213582490696
EFO-27,24964624,2.939505532014586,2.6846007413464186
LoVo,4096211,0.5868958804653562,2.1169511489986887
A2780,2841722,4.258280317113099,4.042254050370093
CAL-51,24771867,-0.5018492111736887,2.696777449819968
G-401,46907787,-0.0293884143124787,1.2462638998229907
JM-1,24772860,-4.004711239665373,-2.8435017458983456
MDA-MB-453,71680916,4.8348560692055695,4.718276655186526
JM-1,11507802,0.223918960474334,0.5651831778728604
A-673,462382,-0.040658639847304,0.49571403034992917
NCI-H661,216345,4.176204855685743,4.153432363016195
BxPC-3,9907093,4.5613416209155755,4.0981175735311375
HSC-4,216468,2.5769925673594227,3.3012070987311817
NOMO-1,60700,-1.0021705320646457,-1.4521910722037803
YAPC,11455910,1.8317787914833017,1.2585565724069645
SNU-449,11175137,3.183352091664916,2.814810039916202
A2780,2113511,4.588817591987419,5.510533244226686
NCI-H146,613753,2.6314812615131222,3.080723561247359
SNU-81,10231331,-2.370371712203436,1.5581088092173374
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109,-4.111329398787591
NCI-H661,168313016,5.326553105852446,4.86554268555163
CAL-51,25126798,3.926975819986009,3.7784353244650726
Panc 04.03,1716436,3.048029385411991,3.1811301282203073
EFO-27,11625818,4.615590718074381,4.5044647078033835
A-498,44495899,4.223152889477574,3.486317047908858
A2780,3825829,2.5427924978442467,3.7870428686974433
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021,4.680367177706072
NCI-H1623,2858523,3.2758661507497115,3.0474814707810483
A-673,49793307,-5.444897343264971,-3.640108067974152
MDA-MB-453,9935249,2.561550169446695,2.657203419106722
MSTO-211H,navitoclax-gemcitabine (1-1 mol-mol),0.5051490037024954,-1.2417838931735279
LXF 289,3062316,-3.851151802003845,1.3872129407371887
MDA-MB-157,2874250,4.29768331905581,4.365885848976241
HSC-4,4521392,4.744801099229743,4.245776894071559
EFO-27,23725625,5.484413053531449,5.405039185641978
MDA-MB-157,navitoclax-MST-312 (1-1 mol-mol),-3.237142139083902,0.6217261421604287
NCI-H2009,5460769,1.3316086312624285,2.9662887889942526
LOU-NH91,654092,0.641619390442256,-0.3103726966891225
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,4.285994613217798
SNU-449,9887053,4.621717664819675,4.041201166768945
LOU-NH91,54618164,4.244208934703923,4.077010872613039
MDA-MB-157,24951314,0.2652102931153908,1.4717299995161044
SCC-9,4261,1.568262163612179,1.8133872851733317
CAL-51,262093,2.862241975448649,3.1027023917864796
DMS 273,100016,5.677769516399485,5.370073893509064
A2780,44137675,1.3252793631369038,3.283420135007347
DMS 273,71466578,4.37241227128359,3.277046653073746
A4/Fukuda,1566236,1.4071330472860828,1.7246434575267622
SNU-61,navitoclax-gemcitabine (1-1 mol-mol),2.2784859242088062,-0.467474670137574
NCI-H2171,25102847,1.8897460049958847,2.067692144187152
MDA-MB-453,60700,-1.6006047446684224,-0.9796497946172766
A-498,11404337,2.25955984981305,0.006015885649385726
NCI-H2171,10302451,3.986494326049399,3.362180624114323
YAPC,10184653,0.1561987566095487,1.2730530742110775
NCI-H661,9967941,4.170813203069281,3.8596666854978667
BT-549,24901704,3.7794480452342,3.533400114740542
A2780,3038522,3.0311112283818864,3.0042484568076553
NCI-H522,67291369,2.1338291538877514,2.2466173458462118
HSC-4,753704,4.983094182740762,5.075765958636215
G-401,44607530,1.0217800111575093,1.7363963549341133
OPM-2,19582717,1.9960397366001383,2.6976856540157472
NCI-H2009,104741,-5.941055510927969,3.5161489460661697
OVISE,9936388,2.6758567859836826,-0.2359970392475428
NCI-H1623,11178236,-2.2917099582879144,-3.0799037685441317
CAL-51,5746,-0.6872762444946757,0.9255486913259614
JM-1,3503,1.2397121319894746,1.9421686410424543
LoVo,26596,-4.043483931746528,-1.0743216926918766
ONS-76,44486219,4.293725912166159,4.327315067366427
SNU-81,vorinostat-navitoclax (4-1 mol-mol),1.2655278546702862,0.8778881361364368
NCI-H460,24964624,3.5490884182562565,2.6811705210524024
A2780,448949,1.9574027813966313,1.676732682049683
G-401,6918878,1.5849207586223315,1.9968501249812687
EFO-27,123631,3.2705036111065957,2.855457435330434
NCI-H460,71466380,4.4879606530616725,4.425208010975182
NCI-H146,126941,0.4535750644224253,-2.623520229463435
SCC-9,JQ-1-vorinostat (2-1 mol-mol),0.3641375851810363,1.1961945798365814
JM-1,25062766,0.7257031347370316,1.7322527876071754
BxPC-3,44819697,-0.5900667288519075,0.21729027693116493
DMS 273,49766530,-1.3487399530522592,-1.5746441143431478
G-401,6918837,-4.518653911968971,-3.4572320055213135
FTC-133,25195348,4.144583358862902,3.4602293582684824
BT-549,5281321,-3.0037540013163433,-1.2971907542863985
Panc 04.03,44241473,4.425072929332434,4.919313480149856
YAPC,5278396,4.010893890545004,3.6088911632638823
ONS-76,5287620,-2.6985711183159573,-2.084411138997774
SBC-5,11612883,3.4240653421197877,3.036977969629931
SNU-81,doxorubicin-navitoclax (2-1 mol-mol),-2.5154002454653277,-1.2465318767886644
A-673,tretinoin-navitoclax (4-1 mol-mol),2.75284038442573,1.030426761207516
SBC-5,219104,3.745930190487188,3.9542372204536194
SNU-61,176870,2.732721688120773,2.462246635056454
CAL-51,36314,1.3238047725901672,-1.7400413629926783
SNU-81,carboplatin-UNC0638 (2-1 mol-mol),2.7350455316868416,3.004268526641707
DMS 273,71751553,4.31191978803821,4.130445137582976
NCI-H2171,400769,-1.2297634018381476,-0.6365674238865737
MSTO-211H,salermide-PLX-4032 (12-1 mol-mol),5.150950565200891,5.087704573723589
NCI-H727,71304818,2.536891878991305,2.4925061380630265
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567,1.4774456300315633
CA46,135398516,0.7680931483587626,1.4340284402351091
MSTO-211H,100016,4.243846732059744,6.236034863323498
NCI-H522,selumetinib-MK-2206 (8-1 mol-mol),3.9815155524182337,2.1639852110104485
NCI-H2171,carboplatin-UNC0638 (2-1 mol-mol),3.641096967492651,3.1095788973053486
SW1463,25183872,-1.2446986167158185,-0.720691841891979
EFO-27,122327,4.8281000238128,4.558639785636128
MDA-MB-157,11222830,0.6776847499576403,1.67504588698979
NCI-H2009,25150857,2.992056775880064,2.6031953942416366
NOMO-1,216468,1.212023833941809,1.371720733864064
JM-1,11152667,-1.617053586455527,-2.030492236526375
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.8366689886743055
A-673,25126798,3.569829443135804,3.5360064538966163
DMS 273,148198,-4.27913692458833,-3.7813787672687487
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203,3.5667086212057937
LXF 289,5329102,1.6667075021580833,2.106840886653185
HSC-4,53495165,1.6708694504220498,0.619116495274671
CAL-51,969516,2.948027689121256,2.7160840628716336
NCI-H661,5746,2.052034109930783,1.3457665406339154
A4/Fukuda,9967941,2.4411204768161983,3.3965921129851737
MDA-MB-157,89928392,-0.9485630303355488,1.530220115045787
NCI-H460,12001922,2.3574763109101253,1.9881659744918747
SNU-81,327653,3.5323829695882267,3.1319691487767103
NCI-H661,124202324,2.0891928025286943,2.6962688815885567
BxPC-3,42642645,0.6313588777440967,1.2015722333018026
NCI-H2009,24772860,-3.0306018162615342,-1.9288635625381159
A-673,6610355,3.502413574243847,4.233445315266564
SNU-61,57330099,3.603690788773508,4.083371156340324
NCI-H522,2749,2.969505400884835,1.5082532690410817
NCI-H661,57519531,4.09429699672183,2.391374349057597
MSTO-211H,2126,4.496176254172968,4.685352142854342
KMRC-1,10410894,3.4812991400934585,3.3534460301532945
EFO-27,44237094,3.2066908421034332,3.205759191668486
LoVo,16725315,3.2447595903434627,4.44516642286007
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552,3.623377477428046
MDA-MB-453,2842253,6.29942483998937,5.421435296502739
A-498,135875424,4.978423270774445,4.217943668328538
Panc 04.03,9903786,4.611047286699123,3.043398218235806
SCC-9,54639665,4.512228528266098,3.348339793741904
JM-1,24856436,-2.211637583066154,-0.6365695009353991
A4/Fukuda,5311037,4.577970147235868,2.8407667759289397
NCI-H522,66577038,3.0388231599187017,2.9339699617700132
BT-549,25154868,5.818557590138654,4.439249341589886
KYSE-70,6505803,-1.025033993677824,-0.5272442794066157
LXF 289,11396600,4.152956454399736,3.8560010413023615
SNU-61,navitoclax-MST-312 (1-1 mol-mol),3.0006796747399394,1.1988049357096184
SBC-5,126941,-0.8684780314881991,-2.6651426538810297
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667,-0.41448459911132135
OPM-2,9933475,-1.3895511853659537,1.553292059151843
YAPC,11214940,1.707662344700129,2.224063207172129
EFO-27,4259181,1.8274060730963064,0.5449825806065856
NCI-H460,446155,3.79922347841428,2.7910882673367086
NCI-H1623,carboplatin-etoposide (40-17 mol-mol),1.5186330340389391,2.761509400356219
A4/Fukuda,3634881,2.7004024711225596,2.7102543855173296
NCI-H661,1566236,3.2299922345410006,2.4142295478244757
MDA-MB-157,6450551,1.4635370045174534,2.9675919734993013
NCI-H146,vorinostat-carboplatin (1-1 mol-mol),1.5707903367584717,2.893038506497942
BT-549,6918328,0.6487197523295809,0.6537431243609576
NCI-H727,11175137,3.085433657363398,2.732242580547326
NCI-H460,3854666,3.1385110084048065,2.0923592588217343
LoVo,44241473,4.10673515965005,4.68278610966003
G-401,10074640,2.6430496317806957,2.9660070658868842
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264,1.0899917435796391
SBC-5,2126,4.14698296213378,4.792802429172822
ONS-76,3503,2.5109588721491938,2.4164619682414004
SNU-61,5470400,-1.745187092277687,-0.601845164150809
NCI-H661,36314,-4.592945905020296,-0.6752858695202972
JM-1,451668,-4.255879556837535,-0.2584347309421646
NCI-H1623,5978,-1.0298747552622975,-1.1181818298270834
DMS 273,136227924,2.538513279360657,2.4191859710980537
SBC-5,selumetinib-navitoclax (8-1 mol-mol),4.706526584593769,1.5984045747787192
A4/Fukuda,6918638,-1.9449982869755031,-0.2747892857098435
HCC1143,16038120,0.5509172721588973,1.3443995683289578
BxPC-3,44185566,1.4327209520395616,2.4846188157457845
ONS-76,2858523,2.9452513130208975,3.05771582621332
NOMO-1,46191454,0.6880471005756411,0.16294721352593686
NCI-H292,216239,2.858200088172953,2.3475928487166895
DMS 273,11178236,-4.200581603954177,-2.553223038930764
OPM-2,10074640,2.1693178922200813,2.876499995431979
ONS-76,5566,3.1751487050742804,2.961981245364628
BxPC-3,10385095,1.8732992891777025,1.4277638936691577
A-673,crizotinib-PLX-4032 (2-1 mol-mol),0.1365223010669094,1.6424228374207368
MDA-MB-453,675434,4.221225816741011,4.380871985301552
SCC-9,navitoclax-pluripotin (1-1 mol-mol),-0.0123473768643266,-0.5664845200575092
CA46,9825149,2.310107059064329,1.6492941295653138
MDA-MB-453,12003241,-0.9610578830621354,-0.493062995779123
A-673,613753,2.7839803669097134,2.8746037061234944
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113,2.8956409135076964
NCI-H460,3062316,3.704520183651484,1.6471722565028029
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364,0.6016501987932912
A2780,11427553,1.40474333506403,2.030804299347689
CAL-51,5287620,-2.338247824560234,-2.125074806530959
KMRC-1,11640390,3.901360175468555,3.524058293005277
EFO-27,16219061,3.8100949831762296,3.5724825734940806
A2780,31703,-4.480868228272363,-1.6520067340101803
Panc 04.03,135440466,2.8713092707831116,2.5577047844545056
SCC-9,16065773,3.2014379284662864,2.7846233279215955
SNU-449,148198,-4.785889264279132,-3.311475895066614
OPM-2,2949965,2.476405976050771,2.425354706010334
ONS-76,44489367,4.840464292002439,4.6469524443972965
NCI-H146,navitoclax-piperlongumine (1-1 mol-mol),-3.055255187933708,0.5474300686447366
NCI-H522,vorinostat-navitoclax (4-1 mol-mol),1.5182214624562833,1.0036324497004288
MDA-MB-453,135411,0.2962177293375728,0.7684302777573567
DMS 273,123631,3.074313122611396,2.2777334730377534
CA46,19582717,2.2741322004032716,3.0071418308745823
A2780,3676137,3.624330330130062,4.384039501668316
BxPC-3,11964036,0.7144816609502266,1.4474421063528815
G-401,71466445,3.182548969694367,3.258496508895992
YAPC,navitoclax-piperlongumine (1-1 mol-mol),3.667001325655349,1.8524328194729
A-673,49766530,-3.0139632371957705,-1.2774188009883714
JM-1,JQ-1-UNC0638 (2-1 mol-mol),-2.068621419812743,0.10441008167050582
SNU-449,11609586,3.2368097564340546,3.1632973906503565
G-401,46199207,3.084348249789013,3.074349162085472
A2780,11612883,1.284093973133662,2.4912740191450427
KMRC-1,2708,5.927603665606935,4.705613079139
EFO-27,SNX-2112-bortezomib (250-1 mol-mol),1.0533662240531856,-1.029364580624153
DMS 273,135875424,3.231864587804135,3.2133533102753775
Panc 04.03,2749,3.2242301239764184,2.3834545022187172
G-401,675434,4.2282934242266235,4.478733141325632
G-401,72734382,4.843742106159305,3.9699179843807206
SNU-81,72376,-4.141271855112041,-2.1418438553738084
LXF 289,208908,1.975389940693236,2.301063323497191
EFO-27,11175137,3.0704812268942296,2.821617006280682
HCC1143,16736978,2.2332113551174415,1.853840438229899
LoVo,24821094,2.523288695365458,3.086696762920949
A4/Fukuda,10322450,2.3588003127389277,3.077675686724055
EFO-27,11152667,1.7712187839859168,-0.36763822727504986
A2780,6918736,-1.942572837589071,-2.3278805533565823
FU-OV-1,285033,0.0377877938075082,-1.5861135540532434
KYSE-70,11626560,2.028097573065789,1.7419814389032573
CAL-51,400769,-0.1641693790968544,-0.48855653163677487
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323,0.9376062052558729
CA46,11507802,0.4399982092061076,0.6489994266181253
SBC-5,tretinoin-navitoclax (4-1 mol-mol),3.0928632602038575,2.63482566432147
SNU-61,44607531,1.8838139804325664,1.4191369858281309
MDA-MB-157,135984461,1.8807242402896556,3.6219582388232086
YAPC,68056272,3.685228443179594,3.9868690918081167
KMRC-1,3025986,0.2913922358554936,-0.9412492553938006
G-401,11656518,0.9589948119457968,1.2058012649788776
CAL-51,25262965,-2.904292987251918,-1.7372277789577653
NCI-H727,31703,0.5895859224805655,-0.6573499190859629
FTC-133,3025986,2.6500554516402515,-0.40451446121575557
OPM-2,11404337,-1.9830798838769188,-1.0668671497362978
NOMO-1,54649381,4.1030759428324455,3.202826337632163
OPM-2,45279963,2.6394525890823335,2.821479943648999
G-401,54619267,3.6389956680017495,3.9500269449832377
SCC-9,613753,3.4469207135602904,3.1957291880479324
FTC-133,3825829,4.910712910753543,4.228045267315556
NCI-H727,6918328,2.020699769993763,0.0904974428149281
JM-1,3384730,1.783412153965406,1.6545519770501127
OPM-2,5335621,3.731372916139424,4.045941932301469
NCI-H727,46199207,3.049846279584177,3.1448903433414976
NCI-H2009,100016,6.24887408197215,6.29272548760502
OPM-2,2742550,2.8639715022070713,3.2057516514619793
A-673,56649450,2.339222019664337,2.8927155809927143
LoVo,135928012,4.12079355273469,4.039443112026211
SNU-449,46215462,1.6240369462021291,2.1749054761177664
EFO-27,10385095,0.896347771716858,1.4272146330975852
BT-549,6917907,-5.828237871920148,-4.8005775741813554
A-673,262093,2.1198375376891705,2.214936136645459
SCC-9,crizotinib-PLX-4032 (2-1 mol-mol),2.600413424515517,1.969487519505571
G-401,2871966,-1.4998546935779766,0.07560662701718615
NCI-H460,6610355,4.949206869720499,4.429468872845349
NCI-H292,56946209,-3.439063202171596,-4.0876413162612115
MDA-MB-453,46907787,-0.524764523127372,2.340860069524511
NCI-H661,9935249,3.279757521015836,3.2227831835935423
Panc 04.03,5311281,5.064761813982229,2.7090654175846156
EFO-27,54765302,4.904683382842226,4.330315194916811
OVISE,24964624,2.347879134584806,2.587237901840905
MSTO-211H,6918878,2.3677965777112653,3.0784408945641517
KMRC-1,1641662,3.91383049133015,3.51197131257297
NOMO-1,3025944,3.969971169930392,3.9306924985331246
MDA-MB-453,10322450,5.853812101119735,3.4577993625939962
A-498,675434,6.195396019607132,4.720061335216764
JM-1,16736978,2.465148690257062,1.2154193346808686
HCC1143,400769,-0.895432113907658,-0.5288393324732056
JM-1,5328940,0.4457439228433418,1.0865936569034025
NCI-H522,156422,4.012108454967305,3.5299157491235365
DMS 273,135999136,4.8097980755766505,2.666925601563156
A2780,44607530,1.3884091000724437,1.6764161521414653
KMRC-1,10302451,2.629362111325239,2.817091707312796
SNU-61,6918736,-1.624439463390885,-1.6549261942237743
BT-549,135999136,1.9798336492119424,4.177709034477877
NCI-H1623,9926054,1.7409203229588674,1.9282999660699869
JM-1,16722836,0.523497579231149,1.0166944179474329
MSTO-211H,613753,2.697490548990984,3.318062196617065
NOMO-1,16725315,4.952538276899841,3.62246649564334
KMRC-1,16736978,2.1404631421072975,1.7334053386458106
A-498,123631,3.2458168084526564,2.6224817944232344
MDA-MB-157,decitabine-carboplatin (1-1 mol-mol),3.837030982901149,4.153183632074166
NCI-H1623,24951314,1.0133274480783143,1.5917125951069804
NCI-H661,11228183,4.275001578251326,2.431470694960496
FTC-133,5479543,4.4305420476204205,3.6736198686773394
NCI-H292,136227924,3.1886204590132654,3.2040229563122016
A2780,6184667,2.4201329833494705,2.7119195674633647
SCC-9,5278396,3.934746070394729,3.6802784662507
OPM-2,5743,-3.6176009576451142,-1.6621937195516605
DMS 273,66577038,3.0260629384717443,2.795060628822418
SBC-5,151289,0.3068057764327633,1.100092454653121
A4/Fukuda,44491742,3.3943913096556444,3.9278018235452548
MDA-MB-453,135928012,3.1518499848728534,3.8872630169579114
A-673,2828334,5.945698490544337,5.955938208853978
OVISE,44185566,3.1371413376940724,2.75739642058609
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849,-0.3824650885562727
KYSE-70,5460769,2.831605222646697,2.8024454177408726
EFO-27,60700,0.0275300045157078,0.33176388010213725
SNU-449,2871966,0.0642629453363792,0.712428208015216
A-498,135411,0.9450284346401692,0.8574883810092959
CAL-51,151289,0.6583498849401344,1.2421257231567906
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.9125776662729508
NCI-H292,54454,1.5363763322568371,2.7745893713796583
MDA-MB-453,984333,1.2010378495759917,0.49326967557777524
A2780,1242560,2.8030380184252346,3.3094217086795754
G-401,11625818,3.256149300060542,3.784317728734857
EFO-27,2729026,3.178460421270277,2.8034526127084485
CAL-51,54454,2.240351559744082,2.4753150248185336
SNU-81,5470400,-5.232383325772668,-0.24965959181073816
JM-1,selumetinib-tretinoin (2-1 mol-mol),2.58796154707147,3.0923034729522483
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821,-0.8144891578919261
LoVo,51037431,2.9518330914759043,2.78940795610776
NCI-H1623,57519531,2.253772853853667,2.629161390179849
BxPC-3,6918837,-2.8801990347910045,-2.408156409942473
SNU-81,452548,-0.1759999006209261,-0.2394481714611765
BT-549,327653,2.9888914918454854,3.3449062833422545
CA46,46199207,1.8825158344658808,2.6112924739766146
MDA-MB-157,10410894,1.6628456414259642,3.5699914960321126
SCC-9,66577038,2.999012470787333,3.154064226770038
NOMO-1,6918878,0.4522523514749809,0.35784015762018667
SNU-61,5281321,-1.743716860572046,-1.3847050903375722
SBC-5,decitabine-navitoclax (2-1 mol-mol),2.675632395894592,2.2436174831655986
HCC1143,9840324,5.44269474449066,5.884885492478526
CA46,11234052,2.4794836109026077,2.985860327328897
CA46,11609586,1.0102139081655188,1.4931489397780309
NCI-H460,10385095,2.2920897819597896,1.362602890506614
BT-549,11625818,5.0921701677816875,4.668059378003558
SW1463,400769,-0.5224692496950973,-0.5638023888252195
Panc 04.03,10113978,5.097338218314276,3.539457862082325
JM-1,9907093,3.962832886035932,3.3859041324959236
CAL-51,23582824,1.0413279539794644,0.5764677949553272
Panc 04.03,135398738,4.347297256699442,4.49264546143039
G-401,3038522,2.1905688095022215,2.924566034203175
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648,2.7895457812663667
NCI-H146,4261,-1.8051480987265105,0.884268339267343
DMS 273,2729026,2.67706862921606,2.511231440755145
SNU-81,1750826,0.9975547695410114,-1.3244515401248784
CA46,168313200,1.9493207867170304,2.7230143978416006
OVISE,vorinostat-carboplatin (1-1 mol-mol),3.460247929578718,3.290458529625661
A2780,57519531,1.3251208810116586,1.8573826725796672
OPM-2,navitoclax-sorafenib (1-1 mol-mol),1.274845961219173,0.6564532421505828
A4/Fukuda,11717001,3.8123333180630103,3.847975641275015
LOU-NH91,3634881,3.4323223488487593,3.427487963731128
JM-1,11485656,1.6613246077420758,1.566256443155853
SNU-61,107985,-3.1587785808489297,-3.4466835912952036
FTC-133,2729026,3.353273516564875,2.7640919037650424
ONS-76,159324,2.5690437216419677,2.9107363013677165
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,2.007324959376267
G-401,9927531,4.9703255494446035,4.0934445578134655
LOU-NH91,25105715,3.511519280721543,3.4234038958588506
SNU-61,15953870,3.2687219409332657,3.3884477367321177
NCI-H2009,navitoclax-gemcitabine (1-1 mol-mol),0.4354090663504973,-0.6205754370900917
EFO-27,24951314,0.9989426715403756,1.607816523456499
MSTO-211H,5311,0.950405781568164,1.8015914512134785
A-673,9444,4.054770941664931,3.802194653509764
MDA-MB-453,6852167,1.219966928776707,2.7006451398985467
DMS 273,3384730,2.794672653243152,1.934440574265341
NCI-H522,24964624,3.0091798278143003,2.0604964386762044
DMS 273,6918878,0.6913807013381441,1.1942974151047978
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,4.536117671255507
CAL-51,5311,1.4183219405835503,1.21629677978584
SNU-449,3136844,4.333259755823753,4.587374660979393
SNU-61,10074640,3.0465009012673923,3.023775994070235
NCI-H292,5738263,3.605646843776872,3.650972798076865
NCI-H2009,135440466,0.1778924686528867,2.4295242914097726
SBC-5,387447,-4.42204631831661,-3.5083431616627223
HSC-4,60700,-2.3901041148359,-0.12662873512481507
Panc 04.03,navitoclax-PLX-4032 (1-1 mol-mol),3.364460655624257,1.969686980493371
BxPC-3,322968,4.585795478380971,4.0940843654193655
CA46,24821094,1.9467424475066963,2.345696961393875
SNU-449,5282054,4.57557530009064,3.90022598063793
CAL-51,11625818,4.1129054868405905,4.345917578027433
A2780,16038120,0.4203115446628392,0.7194042592460204
MDA-MB-453,44484893,4.218904183145372,3.6629357843855894
YAPC,969516,2.7207948170212894,2.9874860055124244
SCC-9,6914657,-2.6898440352771704,-3.7826585981851624
BT-549,156414,4.402880659642667,1.7144917232004646
A2780,10410894,2.69442494781606,3.2241862575797757
HSC-4,1566236,1.9723291328750472,2.844880355577909
CAL-51,53232,2.8018516258833395,2.9681671335221256
NCI-H522,73707371,4.918377506073214,4.320042934262921
FTC-133,2858523,3.137647378022636,2.975189948907207
NCI-H146,2949965,2.1998257096859235,2.6001013053284265
A2780,5291,3.6974106280730767,3.485572520792325
A-673,11317348,1.5484644948233677,2.0742640471019804
CA46,5284616,-8.167802056045408,0.18566872103635262
FU-OV-1,9840324,7.491199941931371,5.902056815993684
NCI-H292,17759555,3.476208496969499,3.836774914669059
NCI-H2009,6918837,-3.78935135271195,-2.278307954940677
NCI-H460,216345,3.827300936034388,3.898950537035964
BxPC-3,54143018,-0.804639103071218,0.27885680172344307
SNU-449,11612883,3.957753067546404,3.3028261639356216
DMS 273,49867930,4.404291499076759,3.817360260771738
FTC-133,15953870,4.441911294632587,3.5370016853250275
NCI-H522,11612883,3.3366707819202666,2.5989090678070967
A2780,9444,3.815396075990075,4.099254011263117
NCI-H460,54619267,4.901891634717457,4.103045752980042
SNU-449,salermide-PLX-4032 (12-1 mol-mol),5.474676464487576,4.91109641228201
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108,-0.7783133872674998
A4/Fukuda,4521392,3.820585335578038,3.8722118698565193
CA46,5328940,1.1838617633473132,0.9963133087613137
NCI-H460,452548,0.6919333948360032,0.35176172962171043
YAPC,25126798,3.983335704988987,3.8965612792751214
SNU-449,322968,4.603056923598163,3.95262407614371
SNU-61,54618164,4.021673833793196,4.000836944877414
NCI-H661,400769,-1.492892337104586,-0.6386361460371891
G-401,24964624,1.4880998129973728,1.9749522590079482
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023,5.402824289243579
OVISE,2945648,2.8352179600513367,3.057498080927081
FU-OV-1,JQ-1-UNC0638 (2-1 mol-mol),1.6948403130228156,1.609936985795109
BxPC-3,984333,0.8836461068661873,1.091368529326541
NCI-H1623,42642645,0.9313727170286358,0.9584346904645829
BxPC-3,71466445,4.819923879864087,4.025532446585673
MSTO-211H,126941,-2.2791548116201987,-3.1669752525235872
MSTO-211H,20959075,-3.222615813929693,-2.554820929857646
BxPC-3,16741245,5.048799679028713,4.013985919019607
OVISE,12001922,2.261742632923514,1.965159649722007
NCI-H2171,135440466,1.9220793929810305,1.9880419618866634
BT-549,119182,-0.6766164524597643,-0.3759509016522572
KMRC-1,65064,5.386842832596526,4.880123864706301
ONS-76,16725315,4.104726960292652,4.305441513937697
ONS-76,6505803,1.3937943977095182,-0.16535675821494164
MDA-MB-453,JQ-1-navitoclax (2-1 mol-mol),-0.5308919352690735,0.7957418205165105
FU-OV-1,25062766,2.359728819743937,2.0575097051459457
KMRC-1,5566,3.18269246163038,3.1744445948951454
NCI-H460,6438330,3.783082395235063,2.3747571820635387
CAL-51,135440466,2.9511327404143755,2.468578865766487
DMS 273,23582824,1.3511796414129456,1.138678799017631
CAL-51,56946209,-4.496983035262223,-4.058974052773972
OVISE,176870,4.342841287056181,3.299102674707687
KMRC-1,11494412,2.978505743964039,1.5395337380478427
A4/Fukuda,54454,2.014078017992857,2.302744999492777
MDA-MB-453,2733526,2.894784526555574,3.529350062108345
HSC-4,11625818,4.485436042124793,4.479487781403418
NCI-H727,2733487,6.440431233061491,6.073526961180387
HSC-4,54618771,2.9865797342969564,1.4165855791265478
CAL-51,12003241,-1.2189714227076325,-1.0778537978430236
A4/Fukuda,52912189,-0.8285591911559074,0.28438317634810195
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.2756646452594242
CAL-51,6610355,4.388066889778601,4.605478511734486
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448,0.4399880135023891
NCI-H1623,56649450,-0.2540238687607088,3.2958880925347285
A4/Fukuda,9444,3.1818692272898423,3.7971994145731527
NCI-H2171,55508,1.786136919471965,2.6437904344670047
NCI-H522,9840324,6.2981118504366735,5.327745810790692
DMS 273,409805,3.6932334728164826,4.305716770320603
SNU-81,selumetinib-UNC0638 (4-1 mol-mol),-1.1313432157917445,2.632160227225672
NCI-H727,16722836,1.5817712487099789,1.5841349852857578
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275,3.781044853663813
G-401,5281672,4.259815588040996,4.327639269036123
FTC-133,4917,3.819256860929221,3.03878772395723
YAPC,selumetinib-UNC0638 (4-1 mol-mol),2.613021216315863,3.214809228026157
JM-1,10113978,2.290370569955518,2.17865422441855
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946,-4.898892808796525
EFO-27,675434,4.38679148408465,4.584931834092187
SNU-81,5460769,-2.0941921209529575,2.465216106050105
BxPC-3,5282054,3.885649252328735,4.010551798449584
OVISE,6184667,4.390472676016808,3.5613547504609113
G-401,16659841,2.2879294183156396,3.272786183581189
HSC-4,19582717,4.479728463380205,4.311542402583791
KYSE-70,1750826,1.0050628158627442,-1.1410954895863537
LOU-NH91,135659046,3.4412725013745336,3.828111405229685
HSC-4,11396600,3.0766488056466104,3.8581037675760665
KMRC-1,11964036,1.816670768699429,1.5538742146731261
MDA-MB-157,decitabine-navitoclax (2-1 mol-mol),-2.3403643839095607,2.2328376793017948
HCC1143,54618771,1.714955024233068,1.659645677542387
A2780,8515,1.754639935244518,3.580783496269055
FU-OV-1,36462,2.321134275550796,2.649458739821435
OVISE,selumetinib-UNC0638 (4-1 mol-mol),4.700379518419309,3.324671259568323
YAPC,216345,4.822006863531136,4.208318437518273
ONS-76,tretinoin-navitoclax (4-1 mol-mol),3.585528237924169,2.410452026351525
LOU-NH91,72193861,1.0473212139197163,2.1927621357358498
NCI-H2009,piperlongumine-MST-312 (1-1 mol-mol),1.2420237661253426,1.9680022608857743
CA46,54618164,3.845436645537388,3.315498464448768
NCI-H292,446155,1.4424758906582096,2.9105129840689123
HCC1143,9936388,-6.988875343339418,-1.2670728517716925
NCI-H727,9907093,4.262034183201205,4.156915542457412
ONS-76,126941,-2.856353430413947,-2.366457889569769
A2780,11455910,-0.8495199814745813,0.5917229909084123
A2780,73707398,0.6651600447827565,0.8413896355077946
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561,0.03312826257468284
MDA-MB-157,24856436,-0.6830375019554852,0.5590841779436563
LoVo,1750826,-1.736017877496402,-0.6005580784836922
NCI-H146,49766530,4.81095512251176,-0.5843446289017716
HCC1143,409805,4.31745443409651,4.895489749590779
OVISE,159324,4.206537691518507,3.1076770851454
SNU-81,10302451,3.60256279960024,2.797759387346904
EFO-27,5282054,3.999430083075576,3.9351994650182758
LOU-NH91,4917,3.4124252266322297,3.141933199741885
SCC-9,5328940,1.568072217369216,1.9243961952256827
OVISE,637858,1.8122421616924396,2.285281065653403
NCI-H2171,44607531,0.7654225162387793,1.1184938538059626
SBC-5,7326481,1.449700392659346,3.082832158824118
LXF 289,9907093,2.975231625485398,4.383300232441218
G-401,SNX-2112-bortezomib (250-1 mol-mol),-1.620175957239239,-1.8600566139716903
NCI-H522,navitoclax-MST-312 (1-1 mol-mol),0.9315063640095164,0.8982965572443125
KYSE-70,159324,1.7590392520862297,3.1641892062610406
NCI-H2009,3025944,4.548991530576528,4.334762546818964
SNU-81,135398516,1.5373988209241822,1.853799912123663
A-673,9911463,3.7053308577681583,3.36553667400605
CAL-51,9826308,0.5677925602140103,0.35657065661709736
SNU-449,10074640,3.65403010435808,3.292765919431432
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273,3.2759614017758802
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687,-1.9855844312248687
JM-1,11213558,1.11781575024048,1.3672835163774164
FTC-133,navitoclax-MST-312 (1-1 mol-mol),0.3680672721218185,0.4997095599254109
DMS 273,11396600,2.9821670224503025,3.0549388316383626
CAL-51,2742550,4.689941422286605,4.103543869725163
SCC-9,salermide-PLX-4032 (12-1 mol-mol),5.953204050581384,4.9916948440158695
NOMO-1,24856436,-0.4465471145990737,-0.11709208027392495
BxPC-3,54454,2.2110977916594945,2.654434277216854
NCI-H2009,selumetinib-decitabine (4-1 mol-mol),-0.75536294855302,4.104297862521448
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838,3.7317809306235734
LoVo,54678924,0.9602640778132784,1.9893262899631836
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853,2.2113996814261565
NCI-H460,9911463,4.421747687015995,3.796283531024344
CAL-51,3062316,-2.5625958708444205,1.8340789987949215
G-401,11404337,0.5096427987118028,-0.5584016778532461
A4/Fukuda,107985,-4.34456564276242,-3.7835706218463603
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323,-1.2848957669184338
SNU-61,9956119,3.7156714580567063,3.3481230416395804
FU-OV-1,navitoclax-gemcitabine (1-1 mol-mol),3.0788972572820597,-0.9529947304920359
EFO-27,53301938,6.290465616373669,2.3524649897958447
NCI-H727,17759555,3.180616959518291,3.4095481965371888
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224,2.6033016728818295
SNU-61,44819697,3.53302657640718,-0.33555092417233223
FTC-133,16065773,0.3113531910395277,2.80578461816002
G-401,tretinoin-navitoclax (4-1 mol-mol),3.928321185847307,1.4536965531822228
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345,-0.5697551520733983
NCI-H2009,107985,-3.3237358160703843,-3.1442863825546192
NCI-H146,3676137,4.978597159303883,4.238542738834025
NCI-H146,16065773,1.505871551892472,2.274229767244429
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.7558338339572193
NCI-H661,60700,0.4833445990508663,0.03047313450434565
A-673,selumetinib-tretinoin (2-1 mol-mol),4.294042915691989,3.6212317925951014
MDA-MB-453,44491742,4.088527945953042,4.186412850706525
NCI-H661,2945648,2.4705894827529984,2.987645730025382
FU-OV-1,12001922,2.2107336164209586,1.991983672681364
SNU-81,serdemetan-SCH-529074 (1-1 mol-mol),1.2075198291977594,1.649232321336459
FTC-133,168312962,3.97521401805193,2.313990358358791
NCI-H2009,24951314,0.5822698862930126,1.5252168268397275
Panc 04.03,3552672,4.635312487107652,3.050594835334037
HCC1143,16725315,4.684699585721338,4.388911478269737
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208,2.0601833393829203
A4/Fukuda,67156097,-3.3575882698535526,-2.0414851731592116
NCI-H460,44507138,4.578042897326484,2.5079507265693763
BT-549,262093,3.1295246575488354,3.1981402238411363
A-673,BRD-A02303741-navitoclax (2-1 mol-mol),2.626339202884455,1.1265827445108239
LOU-NH91,23635314,-2.2216361010230545,-1.954663618999824
HSC-4,11485656,2.41592786996926,2.4371507805873893
Panc 04.03,2858523,3.1704472292667245,3.0843042991379277
CAL-51,31703,-2.726607914110417,-1.144980121020215
SCC-9,11485656,3.6663619913543446,2.4422317855105926
EFO-27,11234052,4.354926990140025,4.432822231523437
NOMO-1,11977753,-1.9426292333262003,-2.2880803024701013
NCI-H146,5280436,1.6778415991784894,3.0850353469412677
SCC-9,44589607,3.476138487776652,3.0565955754439575
YAPC,1716436,3.308380745751715,3.179355648574955
MSTO-211H,72376,-3.945669301292739,-1.4811368854677034
CA46,6438330,0.8057128440407828,1.1502401988758328
SNU-81,46907787,-1.0582449369350613,1.0829301813416117
ONS-76,53232,1.9476307600046912,2.8608223136628466
SCC-9,51037431,5.108150298111964,3.1521505098926266
SNU-61,11719255,3.5581483316812275,3.1518919490017727
BxPC-3,serdemetan-SCH-529074 (1-1 mol-mol),1.9726746361730008,2.332285080146002
NCI-H522,8515,4.67214972936148,3.492336693198634
A2780,104842,-8.58016789938804,-3.902093376295901
KYSE-70,56946209,-4.444419695204879,-3.703656249062347
NCI-H2171,46191454,1.782184086758524,0.836034207265921
NCI-H292,54618305,4.4370648491662195,4.434342574094035
A-498,16725315,5.296109915632034,4.626388075714158
A-498,11494412,3.741733086313002,2.3325134042201916
JM-1,36314,-7.745176622378906,-2.9227711282970112
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082,1.857258619594851
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158,2.0089540667179726
A-673,erlotinib-PLX-4032 (2-1 mol-mol),2.801712278221697,3.245651571061276
BxPC-3,72734382,5.457836982387995,4.661115029955287
NCI-H2009,72734382,3.739945681050146,4.801998202875001
CAL-51,65064,3.306239750209062,4.78503662119086
A4/Fukuda,6252,-3.645065834912594,-0.8239761930463412
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394,-3.8762572230262453
A-673,36462,-0.225010248526114,0.9485933717986383
BT-549,25195348,2.629764497852918,3.5833422831634234
ONS-76,3385,3.2517912405561784,4.0500854715778045
A-498,73707398,1.745059470984177,1.7426475126418666
A-673,56963564,0.0212663307031236,0.013894057715161388
NCI-H522,984333,-0.7488997443424653,0.3248742228510539
NCI-H292,452548,1.0483210578903834,0.6529785317885448
NCI-H661,57330099,4.147264508988866,4.31835194635745
KMRC-1,11167602,5.704956856257104,2.4822572279448383
YAPC,25150857,2.3485140693919178,2.638342564057829
LoVo,6918878,0.5506920931363443,2.8386169569914856
LoVo,5282054,3.3404837473565077,3.798953803992957
G-401,445643,3.8388087856424,3.845256525445405
Panc 04.03,31703,0.9238663549391216,-0.6920662972333672
KMRC-1,25150857,2.932634990579502,2.306993951967266
LXF 289,9903786,1.8485652979864533,2.932147307481163
MDA-MB-157,navitoclax-pluripotin (1-1 mol-mol),-3.540221681232844,-0.59799857124744
Panc 04.03,25227462,1.6849134644206611,0.8385274284783745
LoVo,5328940,0.1711764774474706,1.778590206609541
SNU-81,49850262,-1.5447601433950633,3.35148321364887
CA46,46215462,1.3062506059575565,1.1897103576445216
MDA-MB-157,219104,2.454471278072077,3.880842210024497
MSTO-211H,168313047,1.6297190097298295,2.4166606888911457
NCI-H522,16722836,1.5816295407965617,1.5266609816789878
OPM-2,54626689,3.88605573030338,4.22541621078275
DMS 273,60700,-0.3389173956036069,-0.6151433988039926
OPM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.9302198277032876,0.9559401712998288
SNU-81,9826308,-1.744878476856413,0.16640858891379387
NCI-H661,selumetinib-PLX-4032 (8-1 mol-mol),2.9532845148669495,3.828814187831157
NCI-H292,72734382,4.432039940054941,4.848550825045786
NCI-H661,11507802,0.3336368123539006,1.5155862927441908
Panc 04.03,676352,2.180457258433582,2.4108936893911674
FTC-133,322968,4.798855030018761,3.960085717244009
G-401,16720766,1.0481135004094,0.11851933372809849
G-401,462382,0.38796721763981,0.7808916808790667
MSTO-211H,25062766,2.0532887481804605,1.8895760503029124
A2780,16736978,-0.7643928517553599,1.387359859790984
NCI-H727,2729026,3.015864992302643,2.785121758571232
CAL-51,135440466,2.9511327404143755,2.468578865766487
A-498,selumetinib-MK-2206 (8-1 mol-mol),1.8815723158535835,2.33688947161238
BT-549,72376,-0.6560931555152002,-1.294817865121488
A-673,9933475,1.583729012108943,1.7502049254992194
ONS-76,navitoclax-gemcitabine (1-1 mol-mol),0.9931716655175384,-0.6575066904077046
EFO-27,135875424,4.6207788215281465,3.9913732849898995
A-673,24785538,-1.1944412082957694,1.0336051584884716
CA46,135659046,2.986085914123542,2.819678764182224
CA46,3038522,1.2076902647573031,2.5564158478149337
MSTO-211H,54626689,2.3486455994654767,4.629313921205178
SNU-61,44241473,4.262106100814371,4.544855691412847
MDA-MB-157,25126798,2.9199314308838327,3.861265651027958
SNU-449,10410894,3.985550363358928,3.563047473685003
LXF 289,53232,1.5859701947912777,2.6749169772114025
ONS-76,JQ-1-vorinostat (2-1 mol-mol),1.13707340055611,1.0756378954912063
DMS 273,11234052,4.3748762471871725,3.504087129175947
A2780,107985,-4.859396565896689,-3.5708320266770244
Panc 04.03,44202524,4.489701680422056,2.658784679846267
LOU-NH91,44185566,3.062522771292805,2.8298193599776527
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144,2.0961963990157773
EFO-27,36462,3.079082429258617,2.22612042300944
JM-1,24821094,1.723225199642946,2.382226474308089
KMRC-1,216345,4.164305633353381,3.698355312272382
NOMO-1,168313047,1.7455342513633885,2.0039297988461016
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822,3.3102099060836836
NCI-H522,5282054,2.516149277526254,3.215312143808005
SNU-81,26596,-2.2143193215677925,-1.5473063359262498
LOU-NH91,135875424,2.9424536382603215,4.060870629425362
HCC1143,446155,3.993343592958968,2.9518176867042056
NCI-H1623,selumetinib-piperlongumine (8-1 mol-mol),4.451549095180413,3.2316083551870762
LXF 289,3081361,2.235375481166719,2.6798312465563248
Panc 04.03,6918638,0.956445062850862,0.8965502441553626
ONS-76,46907787,2.0367347893242247,2.0174928074933085
FTC-133,5470400,2.075616738071143,-0.25490182003523254
SNU-449,9884685,0.40134732620175,0.6438252600053852
FTC-133,44566777,0.1715240988601806,0.7144902975266043
KMRC-1,9911830,2.7576147713752532,2.560364957735044
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767,-0.6882021774714329
SNU-61,119607,4.552023022199627,4.82354877395314
FU-OV-1,2945648,2.6612648927829348,3.056191280896192
CAL-51,5282054,3.552468823116285,3.575798115007279
A-673,1750826,-4.326827801164573,-2.395285059363326
NCI-H661,23582824,0.4459994130921247,0.6712398075474674
A4/Fukuda,208908,1.6750686900112284,2.2209978447244874
LXF 289,24180719,2.719444673565486,3.8177983213439903
MDA-MB-453,11647372,0.3935032395331521,1.2574854188957012
NOMO-1,54454,3.4949720971193083,2.3962231306532322
SBC-5,1750826,-0.5333690682178334,-0.7817250338879314
SNU-449,11234052,5.346874708028275,4.365987854145671
LXF 289,159324,2.685439807189008,3.4116135339128846
A-498,11964036,1.806054574855834,1.4878953482344266
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507,-2.858175475446203
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,2.0082597271752154
NOMO-1,11178236,-2.492998231075174,-3.306301587300141
BxPC-3,3503,1.5238678808710824,2.3075436389679225
A2780,5281672,4.494440141018236,4.360607106226063
NCI-H460,57519531,1.7606196796007008,2.533153401316428
NCI-H146,3038522,1.5824622735127496,2.816265542783764
NCI-H146,alisertib-navitoclax (2-1 mol-mol),-3.5747410805145425,-1.0462069998813543
A2780,7251185,3.0282253021168835,1.9783649161860248
NCI-H2009,54143018,-0.2798924220132643,0.5872874410190803
NCI-H661,navitoclax-pluripotin (1-1 mol-mol),-0.6328260588885871,-0.776243064656083
A-673,50905018,4.224820228350104,3.681602628043416
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557,0.9521515637418273
A2780,11640390,3.511086163886132,3.309839578652265
NOMO-1,984333,-1.7512214516120577,-0.23488408166202857
NCI-H292,3062316,0.0480521305272509,1.2651521845558762
NCI-H1623,25183872,0.2518729007636168,-0.6243819916374401
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623,2.4960426538714207
DMS 273,11647372,0.2469617170644157,0.807124193273899
KMRC-1,12001922,2.9414276180440884,1.7019437803012252
A2780,54143018,-1.3409986451592475,0.19043057263794366
YAPC,49793307,-4.348408449857898,-2.369516052411896
CA46,1716436,3.005257864158129,2.53074075973047
HSC-4,676352,2.328446260179327,2.257487647589413
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621,2.8618619883148906
YAPC,12001922,1.7591466639310227,2.112042838883811
MSTO-211H,5460769,-2.0887143253822615,2.8219984906360156
CA46,3384730,2.283076300956678,1.4037699383186635
JM-1,9911830,1.0886367976495992,1.7154142715569733
BxPC-3,1242560,2.823718248478356,3.782794463600242
G-401,44237094,3.2290132612915325,2.5594470668313103
BxPC-3,16736978,1.696086021540879,1.2684124401262735
SNU-61,46191454,1.739312628335972,1.5022047174136393
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763,2.113060841171567
NCI-H460,5329102,3.240160570329804,2.165053779928042
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.2063944719192374
LXF 289,216468,2.2889797638929683,3.2859013683488905
SCC-9,44819697,0.1293575980749295,-0.0030673420407940277
Panc 04.03,675434,5.243078667682196,4.589403555341756
HCC1143,135398516,2.188515967576281,2.524122696137325
ONS-76,25262965,-0.7369683376858831,-1.5047305738516226
A4/Fukuda,53392493,1.8640822641046917,1.9075625790528525
A-673,2130404,3.217416760546526,2.4521714783755764
NCI-H661,72193861,0.3965882674238952,1.8978384917046376
CA46,119607,3.9558807366301374,4.308121802932503
CAL-51,24856436,-0.3083697359271743,0.4250523610514684
NCI-H2009,2828334,6.796615650463657,6.219101614319933
JM-1,135398738,1.1596934849395544,2.433904516268044
CAL-51,49793307,-3.2015156477281193,-2.6746435485249807
HSC-4,10410894,2.7401570440851155,3.1542460391419294
KYSE-70,46843906,3.5210263801871498,3.1148109468225504
KYSE-70,11178236,-1.2639965798928303,-2.817502932361712
EFO-27,6610216,4.772563131438148,4.383903994953498
JM-1,135659046,3.550517545140938,3.090877007336091
A4/Fukuda,3136844,3.333855932915555,3.6503841213335293
KYSE-70,53495165,0.5494520653774981,1.0437759055764448
EFO-27,9926054,1.857839666788878,1.9932665573987478
NCI-H460,16741245,2.175171044948558,3.97910193576091
NCI-H727,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2513080779268564,3.2675367953521843
MSTO-211H,SNX-2112-bortezomib (250-1 mol-mol),-1.2312117350271496,-1.3478028912981972
NCI-H661,107970,2.2398777867932473,2.36592990500947
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149,3.2630414531032277
SNU-61,51039095,2.128467827492616,3.030104327582957
YAPC,104842,-2.4249346234244302,-2.247251575784707
EFO-27,11364421,0.0539420857608272,-1.0293498590149064
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485,2.6048766028854202
HSC-4,5284616,2.67117659303102,2.824466773300843
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351,0.9229318166316623
KMRC-1,100016,6.458679548763862,6.1997774316850425
A2780,JQ-1-MK-0752 (1-1 mol-mol),0.9266829250462012,1.7194970200060806
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735,0.7457013387837399
LXF 289,10184653,0.2846387514020494,1.594086528689695
G-401,docetaxel-tanespimycin (2-1 mol-mol),-6.677172451643826,-4.189833246582657
ONS-76,73707438,3.6763163562039103,4.156092699189841
CA46,10113978,2.0547387812543425,2.396161267996651
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923,4.10122512181422
MDA-MB-453,9444,3.890114397090033,4.032690949490482
DMS 273,462382,0.1050500144131629,0.8026521375931188
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872,2.073457310856162
SNU-449,327653,3.836895463512291,3.1697909250079728
JM-1,4917,2.618606210388543,2.643771342754262
A-673,7326481,2.3948672158707027,2.8404977526421376
LoVo,3543504,4.109477120593384,4.346392278103357
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837,-1.8068061584586916
FU-OV-1,322968,2.943455676205593,3.921347184357471
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.866534732202092
NCI-H522,10172275,5.332939953657848,2.8605779292016327
FU-OV-1,11175137,4.687876560675478,2.8534151375950394
NCI-H292,702558,5.809534673466565,5.526593435504413
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805,-0.28398129184490545
FTC-133,4378219,2.0024564120700874,2.7607493512143146
A-673,322968,2.685664332943325,3.040740750668502
A4/Fukuda,11175137,1.0544671313881684,1.8627271502807785
NCI-H522,9907093,4.234502914187168,3.9495645681071396
NCI-H460,73707398,3.251551904382877,1.6182383744291298
NCI-H1623,11625818,3.770410958253076,4.422290609120404
NCI-H2171,3384730,2.17478810564445,1.8883069493287945
EFO-27,navitoclax-gemcitabine (1-1 mol-mol),2.157503731341055,-0.6981640233561565
BxPC-3,135398516,1.0474106677719497,2.139423060810995
YAPC,6852167,3.757016833172803,3.031655309530745
HCC1143,11178236,-3.0622306456236728,-3.361049777548862
LoVo,168313047,1.791039731088859,2.4801228224504595
CA46,9915743,0.7447060154867644,0.22313406923122409
CA46,16065773,1.8844207098737984,1.718752679663095
DMS 273,2749,1.7681499736943271,1.3931410753119422
OPM-2,9549297,1.1861201303789202,1.7473743543728637
MDA-MB-157,selumetinib-PLX-4032 (8-1 mol-mol),5.042710602125305,3.6655673426640294
G-401,3136844,3.887156631896907,3.7793111010037843
NCI-H727,24901704,2.771852034083143,3.310478251383304
LOU-NH91,serdemetan-SCH-529074 (1-1 mol-mol),2.4104201077494913,2.288399060008801
ONS-76,36314,-4.67770988102335,-0.51690923390259
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356,0.5440683612180327
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401,-0.8130233275227661
NCI-H146,54618771,0.1782763900918093,0.8352513241736612
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514,-0.5097968686709619
BT-549,1750826,-1.15792790160721,-1.2269859377315644
A-673,4521392,3.83212246390289,3.8332434957144663
A-498,10127622,2.6897842830613934,3.8573237569111223
NCI-H146,24951314,0.0243539025761212,1.1793985950961892
LXF 289,11404337,0.1273620702572638,-0.09532280417309917
CAL-51,72376,-2.938334648898351,-1.5067426273351157
HSC-4,56946209,-4.10163917558625,-3.7378492127249223
OPM-2,11719255,1.0053781432887028,2.0503055014129843
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276,2.808113131342265
OPM-2,54765302,3.66991118627716,4.030292138943217
YAPC,107970,2.510985201601563,2.442063793320637
A4/Fukuda,6505803,0.0348674492980193,-0.527260292714302
NCI-H146,421610,3.280213272702812,3.014727971035943
CA46,10427712,3.800630662833656,3.4781559418530628
Panc 04.03,42611257,4.903884607697216,3.504606249406907
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254,1.6575340317442513
SBC-5,54618771,0.9612938071948806,1.3847079213434739
NOMO-1,44819697,-3.3724853213010895,-1.3695742986133703
SNU-449,46843906,3.9850337221839074,3.303601911645243
A-673,2733526,4.173930306540303,3.4901165416923488
Panc 04.03,387447,-4.060832381569581,-3.705626354006205
ONS-76,16038120,1.944596111088229,1.1214843601967082
Panc 04.03,12001922,2.0215480430072588,2.174084188896971
EFO-27,56946209,-4.24663912291577,-4.027425019639288
A4/Fukuda,15983966,4.102938700353478,-4.063347766987501
NCI-H522,10322450,3.5945001970925787,3.5819338883174425
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.3032188774912299
BT-549,16038120,1.0292862217749383,1.3423424873436403
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292,-0.47235194401771563
FU-OV-1,selumetinib-navitoclax (8-1 mol-mol),1.6329291252143736,2.3400087410681945
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912,0.288564461037427
OPM-2,10302451,3.176323712036339,2.828336772895948
BT-549,5291,3.9626748190842167,3.6717130486973897
A4/Fukuda,54143018,0.5698360241890451,-0.31617938288011865
CAL-51,5113032,4.55807021159329,4.754082863790266
A-673,navitoclax-sorafenib (1-1 mol-mol),1.9636796155178384,0.8102808245659605
KMRC-1,15983966,1.4470823508624893,-0.6232493436157485
SBC-5,409805,5.881004535625117,5.0439657131681495
MSTO-211H,11717001,4.186640197436745,4.3508404391318525
MSTO-211H,5351362,0.1292531164344693,1.838850270367141
BxPC-3,navitoclax-MST-312 (1-1 mol-mol),1.414454953268366,1.1076780736240845
A-673,135398738,4.1394757023123505,3.0387278243624776
NCI-H2009,navitoclax-pluripotin (1-1 mol-mol),-1.5280134971991166,-0.47433313155521517
NCI-H2009,12001922,2.0619007134450524,2.136501161258011
CAL-51,3634881,3.319714226315486,3.3212446800937916
SCC-9,5282054,4.577178009511458,4.180964104751275
SNU-449,6610355,5.42598000328545,4.791315482621428
JM-1,100016,5.094244415703564,4.979526076228236
DMS 273,16720766,1.3424969772091375,0.056921759776856574
MDA-MB-453,82146,5.197355724890258,3.5516809705679537
NCI-H727,219104,4.385991256377306,3.877637446518226
G-401,387447,-4.890417311710873,-4.631842992201682
SNU-61,445643,4.910443238015828,3.913625509182257
G-401,445091,4.490925944707375,4.020620223456355
Panc 04.03,10074640,3.644812120140466,3.255167060431175
KYSE-70,3038522,4.319477989558539,3.164547033174086
NCI-H727,5311281,4.417954223041409,2.3966201669635594
OPM-2,24889392,2.046562304125139,3.4188353699547633
OPM-2,9866186,1.7779199456036283,0.27792691441530804
NCI-H292,65628,4.3235700442832625,4.39241641692695
JM-1,5284329,3.614100674193798,2.493757563509843
LoVo,49850262,2.4887252685350227,3.764520909172759
BxPC-3,24785538,1.143761767664292,1.547518409600671
LoVo,176870,1.1282563754131285,3.0874896129091542
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163,1.418388323208594
EFO-27,73707398,1.1269975883077623,1.379915793017361
CAL-51,49850262,3.6300011952383584,3.5408147704714406
NCI-H2009,1750826,0.0733322198534379,-0.8413785392285166
LOU-NH91,9903786,3.184012464559237,3.0869003462196383
NOMO-1,9911463,3.1879476164010243,3.311349560023786
A2780,16722836,0.6661441985838381,1.5414057684297406
MDA-MB-453,11238147,2.2482376857817856,2.8074585424268355
NCI-H2009,11626560,0.9059448501577204,1.9323620464900142
LoVo,2746,2.3133613771451524,3.452673020086668
NCI-H661,9840324,5.7754199175322825,5.8242917122340305
SNU-61,10385095,2.7560205308704044,1.3980312226206104
A4/Fukuda,24771867,-3.7385177445932585,-0.7506426730031328
NCI-H727,654092,0.4388886539996767,-0.22184857536690067
NCI-H661,44507138,1.7319125686737762,2.4277274655622914
EFO-27,16013152,4.523705738143722,4.292711224069736
CAL-51,4259181,-0.5132501801478601,0.31572453457292476
A4/Fukuda,2746,1.0000278581130588,2.069883613215737
NOMO-1,10184653,1.080224838410231,0.6297852569624934
Panc 04.03,135398516,3.776050709281408,2.2278449169851604
YAPC,3038522,4.3203914817087234,3.2713424555894197
NCI-H292,9926054,1.8794077191249725,2.0906633847942784
NCI-H661,5278396,2.727600530538007,3.652548293976661
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654,2.5587621726713103
A2780,9803433,4.475774001896097,4.623258766217517
MDA-MB-157,11178236,-4.597953573249134,-3.318978331450793
ONS-76,44137675,3.612845962454732,3.8886896381967433
LoVo,51039095,1.8047028032602028,2.858807217432757
NCI-H522,tanespimycin-gemcitabine (1-1 mol-mol),-2.467840431866496,-0.961562513743145
SNU-61,25183872,0.0265852822027559,-0.6802706826068541
NCI-H661,10410894,2.079430431888453,3.3052488714636103
NCI-H1623,11497983,5.112351206162292,4.066408305022623
FTC-133,navitoclax-gemcitabine (1-1 mol-mol),-2.9541403252647744,-1.3435811630113235
NCI-H522,6184667,2.532079714436212,2.9159854752184042
MDA-MB-157,selumetinib-navitoclax (8-1 mol-mol),-0.2333098537360622,2.2808553633297546
NCI-H2009,44589607,3.679148722712513,3.2402613767105795
EFO-27,44137675,3.925812188621705,3.8227943187920483
FTC-133,5328940,3.204514542529291,1.8495301366014594
FTC-133,2708,3.4116435244290773,4.8091446159399265
NCI-H661,24901704,2.3315866691701395,3.4847151352465597
MSTO-211H,11719255,2.56955632094912,3.7168308372200243
OVISE,11626560,2.348997135596899,2.0678193402349696
OPM-2,ISOX-bortezomib (250-1 mol-mol),-0.1945134958657626,-0.12311619787724673
CAL-51,9868037,3.5441777448678615,3.3843041464212553
MDA-MB-157,5328940,1.5742504795877947,1.7297191669654595
BxPC-3,19582717,4.685369750995796,4.159040191958124
MSTO-211H,6852167,2.890925130180435,3.008967554553341
CAL-51,5746,-0.6872762444946757,0.9255486913259614
OVISE,17759555,4.197708618199663,3.8280236240261813
EFO-27,6918638,-0.5643283195590469,0.7329734981315474
JM-1,439501,-5.872076466297635,-2.5115245084345528
NCI-H522,44486219,4.336787525166091,4.046402045449074
SNU-449,11167602,2.762483283064935,2.632006478225591
NCI-H661,11640390,3.9877189690607993,3.7070489703284553
SNU-449,216239,2.7953722371364473,2.507740826397822
NOMO-1,17755052,-0.2814114025249274,0.7655256024117706
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414,1.9527215293261317
A-498,54618771,1.1394352833671273,1.2827559112944273
CAL-51,176870,2.9999818119422175,3.4812765372965724
NCI-H292,11404337,-1.5117614396305947,0.07541549344998093
HSC-4,9911463,3.832706037448295,3.9830822627113465
DMS 273,5470400,-1.1243568241206934,0.01403676300102511
OPM-2,25183872,-4.3499490255982085,-2.366701539431395
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894,-0.35692630852032425
LOU-NH91,31703,0.5806868540812907,-0.5153638888928518
NCI-H661,44493528,5.823125515558819,4.376898401047427
SCC-9,10074640,3.673307032160535,3.1999704376980147
A4/Fukuda,11427553,0.0702382308883879,1.5261647040811912
SBC-5,568763,0.2965266090010964,0.6592190278217874
BT-549,25126798,3.990115132251306,3.9008717147735434
SNU-449,9933475,1.8242814161965168,1.90692516452284
BT-549,2113511,7.745487386721322,5.739856679807699
SCC-9,969516,2.533129063350548,2.863441180039429
A-498,11178236,-0.0767055613398424,-3.1801313528396644
YAPC,1242560,3.336355906074855,3.7824926285697997
YAPC,54626689,5.597039319211252,4.790303528714263
SBC-5,BRD-A02303741-navitoclax (2-1 mol-mol),3.4496626470660807,2.727122891063972
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776,1.312398831547558
HSC-4,6918837,-1.8301723200742368,-2.4883213364291317
YAPC,656346,3.528875898488543,1.2485385379554224
LXF 289,5470400,3.745756378340341,0.13479040128115113
NCI-H2171,168312962,2.801787293375821,1.0914708345190223
MDA-MB-453,6918638,-1.2403270134347248,-0.15601712613426988
NCI-H522,1566236,1.6835491869847783,2.2407571401089363
NCI-H661,24964624,2.8216778680067836,2.6590379322042246
NCI-H2009,5281672,4.642324044569225,4.685376390180694
Panc 04.03,navitoclax-gemcitabine (1-1 mol-mol),1.3720951008161577,-0.21909241197128942
NCI-H1623,16065773,2.4078381094703456,2.622902708659746
CAL-51,46398810,2.084696284876613,2.625879782339065
OPM-2,54143018,-0.7196855693728514,-0.2836784511205861
SCC-9,15547703,2.91115041464476,3.2772286376200617
DMS 273,6914657,-3.971712341208325,-4.3798350663098775
OPM-2,3676137,3.169610101166173,4.217454726836475
OVISE,3025944,5.5857056433387235,4.280785187929734
Panc 04.03,4259181,1.0934261994249337,0.6103646790333197
A2780,11683005,3.0394905793504963,3.5015525476882363
HCC1143,5328940,1.7305674649682683,1.889685579353509
NCI-H2009,72193861,0.2482611586799762,1.8576629714104482
NCI-H292,6914657,-3.659053204598075,-3.6969222038445646
NCI-H522,46199207,1.8719788650663136,3.14469478627405
CA46,53481919,3.755788894439918,2.6755879582809654
LoVo,444795,4.8141558651213145,4.578775426882399
FTC-133,9823820,4.816748988305079,4.099103798691732
KMRC-1,6918837,-1.4377118656295438,-1.9721096793291282
HSC-4,44486219,5.375029781512573,4.381696956015673
NCI-H292,54613361,2.8419740491204957,0.06403506638879042
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727,-0.6724942618622904
CAL-51,11234052,5.18044926966805,4.093032872727531
SNU-449,387447,-3.8386512960067862,-4.174936775640263
SNU-61,53232,3.65751057839411,2.9476683621812567
LoVo,16038120,0.8839921956645777,1.0968485855650767
BxPC-3,219104,3.7528053800812615,3.957759338285504
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148,1.0809530565867755
SNU-81,24748573,1.8214275246808207,2.0568742360557355
MSTO-211H,16725315,3.290115596802182,4.226843847747998
SNU-61,25154868,4.341936394973705,4.285334903826027
MDA-MB-453,1716436,1.6727209102312437,2.74885446560146
G-401,5329102,1.4807949874052762,1.7874056374122802
BxPC-3,6610216,4.298723179439111,4.27904359790369
ONS-76,5738263,4.146346761655981,3.3605201491888295
A2780,51037431,1.9184867581168112,3.4250008316985925
CA46,46398810,1.9636985074186508,1.7747969508129864
BxPC-3,9936388,-5.112429278661846,-0.9052126469671496
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544,1.5340333209485766
MSTO-211H,637858,1.3984482263345202,2.069151011467058
A-673,5284373,2.9730764803314496,2.5058117276309666
JM-1,5284616,2.861882362083186,-0.3920553671523556
A-673,64971,3.704564654457452,2.3650096664069635
ONS-76,6918289,2.669224964930956,2.3441090075397626
HSC-4,11167602,1.6360881716966182,2.5930681263978617
NCI-H661,3689413,0.5447440822016135,-0.27896830162291947
A4/Fukuda,12003241,-4.192136354440014,-0.9687763193566967
LoVo,10231331,-0.6826574775964468,1.4835740833808984
NCI-H292,219104,4.068792108053485,4.143079288966726
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.6459268287742119
NCI-H460,216468,4.763843832635099,3.2650862423655918
SBC-5,322968,4.849411960208385,3.901251381430612
MDA-MB-157,135411,-1.5273896245850724,0.7849291680430052
A-498,6918837,-1.461997313484149,-2.1541668621835104
MSTO-211H,decitabine-navitoclax (2-1 mol-mol),0.593652289859318,2.638608739947365
MDA-MB-157,doxorubicin-navitoclax (2-1 mol-mol),-3.2378494218759637,-0.7580734643494541
FTC-133,36314,-6.239918298117373,-0.776373640462329
CAL-51,23635314,-2.261837237964324,-2.029586774233556
NCI-H292,126941,-3.055153146808903,-2.28637914236468
A4/Fukuda,23725625,4.971593284778653,3.8362191276361663
A2780,25105715,3.052833826388835,3.2909527123338127
JM-1,9903786,1.587415218469425,1.8885017739399863
NCI-H460,5566,3.3663694984335533,3.0484466729832347
OVISE,262093,2.7343448368987597,3.1542461478977244
CAL-51,25262965,-2.904292987251918,-1.7372277789577653
SNU-61,448949,2.574317813231787,1.7263703557658372
SCC-9,24180125,3.671852734769843,3.05227053997876
HSC-4,42611257,3.4394582921614933,3.562834730725923
EFO-27,46174525,4.9061854461465435,4.364536334308773
G-401,3384730,2.1525913455039474,2.0011234629209262
G-401,3825829,3.962498358217521,3.6459568564382305
A2780,53232,-0.3956468617212337,2.7336730381298167
YAPC,54618164,4.31457100114165,4.198477712571062
SNU-449,54765302,4.743565917095417,4.272301852650228
NCI-H460,24951314,1.96669984187411,1.447084917565941
FTC-133,11364421,1.174405518858428,-1.5454089726976679
MDA-MB-453,carboplatin-etoposide (40-17 mol-mol),3.9287174119504225,1.7720444593416047
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657,1.1879964395874625
NCI-H2171,24771867,-2.6220866978549444,-0.12307916941568539
A-498,11427553,3.7697046176741185,3.217426761746949
MDA-MB-157,5394,4.303334925677516,3.78343911317118
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134,3.1833758844795317
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372,1.1109199275366102
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477,-0.2915099837511357
SNU-61,15983966,-2.103596771317332,-2.187172016416071
A2780,9927531,3.2712332494904226,4.636414057055299
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275,1.9660957140320294
NCI-H661,168312962,0.9705864877614524,1.9149616862597967
OPM-2,135440466,0.016624870652288,1.7047661095193554
NCI-H727,44486219,4.75896405378265,4.064410134196656
NOMO-1,637858,1.0893367728071195,1.0977978912964903
NCI-H727,23725625,5.500914308976136,4.850735138189034
NCI-H661,444795,4.831383676329662,4.7959607271872855
NCI-H1623,10427712,4.824592613381889,4.377152506402598
CAL-51,11507802,1.2528060552922216,1.4444074731208922
SNU-81,tanespimycin-gemcitabine (1-1 mol-mol),-5.141011099555512,-1.091145593828851
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944,1.8175902989596022
A-673,2949965,2.43157797191215,2.2838915505682227
FTC-133,46907787,3.491897677971775,2.4917142070133758
BxPC-3,JQ-1-MK-0752 (1-1 mol-mol),0.0240612102256537,1.6553204156032715
JM-1,12003241,0.2073989775302392,-1.379906616382702
DMS 273,72376,-2.307681046282287,-2.7347418918913733
A-673,3025986,-4.4852998426095985,-0.9995889814724507
A2780,9823820,2.6289512031423836,3.416596923490665
HCC1143,11152667,-1.9901975183751028,-0.11599326070421494
A2780,119607,4.019563194528792,4.938153524931517
MSTO-211H,136227924,2.717505566177341,2.9113347320767504
A-673,3025944,3.970835118137527,3.9632885443466734
NCI-H146,11222830,0.9953145616857674,1.5486314354549895
NCI-H146,1750826,0.7822669653178473,-1.6780685041650896
JM-1,selumetinib-PLX-4032 (8-1 mol-mol),4.727165716436182,3.5120615616502397
BxPC-3,1750826,-1.1292189334445044,-0.677104816388516
CA46,6450551,1.1375422858810305,1.2468104551325458
NCI-H1623,46191454,1.8980276717062192,1.7260796944282588
CAL-51,24797083,1.5666479073716466,1.5266499665766617
CA46,448949,1.4123991312197492,1.2669007079106924
OVISE,135999136,4.426271635938179,3.901929548294845
HSC-4,2742550,4.46855499399167,3.900806292966667
NCI-H460,168313200,3.91056508525232,3.226999932203836
NCI-H292,1750826,1.4118366921158176,-1.1620076588706167
HCC1143,452548,1.7974899966046338,0.5570885311982638
SCC-9,53325874,4.533787552290022,4.6077774365891795
CA46,24771867,-0.8036362931877258,-0.9346261987880412
A2780,72199292,-0.0351373222218005,0.6767321257427706
MDA-MB-157,216468,1.0474678727125786,3.274409392994741
SNU-449,65064,5.2463646910054536,4.94508332482941
NCI-H292,9952709,2.799114874088216,3.4415903331293647
LOU-NH91,24964624,2.935669445800335,2.7787221759048686
MSTO-211H,5566,3.048712391825719,3.062644913604451
MDA-MB-157,3384730,2.532514051685687,3.0487377151348336
BxPC-3,753704,5.46289082133378,5.2174013946542495
A2780,SNX-2112-bortezomib (250-1 mol-mol),-3.4792243011702957,-1.5157252748100474
SCC-9,12003241,-1.125345709331217,-0.7695805170873271
HCC1143,285033,-0.1452813325821209,-1.3748888611299481
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.7480089011023954
FTC-133,9956119,4.526890245155382,3.7457931099770705
SNU-61,3854666,2.8565665342705735,1.9764813813883633
G-401,16065773,1.1067048318222386,2.063755856911351
G-401,11214940,0.8244141998238856,1.457629080955778
HCC1143,54618164,3.885707225557291,4.211049614621577
MDA-MB-453,16013152,4.031304285322853,4.15238468609125
SBC-5,24951314,1.1707148737631825,1.5067241447426196
FTC-133,135398516,3.4482633492568913,2.2637444863220297
KYSE-70,11625818,4.1356453826336965,4.490735180421119
BT-549,16722836,2.2023880033470893,1.9059229481608781
MDA-MB-157,54678924,0.1283777680712135,2.2361150139396506
SNU-81,10410894,4.450607476297739,3.330860486238791
KYSE-70,9926054,2.326174845830733,2.0756878052609666
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071,-1.2550385637925525
EFO-27,25102847,3.020723568572887,2.658264048854392
MDA-MB-453,5351362,1.2969167061447922,1.5666648717980984
LoVo,9926054,1.9069881185353632,2.0692874028092842
NCI-H1623,46926350,-4.300601402935136,-3.895786443931284
SNU-61,16065773,0.792903808301444,2.3443170133862203
A-673,5287620,-2.2582011832849824,-2.5165131161178937
NCI-H727,9903786,3.725485605999375,2.939788436356062
KMRC-1,72376,-0.8386976675707333,-1.8438219459770715
JM-1,11640390,2.558073354039076,2.483105264330477
A-498,104842,-1.4921326822698753,-1.6478024712052328
LoVo,10127622,2.21220618035224,3.158474348198016
LoVo,11364421,-3.7348040522268624,-1.2178971275804111
FU-OV-1,57519531,3.042184872303348,2.6614546200451397
MDA-MB-453,serdemetan-SCH-529074 (1-1 mol-mol),1.825240779322759,1.8299178112614733
DMS 273,6917907,-5.615473283892677,-5.063972235322377
MDA-MB-453,2828334,5.6655606940020755,6.1489148058704295
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905,1.6567254414830535
A2780,3025944,3.330273751246369,4.125487705267983
MSTO-211H,vorinostat-navitoclax (4-1 mol-mol),-1.2418766725750991,1.4273979987219325
Panc 04.03,11152667,-0.1106415062306802,-0.3250254820828127
SNU-449,selumetinib-decitabine (4-1 mol-mol),5.489476406274314,4.2844927604131415
SBC-5,374536,0.1871414147839566,1.9895774737150498
NCI-H661,11222830,1.6760341955617937,1.6205597028874974
BxPC-3,89183176,5.843393871566337,4.429272741525825
JM-1,135999136,3.9281924738089016,2.2872581352276327
BxPC-3,selumetinib-UNC0638 (4-1 mol-mol),1.3922516322535516,3.3325471576257546
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.2989391762439864
SBC-5,navitoclax-MST-312 (1-1 mol-mol),1.562622268083127,0.8508855891376111
SBC-5,56946209,0.800516243447007,-3.8328847293627075
NCI-H2009,5328940,1.7426808664178373,1.866724543052639
NCI-H2171,navitoclax-pluripotin (1-1 mol-mol),-1.0064664066659004,-1.2053531350722202
LOU-NH91,decitabine-navitoclax (2-1 mol-mol),-0.8280147922678951,2.3866764499005004
SNU-449,9911463,3.778924364931394,4.062968007904206
HCC1143,3025944,4.170847171640537,4.389372136599999
JM-1,969516,2.095061675415332,2.265683081390742
NCI-H460,3384730,3.247736649900264,3.0354074053448086
LOU-NH91,135411,2.1671070624345674,0.7966277393988704
FTC-133,44607531,1.7603587928522244,1.6131464572572574
NCI-H146,decitabine-navitoclax (2-1 mol-mol),-2.2755638944126644,0.7104269067146312
MDA-MB-157,445091,2.3343110617588785,4.361190768800299
HSC-4,16013152,3.4985623845199956,4.37100872212724
Panc 04.03,11427553,3.7212087866143433,3.205118962325131
KMRC-1,10113978,4.2388531684480615,3.1827292621533787
A2780,10127622,1.5174517910950884,3.6315515903029687
JM-1,navitoclax-gemcitabine (1-1 mol-mol),-5.563041913768145,-2.027839080002763
NCI-H2171,89183176,2.3651641452605747,3.159829299210224
Panc 04.03,54618771,1.7180394725494992,1.2013195325874564
NCI-H292,11485656,2.2579953762585725,2.621366432019508
LXF 289,322968,3.971478433961818,4.008114915893981
SBC-5,vorinostat-carboplatin (1-1 mol-mol),1.8980945585311684,3.038847384701087
YAPC,10385095,1.3302689043535871,1.4283678970923317
LOU-NH91,5329102,1.7122787452562382,2.2097905898070658
SNU-61,19582717,4.214212535444011,3.5203722925360608
HSC-4,49850262,4.158516161733518,3.8741295625697516
FU-OV-1,selumetinib-UNC0638 (4-1 mol-mol),1.7956327688699871,3.404572874641085
NCI-H661,123631,1.2265867761007856,2.6168928706258474
KMRC-1,3062316,-0.7612421720697753,0.8046783845763847
BT-549,9936388,-4.888200161073446,0.30840768814767755
HSC-4,24951314,1.4348411807415282,1.5037151269805915
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.6459268287742119
A2780,navitoclax-pluripotin (1-1 mol-mol),-1.8595742905962285,-0.7670608112611772
SCC-9,9933475,1.8547363245124415,1.8741666104540837
CAL-51,9936388,-5.638746232401389,-1.1412379764534035
KMRC-1,ISOX-bortezomib (250-1 mol-mol),0.316621545277449,0.5075559137643257
CA46,72734382,3.577472012209052,3.4241863891309094
NCI-H661,16741245,3.244500107466936,3.7832949311306585
SNU-81,docetaxel-tanespimycin (2-1 mol-mol),-6.596466940190321,-3.056183994931562
HCC1143,11964036,1.1986784595252613,1.3318937468439906
NCI-H661,selumetinib-UNC0638 (4-1 mol-mol),3.9317627584077695,3.812389366876597
A2780,126941,-2.3178428604154746,-2.763576487562259
A2780,navitoclax-PLX-4032 (1-1 mol-mol),1.492192553915411,1.3496265330612627
NCI-H661,24753719,3.905315348750775,4.427384480314147
SBC-5,25126798,4.2020115243555285,3.781657876701152
NCI-H146,6917907,-6.190181636892531,-3.9763961110190706
NCI-H661,1750826,-0.2904028146963975,-1.2416805873792358
Panc 04.03,navitoclax-birinapant (1-1 mol-mol),3.2417464009141845,1.8623260419459533
ONS-76,613753,4.08215787211526,3.169177862585139
SBC-5,3689413,-0.1482568941323282,-0.1343667164647793
FU-OV-1,446155,2.635089718837861,2.890459353022892
SNU-449,216345,4.054978999003172,4.287306205516696
CA46,6918328,-3.721989268042841,-1.6638928126746924
CAL-51,5978,-2.6819752982341463,-2.1363769047950103
MDA-MB-157,57519531,1.1252399396652772,2.6342214476053005
NCI-H1623,51037431,4.287686451446288,3.3238944644101935
A4/Fukuda,5394,2.6676913787283305,3.6483043097176404
MSTO-211H,151289,1.1545674452198869,1.3684394478677833
HCC1143,3825829,3.893715702367038,3.990767134974755
MSTO-211H,374536,3.2477584475462904,2.541614335301535
NCI-H460,6610216,4.838717363885395,4.30577192630864
CAL-51,54618771,0.0049145289548569,1.393161726932799
CA46,1239801,3.4142476342729817,2.940312023211502
A-673,9956119,3.229119212963112,3.2445929926906443
NCI-H460,73707438,4.549718141383013,4.185061832705987
YAPC,9936388,2.1810367621372095,-0.6040441129559693
LXF 289,4705,5.10311909598278,3.4320275825764126
CAL-51,54454,2.240351559744082,2.4753150248185336
JM-1,4788,5.493172342149484,4.914329634508997
SNU-449,262093,3.0394524195162766,3.0834852946515485
EFO-27,46926350,-4.056205960361391,-3.914585374238854
SNU-61,5566,2.945300560810773,3.0156925407794564
Panc 04.03,6610355,5.365295116093154,4.619222971411867
NCI-H727,navitoclax-piperlongumine (1-1 mol-mol),2.3472848325526448,1.7396431413390168
NCI-H1623,56963564,0.7315466561739135,0.6146034187973249
HCC1143,10113978,4.851592729588868,3.632562946275201
NCI-H2009,navitoclax-piperlongumine (1-1 mol-mol),2.538490249667484,2.060440961304734
LOU-NH91,5311281,1.0411900413843744,2.7256926961352037
KMRC-1,24856436,1.3740575733249207,0.7738152254544608
SBC-5,400769,-0.0932857286492618,-0.40574170616569055
OVISE,11964036,1.5054845636014844,1.568990124127812
JM-1,1716436,2.291915875842717,2.453787559813075
SW1463,6505803,0.5252870082270547,-0.7309258181900773
A-673,navitoclax-pluripotin (1-1 mol-mol),-1.5806846608606773,-1.1801919890326764
CAL-51,119182,-1.323881847361974,-0.6754428989860215
A4/Fukuda,4788,3.9402862208503753,5.13917497491316
SBC-5,9926054,3.0567796435466628,1.9360812152177207
EFO-27,vorinostat-navitoclax (4-1 mol-mol),0.8763520950927793,1.4016030388640155
G-401,3634881,2.5006119442923938,2.926143670690364
NCI-H727,9911830,2.860892848593743,2.662757050544057
G-401,9911463,2.712760379614347,3.4746432193102352
NCI-H460,15983966,-0.5601417251503862,-1.9888494825188439
BT-549,serdemetan-SCH-529074 (1-1 mol-mol),2.72716237465292,2.2804294814011654
NCI-H292,31703,-1.868725819699569,-0.47346157897475677
NCI-H292,11175137,3.5103695935197328,2.8482178103739635
NCI-H2009,3543504,4.270240870629309,4.504835000524388
EFO-27,702558,4.734643042503988,5.40594960063391
NCI-H292,107985,-2.5053359043606043,-3.168806249276185
HSC-4,25154868,3.1331848354363063,4.489099323231982
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545,-2.2192447630946974
SBC-5,doxorubicin-navitoclax (2-1 mol-mol),-2.1214883367160113,-0.8958523033321266
MSTO-211H,11364421,-5.484172518994792,-1.788024942888232
NCI-H460,11238147,4.460003386993959,3.0547928994354625
NCI-H2171,60700,-0.3771090207819011,-1.2897530766899683
LXF 289,1641662,3.640483694902119,3.5245639798351345
MDA-MB-157,49793307,-3.250396628323611,-2.355001733854428
A-673,3503,1.5343061624145853,1.9470322910356663
LoVo,10296883,3.831816674357036,3.8304554629319627
HCC1143,6917907,-6.676374133945339,-4.565893617673725
NCI-H661,44185566,2.810411867420033,2.7331201633786075
NCI-H522,23725625,7.287275637495971,4.350948888771225
BT-549,11175137,0.9532540120968724,2.8686734195433172
BT-549,9840324,5.7680719211185005,5.85593361215836
DMS 273,42642645,-0.2214891751848421,0.3283216790621981
LXF 289,24797083,1.462636821965973,1.599288393215657
A2780,9887053,0.4462184617201571,2.959263297164895
G-401,3689413,-2.428789331956376,-0.641788136667984
NCI-H460,65064,5.803776096144955,5.091411660162254
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666,2.3568690069161
CAL-51,452548,-0.9080095532304931,0.31344772319495945
NCI-H460,54613361,2.8642714411834502,0.006644143747619346
YAPC,675434,4.582728256156342,4.747404143995925
KMRC-1,4578,4.295676817145532,4.322270844262007
BT-549,387447,-4.9509675804959,-4.045949109183432
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652,1.597943684238655
EFO-27,11719255,3.4932821683662865,3.7415115986434184
OPM-2,219104,1.446566622432128,2.4491726642737315
NCI-H1623,6610216,4.306736710776884,4.258119772715588
NOMO-1,23582824,0.0799476906959343,0.7556404611018996
NCI-H292,6610355,4.982353204264952,4.505175767378814
NCI-H2009,46191454,2.1369399253900347,1.9509842942111397
NOMO-1,3062316,2.517026306117631,0.6337234913298947
NOMO-1,119182,-3.695250738066314,-2.3618771312562346
SNU-61,decitabine-carboplatin (1-1 mol-mol),5.043967029141517,2.406821267183311
FU-OV-1,11364421,-3.956792545928709,-1.3883559686700548
OPM-2,17755052,0.9533058757913144,0.9132136163024849
SNU-449,doxorubicin-navitoclax (2-1 mol-mol),1.3165597718985669,-0.701553955392665
DMS 273,46199207,3.605640907411319,3.210800615507045
NCI-H522,55508,2.4640988254574356,3.147367629478677
NCI-H292,10385095,1.2562128411100733,1.5328466987218514
SNU-61,piperlongumine-MST-312 (1-1 mol-mol),2.3794490551959107,1.8767530418542875
CA46,107970,1.651382626144423,1.9932849278092406
EFO-27,5746,1.7615281276545924,1.3983182098871245
OPM-2,24856436,-0.767009816479034,-0.32169567851192704
CA46,25126798,3.582571225160254,3.257195408480805
YAPC,89928392,2.607647468641453,1.6557123433115435
MDA-MB-453,3062316,2.3886014193927285,1.396788301772517
MDA-MB-453,387447,-4.667010811634082,-4.1077052569002435
G-401,107985,-4.394015959361378,-3.3654941051598297
A2780,decitabine-carboplatin (1-1 mol-mol),3.747400322321459,2.3998526240177642
SBC-5,135875424,3.947045576812926,4.1340038902665555
KYSE-70,24785538,1.5800117539652696,1.5660483329987656
BT-549,25262965,-2.559107571112332,-1.1985238599771182
G-401,selumetinib-PLX-4032 (8-1 mol-mol),2.777074550060763,3.682802129270935
BxPC-3,2828334,6.44946379786602,6.190082767369623
NCI-H460,3025986,0.3909368316008428,-0.817656000819497
DMS 273,11656518,1.6608448179793895,1.3479026274527737
EFO-27,3825829,4.213579429540561,4.190010815757976
NCI-H146,44493528,1.3818057906729433,4.243001301953633
CAL-51,73707398,0.7053044464230985,1.1242142896845264
NCI-H292,148198,-2.0841293800573446,-2.978506524014258
NCI-H460,2828334,6.134119597935603,6.151255167423681
CAL-51,439501,-2.444412450902406,-2.306884189317507
SNU-449,73707398,1.8238531786702632,1.4099737933590404
A-673,10322450,2.1969870036583323,3.543719294552375
NCI-H2171,71466380,3.3392440967630797,4.2304993883369555
HSC-4,53392493,2.986961827224748,2.75345985963802
OPM-2,1239801,3.3443313732590543,3.0498906921717337
LoVo,9935249,1.1872155844887071,3.221881390190169
G-401,1566236,1.5621622205700352,1.8565514794265123
HSC-4,9907093,5.592562690426939,4.210740980851604
MDA-MB-453,445091,4.203535883394564,4.428071003100367
EFO-27,24821094,3.745327872256005,3.2384814748597552
KMRC-1,3038522,2.3225128068669676,3.154498074275334
NCI-H2009,11427553,1.9586555200212517,3.014070535265793
SNU-449,25227462,3.4571199035251565,0.989622726629335
CAL-51,136227924,2.079284078064279,2.9370902431113524
ONS-76,452548,1.1046001555889895,0.08393630817750268
SNU-449,25105715,3.5056666677867625,3.5095958464033465
CA46,156414,1.2808873732328336,0.650362460782581
SNU-449,400769,-0.6000208096132458,-0.36253354963735135
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076,2.9178138469392696
NCI-H146,462382,-0.5302162316770459,0.4841738235572018
NCI-H460,613753,5.368273372553464,3.2815403418100213
MDA-MB-453,3136844,3.6967063162994114,4.1749055506258035
A-673,5281672,3.4533278359325323,4.316102324165672
A2780,salermide-PLX-4032 (12-1 mol-mol),4.80403055299543,4.7113765067426385
EFO-27,1716436,3.5844471141038823,3.1686022143443937
SNU-449,3825829,4.613153689576251,4.273183097140013
NOMO-1,73707398,0.2786764614411772,0.40049291403848986
A2780,568763,-1.431759576680003,0.3050665984766527
HCC1143,6918878,5.533567107436573,2.878389637597319
LoVo,11455910,2.8170443999319574,1.023349006738676
EFO-27,23582824,2.0177544133250187,0.8036871065493986
DMS 273,crizotinib-PLX-4032 (2-1 mol-mol),1.107090848194829,1.5603559890829777
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711,2.508726602379873
MDA-MB-453,44819697,-2.6195477020037696,-0.2907870139493544
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.3582602050637156
A4/Fukuda,7326481,2.3355820774301206,2.757923701029753
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935,0.18702707546685216
DMS 273,5566,3.001039957404815,2.952549641028554
MDA-MB-157,148124,-6.016678597172854,-1.9879180766054996
LoVo,11507802,0.9778049572121082,1.659455695132193
NCI-H522,9444,4.166279980928258,4.185878078066541
SNU-61,crizotinib-PLX-4032 (2-1 mol-mol),2.112541337520524,1.6460509715726315
MDA-MB-157,9549297,2.7932032986762008,2.775518130930227
YAPC,3689413,3.09003195173071,0.615172837011527
KYSE-70,10385095,0.9665013844498838,1.6925364000305279
ONS-76,11222830,1.7336224967240552,1.6987611072865016
JM-1,11625818,3.7613008305210727,3.362130841966385
LoVo,16736978,-0.2277330125842315,1.3718507495195917
NCI-H2009,10074640,3.329342225437922,3.333722204652113
MDA-MB-157,selumetinib-piperlongumine (8-1 mol-mol),2.303505265933228,3.4697720706903903
NCI-H460,9866186,0.4176494313944011,0.98118898828481
DMS 273,piperlongumine-MST-312 (1-1 mol-mol),1.0735064497414797,1.4422197878012457
A2780,60750,-0.3844759756013921,-3.013789891318197
MSTO-211H,5329102,1.1990183253858175,2.2041788933566675
NCI-H292,60700,-1.1983388185725197,0.13599511494648472
OPM-2,16659841,1.643311806599576,2.6178114558325336
NCI-H661,11427553,3.4193847918785782,2.9754991244788056
DMS 273,445455,4.9732665628078045,4.045836688697799
NCI-H460,9967941,4.030885542149613,3.8352451269399888
NCI-H460,5281321,2.142807178276493,-0.7065795721483284
HSC-4,44137675,2.9134227764609735,3.5610257138119272
HCC1143,2729026,2.66692124656069,2.7052783206313666
LoVo,1566236,1.5203890875485482,2.1417527430056635
NCI-H146,2842253,3.419228107779433,4.655688319598086
BxPC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.1893497843020568,2.053658026955536
G-401,navitoclax-birinapant (1-1 mol-mol),1.830641570341204,0.3985979496225739
NCI-H522,5311281,2.6748920868920125,2.273292967157035
NCI-H2171,2945648,2.4840683519833835,2.4457932753826883
OVISE,9840324,5.37005208850368,5.767172787766939
NCI-H522,11485656,1.866098793785005,1.9584896834559606
LoVo,5280436,3.7935840263164984,3.617056353135331
SNU-61,11152667,-1.0116802565381595,-0.9908029128075739
NCI-H460,2708,4.613368759945332,5.099603292450127
JM-1,6918328,-3.1408711543116854,-1.6557547625369728
ONS-76,1716436,4.404636467874722,3.064053194618826
A-673,vorinostat-carboplatin (1-1 mol-mol),1.8302271851347216,2.3909745977302057
EFO-27,241158,4.165561573655071,4.111669383290833
A2780,7326481,2.2466116261364215,3.1098338185580343
SNU-61,11507802,1.2021022137126776,1.3494424464849515
MDA-MB-157,11404337,0.0143481506183785,-0.3404484431483719
CA46,71466445,1.6737757590775906,1.9594868783130102
NCI-H727,5329102,2.005304296489746,2.039987285274594
HSC-4,51039095,3.5449735354798,2.808224815085228
SNU-61,135411,1.4786327368897634,0.480079040245531
KYSE-70,23635314,-2.258343718513796,-0.7805618368906688
LoVo,54619267,3.1603381625719,4.067541378588993
A4/Fukuda,71751553,4.0599050322296995,4.113838711847451
MSTO-211H,156414,0.8242215144670997,1.6448304708255648
OPM-2,salermide-PLX-4032 (12-1 mol-mol),5.221268337510566,4.582910760991594
FTC-133,44185566,3.3632936032593403,2.737699702502212
DMS 273,448949,2.08082767357287,1.611187341662191
NCI-H2009,71466578,3.1093531088855797,4.831015607113177
G-401,44632017,0.8985354611426208,1.000485267820971
BT-549,selumetinib-MK-2206 (8-1 mol-mol),3.7435094380917793,2.6875254138041504
HCC1143,107970,2.31840177997234,2.4047596355308904
NCI-H661,156414,0.2928474479064595,1.828285036391108
OVISE,216345,4.54917324344274,3.558197250394211
SCC-9,25227462,0.3695734481821194,0.9053275250319868
FTC-133,46199207,4.2182762440826576,3.091665828611249
Panc 04.03,9926054,1.9560696374821285,2.0035590828790095
G-401,6918736,-2.2327850291733577,-1.8758776717033487
SCC-9,44607531,1.3853072214617428,1.7159753113317864
NCI-H146,serdemetan-SCH-529074 (1-1 mol-mol),0.832618254010713,1.6464773781217923
HSC-4,171352865,4.360447231593142,2.5991098733317077
OVISE,613753,2.681502253258482,3.2360700467179644
A-673,5282054,2.3452018577417166,2.8826376641317797
CAL-51,5328940,1.595278406971918,1.7715634394575028
G-401,426756,4.944025345893246,3.9515831922119067
BxPC-3,selumetinib-PLX-4032 (8-1 mol-mol),0.9505923867338788,2.906696863416869
FTC-133,73707398,1.7335394908123083,1.4336542129798309
LoVo,20959075,-3.964629838563966,-2.5792736730945647
LoVo,46907787,0.5340804086119918,2.0420592018326955
FU-OV-1,9907093,3.428205270837273,4.387406158494797
NCI-H146,5470400,-3.389889619220011,-0.4920613431122969
FTC-133,60750,-2.331663889988264,-1.5273106854418521
NCI-H661,637858,2.3544841299222927,2.08660922631457
NCI-H460,24772860,-0.596461213785507,-1.7643132469746157
FTC-133,135999136,5.800253145127344,4.013255249888916
SNU-61,2945648,3.4316222719918903,2.939260124159149
SBC-5,52947716,-5.148190181120178,-0.9311516220434213
G-401,5311,0.6627378317361174,1.0253661777646732
SNU-449,25183872,-0.2769192593247403,-0.50522762360494
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.3237708929346166
A2780,444795,1.1255727490438436,3.6914860915343892
HCC1143,11404337,-0.7051632820466462,-0.15958339467841817
LOU-NH91,23582824,0.7266398713670753,0.9881800234758135
JM-1,24964624,1.3785887120991174,1.1659770349147847
SCC-9,6918328,0.8244293983868239,0.5304329859166256
SBC-5,44507138,1.9527307391432291,2.422264247509592
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084,-0.42298264996848667
HSC-4,3081361,1.976322212956416,2.213865980613366
MDA-MB-453,navitoclax-piperlongumine (1-1 mol-mol),1.490500263606314,1.360879025757744
A4/Fukuda,73707398,-0.4328093310020208,0.4919821664517907
NCI-H146,2130404,3.7873290414593983,2.7407638263191676
NCI-H522,11656518,2.6059049947054533,1.3786023117407786
A-498,11626560,2.3564203123568648,2.2013068599769627
A2780,17755052,-1.4995675278651837,1.810426032112669
HSC-4,2841722,4.578140166849417,4.4922600161050354
JM-1,44462760,2.3346005220819785,3.1058043813594645
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372,1.4919659245958454
FTC-133,4261,1.6400921135700228,1.7356626409037392
LOU-NH91,54618771,2.8270991446030593,1.4815744639489414
NCI-H1623,16720766,0.9555863303424396,0.943054672860542
BT-549,44632017,1.021144372127497,1.8056494698828494
NCI-H292,107970,2.31632347859771,2.41098985238295
SCC-9,24753719,4.411411644196846,4.485871793463154
KMRC-1,4917,3.6746853329943248,3.2071099050198115
NCI-H661,72734382,5.266471995298585,4.758776437031184
SNU-449,4578,4.5704959764236675,4.718157161923349
KYSE-70,9887053,4.5630363901990565,3.9350816634118155
NCI-H460,81146,4.483282466350705,4.933642745860739
G-401,637858,0.5800115670130345,1.1919669912741147
BT-549,5280436,2.325988989460079,3.461156541551398
HSC-4,107970,2.304506496588027,2.248021922022713
NCI-H292,421610,4.310067764922952,3.336517135265053
MSTO-211H,11175137,1.4320314455831638,2.8847388162856746
BxPC-3,11175137,2.81920931641519,2.7180789709731346
G-401,vorinostat-navitoclax (4-1 mol-mol),0.632092146955943,0.5514725422807805
NCI-H292,11625818,5.668815438823822,4.628238664676049
BxPC-3,3025986,-1.3024282207469429,-0.8754651701358473
NCI-H460,11364421,0.3566052665939138,-1.4952340731287623
MDA-MB-157,3385,-0.6145392702282009,4.391187869927946
DMS 273,44589607,2.105355871894398,2.0655848801032497
SCC-9,107970,3.0149180037966095,2.4248344227191003
Panc 04.03,17755052,3.2992451395509503,1.955884127804917
LoVo,10427712,4.119455144779727,4.215044979842354
MDA-MB-453,ISOX-bortezomib (250-1 mol-mol),-0.3200221310037367,0.8189841882055261
OVISE,9825149,2.776616936788869,2.3569469596635724
DMS 273,44185566,2.401025824688418,1.947062247081948
SBC-5,selumetinib-MK-2206 (8-1 mol-mol),4.137952563186265,2.3766462461370885
EFO-27,5329102,3.2209933806874926,2.3307768281949834
NCI-H2009,3503,2.6223022737526085,2.399249538767511
SNU-449,66577038,3.1506640300230075,3.0887790337958636
SNU-449,135999136,4.264029635041134,3.643719707035254
MDA-MB-453,16725315,3.1590887754383847,4.437375076493904
SNU-61,6505803,-0.8091898598550518,-1.0962717514729639
Panc 04.03,6438330,3.1739512088269968,2.5766708381023973
SNU-81,124202324,-1.5604837877349913,1.7656922727728233
Panc 04.03,navitoclax-piperlongumine (1-1 mol-mol),2.817487895898936,2.055462399177015
FU-OV-1,49850262,3.0107305406398206,3.9747363592472436
FU-OV-1,selumetinib-MK-2206 (8-1 mol-mol),-0.4869777969309855,2.5878793720867237
ONS-76,54618771,0.5276024038238057,1.363702034311286
SNU-61,5311,1.5459052759872411,1.0045384268690372
CA46,11612883,1.866301185217262,1.712393398694019
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009,1.9532028224452318
A-673,11960529,3.1772019850221054,3.6137696073979635
YAPC,400769,-0.4056066486406303,-0.24852696385501027
KYSE-70,107970,2.5727619321994353,2.2382989463205143
JM-1,5291,3.241129374385646,2.8365470247553928
KMRC-1,9444,4.31479767249553,3.9405105712096207
NCI-H727,44819697,-0.26094531007839,-0.24149975579035818
NCI-H2009,5351362,1.2372754831617516,1.7652379754201488
LXF 289,53495165,1.0389398894889437,0.8583279514709247
ONS-76,vorinostat-carboplatin (1-1 mol-mol),3.120131426487973,3.0602126497365356
NCI-H727,123631,2.758434269009812,2.3428783385953884
NCI-H2009,5311,0.3641463076187463,1.566759137090977
MDA-MB-157,241158,1.407364121620741,3.9239741046636176
LXF 289,24785538,0.6202102990423739,1.8986659949097924
BxPC-3,10074640,2.675443562621253,3.208939406916811
G-401,4378219,4.593157039926137,2.062789028178483
CAL-51,445643,4.334473435217703,3.9076872319230493
OPM-2,2858523,3.124441680057984,2.809581644037763
NCI-H522,tretinoin-navitoclax (4-1 mol-mol),4.26592131531013,2.2835381483593613
HSC-4,11175137,3.5997845208099797,2.745576136924192
MDA-MB-453,25126798,3.9955340419002057,3.64246836254784
SNU-81,159324,-2.5700546068481502,2.2018574091639618
SNU-61,3552672,2.025857953798933,2.6156117060241946
FTC-133,246676,4.92384525208296,4.444186046899179
MDA-MB-453,11364421,-1.677319267600166,-0.5703377101093715
CA46,122327,3.963727711050333,3.6572401527724088
LXF 289,262093,3.4150141342974605,3.1252345209352854
NCI-H292,6918289,2.42392533304279,2.7704056800530354
NCI-H661,25154868,3.681430006213129,4.399402311751226
NCI-H522,327653,3.011425661783578,2.9817920964952735
KYSE-70,44202524,1.884457998669868,2.4403262442196283
A-673,8515,3.2253171108003023,3.4512828674425418
SNU-449,6505803,1.2866498789511422,-0.1840798665016514
FTC-133,10074640,3.79174067417729,3.169187227739041
NCI-H522,72734382,6.037966635177564,4.266962170177431
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-0.8109781954548295
NOMO-1,46943432,0.592792127892358,0.8090316265049493
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056,6.224228964460428
MSTO-211H,15953870,2.3250629767102273,3.6745750038639953
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373,-0.9164004075082086
NOMO-1,24951314,-0.0494287054100275,0.2025069434883182
NCI-H292,6918328,0.4467511585294103,0.2702404833691675
SNU-81,72193861,-0.4444993909438327,0.6674285593522505
SCC-9,9956119,4.352516606884389,3.803365402614448
CAL-51,66577038,4.134711160885491,3.096191722772625
MSTO-211H,44489675,3.600660518296678,3.963132616714762
SNU-449,11494412,2.814472666417892,1.852340614173508
OPM-2,navitoclax-MST-312 (1-1 mol-mol),0.8084377370546902,-0.0338499739260319
NCI-H522,11364421,-6.31463288554187,-2.5073322576676897
OVISE,11222830,0.6942836946088363,1.9459158189348642
LoVo,135398516,0.8347424818537327,2.202121035873929
MSTO-211H,409805,4.793476239157615,4.887221580168395
SNU-449,selumetinib-piperlongumine (8-1 mol-mol),4.611443902148163,3.6771023285460616
MSTO-211H,9926054,1.9546831701161536,2.244414762205467
NCI-H292,2749,1.484796478537434,2.135712038229192
OPM-2,702558,4.8466631372101725,4.169142765343398
LoVo,71466445,2.646256567071358,3.9452962271015655
BT-549,16659841,4.205377629414311,4.092867972088951
KYSE-70,3025986,-0.3454993097331295,-1.1121353148017894
NCI-H2171,15953870,3.344319567560605,3.177849310334444
Panc 04.03,11640390,3.824707626147026,3.7601294573664568
NCI-H292,5278396,3.8202006656128735,3.6812765474936895
NCI-H460,5311,2.161812802665503,1.5549532859834247
CA46,54596558,4.227379600712383,4.2164366653343315
NCI-H522,50905018,5.2003053075185734,4.014070165468739
JM-1,54596490,4.858476490911798,4.1028871342617625
KMRC-1,5281672,4.43646792139098,4.668524850060494
SBC-5,46199207,3.436092011920994,3.2562627005926688
NCI-H661,46907787,3.1119891404607083,2.561687505022358
NCI-H1623,11222830,2.056201659978474,1.7814540792665874
SBC-5,3038522,3.9213361824350024,2.9950640514855893
NCI-H661,9926054,1.7811448977738318,2.0477910578875687
LOU-NH91,969516,2.9922565120136944,3.0833449845400636
MDA-MB-157,5329102,3.39801486229995,2.15642991502972
SNU-449,445643,4.11461116511151,4.030805346002991
NCI-H522,9887053,3.177768808520637,3.425127843962278
NOMO-1,16065773,2.6012917178973405,1.8780244069408603
G-401,67291369,1.7656191364648908,1.8625645847574057
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076,2.024746837476472
MSTO-211H,11609586,2.648073114002603,3.208081480549518
A4/Fukuda,25195348,0.8993846970771071,2.6165217676628973
NCI-H2009,54649381,3.659944396907473,3.933235524377454
CAL-51,3025986,-1.0834382414923172,-0.5622120712167523
EFO-27,52912189,5.780518526906142,2.5035163017450923
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942,-2.004782142737084
A-673,123631,1.860693828866879,2.2736885972488343
A2780,44632017,0.0856486258730489,0.7909901712859402
A-673,24901704,3.0162186042420966,2.7676173985477597
OPM-2,168312962,0.8773607091058507,0.974941527814165
NCI-H292,46398810,2.6001901820453166,2.7329821133267576
SNU-449,53495165,1.8844225218094013,1.2539680006425042
YAPC,2749,2.2394739682848512,1.9331628852237108
NCI-H460,4788,5.894567383019075,5.682031753912988
LOU-NH91,637858,2.168731257760998,2.2255960729785924
NCI-H727,11427553,2.8726920198872397,2.6283999439025347
NCI-H2171,5978,-3.1305615418900468,-2.914659293353618
EFO-27,969516,2.57565712333896,2.9291624563593626
SNU-81,11152667,-1.3658791794225291,-0.6915970798204013
LoVo,2858523,2.923658201852042,3.0582639344187585
FU-OV-1,56946209,-4.492733112758285,-3.8020980052935416
CA46,9549297,1.0960598621603344,1.4649841820082816
ONS-76,6917907,-5.751164378556486,-4.84204346249983
NCI-H460,51037431,2.104101453867928,3.2221748350833237
CA46,68056272,3.136594245199668,2.8422724943425886
CAL-51,54143018,-0.6388505972102335,0.31043456725647545
SNU-449,5284329,2.300938885216567,3.598343812240801
A4/Fukuda,11609586,0.4485915276425587,1.9348602758726219
NCI-H146,9933475,1.6402256772331771,1.9683193861682549
NOMO-1,9927531,5.049638663441057,4.339354528804459
A-673,148198,-7.755828732328633,-4.095165049159021
SNU-449,2113511,6.338115821615388,5.735007698290836
NCI-H522,49793307,-5.2014711504438,-3.0667345088472304
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332,6.154089078303859
FU-OV-1,44493952,2.9850522959236883,3.776301468451434
NCI-H661,5328940,0.9675290055268168,1.8461478525468056
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693,3.996527655497307
NCI-H727,60700,1.7894131654495464,0.08979864146532444
MDA-MB-157,10385095,0.7848337329764868,1.326656302589089
DMS 273,46224516,2.6849968878024297,2.436623258580356
G-401,1641662,3.2482177517563766,3.1855807008128014
NCI-H292,448949,2.3471350598248795,2.173207338776738
ONS-76,3038522,3.87205505246704,3.1517507482636757
G-401,216468,0.7704979015554879,2.1386836960594935
NCI-H727,10127622,-2.4732053445147333,2.9671316567462593
JM-1,erlotinib-PLX-4032 (2-1 mol-mol),3.366484807659052,2.8414335445476957
LXF 289,16722836,0.8079280065417594,1.8146526350325203
FTC-133,11167602,2.051836472120041,2.904839419623558
LXF 289,3825829,3.6707575370566534,4.297006810167069
CA46,25150857,1.719157108492683,1.4421068791071365
NCI-H727,3025986,0.1020219293656271,-0.5878016506338878
MDA-MB-453,107985,-4.386344018126506,-3.7390853156928667
NCI-H1623,72193861,2.1993190803521423,1.858599789252048
MDA-MB-453,decitabine-navitoclax (2-1 mol-mol),3.3987025983008468,1.5111370441254863
ONS-76,12001922,1.7268373273866384,1.9222164410227782
LXF 289,5460769,3.06478422280727,2.7735116251612846
MDA-MB-453,doxorubicin-navitoclax (2-1 mol-mol),-1.00600213948852,-1.036611467144177
LoVo,9967941,3.621110602900207,3.7188878624714774
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849,0.9559596830302941
NCI-H727,5113032,6.018394893069797,4.694673198372487
MDA-MB-157,5351362,0.7984725267524495,1.576228963657608
JM-1,1641662,2.861679408031504,2.752347082394049
A-673,JQ-1-navitoclax (2-1 mol-mol),0.2328293171340499,-0.18058834962529388
MSTO-211H,445091,2.4700472101717312,4.67272127998076
NCI-H146,11404337,-1.5914515878545687,-0.6187706359693397
CAL-51,11364421,-3.809863778172731,-2.119324127194238
A2780,4096211,0.5297517602102724,1.5353871346946977
SW1463,23635314,0.7077124425294024,-1.8887311818380972
EFO-27,9933475,2.2279721994416364,2.062012576930979
CAL-51,135875424,4.33643967165441,3.7515074163910396
NCI-H1623,15983966,2.013058792543676,-0.04645151384453644
SNU-449,3038522,2.1807259662851735,3.223347655030338
SNU-81,969516,2.098687325749346,2.6484269501532163
SNU-449,9935249,2.650976699885872,3.349527891192036
LoVo,10385095,1.3603816893768768,1.3673628554000203
ONS-76,322968,4.979501026393853,3.8230627672971265
DMS 273,9933475,2.0005654751864865,1.8962561315110562
CAL-51,71466578,5.340961831553399,4.6506466635164
Panc 04.03,selumetinib-PLX-4032 (8-1 mol-mol),4.2289817394660805,3.6356878844649687
MDA-MB-157,1750826,-3.091616753079083,-1.4116889484768487
G-401,salermide-PLX-4032 (12-1 mol-mol),5.25337589730296,4.577927080474541
NOMO-1,702558,2.777027807122979,3.94624060935473
YAPC,60700,-0.2763967023007928,0.008570429474587676
CA46,5287969,-2.5448622649608925,-2.156294598231107
CA46,15953870,3.0438117584706164,2.9628002989082143
A2780,selumetinib-UNC0638 (4-1 mol-mol),2.0119949051388493,3.185544155736471
YAPC,6610355,5.243598963135711,4.6784981315993415
SNU-449,4477,0.3396527753410003,0.6568055013273689
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152,2.121063122074402
SCC-9,168312962,1.0708744032070256,2.2255746949234947
SNU-449,119607,5.345576432951938,5.42970964806979
LoVo,135999136,5.7154474843469565,4.190230596585983
NCI-H146,984333,-0.904410626141992,0.4303693632994014
KMRC-1,54619267,4.117989845600413,3.973944932813603
A4/Fukuda,11485656,1.5130746228374388,1.5086347820695507
BxPC-3,5311,1.3160685062040935,1.6997937684986766
NCI-H522,3038522,2.4524519125835473,3.0784981059574945
SNU-61,89928392,1.2163192063780537,1.2703116414187319
FTC-133,5287969,-0.5047683720981219,-1.6905454783331917
ONS-76,25062766,2.430053801867403,2.0706130189990386
NCI-H2009,44486219,4.368704582532332,4.2221709445845015
NCI-H522,637858,0.9732265340904396,1.6871751250922535
NCI-H522,44632017,0.530418286591973,1.2316120826481365
SW1463,11485656,1.9271812519349985,2.0192818138624653
SCC-9,46843906,3.309522412048413,3.3337662999162436
A4/Fukuda,6914657,-5.308594861321554,-4.5897431295844795
LOU-NH91,36462,3.2256365983613677,2.420634802597689
NCI-H1623,3825829,4.488518875119825,4.119564672384279
MSTO-211H,56946209,-4.75779739938848,-3.5542317508890733
YAPC,11427553,3.397606686380644,2.8979292094612306
JM-1,426756,3.661156723786521,3.9040309086316216
JM-1,10184653,1.3269176228991806,1.1527738341127673
NOMO-1,11497983,-3.443590431300748,-0.995649267691239
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926,-0.31743179623678186
A2780,9952709,2.339079626269582,2.8159566149165673
MDA-MB-157,9866186,-1.7048510464532898,1.3432194533017088
CA46,216239,1.3191761483145148,1.792592987466991
MSTO-211H,176870,1.3974668510804569,3.3974906644770986
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631,1.3048887186033802
OPM-2,135928012,2.8826672527394956,3.9217754471001314
BT-549,9915743,2.34179420613382,1.452258921784681
LXF 289,71304818,2.1201305139291033,2.7229968665460613
HCC1143,11214940,2.1301365232114144,2.20885551899415
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668,0.4982363164695995
KYSE-70,11404337,0.2060464556058333,-0.45663850240365755
NCI-H2171,11152667,-0.915095731247344,-0.800767429925788
HCC1143,46191454,1.52291312584366,2.112307670723945
SNU-449,71680916,5.959793136995753,4.7941744085897495
YAPC,219104,4.027438046449075,4.037428312885137
JM-1,446155,2.7706022090916793,2.349846808539228
BxPC-3,46398810,2.2883583084835126,2.626966315005947
OPM-2,2828334,5.82639787583413,5.632839562887544
A-673,44137675,3.4578104481213905,3.4480480591181997
FTC-133,7251185,3.0292037228467628,2.5535915412901677
KMRC-1,676352,1.883475825529446,2.1241470002178375
EFO-27,1641662,3.8267974599371417,3.6623427013329404
G-401,168312962,3.2015141434031547,1.8342623254257324
CAL-51,2945648,2.7250935788350064,3.001719167609408
CAL-51,71466445,4.7818956768695715,4.143320516514349
JM-1,5113032,4.766616079684312,4.093951130488148
SCC-9,24821094,2.906183993814488,3.0497694264875714
NCI-H661,piperlongumine-MST-312 (1-1 mol-mol),1.6507934598054954,1.796935570953586
NCI-H292,216345,3.474677020151061,4.02654893007099
MSTO-211H,JQ-1-MK-0752 (1-1 mol-mol),2.3232645118005015,1.7174341015416406
SBC-5,9549297,3.510799485826288,2.3026696627653225
CA46,156422,3.7635879578153126,2.6766831367931
MDA-MB-453,71466445,1.9167870178623896,3.606408924185305
A-673,54596558,3.847043372257958,4.560116022712666
OPM-2,10231331,0.6444733525039235,1.0168067543218182
HSC-4,5335621,5.235604448739508,4.8277057440265665
CAL-51,11719255,2.5837610433465588,3.594210421496143
Panc 04.03,44493528,4.362737332857046,4.378922005295344
SBC-5,carboplatin-etoposide (40-17 mol-mol),1.335045540127449,2.808278012050699
NCI-H522,24821094,2.425713290484283,2.7591011580083995
CAL-51,6610355,4.388066889778601,4.605478511734486
MDA-MB-453,6438330,2.0150251794967655,2.0500157818164557
Panc 04.03,46199207,3.759856924739056,3.2134303312585137
SNU-61,9866186,1.5207851909017442,0.6726260322670119
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137,4.453282844399602
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645,1.9517423070783184
Panc 04.03,71466578,5.726073349824824,4.817569172559876
NCI-H727,107970,3.133468251114326,2.3835089325437107
BT-549,60700,-0.4810674620852896,-0.06063423042114498
OPM-2,51037431,4.229346700902662,2.9831138668773836
MDA-MB-453,56946209,-4.730570165381635,-4.166641271059313
NCI-H460,72376,-0.5460239014371263,-1.4537744978057965
BT-549,44241473,4.976602861760902,4.978221124190691
A2780,24748573,1.2286507677110594,2.0182694479324392
NOMO-1,5311,-0.031303965270056,0.593314740886219
A-673,9927531,4.216692000672551,4.453754850773343
NCI-H1623,46199207,3.747077477678168,3.1423606908948365
NCI-H292,71304818,2.830949431838268,2.5843565238037325
NCI-H1623,9911463,3.95788841498078,3.9521171925050798
SBC-5,9825149,2.9056064620320896,2.1066111852027207
NCI-H460,11612883,2.88158995470921,2.8675088421685673
OVISE,6918878,5.066606594706477,2.8164766305133977
FTC-133,5278396,3.726623182659884,3.680638507574418
Panc 04.03,24775005,4.54660450697204,3.8219065327105697
CA46,1641662,3.144498035259472,2.756021793009163
MDA-MB-453,16722836,1.2443221263797826,1.6184063703086162
CA46,54618771,1.203400154931592,0.22970654341014968
HCC1143,613753,3.4353326628352714,3.326909193635043
A-673,60750,-4.61356677624384,-2.9835914664632854
A4/Fukuda,1641662,2.3667755294261297,3.0231847425409386
OVISE,navitoclax-piperlongumine (1-1 mol-mol),0.5165659112827317,1.8755120245929324
MSTO-211H,375860,0.0606650448750636,-0.11627715490805325
BxPC-3,6184667,3.26727461265582,3.109695281138462
CA46,227681,1.829365253324193,2.5331336735206333
SW1463,11964036,0.627645429671571,1.217028621780448
NCI-H2009,vorinostat-navitoclax (4-1 mol-mol),0.5355412888346941,1.5919208282788824
FTC-133,49766530,-1.1381086002707512,-0.5825651389860256
SNU-449,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2718140952083585,4.196532128068799
NCI-H292,11364421,1.76762986564817,-0.7227738339791802
KMRC-1,44819697,1.235264283084374,-0.12706799495708102
NCI-H661,9907093,3.834837743900246,4.251307650188454
DMS 273,17755052,0.9609599247674856,1.815358075172196
SCC-9,11364421,-0.952029021799848,-0.3494598356519998
FTC-133,135984461,4.350998124633342,3.7199900400258765
JM-1,11497983,-3.7280544169699192,-0.24998643602647874
MDA-MB-453,24753719,4.38597739181452,4.182846899101832
ONS-76,168313047,2.901208476511606,2.342486777722811
NCI-H460,67156097,3.7191617083219097,-0.36494277799627883
SNU-81,selumetinib-decitabine (4-1 mol-mol),-2.7455044109926168,1.4143476044539531
A2780,9866186,0.3046354439957303,0.7716611092671699
HSC-4,219104,4.150323587810277,3.925800101083733
SBC-5,168313047,3.954131669958023,2.3938151258391644
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333,4.218892005717626
NCI-H292,15953870,3.631273190289841,3.832224045392036
SNU-449,5281321,-2.557888043471457,-1.1623126477097145
HCC1143,702558,5.703077608026742,5.144188786183175
EFO-27,644241,3.241988529302909,2.4037159886493735
Panc 04.03,9911830,2.4999304852863404,2.767255138782334
NCI-H522,9967941,3.44539283334302,3.4158158655731112
BT-549,44607531,1.5480457992975702,1.8223172396415341
BxPC-3,44607531,1.3275313586220698,1.4986874079564592
KMRC-1,24951314,2.7376925539969927,1.4006354226246858
JM-1,10231331,5.343116821873739,1.0586851725473603
A-673,25262965,-3.9892118887375303,-1.9769999476745665
FTC-133,1716436,3.3698315146098015,2.816378291546191
OPM-2,2733526,4.066729211955922,3.333678034976626
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345,2.1734238389987173
DMS 273,3825829,3.788583241717048,3.5802462518505274
KYSE-70,3825829,3.6022414485207452,4.038242036833599
BxPC-3,5351362,0.9304368738373464,1.5399663199733375
NOMO-1,6918736,-3.755126975181922,-2.3284995550255743
A4/Fukuda,11977753,-3.131569873612884,-2.3520225281097926
SBC-5,navitoclax-pluripotin (1-1 mol-mol),2.5594903061856744,-0.7880604512311331
MDA-MB-157,navitoclax-piperlongumine (1-1 mol-mol),-2.7470196870152894,1.6553102350061766
A2780,73707386,2.710080958425795,2.6468249330682694
SW1463,44819697,-0.8614164905769626,-0.5288182397678465
YAPC,24180125,3.806846010722946,3.0239440460897993
NCI-H727,54649381,3.660865770056845,3.7232768738737594
SNU-449,2708,5.735631765174737,4.866999141267389
CAL-51,54143018,-0.6388505972102335,0.31043456725647545
LXF 289,753704,4.962227230589067,5.198116988056407
NCI-H2009,9907093,4.391694288558607,4.427114282860992
EFO-27,387447,-3.111228692284437,-3.8626392228174136
NCI-H661,65064,3.46809117241053,4.74567298514465
SNU-61,5278396,3.627128978826316,3.409712715499997
NCI-H727,452548,3.7056139041011034,0.11568337992869346
NCI-H292,16720766,0.3451831901206211,0.8472844994629896
SBC-5,serdemetan-SCH-529074 (1-1 mol-mol),2.482890846632963,2.113138362818057
A4/Fukuda,100016,4.8831896191852096,4.9669224150101625
G-401,25126798,3.708942608188802,3.723859673240263
SNU-61,24951314,1.416243399270427,0.932939126431899
CA46,89183176,2.547561715641907,2.9655736160204302
Panc 04.03,2746,3.3610494767062513,3.5630267450232456
FTC-133,107970,3.2744864550719126,2.361092180368062
NCI-H661,6918878,1.4921814323330362,2.9527169015504655
YAPC,24951314,2.2257819926279243,1.606940429360059
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925,2.368009302719703
LXF 289,216345,3.67485776854348,4.30045408053463
G-401,5287969,-2.352936827953192,-1.8947963476134413
LXF 289,5566,2.9960878643930218,3.139240352186164
JM-1,71680916,3.747509118270568,4.134053233429962
LoVo,16741245,3.141864677583783,4.020456977299382
NCI-H661,54649381,3.920223147571483,3.986285181156775
EFO-27,25154868,5.200143123549252,4.538769796413701
SCC-9,25126798,4.663845786250664,3.8772890758638194
A4/Fukuda,24964624,-0.76967256635286,1.6251636570858807
A-673,11178236,-6.344930978772708,-3.287396142429715
SNU-81,3825829,3.873341985908314,3.6597695497740754
KMRC-1,36462,3.0698954920529324,2.2473052315639936
NCI-H661,262093,3.4983141095274126,3.0137869786808067
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743,1.1312316412078847
G-401,676352,1.5550652369933835,1.9669169610508697
SNU-81,11228183,0.0397441918833689,1.248535386750323
MDA-MB-453,10385095,0.8735195901829151,1.1919785422329958
KMRC-1,16065773,3.457331493974802,2.6489457381401222
CAL-51,5328940,1.595278406971918,1.7715634394575028
CAL-51,56946209,-4.496983035262223,-4.058974052773972
FU-OV-1,5329102,1.609553320034118,2.371041991741446
YAPC,3062316,1.4892918633711576,1.4731655627128577
NCI-H661,11609586,3.2377833862635206,3.0887784620710965
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985,2.2706703893483278
NCI-H661,serdemetan-SCH-529074 (1-1 mol-mol),2.3260585064542014,2.1079728102021082
JM-1,36462,-2.702351282209385,0.20917885131359568
EFO-27,55508,5.431657737658487,3.453640879778663
CAL-51,10296883,4.0377332681132305,3.8575340903973507
CAL-51,123631,2.4616591372530605,2.315068327320603
A-673,53481919,3.7180877845578073,3.3883102530488953
JM-1,107970,1.4704012549786991,1.6625826424970847
CAL-51,5278396,3.885366261927898,3.532368350998634
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475,-0.05360855672172224
KYSE-70,4096211,2.254549645630953,2.453835890762071
DMS 273,11609586,1.9163652577621844,2.2089496142299647
EFO-27,9903786,4.039986452778869,2.949910802421532
CAL-51,6917907,-8.395782425589301,-5.452347304273312
A-498,54454,2.893611310147977,2.643438930894833
A4/Fukuda,49793307,-5.572580515048152,-3.7912874378158095
NOMO-1,4259181,0.2459758371125145,-0.45462575017979495
SNU-449,107985,-3.1392486992039235,-3.3743468085799253
FU-OV-1,5278396,3.713343254157872,3.665228634831103
SCC-9,selumetinib-decitabine (4-1 mol-mol),6.773727258865908,3.7952553024498514
A-673,5460769,1.3883868162718005,2.3137565779571485
SCC-9,568763,0.9120329628896908,0.8956689015798313
CAL-51,72199292,1.0008292341873897,0.6672525668829536
MDA-MB-157,8515,2.4995790404865983,3.868395754693015
NCI-H661,374536,3.546483103952357,2.350504477887235
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077,2.189288050126155
FTC-133,53392493,3.195209876090235,2.68582480278941
SBC-5,selumetinib-tretinoin (2-1 mol-mol),5.430491518611957,3.3355042601248304
SNU-61,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6699368728217061,3.296459328897486
BxPC-3,selumetinib-MK-2206 (8-1 mol-mol),0.2275715298784707,2.446509802788073
NCI-H2009,3825829,4.333180881174198,4.182212575462542
A-673,6610216,4.190818336865809,4.139613641727131
LXF 289,1750826,-0.5305094201812034,-1.2136312377923075
MDA-MB-453,44543605,3.7347256504274418,3.297736670402374
BT-549,24964624,2.3327253679943696,2.7143747787643138
DMS 273,24797083,1.0969779553781829,1.2889116328144035
NCI-H2009,24856436,-1.037334288977755,0.9897884213273973
ONS-76,73707440,4.1934861569389845,4.029521362393208
NCI-H2009,1242560,3.090706196906407,3.8656654101694112
NCI-H2009,6610355,3.511475006316147,4.690974044605006
CAL-51,51039095,2.1842093640891416,2.7655259077903533
CA46,11404337,-2.4021967063511434,-1.1709945621716733
A-673,decitabine-navitoclax (2-1 mol-mol),0.9419890820834614,0.23755105646255587
NCI-H292,11152667,0.5464898224488388,-0.2961120955073726
CAL-51,25154868,4.656760297450745,4.391980392162764
NCI-H727,doxorubicin-navitoclax (2-1 mol-mol),0.353164953880874,-0.6952072350700239
HSC-4,66577038,3.591157601556467,3.0751365559931902
LoVo,11175137,1.7419612548831422,2.641336699234301
Panc 04.03,46215462,2.9027075063139804,2.1685811358270506
G-401,1750826,-3.031444880989549,-1.7952692442932852
SCC-9,462382,0.912003027061621,0.7356064575661827
NCI-H2171,71304818,1.9125624841179896,2.095581149627195
NCI-H2171,6252,2.1051572182795,-0.7812984893833861
G-401,51037431,3.9974576184013726,3.1491621576108906
SNU-61,219104,3.1068483513637033,3.283480688212004
SBC-5,60750,-3.858196401702703,-2.0015698213344013
JM-1,72734382,2.7239851923699443,3.283004786530104
EFO-27,2733526,4.707486415914075,3.89720753833044
A4/Fukuda,71466445,1.4546499284121797,2.3436398659716615
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355,2.7897114220834918
NCI-H460,24797083,0.9153025805785596,1.3929276572786191
A4/Fukuda,54596558,4.022693113590735,4.372083452208526
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405,-0.48984688337521404
NCI-H2009,serdemetan-SCH-529074 (1-1 mol-mol),2.304731385362492,2.2886553832773653
HSC-4,44202524,5.184990397771561,2.1618764260015113
MSTO-211H,erlotinib-PLX-4032 (2-1 mol-mol),1.1572104860425592,3.1994024520288447
SNU-61,selumetinib-piperlongumine (8-1 mol-mol),1.4116770683714617,2.4104821674341266
OPM-2,9915743,0.7579871544404475,0.44433374108103263
CA46,56949517,4.303265452215328,3.6117846146797956
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361,-0.8769185410637135
CAL-51,24785538,0.7720267524795773,1.7178065767532902
EFO-27,navitoclax-piperlongumine (1-1 mol-mol),2.507192070148125,1.8762417592725449
CAL-51,10322450,3.881825194853649,4.006373593634104
A2780,241158,1.61479428578643,3.2041553505494265
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928,0.18152145389578492
LXF 289,10074640,2.806214579062189,3.1265819728577053
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928,-0.6589402416650549
NCI-H522,119607,5.115168095819997,4.8236661197028905
A-498,6918638,1.620608219340894,1.0138815964183743
CA46,10302451,0.2515382956842912,3.0432963222599887
NCI-H727,11152667,-1.354343634557878,-0.3032842316339674
NCI-H292,135999136,4.360218039072087,4.14194588327309
NCI-H292,322968,4.489137987914782,4.286501999314897
KMRC-1,11238147,2.6910045327617422,2.7629592631078
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264,1.2867577917411976
NCI-H522,9911463,3.273817127322074,3.570461594272923
A4/Fukuda,26596,-3.7061252239164553,-2.201878063181085
CAL-51,2945648,2.7250935788350064,3.001719167609408
FTC-133,10113978,5.149340897630058,3.194783135492287
G-401,25227462,-4.354739504605027,0.038260402902120745
CAL-51,3634881,3.319714226315486,3.3212446800937916
NCI-H522,5280436,1.9285860105900432,3.2046433188429155
LOU-NH91,JQ-1-MK-0752 (1-1 mol-mol),2.239144963977278,2.314159558220891
A-673,285033,-3.783680268063714,-2.4047978602176183
KYSE-70,11497983,4.3699696445826035,3.599804498763098
EFO-27,135423438,3.7049046399150134,2.408816673460423
CA46,26596,-3.5845712744961324,-2.685642244323863
A2780,24785538,0.5365701421591345,0.9593658431921678
NCI-H2009,8515,4.894015987740437,3.995506350823897
DMS 273,carboplatin-etoposide (40-17 mol-mol),3.245479848916456,2.3553613148553727
JM-1,387447,-6.033292615187937,-4.900123158928475
DMS 273,9956119,4.190734481617164,3.508294785805582
A2780,navitoclax-birinapant (1-1 mol-mol),-1.2503932555480053,1.0566484529696434
NCI-H146,36462,-0.9223549938225544,1.6071434371176267
NCI-H1623,11485656,1.644044907667622,2.551704417518302
NCI-H1623,24821094,-0.2323488781711246,2.8535602162918985
HSC-4,53301938,4.738168418112686,2.482143100574048
LOU-NH91,676352,2.464978676736505,2.215546205570386
NCI-H146,46926350,-6.324766796143129,-4.372278682758913
ONS-76,16722836,1.7132123007700326,1.63924793912273
YAPC,327653,3.117178905090827,3.3859094278297266
OVISE,24901704,4.2849421736627615,3.366641034118818
JM-1,54618164,3.458143614246244,3.5171035319166446
A-673,445091,4.1466370846962075,4.072261440546589
OVISE,5329102,2.956482132219437,2.3965530823581447
HCC1143,5470400,2.3870928447001867,-0.45600583863594535
BxPC-3,salermide-PLX-4032 (12-1 mol-mol),4.912455807166081,4.957569395341763
SNU-61,3503,2.986460298481687,2.218447094273054
DMS 273,11455910,0.4737958394902512,0.6318950629032222
NCI-H460,46907787,4.3372157131836255,2.614525096555309
CAL-51,216345,2.9520334452605637,4.018411645654833
A2780,6450551,0.1349302943593443,1.9277085125154902
LoVo,46398810,1.578557668618055,2.6681194140602646
SNU-81,15953870,1.3050219745867302,3.548321052296976
A-673,54613361,-0.6759826855411176,-0.3277301230924139
SBC-5,11234052,4.136817608168693,4.067406622556865
NCI-H460,36462,3.103581216464206,2.1014189879246516
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963,1.27651876132761
A-673,168313200,1.7801049656035806,2.7257122439402797
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645,2.1378814673168867
A2780,100016,4.757543521992015,5.833569298818888
NCI-H727,selumetinib-tretinoin (2-1 mol-mol),0.6638203077807998,2.8093682641886426
CA46,25105715,3.628482142858773,2.8710377077264098
HCC1143,9911463,3.749174224015704,3.9778129050451354
LOU-NH91,4477,1.3512747052000795,0.44968317425776827
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108,1.0147301837293567
FU-OV-1,25154868,3.6525772823030502,4.516515769751492
A2780,168313016,3.896841135664639,4.393592302677843
MDA-MB-453,JQ-1-UNC0638 (2-1 mol-mol),-0.1830175507337199,0.9009609178401551
FU-OV-1,selumetinib-piperlongumine (8-1 mol-mol),2.8006116127321463,3.2728745643726325
NCI-H292,15547703,3.23498204624142,3.359144737383663
JM-1,5329102,1.4301495534996294,1.3094601844118967
NCI-H522,3384730,2.8239588226941104,2.152838557484036
A2780,9911463,2.7303797257759235,3.6013861936230485
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744,1.4707839344184628
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642,3.3463547608087265
YAPC,9887053,4.707664045043398,4.077876884383498
HCC1143,10074640,2.8253679093766104,3.1580561738260866
LXF 289,11178236,-2.9660816129263297,-2.9584958271462636
A2780,ISOX-bortezomib (250-1 mol-mol),0.49630436037141,0.5794172679805469
KYSE-70,135398516,2.3739819683449697,2.232875385553023
A-498,57519531,4.461574036812888,3.1141094337016657
NOMO-1,9840324,6.741383080584752,5.407105074481215
BxPC-3,10427712,4.346184062898943,4.238427685738397
NCI-H292,selumetinib-decitabine (4-1 mol-mol),4.672876887029793,3.8168786232045973
LoVo,25062766,1.8850615394111836,2.208846825022118
FTC-133,262093,3.024825063724614,2.729285254424231
HCC1143,44819697,-2.8669414823386115,-0.17981115449777618
BT-549,5351362,2.1022372489581227,1.63676535756023
FTC-133,selumetinib-navitoclax (8-1 mol-mol),3.0170288782836163,2.1844010023181855
MSTO-211H,53325874,5.432400358349695,4.727415412710325
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.2063944719192374
DMS 273,7326481,3.48743847164077,2.9775961581439487
JM-1,11955716,-2.692308040243548,-2.0640219196875282
SNU-61,JQ-1-vorinostat (2-1 mol-mol),1.221813874955551,0.45815393379304675
MDA-MB-157,2842253,6.170125707570699,5.466711785034976
SNU-61,54454,3.789888893365768,2.809889784344232
NOMO-1,5460769,4.769752092364765,2.2348659488406284
A2780,285033,-3.502152061737446,-2.283096478041367
HCC1143,44495899,4.517503920361928,3.4775677114125023
NCI-H661,31703,-1.814857416200904,-0.9757590623065151
A-498,piperlongumine-MST-312 (1-1 mol-mol),3.2083615282552853,2.1308546151976393
YAPC,navitoclax-pluripotin (1-1 mol-mol),-0.110540489139909,-0.6070640944743423
A2780,2729026,1.9590477988732768,2.4698530329185435
JM-1,89928392,-1.0810313065311572,0.4218268630542037
JM-1,10410894,1.2527004533251185,2.745607053607676
NCI-H661,16038120,1.553795977052523,1.228577496220708
LoVo,135421197,2.0078610802467307,1.8380909893993098
HSC-4,24901704,4.088081803824046,3.543154989981334
HSC-4,135411,-0.261300177061483,0.9296198869771483
NCI-H522,4917,2.9130794248329392,2.994197400153181
JM-1,11364421,-7.32386861469755,-4.355707341382571
NCI-H2009,10127622,-1.471627480680591,3.5149455177328606
DMS 273,4917,3.103248515982538,3.0501919467685767
OPM-2,44462760,2.3304413416808463,3.002360938742661
YAPC,9956119,3.92905072911681,3.6972557157627004
A4/Fukuda,5113032,4.450145517718883,4.367861498304433
NCI-H1623,49793307,-1.4788317062169576,-2.3890779299986638
BxPC-3,637858,2.219072546092823,2.20104675695342
NCI-H1623,1566236,4.077529389730835,2.5163165719392753
G-401,23725625,4.115882586635449,4.123838173178189
SNU-81,crizotinib-PLX-4032 (2-1 mol-mol),1.4380831221683867,1.5835874931136964
DMS 273,252682,6.321322886147215,6.550779103609247
KYSE-70,135411,1.9014599224142343,1.1041708245144484
NCI-H2171,49867930,3.814749813399888,3.6165531235347057
SW1463,10302451,2.197754569420114,3.213953377284071
Panc 04.03,salermide-PLX-4032 (12-1 mol-mol),5.297407479315669,4.949639557260254
NCI-H522,71466445,4.480637973076106,3.252725035146637
NCI-H727,6610355,5.167779637611195,4.6861540780801985
A4/Fukuda,613753,2.966875582154842,2.9392270608759445
ONS-76,4261,2.2909626551681757,1.7322326632966714
YAPC,serdemetan-SCH-529074 (1-1 mol-mol),2.033605312871709,2.2836786576544483
KMRC-1,31703,0.3325905755235477,-1.2156125834029268
SNU-449,445455,4.484776409201516,4.8220838996263105
A-498,6918878,4.306638073301365,3.2816275117005618
SCC-9,selumetinib-tretinoin (2-1 mol-mol),3.7791942672746974,3.5672776825846
OPM-2,1750826,-5.079410714013139,-2.967021197574388
NCI-H1623,9915743,-1.6977137550638366,1.005522463786245
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,2.007324959376267
SNU-449,7251185,2.777592648573664,2.6703443405871146
NCI-H522,2733526,4.089503686239825,3.5258750908152665
LoVo,24180719,2.381979820549913,3.296599760711186
A-498,49793307,2.582548635431232,-2.0183041145659675
FU-OV-1,selumetinib-PLX-4032 (8-1 mol-mol),1.0793153404708502,3.672012885359085
NCI-H522,4788,5.8756804910396925,5.3953781437746855
G-401,374536,1.448879337840406,2.1336691294695416
SBC-5,135440466,3.787084066930897,2.293156484961129
BxPC-3,36314,4.043064497836865,-1.2677103405800343
SBC-5,11626560,2.9533832336239985,1.9711773560749244
OPM-2,613753,2.6904302784099845,2.9015972249577895
G-401,71466380,4.3225707153388,4.338359384175478
G-401,45279963,3.527434868311602,3.1764306935993987
MDA-MB-453,1239801,4.069717893467032,4.196135317764528
A2780,11719255,1.8256962189728296,2.904255276673701
KMRC-1,navitoclax-gemcitabine (1-1 mol-mol),-4.218093403904549,-0.8412707211851262
HSC-4,11404337,-0.2351979780524762,-0.2825555626383797
A2780,crizotinib-PLX-4032 (2-1 mol-mol),0.8552062968209889,1.5611921465203844
JM-1,5978,-5.097158196512326,-3.3809096811588044
BxPC-3,6917907,-5.822397614063261,-5.042211416252891
NCI-H2009,52912189,1.2519346625881922,2.402991337713566
KMRC-1,6917907,2.5901706443444477,-3.20316150064813
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592,1.2935924955263576
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367,4.2159093563049606
KYSE-70,2746,2.8005709054024224,3.4273567075600937
BxPC-3,638278,3.0042450495358923,3.2399709004504276
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.7930912883472209
HSC-4,31703,-2.446577735650292,-0.6333772034549506
NCI-H661,11152667,-1.7022631730770723,-0.44396190914546296
SCC-9,73707398,1.5896934234406246,1.3615502250987634
FU-OV-1,148198,-3.302287500778492,-3.35247991733954
MDA-MB-157,5287969,-2.775456728988527,-1.7437476974123773
OVISE,6918289,3.317561176891493,2.9486911848866475
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.8750357937529921
HCC1143,10296883,4.463772522749199,4.058679967640034
FU-OV-1,25150857,2.264135178575504,2.671165130121729
LOU-NH91,ISOX-bortezomib (250-1 mol-mol),1.5845315088477396,0.8159519966273472
BxPC-3,16725315,4.1100247270568815,4.678805303588231
EFO-27,11707110,4.483747329636401,0.6608914066227285
A-673,2858523,3.068752318729834,2.9591887588702472
OVISE,5280436,4.204860612632051,3.5600943133442433
NCI-H727,122327,5.896927010318378,4.464795534677296
CAL-51,448949,2.479839067238928,2.0019457175539235
NCI-H2171,serdemetan-SCH-529074 (1-1 mol-mol),1.0572285020282108,1.687499661509321
HSC-4,72199292,2.0552941548988506,0.6526482550756764
NCI-H2009,36462,0.0033291412741449,2.3495286675712914
Panc 04.03,JQ-1-vorinostat (2-1 mol-mol),1.3014737329174946,1.187142541433541
JM-1,71466578,1.9829041072742877,2.97633078952191
A2780,JQ-1-vorinostat (2-1 mol-mol),0.2041997396935529,0.8791789189063494
LXF 289,67291369,3.4412292386368746,2.9734443124328256
NOMO-1,5281321,-2.1390969134868656,-2.4240936315901234
NCI-H661,387447,-3.746079371333459,-4.143569853580253
NCI-H460,10385095,2.2920897819597896,1.362602890506614
EFO-27,3543504,5.270070957864149,4.559590765981215
NCI-H2009,11497983,-2.437134563400756,3.9595500514307345
NCI-H2171,4917,1.7834364774656617,2.6144441808137815
MDA-MB-157,4578,4.4846224734546025,4.716830025563868
A-673,9935249,0.595201632659186,2.281551440022552
NCI-H146,4096211,2.4692816884948856,1.731539263386705
NOMO-1,60750,-2.6028640292275567,-2.9193279545439936
NOMO-1,676352,2.3647709516043336,1.8323855306934382
SNU-81,168312962,1.078666024421789,1.4823750729669
A-673,3081361,1.7117642477526505,2.10072384635247
NCI-H460,46398810,3.30325787352206,2.682737890133595
FTC-133,24771867,3.849205905915908,3.0588188742445097
KMRC-1,409805,5.852991634240623,4.856183532785419
LXF 289,2708,6.094251503540483,5.0185124763005815
A4/Fukuda,11647372,-0.68075141177871,0.6369631171048956
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735,3.3311890301494316
NCI-H522,3025944,4.039653719751215,3.9837930326413424
HSC-4,6918289,2.856015155241233,2.886840227076343
MDA-MB-453,erlotinib-PLX-4032 (2-1 mol-mol),2.999832239704596,2.7413789700358238
MDA-MB-453,67291369,1.3466484853812946,2.6985555802623726
A4/Fukuda,11178236,-5.149024442366163,-3.4961623495519194
NCI-H661,168313200,3.81404568417466,2.9447228364909703
EFO-27,219104,4.121088157278177,4.030829288509563
KYSE-70,46191454,2.1451937437577575,1.6840989712853445
SCC-9,9927531,5.254709651648818,4.762132963500232
A-673,navitoclax-piperlongumine (1-1 mol-mol),0.5796855962539734,0.7521811259520471
CAL-51,16038120,-0.248771562775031,1.0846829538544833
JM-1,3634881,1.559410928505107,2.4854415030939943
SCC-9,5113032,4.570528604758655,4.929162568403476
CAL-51,68056272,3.9955701948507247,3.4976844773006617
CAL-51,4521392,4.667802355757324,4.443166791417772
BxPC-3,navitoclax-piperlongumine (1-1 mol-mol),1.3224342280969303,1.7441574336590773
Panc 04.03,BRD-A02303741-navitoclax (2-1 mol-mol),3.819752111817625,2.8013164637462786
A-673,serdemetan-SCH-529074 (1-1 mol-mol),0.8484968738221454,1.7098074842875313
SNU-61,9887053,4.377899885829067,3.217058346903761
NCI-H2009,25102847,2.121570289721804,2.6112219351392967
NCI-H661,54454,0.5886754914082402,2.585738385810386
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603,3.4672104420927554
MDA-MB-157,46174525,4.215722898807237,4.690487855043714
LoVo,5978,-0.9838296745754056,-1.666998396266302
NOMO-1,44137675,1.7607667559168472,3.01324472472035
JM-1,ISOX-bortezomib (250-1 mol-mol),-0.4363685688396392,-0.08336381871978774
FTC-133,216468,3.7386330008080018,3.5498368123467867
NCI-H522,5284616,3.1429047752915036,2.065945259577124
A-673,6450551,1.2504532759531255,1.6499017823610287
MDA-MB-453,2126,4.599537631708682,4.453135947907974
FTC-133,12001922,3.1425787892022656,1.966483781433761
BxPC-3,6610355,3.939463034432562,4.660236326762492
Panc 04.03,72193861,4.339971647759762,2.126786550634452
DMS 273,984333,0.9143511576606916,0.7069638850418098
NCI-H460,126941,-2.220790788147435,-2.696381332407031
SBC-5,11178236,-5.106449128542812,-3.355558150991649
A2780,11497983,-3.587231584220661,1.747797552436911
EFO-27,5278396,3.98166727080577,3.7341318810097994
NCI-H460,40482356,5.06381124686115,3.845788120305151
OVISE,51039095,3.497583622307714,2.9787998008868133
HCC1143,56946209,-4.25120546555742,-3.5633164685055134
NCI-H2009,3025986,-0.6988289053859157,-0.6422078966910751
DMS 273,44543605,5.15097132829554,3.886315130475501
HSC-4,23635314,4.118860430098142,-1.5696875816426827
FU-OV-1,107970,2.0514231206369686,2.353843108441191
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744,1.1633223113346083
A-498,5284329,4.906845392884974,3.731050932821369
NCI-H522,selumetinib-piperlongumine (8-1 mol-mol),2.5567872657123307,2.9019318851497093
A-673,11612883,1.6900414301434703,2.200289368579305
DMS 273,11507802,0.7884214749573938,0.9566841512962487
NCI-H661,44486219,4.876697308801278,4.3935212636640335
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178,3.2264911950208135
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123,3.610557788246199
LOU-NH91,JQ-1-navitoclax (2-1 mol-mol),-0.9494893938719444,1.1904441684557123
SNU-449,135875424,4.841371934548395,3.7377398313526164
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157,3.271998647013571
NCI-H292,72376,-2.1951743702669573,-1.4813066156022976
CA46,36462,0.0715644321871689,0.19445674019732886
A2780,54678924,1.3135335490837166,1.5879880970545976
JM-1,9926054,1.6867956204893688,1.6696273938540234
LOU-NH91,4788,5.956614254075031,5.838851967463675
G-401,navitoclax-piperlongumine (1-1 mol-mol),0.8522562027001119,0.8471393383579786
YAPC,9929138,5.651296587688524,5.477098567880463
CA46,613753,2.777360120502711,2.856633822036402
BxPC-3,159324,1.5239234886257875,3.292904978664246
DMS 273,9911830,2.0619640796568848,2.111162753324234
LOU-NH91,selumetinib-navitoclax (8-1 mol-mol),0.0322992078492161,2.267474757336809
ONS-76,17755052,2.9613727126940126,1.9457564529938716
Panc 04.03,navitoclax-MST-312 (1-1 mol-mol),2.2985193388482177,1.2096230672280024
DMS 273,serdemetan-SCH-529074 (1-1 mol-mol),2.0860866366199584,1.7117518675240067
BT-549,56963564,0.7590937126260752,0.5711627706882464
A4/Fukuda,135398738,0.2588260022635366,2.345651851696722
FU-OV-1,6918328,-0.3184221939986219,0.3421056585278265
NCI-H2171,119182,5.854927706564024,-1.1546255818487199
LXF 289,46224516,3.632609368126253,2.5176466056213247
BT-549,66577038,3.347380186099457,3.043431873136289
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528,1.1008813484566269
NCI-H460,25183872,2.110783783288614,-0.41368630877246604
CAL-51,17759555,3.5733302595078182,3.46657978025504
HCC1143,4788,5.8180322078124265,5.6252408873465995
NCI-H727,selumetinib-PLX-4032 (8-1 mol-mol),-1.7195859584086806,2.8581513181493965
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103,2.1552536839843013
A-673,11656518,-0.6930464248114873,1.206945370042096
NCI-H522,12003241,-1.5672925136718587,-0.8139863769813692
NCI-H2009,19582717,2.816304614086765,4.350762029592986
LXF 289,9911463,2.935801973679381,4.029640446714357
NCI-H1623,44202524,1.6623127043604982,2.1602333756532364
NCI-H522,9952709,3.5153076410238477,2.7097511719936445
EFO-27,4378219,5.419366677908557,2.7043672168829547
FU-OV-1,11404337,-0.2130364442314083,-0.11179720558064526
FU-OV-1,119607,4.651010364988691,5.311124298953955
NCI-H146,135875424,2.9115600315347057,3.6453296406022186
LOU-NH91,11152667,-0.304989451834292,-0.38610106192905147
SW1463,439501,-0.3046644173954531,-1.9910893233686604
LoVo,25022340,4.929882293123705,3.0940662978453046
NCI-H1623,23725625,5.633484297207613,5.323894959301302
KMRC-1,439501,-2.7889227637684773,-2.056503162654223
A4/Fukuda,9907093,3.513986602103764,3.673941410023539
A2780,969516,2.2684147801302155,2.5553042706522175
HCC1143,24753719,5.247680835091332,4.404237936476741
DMS 273,25183872,-1.4455230978287994,-0.927311919266209
SNU-81,3854666,0.9917295007006844,1.646248818016389
NCI-H522,57330099,4.380671698756577,4.204972586216713
A-673,135421197,0.3124298336996849,1.635571437857348
NCI-H460,46398810,3.30325787352206,2.682737890133595
NCI-H661,52947716,-6.022145864838143,-0.4999562103603045
CAL-51,9907093,3.7886359098281783,4.1478301409564775
FTC-133,erlotinib-PLX-4032 (2-1 mol-mol),4.762605584233989,3.0702764147938124
SCC-9,11640390,4.170413196512925,3.7476829604462125
SW1463,56973724,0.8689023909239705,2.565786448682619
HCC1143,24180719,4.266131781804432,3.703765344246432
KMRC-1,135398738,5.381791034510906,3.794802423898213
BxPC-3,36462,3.4182720226712457,2.0428816221474384
MDA-MB-157,4261,1.9483424687424111,1.7222701455753275
NOMO-1,2708,4.2098167660909525,3.1191233385888895
A4/Fukuda,10410894,1.64506751408979,2.9454420071509526
A2780,3384730,1.1479192192658911,2.3563338247516703
SNU-449,439501,-4.772752939359215,-2.1988684280908206
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288,-1.0223683113948963
DMS 273,51037431,4.4079331684726775,3.327181422633281
A2780,16741245,2.3123767413084786,3.6066701171476363
SNU-81,42642645,1.3921275935464503,0.1886336434304016
CA46,44632017,0.5480853683486498,0.6960595400428331
A-673,71304818,1.350808371963784,2.099287770473873
SNU-449,6914657,-4.967870149056919,-4.017028347275251
MSTO-211H,25150857,2.632878402859221,2.354320088033786
MDA-MB-157,26596,-2.8480155125253623,-0.738948353883992
LXF 289,9929138,7.38651684018349,5.46892853780436
G-401,25183872,-1.5190566583165497,-1.1118142992097915
A-673,241158,1.6738540084680422,3.1656635066197407
SNU-61,25195348,2.878615726844662,3.272829429851573
MDA-MB-157,53392493,1.7008245883035995,2.8001280046638373
LoVo,68056272,4.365145786196869,3.6981750949266377
NCI-H2171,6918837,-5.273009588122425,-4.172202211993331
NCI-H460,168312962,-1.8333752522095308,1.8842054999880995
CAL-51,44259,0.1826439745217317,0.8230763142378453
HSC-4,285033,-0.8602386046724618,-1.5922111930744451
EFO-27,25105715,3.778793980481446,3.437507265757799
A-673,1641662,3.2069303925294625,3.1727085598790072
KMRC-1,3854666,2.659759078644905,2.334202021491711
DMS 273,375860,-0.4468381354972334,-0.28626457397715455
NCI-H661,10231331,4.850159308010921,2.1297232750709783
DMS 273,16725315,5.248612259787856,3.972488680368561
NCI-H292,crizotinib-PLX-4032 (2-1 mol-mol),2.353099722482166,1.9536082401860986
NCI-H661,73707398,1.1965083244926786,1.379103268910613
OPM-2,JQ-1-vorinostat (2-1 mol-mol),-2.42287599285764,-0.41213383905839096
NCI-H1623,135421197,3.7764453326534855,1.962632794335233
BxPC-3,24951314,1.2340413323146109,1.6085965987922517
MSTO-211H,navitoclax-birinapant (1-1 mol-mol),-0.9866972359238844,1.149757203161012
NCI-H146,119182,2.1823445512420308,-0.5900351501756045
G-401,4578,4.054730999265937,3.911221597624749
MDA-MB-157,6918837,-2.759774975538005,-2.3207632360368557
EFO-27,9907093,4.474758252228614,4.349893600276912
HCC1143,navitoclax-gemcitabine (1-1 mol-mol),1.7090792961792267,-0.7351858607234101
NCI-H727,navitoclax-MST-312 (1-1 mol-mol),1.3064491848942938,1.1994391726522369
FU-OV-1,carboplatin-etoposide (40-17 mol-mol),3.4615233575458992,3.2993989987631975
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023,-0.6084700818228911
NCI-H460,3025944,5.476008686130055,4.117252904866053
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122,1.9518730124222383
NCI-H292,9915743,-0.4817131806939655,1.0297293326445403
LXF 289,44202524,1.498501439362416,2.5658700265171874
OVISE,135411,0.7729741022965545,0.8367147156712658
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445,4.76574066872387
NCI-H2009,5746,1.7505534195957702,1.600468847748785
A4/Fukuda,10184653,1.3612642262853822,1.1874495234852813
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382,2.088407240431915
BxPC-3,ISOX-bortezomib (250-1 mol-mol),0.0666490306431122,0.8350442218752205
JM-1,375860,-0.4977027167273706,-0.6621481637737776
SNU-61,46943432,3.2717403410494397,1.8464577143653518
NCI-H146,168313200,1.5894074456272884,2.690241818790119
HCC1143,piperlongumine-MST-312 (1-1 mol-mol),2.011691576039941,1.8563545025548183
NCI-H2171,6184667,1.4164127707768046,2.5279253043989995
DMS 273,10184653,1.3805891581139824,1.5067906946206742
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025,0.9536916086906041
SNU-81,24856436,-0.0712468901893707,0.4869967426934545
LXF 289,71680916,5.339150924844951,4.772040909407763
CA46,5291,2.960224941202677,2.864567608484687
NCI-H2009,5329102,2.1297157842750756,2.1469291734973246
HCC1143,49793307,-2.279288310815399,-1.9198026486136646
HCC1143,15953870,6.0969880807250085,3.7501900698980313
BxPC-3,2749,2.8971498792709784,1.9919481158685146
SNU-449,12003241,0.2005365129445947,-1.3151721891311996
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393,2.3008843708736215
MDA-MB-157,2733487,0.3711294020076626,6.245581840439716
NCI-H292,3025944,4.3344233170115185,4.260025628675604
FTC-133,637858,3.731185140297224,2.226860291694693
NCI-H1623,387447,-3.670338978810225,-3.9245149342455106
JM-1,5394,4.3191880254190425,3.2598441894844736
NCI-H292,alisertib-navitoclax (2-1 mol-mol),2.7354640490460724,0.9483805324382212
MDA-MB-453,24964624,0.7400526464517642,2.2421332204674576
SBC-5,637858,3.033148612268187,2.147785047946795
HSC-4,3825829,4.330540788358233,4.017675723252843
LOU-NH91,26596,-0.8372049149458933,-0.9137794287575854
Panc 04.03,24180719,4.502790622897018,3.6350694212992596
MDA-MB-453,44486219,3.97168660448306,4.160952318347699
ONS-76,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0736426571342059,3.0942065870562083
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566,0.6067304143056842
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609,1.343254838955997
MDA-MB-453,carboplatin-UNC0638 (2-1 mol-mol),3.2412925949460223,3.15683683933474
A2780,46398810,1.6945681809511193,2.2059554260539933
ONS-76,44493528,4.396938069944904,4.41524208457532
HSC-4,3854666,2.969420021692798,2.5201505657078203
SNU-449,5291,3.951163668523845,3.6193025956002685
MDA-MB-453,216345,3.4613524333124337,3.6621004962247166
NCI-H727,71680916,5.541731669631066,4.907439805860438
NCI-H460,4261,3.676509117184606,1.6743653735408628
NCI-H2171,10184653,0.99528741531969,1.0254775370459668
FTC-133,54626689,4.834884112239084,4.772934851425004
A2780,55283,0.78738067747292,2.5982792713152234
OPM-2,753704,3.6202062566191984,4.095555866159675
NCI-H522,53392493,1.8355339375888644,2.4248210402356083
DMS 273,10127622,5.766745520319409,3.8772111646642564
ONS-76,BRD-K58730230,4.314454311755605,3.8220974792238183
MDA-MB-453,49766530,3.3081056054922064,-0.048819431549687396
A2780,16065773,0.67384212990199,2.284642936857548
JM-1,241158,1.7269305863155773,2.4235948153575295
A4/Fukuda,71466380,2.851115718652883,3.9318274289572823
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322,3.68088826898729
MDA-MB-157,16722836,1.792866712111087,1.608245117801822
NCI-H460,6852167,4.590065962834362,2.982649251400188
SCC-9,375860,0.1694000381305893,-0.25788989433755577
CAL-51,54649381,3.902782783768603,3.9092183467954316
EFO-27,2708,5.128228617584202,5.20415101871306
G-401,6450551,1.2745400494425214,1.6840545799433895
SNU-449,168313016,5.914877518762689,5.0130946434002
NCI-H661,654092,0.3537062860674825,-0.06691817129673598
SNU-61,5284616,3.808934677012338,2.0684050521131314
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113,1.3624054074469907
KYSE-70,25195348,5.534160735777195,3.342210281376759
NCI-H2171,135421197,2.0026019926205185,1.500425087044384
NCI-H460,4261,3.676509117184606,1.6743653735408628
DMS 273,1641662,3.247845954250749,3.0850406034114606
BxPC-3,6914657,-4.023901786471393,-3.766029381462795
CAL-51,9936388,-5.638746232401389,-1.1412379764534035
A4/Fukuda,25161177,3.5710974046751804,3.3994808409046278
NOMO-1,24821094,3.1222382635594967,2.755164134258905
A4/Fukuda,53232,1.4709221708336295,2.772663185018509
A-673,9840324,5.96119566119886,5.585013819608724
LoVo,613753,3.444351424595812,3.3106722660261827
FTC-133,4477,0.2258553638980791,0.40424669071247865
MDA-MB-453,11214940,4.455338804672604,2.2616390480786244
A2780,56649450,-0.3009304069219352,3.1624882140981496
HCC1143,89928392,0.2924123173203115,1.5837720383554645
BT-549,6852167,2.654575121453327,3.170807136190394
G-401,375860,-0.2910974790080222,-0.22804758444634576
NCI-H661,613753,3.3170674343428708,3.361280562919845
YAPC,71304818,2.728620236586343,2.638995136236403
NCI-H292,3503,2.756562172316919,2.4559060048370367
OPM-2,44819697,-1.6539436611429392,-1.1860969256558453
HCC1143,60700,1.3373007617879429,0.08629632442628182
MSTO-211H,446155,-0.2868964860821164,2.619266456162515
A4/Fukuda,2708,3.0461577581065007,3.4469020496798235
SNU-61,126941,2.173772773827979,-2.41220396633275
DMS 273,selumetinib-piperlongumine (8-1 mol-mol),4.661418163963333,2.336271243887857
HCC1143,444795,4.803024181226615,4.688231593595056
JM-1,441298,2.4952150007247393,2.278286307982641
DMS 273,44507138,4.08877163590395,2.528708735517893
Panc 04.03,5291,3.9842309161066063,3.6088347462629553
BxPC-3,3062316,-1.891072672499,0.8339942123943912
KYSE-70,15983966,-0.1847866067827735,0.0006021993412744498
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932,-0.9308236098269219
DMS 273,44607531,1.5313743675110545,1.483407661654352
NCI-H292,5746,0.9253562515034884,1.6582865955739978
NCI-H146,6914657,-5.6838858588772245,-4.100489966959768
EFO-27,25150857,3.1416161415552173,2.621250781107433
SNU-61,54618771,-0.470226071786205,0.9557597703420404
BT-549,1716436,2.964006130486385,3.170321416748132
BxPC-3,4521392,4.6952932183187,4.342906710034028
BxPC-3,5328940,0.9544734009845622,1.6922076778708237
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014,3.34561728795948
Panc 04.03,16013152,4.359497957481629,4.407178032246873
A4/Fukuda,3062316,0.4248767517614322,1.1745560621768396
A-673,11609586,1.032418246609784,2.103615827414559
SW1463,322968,1.9625017896764745,3.3495754704350493
JM-1,11427553,0.2949480151387566,1.281263910870029
CAL-51,11497983,2.6322425573174213,3.9165674074966272
Panc 04.03,12003241,0.3752932920389255,-0.9183239074431951
FU-OV-1,216345,4.02478525181321,4.111541799797977
NCI-H522,89928392,1.1479343378844449,1.1082442753755217
NCI-H460,11485656,2.6212830818798065,2.420116402911575
LOU-NH91,6438330,3.480541802748286,2.470659523179589
MDA-MB-157,11228183,0.9797898244038654,2.470318231336319
A4/Fukuda,10385095,0.4549399411675465,1.0129420524744825
G-401,241158,1.9889661714459972,3.2493755344035353
MDA-MB-157,5282054,1.4096594950320644,3.841024529849339
NCI-H522,11404337,-1.4542746262182442,-0.4465233373906471
NCI-H661,322968,4.732962604670861,3.9292610062357607
NOMO-1,65064,5.083490310509571,4.128147364147555
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284,0.0055589276658771095
BxPC-3,1716436,3.6064873492654943,3.03206819733836
NCI-H2009,24753719,4.192950544032197,4.516007297485953
BxPC-3,136227924,2.62858882862477,3.044157489510224
OPM-2,alisertib-navitoclax (2-1 mol-mol),-2.0231135401510967,-1.2704446268968281
SBC-5,3854666,0.5257720708282073,2.0396136769609527
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876,0.31191506044594564
NCI-H460,1750826,3.3189287492303197,-0.7981843886588235
A4/Fukuda,4705,2.104501352907832,3.092077665867878
BT-549,24821094,3.680768028115557,3.053027794791003
NCI-H727,vorinostat-carboplatin (1-1 mol-mol),4.5535915499208,3.015458466985789
A4/Fukuda,46398810,1.5683404384737003,1.97035725907286
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702,1.014980052048972
MDA-MB-157,3062316,3.257879214731084,1.1655216659338152
NCI-H727,71466380,5.170266193783112,4.648166116836124
OPM-2,selumetinib-tretinoin (2-1 mol-mol),2.843446228896377,2.719918304548554
HSC-4,16038120,1.7232268235274473,1.2469668389694106
FU-OV-1,53392493,2.412509849766808,2.917096244041176
NCI-H2171,3634881,2.317126021520602,2.704540526057842
DMS 273,54618305,4.272082763698834,4.386520337107186
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701,-3.40232233466938
SNU-61,9926054,1.8929452670989917,1.8331582690646084
MDA-MB-453,216239,1.9202357593604051,2.4018271224640184
A4/Fukuda,252682,6.117343290485243,6.452016969996224
Panc 04.03,11455910,2.454958233695195,1.475316592336887
MSTO-211H,24951314,-1.1401244239295247,1.739667537118239
A2780,navitoclax-sorafenib (1-1 mol-mol),1.0762822607268765,1.164518692285581
NCI-H146,67156097,-2.3396756899377595,-0.5815641067620261
NCI-H727,alisertib-navitoclax (2-1 mol-mol),5.700791179880255,0.5435480709232813
FTC-133,25150857,3.5794152247995004,2.3977436436492012
KMRC-1,24797083,0.8876318381449373,1.6499150300782262
KMRC-1,5282054,4.624285853166485,3.738353653295322
MDA-MB-157,36462,0.1516360669313773,2.426337644108541
SNU-61,11609586,2.423992088951442,2.497674602485526
MDA-MB-157,4378219,2.6716514190617104,2.6661485483792315
NCI-H2171,navitoclax-PLX-4032 (1-1 mol-mol),-0.7537972454626107,0.05475146141466798
A4/Fukuda,57519531,1.5811593813701257,1.6630464977364985
EFO-27,136227331,4.702115323060179,4.214040197874497
MDA-MB-453,9952709,3.2945084007394616,2.98186305090878
G-401,54143018,0.971383874427432,0.25837358559787654
EFO-27,9927531,5.387402639259967,4.839903951576892
DMS 273,3025986,-1.574939205922683,-0.9139022476837632
NCI-H522,26596,-2.5500947066960276,-1.4901214003342786
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373,2.297873873141757
CAL-51,5280436,3.749440064194485,3.401614309868112
SNU-449,25150857,3.008716268425874,2.4659612515011378
KYSE-70,23582824,2.6933165956875964,0.8743284003076209
OVISE,54454,2.25285494204451,3.0090300819208533
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569,3.1326868473796012
MSTO-211H,5282054,2.057664237493602,3.932602996891082
CAL-51,16720766,0.5416929462446769,0.1316246796921092
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253,1.724247271648437
EFO-27,navitoclax-pluripotin (1-1 mol-mol),-0.1072190892754552,-0.4677876025243629
SNU-449,446155,0.8119451390236352,2.617081403834436
NCI-H146,375860,0.4213004900992469,-0.03472760194213167
CAL-51,5281321,-0.4656602142962174,-1.0441090734173448
SNU-449,navitoclax-piperlongumine (1-1 mol-mol),2.97767132898613,1.996937052624962
NCI-H2171,44462760,3.915746717375186,3.273823370260875
SNU-61,151289,1.0402759766313254,0.8817458612973911
DMS 273,24856436,0.3584417497554937,0.22574804980881777
CAL-51,71466578,5.340961831553399,4.6506466635164
HCC1143,44607530,2.3193328073886628,2.07393824412887
SCC-9,3136844,4.895725881728452,4.472791774676043
CAL-51,148198,-3.728190383000159,-3.7101690087749057
DMS 273,25126798,4.049346019168164,3.5846820604215814
A2780,JQ-1-navitoclax (2-1 mol-mol),-0.0889318851591051,0.3310080118451609
A2780,9825149,2.396834344892177,1.942242844227482
CAL-51,104842,-3.020036586723177,-3.26186443268448
A-673,676352,1.522059533133182,1.8854820964925565
FTC-133,9967941,5.123707260677636,3.69194323121405
NCI-H2171,56963564,-0.0417490265139498,-0.09325933114282263
DMS 273,753704,5.000496745911757,4.450913357620933
JM-1,6918837,-6.173851145057706,-4.684131204700309
KMRC-1,285033,-1.948983558292048,-1.7551379735965194
FU-OV-1,54454,4.96368280899624,2.644923460624627
LoVo,11152667,-3.1828514843907967,-0.4493699336238818
A2780,3081361,2.3669572433114663,2.3249049281370997
CA46,11497983,3.715862022418827,-0.29915319598629564
EFO-27,9952709,3.7128554087131658,3.264190357679851
SCC-9,3503,2.580691900576731,2.3891640247381045
CAL-51,42642645,0.4324607401831485,0.5339374888709844
NCI-H522,462382,-0.0152056919239,0.7749755519678558
NCI-H661,44632017,0.8459474985730225,1.3054012186785338
LXF 289,44137675,2.0502885463252665,3.9214923790207763
SNU-61,11404337,-0.7844361329588494,-0.21171791451859112
FTC-133,15983966,2.5675405254421113,-0.5266522732570746
KMRC-1,56946209,-5.003023698532595,-3.5134357547809016
CA46,9866186,-0.3275085520058725,0.28841162800378567
DMS 273,23635314,-4.293922540672693,-2.673416640739587
LOU-NH91,4259181,1.0248896787271708,0.5392050279472658
SCC-9,46224516,2.803045033456012,2.64519193122149
SCC-9,6918837,-2.658799999554452,-2.657887137223875
FU-OV-1,tanespimycin-gemcitabine (1-1 mol-mol),2.043943445508653,-0.10471356895407577
LOU-NH91,15983966,2.104720476479653,-0.5362676058305349
NCI-H661,285033,-2.1039671806681985,-1.903662923063633
G-401,16722836,1.0452487365316014,1.5742623018524795
SNU-61,11964036,1.5202881054490238,1.2110830910379549
MDA-MB-157,374536,-0.5698586384338129,2.2372022378763172
OVISE,168313047,2.139797955827927,2.4540522155092988
LXF 289,400769,-1.8947060859446272,-0.4869146901111829
BxPC-3,10302451,2.105262518783424,2.498393824996374
KMRC-1,446155,2.327207673229407,2.786269114114205
KMRC-1,selumetinib-decitabine (4-1 mol-mol),7.0489920004822855,3.382670469891812
MDA-MB-453,421610,2.7771188964172664,3.291022863296268
SBC-5,navitoclax-gemcitabine (1-1 mol-mol),-2.8520173060125296,-0.9859841916503466
OPM-2,2113511,3.5660346238413565,4.787599382510798
ONS-76,31703,-1.5971524717515937,-0.6321963552437958
CA46,100016,3.773189878640827,4.872286096140575
MSTO-211H,tretinoin-navitoclax (4-1 mol-mol),1.3222230725566817,2.88089291034656
EFO-27,11167602,3.5204241483481686,2.8061178895459933
SNU-81,6505803,-0.5044882096333503,-0.7272572928799488
NCI-H727,1716436,2.7605133955676178,2.874955738129089
OVISE,10302451,2.747913318530857,2.7233484492469193
NCI-H292,24772860,-1.7688616980402292,-2.01047362222081
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279,2.0770512605432914
Panc 04.03,702558,5.6133476434957,5.4482081817768675
NCI-H727,24964624,2.2819429425827984,2.3290894367047743
MDA-MB-157,2828334,5.757584300180036,6.1763505359286865
NCI-H2009,67291369,0.975633217461442,2.711477454851023
EFO-27,421610,3.836140121936173,3.3054508339885267
G-401,vorinostat-carboplatin (1-1 mol-mol),1.81058220615163,2.603151147038777
LXF 289,11626560,1.452143156792952,1.9322133663775467
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614,2.8280093633510446
NOMO-1,9444,3.521396869825756,3.70338320793494
KYSE-70,24821094,5.190593902676824,2.6398543165833273
NCI-H292,104842,-3.713576042756873,-2.2302334484750275
CAL-51,23725625,3.781531245600544,4.854391192525328
MDA-MB-453,11175137,2.676203543730399,2.439093048014506
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982,-0.9103608355871446
OPM-2,3038522,1.4393753112244685,2.7509024369080293
KMRC-1,107985,-3.501321688193531,-3.3602612511053156
G-401,selumetinib-piperlongumine (8-1 mol-mol),2.3292817687818768,2.8373053241607415
FTC-133,9549297,5.410509835078823,2.7186271529905977
HCC1143,66577038,3.1905565845946993,3.2882010597595097
A-673,73707438,5.240927680887528,4.206614523075425
LoVo,44137675,-1.419079349485425,3.681633820273861
SNU-449,3503,2.7484718807665396,2.435190041677487
JM-1,11960529,4.3881984442046384,3.457796517800986
FTC-133,5460769,4.281031552964228,2.93465080607833
LoVo,3025944,2.9449078290251256,4.259891481262499
A2780,613753,3.052273906836147,2.9306548565003703
NCI-H661,navitoclax-MST-312 (1-1 mol-mol),1.292744867259036,1.0057416075784165
NCI-H2171,navitoclax-piperlongumine (1-1 mol-mol),-0.1756857272470243,0.30608885448383605
NCI-H727,119607,4.980733327072692,5.06797017335432
A2780,15983966,-5.363621110890126,-2.6337990159805633
LOU-NH91,52912189,2.021653283813576,2.5040339419197895
NCI-H2171,46926350,-4.867098709680934,-4.037322532931876
JM-1,11222830,1.159649219525665,1.0550220144393632
Panc 04.03,9887053,4.247469701197239,4.285912681035887
MDA-MB-157,6918878,0.7604288199483474,3.0601657317147146
DMS 273,25150857,2.151062266440261,2.025450196389415
NCI-H2009,637858,2.463099291034241,2.36989215096734
A-673,89928392,0.0772153864579325,0.8396857479778689
OPM-2,56646779,4.429673228200906,2.5815861767398394
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117,1.6917107626865886
MDA-MB-157,104842,-7.463907387011825,-3.028673135774018
ONS-76,tanespimycin-gemcitabine (1-1 mol-mol),1.9345282385200928,-0.42300355166323855
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,1.8366689886743055
SBC-5,23725625,4.5493880465204235,4.90463019293491
CA46,16736978,0.453820731366511,1.0393393540318152
SNU-81,5287620,-3.371703836172312,-2.0163319600607594
OPM-2,9929138,4.40255967212205,4.786744674677036
CAL-51,107985,-4.126908547019261,-3.626990669314883
SNU-61,4261,1.9153687598051303,1.3866097858611932
KYSE-70,5311,1.3049127753558711,1.7484228491372433
A2780,2874250,4.6617329815359545,4.6294111495122765
A2780,46843906,2.4977538844634637,2.2788625648669205
FTC-133,11234052,5.0298463189452445,4.281936876526721
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448,2.459492226486462
OVISE,5282054,4.4060399380094415,3.995581671573782
HCC1143,4096211,1.556998125169598,2.2107762401644258
NCI-H661,11364421,-5.690348879388773,-1.134247048058626
MDA-MB-453,docetaxel-tanespimycin (2-1 mol-mol),-3.838890117483947,-3.2801788879766063
A-673,11427553,0.6536689467636717,2.0179484606901275
JM-1,6917907,-6.147483124234289,-5.406376583830805
A4/Fukuda,9926054,1.7963505717751411,1.8082577595319556
Panc 04.03,65064,5.203402541242721,5.040161990319252
MDA-MB-157,25154868,5.338832763625219,4.4303774583701845
A2780,3689413,0.5219259729031659,-1.1097768520646547
NOMO-1,2828334,5.727397129817869,5.700144144353511
NCI-H292,selumetinib-PLX-4032 (8-1 mol-mol),2.9334189816499476,3.25254144908787
JM-1,carboplatin-etoposide (40-17 mol-mol),-1.4071886446096369,0.5397141351645725
A-498,10385095,3.0502652475567347,1.6174041778097834
NCI-H460,5280436,4.847067650781305,3.6670368768544743
NCI-H146,71304818,1.6140243095299662,2.1195114826305583
SNU-61,135398516,5.118120351018792,2.019955240772303
HCC1143,9967941,5.23006520077408,3.9226888384789147
SBC-5,51039095,3.807088636542375,2.671290426117831
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.082109662926556
NCI-H1623,vorinostat-navitoclax (4-1 mol-mol),1.3203635672750993,1.0482957941584594
HCC1143,44137675,2.963488174732173,3.626948078897233
EFO-27,15983966,2.453959425588555,-0.3029969403504086
NCI-H1623,10184653,-1.536462891864862,1.2086054851962782
JM-1,216468,0.5768131010636649,0.9257313900695897
KYSE-70,5278396,3.1929088159597656,3.494606482643819
SW1463,216345,4.078496637973622,3.779155123891198
MDA-MB-157,54619267,4.18775168816921,4.237552562594798
LXF 289,16065773,1.584092119185821,2.699295142711003
Panc 04.03,107985,-4.416167995938274,-3.386148179214483
SNU-449,11238147,4.105269625362408,3.1084435535138915
ONS-76,66577038,3.2799369572038977,2.9833092428400105
NCI-H1623,156414,-2.396664487331107,1.394451726739951
DMS 273,4578,4.680938801431088,4.272585369993148
NCI-H2009,selumetinib-piperlongumine (8-1 mol-mol),-1.1472655544324035,3.4816913223699997
OVISE,73707398,1.6715872061037895,1.573522242083779
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818,2.471098676796487
MSTO-211H,navitoclax-PLX-4032 (1-1 mol-mol),-0.7263097826113902,2.2813330560208365
G-401,2945648,2.835527608429738,2.6761386895758226
BT-549,89928392,1.2423762488932544,1.687618447173512
NCI-H146,107970,1.621489555747201,2.436404212032707
OPM-2,71466380,2.758760560312852,3.890059279441508
HSC-4,15547703,3.6362413258054063,3.142777601634563
JM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.7552309582979843,0.8588847830146671
EFO-27,navitoclax-sorafenib (1-1 mol-mol),3.3507850442139024,1.7555227159743847
MDA-MB-453,navitoclax-MST-312 (1-1 mol-mol),1.1594914654574615,0.9656711937237268
HSC-4,17759555,2.4253306074953978,3.6231852858656683
FTC-133,2945648,3.116487231281591,3.0695140101551983
BxPC-3,3825829,3.4267099071969738,4.071879020097153
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699,3.914257403534137
NCI-H1623,3025986,-1.391492623029173,-1.1194631823253278
BT-549,3025986,-1.1986125704978905,-0.5872788124162004
JM-1,25227462,-4.63830716322272,-2.3225272673353325
EFO-27,4477,1.1283660363220671,0.4036437586455023
LOU-NH91,52947716,2.984350097195249,0.9564450277206851
CAL-51,44489367,4.725330666921359,4.541776284685776
DMS 273,2949965,2.5486766063035056,2.556555957859627
MSTO-211H,36462,1.134601353001676,2.335779326669465
BxPC-3,4917,2.980696163243889,2.969397684987681
CA46,9903786,1.650432742323398,1.9599850241762957
CAL-51,156414,1.13799157004995,1.5450079084984625
OPM-2,6610355,3.590135914900994,3.9878128220438605
FTC-133,doxorubicin-navitoclax (2-1 mol-mol),-1.6634242865770594,-0.9621217270452691
NCI-H661,439501,-2.903837615768139,-2.0919584889186713
Panc 04.03,9952709,3.610885547265169,3.3057081717388286
BT-549,navitoclax-birinapant (1-1 mol-mol),-2.097754918128948,1.9082841531752885
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.7558338339572193
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.47004672307378187
OPM-2,2708,4.148168261065231,3.222228059679297
NCI-H661,10385095,0.8549868667974337,1.2148435425455295
JM-1,24785538,-0.4888535449792195,0.20193019954404332
FTC-133,6610216,5.488595178062795,4.359495100831987
MSTO-211H,216468,0.7149646325927866,3.1647253223067424
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864,1.9614442144885555
NOMO-1,5978,-2.430694050184869,-2.59871478622307
DMS 273,216345,4.389361768667068,3.4386820730951566
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883,2.7592095783759305
LoVo,676352,2.5317553470156646,2.0982096549351894
Panc 04.03,107970,2.70125557955606,2.4865896373387053
HCC1143,11427553,3.376761154443363,2.8543935619220715
BxPC-3,piperlongumine-MST-312 (1-1 mol-mol),2.334096835358741,2.119597546020034
FTC-133,salermide-PLX-4032 (12-1 mol-mol),5.419117653198884,4.6386439879798225
NCI-H2171,vorinostat-navitoclax (4-1 mol-mol),-0.1406498808904326,-0.16187419758527313
NCI-H292,11626560,1.446983052748098,1.9528321876935895
EFO-27,3062316,-1.351094232476051,1.2420141037394377
MDA-MB-157,2746,2.873003215594031,3.4524504634207953
LOU-NH91,24180125,2.532676427085935,3.0931562654946707
JM-1,135411,-1.048960589681706,-0.09264817480067135
NCI-H146,644241,1.2089846023639548,1.7036398711792564
A4/Fukuda,72199292,-0.4044306818473915,0.5515278918775101
SBC-5,135421197,2.079587314097717,1.9623791357360567
SNU-81,6918837,-2.735310336273069,-2.7815039429725266
JM-1,7326481,2.606242200480973,2.7099793106845675
LXF 289,67156097,-1.7104573080698593,-0.33818193662061224
CAL-51,89928392,1.068329558331595,1.4329528540836798
A-673,6505803,0.2745970276233078,-0.563886947895688
FTC-133,carboplatin-etoposide (40-17 mol-mol),1.440649023013039,3.0800524899096677
SNU-61,15547703,3.101064478021952,3.179851085750177
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585,2.1322746547302796
SNU-449,16065773,2.84526561612217,2.7292478473275525
MDA-MB-453,53392493,1.7017875748321412,2.512966487563462
SW1463,11317348,3.510696959395443,2.460519265273656
MDA-MB-157,11214940,-0.245291289631715,2.2414238188749294
ONS-76,navitoclax-pluripotin (1-1 mol-mol),-0.9678858040482444,-0.7890566876070334
OVISE,44202524,4.183655897410181,2.9094280382639823
A-673,11964036,0.9382905451812168,0.7706536226306443
LXF 289,3503,2.5386473527097837,2.3622639508755703
MDA-MB-453,54678924,1.5140521677167769,1.932798793010245
SCC-9,2749,3.600343159035071,2.0743233947751833
CA46,9840324,5.575806842573594,5.47663730553782
DMS 273,54143018,0.522600880214995,0.28442814504761227
KMRC-1,selumetinib-PLX-4032 (8-1 mol-mol),3.77714123562175,3.2873743171002694
FU-OV-1,25102847,2.696211974787464,2.5712009460657725
KMRC-1,73707398,1.5458693028147192,1.4882700573487349
A2780,5287620,-3.13264442622338,-2.041180217196107
NCI-H460,54619267,4.901891634717457,4.103045752980042
EFO-27,2945648,3.241602940948522,3.17543655091144
NCI-H522,25105715,3.4847863866008755,3.436678186901617
SBC-5,638278,3.4285441526954687,3.3273776735559553
KMRC-1,piperlongumine-MST-312 (1-1 mol-mol),2.0343376342805906,1.8887953729571347
CAL-51,6918328,0.3807555589851347,0.22716101785976206
NCI-H727,11497983,4.370504456176288,3.478129335414336
NCI-H460,4259181,-0.2054535095090753,0.16511807058008213
FU-OV-1,16741245,4.362196150231273,3.7238132978947336
SNU-449,9911830,2.1326623866395487,2.704769462952393
NCI-H727,5278396,3.8599732465447247,3.5994854251746258
MDA-MB-157,44566777,-1.1276584651283623,0.6117391485148755
LXF 289,656346,1.157307128170796,0.8977060790275071
CAL-51,176870,2.9999818119422175,3.4812765372965724
NCI-H661,JQ-1-vorinostat (2-1 mol-mol),1.2466897580827978,1.340469282084271
SNU-61,10184653,-0.5580603125211917,1.202425819526768
OPM-2,25126798,3.830489811395835,3.2417859195557823
SNU-449,49793307,-2.0136733678876335,-2.1678054599803476
NCI-H2009,60750,0.952457111724262,-1.8850332806426187
MDA-MB-157,60750,-2.031758614917575,-2.033678046997526
Panc 04.03,selumetinib-tretinoin (2-1 mol-mol),5.031160903281955,3.3609933172027513
MDA-MB-453,44137675,2.41330993625909,3.3325273798831847
DMS 273,5287969,-2.213452126148289,-2.0454768382001514
LOU-NH91,11609586,3.3390226168587716,3.1918571393807604
NCI-H661,24951314,0.8780582238506052,1.5712916437162183
A4/Fukuda,6852167,0.513003696591474,1.987065756452418
CA46,5311281,1.0891225881142432,1.889435607994112
A2780,11625818,1.819164792403796,3.879258027312992
LOU-NH91,51039095,2.9779244840652295,2.8313138758044754
NCI-H661,4096211,1.4698398043308702,2.1296576417768334
LoVo,4705,1.5085236639058903,3.1518643820877954
MDA-MB-453,46926350,-4.337117227146235,-4.4065128804107925
SCC-9,5738263,4.330654025732234,3.51056707287386
YAPC,46199207,3.321634350680955,3.2251195062833444
A-673,71466578,4.1904953682389,3.7307555586828913
G-401,10127622,3.1466102465201793,3.482926331867123
A-673,5311281,0.6354511881397967,2.054874808556998
Panc 04.03,6917907,-5.49357619863333,-4.451856159129413
OPM-2,216239,1.2934585013066655,2.0624945471464686
KYSE-70,1716436,3.404085131889099,2.7147355462908327
NCI-H727,9887053,6.41036176282966,3.8304651650169217
NCI-H460,11404337,1.7201854837770862,-0.3350039696108346
CA46,24901704,2.114836921018661,2.0914385883991042
NCI-H292,9903786,2.498172259524573,2.8240787776832774
A4/Fukuda,9927531,3.7257201794253776,4.388912164391837
CAL-51,2113511,6.39897875596168,5.540878245104883
OVISE,409805,6.403340651497087,5.157932973224755
HCC1143,11626560,1.5863706836040057,2.0966936072109985
CAL-51,26596,-1.4638590943230956,-0.8752007689010375
A-673,23725625,2.0065405091728272,3.95718959035608
DMS 273,6610355,5.006954006570411,4.290419573363471
A2780,24901704,1.9524214470888757,3.057631228862355
SCC-9,11494412,1.4365999648395638,1.9521849089632033
DMS 273,4788,5.897035505528926,5.524471699388694
NOMO-1,46907787,-1.215006340822028,-0.27665914904083594
EFO-27,676352,2.5978940444924703,2.214520292773695
A-673,44607530,1.766367479354274,1.5433821045979679
SW1463,9887053,1.032433665952219,3.845488682577918
EFO-27,54619267,4.322845534804342,4.243306677379982
G-401,9907093,3.2734126555601506,3.804855741920236
NCI-H460,24772860,-0.596461213785507,-1.7643132469746157
NCI-H292,JQ-1-vorinostat (2-1 mol-mol),-1.255345642631911,1.3814694474686464
FTC-133,119607,5.542629368531396,5.288455637013141
SBC-5,11364421,-4.061592659681506,-2.2041782018644414
Panc 04.03,5566,3.3462548914340204,3.1541902177013212
NOMO-1,6505803,0.1224616163714439,-0.7737384480131457
NCI-H146,24772860,-4.237473750878659,-2.1660979275414
NCI-H1623,11609586,3.053283731487635,2.9844313855939
CA46,208908,1.4900061271350116,1.908836249877605
BxPC-3,9956119,3.6276214672042975,3.643413755356271
SBC-5,BRD-K27188169-navitoclax (2-1 mol-mol),2.901601885739978,1.990682523578479
CAL-51,10410894,3.3356149928792513,3.301090945166931
JM-1,9927531,4.0230036766634125,3.754734262240671
FTC-133,9866186,-0.0573555179634338,1.2322452562205581
OPM-2,3136844,3.3377711403827783,3.472135769248823
FU-OV-1,3815108,2.287889788505342,3.157275443994526
CAL-51,10410894,3.3356149928792513,3.301090945166931
FTC-133,selumetinib-piperlongumine (8-1 mol-mol),4.667559315189104,3.311592238438971
LoVo,5329102,1.3429054297502294,1.9452784310197146
A2780,168313047,2.060680306449853,2.3102287374358665
HCC1143,104842,-3.076711821193911,-2.0216865930269003
NCI-H2171,JQ-1-MK-0752 (1-1 mol-mol),0.9706610774505884,0.8275309931779826
LOU-NH91,6918736,-0.749268328982244,-1.615321966714386
LXF 289,11625818,3.3628594045115805,4.5896991281178945
LXF 289,5311281,0.8902308213691446,2.3928996942609504
SNU-449,5351362,1.2849200933546208,1.7177458582435619
NCI-H522,135875424,3.5456342124976445,3.3829800118456785
MSTO-211H,44185566,1.3875680654995235,2.8522348243280238
BxPC-3,24964624,2.317613094015834,2.6612684674842186
HSC-4,6852167,2.6632521076475446,2.7466395255174825
NCI-H661,409805,4.01937565581764,5.103863957632751
NCI-H2009,16038120,-1.1539994385349277,1.2564148869750813
NCI-H2009,5978,-2.257242885332271,-1.4310205447597204
EFO-27,56649450,4.209581770525167,3.4912351087405984
DMS 273,5287620,-2.166812480100597,-2.0788574281323826
LOU-NH91,613753,3.2819891552194327,3.3813051100775646
NCI-H460,73707438,4.549718141383013,4.185061832705987
LOU-NH91,24785538,0.7950573935003075,1.9887357542306718
KMRC-1,71304818,3.217910603872335,2.5335480096402914
MDA-MB-157,carboplatin-etoposide (40-17 mol-mol),-0.0660482957905645,2.9856291530367405
LOU-NH91,15953870,3.547895487506012,3.795993431009195
SNU-81,3384730,-0.4505726212948157,2.3252856261190225
SNU-61,1750826,-4.373387519590766,-1.525627310958271
MDA-MB-453,753704,5.23059705064669,4.919125962155633
A-673,119607,5.020937738944074,4.815100844914977
KMRC-1,9907093,4.272059047954712,4.217583672864698
CA46,11640390,3.3312213559791397,2.3592937039974737
SCC-9,24771867,5.065268858490301,2.877160570435284
ONS-76,5280436,3.697781558026248,3.439820506866154
JM-1,10427712,3.737784417116883,3.5722406375219173
FTC-133,3081361,3.8958462184451697,2.679361135658987
KMRC-1,56649450,3.8757723452520136,3.456458217044514
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073,-1.7532597940235635
LoVo,159324,-0.9516179858777442,3.221881390190169
ONS-76,2841722,4.548555296080543,4.4637187305977575
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152,-3.0872657183515035
SNU-449,5460769,0.9117409452183444,2.544832549570648
NCI-H460,6852167,4.590065962834362,2.982649251400188
OPM-2,tanespimycin-gemcitabine (1-1 mol-mol),-0.8527630037012235,-1.747401135851483
KYSE-70,176870,5.518340217914711,2.985211036120705
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388,0.740297483997134
JM-1,vorinostat-carboplatin (1-1 mol-mol),1.5414150367145687,1.8431741960914354
FU-OV-1,15953870,3.743404981829692,3.7700212371031006
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,0.9761248284949606
SCC-9,navitoclax-MST-312 (1-1 mol-mol),0.9061907565004998,1.0864852497352684
LXF 289,654092,-0.8888310934038361,-0.30687258042603044
BxPC-3,9826308,0.5055656835854033,0.7028957081671708
LOU-NH91,25150857,3.1116403082593096,2.627826596883963
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218,0.9647040852643147
A2780,375860,-0.912616297645574,-0.5209503245029011
LOU-NH91,6852167,3.2671273023515934,3.171221448418271
CA46,24753719,4.040239779097469,3.3832767754760447
HCC1143,135999136,4.602247958833588,4.018203376044479
SNU-61,selumetinib-MK-2206 (8-1 mol-mol),0.3339128925553656,1.4048301755616288
CAL-51,11960529,3.662834723962616,3.9126186025432204
SNU-81,20959075,-6.025577396301825,-2.579964377592106
NCI-H522,57519531,3.3673050119485555,2.1235944904907513
HCC1143,135421197,0.8918606552263807,2.000955010348076
SW1463,24978538,1.1634359901262634,1.2297464657007349
HSC-4,445091,4.370395830414555,4.5275601963231455
SNU-61,5329102,2.445912447276521,2.0399442187926202
G-401,23582824,-0.1091259215243222,0.7533402589657371
MDA-MB-157,11485656,1.3019788320898549,2.459252579498963
NCI-H1623,11964036,0.5644570453188236,1.3030082269975045
MSTO-211H,1242560,2.686361074048806,3.5176168804130894
A-673,65064,3.1048319417370775,4.0534135528125015
KYSE-70,208908,2.5295165235288004,1.6439919034765322
SBC-5,2733526,3.427490731511537,3.846627306464847
ONS-76,6184667,3.7303112000686256,2.9852082935460214
A2780,23939,3.9158411595028046,3.787661141190366
JM-1,1566236,0.6280103536338946,1.4289178853512183
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.6204480178389533
NCI-H727,ISOX-bortezomib (250-1 mol-mol),1.608281700069038,0.8003021075024433
CA46,11396600,2.515122226404857,2.4664936429289988
BxPC-3,262093,3.443903516481154,2.979826912291923
CAL-51,1566236,2.769525954778687,2.1411762068195452
JM-1,3025944,3.553601432401545,3.7336733479951816
CA46,31703,-2.2435350155349023,-2.818339973457585
FTC-133,25105715,3.757366730830659,3.40159958711199
LOU-NH91,54649381,2.7277802519486514,3.963698287177373
A4/Fukuda,11364421,-5.769651092108399,-4.070218833950457
A4/Fukuda,5978,-3.163562671527086,-3.2981806831644254
NCI-H1623,969516,3.836806795163693,3.0023507992951433
NCI-H2009,5113032,6.328717344861362,4.8621928459696555
HSC-4,7326481,1.9301811465772087,3.073253779751163
DMS 273,54639665,4.46621146803559,3.227950346454011
YAPC,9926054,1.8358643335634888,1.806865197154393
NCI-H460,11238147,4.460003386993959,3.0547928994354625
OPM-2,9887053,1.8393709016316329,2.78093690398485
JM-1,168313016,3.8541200519849017,4.046870181445044
NCI-H1623,285033,-2.516722374910668,-1.5607524483049986
KYSE-70,5351362,2.601126509135012,1.6661146439742516
NOMO-1,10113978,3.435868796737405,2.3549841213508995
HCC1143,17759555,3.749709067386792,3.5859337982248407
NCI-H292,11964036,1.1514824488888922,1.6632136742686854
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039,4.159099067843209
FU-OV-1,46943432,0.7627718951481175,2.9937052430518314
NCI-H292,4917,3.248446822462735,3.0887799752869385
FU-OV-1,452548,0.3745426606957432,0.2414638023416768
A2780,24180125,2.723679145549484,2.8262585531957756
SNU-61,9911830,2.7749851076050187,2.0529382196993766
DMS 273,6918837,-4.776469138555483,-3.8188464053230153
NCI-H460,54454,2.7807551042334935,2.526922362442616
SNU-61,5978,-3.491631614089224,-1.6748501711539256
G-401,5287620,-2.7219963273379766,-2.0998245261685056
ONS-76,9884685,2.079600161824297,0.6310424836949392
NCI-H460,6610216,4.838717363885395,4.30577192630864
CAL-51,51039095,2.1842093640891416,2.7655259077903533
MDA-MB-157,2871966,-0.7905554969861216,0.7799962182667072
G-401,46926350,-4.213486210672068,-4.034996912750675
LOU-NH91,navitoclax-PLX-4032 (1-1 mol-mol),-1.9251020200365585,2.132943848043821
OVISE,10184653,1.818458167845024,0.953654333386563
A-498,6918328,1.134294475717993,0.4102492136057546
A-498,10302451,3.720340150939392,3.3942014955394
CAL-51,9935249,3.84795648434564,3.157340100739016
NCI-H292,24856436,1.0729923244387796,1.02540619665705
A-498,409805,6.12415200666612,5.475500030003584
EFO-27,24889392,4.405449300162506,4.092877275693212
NCI-H1623,navitoclax-piperlongumine (1-1 mol-mol),2.7839098581302366,1.5752803533703783
NCI-H460,159324,4.0462841352482855,3.2750248520314362
LXF 289,16720766,0.4842655504206017,0.7299854921694141
LXF 289,54649381,3.6309892426510406,4.004066047404491
G-401,decitabine-navitoclax (2-1 mol-mol),2.109547843543789,0.7104515531925402
JM-1,71751553,4.311473922741218,3.7488258073553324
MDA-MB-157,2945648,2.730573332542116,3.1447940039357114
SCC-9,navitoclax-birinapant (1-1 mol-mol),1.9538462590257963,1.5203068910515065
SNU-449,67156097,3.7845495552330024,-0.030170752662468447
NCI-H2171,24951314,0.4758147687646419,0.4793333475168312
A2780,24180719,2.9021439553303026,3.564835705996984
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175,-0.35290919723069175
A2780,54454,-0.2144211598876236,2.490291416297823
A4/Fukuda,16659841,2.2699989015311437,2.797829569052071
Panc 04.03,44137675,4.02019355498934,3.6542546223225996
HCC1143,25150857,2.69660437037969,2.660447168657923
BT-549,104842,-3.414515083122074,-2.436788327311549
NCI-H146,11960529,3.5646000180725146,3.5714503893008276
MDA-MB-157,11238147,1.748896698587814,3.012069353419978
SCC-9,72376,-1.0275629780171365,-1.612916236648643
MSTO-211H,57330099,2.804758704858228,4.233540931015309
MSTO-211H,135999136,4.2061059176098645,4.23899696432664
LOU-NH91,46907787,1.567116016960845,2.903779801198449
G-401,navitoclax-MST-312 (1-1 mol-mol),0.8926313701991264,0.5822942723086207
NCI-H2009,71466445,2.5164920571758036,4.199114997184171
OPM-2,54618771,0.7318105179081044,0.4581220452466465
A-673,1716436,1.8403672814357532,2.9026118913740904
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022,1.8762807107190718
SNU-449,selumetinib-tretinoin (2-1 mol-mol),6.057400941930893,4.201020959634321
FU-OV-1,327653,2.5930307991109784,3.2383689265874716
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247,1.259661885196178
NCI-H522,56973724,3.7409361942384183,2.4591306124709593
NCI-H146,25262965,-1.0264838155868825,-1.5743786089681064
CAL-51,2749,1.4482754145936665,1.8706786604223404
MSTO-211H,4477,1.290064962685197,0.534110238069427
NCI-H292,637858,2.5198155256882813,2.343588549139599
DMS 273,3136844,4.133948633698644,3.766171523785255
HCC1143,654092,-0.1725481204081408,0.06886004350745605
NCI-H727,72734382,4.575159301501077,4.54922684475761
NCI-H1623,ISOX-bortezomib (250-1 mol-mol),0.4701818373659249,0.789532339008291
NCI-H522,6918837,-4.666914399076351,-3.169895133570962
HSC-4,11228183,2.0585180361700313,2.332594030004616
NCI-H1623,107970,2.966658693868389,2.362191727130837
A4/Fukuda,5278396,2.678829799859676,3.3309387013916614
SNU-61,25062766,2.174077685737065,2.0242480211618514
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864,1.0562356967245037
ONS-76,5460769,1.8809234095271896,2.9116757261424424
BxPC-3,448949,1.967823553768285,2.1841403934441757
FTC-133,42642645,4.559192948180462,1.1125366280824984
MDA-MB-453,4705,2.8938913201458583,3.1093923713378513
NCI-H727,54454,4.237398664855094,2.7797936724411145
SCC-9,selumetinib-MK-2206 (8-1 mol-mol),2.3963375706124967,2.5284921664308326
MDA-MB-453,tanespimycin-gemcitabine (1-1 mol-mol),-3.3001321684488825,-1.6092021786564785
NOMO-1,19582717,2.563142509513499,2.9409148967970435
A2780,445643,3.2119323974162786,3.975923660679224
MDA-MB-453,6918837,-5.413037386455184,-3.474121599300109
BT-549,72193861,1.0619418160757952,1.8919736528603943
HSC-4,44607530,1.7156299328297433,1.690724836771629
A-673,11455910,-0.0977898825280259,0.7798372500630907
SCC-9,262093,3.396257832039873,3.1923518348833526
JM-1,148198,-6.864264453079388,-4.2809853129453845
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576,0.9858223122052288
CAL-51,8515,3.5852991976047863,3.851243396844396
NCI-H292,49793307,-2.523289852336332,-2.3730669795401753
NCI-H1623,2708,5.67986318014104,5.1471994827574985
SCC-9,3025944,4.376039606027409,4.326678357610746
LXF 289,24772860,-1.828128181459349,-1.8908361882826303
NCI-H1623,5287969,-1.6741359655835943,-1.7846922412304282
A-673,54454,2.1191092291244877,2.632559547931129
HCC1143,10302451,1.8641137803790455,3.4121291490096066
NCI-H292,54649381,3.811841265663476,3.899304828804739
FU-OV-1,44607530,1.1358438423183184,1.930798538463765
OPM-2,5702613,2.283159730657738,2.123662145006608
LOU-NH91,11612883,2.793800542696417,3.0076904705359335
DMS 273,11214940,1.0513565801549722,1.2365112023440312
FU-OV-1,65064,4.9743661807936235,4.9168874519768595
A4/Fukuda,23635314,-5.004930640559638,-2.8270228518502476
NCI-H146,44137675,3.928890295501361,3.3127858972017905
NCI-H727,carboplatin-UNC0638 (2-1 mol-mol),3.50410186086625,3.328885243839166
YAPC,navitoclax-gemcitabine (1-1 mol-mol),-2.531110642636913,-0.47043593822332563
SCC-9,25105715,3.642638215460893,3.2751174904979354
HCC1143,219104,3.69834662828724,3.779256845266288
CAL-51,46215462,0.9657515518660452,1.8034342201866003
FU-OV-1,9936388,1.7648084748519457,0.4216398090062203
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725,4.2070019086145365
A2780,65628,0.1843862993724733,3.9933868944031974
SNU-81,11647372,-4.046967337474091,0.6242645301295129
NCI-H460,44589607,4.73035444754351,3.172026922800504
SNU-449,9549297,4.8793656902716345,2.6419156227661307
SCC-9,11625818,5.698343618019975,4.537619185488503
LOU-NH91,54619267,4.2625648850210665,4.0941587262625765
SNU-81,676352,1.7899908822518449,2.0482406359379546
CA46,4096211,0.9281979530192106,1.0466395583788506
FTC-133,6918638,0.7173410835371117,1.0081851612915156
A-673,10074640,2.0498537136670696,2.993860957596449
FTC-133,9907093,5.562055210260789,4.0363552440262165
HSC-4,24775005,4.677905847548428,3.7586524816631965
A-498,selumetinib-PLX-4032 (8-1 mol-mol),2.57044020856199,3.6091093252946713
CAL-51,11964036,0.7531640395115359,1.277456821841888
NCI-H146,16736978,0.7510083752799234,1.3578303333340032
YAPC,15547703,3.1542356669454055,3.3208861630124216
NCI-H1623,25195348,2.589072393428722,3.3852485537894847
JM-1,5311281,0.5908340552261697,2.031073113931286
SNU-61,9840324,5.730394861191507,5.584491522166583
CAL-51,322968,3.332930006684798,3.5831770882882785
BxPC-3,613753,3.1887459622848935,3.361953149019113
A4/Fukuda,9887053,3.945623871756388,2.83296834979706
ONS-76,119607,5.207716304164231,5.205312285968017
G-401,11955716,-2.313708507563708,-1.5202140793015895
EFO-27,9840324,6.098788849131883,5.823182344732593
Panc 04.03,219104,4.644038290885272,4.095168002408945
HCC1143,25262965,-0.487374364701845,-1.0238987832500153
EFO-27,25227462,1.7048102531951876,0.9609841613231893
HSC-4,10074640,3.187745953835862,3.2318141587950127
SNU-449,5287969,-1.7501228923890362,-1.8302852397331828
BT-549,49836020,-1.94641857460656,2.885669554954725
BT-549,36462,2.0708174288882075,2.550844321042753
SNU-449,135421197,1.7191553190938056,1.9000548481667223
EFO-27,49867926,4.359647239344765,4.305224460124314
NCI-H727,568763,0.1873556014231215,0.5499105948656949
SCC-9,5287620,-3.0509576220001953,-2.0882859947757253
SNU-449,3543504,4.913571994290616,4.470317370446788
BxPC-3,12001922,2.0478076671218317,2.181135320883632
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333,2.530980095150532
NCI-H661,54618164,4.023349318575714,4.083289520097803
ONS-76,JQ-1-UNC0638 (2-1 mol-mol),1.9548647661287404,1.7377592791011967
OPM-2,5287620,-2.918074250075414,-2.126396060758868
SBC-5,71304818,1.011143162310159,2.462709221074545
NCI-H522,navitoclax-sorafenib (1-1 mol-mol),2.7725846762531856,1.5360430765603257
CAL-51,216468,1.370586512271769,3.1280576856830162
MDA-MB-157,25150857,3.068531629493821,2.4543356593000505
ONS-76,10074640,3.173150149140259,3.3217889390439863
NCI-H2009,5470400,0.3791383114910072,-0.18462663211351374
CAL-51,54619267,4.1828818787298765,4.137523512971451
A4/Fukuda,5738263,2.3624425097256676,2.732315293234695
SCC-9,1239801,5.7667211168431205,4.143024274747392
CA46,11152667,-1.1506421067609531,-2.21136979576932
LXF 289,9444,4.020808033871241,4.2090917205997
Panc 04.03,25062766,2.3535958479396166,2.421968290307953
MDA-MB-157,71466445,-0.8161407888171323,4.188787419753641
NCI-H661,10302451,1.6315200392387812,3.6923501068295184
NCI-H522,10385095,0.7404415633977295,1.3540058979101246
LoVo,53495165,-1.2075385636979648,0.35592992191460754
NCI-H1623,613753,3.253043904005535,3.3137449005112165
SNU-81,49836020,-3.195484765979539,3.2466793625891937
A-673,73707371,5.345141037142936,4.221455352636774
JM-1,71466380,3.0146886034862885,3.7325461178607804
MDA-MB-453,135659046,3.699316020945489,3.7855230819036443
LXF 289,72193861,1.9781400147016948,2.057478716842235
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165,2.4136015959248036
Panc 04.03,46843906,4.199928797005276,3.339308024932362
NCI-H460,16725315,5.407057101640495,4.424731993261769
SNU-61,375860,-0.3575080218905608,-0.18238510789255608
SNU-61,216345,4.373705885149758,3.66071517060436
CAL-51,25154868,4.656760297450745,4.391980392162764
NCI-H146,10172275,4.247153556222009,3.3102959638111997
SBC-5,122327,4.539216274618647,4.50542421327167
A4/Fukuda,24785538,-4.18833617701787,0.7148924959502887
NCI-H727,54618305,5.896457883643312,4.497920706781351
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698,1.390853639651441
NCI-H727,6918736,5.488213607701973,-1.3992420655125457
NCI-H522,168313200,1.7984937800694238,2.8520720870525538
OVISE,11396600,4.241731433198166,3.790393553326678
ONS-76,25154868,3.0856348617246048,4.510837376512234
LXF 289,135398516,1.6034740470130215,2.291213403073505
G-401,9967941,2.755238424074781,3.2545803242734617
NCI-H2171,44493528,3.677120674941258,3.9935734469360242
DMS 273,135398516,0.9081791710880508,1.7244635848175127
CAL-51,219104,3.260140555917495,3.85246513870924
SNU-449,9927531,4.924705078398161,4.954458268331191
A4/Fukuda,9840324,5.782088483619631,5.457290107992907
DMS 273,11404337,-1.7233190830375906,-0.3046225189541422
MDA-MB-157,24964624,3.531877357122639,2.535903074805101
CAL-51,44486219,4.943814728636009,4.281915782605802
LOU-NH91,216345,4.715464564049095,4.3319567540919595
LXF 289,124202324,2.1762748500922657,2.4873631775778073
HSC-4,23582824,-0.585849233367442,0.7432062679112705
LXF 289,25126798,3.2757893610597923,3.8948204866421805
SBC-5,4788,5.245695847909484,5.6721579121859484
ONS-76,24856436,1.9295271968291927,0.6409330524996486
SNU-61,24753719,3.71513491278392,3.905807500990296
MDA-MB-157,vorinostat-carboplatin (1-1 mol-mol),2.089611871642824,3.3499340664863957
LXF 289,54618305,4.64176895308047,4.583619618229126
CAL-51,9926054,2.2227862000004577,1.930893714753918
DMS 273,11427553,3.72076353850383,1.9513311189232783
NCI-H460,25126798,4.092385726400508,3.845009682377783
SNU-81,1716436,3.163180638308135,2.7968362139396117
SW1463,426756,2.2352578961733967,4.181411410299254
NCI-H1623,6918638,-0.0742651507067239,0.5779022994760203
NCI-H522,46191454,1.7170402718959707,1.44980264147802
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885,1.7745602423105868
MSTO-211H,49766530,-4.866552298919663,-0.9078382764038454
NCI-H2171,11228183,-0.0614644470988351,1.2451716369154902
HCC1143,5311281,1.3434544130633397,2.5405886797714086
ONS-76,10410894,3.505250871213463,2.9752657375843916
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411,1.581097273841741
SCC-9,46398810,2.8303032541075455,2.767915018933574
OVISE,5351362,2.5456705040985708,1.9014772802011684
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992,0.3286015449449578
NCI-H522,5287969,-0.7039868347543177,-1.8276229795259815
KYSE-70,9840324,6.215387239369238,5.587458776035053
G-401,2708,4.061322582720861,3.9248923079738325
MDA-MB-453,selumetinib-PLX-4032 (8-1 mol-mol),5.5493324312500825,3.4844302556082662
SNU-81,selumetinib-MK-2206 (8-1 mol-mol),-1.5641952931996328,1.9573906686334084
A2780,9868037,1.6123332444026346,2.555583058930821
EFO-27,selumetinib-MK-2206 (8-1 mol-mol),3.7293539227770824,2.494034332212975
NCI-H292,2708,4.789540620747355,4.998033364148273
HSC-4,11238147,3.6589845000918504,3.048018345966165
NCI-H2009,168313047,3.1000323585702083,2.6060091868776762
OVISE,3689413,-2.3316050545360136,0.20546700488352518
NCI-H522,71751553,5.137300136027492,4.338392628132334
NCI-H661,9444,4.500292949687679,4.3080852517088735
BxPC-3,54649381,3.6406106092590007,4.005155392355534
KMRC-1,selumetinib-piperlongumine (8-1 mol-mol),4.604012019572112,2.692896146695853
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247,0.7245633290102887
KMRC-1,10427712,4.418169957842134,4.1464690218599465
FTC-133,9935249,4.194644265855045,3.429670506839487
LOU-NH91,alisertib-navitoclax (2-1 mol-mol),-1.2312433531350488,0.9783024249822039
SBC-5,5280436,3.662085558148715,3.363863889916485
JM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.97629163512536,0.318949542762206
BT-549,462382,0.0307570083617302,0.8196958686253089
Panc 04.03,445091,5.978315194185719,4.63632881993959
A4/Fukuda,3011155,4.269088750580724,2.512011990842324
G-401,selumetinib-tretinoin (2-1 mol-mol),2.678729484296938,3.3870586032185757
A-673,57519531,1.198988142705803,1.9452740363156231
SNU-61,3025944,3.777150750907422,4.210251006199926
CAL-51,11497983,2.6322425573174213,3.9165674074966272
JM-1,12001922,1.1772658700026328,1.5601680648037615
A4/Fukuda,375860,-1.1918610484687095,-0.685465371961211
LXF 289,5978,0.6093029371771528,-1.580884194219378
FTC-133,5329102,4.217502606235289,2.0750531348316383
LOU-NH91,erlotinib-PLX-4032 (2-1 mol-mol),3.00809922416846,3.3504057866262076
OPM-2,10296883,2.7550650350156474,3.1208787816149033
FU-OV-1,4259181,1.2776952629591818,0.22464847616106998
BxPC-3,100016,6.453363473458683,6.210224982662047
YAPC,168313047,2.3481335437424957,2.542215552064904
NCI-H460,10184653,3.574651577310896,1.5286841586520148
OPM-2,3062316,1.3077504545650411,0.7209150587767255
NCI-H460,9956119,4.485375019847723,3.7497281596197922
ONS-76,3815108,3.0019527232257555,3.029378315752294
NCI-H2009,6918878,-0.4863456687538305,3.121238342783984
NCI-H727,10302451,3.178772538514987,3.052734408625709
NCI-H727,2945648,2.622160220955332,3.0886074789786817
SCC-9,71751553,4.89059631642312,4.600349800348
SBC-5,36462,0.3494520767872783,1.9413645231919916
G-401,4477,0.236688812816839,0.260089930812956
DMS 273,9926054,1.8030373867492464,1.8297893394619646
MSTO-211H,2828334,5.714930690846282,6.213265775961666
A2780,24797083,0.8113195258872324,1.3222859974112475
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546,1.0893270880052317
FTC-133,44486219,4.933137185021197,3.9944091953182004
CAL-51,6918736,-2.0480142356294637,-1.6254551023615265
NCI-H522,72193861,-0.7243330419144597,0.9014523866986608
BxPC-3,JQ-1-navitoclax (2-1 mol-mol),-0.3389644558379706,0.9894221481161203
ONS-76,25102847,3.483061373005376,2.894196234566883
NCI-H727,168313016,5.705554517808247,4.751442921268046
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484,2.041664421661579
OPM-2,25161177,3.2493247866394497,3.2119740625113917
NCI-H292,374536,1.098561227965989,2.3344540551773516
NCI-H522,54618771,1.252244709003548,1.0416246011693857
KYSE-70,44486219,3.9722791166403657,4.079384755108204
FU-OV-1,72193861,4.196952295232924,1.9120747669517286
CA46,56973724,2.349278499068081,1.460327295852908
A4/Fukuda,2729026,2.569130626356953,2.3342799410486648
YAPC,148198,-3.117185181322903,-3.1646809209055764
A-673,24753719,3.397650756866718,3.759663912005359
NCI-H1623,16659841,4.138965758514941,3.9160509228762397
NCI-H727,637858,2.2360670355510086,1.9831905507572822
NOMO-1,31703,-1.8429032714500968,-2.3766114830865592
LoVo,65628,4.171555925906434,4.501772201401199
EFO-27,322968,2.5694057659070264,4.037942755662663
NCI-H2009,216345,4.438201480917741,4.132255551541365
BT-549,5282054,2.5925054001589976,3.8838970770552903
FTC-133,6918837,-2.2077574090678307,-2.430979533595011
DMS 273,54626689,4.997985813086497,4.446844840923145
HSC-4,16741245,1.7716610997683242,4.0495235172649595
SNU-61,6438330,3.4216884605560085,2.3239070123825716
FTC-133,9936388,3.0046059879710363,-0.578382242994512
OVISE,3815108,2.0996140723315913,3.0397631703151817
NCI-H522,navitoclax-piperlongumine (1-1 mol-mol),1.629477440849753,1.191917200176267
NCI-H292,5281321,-0.9498489394799606,-1.0546329474782403
BxPC-3,25126798,3.172026591671247,3.86071671939927
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968,4.432974433882282
BxPC-3,11213558,1.5061777503093252,1.8128519766386353
BT-549,3503,1.5652779265398058,2.482089937002867
FU-OV-1,1716436,3.524722071533676,3.176018587817402
MSTO-211H,15547703,3.049193057044517,3.446383897732921
KMRC-1,11427553,3.2258060185151343,2.6378846504986098
NCI-H292,46191454,0.9903655583180804,1.9092610455133316
CAL-51,135928012,4.192641653546412,3.8764610255439464
NCI-H2009,44202524,1.444691297679544,2.300667788356141
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324,3.0375100555933523
SCC-9,2858523,3.190510944053216,3.1470666391883304
BxPC-3,15953870,2.831569416015373,3.639674873373
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291,-2.363198224508857
SNU-449,135398516,1.5851782119809552,2.4375496546483437
SNU-81,9843750,-0.6437789188002867,3.7499182778278244
SNU-449,11427553,2.8197595076352564,3.0041921831326217
OPM-2,11656518,2.629079922396914,0.34518656724053576
BT-549,135398516,2.1186047788766085,2.538971911190285
OPM-2,176870,3.9257377377060383,2.710289816062611
OPM-2,46926350,-5.934740852723627,-4.48680121371634
HSC-4,2729026,2.4603123985812276,2.6855028604133753
KYSE-70,9444,4.1582482593031145,4.222193373052189
FTC-133,9933475,4.176811369298493,1.9027550145845213
MDA-MB-157,51037431,2.1321019948022046,3.2437435591504156
NCI-H522,carboplatin-UNC0638 (2-1 mol-mol),3.513501660159428,3.2719236851035323
FTC-133,44493528,6.31419839504633,4.414828612564377
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882,-0.357423564354964
KMRC-1,11507802,3.5140789318254426,1.8698497827896248
KMRC-1,25183872,-1.331773303463366,-1.0928105178043879
OPM-2,16219061,1.6139038412518538,2.5102730924797445
LoVo,25183872,-1.0423877479811554,-0.6210311614830553
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.47004672307378187
FU-OV-1,6623618,4.441105176868704,2.431718579365592
DMS 273,4259181,0.4383145170351891,-0.36373673631548115
A-673,docetaxel-tanespimycin (2-1 mol-mol),-8.62633538117336,-4.297596158757513
KMRC-1,89183176,5.996613867274686,3.969782364626369
MDA-MB-453,9825149,2.3540085594050204,1.9506237095552137
Panc 04.03,decitabine-navitoclax (2-1 mol-mol),3.786860225423862,2.31504675314332
G-401,4788,4.978954455161412,5.25705330663246
MDA-MB-453,52947716,-7.0217551266009375,-1.0588279471268016
SBC-5,6918328,-0.0891350348900322,0.162677956430623
HCC1143,49836020,2.702530837822698,3.042787314287813
MDA-MB-453,9956119,4.182542041452956,3.8093436129905247
A-673,136227924,1.815433973878695,2.576120880359042
HCC1143,9956119,3.9159046092458785,3.861029735189673
OVISE,ISOX-bortezomib (250-1 mol-mol),-0.1243058727191033,0.818450467435197
BxPC-3,11234052,5.706263551465742,4.226814040901198
NCI-H727,44259,1.5490626006331412,1.0749942199935374
SNU-449,24964624,2.993830455857875,2.8265620706164096
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919,1.1575713024948706
LXF 289,3025944,3.4981276099044134,4.305293655691257
A-498,24964624,2.395732501339878,2.742391833743266
DMS 273,4096211,1.7794100041919845,1.2621664222854267
NCI-H146,SNX-2112-bortezomib (250-1 mol-mol),-4.105126294975654,-1.441428814921766
SCC-9,16722836,2.261290441734353,1.859106911276453
LOU-NH91,452548,2.191181432305291,0.26425408964362146
KYSE-70,2828334,5.886367586734188,6.272221114748729
EFO-27,6450551,4.042476340029328,3.0458654768272977
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542,3.018529774635973
SCC-9,1716436,3.7585685406918783,3.08878336849535
NCI-H2009,409805,3.859994247591149,5.071821155200896
Panc 04.03,SNX-2112-bortezomib (250-1 mol-mol),-2.269720015649412,-0.9621578543178623
SCC-9,54618164,4.4493976732458576,4.1692274930344295
OVISE,5470400,-1.924229347102114,-0.5153195995801071
EFO-27,44607531,1.7985046151445,1.7269970639148562
KYSE-70,439501,-1.7979650249976522,-2.33957490017406
FU-OV-1,JQ-1-navitoclax (2-1 mol-mol),0.4181206302825215,1.0949206012262487
NCI-H460,11175137,3.7005840280640374,2.8579755446440145
ONS-76,71680916,4.956248935312428,4.559896718861153
NCI-H1623,10410894,1.736668634267143,3.3535891876547503
KMRC-1,6918736,4.048742051120841,-1.0831219159223038
CA46,25161177,3.91788686206549,3.2554105583283497
MDA-MB-157,6852167,3.8998726158787007,3.0512137974237925
HSC-4,11364421,-0.0916399418549534,-1.0067205508694597
CAL-51,2746,3.539110169106334,3.130109978779743
SNU-449,24748573,1.9316038598597545,2.496941442085196
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188,1.8477764030746864
KMRC-1,9926054,1.768451409600443,2.1478732360186883
SNU-61,4917,3.0491510397841015,2.9939838978805127
FU-OV-1,5335621,4.183078950789895,4.438320683463839
LXF 289,44607531,1.6515112206427849,1.574202881459655
A-673,11640390,1.6795118149646189,2.863172190539957
DMS 273,51039095,3.4577395537233526,2.52821926180606
NCI-H460,126941,-2.220790788147435,-2.696381332407031
NOMO-1,5281672,5.39154363605107,4.271755917491437
SW1463,11214940,-1.9875595606860448,1.660422381432901
SW1463,72376,-4.419423024557842,-2.237214537272214
OPM-2,613000,1.2483941007528057,2.4438073735318273
NCI-H292,445091,4.263425815338472,4.530647825228007
MDA-MB-157,46926350,-4.132103643787292,-4.004254352079217
Panc 04.03,10296883,4.422301293811254,4.120788379251328
SCC-9,11964036,1.807051006133268,1.2979300288554954
YAPC,11626560,1.7222365359336271,1.8834599263178786
LOU-NH91,375860,-0.2088041582630222,-0.1579162145927326
MSTO-211H,JQ-1-vorinostat (2-1 mol-mol),0.928346567061831,1.2639705439666433
A2780,374536,0.6453837370733745,1.667001916025426
LoVo,5351362,1.2957137522113673,1.343440805823641
DMS 273,navitoclax-PLX-4032 (1-1 mol-mol),3.5987731605667284,1.2686519263989227
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277,-0.9268713453738837
LOU-NH91,322968,3.304915281144932,4.315049403447569
OPM-2,54596558,4.064764759335406,4.177250760648361
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448,1.9744148650053632
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112,1.7648579881295567
MSTO-211H,44137675,1.9879298255329003,3.934804168532036
NCI-H2171,42642645,-0.8345775302937554,-0.19363832693643487
A-673,5287969,-3.109107778120567,-2.065360901272689
HSC-4,5566,3.1631957469062684,3.053461916411253
NCI-H146,5284616,1.616711114994892,0.9882049493737238
FTC-133,10184653,4.443025626482117,1.1373341757512845
BT-549,241158,3.5488750117076484,3.981090271617674
CA46,25195348,1.4184238486273535,2.654716553831031
BxPC-3,11497983,5.307904838671978,3.81420226424584
MSTO-211H,4096211,1.4030307395810702,2.3555883880864315
CA46,11175137,1.918070959510412,1.5884127848842926
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-0.7751553567094159
NCI-H1623,5566,3.3003894636357565,3.06826513455858
SNU-449,25262965,-2.560427276701697,-1.1076361746767303
FU-OV-1,16038120,1.1817724128349547,1.0889313079931617
NCI-H460,6438330,3.783082395235063,2.3747571820635387
SNU-449,selumetinib-navitoclax (8-1 mol-mol),4.616443457041138,2.0579384173880877
LOU-NH91,12003241,-1.4006618643370652,-0.8504207266714849
NCI-H2009,89928392,1.462956527326012,1.9449919882213829
OPM-2,selumetinib-MK-2206 (8-1 mol-mol),1.6316326577463918,1.6961669895066782
NCI-H661,53495165,0.322884771008066,0.6880804577455034
FTC-133,16659841,4.779782303247626,4.100645606597426
FU-OV-1,176870,2.993075468358777,3.6124163543004113
MDA-MB-157,24771867,-2.9284017086321197,2.7028874674649495
MSTO-211H,5328940,-0.7344582610548551,2.0405946548440412
A-498,25126798,4.108305960475203,3.935866518481813
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637,2.125452867898242
HSC-4,5460769,1.9290612526481368,2.7804421203359793
JM-1,9826308,-1.254578223347674,-0.33322099374400366
ONS-76,124202324,3.376244033970937,2.3629269270328876
YAPC,135984461,4.395865755985396,4.251399970906684
DMS 273,5746,-0.0149388723107023,0.6771687474488561
FU-OV-1,4917,3.642085139957623,3.1161626940834695
LXF 289,49793307,-1.960491877422628,-2.3991704565869303
OVISE,107970,3.0608588072726444,2.416610276012981
BxPC-3,446155,2.3080345350315015,2.7558151024655855
OPM-2,65064,2.528451354351822,4.064803501858035
SNU-81,5278396,1.9031243607798085,3.3970511996769126
NOMO-1,5351362,2.08054014163225,1.0080872596023411
A4/Fukuda,675434,3.712142385749843,4.172462841764313
ONS-76,44241473,4.684511997660941,4.861219518987349
NCI-H292,54619267,4.1033140795833445,4.234378238925723
NOMO-1,5470400,0.2862684612003833,-0.24257333100303233
LXF 289,1716436,2.59582131383783,3.1111255021241395
OPM-2,71680916,3.9051822114426025,4.087306372886962
YAPC,72193861,3.178335780336401,1.7826824153592733
HSC-4,148198,-2.795908666323494,-3.1665310963527507
Panc 04.03,piperlongumine-MST-312 (1-1 mol-mol),2.325884658046027,2.1148387119112146
A-673,25161177,3.4603475867806788,3.7755295409930945
NCI-H522,9866186,0.2313673592680447,0.865344513592807
CAL-51,24772860,-2.425084956958233,-1.9793121057215044
KYSE-70,72734382,4.428008981499565,4.877417792214548
EFO-27,44491742,4.311239061696844,4.324701651924042
CAL-51,322968,3.332930006684798,3.5831770882882785
OPM-2,68056272,3.036834126647856,2.6040085663083996
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417,3.3881074466297814
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226,2.948752833629147
LoVo,11485656,1.8604760547282393,2.2733142985376054
LOU-NH91,selumetinib-MK-2206 (8-1 mol-mol),3.1932369628338195,2.817521615785148
CAL-51,10074640,3.192334769578339,3.110016601255972
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718,1.101136748818732
SNU-61,452548,0.6134547199912214,-0.19186433937537528
MDA-MB-453,5311,-0.5257883568365231,1.189371063018207
HCC1143,23582824,-0.3689859010226292,0.7899328266233401
SBC-5,7251185,3.120445126947185,2.6769879280655
NCI-H292,24901704,3.391496569820259,3.4540729190755006
NCI-H522,10410894,2.9293088965189553,3.1651750463817683
SNU-61,23582824,2.5643180100002225,1.0215355933518497
HCC1143,16065773,2.712611567173667,2.4942795478992976
MSTO-211H,46191454,1.2859626841233986,2.048823663787824
DMS 273,72199292,5.337691921623293,0.8119827167641059
LOU-NH91,46398810,3.045211454343731,2.73021681522095
HSC-4,135928012,4.241462346184107,4.274336237557752
NCI-H727,3384730,3.6794289647639737,2.9017729865013377
SNU-61,4788,5.909414847709577,5.782938845502803
A2780,5329102,1.3737092942346336,1.8502448468559112
MDA-MB-453,444795,4.759998515464953,4.473459954738675
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.41696040123172
BxPC-3,11507802,0.9945684314547258,2.025992038895653
Panc 04.03,24889392,4.270107644861146,4.221742374035179
MSTO-211H,46215462,0.9168806818627014,2.1741309877982897
MDA-MB-453,11167602,2.244240898320102,2.601992928843367
A2780,400769,-2.1774855243121425,-0.6146339223617797
ONS-76,52912189,4.881284158574923,1.8483135942513473
BxPC-3,44137675,2.990010873447489,3.7055600123695442
HCC1143,753704,4.831564496260181,5.07805848732414
SNU-61,9915743,-0.5579526190142376,0.4201548038143564
OVISE,1242560,3.5076159129293956,3.8277760429472396
CAL-51,6914657,-5.067352950634086,-4.423974458502476
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057,2.861000692949874
NCI-H292,9907093,4.58058164849987,4.3053078446489135
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032,0.8295703966402062
Panc 04.03,vorinostat-navitoclax (4-1 mol-mol),1.7756869415630383,1.467403603032966
EFO-27,6852167,4.289895730200754,3.090056257114652
A4/Fukuda,148124,-6.6912736941139865,-2.9844679150289415
MSTO-211H,24785538,0.8010437121318222,1.936508839910768
NCI-H661,49850262,3.557667726590132,3.850924211525735
BxPC-3,navitoclax-PLX-4032 (1-1 mol-mol),1.642487970123168,2.0658311454057716
EFO-27,4521392,4.521895501485345,4.344241312857238
A-673,65628,3.827084992759042,3.731907755751808
SCC-9,11427553,3.060791645335887,3.1557877372727314
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954,1.5497664742702337
NCI-H661,36462,2.012090600363037,2.2105941815982835
CAL-51,11625818,4.1129054868405905,4.345917578027433
SNU-449,252682,6.455952915446744,6.674071690990866
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202,1.5873307256772222
HSC-4,2828334,6.111197262680893,6.297115512283829
MSTO-211H,selumetinib-navitoclax (8-1 mol-mol),0.5648552965523568,2.293591154494161
A-673,753704,3.1138845387287657,4.537063580582917
NCI-H292,409805,3.708436738901026,5.116805491091574
NCI-H2009,72376,-1.9106633783650309,-1.680409464037804
OPM-2,24753719,4.370940438199297,3.6638707654432205
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098,3.1797346578388823
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073,3.4824986967128795
LoVo,9915743,-0.8819018227786422,0.6698522607538423
BT-549,4788,5.920199401047736,5.7661470583443375
CAL-51,2858523,3.1959449804225524,3.0261467146425223
OVISE,2742550,5.280611289386831,3.9535096367243407
HSC-4,5470400,-1.775367561967962,-0.47408833696595665
FTC-133,3503,1.9089172693495084,2.233607606086066
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951,0.8834398271138807
MDA-MB-453,4578,4.4862028800041545,4.285921878480838
EFO-27,16038120,2.346094356536249,1.2683599559032062
SNU-61,66577038,2.989851386241242,2.820108700715574
CAL-51,4259181,-0.5132501801478601,0.31572453457292476
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043,0.19573381972167067
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786,-1.257051138561619
SNU-449,3552672,3.5064135830435563,3.0204510790980827
SNU-61,44589607,2.748444545219875,2.541113631698169
ONS-76,2945648,2.901632251679741,2.900292629114017
ONS-76,44607531,1.762572438348297,1.4253906337954703
DMS 273,2874250,4.3291006423311025,4.350899009700003
SNU-449,9840324,5.822936489993131,5.789643608037402
NCI-H460,6610355,4.949206869720499,4.429468872845349
HSC-4,11612883,3.5946567658341197,2.9121194124654313
NCI-H522,11175137,2.853962760117135,2.513712553050421
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345,3.598880593974946
A-498,5281321,-0.4472251536664238,-1.1318270022928854
OVISE,25154868,4.508600245054991,4.267720723166215
Panc 04.03,44185566,3.115745823738928,2.6022433303868815
SNU-61,49793307,-2.3504304765085573,-3.2205957335186373
CA46,44607530,1.320133740199814,1.2899806349566856
SCC-9,10385095,1.4052834583911455,1.4793623102609925
HSC-4,675434,4.235689784331333,4.591362891647837
NCI-H522,16725315,3.2253372097194752,3.8058968169915284
FU-OV-1,1750826,-4.024957616345245,-0.9828272236116833
HSC-4,57519531,1.2769425534379089,2.5594153866192544
NCI-H292,9868037,4.01216306257403,3.5231382529117012
G-401,52947716,-7.497954818853376,-1.2983739780351187
EFO-27,5280436,2.3763113561475997,3.735475566906865
SNU-449,11625818,4.573588862325648,4.471147887575739
CAL-51,135999136,4.2132345103647015,4.1119466044226725
NCI-H146,19582717,2.457603508665216,3.825191642162053
HCC1143,1716436,2.8430583337953284,3.0057416532958223
DMS 273,9911463,3.7655644930376257,3.409784807283416
NCI-H460,54649381,4.173104904963283,3.801948168872834
NCI-H727,6918837,-1.02939028052569,-2.836806310534489
BxPC-3,6852167,2.5268139587107754,3.0912188934669484
MSTO-211H,168312962,-1.9489367550084584,2.184941454310233
CA46,17755052,1.7120394846678155,1.1651761737074195
ONS-76,3676137,5.654292431942107,4.661790160589408
A2780,11175137,0.1901581111291173,2.3691678373785674
NCI-H727,10427712,4.338841626329874,4.155957528337925
LoVo,241158,4.012317425862525,3.96831464372581
Panc 04.03,3062316,3.5966054915380647,1.3454436315489067
SNU-81,54454,2.7601348658589,2.714491888386909
SBC-5,3136844,4.085952663076754,4.340663172799686
BxPC-3,4261,1.8613797726144792,1.7083269978341138
YAPC,11364421,2.3126725462898508,-1.173534083910018
NCI-H727,387447,-3.6268426938273457,-4.150725326583309
A-673,11955716,-2.8120675934907107,-1.3922916280110615
Panc 04.03,selumetinib-decitabine (4-1 mol-mol),4.200719534788661,4.067238543628192
FU-OV-1,135440466,0.9480137026796296,2.423162244638894
NCI-H146,25150857,0.3973439930915976,1.9918713860003519
SNU-449,46926350,-1.1609870247475182,-3.9698203238886385
MSTO-211H,9840324,5.369584805162093,5.913763706659763
G-401,5460769,-1.872739736028161,2.563909501327444
CAL-51,568763,0.0917223714484538,0.538724171967404
MDA-MB-453,5951923,4.303369563038856,4.342063130821756
KYSE-70,66577038,3.0162273972396005,3.024533932142702
LOU-NH91,16722836,1.148829534310261,1.8808876104612509
FU-OV-1,613753,3.071481920375854,3.2534398654148577
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454,-1.0758421076103637
CA46,49766530,-5.499020578204802,-2.30807125678121
SNU-61,11175137,3.4257878627613505,2.5650290134697453
HSC-4,969516,2.6364274978390703,2.933472148988218
A2780,10074640,2.580771204793581,3.012522772411833
EFO-27,10410894,3.5790791622635907,3.384837123262959
SNU-81,8515,4.116210915577815,3.4298228481880813
KMRC-1,322968,4.639571189041566,3.816132387624916
EFO-27,54626689,4.866384531477491,4.614090790707662
LOU-NH91,9911830,2.650870613913377,2.81986857270553
OPM-2,135659046,2.7260896342727396,3.1756672135905295
OPM-2,6917907,-6.048813777211379,-6.027834001449874
SCC-9,151289,2.789872420286255,1.3241902706030706
NCI-H661,4705,2.5155315968978127,3.4652472500025486
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904,3.72243414601214
LOU-NH91,25154868,5.6992218929630205,4.642771593484283
NCI-H522,54619267,4.072629967998864,3.8755825566134248
BT-549,11222830,1.721965279957128,1.7894158703407126
NCI-H146,53301938,3.7804038583893504,2.5580404829781442
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434,2.015660427702853
NCI-H727,selumetinib-MK-2206 (8-1 mol-mol),-1.8356480928534216,1.914877708442563
MDA-MB-453,7326481,2.376694251985227,2.8963387097747857
HSC-4,6914657,-3.070952064512468,-3.5836416545348184
MDA-MB-453,72376,-2.4391350280385033,-1.6289846772485654
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548,1.528705573614295
CA46,2130404,5.640885888744477,1.9150829904840296
G-401,216345,1.83916726924219,3.489429153370949
LXF 289,54143018,0.7636513295056184,0.7510692208812704
MDA-MB-453,246676,1.942789144720036,4.081628500257025
A-498,19582717,5.689025629434131,4.171637382610971
MSTO-211H,11964036,1.836732040985672,1.5392600330075532
A-673,3552672,1.3462933778606576,2.393361350206083
CAL-51,11152667,-1.203722258692511,-0.16117819576287082
CAL-51,67156097,-2.385254348530768,-1.073315313825371
CAL-51,65064,3.306239750209062,4.78503662119086
A-673,piperlongumine-MST-312 (1-1 mol-mol),1.0809583866306374,1.4042581928680915
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967,-0.623819266159418
MDA-MB-157,6917907,-6.62909111977728,-4.5197482587664926
HSC-4,64971,1.7199562834608897,2.991346762433429
NCI-H460,135440466,3.295247648571462,2.252970742564282
MSTO-211H,57519531,1.3086690033484818,2.6444848657162097
G-401,9926054,1.744192331951833,1.7147850702673748
OPM-2,24821094,1.5161257655930716,2.621520701127317
NCI-H727,1641662,3.969866081416476,3.5553200764986057
YAPC,66577038,3.3954554117120224,3.156240976758644
A4/Fukuda,36462,-0.7730347482869518,1.0675161805177198
DMS 273,135440466,3.3485559592244214,2.1069334446689565
FTC-133,445455,5.178470647326205,4.628275589547231
Panc 04.03,72376,-2.048199615123948,-1.708636861006067
CAL-51,10302451,1.350542324147247,3.5587588436484947
JM-1,11214940,0.7147440273172748,0.897494829917537
A-498,25183872,-0.6220750954527926,-0.0349961516791327
OVISE,44607531,3.0758971794813093,1.5699583093742888
A-673,53392493,1.8369213613876785,2.0698909576489544
LoVo,11719255,3.552916809155198,3.427061231066552
SNU-61,439501,-1.3808373898758073,-2.1388138664095955
NCI-H460,104842,-2.7771726159534773,-2.536413737618879
CAL-51,11364421,-3.809863778172731,-2.119324127194238
BxPC-3,71466578,5.509660254732227,4.65050516237227
NCI-H522,12001922,1.5621076115514363,1.6495724771493412
KMRC-1,11626560,2.283484204530191,1.651370916726845
MDA-MB-453,5329102,2.150481946774112,1.892008447439482
DMS 273,navitoclax-gemcitabine (1-1 mol-mol),-2.068576653592491,-0.9149441915436727
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.7146552383324984
ONS-76,16720766,0.8880370259188662,0.6091635428975288
EFO-27,56949517,4.565823410262603,4.277764284426884
DMS 273,11222830,1.4389641717758948,1.310892022751371
LoVo,36462,0.97058855741136,2.3755178778589983
OVISE,SNX-2112-bortezomib (250-1 mol-mol),-0.8591608441303084,-0.6972843416814699
Panc 04.03,16038120,1.7157321990683845,1.265272106140644
LOU-NH91,3062316,-1.7568876367320156,1.610163016978964
A2780,9903786,1.372407357095215,2.836051284874506
OVISE,49766530,-2.0570642495309004,0.09075420223019966
G-401,doxorubicin-navitoclax (2-1 mol-mol),-2.722419727945218,-1.9692614215940378
SNU-61,11427553,3.286064968901604,2.228249490597855
A-673,72193861,0.2228627716233472,0.6000397070918634
Panc 04.03,tanespimycin-gemcitabine (1-1 mol-mol),-1.7855747696836677,-0.8024478295964811
NCI-H2009,3815108,3.061482559784255,3.0318323763106827
A-673,2126,5.190382873813306,4.17915121924096
ONS-76,10302451,3.399700001459874,3.374094081658628
G-401,9825149,1.4427851681991832,1.9432379859654927
NCI-H522,44202524,1.1337498661514331,2.0426057682235794
SNU-61,52947716,-2.831948664567002,-0.41698929953204134
A4/Fukuda,2945648,2.3216808345706035,2.5613241891778005
A-673,25105715,3.2161270828318207,3.3748684257311146
NCI-H522,11178236,-5.864645603629742,-2.7864825637617088
JM-1,216239,1.5816975151035817,1.7187026795516085
CAL-51,9903786,2.1849161121493847,2.8543665487306886
SNU-449,9936388,0.4589950900054629,0.5668011205151495
NCI-H292,9927531,4.942242070848643,4.849932032513614
NCI-H2171,25262965,-0.9052216234257174,-1.6440673475259067
OVISE,selumetinib-MK-2206 (8-1 mol-mol),3.824616242676661,2.4040393989747426
JM-1,24901704,1.786623485766962,2.2308982542126348
SBC-5,656346,0.6270929807498155,1.0635717992288363
KMRC-1,89928392,3.173061856078121,1.7043895166178027
NCI-H292,156414,1.4083938325335852,1.7983193033771647
LXF 289,135875424,3.2815298243266553,4.2212617507912995
A-673,11494412,0.2373053627626316,1.1590690694862504
A-673,5746,-2.085801833901771,0.2607300889286828
DMS 273,9935249,1.448801275140577,2.0598936296912242
FTC-133,11404337,1.1811341910019733,-0.19013684659405944
MDA-MB-453,57519531,4.708696705883037,2.405246300875229
FU-OV-1,11152667,-0.9879051128837576,-0.3499614964100467
A-673,44493528,4.641329710074662,4.380716732655987
NCI-H460,2828334,6.134119597935603,6.151255167423681
NCI-H2171,16659841,2.989016667138281,2.9398395936091593
FU-OV-1,73707386,2.8924737769549633,3.1225384078999543
FU-OV-1,24901704,3.02942514713799,3.496134623068492
NCI-H727,4259181,-0.7375001764594127,0.23790038476949193
LOU-NH91,tretinoin-navitoclax (4-1 mol-mol),-1.081702007915755,3.0399922438899565
KMRC-1,navitoclax-PLX-4032 (1-1 mol-mol),3.702338136233157,1.5791794012117917
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574,0.16088418236480195
MDA-MB-453,17755052,-0.3952702915340721,1.2205592680706028
DMS 273,46398810,2.5474695176149527,2.122601982481847
G-401,5278396,3.0023073980849424,3.334374472646987
NCI-H661,24821094,2.278259467148376,3.1845960882263227
NCI-H146,11364421,-6.559818289293388,-1.5949749057706595
JM-1,24797083,0.8026470280931975,1.0545119385585837
NCI-H522,168312962,3.69802370811012,1.853993817258622
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764,0.9965392865701803
BT-549,16736978,2.673955173636492,1.9207575384356348
A4/Fukuda,46907787,-1.6446005772830188,-0.18110319123652083
ONS-76,654092,-0.1261556450149646,-0.37082481530181705
NCI-H661,6610355,4.759868911507443,4.746799484514721
Panc 04.03,JQ-1-UNC0638 (2-1 mol-mol),2.939045539650312,1.731989483869117
G-401,25154868,3.6071608181606063,4.268775530153912
MDA-MB-453,4788,3.7423511350995255,5.336283314801184
MDA-MB-157,11960529,3.789984251684095,3.987738843509316
SCC-9,16720766,1.7269628893506093,0.6980137778163064
NOMO-1,753704,4.4431191000277375,4.241804691506323
A4/Fukuda,6450551,1.0528971846899622,1.6269608255300678
YAPC,24964624,2.625771283300636,2.564417638006505
A2780,82146,3.1377115486631273,3.252132138363754
MDA-MB-157,1566236,1.4232096904008935,2.451590221712165
LXF 289,25183872,-1.882522005728347,-0.7491724763350327
KMRC-1,24753719,4.192591897270876,4.311070503674402
LoVo,44607530,0.9946707755477716,1.6327919191643914
SBC-5,44632017,0.6241642112624288,1.0890863496119445
SBC-5,23635314,-2.6646956028329223,-1.6352017766196867
LXF 289,54619267,4.7435335143288935,4.170917459967165
BT-549,46199207,3.7007120058669623,3.222612750072784
KYSE-70,6914657,-2.943523310206574,-3.2552412138394207
A2780,89928392,-0.8241966309638568,0.8443822964650479
MDA-MB-453,54618164,4.967166731196573,4.135649429941849
SNU-81,selumetinib-tretinoin (2-1 mol-mol),-2.852334261178199,3.1240556528541994
NCI-H460,4788,5.894567383019075,5.682031753912988
DMS 273,24951314,0.5391494064850418,0.4531462222305989
NCI-H460,1750826,3.3189287492303197,-0.7981843886588235
CAL-51,2749,1.4482754145936665,1.8706786604223404
OPM-2,1566236,0.7571858740606694,1.5948020270930217
A-673,selumetinib-decitabine (4-1 mol-mol),3.170233971616513,1.9296594429658305
EFO-27,11626560,3.0674086659258646,2.1794251668864972
BT-549,216345,4.357029009920563,4.213764638109407
KYSE-70,3081361,2.4267899196210982,2.5230498195564857
NCI-H146,156414,1.153076826996135,0.8079627925030244
NCI-H522,135411,0.5669945497970937,0.48221244617152664
BxPC-3,6438330,1.9774707221451924,2.61047944382448
MDA-MB-453,9903786,4.505035222499518,2.775651298531098
YAPC,5281321,0.2366473375234088,-0.909123650920394
MDA-MB-157,71304818,1.9463509570918949,2.4015590422683024
BxPC-3,56946209,-3.950691768305054,-3.8828897073729878
LOU-NH91,6450551,3.4853298595759687,3.0432296599991195
G-401,1242560,3.581659075050411,3.331875020115525
MSTO-211H,3854666,2.1662920246080963,2.2051257413830707
NCI-H522,25062766,2.616535601519866,1.887373690990635
Panc 04.03,3038522,3.0958365698912154,3.3191994218460494
NCI-H460,25183872,2.110783783288614,-0.41368630877246604
SCC-9,71304818,2.8421374335972653,2.5007148711923195
SCC-9,65064,5.356580923551092,5.048427338350608
NCI-H727,25183872,0.4102957812787974,-0.4665118461556769
NCI-H460,81146,4.483282466350705,4.933642745860739
OPM-2,navitoclax-piperlongumine (1-1 mol-mol),0.7945063119799598,0.18041079590740833
MDA-MB-453,54765302,2.0573663082868405,3.8534011200536065
KYSE-70,10302451,3.1884398798129525,2.9433005863443187
LoVo,49793307,-4.412709808216002,-2.821914213186525
SNU-81,36314,-5.848392982376778,-1.1019278153869914
A-673,navitoclax-birinapant (1-1 mol-mol),1.618517186072499,0.21627689861386046
Panc 04.03,2733526,4.292486036611722,3.8089348064007154
CA46,9926054,1.6892727173627182,1.5052169497091006
NCI-H522,2746,2.8917767436803414,2.6110362563455194
LOU-NH91,67156097,-3.1227398262817587,-0.41240428528661127
NCI-H146,5284329,3.6277290639514455,3.1332738598629777
KMRC-1,644241,4.9037113640465035,2.3516865037682164
A4/Fukuda,60700,-1.3381290141173086,-0.8867856830296321
NOMO-1,24753719,4.496099764979975,3.451009790092452
NOMO-1,9903786,1.612481289648159,1.699206021055688
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182,2.937078628103927
JM-1,54618771,-0.5043757930015165,0.2024727517888158
G-401,3854666,0.6606077023561356,1.2108359231844004
EFO-27,24978538,3.143555245211511,1.6389407428428973
OVISE,322968,2.654176014952692,3.8466777406658137
EFO-27,alisertib-navitoclax (2-1 mol-mol),2.9537662820479693,0.7632809060002331
FU-OV-1,637858,1.762395691671764,2.001873519254189
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,2.2374665573695283
ONS-76,11626560,1.9844806011562912,1.735941983847936
LoVo,216345,1.1599721320761718,3.671684230884228
SNU-449,9926054,1.9385314164963827,2.1137641375955365
HCC1143,568763,-0.6390257750571487,0.6982071331016775
MDA-MB-157,JQ-1-MK-0752 (1-1 mol-mol),3.739596804581883,1.8127845247435648
NCI-H292,72193870,4.439424680926146,2.41495878332399
NCI-H522,11228183,3.862798460505377,1.2174723390734166
CAL-51,4788,6.061217822513647,5.519850354093561
LoVo,4521392,4.145025799048703,4.276867504454504
HSC-4,11626560,2.5873766751252436,1.9985515557249314
NCI-H460,60750,-0.8382921927225392,-1.894448785735395
JM-1,44137675,3.718094845766921,2.82709040582465
HSC-4,71304818,1.898043557267106,2.6089337388283607
CAL-51,25150857,2.2346870378683934,2.5079204006306126
CA46,2871966,-1.7971239931694716,-0.20818804653968828
DMS 273,54454,3.225049529812471,2.7257310605771257
ONS-76,25183872,-0.170903852827654,-0.7144784657569951
SNU-61,984333,6.216581141210495,0.682370628046489
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.0433928953067149
A2780,71466578,2.665399831677294,3.7409105846672794
HCC1143,docetaxel-tanespimycin (2-1 mol-mol),-1.7966403961348645,-2.752742251479796
CA46,24797083,-0.1839530161688024,0.9120149946244832
CAL-51,135875424,4.33643967165441,3.7515074163910396
NCI-H2171,3689413,-2.7117222930063867,-1.1027098030983542
A2780,11396600,2.9320615716687564,3.219981997764945
SNU-449,navitoclax-PLX-4032 (1-1 mol-mol),3.4557412405701258,1.923473426988501
G-401,56963564,0.504836775176006,0.24090696851190369
LOU-NH91,44632017,2.871860814691948,1.793601374999367
CA46,11214940,-0.2735426892992921,1.0467799443069472
NOMO-1,67156097,-2.629595584457773,-2.179417554934289
NOMO-1,26596,-2.074766602044621,-2.4467085791971446
JM-1,50905018,4.16446369685189,3.5215509653145456
NCI-H2171,445455,3.811797523558628,4.0714722530380785
EFO-27,16736978,1.8793599511128067,1.4697831355812903
JM-1,54678924,1.2599632015511184,1.3193032547414993
NCI-H460,5281321,2.142807178276493,-0.7065795721483284
SNU-449,5738263,4.026622535351311,3.7681005633368385
SCC-9,216239,3.331867398285969,2.5422840657849513
G-401,10410894,3.279247022117546,3.2234937215467347
SNU-61,11222830,1.6415416447740467,1.5861571313206289
CA46,2113511,3.5674790523720317,4.787743194233507
NCI-H146,72734382,2.9399655016804114,4.05899879593079
NCI-H522,613753,2.504960527289346,3.137779469315066
G-401,156414,1.0662464633968871,1.2809681731514289
BxPC-3,5470400,-0.5134005920596514,-0.5877512499496546
KMRC-1,1242560,3.860865345198952,3.6352952809009684
BT-549,1242560,4.319126066576065,3.7350025251647287
OPM-2,66577038,2.8274271292709536,2.4516304403643976
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531,3.3315740052631604
DMS 273,16013152,3.9042510131977353,3.2020825592248765
NCI-H522,448949,1.6947060599097594,1.6914543011933976
MDA-MB-157,5566,3.489209385839125,3.0983317222592506
Panc 04.03,53392493,3.71782736184095,2.7732804059136216
BxPC-3,55508,4.124435576281598,3.392176678756116
EFO-27,carboplatin-UNC0638 (2-1 mol-mol),4.02907602487195,3.540889491675498
NCI-H661,4521392,4.344795346058825,4.345492100164656
JM-1,119607,3.9456515069078,4.392742905309017
NCI-H292,SNX-2112-bortezomib (250-1 mol-mol),-1.594180190580018,-1.3229879616120739
NCI-H460,3385,3.2657114863965573,4.286393212360572
A2780,327653,2.026169684275287,2.8939439158530047
SBC-5,vorinostat-navitoclax (4-1 mol-mol),1.5319499176143987,1.5734772076936472
MSTO-211H,crizotinib-PLX-4032 (2-1 mol-mol),1.678384538966045,2.0182651000478655
JM-1,4261,-0.3533034531676731,0.3340883828432995
HSC-4,135875424,3.4627713632233537,4.028726856166764
A2780,44491742,3.4077888459991774,4.274761145483278
Panc 04.03,135999136,5.549073334475873,4.336800486808851
SCC-9,57519531,3.918058558817349,2.758672920978944
LoVo,3815108,2.2685826541267615,3.209207368016683
DMS 273,71466445,2.157471967137961,2.650911510235905
NCI-H661,44241473,4.80522256986357,4.944269126616383
ONS-76,6438330,3.0471678199579206,2.3684182591930276
Panc 04.03,2949965,2.626604824548014,3.1852449769088933
OPM-2,676352,1.691725548140899,1.964763771408113
SNU-449,16722836,2.5551835494173325,1.8307799367962232
A-673,11152667,-2.304412849002376,-0.8454560361632862
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262,3.1472005437277564
G-401,151289,0.7906130786084481,0.5946576521310368
OPM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.0013874340560274,1.3435407371757606
LoVo,25195348,3.880726101323461,3.424011161223167
NCI-H1623,11404337,1.3417738865788873,-0.04638394390740021
BT-549,3062316,0.532185160328145,1.7224841764490093
NCI-H146,doxorubicin-navitoclax (2-1 mol-mol),-3.7183112313857216,-1.5303122807298777
EFO-27,44185566,3.1194970070950276,2.7401772747542674
A4/Fukuda,16725315,3.095723533871789,3.659470341236697
LOU-NH91,3854666,2.9087049696787544,2.6904142443264276
NCI-H460,676352,2.985829219207002,2.2167135749874256
MSTO-211H,23725625,2.234746785874409,5.048803762991658
SCC-9,5351362,1.6846115382104403,1.6564743922660972
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699,-0.4692159370664804
NCI-H522,241158,3.3210308536521156,3.0650924581605965
A-673,10127622,5.418104152685571,3.503040451834374
MDA-MB-157,serdemetan-SCH-529074 (1-1 mol-mol),2.3164799956967665,2.155268715352418
G-401,53232,3.5991410971239866,2.638865193117587
OPM-2,5287969,-2.4106191892149185,-2.3457259941657695
SCC-9,637858,3.7694424070181127,2.123645129641071
NCI-H2171,5282054,2.409902559914623,2.6672122224011185
NCI-H292,1242560,3.487131794973456,3.6096047015547543
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974,1.282769182103965
CAL-51,3503,3.2899889427654245,2.2983458751029286
DMS 273,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1319495853751045,3.546507934183903
Panc 04.03,51039095,3.732934843851844,3.183672558019008
NOMO-1,5329102,1.5937414073922636,1.4393515604030571
ONS-76,1242560,3.484199229378892,3.5879827598249405
G-401,24180719,3.4290114124184568,3.4884054795429766
A-673,11485656,1.6006257465541904,1.8516078296239789
NCI-H460,5278396,3.885794996406102,3.6747230404255675
ONS-76,4788,5.851184911612036,5.683572286587344
NCI-H661,11234052,4.193192571907383,4.199657707582719
LoVo,46174525,4.300656487428364,4.531819724433469
CA46,135875424,2.985562686352135,3.1673378989161547
SNU-81,6610355,3.7225360861185592,4.526760915170945
MDA-MB-453,JQ-1-MK-0752 (1-1 mol-mol),0.5621675718726626,1.2796569960214774
A-673,1566236,1.6605846703776754,2.2417134781670005
LXF 289,55283,4.7983814176360715,2.677935300451337
DMS 273,1566236,1.8001113918747356,1.8798134197166838
SCC-9,4477,0.0462068475019735,0.31347996118553456
BxPC-3,439501,-2.27553783948146,-1.8290405453091247
G-401,3503,1.5245243202568906,1.9675028228791305
SNU-449,5280436,2.098309971831213,3.516762483443424
LOU-NH91,119607,5.561970464467383,5.480647549131715
MSTO-211H,6918328,-0.4462053694736546,0.24495032961452806
A2780,10231331,0.3686619766312378,1.819191233971723
SNU-449,44137675,3.6126407514409378,3.7504129175462038
Panc 04.03,9866186,0.4755964236535121,1.1379402864759525
JM-1,40482356,5.622716652052393,2.8118483236984826
CAL-51,49766530,0.4609697007955676,-0.006222180748342691
G-401,11960529,4.93979495553103,3.3968799273423445
HCC1143,6505803,-0.5233928936461414,-0.10579858161093042
KYSE-70,676352,2.557270596786296,2.139557776607343
A2780,135398516,-0.3122960179418635,1.9527893224470545
NCI-H292,23635314,4.8326715815763395,-1.6552725850806425
SNU-449,15547703,3.400796461378631,3.4015135118676967
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034,0.07255806875199403
LXF 289,46843906,2.101940493524925,3.358074239042097
DMS 273,46174525,4.164871991455526,3.496088267341081
NCI-H727,selumetinib-decitabine (4-1 mol-mol),-1.5172256962408457,2.8690654439560683
SNU-449,6917907,-5.317414756413243,-4.94932959668997
A2780,4705,2.567744201920244,3.220336371708366
KYSE-70,73707438,4.323396479680616,3.905663162831636
NCI-H460,5329102,3.240160570329804,2.165053779928042
NCI-H661,5282054,3.5253080606128133,3.86017017414597
NCI-H1623,119607,5.952206355872506,5.339382539927687
NCI-H522,64971,2.9291780846019413,2.6724653500186846
CAL-51,11222830,1.6762547521470548,1.6817809701352378
A2780,vorinostat-carboplatin (1-1 mol-mol),2.197042842116113,2.5678883658545164
SCC-9,25062766,2.812414712404745,2.198473128056139
YAPC,31703,-0.7401868256368748,-0.7536296765718988
KYSE-70,2858523,3.054228167220651,2.982741419629428
MDA-MB-453,1242560,3.902800159671119,3.39056270431272
MSTO-211H,71466380,4.302501611697816,4.410361174877352
NCI-H2009,3689413,0.5343246791806224,0.8672070394466651
G-401,15547703,3.220896426279267,2.9470328848911116
NCI-H522,11719255,2.5592835843852337,2.8961576781996166
LXF 289,46191454,2.351463869671111,1.92495239160164
LoVo,71304818,2.0724805960279027,2.4308615108988114
A-673,5311,0.6764453858481513,1.06066692634467
KMRC-1,11175137,2.246406512349146,2.5971121687048844
MDA-MB-157,568763,-0.4149964884485024,0.7467903852965481
LOU-NH91,11213558,0.661761515775888,1.9141024742972823
CAL-51,2733487,8.211583338705053,6.20965945856865
LXF 289,16741245,5.010251526780332,3.7579101220742968
SNU-61,24797083,1.0556452382424049,1.399372333487063
BT-549,44137675,4.586830027774197,3.700638154204765
CAL-51,15547703,3.503799403292956,3.2294340630621026
JM-1,3136844,3.4340507925237307,3.599425240407963
NCI-H460,46191454,1.6495265120274705,1.9917795345907845
CAL-51,16722836,0.8083581946159574,1.5092724758423497
FTC-133,25227462,2.318225674680384,0.8052355364668635
A2780,51039095,0.059669762784491,2.690742424092326
OPM-2,54613361,-1.307423897840743,-0.7271395222887578
LOU-NH91,5328940,1.6284519107294106,1.8989253082588886
HSC-4,11640390,4.10313790521596,3.645546569535506
LoVo,11222830,1.6500045227885836,1.635809679065853
NCI-H2171,53495165,-2.473385034422452,-1.5896483270168056
MDA-MB-453,5281321,-0.6344069396712416,-1.187731722391794
FU-OV-1,9926054,2.079351745951841,1.846125092749817
G-401,36462,-0.1566510321668276,0.9265816993990567
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987,1.0266373745487956
NCI-H1623,11427553,2.6307082318350132,3.1643363647981873
A-673,6918638,-0.1443248090306654,0.13643561093877812
OPM-2,54596490,4.128803973627264,4.237864403920984
G-401,24753719,3.1602445998928186,3.6581896012541275
FTC-133,selumetinib-MK-2206 (8-1 mol-mol),6.933601402972985,2.1056612212115513
DMS 273,637858,1.5802330029013405,1.1951127791154605
OPM-2,72199292,0.0645754970830883,0.585272620898433
SNU-449,5328940,1.97588831229785,1.9225488049775947
OVISE,49793307,0.0210083556696064,-2.9136077844872768
A-673,11647372,1.3285775791052634,0.4639014496710596
OVISE,6918328,1.4244682512544402,0.19505172001193183
Panc 04.03,25154868,5.1819399857498025,4.516290488556254
EFO-27,17755052,1.748867275877649,2.05977120997686
EFO-27,decitabine-navitoclax (2-1 mol-mol),3.595019869203868,2.0440188695638195
SBC-5,375860,-0.6399303579455221,0.007564651135999954
HCC1143,selumetinib-piperlongumine (8-1 mol-mol),2.549848868109157,3.41803620641049
MDA-MB-157,451668,4.959725465812671,4.01739713038538
YAPC,54619267,5.29132207947154,4.199747439110282
OPM-2,36462,1.377546018006998,0.10640939631347798
BxPC-3,3081361,1.7902484572067556,2.255249649421002
SNU-449,11455910,0.8938620280411973,1.128586766206186
NCI-H1623,25022340,5.5347014016683875,3.447740362022933
NCI-H522,409805,3.737006742854017,4.412056912300055
CAL-51,568763,0.0917223714484538,0.538724171967404
HSC-4,12001922,2.169357927696289,1.994939727747161
CA46,2742550,3.5037926309603944,3.0910468248207765
LOU-NH91,11507802,2.1124947170440533,2.0706045093128975
LXF 289,6852167,2.2044562779321635,2.7689956089355054
ONS-76,26596,0.1332187247782509,-0.8720785315717897
KYSE-70,9903786,2.353212274658888,2.8150961108566226
DMS 273,10385095,0.5027476993233067,1.0672155102993757
ONS-76,3025986,-0.4351415981508911,-1.0226476074718713
MDA-MB-453,89928392,1.7795585771799345,1.5545088526134467
LXF 289,676352,2.537691956872654,2.191205131787796
OPM-2,navitoclax-gemcitabine (1-1 mol-mol),-1.0437605792762972,-1.9490103927075253
HSC-4,135659046,3.804399419736421,3.618543266359416
OVISE,alisertib-navitoclax (2-1 mol-mol),-0.6471026369576864,0.6925037105996239
SNU-81,6623618,-2.7236989498385733,2.465454907037192
HSC-4,5282054,3.7951129778884822,3.912161914678191
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798,1.0970245167747008
A-673,16219061,2.4523595679466954,2.6104640802628967
SCC-9,123631,1.8109604294388877,2.3913820233925245
A-673,11364421,-5.84995188170368,-3.229635172882539
A-673,216345,3.678855080389337,3.439876952176464
A-673,439501,-3.092013019617277,-2.6452123016918305
NCI-H460,1566236,4.3513012021592505,2.391363787380779
LOU-NH91,25195348,3.759766884877561,3.2256455852205645
DMS 273,23725625,4.676663171220921,3.981559586396274
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706,2.0335213993396364
CAL-51,6852167,2.546662292056567,2.8831930935885577
OPM-2,5738263,2.0935625564909737,2.5827348458438193
SCC-9,5311,1.75647433259966,1.674172629132781
SNU-81,5291,3.232691727920098,3.4527829987038943
FU-OV-1,262093,2.4810055989466018,3.1859144225196743
LoVo,56949517,2.258326270055845,4.213068601375197
A4/Fukuda,9825149,-2.050748608979426,1.860493041077709
CAL-51,53392493,1.8808489153668793,2.631069477035746
NCI-H522,4521392,3.962796694444569,3.9991615191869534
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518,0.2895708539091709
NCI-H2009,11612883,2.3268324416241777,2.882279404833343
NCI-H292,65064,3.148033598452649,5.309188454370903
NCI-H292,44589607,3.354505508461316,3.0430011281690317
KMRC-1,462382,0.2791911345900462,0.860815861566705
A4/Fukuda,5291,3.6218734753047226,3.2363686967800107
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.9633687162437988
A-673,135440466,1.1776565801361647,1.749333514812013
Panc 04.03,60700,0.3719609401953118,0.1020431015923769
LOU-NH91,66577038,3.4622279905398052,3.1408136799089634
A2780,24856436,-0.502193855863573,-0.009160201968432737
CAL-51,6852167,2.546662292056567,2.8831930935885577
JM-1,5311037,4.072371281952103,2.6106931706658254
NCI-H460,374536,2.933441634270558,2.234056721200275
NCI-H460,216468,4.763843832635099,3.2650862423655918
SW1463,421610,3.2195561799423804,3.117707721337553
NCI-H460,439501,-2.362377537788676,-2.06973304670568
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393,-0.21825714346149333
MDA-MB-157,24978538,3.306703195844951,1.312413225994271
MDA-MB-453,54618795,1.052632381834858,1.0999281390339923
EFO-27,6914657,-5.685084863882177,-3.762132910732544
NCI-H661,9866186,1.9017456959186525,0.89452567488546
CAL-51,6623618,2.223133904662847,2.3781709327560634
OPM-2,5281672,3.1701528707347015,4.138451622363333
CAL-51,1716436,3.275997904874087,3.0319940420607163
NOMO-1,25183872,-0.6960845434284378,-1.9706538468442967
EFO-27,216239,3.3875560857040887,2.686440756445973
NOMO-1,54619267,3.207870909981956,3.7076934458581166
NCI-H460,400769,-0.4007490431715684,-0.46021858259349036
SNU-61,6610355,3.885584601382451,4.263419269227767
BT-549,vorinostat-carboplatin (1-1 mol-mol),4.114114464716558,3.500104606061613
JM-1,10077130,2.0136903876831993,2.57005008078249
NCI-H661,81146,4.823771143587,4.8487394664094206
LoVo,56946209,-4.467950537911531,-4.17935327003984
NCI-H522,5460769,0.5614535105182378,2.7489384155705388
CA46,9927531,3.0223750820915978,3.958517174193525
CAL-51,11612883,1.9359641259018452,2.7454631107910723
CAL-51,11427553,2.069280384014222,2.7903974641764724
NCI-H727,5746,2.1304383256196293,1.0859188521915046
MDA-MB-453,16219061,1.5030881414961583,3.233464742825536
MDA-MB-453,68056272,3.261695748545246,3.1777333188859513
A4/Fukuda,6610216,3.4719570509087445,3.9365565952474926
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.9125776662729508
SCC-9,107985,-2.37702169012632,-3.221761371968066
MDA-MB-157,23939,3.513284021833553,3.8167768468513064
OPM-2,262093,0.5720462757198622,1.7316608801855302
NCI-H661,5351362,2.412641003608378,1.4792443029618596
BT-549,53495165,-2.465962418573161,1.1781903920786894
A-673,decitabine-carboplatin (1-1 mol-mol),2.7905557903359246,1.800232704243239
HSC-4,1716436,3.018983829466311,3.0701143203551515
A4/Fukuda,10231331,-0.0070700765814584,1.1841683184586904
OPM-2,25105715,2.7306053213312027,3.3073952627251635
CAL-51,3384730,2.4775948365465905,2.9418421046730816
DMS 273,vorinostat-navitoclax (4-1 mol-mol),0.8220813286666946,1.0094693593615784
KMRC-1,262093,3.6313310555506817,3.0463480344109986
KYSE-70,5311281,3.780874632943925,2.3190840302913505
Panc 04.03,135659046,3.760242578723066,3.965268962535591
NCI-H460,46199207,3.5033257005335163,3.175826682735016
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062,-0.012927368752481789
NCI-H522,285033,-5.015646919007219,-2.034417089321644
NCI-H1623,31703,-1.093718795909536,-0.5052751624431477
CA46,8515,3.648186715161825,3.192359535326632
A-673,54618164,3.9765209939943857,3.927655354792255
MDA-MB-453,71304818,1.4463301677266325,2.262908832638769
SNU-81,656346,0.6811147423088999,1.051487916467115
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376,-0.30296547957866976
SCC-9,alisertib-navitoclax (2-1 mol-mol),1.3350821103573205,0.7767060588357322
OVISE,71680916,3.981894618274443,4.614327395925691
LOU-NH91,56963564,0.9665729866263152,0.7047074956192145
NCI-H661,23635314,-2.0342629068452056,-1.8839892531347429
LOU-NH91,12001922,2.55699926148122,2.055586873104273
JM-1,31703,-4.919166892515249,-2.5837009712809054
EFO-27,16065773,2.8503557299543063,2.748442487995786
DMS 273,107970,2.226748766743483,2.1986323265435685
MDA-MB-157,67156097,-2.087594374926874,-0.6683052297210738
BxPC-3,JQ-1-UNC0638 (2-1 mol-mol),0.9591872546469856,1.6169146440726763
LOU-NH91,46199207,3.3608515659177147,3.300915857966442
DMS 273,JQ-1-vorinostat (2-1 mol-mol),0.2212996861992737,0.34747491411889475
BT-549,2871966,1.6191257261573118,0.6521969117911977
BT-549,46926350,-4.493585638609818,-3.8636684849164027
OVISE,54626689,4.712933516379989,4.701121559888286
NCI-H460,119182,0.2489341964189734,-0.5420445216494391
MDA-MB-453,7251185,1.8406187352582624,2.3400919954285913
JM-1,4521392,4.181937683636394,3.9300723745129638
LoVo,44589607,1.625549992230134,2.9855792131354675
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393,1.5213022583570892
A-673,24951314,0.6400096482448101,0.7133088164396818
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525,1.4400754611509934
A2780,11152667,-1.0749204847082217,-0.9564406931960692
BT-549,5329102,2.9790267437316285,2.128399188528016
G-401,17755052,0.028133790527295,1.5212095491918458
CAL-51,11238147,2.100409816322544,2.894390504801417
FTC-133,16725315,5.918216987208106,4.447218044098732
HSC-4,10127622,4.548794444843462,3.841636790059097
NCI-H2009,JQ-1-MK-0752 (1-1 mol-mol),0.489585373897599,1.9963841764123544
HSC-4,72376,-2.108784759313747,-1.5281648541005766
HCC1143,11455910,1.411815978618001,1.5040849364022688
G-401,6610216,3.9425308150709,4.1094752023476975
OPM-2,73707398,-1.391957592490296,0.3587227391141902
Panc 04.03,crizotinib-PLX-4032 (2-1 mol-mol),2.2047528734152655,2.002491838791565
MSTO-211H,11396600,3.2938939565791765,3.9155979314213147
NCI-H2171,15983966,-6.379176066325201,-2.0736110155477934
HCC1143,9903786,3.3387804215378885,2.8476448169980673
JM-1,3385,1.6679469335870958,2.915307980844952
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.2756646452594242
JM-1,44487872,4.651129481786086,3.8768841247964034
NOMO-1,439501,-2.35226533453039,-2.445044829258146
Panc 04.03,568763,0.8595160951448656,0.6128577838817307
A-673,15953870,2.6171812575314757,3.215649474878617
CA46,6917907,-5.812984110767001,-5.603604974649775
A4/Fukuda,11404337,-2.650657466190433,-0.8463500362618188
MDA-MB-157,6184667,1.80494393962058,3.2914687256384063
NCI-H2009,JQ-1-vorinostat (2-1 mol-mol),0.1591835457896471,1.2020233429002796
NCI-H522,25102847,2.0692872541383784,2.4995778919648144
EFO-27,2113511,5.820212709586459,5.761943994216091
Panc 04.03,2729026,3.1546590032208948,2.8587106147980497
MDA-MB-453,9866186,-0.0857862406385878,1.0166262399955242
CA46,44491742,3.801952242992866,3.770417459889562
MDA-MB-157,16720766,-3.610201854539628,0.4568599394054005
NCI-H522,168313016,4.366007701234683,4.322458954713676
JM-1,53232,3.389128909220105,2.6191938199665477
ONS-76,24901704,3.4855009095109435,3.23846006027723
FTC-133,3136844,4.271719807093853,4.322947475530259
CAL-51,54619267,4.1828818787298765,4.137523512971451
NCI-H146,17755052,1.2442303799433287,1.7252719408238062
FU-OV-1,2858523,3.1344850445874752,3.1691117287054844
NCI-H292,5280436,4.014624366310106,3.655344030451066
BT-549,15547703,2.0718927663287703,3.448499512036798
A2780,25126798,3.236047242798602,3.7700409569578053
Panc 04.03,2945648,3.066534391812563,3.1194316605675723
SCC-9,56963564,0.633234370730304,0.3646184531098484
A4/Fukuda,11507802,0.3746235533355334,0.8149787193370288
Panc 04.03,3025944,4.694936485248253,4.277869234584341
SBC-5,46398810,3.6562963267762183,2.656418371581488
JM-1,49793307,-5.3555461291239075,-4.293373718969212
SNU-81,67156097,-1.5845934662844448,-0.8748444041872093
A2780,72376,-3.651935268939024,-2.404614348618289
CAL-51,25195348,5.6667768045179905,3.326098897211334
NOMO-1,10074640,3.0496099519927435,2.8449032226343305
FTC-133,46174525,5.692041239325808,4.5855190887369695
YAPC,409805,4.253424942012428,4.929432044266458
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276,2.045209637496836
SNU-61,11626560,1.823906724750755,1.5080481411810949
A-498,16736978,3.6467697702535182,1.7707399646065765
JM-1,9967941,2.969647244173239,3.0849445522366916
MSTO-211H,3815108,2.5678993468563913,3.1171126929824
KYSE-70,637858,2.812350468450961,2.216447345918456
A-673,16013152,4.069813049540754,3.5081510963666944
A2780,4521392,3.924686212385386,4.046111855329784
A2780,23635314,-2.3171748001501635,-2.1180359500501806
JM-1,3689413,-3.612287026066889,-1.2686303271051453
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057,0.09709896683472563
OPM-2,64971,2.0053510879561296,1.9222086267583551
LXF 289,9935249,3.315625346230847,3.4116135339128846
Panc 04.03,984333,1.398892433045171,1.1716022120396061
DMS 273,676352,1.7083859345894283,2.1838779877789647
MDA-MB-453,4096211,1.6956492567589403,2.430987119068449
DMS 273,9903786,1.811418424711566,2.7604333634499847
BxPC-3,3634881,3.024771766376516,3.2925155861815307
ONS-76,54618305,5.4771970245541866,4.682716901960558
Panc 04.03,44491742,4.30815140156182,4.438301666683331
A-673,tretinoin-carboplatin (2-1 mol-mol),4.33843308891482,4.00632700747639
MDA-MB-453,123631,2.1950816453081545,1.98290222604697
A4/Fukuda,426756,4.168045276817785,3.866915206119303
CA46,252682,5.8821335535914905,6.540897467106146
Panc 04.03,2828334,6.268769524950107,6.2829958010461215
EFO-27,135411,0.9008731550993504,0.9147133967843714
LXF 289,15983966,-1.3187435990338214,-1.201688044659912
A4/Fukuda,3384730,1.825152720179272,1.5509249558110858
SCC-9,11404337,-1.771041191231111,-0.09949397234895824
SNU-61,6610216,4.086517799339023,4.194797013569379
LOU-NH91,446155,1.33101507486467,2.648533846010319
KMRC-1,71466380,4.698779777562497,4.534821107883091
SNU-61,46398810,2.7474251169458346,2.2689383974357122
NCI-H2009,9826308,-0.026532071259288,0.6669493333876965
NCI-H2009,56946209,-2.630012103472263,-3.990761870697597
HCC1143,46843906,3.1964507186723305,3.3155087122015927
A-673,2742550,4.033526638201744,3.541058738173744
SNU-81,11507802,0.99367607100598,1.1797579594085321
KMRC-1,11485656,3.5314695534539045,2.472100885169249
SBC-5,57330099,2.8388792643726295,4.364380653377383
LXF 289,219104,4.555444774518925,3.880673125878398
Panc 04.03,9907093,4.451330392346362,4.261227202008012
DMS 273,19582717,4.273838780275844,3.167778220479812
SBC-5,3815108,2.9831729144642956,2.8941500907042683
OPM-2,168313016,3.5498730155612863,3.944427484349538
ONS-76,10427712,4.642311539672088,4.399641122107759
NCI-H522,54765302,4.051221649365855,4.162161094508246
JM-1,44620216,4.114569245447781,3.2198432102802177
MDA-MB-453,9887053,5.45770037243801,3.3188489505964807
A4/Fukuda,72193861,-0.8043632874402014,0.48101655107555724
G-401,25102847,1.393287045797279,2.261193666331226
SBC-5,11507802,0.0977610232609949,1.6607345940519613
JM-1,168313200,1.89690041567587,2.614892065504043
FTC-133,3634881,3.4388146515237468,3.153827701100697
NOMO-1,10427712,4.067466468396052,3.6250289598085907
SNU-61,6918328,0.4046547109968232,0.06357974734601558
NCI-H2171,23635314,-3.6505205606038382,-2.1514798583946635
SNU-449,6438330,2.777557669825017,2.6492384547382635
JM-1,25161177,3.865095276574429,3.7139588916573865
LOU-NH91,3025986,-0.3413799803632848,-0.4584079857109484
HCC1143,53232,5.137172207040132,2.969142111011988
LOU-NH91,53232,2.5403477328432933,2.7809733679582296
NCI-H1623,24797083,2.165751455730843,1.6403019019839262
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651,3.1922054005903284
LOU-NH91,crizotinib-PLX-4032 (2-1 mol-mol),1.9615360492611609,2.262145821929302
SNU-449,3025986,4.266276949739511,-0.5066106298522994
NOMO-1,2858523,2.9127751570608136,2.8371523424209646
A-673,6918736,-0.9753951922870552,-1.8102668315909847
A2780,44202524,1.0300821380640774,2.0458803091271904
DMS 273,25154868,4.488535380180048,4.274410100204516
NCI-H146,navitoclax-gemcitabine (1-1 mol-mol),-4.8472150579078646,-1.1948795527941767
BT-549,100016,6.139281322747303,6.397841306557815
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006,2.920223181991391
SCC-9,148124,-0.9222891029936632,-1.6932095623605112
DMS 273,11494412,0.2734180035919979,0.6447776542154032
A-673,ISOX-bortezomib (250-1 mol-mol),0.1019689677537875,0.42823811776063553
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355,0.9030745522496804
EFO-27,16725315,5.151426492732951,4.385173442746527
KYSE-70,3689413,0.9447440025313596,0.11631474943684907
A2780,navitoclax-MST-312 (1-1 mol-mol),0.9234968671687596,0.6971063131706517
NCI-H460,285033,-0.7054560098467199,-1.7062311326195152
KMRC-1,5311,2.4483949186029794,1.484864885172999
Panc 04.03,54618164,4.2869772681873695,4.2724488859436125
NCI-H727,676352,2.629502567411482,2.144557355356001
HSC-4,24779724,5.454925638847944,4.733697921348057
A2780,23725625,2.4195603562256873,4.162022586741452
CA46,56946209,-5.9555571874685755,-4.872129599571266
NCI-H146,6252,-1.7817409080320272,0.5295603838850742
SNU-449,44589607,3.7188226068257872,3.1662086401378016
LoVo,969516,2.402995535890804,2.8322071784704725
KMRC-1,carboplatin-etoposide (40-17 mol-mol),4.177751638329711,2.87608743407837
CAL-51,9935249,3.84795648434564,3.157340100739016
NCI-H1623,53392493,3.831222645051568,2.8317707854721816
MDA-MB-453,54596490,5.641262539800198,4.752872193158287
A-498,42642645,1.5845020846141176,1.2058663243791496
FU-OV-1,4788,6.1006518616017615,5.65458339352345
DMS 273,6852167,2.1769146352356707,2.5136754832265953
LoVo,11612883,2.4190290931093954,2.798481870103991
A4/Fukuda,54618305,3.964460418875751,3.8923316129295698
NCI-H2009,17755052,1.0629457660851225,2.077000716106065
EFO-27,5113032,5.5462842201226925,4.987126985920249
LoVo,9907093,0.4604974674369004,4.193561415174881
SCC-9,44491742,4.764074483400304,4.238796881393225
NOMO-1,53392493,1.775943290565707,1.7614826212073533
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924,2.6237219221211485
SNU-449,16725315,5.255161508937853,4.4082961332134865
SNU-81,9825149,1.815233140933264,2.101336704091505
NCI-H522,60700,-0.5552110519793028,-0.31694876100448965
NCI-H2009,375860,-0.9754800160336818,-0.07955211170154176
OPM-2,44607530,0.8834373674969361,1.2300538561437313
MSTO-211H,2708,3.2234156242084073,4.8462462771845045
OPM-2,15953870,2.653227585048534,3.104458424032759
DMS 273,11238147,3.12717198165546,2.2964139005319186
OVISE,3062316,1.3579552700407893,0.8880453672933771
NCI-H522,11955716,-2.355417617820864,-1.1579644645426719
LXF 289,44486219,3.8558224358877298,4.32652956796031
NCI-H522,4261,1.255814980012561,1.2276751669618002
SBC-5,11396600,3.6683316442381617,3.9973436573060606
NCI-H727,448949,2.521247711014773,1.875952287723495
CAL-51,126941,-2.448006630223804,-2.7909956332838863
MDA-MB-157,156414,1.5733069512528617,1.338813237509261
Panc 04.03,selumetinib-BRD-A02303741 (4-1 mol-mol),4.320411537707366,3.5226088781817095
A2780,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4355880611725125,4.104846912962954
FTC-133,2871966,2.512715884905784,0.8194061697674959
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.7146552383324984
KYSE-70,168313047,2.1859183661660624,2.426922342754489
OVISE,serdemetan-SCH-529074 (1-1 mol-mol),2.136633519186749,2.242245419691752
LoVo,54454,2.7172548619434025,2.7223714806528334
SNU-61,73707398,0.7144154314829279,1.120670062070503
MSTO-211H,9866186,-1.5986440722967756,0.8736554856068502
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416,0.8346175275458262
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909,2.9025575586715058
NCI-H2171,57519531,1.5586354952126105,1.6534463859268274
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.0433928953067149
NOMO-1,451668,-1.632426084818391,-0.46203689573451034
CA46,5282054,2.3254868404716755,2.5510736234895752
MDA-MB-157,54618795,2.0481333451118204,1.6257397625398788
OPM-2,11707110,-2.1571352516283113,0.6940135115810007
CA46,3136844,3.7113001526336338,3.61947905207354
NCI-H2171,984333,-0.9596445260901963,-0.2458849251079512
NCI-H1623,11507802,3.5238050648518136,1.8921709686073265
NCI-H460,46191454,1.6495265120274705,1.9917795345907845
EFO-27,BRD-A02303741-navitoclax (2-1 mol-mol),3.819919815231351,2.4290720587216232
MDA-MB-157,7326481,2.299098205794017,2.9657075359648872
EFO-27,1239801,4.748117996702423,4.433233554597115
NCI-H460,969516,4.1763077592827225,3.0294235280821566
G-401,44202524,1.447982360696086,1.839820015231853
A-673,JQ-1-MK-0752 (1-1 mol-mol),1.0252952721702926,1.0029261237095055
NCI-H460,2749,2.5004778765083695,2.329901585933091
DMS 273,119607,5.531574360726778,4.721604921130274
FU-OV-1,10074640,3.835416148861087,3.302627969475744
DMS 273,navitoclax-MST-312 (1-1 mol-mol),0.9055949261710712,0.45589447702367836
MSTO-211H,9911830,2.3480580098381747,2.512922694631477
SBC-5,135411,0.301348299555382,0.7090841457404485
MDA-MB-453,6610216,3.7821562137745217,4.13854035711665
SBC-5,2708,2.061546130614232,4.835206446796852
KYSE-70,11396600,3.829938839575827,3.5033207893522995
OPM-2,vorinostat-navitoclax (4-1 mol-mol),0.1768151572883334,-0.20474408247002732
A4/Fukuda,11152667,-2.4230854517211977,-1.7765770735868573
SBC-5,36314,-4.885811702708602,-1.3780680105626248
DMS 273,9884685,-1.1971048738595964,0.16076442201535646
SNU-61,vorinostat-navitoclax (4-1 mol-mol),2.3944367596721547,0.8299862628433999
NCI-H2009,439501,-2.087429471182781,-1.8938444928246634
MDA-MB-157,1716436,1.1718034720311097,2.838526240635177
ONS-76,216239,1.6729885995968985,2.344367666484676
NCI-H460,9911830,3.1326305509826824,2.596253429817361
A-498,2858523,3.0988346297597293,3.1866566284382123
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205,2.998358434232766
OVISE,969516,2.883429877122848,3.054898862674459
SBC-5,3825829,3.3495967392740953,4.194838616343464
LOU-NH91,5278396,3.7974378044691495,3.689756444996531
MSTO-211H,9935249,0.534197831206919,3.526924888501624
JM-1,9911463,2.675259516581914,3.0976011405158603
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477,3.2129303211030305
SCC-9,60750,4.9910553033212866,-2.426171124118925
SCC-9,387447,-4.584813930042193,-3.958120453847117
SNU-81,25062766,1.4859068805404914,2.118385043145486
NCI-H661,2708,6.321788786635088,5.116086844797607
NCI-H460,57519531,1.7606196796007008,2.533153401316428
KMRC-1,613753,3.207263348750723,3.083260538441538
KYSE-70,67156097,-2.3379446798215127,-0.18470621625581565
OPM-2,10127622,2.4771662101119194,2.701085825826997
LOU-NH91,5291,3.971687681340124,3.6178740973928787
DMS 273,6918638,-0.6329393875591668,0.30391212392846506
A4/Fukuda,16722836,0.6102638619225811,1.148529709278355
NCI-H1623,11175137,3.026300100874371,2.768133687483909
SCC-9,122327,5.629849115039079,4.750249671192708
CA46,11625818,3.63093624941088,3.1427393426784307
FTC-133,navitoclax-piperlongumine (1-1 mol-mol),0.208088727166438,1.4433702569085551
Panc 04.03,156422,4.828457411788627,4.272112817496968
DMS 273,5278396,3.2906012116635694,3.317805310934552
HCC1143,53495165,-2.177337144630303,0.9087029601077602
OPM-2,1641662,3.0681099569104653,2.964822758902368
A2780,BRD-K27188169-navitoclax (2-1 mol-mol),1.5548908643939203,1.440444732653538
NCI-H1623,doxorubicin-navitoclax (2-1 mol-mol),-1.3303127155633732,-0.809083928230963
FU-OV-1,navitoclax-MST-312 (1-1 mol-mol),2.560090479517714,1.1117398660041977
A-498,6917907,2.9475757171512575,-3.7018061611119184
G-401,10385095,0.8697787767816428,1.0698365911769028
MDA-MB-453,702558,3.1332940697725435,4.971358620986181
BxPC-3,15547703,0.9056764589340796,3.2902903916890955
A-673,44632017,0.706241354368095,0.8399986914039872
FTC-133,JQ-1-navitoclax (2-1 mol-mol),0.6314108059190333,0.5919791797919626
NCI-H661,11626560,1.806538061239003,1.9802746278820056
SBC-5,9840324,4.760330511699364,5.568766075628422
NCI-H727,46398810,3.032466795061864,2.5557390306641774
HSC-4,654092,0.2566378579351391,-0.14977132780923472
G-401,5978,-3.1887203575088727,-2.493364728380103
A4/Fukuda,11238147,1.0973923844128086,2.0141560594159467
MDA-MB-157,JQ-1-navitoclax (2-1 mol-mol),-0.7190689296194697,0.8511767040940341
NOMO-1,54678924,1.1055951494804663,1.4927911237195908
JM-1,135421197,0.410328587733175,1.3464357098008137
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774,-1.884605440184369
BT-549,216468,4.5222519285579885,3.734951193935379
NCI-H2009,136227924,2.9896301065010933,3.2577482295708853
SCC-9,2828334,6.128266495621781,6.3892171646827975
LOU-NH91,3025944,4.356407657994756,4.314711465176128
ONS-76,5329102,2.3644433253395545,2.226520441035295
DMS 273,53495165,-0.9870251488119351,-1.2266789427107545
NCI-H1623,3634881,3.389178636612412,3.215575054846263
NCI-H1623,446155,4.270765867841268,2.9565127244699703
ONS-76,984333,0.6472143254241693,0.8697908818729223
SBC-5,3081361,3.306292226806483,2.369954760976483
NCI-H2009,11625818,4.7000574258268255,4.591664410834258
CA46,24775005,3.732581966598925,3.401162142665878
SCC-9,11222830,1.8600220042192213,1.9153182399080209
KMRC-1,12003241,-1.418239320082467,-0.6477419745978055
SNU-61,613753,3.0121134483838037,3.149482710352196
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433,1.2213372214550489
SBC-5,4261,2.0931810634834105,1.3765792254294376
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505,2.10341099260834
JM-1,445091,4.048660068158945,3.869900393346607
NCI-H292,44185566,2.325959343920572,2.6977606784866763
SNU-81,6918328,0.0758058419703895,0.00648527607906927
A-498,16659841,6.0591016575330325,4.297655880511465
NCI-H460,51037431,2.104101453867928,3.2221748350833237
MSTO-211H,5978,-2.861470631068365,-1.9831394349124087
SBC-5,6918736,-1.7962623830849138,-1.211190584802644
NCI-H2171,11178236,-6.134942659978268,-2.8234425881308596
ONS-76,11427553,2.8550216000544695,2.765566577744047
JM-1,11234052,3.3092904099829115,2.8243862232959214
NCI-H661,ISOX-bortezomib (250-1 mol-mol),0.8750807194042233,0.5840674468251338
MDA-MB-453,11719255,3.0016884563631057,3.5030761669520825
HSC-4,241158,3.797905223062241,3.948470423913689
SNU-61,49766530,-2.178873950286192,-0.8899328104192815
ONS-76,54454,1.5364254879481318,2.721354755559698
NCI-H2009,54618164,4.160237516111787,4.179801846133324
CAL-51,3136844,4.799885860604426,4.442068588643295
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096,0.6079615525669164
SCC-9,46926350,-4.135183666473923,-3.8838172592837954
YAPC,5460769,2.316930709954587,2.835424861585436
YAPC,135411,0.9254838530178896,0.930566125529568
A-673,11228183,1.918128583172148,1.1099446889863538
MSTO-211H,24856436,-1.8779899697418416,0.7012779501403564
LXF 289,44185566,2.4809324153017265,2.6983628641582915
OVISE,654092,-1.3076939787912127,-0.19512681024523637
A2780,6918328,-1.1386748973241003,-0.24745918603159883
FU-OV-1,44819697,-2.23904448126328,-0.4379229200342092
BT-549,42642645,1.6219324424635808,1.0561907439505651
JM-1,216345,2.231105973795255,2.876215861824463
G-401,73707398,0.5507155331982622,0.867565299687897
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.9524555647636133
KMRC-1,16722836,1.9243244677044424,1.747875058020604
NCI-H1623,135875424,3.67415188779786,4.040141644042869
NCI-H2009,638278,3.464543124143687,3.376366493201542
NCI-H727,168313047,2.9561297907786717,2.6818762876978934
SNU-81,439501,-1.707157001292212,-2.0834711600905256
MDA-MB-157,11234052,1.0821323764870938,4.054008818680429
NCI-H727,11364421,1.2179988120980565,-1.4353209736093462
BxPC-3,2729026,2.140647578797141,2.671542272613363
NCI-H292,46224516,2.488403107417036,2.7183146421230275
MSTO-211H,5746,0.1838030897357816,1.3181577797491093
NCI-H727,5280436,4.172163827724594,3.6724247826167606
NCI-H727,9911463,4.409308573364914,3.87205527025286
LOU-NH91,9907093,4.908801109640004,4.349264464345143
HSC-4,24772860,-3.179601965562413,-1.414775391660264
MDA-MB-453,10302451,3.3014196832790628,2.9869641990689995
A-673,2945648,0.1856393110329161,2.33934595504948
G-401,56946209,-5.714614119541748,-4.466152728782751
MSTO-211H,452548,-2.0931551112296742,0.24296013485011728
NCI-H2009,5280436,3.59103147994178,3.8869577969155307
CAL-51,241158,3.781489879449518,3.820547470529643
FU-OV-1,24772860,-2.86759244210788,-1.898011241223437
DMS 273,54596558,4.317274835352231,4.387740452797564
DMS 273,71466380,4.5698020131067745,4.175855257482803
ONS-76,11175137,2.2807611594224975,2.623143416737952
NCI-H522,136227331,5.948504593030567,3.4765916803087964
KYSE-70,262093,3.701785722517592,2.7303497453656256
KMRC-1,119607,5.885636542486439,5.250934581462024
CA46,16722836,1.2778374610309875,0.9165753954910315
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874,2.881597367273768
SNU-61,24772860,-2.9174361907600592,-2.120035575157409
LoVo,322968,3.2361743048313536,4.014856231020072
NCI-H460,168313047,3.736921155938788,2.3656108925435237
LOU-NH91,123631,3.064358892537756,2.549060623103199
NCI-H146,10410894,2.10877812565835,3.1857726415693772
OPM-2,107985,-4.911691484457119,-3.7424435097410087
HSC-4,4917,3.66079963002401,3.1217583682374817
SBC-5,72376,-1.1693945126287038,-1.7218200542491422
KYSE-70,11238147,3.36128873589197,2.860096765785761
CA46,9935249,0.2545497442771542,1.5706876064871034
SCC-9,135421197,2.7056920215811293,2.079823022656376
FU-OV-1,123631,2.446979601054181,2.657416212888456
MSTO-211H,12001922,2.4775669078904397,2.097407985677613
NCI-H661,3543504,4.269759852401949,4.4869856976222735
FU-OV-1,53495165,2.0201630022514263,0.8103050422919686
NCI-H2009,448949,2.535639173937985,2.16795781435135
EFO-27,285033,-1.172211692399995,-1.4101737147876805
YAPC,5978,3.3733616775717716,-1.1662632131602029
BT-549,9911463,4.268645247281358,4.12674354295946
NCI-H522,2113511,5.298827483301359,5.377794709833129
SNU-61,1242560,3.7603648536411622,3.4099745847791123
A2780,3503,2.123197367997407,1.9880879868006536
JM-1,262093,0.3077511100871351,1.5156009709960685
DMS 273,11612883,3.047294051558191,2.3226983365323566
A-673,156414,1.4246196000990916,1.118938800216521
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223,1.4154010090307938
SNU-81,3385,3.194341332216005,3.710734335787109
SNU-449,44486219,4.185988120780244,4.280151852772673
SCC-9,25262965,-0.8228501050995407,-1.268465213753486
NCI-H146,9967941,1.5373910611842192,3.4020438850224872
HCC1143,969516,2.4763079586135546,2.9014293494002636
ONS-76,12003241,-1.3579895274230906,-0.8393156951940086
SNU-61,selumetinib-tretinoin (2-1 mol-mol),0.2011452068154318,2.7463692739301466
OPM-2,26596,-3.75281027154887,-2.5576063485299927
KMRC-1,11955716,1.3700469468180672,-1.2055934745039059
ONS-76,445091,4.207927105180806,4.324818551839046
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.7936184083777188
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.216243108648912
JM-1,11964036,0.6346833811859819,0.42895534543759667
MDA-MB-453,24180719,3.640576555720147,3.3923674100360337
NCI-H146,3689413,0.5626872136369616,-0.431931949033643
A-673,5335621,4.03269099593382,4.099004564661759
FTC-133,44491742,4.538470926749077,4.27991940786167
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712,1.5461271852942267
LXF 289,23725625,4.938564251049365,5.206533641389757
OPM-2,11612883,1.2708799210561326,1.8287384667560185
CA46,11485656,1.2289823963881294,1.4960841218179317
SNU-61,227681,2.9666568152307993,3.3314527816626196
NOMO-1,135421197,1.2386186938920458,1.3545870531982107
NCI-H1623,vorinostat-carboplatin (1-1 mol-mol),3.549282836614641,3.2404414450861316
BxPC-3,135421197,1.4419000032460958,2.129380187095528
CAL-51,66577038,4.134711160885491,3.096191722772625
BxPC-3,11485656,2.0481416814216375,2.406802299983111
LOU-NH91,3689413,0.742189593443008,-0.17384779729577043
OVISE,crizotinib-PLX-4032 (2-1 mol-mol),2.5474980530955844,2.096611148798154
JM-1,49766530,-3.0151701370453794,-2.1570048348438333
NOMO-1,15983966,-5.011559396504552,-3.802320008925292
HSC-4,24856436,1.7831446753384608,0.7878948887443835
OPM-2,387447,-6.258797979541162,-4.87510957389573
A-673,54765302,3.022220101838166,4.089292610953246
A-673,5479543,3.2499245267113928,3.03226213068661
SBC-5,docetaxel-tanespimycin (2-1 mol-mol),-4.858337371172803,-3.1086163063945698
A2780,441298,1.2276441630256645,2.3980466062399737
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923,0.7215762307070787
HSC-4,65064,5.180183799352401,5.084886726157524
OPM-2,3384730,1.6721258053175836,1.5424967468663489
NCI-H522,387447,-5.403881314975521,-4.518399670406504
MDA-MB-157,11640390,1.4666591993417384,3.720676691821034
CA46,9911463,2.565133854881976,3.1017137011649236
FTC-133,227681,2.0408407851095416,3.3704710083112817
JM-1,285033,-4.464347137363986,-3.4312382579518292
KYSE-70,16736978,1.1213704825993671,1.6671322112557425
MSTO-211H,2729026,1.9618514095460544,2.852405877080532
NCI-H661,24180719,3.917772031076744,3.6468319861699645
NCI-H1623,400769,-1.0076663191396935,-0.4614113764046014
YAPC,9840324,5.782457936566159,5.785982270940679
Panc 04.03,57330099,4.388225142481581,4.257672000134756
G-401,135659046,3.5574575455214608,3.447984631361578
A4/Fukuda,148198,-4.99238512913244,-3.72319296482325
CA46,126941,-4.174426911659592,-2.987022409561534
SCC-9,6610355,5.330005746360321,4.566381695222194
KYSE-70,44185566,2.2395157674699875,2.618198805427741
NCI-H1623,462382,1.1150663609789129,0.666121360090197
CAL-51,6914657,-5.067352950634086,-4.423974458502476
A-673,selumetinib-BRD-A02303741 (4-1 mol-mol),7.378712483637354,3.9699110484074156
EFO-27,54618164,4.628305371415217,4.17193654954523
JM-1,23582824,0.2805180690676545,0.7142862349128153
NCI-H460,44185566,3.2105564381381035,2.6085211918868403
CA46,52912189,-0.9978651387823436,0.128525464417541
NCI-H2009,9935249,4.414461781647313,3.410698984047819
NCI-H2009,135928012,4.098076343567735,4.25234855130695
CAL-51,60750,-3.4379358682898973,-2.652298883805035
MSTO-211H,8515,1.6806311840995682,4.226019279591229
ONS-76,15983966,-3.1712265481751243,-0.45015795630585
NOMO-1,56946209,-4.862706213909506,-4.384260164456423
NOMO-1,24772860,-3.4546209155075687,-2.8699020553267673
FU-OV-1,44185566,3.182046500186311,2.804180393210828
NCI-H2171,11977753,0.3036523614034643,-1.7461073074606026
FTC-133,31703,-0.768913830642622,-0.7456380697647179
EFO-27,984333,0.9554706085777084,0.8328007319621916
NCI-H292,5329102,1.7855476735914897,2.1612723722734772
CA46,409805,3.3808362620175187,3.768925020822065
MSTO-211H,25183872,0.3972499543283658,-0.8376383561918902
LOU-NH91,24180719,4.451607655435679,3.538788204146723
A2780,44185566,1.1999498835751436,2.2040456602308187
JM-1,piperlongumine-MST-312 (1-1 mol-mol),0.8602384647056689,1.146918402277345
NCI-H2171,6505803,-0.0596794204500112,-0.20397254511260396
CA46,66577038,2.896384523521911,2.5562503659109295
NCI-H2009,navitoclax-PLX-4032 (1-1 mol-mol),4.434532653738059,2.4125252062554003
CA46,12003241,-2.799565618947511,-1.537981060810721
NCI-H661,10427712,3.832896992750264,4.443766080523231
SNU-449,107970,2.557902386411369,2.5416014314986692
Panc 04.03,2874250,5.078270927101478,4.79741962013008
NCI-H292,54626689,4.661071465435288,4.722405838648848
NCI-H460,23725625,5.666756485817308,5.065081850933385
CAL-51,53232,2.8018516258833395,2.9681671335221256
FTC-133,decitabine-navitoclax (2-1 mol-mol),1.1951853583551142,1.5928953880018062
EFO-27,53495165,0.9078503906950024,0.7333381297786156
SNU-81,65064,4.179756271690876,4.543886639561577
BT-549,3689413,-0.9397914335397376,-0.22629890104617523
NCI-H2009,66577038,3.427367822074961,3.24074799057177
LOU-NH91,10302451,4.426232341068122,3.5591908795936877
CAL-51,168313047,1.9592520089902103,2.4207900657822408
NCI-H292,135411,0.5538002090667975,0.7763695957939984
LXF 289,2874250,5.409057432200043,3.964490486799004
EFO-27,4261,1.4655103146060633,1.8984682945292581
ONS-76,25150857,2.480326692853007,2.2820044661702847
G-401,11175137,1.9335599830838224,2.365922703275599
OPM-2,5460769,4.223891374112808,2.0617072688241582
NOMO-1,10385095,1.0593467546243338,1.0001290147527606
LOU-NH91,2126,5.273491801207327,4.782428098358784
MDA-MB-453,11625818,5.002273286989784,4.251164906783758
OPM-2,44632017,0.7121474472673729,0.7060866892396522
LoVo,135411,-0.4629764704945864,0.6817626589740654
EFO-27,16722836,2.503686118945589,1.8639249567126654
LOU-NH91,10074640,3.3386477352477715,3.2501551888358993
DMS 273,11719255,4.586791904076426,2.459847201482851
OPM-2,136227924,1.7425170628423947,2.3090691475024823
YAPC,vorinostat-navitoclax (4-1 mol-mol),1.7986594173334518,1.2317403099714812
KMRC-1,vorinostat-carboplatin (1-1 mol-mol),4.1908249815251075,2.9919203771097047
NCI-H522,2828334,6.021027928266713,5.882353580032808
KYSE-70,72193861,1.5917149982909504,1.881220804115286
MSTO-211H,9911463,2.6842905920893108,4.09939422757406
MDA-MB-453,969516,2.9001694226946153,2.8544554831202413
CAL-51,44632017,0.9975947899898204,1.3915325657260007
LXF 289,10231331,2.4249622135671824,1.9865159362125495
A2780,25195348,2.1109786238814943,3.054401460454569
NCI-H2171,44202524,1.9759332673432517,1.684227799014473
Panc 04.03,1641662,4.251343925322988,3.6010775034777684
NCI-H292,54686904,5.52345614596139,3.742100954132713
DMS 273,7251185,2.13119393000196,1.851120839629468
LoVo,9956119,3.291456775833892,3.6810457559691265
BxPC-3,11404337,-0.6361724208993981,-0.17341075615110466
NCI-H2009,119182,-1.1305543955582442,-0.6044723862057544
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206,1.7673418034682473
NCI-H2009,5278396,3.446569775137936,3.7364266964890844
SNU-61,327653,2.3439595497702985,3.049101627096543
Panc 04.03,11238147,2.6863632300229936,3.075146664977881
LOU-NH91,9926054,3.1176474597994908,2.188904885662852
NCI-H727,5566,3.3170373665309416,2.962882430827561
SBC-5,25150857,3.1636616713903893,2.4908924986698384
A4/Fukuda,11719255,2.014724282446697,2.512268316493217
NCI-H460,374536,2.933441634270558,2.234056721200275
Panc 04.03,135875424,4.739147054003967,4.347771467975217
NCI-H522,9825149,2.538976142931882,1.9449358449167868
NCI-H522,11964036,1.1738559849313974,1.095266207554071
NCI-H727,docetaxel-tanespimycin (2-1 mol-mol),-0.2306371483754844,-2.0100818429044156
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.5959114486240115
SCC-9,5566,3.224791432055543,3.047239821922712
NCI-H460,9936388,2.3098343611543415,-0.5800589880754181
A-673,salermide-PLX-4032 (12-1 mol-mol),5.197476716146756,4.687300038886735
NCI-H460,16720766,0.8258921674033131,0.7006740619793799
FTC-133,54618164,4.149608396421597,4.0283649380420945
NCI-H727,5281321,2.7498034475542803,-1.2015645069198566
BT-549,31703,-0.610163723442028,-0.820230686205287
JM-1,11609586,0.7887510712984062,1.5361534011409603
MSTO-211H,65628,3.7458295220001,4.4708436656189345
NCI-H661,9887053,5.171148908960024,3.9426603151287827
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053,3.2264066167643115
G-401,9887053,1.7608751069117703,3.207586296663846
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126,0.679148713609928
A-673,7251185,1.3487938120123666,2.0540624516076535
ONS-76,4259181,0.68334491499701,0.02897553937086095
NCI-H292,613753,2.7114183475644857,3.3359487554945493
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647,1.179406949947312
JM-1,25126798,3.029145333632086,3.27137030211475
CAL-51,3815108,3.0623029951861396,3.0064529419201524
SCC-9,16725315,5.212889946477865,4.351843137997063
NCI-H661,alisertib-navitoclax (2-1 mol-mol),3.068945671773435,0.16524940179115802
NCI-H522,serdemetan-SCH-529074 (1-1 mol-mol),2.019053107898385,1.6536313525517914
LoVo,16722836,0.1488668556579147,1.631394036663853
A4/Fukuda,25262965,-4.823082336145625,-1.9345873230408475
OPM-2,53392493,1.6243275023991692,1.745677877609098
HSC-4,9926054,2.0278633205902468,2.0649184817001522
SNU-81,9936388,-6.314751034125396,-2.817983447613867
G-401,9823820,1.4384887897470693,3.380136145146248
YAPC,24753719,5.0641073859888,4.348126056512725
OPM-2,24772860,-2.8738620885527153,-2.938741747820009
MDA-MB-157,10427712,3.542893078297904,4.523262796294799
A-498,4259181,1.547873530266754,0.6543313791144766
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196,-0.09092814353251916
SBC-5,9927531,4.452264212548339,4.85115409896036
LXF 289,119607,4.549732560104057,5.527879773753947
MDA-MB-453,piperlongumine-MST-312 (1-1 mol-mol),1.140334319354309,1.9359937344970788
NCI-H2009,11396600,4.054693544346837,4.144041655313048
SNU-81,15983966,-3.5187473914136738,-2.1536563278426555
Panc 04.03,11494412,3.764008563191269,2.3009247045937555
OPM-2,216345,2.3930113976289364,3.177567995187827
JM-1,66577038,2.266129645862272,2.592327578658936
SNU-449,15953870,3.8419288275174326,3.636384244040339
BT-549,9903786,2.513972936103366,3.1344486482491907
OPM-2,44202524,1.1830318509158162,1.44530828633209
OVISE,6623618,2.0550481440983153,2.460764106507085
SNU-449,11657048,5.413893492178721,4.391930503422497
NCI-H2171,67291369,-0.2342814323553679,1.726443731853953
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767,1.1585926144439527
NCI-H522,11238147,3.4337502548923404,2.436786903325827
MDA-MB-453,16065773,1.7584918793826552,2.235961144168667
LoVo,136227924,4.6796674015936075,3.015932716645771
LXF 289,3854666,2.0847029854583377,2.268766438247207
OVISE,984333,-1.5189255907846522,0.8217725275913499
A2780,159324,-2.166969557176003,2.3079869302372917
SCC-9,17755052,1.3521912896367647,1.5580517142281332
OPM-2,9823820,1.0965123517529505,3.090652933865205
DMS 273,12001922,1.9670879212293255,1.6894948024412522
KMRC-1,24180719,3.956198558970242,3.4383005339857946
KMRC-1,637858,3.0556928718558707,1.9999441822801405
NCI-H2009,6917907,-5.363195379340594,-4.918239275669452
SBC-5,24748573,1.8248605513332548,2.0953974949678935
CAL-51,452548,-0.9080095532304931,0.31344772319495945
BT-549,2858523,3.192172893232417,3.137362464397668
KMRC-1,219104,4.439460794922528,3.6327550176509362
LXF 289,2858523,3.038787864461457,3.034943406555121
NCI-H1623,9907093,3.838952634819664,4.1893368478637765
NCI-H460,168313047,3.736921155938788,2.3656108925435237
JM-1,5287969,-2.2665073107333997,-1.9825606107144125
NCI-H1623,2828334,5.745033734102683,6.3077856482913175
NCI-H522,53232,3.4340993190045763,2.698401404544886
MDA-MB-157,24180719,1.846017762198611,3.4459079416894896
NCI-H727,2858523,2.9690043699309094,2.9826558040546898
HSC-4,3384730,1.6775009570022803,3.056258732308225
MDA-MB-453,66577038,2.2210808109899687,2.9894999953041776
CA46,54619267,3.4754479185856604,3.3096881020856297
BxPC-3,selumetinib-decitabine (4-1 mol-mol),1.0861669276123684,3.2683398670705395
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147,4.434092926085954
DMS 273,89183176,4.012998903778193,3.717006455770296
LXF 289,89183176,5.264029999533809,4.416980963539872
HCC1143,25154868,3.6479876335061863,4.42299802818539
NCI-H460,5566,3.3663694984335533,3.0484466729832347
EFO-27,3384730,3.632582575012134,3.3767048614078794
YAPC,3854666,3.60977300269674,2.574324521411533
CAL-51,11960529,3.662834723962616,3.9126186025432204
NCI-H522,4096211,1.7167000910654833,1.6710170370641442
LXF 289,46199207,3.0446562724495676,3.206857604145573
MSTO-211H,44507138,3.561974329612715,2.3628828449865686
BxPC-3,10127622,0.1850831315580212,3.449635272167262
SNU-81,57519531,3.6375637578947098,2.0987619506390627
NCI-H522,46926350,-4.757002390021422,-3.943233131648291
LXF 289,675434,4.434927450149955,4.801176267899145
SBC-5,2858523,3.0625939376722147,2.9664604193644277
YAPC,3025986,-1.0818355674515514,-0.5582175439891364
G-401,753704,3.840031862409327,4.58435055278883
NCI-H2171,9933475,1.8341202855706125,1.8871653243821351
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609,2.78425009248493
BT-549,5746,2.744550621458616,1.4139904118566977
MSTO-211H,2733487,6.00734552009151,6.193167409595443
LoVo,9908783,4.437010992006648,4.989685711286594
NCI-H2009,46398810,2.5614683956162554,2.712591148632614
NCI-H292,15983966,2.054572304908195,-0.14898101601232608
G-401,46943432,1.6295589064479152,1.9881650667447905
LXF 289,54618771,-0.5375230222620658,1.4792218887086712
NCI-H2009,4261,0.1994590765469732,1.9134512262706826
NCI-H292,119182,-1.3574963176080912,-0.6420943337423892
LoVo,675434,4.114717976727459,4.422810194206139
CAL-51,613753,3.3238399640193177,3.08935476678198
OVISE,tanespimycin-gemcitabine (1-1 mol-mol),2.9974689860461785,-0.8127709486788716
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125,3.727034597318841
MDA-MB-157,7251185,1.2275966709755557,2.611181217068225
LOU-NH91,168313047,3.5347026371928565,2.459054743733922
Panc 04.03,11175137,3.811547013287204,2.919103239715602
YAPC,46191454,1.528991916080322,1.8435699560546817
Panc 04.03,246676,4.5210437514033615,4.571922734410684
LOU-NH91,107985,-2.204555775629559,-3.4030919942112705
JM-1,9884685,0.5602575931973728,-0.19932598786649489
KYSE-70,26596,-1.4453873864890578,-0.8253892583092397
SBC-5,11238147,3.923057921789592,2.8503093425265837
CAL-51,5351362,1.1872361858703535,1.5815871679066793
CAL-51,148198,-3.728190383000159,-3.7101690087749057
MSTO-211H,10074640,2.8901374693183848,3.269324659524927
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576,-2.3576715173321743
Panc 04.03,54618305,4.994656380487723,4.64656602646966
HSC-4,9444,4.231424733159592,4.201413214073557
ONS-76,136227924,2.542073211711186,2.9432103921435067
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176,0.09896588444557658
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066,0.8459077157993584
A-498,4705,4.1964696083385595,3.2546498108476873
NCI-H292,4788,6.000922818610643,5.790261073374057
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293,1.7512245505510153
A4/Fukuda,168312962,0.589698091471745,0.7034557329027207
MSTO-211H,135421197,0.8053711662366769,2.1755348881308674
G-401,9826308,0.736562536874994,0.11903100838869435
JM-1,44202524,1.2333959484520816,1.3259328686316172
SNU-449,135984461,4.468051833024593,3.86413878287669
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854,1.9675540975346368
HSC-4,135999136,1.7584955345229645,4.274563602247806
HCC1143,6918328,-0.4969866258783406,0.2847017445022791
A4/Fukuda,2871966,-1.2628046939905593,0.01953253474643055
HSC-4,89928392,1.9678897287961257,1.9737800521867035
CA46,7251185,0.9564015595877396,1.5533896290606308
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632,1.686169004629906
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907,3.6181812974073506
LOU-NH91,navitoclax-pluripotin (1-1 mol-mol),-2.6950691306043297,-0.8777184398394365
YAPC,9967941,3.379913520192136,3.927353825306191
Panc 04.03,119607,5.706581209982884,5.43598017932624
KMRC-1,46926350,-4.153095302049271,-4.015315887697772
OPM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5972514317296775,-0.03586083490076229
OVISE,5287620,-0.8119274098935182,-1.7999671947182825
NOMO-1,135440466,1.6123042261647436,1.6805082451196534
A-673,11507802,0.3878845266361032,0.7163849703348489
G-401,tanespimycin-gemcitabine (1-1 mol-mol),-2.3448363007854325,-0.9293235510913083
NCI-H2009,3854666,0.912328636385412,2.3915241838864696
SNU-81,2749,0.983670801340458,1.6005666942866523
A4/Fukuda,25105715,3.290295740743095,3.1344679431041214
OVISE,erlotinib-PLX-4032 (2-1 mol-mol),3.714460286615586,3.119211518209823
ONS-76,salermide-PLX-4032 (12-1 mol-mol),5.250502452848782,4.509828513923177
CAL-51,9903786,2.1849161121493847,2.8543665487306886
LXF 289,5113032,5.558232749512156,5.10087937477046
NCI-H522,46224516,2.9506377913569244,2.3430889766318486
FU-OV-1,56649450,4.970206677695459,3.6211729490726827
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033,2.8403501295715214
MSTO-211H,9887053,4.1066593545259975,4.278076053818013
CA46,6610355,3.575030613446337,3.9097694592163545
NCI-H522,445643,3.9693726836499863,3.9020962493820224
A-673,46224516,0.8314688808424526,2.41139013478486
NCI-H661,6918736,-3.5059805921507823,-1.5926978861394545
NCI-H522,selumetinib-PLX-4032 (8-1 mol-mol),4.633194208623746,3.8926549126146575
A-673,3825829,3.830298825271896,3.613870674173198
ONS-76,11396600,3.887590392789339,3.725593632728401
LXF 289,5282054,3.512278681739004,3.9085359364153396
A-673,54618771,0.7910545462175201,1.2124997622186524
KMRC-1,25062766,1.7411663615582824,1.9754055455411383
EFO-27,71751553,4.378478985868248,4.6797192257963225
EFO-27,10074640,3.872803440374816,3.227350761645443
ONS-76,24964624,2.710261416606334,2.4352699941065725
LOU-NH91,53392493,2.3846272258457737,2.8057245601867837
CAL-51,46199207,3.548155956826357,3.2033557591894914
DMS 273,227681,4.814934070367145,2.9863956724018816
HSC-4,9908783,6.127900398037499,5.240809672701163
HSC-4,10184653,-0.7296444895073179,0.6277983109032129
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546,2.5933224782334423
NCI-H1623,44185566,3.0587688781610667,2.685640796333743
KYSE-70,6918328,0.2213620303324437,0.05035210481798182
MDA-MB-453,327653,2.9444810987281533,3.1990767685863126
FTC-133,4259181,2.1331002918337925,0.5183261736244001
NCI-H292,60750,-3.187051343712646,-2.1415757001623605
KYSE-70,60700,2.818490002790748,-0.3749471050658598
MDA-MB-453,24821094,0.7464785951288041,2.3370905044574073
NCI-H2009,656346,1.3969032628362248,0.973347109008348
SNU-61,24964624,2.494415785344137,1.7525957979819744
NCI-H661,4261,1.9569329914003135,1.89777467333008
SNU-449,54618305,4.668068655096509,4.054888300009996
LoVo,135875424,3.182508442374063,3.752768881547561
LoVo,6623618,1.7195113979524326,2.4736628506187857
A-498,135398516,3.177268179593805,2.181299387160941
BxPC-3,26596,-1.629746525957504,-1.083107501146188
NCI-H460,2749,2.5004778765083695,2.329901585933091
KMRC-1,46398810,3.012918063271682,2.4380063987890854
NCI-H522,5291,3.860595721411624,3.3652417713945435
SNU-449,36462,4.301758862194218,2.455992074242676
SNU-449,6918837,-1.494845192804234,-2.262896803682562
CA46,11955716,-2.7152267118714204,-2.3363047477046637
NCI-H1623,168313200,4.911870039242249,2.942762742062151
NCI-H2171,10427712,3.6918148562663937,3.8514186019426857
NCI-H522,262093,3.0660845932794656,2.4020474321883145
BT-549,168312962,3.315695506914068,1.9701354720003454
MDA-MB-157,15953870,0.7968689532543627,3.6446235478016713
BxPC-3,carboplatin-etoposide (40-17 mol-mol),4.727119373262846,2.9342581787143462
SNU-61,11364421,-2.983927558247801,-2.3238146787881537
SNU-61,3101542,4.3555934573063695,2.6814669054838043
NCI-H460,52947716,-4.997624319891589,-0.3247394243397397
CAL-51,44543605,3.919885801001582,4.064643951637172
NCI-H292,12003241,-1.027467238096921,-0.8507427452182642
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957,1.046578388066779
Panc 04.03,navitoclax-sorafenib (1-1 mol-mol),3.337045495454646,2.1047431714390212
NCI-H292,25154868,5.001413217408079,4.486545773189561
NCI-H292,36462,2.4286801987130486,2.527990771263187
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746,-0.6473506965447197
NCI-H292,159324,3.210621191245253,3.3459385414125338
SNU-81,24978538,1.1236702452048486,0.585733895742945
A2780,9929138,3.988043631552867,5.536978927689159
HSC-4,16065773,3.311693132411482,2.722321773611457
A4/Fukuda,400769,-1.555916482707746,-0.9025171077877099
A2780,11977753,-3.718954593203518,-2.132371685104638
FU-OV-1,60700,0.8482129777629449,0.1074941156674839
DMS 273,168312962,2.633531304827929,1.455356468000083
SCC-9,8515,4.77911141452934,3.978848561027749
A2780,71680916,3.658218554445846,4.378178477158556
FU-OV-1,5328940,2.1307155577669143,1.8935135881232221
NCI-H661,42642645,1.2812432760018797,0.8533288364503736
A4/Fukuda,2113511,3.845432548996496,5.2296558954881265
SBC-5,19582717,5.27972019168548,3.9997532413181
HSC-4,11222830,1.068056053085511,1.7643784496949129
CAL-51,10427712,4.2973287072996085,4.203901082387926
A4/Fukuda,44185566,1.3030950937163224,1.7014264803638366
ONS-76,5278396,3.742938248744769,3.5050037683604107
MDA-MB-453,46943432,1.9398007817238585,2.63230002410135
NCI-H727,984333,1.9308701128060968,1.0129440455274874
MDA-MB-157,24889392,2.1225906954298535,3.974988250126831
FU-OV-1,ISOX-bortezomib (250-1 mol-mol),0.954548859556388,0.6929207127261854
A4/Fukuda,46843906,1.071626560517578,1.2789357681255062
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.370622321562245
HCC1143,44241473,5.874360916813842,4.88815140396625
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.4377861128923997
EFO-27,6918878,4.955152670116511,2.947911983731416
CAL-51,5281672,3.9430830045045857,4.559469014124767
NCI-H146,9915743,-0.2957101551438801,0.594432359207921
G-401,89928392,0.7343580800154272,0.7246596438225125
SCC-9,navitoclax-piperlongumine (1-1 mol-mol),2.9839395541067515,1.753818056272346
EFO-27,6184667,5.467001643500489,3.239058246858389
NCI-H727,3854666,3.6466691501950512,2.2158317414818187
LOU-NH91,9825149,6.244850491409518,2.3360740601431673
NCI-H146,11178236,-6.140205122942071,-3.366571781437224
HCC1143,navitoclax-birinapant (1-1 mol-mol),-1.1255303234100646,1.0705160583359636
ONS-76,448949,2.486443038536461,2.093020167678642
BT-549,57330099,4.335540938726609,4.237345738063186
CAL-51,44819697,-1.9765663783606575,-1.1580993236870158
SNU-449,5278396,3.499051739077657,3.7463142387971953
LXF 289,9956119,3.057634534881657,3.694641914779274
A-498,9933475,2.3013420942123655,2.201814218156975
DMS 273,10074640,2.948045052381196,3.1503004346931953
LOU-NH91,25102847,2.3579155704363206,2.5657813604704067
G-401,5311281,1.6046025374895514,2.1589100780926525
A-673,219104,2.2996165619151507,2.899409413804907
FU-OV-1,42642645,1.0692746742635495,0.925934926919318
NCI-H460,135411,0.3374737909082799,0.6086000121875925
CAL-51,6252,-0.2076922850947726,1.0573460692006618
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903,1.223300133052508
LXF 289,10296883,3.609856485747645,4.136818329229748
KMRC-1,54626689,4.972873475873264,4.706443549261118
A-673,JQ-1-UNC0638 (2-1 mol-mol),0.3202130450215845,1.214775122082919
HCC1143,1750826,-1.2654463091368686,-0.8219645391825608
SNU-449,24785538,2.8069089427026346,1.6250775658352419
LOU-NH91,53495165,1.612116489462364,1.0256647256284952
EFO-27,11609586,3.640431752283184,3.144907270470228
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083,-0.8830753625678419
Panc 04.03,104842,-1.0125052126256155,-2.2860367668209456
NCI-H522,6610355,5.34603712705315,4.456680886648094
NCI-H661,11656518,2.215339329496845,2.0151310188728657
NCI-H661,6505803,-0.5859050253944337,-0.25270592713108814
NCI-H292,5351362,1.0382380370911135,1.584273899873282
EFO-27,11612883,3.4595212211892377,2.987948849009919
FU-OV-1,vorinostat-carboplatin (1-1 mol-mol),2.1636839207385914,3.4343758430075826
HSC-4,10302451,2.384078053411002,2.9603937707853087
NCI-H292,46199207,3.366381535989616,3.3289987642220034
LoVo,262093,2.370412929490009,3.0648796166521732
BxPC-3,445643,4.432772060189362,4.016887978745882
A-673,carboplatin-UNC0638 (2-1 mol-mol),1.4546927004142935,3.129228232396579
A4/Fukuda,46224516,1.3171235816864948,2.280009925532774
JM-1,3854666,0.4999957819555636,0.8982168681766519
NCI-H292,124202324,2.857386903129287,2.6501719177286573
BT-549,1566236,1.7296376770428397,2.37811992468779
LXF 289,11364421,-2.6687395721676577,-1.3302562001566685
NCI-H146,navitoclax-sorafenib (1-1 mol-mol),-1.8992247000680913,0.909938475294925
FTC-133,148198,-1.6568063805549866,-3.1531030867850727
LXF 289,11640390,5.398484732926136,3.9979519379296438
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944,1.5844787652965637
LXF 289,2749,2.818144236178911,2.254256173611299
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522,0.2283172666395366
JM-1,135875424,2.019666731209586,3.256996272738903
SCC-9,4705,2.492131143046821,3.145186976332399
NCI-H2171,151289,1.4157771037164255,0.9329682259364841
NCI-H522,644241,2.1349742590503427,1.2422951619144396
A-673,445643,4.040507929851862,3.9019221470590213
JM-1,6252,-5.0324479776154885,-2.2606698296753525
NCI-H292,208908,4.322795663590344,2.1693728478126992
A-498,2871966,1.0686849145956876,0.8465890666984047
G-401,12001922,1.3873374697674952,1.7773171853490433
DMS 273,44491742,3.7307306463602545,4.122805877611058
A4/Fukuda,11396600,-8.215434514364686,2.821413825972203
HSC-4,3689413,2.5472025828962055,0.05999083161823077
MDA-MB-453,4378219,1.7417226469020404,2.2200604566031417
ONS-76,387447,-4.115404850127739,-4.279476908783394
LOU-NH91,656346,1.0077735762311986,1.0621606776247292
A4/Fukuda,3081361,1.810117399969756,1.7710662086766313
NCI-H460,6505803,-0.4074860596498978,-0.6687667971005606
NCI-H146,45279963,2.8359939324557706,3.2998241018459957
OPM-2,6184667,1.6391974127027074,2.5831673140363165
HCC1143,148198,-3.881060339055355,-3.5254412175974097
A-673,421610,1.6759942643549426,2.8579588914773972
SNU-61,4259181,0.2985440005718957,0.05653343359468718
LXF 289,44819697,0.5606163889857397,-0.12275059894016545
KYSE-70,168312962,-0.2970816131627225,2.1461700793261116
NCI-H146,11494412,-1.136229477240518,1.0221015572354966
OPM-2,2746,0.9082445461467812,2.0519275796514695
MDA-MB-157,6918736,-2.3678025624565175,-1.3592203025269007
DMS 273,135659046,3.477426326571923,3.3793265888344677
HSC-4,126941,-2.3076253927529127,-2.2932261527025464
CAL-51,57519531,1.893237876741888,2.4444560018750066
MDA-MB-157,3038522,4.043799431595376,3.215237624304902
ONS-76,SNX-2112-bortezomib (250-1 mol-mol),-0.0712128201037348,-1.2078857893068207
BxPC-3,54613361,-0.6294380958983512,0.19186196981193746
CA46,25102847,1.8345278315547784,2.0483772853388684
FTC-133,5746,0.3858378554684238,1.2897695442159343
BT-549,10113978,3.95693770646699,3.4902500564731747
A2780,54618771,-0.248592168161829,0.8909286631205936
SNU-61,6917907,-7.995083965311066,-5.586147137177002
ONS-76,3384730,2.185678697527176,2.7553608804729923
LOU-NH91,11228183,0.5456186750940368,2.652679316937701
MDA-MB-157,25227462,1.286146426910961,0.7974779623992327
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286,1.6272726045638444
BT-549,439501,-3.1266914034371567,-1.9784717247062573
LXF 289,409805,5.2068809837223435,4.609886118863409
OVISE,148198,-3.4121309130102055,-2.9942605656055905
YAPC,262093,3.6115167721531343,3.0680591669174233
NCI-H727,5738263,3.354715168796171,3.287769388713165
A-673,6918328,-0.9424380212903694,-0.41905883498814084
MSTO-211H,navitoclax-piperlongumine (1-1 mol-mol),-1.4716070020924246,2.1673495608691122
JM-1,445643,3.755930816022248,3.6124142522597884
A2780,25154868,3.617715738937927,4.4246073867668425
Panc 04.03,81146,4.4293645850092735,4.871821260449818
MDA-MB-453,4521392,4.261545411784443,4.322743311417192
CAL-51,5460769,1.3780575552768597,2.512605637388526
SNU-81,9926054,1.3093723678717843,1.9937836201285837
CAL-51,2113511,6.39897875596168,5.540878245104883
NCI-H460,136227924,3.925006850615035,3.1695322750605626
NCI-H522,24856436,0.0798065953372803,0.21204629700700386
SBC-5,9967941,3.629642521259923,3.498858387686054
A4/Fukuda,462382,-0.2406989279082468,0.6274149216010585
OVISE,11640390,4.491956307789174,3.5844385061686417
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843,2.247171291451764
CAL-51,24180125,2.8082301472193203,3.0800515094915806
LXF 289,25262965,-2.558275633709226,-1.0586954580698005
NCI-H2009,9903786,1.8298580590992315,3.0627838498062725
SNU-61,54678924,1.5881868934361725,1.8605722706475487
YAPC,24785538,1.575520805381804,1.4409084388922044
NCI-H2171,676352,1.591250217642193,2.0984723701029595
SCC-9,carboplatin-UNC0638 (2-1 mol-mol),3.5571818540455413,3.563197497623762
ONS-76,BRD-K27188169-navitoclax (2-1 mol-mol),3.629677877626108,2.5321001889753134
NOMO-1,3689413,-2.5325178418163174,-1.2297461952849316
OPM-2,5284373,2.335601496737994,2.397852377590213
NCI-H661,10127622,4.958480333722226,4.40127301999836
ONS-76,44185566,2.3053400119978735,2.310620693753787
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053,3.1114091559023676
HCC1143,11485656,1.8564802256291268,2.550483861828901
G-401,613753,2.8041503953296187,2.941100548241513
MDA-MB-157,11657048,4.26764748298064,3.779471125942964
ONS-76,24951314,1.2212354664419371,1.3434184936919746
A2780,36462,-2.0824592368546893,1.3756518797228916
FTC-133,vorinostat-carboplatin (1-1 mol-mol),4.046796900888368,3.230363643752048
OPM-2,72376,-3.1510357921092376,-3.1606722625203765
OPM-2,6918328,-2.875264730320658,-1.5989954076970552
NCI-H522,decitabine-navitoclax (2-1 mol-mol),4.970964992537572,1.1075007866774336
EFO-27,168312962,3.0506772104926343,2.6509727184960776
NCI-H1623,107985,-2.7226564689550488,-3.25985709973519
MDA-MB-453,46398810,2.51328952557295,2.458723112031455
SNU-449,49766530,-0.9876450445747244,-0.20727166825844795
OPM-2,25102847,1.4573873057147737,2.406598218196441
G-401,3081361,2.1638535645332664,2.1364406552312576
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866,4.415851873131743
A2780,24951314,0.3580646626980762,0.693292389393413
SCC-9,2871966,2.1501352130214695,0.653702348712637
EFO-27,53232,3.845715413797161,2.8924073880663186
A2780,5460769,-5.6757466443406575,2.613495412012636
Panc 04.03,10322450,4.721553837851545,4.000815291719224
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783,1.547483498070002
SNU-449,23582824,0.6769149785817056,0.672566478804065
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531,3.5495734095370337
ONS-76,3854666,0.984876663182433,2.0953370887314375
MDA-MB-453,71466578,1.854784458712459,4.316158140681504
BT-549,piperlongumine-MST-312 (1-1 mol-mol),1.4526674208496635,2.0686344953336957
MDA-MB-453,15547703,3.861172408325267,3.2409025482561127
MDA-MB-157,252682,6.150103454129247,6.5299141467124775
G-401,46398810,1.5664917458517695,2.44294192904972
NCI-H1623,327653,3.600793829240414,3.2717229213104075
SBC-5,6610355,5.221010400785003,4.631345368664476
A4/Fukuda,6918878,-0.3411937140873722,0.6226055536642857
SNU-81,3062316,2.330723232319837,1.3176936226636564
OPM-2,9903786,2.6412283094975657,1.8038395380542536
HSC-4,15953870,4.269670192757531,3.4770154752034546
JM-1,984333,-1.6115401451915106,-0.18384544096421362
Panc 04.03,46174525,5.826098059849913,4.565144937660739
NCI-H292,5460769,0.0770188109309223,2.6836859054489497
FTC-133,216345,4.490711794352075,3.9148368640484272
BT-549,alisertib-navitoclax (2-1 mol-mol),-0.0458580768045358,0.7644440369329175
FU-OV-1,5311,1.028726852721831,1.7070230897887515
LoVo,9911830,1.9062113768292104,2.6066618068493086
CA46,23582824,0.075225101675958,0.6111267508414042
JM-1,alisertib-navitoclax (2-1 mol-mol),-3.873969254990661,-1.5540431833373842
EFO-27,24797083,1.960036113572856,1.4344928965861343
NCI-H1623,5460769,3.63452416726077,2.5962589305489883
NCI-H661,5311,1.0541651051557333,1.4979508368495187
G-401,119182,-0.7625552993148171,-1.4523884506742804
KMRC-1,navitoclax-MST-312 (1-1 mol-mol),0.8819471903820566,0.8651235364614231
ONS-76,11507802,1.2556507557201144,1.6834642545289669
KYSE-70,6918736,-3.61435843984592,-1.0150970171408724
NCI-H2009,4788,5.716428228211685,5.79414072522315
ONS-76,54686904,4.527599605979478,3.4720632385157906
CAL-51,2729026,2.5757432896171517,2.5922196121813004
ONS-76,3689413,-0.2845128895134612,-0.10686759528602142
JM-1,676352,1.381688063426603,1.7144362590169056
NCI-H2171,11238147,2.9150011478889795,2.321601353719991
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715,2.632440296984005
Panc 04.03,5738263,4.451939152518209,3.759615812792484
HCC1143,71304818,2.928848735179534,2.526889833678027
OPM-2,9826308,-1.153894104617258,-0.2140635730194311
OVISE,73707438,4.551111956107329,3.951020070158525
KMRC-1,448949,2.0346247593103257,2.0089767706706745
NCI-H661,44589607,2.97822499860898,3.131465278707813
YAPC,3503,2.818608145608573,2.492236911575889
NCI-H522,3825829,3.960912701697082,3.8487718227487644
NCI-H661,5738263,2.7657344337958687,3.4965625647028395
CAL-51,168312962,1.4117577594763937,2.0794901129564725
CA46,4261,-0.8863355705331979,0.16443629320622286
CAL-51,241158,3.781489879449518,3.820547470529643
A-673,2874250,4.616954738528679,4.366784957985173
BT-549,46191454,1.72486803708685,2.163796303991946
JM-1,6918878,0.0294179493888284,0.5048066848435002
CAL-51,4521392,4.667802355757324,4.443166791417772
CAL-51,9915743,1.1260994347217144,1.0598864598799178
NCI-H146,46943432,1.2283557348915184,2.2142763101054674
YAPC,168312962,3.6522382892319185,2.209829951683789
NCI-H522,44493528,4.173254194812623,4.209108474156865
BT-549,10296883,4.161421407524775,4.013686829457427
OVISE,11152667,1.81896217810704,-0.1022116695637015
G-401,6852167,1.9492633511801831,2.606233092350725
NCI-H292,168313047,2.7678931286458974,2.4168201098463764
A-673,5329102,0.93841525470917,1.6490569379429822
A-673,11404337,-2.7698937773977033,-0.568712175889173
BxPC-3,11222830,1.6538054387944447,1.7150142909318433
KMRC-1,25102847,3.2500467863275735,2.561131897959941
MDA-MB-453,400769,-1.402270827463697,-0.4072254865440506
OVISE,89928392,2.0483381338479907,1.774931402337177
MDA-MB-157,136227924,3.402219650297347,2.96734995239655
SNU-449,JQ-1-UNC0638 (2-1 mol-mol),5.2681139205860354,1.967312024163396
BxPC-3,5738263,3.0337675506106576,3.4396035674973207
NCI-H292,16741245,5.797273118380107,4.030471231268736
Panc 04.03,11404337,1.3784278741672673,-0.1330489858686704
HSC-4,2130404,3.512147769522711,3.3853458007085298
SBC-5,5329102,3.79532117952851,2.142898348717943
SNU-449,57519531,5.8010509150022145,2.8275575679079
KMRC-1,1750826,-1.909836969824086,-1.9968113711680127
DMS 273,53245473,3.723579099176344,3.103154012948303
A4/Fukuda,44137675,1.307300702935143,3.2307702101879534
LoVo,72734382,4.052668353480041,4.489841620965313
SW1463,57519531,1.6287135351441295,2.20601145626403
SNU-61,16038120,1.3103584397228891,0.8105711483559879
CAL-51,9926054,2.2227862000004577,1.930893714753918
KMRC-1,15953870,4.40931040558564,3.6895915938706025
A4/Fukuda,46191454,-2.2780561859524457,0.6509632075749568
EFO-27,6505803,0.9411407576336728,-0.4473160310465118
A4/Fukuda,24951314,0.2081517019188384,0.41929567075087215
A-498,10184653,1.9377607214538883,1.7045436494308626
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932,-0.6727500325718117
NCI-H522,9911830,2.121034111225194,2.2827192259638442
YAPC,53392493,3.0834263437199705,2.8220705996883275
FU-OV-1,JQ-1-MK-0752 (1-1 mol-mol),1.194664031604259,2.1672644136724637
FTC-133,15547703,3.427766539334031,3.3724620942336934
SBC-5,11404337,1.1992857421773124,-0.17174586851007376
NOMO-1,654092,-2.6158486127541343,-1.025615973998814
JM-1,navitoclax-sorafenib (1-1 mol-mol),0.8658356793776997,0.5795788130849612
OPM-2,49793307,-4.879066461483742,-4.18435530777378
JM-1,11717001,4.327873015149225,3.6699083190850117
MSTO-211H,969516,2.440842922513423,3.1120204680284846
NCI-H460,9926054,2.081701465030928,2.004436204951788
LXF 289,9936388,-5.793518221083613,-0.7743718954173461
LoVo,10184653,-0.0525672628767589,1.4083127628278818
G-401,9866186,0.2347893748246883,0.3064496945638615
ONS-76,BRD-K99584050,5.369990310930208,2.594814365273879
KMRC-1,168312962,3.867746451267385,1.295399172514808
YAPC,452548,0.3485834104810916,0.3340071049592737
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597,1.8039236422827136
FU-OV-1,6450551,4.626381712180732,3.01221381717386
EFO-27,carboplatin-etoposide (40-17 mol-mol),3.749556119159122,3.0861514040343097
SNU-449,5978,1.8233754703073703,-1.2056277764665309
LOU-NH91,44589607,2.878199319266369,3.0951828929977245
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,5.0474051858179365
A4/Fukuda,65628,3.8428022223998366,3.542122022028826
A2780,42611257,2.862805810765337,3.4177559407114932
FTC-133,49867930,5.271360985380777,4.666908643317663
SNU-61,56946209,-2.5026309203687314,-4.263120589329832
FU-OV-1,3062316,-5.013660753129892,1.152998623281728
KMRC-1,vorinostat-navitoclax (4-1 mol-mol),1.4468975732833491,0.9664671504401862
NCI-H522,123631,2.114949756755372,2.336801450316047
NOMO-1,52912189,-0.5265680930430634,0.3878056893097713
HCC1143,selumetinib-tretinoin (2-1 mol-mol),4.123174212921891,3.966652753715835
CA46,2733526,4.193969711090682,3.089611298348875
G-401,44819697,-1.6952135460319926,-0.7564338547214057
MDA-MB-453,44507138,1.496822662467132,2.160769005410275
NCI-H2171,9825149,1.181898582623386,1.8389256093300579
OPM-2,8515,3.0418796641091226,3.332171954777566
Panc 04.03,4096211,3.5665133346619684,2.4392855933854873
KMRC-1,6610216,4.1544949822147,4.386698278773335
NCI-H460,25150857,3.536831166282903,2.5540865976593956
OPM-2,11977753,-4.6820583055789,-2.590330308842488
G-401,49793307,-5.199300209786212,-3.4273396326181147
A2780,1239801,3.465676691044825,3.667348470606046
Panc 04.03,46398810,3.688960594211219,2.647693449620761
G-401,65628,4.0909837295628275,3.808994087111153
BT-549,53232,2.511840395622571,2.8792319336778553
NCI-H727,104842,-0.3454800108905812,-2.5146663917598433
NCI-H292,6852167,2.409220580223775,3.013650425124719
KMRC-1,15547703,4.785371110425684,3.1925510969657704
SCC-9,vorinostat-carboplatin (1-1 mol-mol),4.0549639225779615,3.47097242914371
BxPC-3,16722836,0.8866010617403134,1.7996794379135819
OPM-2,BRD-A02303741-navitoclax (2-1 mol-mol),2.1588596939971625,0.6754277561141082
LXF 289,168312962,1.364587801939814,2.619018688344693
G-401,11626560,1.1843690178322546,1.5975458596252325
YAPC,3825829,4.484241364021175,4.084667323776796
NCI-H2009,46943432,2.8478796444115835,2.936023068740645
SNU-449,16038120,1.104181711259477,1.0832423456861133
MDA-MB-157,72193861,0.2105280638919307,2.0440664968798092
ONS-76,46191454,1.5088295462826262,1.8947640033547801
LXF 289,439501,-1.653941874457911,-2.2815734418401172
MDA-MB-453,54649381,4.094182376460235,3.75709312239602
EFO-27,11507802,4.116687062031661,1.9065055411627474
ONS-76,crizotinib-PLX-4032 (2-1 mol-mol),2.136807968488312,1.8333360497146607
SNU-81,11427553,2.1196099795437733,1.9571372087408176
SNU-61,54143018,-0.3273600933762652,0.16846922928871788
HSC-4,17755052,1.8179922614483863,1.76423352912916
EFO-27,2130404,3.4270754566369748,3.614069785841102
FTC-133,24821094,3.776872089794721,2.7345605321703617
SNU-449,44607531,1.5485785292308227,1.6471316437601098
KYSE-70,24772860,-1.2328668610311222,-1.313643837531082
NCI-H522,11214940,1.077396173859641,1.711348999359594
SNU-449,1474550,4.524224948734458,3.797415993846555
LXF 289,44589607,3.4320685896186585,3.1456398625575503
OPM-2,31703,-1.5109362720248076,-2.5516214530862475
A4/Fukuda,445455,4.756694709293823,4.032779331217751
LoVo,71680916,4.224958300762603,4.8914482491088815
KMRC-1,25262965,-3.4791684180939,-1.4207006025792628
NCI-H1623,54613361,0.8976129642368637,0.003854570031629575
DMS 273,15547703,2.68216153568037,2.9288204476872584
HCC1143,5311,1.090656828429124,1.568398308277515
SNU-81,JQ-1-navitoclax (2-1 mol-mol),0.6755199584386623,0.4131965955899599
MSTO-211H,11977753,-3.756718801235006,-1.389356740285969
NCI-H661,51037431,4.262261435001038,3.4073095726991425
EFO-27,25183872,0.6822597295955183,-0.3245801169866142
BT-549,docetaxel-tanespimycin (2-1 mol-mol),-6.584782072874471,-3.5572180634261286
MDA-MB-453,16659841,4.43927192393091,3.8843002543702903
SNU-449,3854666,3.254678167809475,2.488207698457198
JM-1,selumetinib-navitoclax (8-1 mol-mol),1.96596855152698,0.8072505602801678
HSC-4,46174525,4.818915916273074,4.753563607926116
NCI-H727,25062766,3.0095924827905813,2.068061601333662
EFO-27,9823820,4.474335567240953,4.236338601622272
CAL-51,4917,3.122174268556499,3.020875802158081
SCC-9,676352,2.0394457592349093,2.1142040110844507
MSTO-211H,4259181,-0.7585521679245923,0.3270855797827447
Panc 04.03,3854666,3.6180263181428622,2.5880076492063178
A2780,11214940,1.8716907673631955,1.167114305617282
Panc 04.03,445455,5.108054343544362,4.852674651020328
SCC-9,SNX-2112-bortezomib (250-1 mol-mol),-2.0018823279326776,-0.83330410329159
DMS 273,3081361,3.0365977955778805,2.2891089075900455
BxPC-3,126941,-2.8667568441276083,-2.3916376721734394
EFO-27,6918837,-4.778560341054376,-2.1436738907476593
JM-1,9956119,1.3894298966841814,2.836266146630416
CAL-51,60750,-3.4379358682898973,-2.652298883805035
SNU-449,12001922,2.031450773900583,2.0634116122267594
SNU-81,119182,-3.3799134284972614,-0.6020121027107794
CAL-51,6918878,3.0110486558166274,2.9482257017312423
CA46,44819697,-3.819793103454841,-1.7145702127503142
OPM-2,46199207,2.048842595102616,2.7203879080881803
JM-1,11977753,-2.0561747941195674,-2.418274208531434
MDA-MB-453,16038120,1.4822204990084098,1.1811082650939135
BT-549,selumetinib-tretinoin (2-1 mol-mol),5.357160165486871,4.198365454840611
G-401,135928012,4.758772301459146,4.001355851575991
LoVo,445455,4.556737788306169,4.551041340607718
FU-OV-1,11964036,-0.3048537688067435,1.6613411263604656
CAL-51,3825829,3.9510679995615257,4.013678126142293
NOMO-1,66577038,2.985459327680272,2.634230088753491
YAPC,4259181,0.8211273757017798,0.5108910656358578
BT-549,2708,5.415828272287544,4.932508054655267
OPM-2,4477,0.1075725295912922,0.1671259545327449
ONS-76,23635314,-1.3572631369234491,-1.4101912558348788
Panc 04.03,168313200,2.993774278353398,3.2261122153687785
A2780,25262965,-4.532154518345387,-2.041124092814049
LoVo,24951314,0.8531724175888866,1.449498386466661
SNU-61,6918837,-2.02709157063253,-3.34709662919866
LOU-NH91,6918878,5.623996708869271,3.1238916591839057
LOU-NH91,16725315,5.120050781978422,4.378267664678157
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376,0.9955695287493489
NCI-H661,16722836,1.177222753188902,1.750710933548993
A-498,9935249,3.347418171794467,3.328383784360438
NCI-H2009,44185566,3.0429431135599607,2.7510635684520217
Panc 04.03,25126798,3.7756614801897377,3.848231205156687
LOU-NH91,24771867,3.0978851297923895,3.0699285484938144
Panc 04.03,10231331,4.944041434313903,2.303635768442828
Panc 04.03,9967941,5.787601223768576,3.770752114200266
HCC1143,11497983,5.345504804401821,4.179512459985444
MDA-MB-453,6505803,-3.8322805026755806,-1.0504092594390004
LXF 289,285033,-1.4335563326434544,-1.523685846269138
NCI-H292,3689413,1.7536313837601494,0.48039884837524766
OVISE,54618771,1.319775250733869,1.1734572810352608
SNU-81,135411,1.0381613293566891,0.4064878196807604
NCI-H2009,451668,5.323035746604961,4.383183839984378
SNU-81,3689413,1.1974270464491454,-0.16007010748101233
FTC-133,5738263,4.07617232189308,3.450154664868643
NCI-H1623,5291,3.880629558524794,3.6760862923451048
NCI-H727,51039095,2.7124063556691267,2.9606194151566614
DMS 273,262093,2.141936221481062,2.2054399809604077
CAL-51,6918328,0.3807555589851347,0.22716101785976206
A-498,24951314,2.536702379510054,1.734768813035447
OVISE,135440466,-0.9475229728449716,2.4345630265207263
A2780,11404337,-0.8981705286722745,-0.635468107727673
OVISE,selumetinib-navitoclax (8-1 mol-mol),1.5927997425042688,1.924177949824793
Panc 04.03,24951314,1.470760951451068,1.6567084360871511
NOMO-1,4705,2.5023829157060926,2.731322590596423
BxPC-3,176870,2.768163283404042,3.143256806750667
G-401,11609586,0.8694160359503889,2.2508849197741485
EFO-27,doxorubicin-navitoclax (2-1 mol-mol),0.6327917719948324,-0.7791902614013033
NCI-H2009,tanespimycin-gemcitabine (1-1 mol-mol),0.2582692893190324,-0.4347568380918472
NCI-H2009,15983966,-3.9047819028388178,-0.9569166722465624
JM-1,16659841,2.088291676862089,2.556107280999485
NCI-H146,5311,-0.0389435386139853,1.351644942094283
A2780,72734382,3.371521062177298,4.207371736863797
A-673,2708,2.956024737310482,3.8354083007241706
NCI-H460,11152667,1.2005763717636435,-0.43365707639615997
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945,3.4957124626683815
G-401,60700,-0.931594906554522,-0.9309412311556784
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633,-0.4604507306129713
NCI-H146,31703,-2.278385754586821,-1.5200711129967395
KMRC-1,445643,4.4248475697731005,3.8476014727343473
SNU-61,tanespimycin-gemcitabine (1-1 mol-mol),-0.5770554338848054,-1.3878167840168916
KYSE-70,54613361,0.0645626216296427,0.09869407422850215
CAL-51,444795,5.053001195278548,4.514149060136689
KYSE-70,54619267,5.587983352589812,4.1370889688036305
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506,2.7336539298601044
NCI-H522,135984461,5.248212763135773,3.332843957589533
CA46,10385095,0.6992054873225039,0.9983000077589627
G-401,16038120,0.8239725572719159,0.6715196005856566
A2780,selumetinib-tretinoin (2-1 mol-mol),2.739843613325444,3.487536989637077
NCI-H1623,6918328,0.1782181011891448,-0.015968936437538484
G-401,31703,-2.7567506026552904,-1.634108686600602
OPM-2,11497983,4.2316824511311,0.021265999190402583
NCI-H522,46215462,1.6065433434555243,1.7500652889663129
JM-1,selumetinib-UNC0638 (4-1 mol-mol),2.9715297614660474,2.172476041638535
A-498,selumetinib-BRD-A02303741 (4-1 mol-mol),2.466660305447313,3.750883814020035
A-673,16741245,3.6856166817392393,3.756980766965076
DMS 273,44486219,3.889102530118227,4.135530484293402
ONS-76,3062316,0.3527292351029743,1.4058828451543588
NCI-H1623,4521392,4.396491619301915,4.238125838345666
SBC-5,3062316,3.347274022566764,1.6092534383229902
OPM-2,374536,1.7033153768622478,1.1403191069885383
NCI-H292,5291,3.74340966649761,3.68642293983507
G-401,123631,2.330078370852269,2.300056240007794
HSC-4,135423438,1.814117839489682,2.7256217367931033
CAL-51,25126798,3.926975819986009,3.7784353244650726
NCI-H727,409805,5.9670224431598875,4.7533948972245845
A-673,4917,1.8117239982797952,2.954831794809395
DMS 273,57519531,1.9430749026869305,1.9739603107641646
MSTO-211H,vorinostat-carboplatin (1-1 mol-mol),3.1229894172951043,3.496351265016328
HSC-4,25262965,-0.4495508061813805,-1.4399524181607606
OVISE,327653,2.506626214633075,3.341603079157324
A4/Fukuda,71680916,4.641498651595925,4.221266804199177
EFO-27,104842,-1.4311942194738418,-2.3199370219466173
A-673,11626560,-0.097195247735582,1.2940503286725837
NCI-H146,3384730,2.6214971804948908,2.6807652003221416
MSTO-211H,26596,-0.5653018529577997,-0.6577591885481546
JM-1,445455,3.9843646189648863,4.036815238338787
CAL-51,11427553,2.069280384014222,2.7903974641764724
SNU-61,20959075,-3.60077638491687,-2.555244340702258
LXF 289,25062766,1.8533275351899623,1.9905081589986335
LOU-NH91,24797083,1.602297413523094,1.5439275827907049
CAL-51,24771867,-0.5018492111736887,2.696777449819968
NOMO-1,44632017,0.9405041708842384,0.7182747070862865
NCI-H146,25195348,0.0229507172684141,3.3238651817610427
A-673,151289,0.5990139557366498,0.9476108257182924
JM-1,72376,-3.929922218649067,-3.5664534433173736
NCI-H727,12003241,-0.657143782776601,-0.7933015123446477
JM-1,24180125,1.1035620934920058,2.2513199630232714
LoVo,24964624,-0.96112559187181,2.448842956427463
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224,0.5054883294245245
OVISE,6610216,4.867128617935935,4.056504561953538
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466,4.960306887306413
CAL-51,11507802,1.2528060552922216,1.4444074731208922
A4/Fukuda,25227462,-5.883792654516593,-1.4443523177334063
BxPC-3,5566,2.8001360517565628,2.9843756158857677
DMS 273,119182,1.6620070398785467,-1.1841726637863994
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465,1.275241032607905
NOMO-1,168313200,3.152434526133537,2.790951492791682
A-673,navitoclax-PLX-4032 (1-1 mol-mol),0.8994506626912233,0.4497734842562314
NCI-H727,24856436,1.7647429516878397,0.6352322823674086
KMRC-1,72734382,5.690666345136703,4.356065202542817
A-673,56949517,4.212065281653062,4.1883104532332736
BT-549,135421197,3.4062158650675265,2.081919666384106
DMS 273,vorinostat-carboplatin (1-1 mol-mol),2.6049111550172506,2.4664436303644885
NCI-H1623,10074640,3.727129107489099,3.1703281886799832
YAPC,5329102,2.676937714502371,2.2063580146629604
YAPC,docetaxel-tanespimycin (2-1 mol-mol),2.5986620559096902,-2.1848740032870397
NCI-H2009,4917,2.9963488408029417,3.1309318822943855
NCI-H727,44589607,2.894616632949603,2.89433194903951
G-401,5328940,1.7098947779411977,1.3741487933047214
FTC-133,10410894,5.920528547603018,3.4272586828567015
CAL-51,216468,1.370586512271769,3.1280576856830162
MDA-MB-453,227681,3.97271964535407,3.137425023331058
A4/Fukuda,5284616,3.229953451024844,0.8313872994001238
NCI-H460,753704,5.635234970240753,4.946079479547954
NCI-H2009,vorinostat-carboplatin (1-1 mol-mol),1.7172571438659243,3.327999576547179
SBC-5,crizotinib-PLX-4032 (2-1 mol-mol),2.792734881189652,2.0939705278432066
NCI-H1623,25150857,2.7146098705885127,2.503770211792938
YAPC,JQ-1-vorinostat (2-1 mol-mol),2.9118979144458548,0.943565386803303
LOU-NH91,2729026,2.877851429076431,2.8153982753710864
CA46,46191454,-0.333651418813281,0.098044831287104
FTC-133,65628,4.302527639906617,4.399209440565832
A2780,72193861,-0.1120033238626439,0.703770715513516
SCC-9,49793307,-2.052824266331224,-2.4744846939497194
BxPC-3,135440466,1.2091890795281053,2.0031378684994485
NCI-H146,11455910,-0.4209962248823531,1.23383882346006
A-673,46398810,1.6125076634642133,2.221093529292877
SNU-81,11626927,-0.7774954189098839,2.3766304989585847
JM-1,45279963,2.536030346276664,2.923066505119147
MDA-MB-157,5746,1.4435337882328911,1.2827477530606637
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684,4.629228689766182
ONS-76,2874250,6.058821088556036,4.5462362987029925
A2780,5284329,2.502098244540034,2.7572491331538687
LoVo,53232,3.084407514553567,3.0128572449930586
ONS-76,navitoclax-PLX-4032 (1-1 mol-mol),4.335120397658034,1.88461579929246
OPM-2,9927531,3.0625153090482757,4.358538843573437
SNU-449,44202524,4.173676721592596,2.6343331987351335
SNU-61,124202324,2.5924607447988643,1.7763665254324823
JM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.853804462612268,-2.470286310142257
CAL-51,44819697,-1.9765663783606575,-1.1580993236870158
FU-OV-1,2708,5.501261259949465,5.081229983657297
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408,1.8698843123395057
SNU-81,16722836,0.5712028725805488,1.484734509237881
SNU-61,1716436,2.6740680266491763,2.8950159953163705
OPM-2,3854666,0.6659331794855328,0.9845881663632468
DMS 273,71304818,2.423766397759693,2.275498847561287
OPM-2,44185566,1.967847411757682,1.6173762414426904
SNU-449,25154868,5.089625763576692,4.474432272848609
JM-1,serdemetan-SCH-529074 (1-1 mol-mol),0.850280297026697,1.3690984566395088
NCI-H661,5281321,0.7671093512543088,-0.8573078783737589
SCC-9,44185566,3.0958673753547785,2.713143038751259
MDA-MB-453,16736978,1.2653262263884038,1.4388258946950452
KYSE-70,9935249,3.427959003246725,3.1641892062610406
MDA-MB-453,11178236,-5.341922221503707,-3.0324741510529862
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496,5.064965519524412
EFO-27,24180719,4.15462806748021,3.8282873477936983
NCI-H727,44607531,2.33451518290986,1.5772353599005546
NCI-H292,10410894,3.620691172443616,3.478665887727294
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943,-2.536129668725363
MDA-MB-453,10184653,1.4947310227918462,0.5526982868943222
MDA-MB-453,11228183,3.436796326739784,2.091844290280036
DMS 273,67291369,1.8884432049214537,1.172205514426572
NCI-H2171,54619267,3.4799425585632204,3.8785126181156033
MDA-MB-453,448949,2.258073743229602,2.2790588649208385
A2780,135440466,1.248320725279374,2.2651285557008736
NCI-H146,9866186,0.8123633746782326,0.8069029974698946
CAL-51,JQ-1-UNC0638 (2-1 mol-mol),2.957186158032418,1.865698788926827
A4/Fukuda,10074640,2.009206402328629,2.8722855792822988
KYSE-70,31703,-0.0860185315527888,-0.7023009994862579
A-673,11497983,-0.3979292238924095,1.0105523702191876
A2780,12003241,-2.743381978251489,-1.1338514336410084
A4/Fukuda,25102847,0.4372365282678318,2.09491185775542
KMRC-1,11717001,4.773123606238519,3.8586002527660725
FTC-133,36462,0.6793689394766376,2.3512532903816
SCC-9,23582824,0.351039434592286,0.8491284420236717
BT-549,2729026,3.014205222238777,2.856004118361455
EFO-27,selumetinib-piperlongumine (8-1 mol-mol),4.5130277383980015,3.9747057475309027
LXF 289,46943432,1.4312531154305732,3.013095843022133
NCI-H727,11625818,5.425399240643101,4.287283882206979
HSC-4,44507138,3.308450875381542,2.800492494868619
A-673,969516,1.3043572294505754,2.5046374673553817
FTC-133,969516,2.842702479050133,3.0076705885860595
HCC1143,11609586,3.6708937391840206,2.9101398356807398
DMS 273,2733487,6.43119993607997,5.343346230347719
LoVo,10302451,1.0215583424111876,2.9456615796331738
KYSE-70,46174525,4.613744209458669,4.698485910817427
SBC-5,65628,3.417870630997437,4.446272668223954
DMS 273,24180125,3.0640550148835812,2.7208531621850534
OVISE,452548,1.282500130328104,0.4420267311268558
BxPC-3,71304818,2.4465042326182247,2.615084567349671
ONS-76,54143018,0.4309751541382265,0.4450328492667701
OVISE,24856436,2.006053298804951,1.0644212355117622
MDA-MB-453,71729975,-0.0804754192781109,1.9289595246740243
NCI-H1623,65628,4.265717950525356,4.488858116100759
DMS 273,9927531,4.953960158421894,4.467541920173364
BxPC-3,426756,6.38858222821808,4.2170505068053075
NCI-H2009,49766530,0.9767616789625324,-0.11901212592419717
JM-1,2858523,2.95851246958296,2.6210209160458606
YAPC,9935249,3.6850704434892823,3.387785724313344
A2780,654092,-1.3080416104753447,-0.4956863319276685
OPM-2,6918638,-1.573449675489913,-0.5102324309065853
NCI-H2009,alisertib-navitoclax (2-1 mol-mol),-2.130413891599744,0.8759424479046192
SBC-5,25105715,3.9151038194938352,3.3109442937040243
SNU-61,168313047,1.9617236271133212,2.3921935655620965
A4/Fukuda,11317348,1.1392337694005448,1.5866620938184008
NCI-H522,25262965,-1.3157493467877637,-1.2560799196858847
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021,1.1143918451836234
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567,-2.8662483866246578
MSTO-211H,44607530,1.4093785076150551,2.1485011553978155
HSC-4,984333,1.2474358256824072,0.8205243919739328
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.059432900039127004
ONS-76,9967941,2.912852232249919,3.8283565119030043
DMS 273,24753719,4.257561408038297,3.705540600151203
CAL-51,24772860,-2.425084956958233,-1.9793121057215044
MSTO-211H,44632017,1.2059374560785627,1.4559241626027468
NCI-H146,5978,-4.422435519224839,-2.5692611554742615
G-401,2746,2.560873344661061,2.5144590869931998
A-498,navitoclax-sorafenib (1-1 mol-mol),1.1504287043269172,1.8327280240317685
NCI-H2009,11152667,-0.3244172236423036,-0.31627417424215293
BxPC-3,erlotinib-PLX-4032 (2-1 mol-mol),3.269235353902274,2.224030152648671
MDA-MB-453,219104,3.605347452429255,3.7201887232891333
KMRC-1,5280436,0.1724698964633139,3.433633410405314
A-673,25154868,2.9619598302203176,4.399249260370123
A-673,135999136,4.231524255529223,2.9377817451550454
FU-OV-1,9884685,-0.2158788705773567,1.138214426978096
NCI-H727,11626560,1.656358651993978,1.9818373739107937
CAL-51,9866186,1.45916914556855,0.649306830075862
HCC1143,44507138,1.5952303095871043,2.383306052750086
CA46,9823820,1.6053302041689723,3.0079019863120124
NCI-H522,docetaxel-tanespimycin (2-1 mol-mol),-6.262465399444894,-3.550932639644304
CAL-51,12001922,2.008779489179369,2.028107701928291
FTC-133,selumetinib-PLX-4032 (8-1 mol-mol),5.295700336992507,3.544559845709738
NCI-H292,19582717,5.466560288208149,4.496764494505641
A4/Fukuda,374536,-1.0311095755670416,1.1230404242691072
OPM-2,10113978,1.3298356496360293,2.2546197731929456
SNU-449,9903786,3.696408358539977,2.944491154069673
JM-1,25195348,3.46638875562813,2.6564340686144075
NCI-H1623,5746,-0.5390712999232294,1.3099465768163838
KYSE-70,71466445,4.079477869375345,3.8992533758371293
NCI-H460,44185566,3.2105564381381035,2.6085211918868403
MSTO-211H,6918837,-2.204195063499652,-2.0810571797813107
CAL-51,54613361,0.2180057854442524,-0.013666177443219159
A2780,216345,1.0708930445758365,3.4806201950100126
HCC1143,100016,7.122041956726765,6.1339372753745485
NCI-H522,5278396,4.518604091155278,3.296984525133494
SNU-61,54619267,4.677926252875765,3.9541553012951796
OPM-2,135421197,1.341685947169011,1.3189584657894622
G-401,72193861,1.057396802085585,0.8904211997026239
NCI-H727,15547703,3.504014494953252,3.131370847861155
NCI-H292,11178236,-4.939590057195551,-2.7911785284733095
MDA-MB-453,44241473,4.685974466458818,3.918427184960223
MSTO-211H,60700,-2.4521642225491065,-0.24920323309334766
BxPC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.5266408566121297,-1.2150578249240342
NCI-H2171,4096211,1.8093642806404184,1.3049208453678423
NCI-H146,68056272,3.3997347898500063,3.274539116110717
A2780,984333,-1.5561630492039429,0.3567669118129735
NCI-H2171,5479543,3.509510962528721,2.528954336779429
ONS-76,6610355,5.379398654611739,4.756943237653822
G-401,2742550,4.179048555325354,3.5528191821754147
OPM-2,44137675,3.238695939616315,3.169147125088121
NCI-H661,selumetinib-navitoclax (8-1 mol-mol),5.100563052002661,2.102591097772923
FU-OV-1,387447,-1.63105242136749,-4.106620245216019
LoVo,3825829,3.571391318080427,3.9942724411704704
JM-1,11404337,-2.1014875230304315,-1.0048952028897506
FU-OV-1,9929138,5.415072941349914,5.503574325257764
SBC-5,5738263,3.46908634421933,3.525650610958654
KMRC-1,navitoclax-piperlongumine (1-1 mol-mol),1.9271011950938683,1.581527794950678
G-401,4917,3.172752348635073,2.974392980666199
A-673,44589607,3.5509265356046305,2.224949870566547
A-673,selumetinib-navitoclax (8-1 mol-mol),2.703259710676399,1.4123422599214885
CAL-51,2828334,6.190580852669228,6.174606786516281
MDA-MB-453,BRD-A02303741-navitoclax (2-1 mol-mol),4.399808633782925,2.157727318677109
SNU-61,67156097,-2.2274361546113854,-1.1726929459918651
OPM-2,65628,4.597670741376445,3.547371122947997
MDA-MB-453,3038522,2.334816038150176,2.9490180129417114
HSC-4,2708,2.9878251305615477,5.05749098031623
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472,1.8099756072630544
CA46,54678924,0.940253932332064,1.3405680402880922
SNU-449,11964036,1.3997299371502423,1.5844341207789292
DMS 273,54613361,-0.0987092047967699,-0.49211559753371625
SW1463,2749,1.5016847157281326,1.8210265317120653
A2780,4477,0.2147996237825641,0.2578167869908479
NOMO-1,9907093,3.6530797436282434,3.5426069812936714
A-673,54618305,4.212251300263772,4.029522716620476
LOU-NH91,65064,5.187256751294022,5.085199507093876
NCI-H2171,72376,-3.3432588050758296,-2.6939989896823313
MDA-MB-453,72199292,1.3092335372039157,0.7525006715344089
NCI-H522,107970,1.611650854248594,2.380051050080122
A-673,444795,4.685959151928419,3.856342304726695
HSC-4,6505803,0.688410933428746,-0.7111254741956592
CA46,11455910,-0.2967360934235351,0.471783348940807
NCI-H460,6252,1.4342703041264255,1.301132716860092
BT-549,49793307,-0.000238716840207,-1.9917109859342106
CAL-51,68056272,3.9955701948507247,3.4976844773006617
A-498,vorinostat-navitoclax (4-1 mol-mol),0.5641326032533043,1.351720482205738
A-673,227681,3.19347186106623,2.9739458474343055
BxPC-3,54618771,0.182098153600537,1.2009372385712345
A4/Fukuda,3385,2.3595203579832553,2.9160947375869175
LoVo,36314,1.7018910931264415,-0.9291071364833189
BxPC-3,11152667,-1.4400195695513092,-0.3115798336872249
SCC-9,3025986,-0.0492814979551807,-1.1742401029115412
MDA-MB-453,4259181,0.7923345004369465,0.4376717318059078
Panc 04.03,9927531,5.313421559596226,5.034653548838577
LoVo,448949,1.89047161937067,1.9130646549872388
KMRC-1,5978,0.0310598033875183,-1.2478503686840101
NCI-H292,262093,2.9868554632365556,3.142972881577705
CAL-51,9884685,-0.2528326244590672,0.4070285218409662
KMRC-1,135421197,2.781168744821282,2.1949680853036697
A2780,56973724,1.317874340119369,2.465751356697822
A4/Fukuda,46943432,-0.0927442133672991,1.1815732602790485
HSC-4,50905018,4.462883747891921,4.371739207353319
JM-1,448949,0.7740790697885386,1.37721749588585
EFO-27,11964036,1.3211691780165964,1.558700706038342
A4/Fukuda,637858,0.8198578842358093,1.103171896689836
OPM-2,5282054,2.4375164125334217,2.8146825695708815
ONS-76,637858,2.646425044184718,1.918614775971651
HSC-4,439501,-1.7709622187792924,-2.245112976616675
KYSE-70,24964624,1.4483005111507754,2.240545264514642
LOU-NH91,5282054,3.3765969574471315,3.9981860194549825
A-498,selumetinib-UNC0638 (4-1 mol-mol),2.905526592026194,2.705670857946712
SNU-81,5281321,-4.892530389502709,-1.2075098032331382
HCC1143,168312962,3.1559735288767468,1.8204985793692297
JM-1,126941,-4.3883192692313955,-3.0915599655094548
SCC-9,54143018,0.8755026739061308,1.0184102108630235
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798,2.792442148992217
SNU-449,1641662,3.672188762237013,3.6156468462437625
NCI-H146,54765302,2.77091239654666,3.7593856362492466
NCI-H146,11427553,2.364557310661393,2.3079855516110914
CAL-51,159324,3.1794720270506307,3.157340100739016
YAPC,71466445,6.285156806731666,4.314474607720312
ONS-76,5351362,1.281569720069414,1.4813297454372278
NCI-H292,doxorubicin-navitoclax (2-1 mol-mol),-1.8265545031559949,-0.5709290122717051
BxPC-3,6505803,-3.0514917868960767,-0.691882556442115
A-673,45279963,3.7593508340409287,3.369535017923422
CA46,3465537,3.345448990020783,2.0556459350256886
HCC1143,168313016,5.718985268806146,4.910992702525212
A-498,400769,-1.6101267353788036,-0.21829113206201506
NCI-H2009,10184653,1.0890186290305244,1.4974061286384261
NCI-H522,426756,6.015863149473534,4.115706482174014
NCI-H2171,44819697,-4.1780638649943675,-0.7898914104713878
DMS 273,24785538,0.640909019865508,0.5940971609916561
NCI-H146,6918638,-1.4860665745363582,-0.1532663715449341
NOMO-1,3543504,4.095340640265792,3.971151694324482
NCI-H661,151289,0.3755226510544496,1.1546152284982638
G-401,53495165,-2.4189675718778516,-0.5682475614233023
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136,2.022568668021943
YAPC,6918837,-0.3723714565085887,-2.296546201735254
BT-549,219104,4.096633484715141,3.954373649431988
LXF 289,24753719,4.56569970094865,4.50333179333039
CAL-51,25102847,1.94226811064499,2.287884855595305
A2780,doxorubicin-navitoclax (2-1 mol-mol),-3.696476342878232,-1.7237119565245889
OPM-2,54618164,3.637238343412542,3.7346375325567838
MDA-MB-157,2733526,3.146610844933737,3.89442515267701
KMRC-1,54618164,3.981312375484732,3.906363188337656
CA46,375860,-0.5712781411665353,-0.6147595706920517
G-401,24772860,-1.622851891505981,-2.2469453218409265
NCI-H1623,119182,-1.1196330586869003,-0.18557939269346202
A-673,984333,-2.7710011035310074,0.09649212963267877
KMRC-1,49793307,-2.5218593870176793,-2.430201750768854
ONS-76,alisertib-navitoclax (2-1 mol-mol),2.05248890000496,0.6067248668670697
DMS 273,11152667,-1.0918930552191226,-1.1256464020836747
NCI-H460,44620216,3.8133491956675902,3.711329999711361
MDA-MB-453,19582717,2.5916230237173696,3.910094162934904
SNU-61,53495165,-0.6572534585269733,-0.42556358731131644
JM-1,6505803,0.12933264701109,-0.6841074351007648
SNU-449,60700,1.1315850608054705,0.12341686299169137
CAL-51,676352,2.3367523995253454,2.159669685323189
LXF 289,89928392,2.4967474535679623,1.7825214108820222
LOU-NH91,11625818,5.704636625331963,4.641728484230101
MDA-MB-453,156414,0.9469838239648454,0.6707035132195124
OPM-2,462382,-0.5185214646773461,0.7336102731497429
A2780,53392493,1.4842280461046395,2.1759348694742178
DMS 273,9823820,3.9764583445605006,3.2874883538747146
ONS-76,24772860,-0.9083480450936676,-1.589192003514944
KYSE-70,11612883,2.3570058511886396,2.894399532775399
SCC-9,3854666,1.6335835525169635,2.4910053391630265
KMRC-1,375860,0.0373834100132385,0.09892379472933406
SBC-5,9866186,-0.1944977114504531,0.9655302540427555
NOMO-1,11719255,2.6566855899212944,2.3518242388764445
CAL-51,702558,3.5144984342436563,5.295671965805445
ONS-76,51039095,3.253449307143194,2.7893216072143203
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.3032188774912299
BT-549,carboplatin-etoposide (40-17 mol-mol),3.0956073566699147,3.2337530496071922
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355,2.441238283493965
BxPC-3,216468,3.632186197150132,3.1867218307713063
SBC-5,2742550,4.323082293816951,3.789753648560873
HSC-4,24797083,0.9836127584085878,1.666741858348517
OVISE,4788,6.030976207458705,5.743714980009405
LXF 289,11455910,1.909862916296106,1.354034239878212
SCC-9,16659841,4.917362195715636,4.009605733093572
G-401,49766530,-2.7444300270308113,-1.2713777573712157
HSC-4,6450551,4.030000721690881,2.959024377334182
CAL-51,6918736,-2.0480142356294637,-1.6254551023615265
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208,-0.5019281846855992
SCC-9,4096211,2.914802879806832,2.4094525535948192
EFO-27,168313200,3.5651936579716277,3.0464282191498824
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573,6.535746905850286
SCC-9,448949,2.996737074861378,2.2002156563968747
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338,4.508001350819532
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.216243108648912
NCI-H661,15953870,2.9876041506010003,3.6228356240380117
KMRC-1,6918638,1.621172594092556,0.7646347042499775
Panc 04.03,44489675,4.301555650291772,4.08278218030704
HSC-4,54143018,5.46718478704898,0.41593833405173586
NCI-H661,11175137,2.5272908163527745,2.55984295554456
OVISE,piperlongumine-MST-312 (1-1 mol-mol),1.6778401901556628,2.3244974590022203
NCI-H292,24753719,4.2962074219620225,4.470459033955428
NCI-H146,11228183,-2.941805953111262,1.2845506989089779
MDA-MB-157,65064,3.084719541991811,4.88746556223592
HSC-4,44491742,4.173988284907792,4.396158496570717
CA46,9933475,1.582522184359856,1.5121595543319635
JM-1,53245473,3.7598021769733414,2.6261537979200984
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.4899341734023577
KMRC-1,702558,5.7321455674333475,5.147356095899177
EFO-27,262093,3.0007323703470896,3.107191403212633
A4/Fukuda,72734382,2.815137004147321,3.6917843519418363
NCI-H727,44185566,2.6786881549102626,2.603386020453787
OVISE,25062766,3.2029018764111896,2.506124408953531
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226,2.4411804067633325
CA46,3825829,3.8503527939376583,3.1110806891148894
EFO-27,JQ-1-navitoclax (2-1 mol-mol),3.2464971768878086,1.1476943484808977
BxPC-3,60750,-2.6920891843690273,-1.669053175618105
EFO-27,1566236,1.9834366009012432,2.358446945429419
LXF 289,53392493,2.5437082258312804,2.8909893381792204
NCI-H460,135421197,3.2510260026522233,2.0572383177544746
JM-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.316937276009384,-1.9469696429657732
Panc 04.03,44607531,1.8924568500741572,1.5585691969312416
ONS-76,15547703,3.220128707821482,3.0471518622757947
BxPC-3,123631,1.9141625570683185,2.3679762881510276
NCI-H2009,24180125,3.399696031265864,3.217310816278686
A-673,19582717,3.777631654850071,3.2756257868872143
FU-OV-1,12003241,-1.039273875540509,-0.9926623113306283
SNU-61,409805,4.743067556302579,4.556715824128398
DMS 273,11364421,-1.741561290091182,-3.5798543709110726
Panc 04.03,11214940,1.7867172186781857,2.03946364954519
NCI-H522,31703,-1.0005486569838078,-1.4399344387981063
KYSE-70,5287620,-1.7159794680358271,-2.0667817470665013
A2780,11507802,0.380240885087182,0.9659632867712802
ONS-76,54613361,0.8570205233962582,0.012510025875072111
KMRC-1,2729026,3.101959850286169,2.7496034754177696
NCI-H522,136227924,2.2034936459857506,2.7993725649503585
NCI-H661,52912189,3.763222756257729,2.5119718684753063
ONS-76,262093,3.354802573562099,2.7742758648398733
A2780,675434,3.840840752716624,4.441802168064897
EFO-27,24771867,3.839082818590537,3.3805509453278204
BT-549,44185566,3.1570730526396407,2.7314446123053706
NCI-H2009,89183176,3.352860584382055,4.60675196462456
A2780,2949965,2.158264003903123,2.555986079017406
MDA-MB-157,119182,-3.4496410534325093,-0.28007856081293153
MDA-MB-453,2949965,2.588847266095094,2.7046131888073313
MDA-MB-453,71576739,4.365206221166654,3.8144968165007556
A-498,11455910,2.747308138802023,1.6544252079544355
A4/Fukuda,448949,1.1686862984883333,1.5372441087870024
OPM-2,10385095,0.6586756349946576,0.9589376363306319
BxPC-3,52912189,1.4214477046132656,2.258959802926716
JM-1,46907787,-1.9243382261841309,-0.5467663569679452
G-401,3385,1.38862488630676,3.3716661912627255
LOU-NH91,24978538,-2.307670841327046,1.6383173207869848
BxPC-3,25262965,-1.1326145626109247,-1.2198454554481475
KYSE-70,9915743,1.2522553618909642,0.6919290827529216
A4/Fukuda,42642645,-1.373677794386147,0.274096583172227
A-673,44202524,1.1944686936342714,1.775410982463682
FU-OV-1,66577038,3.5319441468561648,3.058768142130831
SBC-5,BRD-K99584050,5.772271611565925,2.050836878510324
MSTO-211H,2749,1.2029234831790616,2.018913325450744
EFO-27,2858523,3.4178086224101527,3.0517613376917803
NCI-H2009,54613361,-1.6701870677586086,0.1956129944925526
CAL-51,11626560,0.7349282975065881,2.0013886965631844
YAPC,446155,3.8433351119798695,3.065194271663771
KYSE-70,3854666,1.6457032232411275,2.2843549770759104
MDA-MB-157,49836020,-4.4611089332084335,2.4898746005950563
Panc 04.03,10385095,1.3607276101908192,1.4604035112487341
NCI-H522,piperlongumine-MST-312 (1-1 mol-mol),1.211540874463276,1.5307782000440346
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.95516867139764
NCI-H460,31703,-0.6563705559837907,-0.7416860287974464
HSC-4,135421197,2.1482643592466495,2.2502217543808456
KYSE-70,216345,3.953496119268799,3.6523742043331895
NCI-H2009,44259,0.1981246725332563,1.164342505399984
NCI-H661,24771867,2.8989054210712784,2.858549170167036
LOU-NH91,89928392,1.577129115434841,1.7357183496016637
SBC-5,44819697,-0.6119786373907494,-0.29523531559024496
CAL-51,135398738,4.757337519270393,4.607799262285017
A2780,11234052,1.762226904306368,3.653139307181233
EFO-27,5287969,-2.249416082595734,-1.6758854041632216
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167,0.9810083631413142
EFO-27,72734382,4.838814549837177,4.805915564606406
A2780,2126,3.67742533530732,4.162758463761247
NOMO-1,656346,0.9377734591624955,0.5766485817548724
NCI-H522,439501,-5.784929410118117,-2.514208552287175
NOMO-1,4521392,4.093982124965485,3.884796737940192
NCI-H2009,452548,-0.9979896146805513,0.4382794634621273
NOMO-1,327653,2.81345515165661,2.547054450778526
A-673,46191454,-1.7005324627981964,0.8768318812190925
A2780,168312962,0.1167104942518841,1.5578039417397165
HSC-4,11214940,4.953530718305131,2.4172089858768735
KYSE-70,44507138,1.8487883665285316,2.7359275083931935
MDA-MB-453,5566,2.956907653722259,2.5799396538368553
SNU-81,selumetinib-PLX-4032 (8-1 mol-mol),-1.7498226144583562,2.951613409907016
SNU-449,24753719,4.452712705797618,4.461519297359806
HSC-4,6184667,2.683776581109496,3.135442690162682
Panc 04.03,4477,1.027037586587599,0.6730936829466643
CA46,24951314,-0.0442972386064399,0.2615638029781424
MDA-MB-453,JQ-1-vorinostat (2-1 mol-mol),-0.5883390027404639,0.9425753117226923
NCI-H460,637858,3.384702960830197,2.349692623330605
MSTO-211H,54618164,3.0389284404004795,4.190203531537276
BxPC-3,135875424,4.118804534986376,4.065017558487793
LoVo,374536,3.1459286411718055,2.3189629194813985
SBC-5,65064,5.87027592575748,4.903744059225726
A2780,2708,1.6817262399506028,4.134359623257786
NCI-H292,11427553,2.7677841547579347,3.2007015508445202
EFO-27,10184653,2.474041422726229,1.5987475382162861
LXF 289,16038120,0.5250135720403194,1.0896088883137218
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717,1.8101116636121746
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823,1.6546305993727315
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893,1.7631181955893291
BxPC-3,10184653,-0.596247884950306,0.9323055009862657
KMRC-1,54618771,0.2036698487849761,1.1551235713205288
FTC-133,4705,5.547028107549284,3.3509712816138046
A2780,107970,2.1177540249197246,2.3637443575651007
DMS 273,15983966,-4.308041598319055,-2.967752802579793
DMS 273,JQ-1-UNC0638 (2-1 mol-mol),0.3284926048856003,0.8657535396892677
HCC1143,637858,1.5767538824178036,1.9953740042832797
OVISE,753704,5.218614122812972,5.064700522050831
NCI-H1623,148124,4.04127286799143,-1.272836558055421
NCI-H661,1716436,2.7606212382296205,3.1329025474507968
A2780,5328940,1.6938804432156576,1.694091713696897
Panc 04.03,doxorubicin-navitoclax (2-1 mol-mol),0.7758881761631229,-0.020519126091265476
A-673,52947716,2.7267743407084333,-1.0085901393008787
LXF 289,51039095,1.6878089310027404,2.753156067799186
LoVo,24753719,4.853832341629896,4.332579114822483
FU-OV-1,16065773,3.3464590574422424,2.5958372611995126
Panc 04.03,439501,0.3022334331499904,-1.6901550074727485
NCI-H2009,44137675,2.9238442509206606,3.9784541437915117
SCC-9,24964624,2.350052808289582,2.7349177273803273
BT-549,56946209,-4.178729112607428,-3.6161267584588384
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038,2.896616582613456
NCI-H460,1716436,4.318712917611328,3.211657609333817
MSTO-211H,4917,2.9904400598930088,3.1596983138755292
NCI-H2009,5282054,3.436101167626708,3.873979417963825
FU-OV-1,53232,3.5510277872612903,3.1275392405551163
NCI-H460,3503,2.4668231300278154,2.5086224116525457
CAL-51,6252,-0.2076922850947726,1.0573460692006618
CA46,44607531,1.0933116261411373,1.1699909598767517
NCI-H2171,44589607,1.1207968177639505,1.881727848554277
ONS-76,selumetinib-PLX-4032 (8-1 mol-mol),-0.2158611974685485,2.8670668273970845
BT-549,5311,2.3943998607281314,1.7435057740381106
SNU-61,44491742,3.859456688826312,4.128712700071338
JM-1,46943432,-0.1491870155181681,0.8814893752279768
HSC-4,156414,0.4374127066870092,1.3366151938989157
EFO-27,tretinoin-navitoclax (4-1 mol-mol),4.088217515777896,3.211170421920873
OPM-2,42611257,3.2957467857000404,3.1988654743910714
A2780,136227331,3.7351205807719863,3.2919893633955053
MDA-MB-157,71751553,2.589623955944651,4.581168165155651
HCC1143,262093,2.740628946324062,3.1361045283348097
NCI-H522,56946209,-5.885513086137786,-4.272255186157266
A2780,67156097,-2.4563073864206633,-1.405453813003183
FU-OV-1,136227924,3.2834953568281597,3.1219003858934453
NCI-H1623,241158,4.3681147628536445,4.0630012100642245
ONS-76,2828334,6.172523844471339,6.191450817277886
BxPC-3,11625818,4.084435736278963,4.569742096264965
DMS 273,5281321,-3.764975659067455,-1.8943494558577942
KMRC-1,3825829,4.43742858244417,4.087484387816513
JM-1,5280436,0.8051765864900793,2.3144940066857593
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846,2.8794467739100202
MDA-MB-157,9927531,5.35009923211275,4.695420917845399
OPM-2,56963564,0.1507827744052812,-0.3618750742624859
JM-1,9825149,1.1101255190052433,1.423599829907028
A4/Fukuda,136227924,1.9204852137512072,2.3300522995357467
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266,1.1507053544433934
Panc 04.03,16065773,3.1082338307326687,2.670306423617744
KMRC-1,148198,-3.0121915653316953,-3.04436518579704
NCI-H727,11612883,2.6691234813665226,2.580570192291437
A-673,25183872,-1.50300168442849,-0.9302411386609323
NCI-H292,5470400,0.7410873105484811,0.19496632222674812
SNU-61,24771867,2.3194270269791772,1.1028553526821485
ONS-76,2729026,2.9392891978845626,2.6596268129112253
NCI-H522,54618305,4.230012053256092,4.305849717456726
MDA-MB-157,6918328,-1.4439105140240134,0.15247242454420626
SCC-9,11609586,3.4579622750703902,2.966021756207994
NCI-H2009,73707398,1.4628489872410333,1.323437473488064
BT-549,613753,3.1113642662223913,3.331182672253763
NCI-H522,11396600,3.374818989992459,3.5209977022575254
A2780,227681,3.163289337051595,3.0941837010440842
SNU-61,42642645,0.1547953205487765,0.48628479345262826
EFO-27,24753719,4.6250624916483405,4.383682526870129
NCI-H522,1750826,-4.884358581349171,-1.8025137583086595
NCI-H460,3854666,3.1385110084048065,2.0923592588217343
Panc 04.03,16736978,2.069266987472695,1.5420062032782247
KYSE-70,135875424,3.720063911223788,4.0163593208742085
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981,-0.16954376813861619
NCI-H727,4369359,4.470803757423574,3.6076276277726915
SNU-61,10296883,3.559313583941647,3.563980227706098
MSTO-211H,24748573,5.719931334372704,2.270883794730844
SNU-81,5479543,2.97701110816304,2.8835103342494026
BT-549,2733526,4.582584043539932,3.723553464570585
A2780,135423438,1.4521240670524396,1.4291777669128534
A-673,24772860,-3.1744597884682997,-2.3419755276392284
G-401,15953870,2.2768915791068483,3.246379217079848
DMS 273,5738263,3.533950076223639,2.855397708816124
BT-549,SNX-2112-bortezomib (250-1 mol-mol),0.8532729508269209,-0.9132013708984374
MSTO-211H,10385095,1.0224754227931234,1.3569081538147763
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616,1.746123110354644
EFO-27,25062766,1.510659268863457,2.1858690102930054
FTC-133,11612883,4.310092339589411,2.9306780765901737
MDA-MB-453,11455910,-0.0078824359576409,1.1211787053079159
FTC-133,23582824,1.291713189645836,0.7329417759263989
MSTO-211H,6918289,3.158366552983379,2.4800940584918623
CAL-51,9826308,0.5677925602140103,0.35657065661709736
OPM-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5033566295439995,-2.501635568267035
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428,1.2247696695767254
NCI-H292,25195348,2.925898223014509,3.4760019083462153
NCI-H661,71466380,4.502023854991524,4.650608117166189
SNU-449,17755052,1.8812917370069304,2.1787846888273528
SCC-9,11977753,0.680369597029185,-1.0001699360837006
DMS 273,selumetinib-PLX-4032 (8-1 mol-mol),5.046947236193085,3.762740371915391
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116,4.332207196088919
JM-1,carboplatin-UNC0638 (2-1 mol-mol),2.589326672729891,2.61480408096542
OPM-2,56973724,2.552424788495835,1.4208019265902883
ONS-76,24785538,3.425081329750359,1.8611707448753227
OVISE,6914657,-4.467384055269322,-3.374936760132246
CA46,7326481,2.91557869092902,2.7769680608011975
SNU-61,445091,3.84586130327939,4.090436644688385
SNU-81,387447,-4.728664972971387,-3.38019275951498
A4/Fukuda,613000,-0.1954730319333323,2.566101647400574
JM-1,54143018,0.7319009489566454,-0.5306487918125765
FU-OV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2027157770718528,-0.6528290110147946
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911,-0.4057655825725709
NCI-H2009,11222830,1.732127254120576,1.731371984214254
Panc 04.03,25105715,3.6014191473601236,3.4521705715832693
BxPC-3,3038522,3.5132521338876352,3.243610598783468
SBC-5,2945648,3.183732803518487,2.8337582108327917
SNU-449,6450551,3.816508101047544,2.9975392843770607
A2780,4261,0.5678575604143293,1.2242723560031066
JM-1,54639665,5.005029028557516,3.2050014955804986
MDA-MB-453,55508,3.100658329893645,2.902048997268379
FU-OV-1,vorinostat-navitoclax (4-1 mol-mol),1.2627597867759035,1.3089390710622113
OPM-2,71466578,1.093801721105574,2.488463668298491
DMS 273,219104,2.8685320291275276,2.709098912691733
MSTO-211H,36314,2.7056254754018,-0.4069370675201042
NCI-H661,135999136,1.375733620998009,3.8854750012260695
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011,3.5625955626986454
A4/Fukuda,387447,-5.631039688913266,-4.6600157489446055
ONS-76,65064,5.2757302482281005,5.045428223588048
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606,2.0524566292854804
LXF 289,613753,3.241655631161551,3.1116457532518336
NCI-H661,25262965,-2.0298208680132253,-1.242413433263816
LXF 289,6438330,5.338014468481796,2.489911340732365
HSC-4,51037431,1.5211622982639597,3.32460799999262
HCC1143,ISOX-bortezomib (250-1 mol-mol),0.6900085602161256,0.6358251794987617
A-673,613000,2.3658771635142877,2.3953183324856697
A4/Fukuda,135421197,1.440002399326734,1.5098197219524423
G-401,tretinoin-carboplatin (2-1 mol-mol),5.235487615212222,3.9294335145755745
NCI-H522,322968,2.453472191773609,3.345169921983546
JM-1,702558,3.1195416036187646,3.943054764879033
NCI-H1623,60700,-0.6326390393669364,-0.1360591874367607
KYSE-70,71466578,3.801340757329347,4.5421767418638135
OPM-2,969516,1.7213945625906069,2.448532370425157
FTC-133,71751553,4.47121108066688,4.565300636130305
HSC-4,4261,2.7283942469645424,1.7314084656943567
DMS 273,60750,-2.8080851182888096,-2.5610307651960578
BT-549,11955716,4.243153956403502,-1.1566398199275303
ONS-76,104842,-3.1760610756826826,-2.3377498541084556
JM-1,54619267,3.2762986321752656,3.3753114774136974
NCI-H460,11427553,3.3912724357702873,3.2081983403069914
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037,1.5692237397205295
KYSE-70,3503,4.330341802091645,2.2875228120878184
LoVo,6505803,-0.2027234925460443,-0.730136711480062
A2780,123631,2.055120977987268,2.3333374578670156
CA46,216345,3.098455032375494,2.8333846034728483
SBC-5,216345,4.3270666561224935,4.1486325677519424
SBC-5,104842,-4.617883126488141,-2.8889873902256
KYSE-70,3025944,3.9400169946897226,4.2471461415941425
JM-1,16725315,3.055633956084052,3.5875586653325535
KYSE-70,3385,2.7043091028991175,4.049525076966904
SNU-61,241158,3.885428513145571,3.4256402360593556
Panc 04.03,44819697,-0.3269217472163675,0.11983565038378126
LOU-NH91,151289,1.7382502757713727,1.3724352327959368
SW1463,72193861,2.3780707386668563,1.0343735809869745
FU-OV-1,3081361,1.2672435670761582,2.645215553993209
NCI-H2171,5311,-0.0981787470707459,0.9612696271735391
OVISE,15983966,2.4746719809654474,-0.33560319419451445
CA46,56649450,3.397645307363617,2.7828735471759476
G-401,135398516,1.567409789625541,1.8918918797527053
A4/Fukuda,285033,-4.063528792592557,-2.8176422393949543
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546,-0.5647813723908485
SNU-81,2113511,5.998073078967423,5.580326790818102
SBC-5,984333,1.1242620116457585,0.7920985191080612
DMS 273,31703,-1.0453531837534489,-1.3412988990922587
SNU-449,11955716,-1.9372940063200903,-1.3634149994280071
JM-1,156414,0.9517000986854224,1.0460987124727459
A-498,5746,0.9967598286589636,1.4754284320313795
CAL-51,168313016,5.819136604546001,4.880953733592949
SNU-61,doxorubicin-navitoclax (2-1 mol-mol),0.8790870297518688,-0.9636264085836352
SNU-449,selumetinib-PLX-4032 (8-1 mol-mol),4.586042131351809,3.822816307925892
DMS 273,285033,-4.2902604104934685,-2.256375783402997
NCI-H1623,25227462,1.3835292391956049,0.9768030858340988
SNU-449,46199207,3.2102080061749665,3.262570870419612
NCI-H727,54619267,4.766187279700058,4.051198882426425
KYSE-70,2729026,2.877153539650856,2.7027448854096576
JM-1,9866186,-1.392842627261666,0.2333505908881025
CA46,9956119,2.2503821303322864,2.7896434112056196
NCI-H1623,10302451,3.5735543079001553,2.9113752390414165
NCI-H460,119607,4.735621464768821,5.159179445742001
LXF 289,36462,2.912637639845359,2.650440935938156
HCC1143,208908,2.564266394778906,2.157269190118599
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936,-2.8049837971372615
HSC-4,10296883,4.12801319058873,4.021286921150131
NCI-H460,44819697,0.8384181776379687,0.23079372490496627
A-673,644241,3.265724898737132,1.23269442205147
SBC-5,55283,1.6476943611515316,2.601979380043922
CAL-51,60700,-0.6497243984818711,-0.35714431435289584
NCI-H460,44819697,0.8384181776379687,0.23079372490496627
NCI-H460,2113511,6.407699041859446,5.757984748396601
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.3918338398665528
NCI-H146,44819697,-3.0409273944044672,-0.2586088507696058
CAL-51,2729026,2.5757432896171517,2.5922196121813004
OPM-2,25262965,-5.528707504919602,-1.9230072036821
BxPC-3,67156097,-2.0030489961064664,-0.4071985471662827
SNU-61,11455910,1.387165489844305,1.1889863615034648
MDA-MB-157,6252,-1.2956844965038024,1.4785152283297214
BxPC-3,decitabine-navitoclax (2-1 mol-mol),-0.3566314519475204,2.111405165321833
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777,2.0557685377634196
MSTO-211H,5284616,-7.533473618112548,2.582930474939621
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.7936184083777188
NCI-H146,11609586,1.562173805318663,2.5373836924933015
A2780,tretinoin-navitoclax (4-1 mol-mol),1.5980580193271057,1.8053816313163327
KMRC-1,9908783,5.060189279561186,4.769624769441306
OPM-2,3825829,3.9075204590636226,3.3468368884536814
FTC-133,439501,-1.0725688155870328,-2.3311936027440168
MDA-MB-157,73707398,-0.5856522541525173,1.2551894185273686
YAPC,71466380,5.668462841036745,4.688248779269176
YAPC,81146,5.922853011724604,4.711445463847248
SNU-61,9935249,2.942554259952632,2.4480150531250597
FTC-133,72193861,2.4976681850124516,2.0120274737475836
NCI-H2171,3025944,4.816182739912449,4.013353775445283
BT-549,6918638,1.3825585614023566,1.0560092218628514
A-673,24180125,1.1732098097274752,2.6111064723119046
KYSE-70,46907787,2.9670215892594793,2.4630596314868076
NCI-H2171,54678924,2.405018759443171,1.4757459489278486
FU-OV-1,15547703,4.297867355017808,3.39061242649349
EFO-27,49846579,4.098108273885428,1.6041853438409857
HSC-4,24748573,1.230311327364621,2.3709819640115697
BT-549,10427712,4.3521452258648505,4.442610069456332
EFO-27,126941,-4.256911665013358,-2.4949237511448943
NCI-H2009,4096211,1.934112859371262,2.3160038608328843
MDA-MB-157,salermide-PLX-4032 (12-1 mol-mol),3.2199843556039593,4.768630255070621
NCI-H146,135999136,1.6477982136645704,3.4568489136215335
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932,3.7039045436655953
SNU-449,2746,3.928036011173348,3.43813408205058
CAL-51,11228183,3.6770505489909007,2.532895119908106
Panc 04.03,123631,3.678186856777378,2.608298562701036
MDA-MB-453,6184667,2.451074325070958,3.0556158622990934
EFO-27,6438330,1.8682975687900552,2.4973409848360353
NCI-H661,11497983,4.324872079299071,4.0164846932161815
Panc 04.03,637858,2.9634699724220783,2.395274055487215
SNU-61,168312962,1.49910092402229,2.125413245362361
NCI-H522,25183872,-1.6150957585419312,-1.0708828795141594
A2780,6252,0.4918472463671758,-0.7346043552671201
A-673,15547703,3.0802315016781843,3.0109093997637895
NCI-H1623,36462,0.862958596391428,2.121428385455035
MSTO-211H,44819697,0.327886174428457,-0.44523624531940115
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-0.9099218586937239
SNU-81,19582717,3.466001022974326,3.4176789483123997
A2780,6610355,3.3735704633901973,4.380993011603353
SCC-9,119607,6.006958395758143,5.266607996637067
NCI-H146,11625818,3.4222174762792843,4.138396975223711
CAL-51,11178236,-3.674192911743539,-3.1643892907209556
NCI-H460,168312962,-1.8333752522095308,1.8842054999880995
NCI-H661,4788,4.879892558412017,5.51600437374289
JM-1,4705,3.374089362448498,2.9521547872206217
LoVo,3634881,2.800959668083557,3.3202444285114456
OPM-2,11178236,-3.008129792299995,-3.0883648831457196
CA46,9884685,-1.0270691788705264,-0.30129304815850877
MDA-MB-453,44589607,2.562256212112598,2.7952383386647206
SBC-5,54454,2.279469523172582,2.8261628464926893
LoVo,5311,0.3380696500116906,1.4942072951622833
NOMO-1,100016,4.546215242968586,5.05180115064458
CAL-51,71304818,3.0248956992793565,2.5309647206231505
HCC1143,216345,3.8986832350959792,3.8813477033131942
CAL-51,54618164,4.021329289838694,4.144697925987657
NCI-H292,135398516,1.6270415918019412,2.2828935267976433
HSC-4,71466445,6.061667629347064,4.340583344946367
BT-549,51039095,3.595187367514741,2.8538174621298737
MDA-MB-453,26596,-1.0726693130426117,-1.140615375427877
CA46,4259181,0.0375174782651609,-0.31643764872192387
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345,0.9197491237233818
SBC-5,9887053,2.384081187432928,4.0894400025037605
FTC-133,25154868,4.81278236826852,4.458605536131777
SNU-61,44202524,1.623676041505741,2.236151837823519
Panc 04.03,6914657,-3.724597953552904,-3.2639381812378785
EFO-27,445091,4.884678811382666,4.645599126439179
SCC-9,54619267,4.260733417129102,4.18035327700224
LOU-NH91,3815108,3.3787088400125422,3.2299957461455113
NCI-H2171,135875424,2.950178944342904,3.304451280942448
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381,3.610872396286142
LOU-NH91,11404337,-0.9599092047687252,-0.03155172800640272
SBC-5,5746,-1.5208844717109098,1.0130064569585704
NCI-H460,135440466,3.295247648571462,2.252970742564282
OPM-2,1242560,2.912152501304371,3.226759512676371
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,3.2042320541372673
BxPC-3,11364421,-1.186359589843585,-1.1868765651956068
NOMO-1,11626560,1.0628914473501356,0.8893210120599754
MDA-MB-157,5311281,2.9465431337253065,2.4117891836742773
LoVo,753704,4.37626239298451,5.04897608435984
LoVo,1317464,3.6287749925486743,2.832948186782848
LoVo,11626560,0.8234069861143318,1.8100242459279121
SCC-9,60700,0.6764265945588348,0.029216235900849718
YAPC,5351362,2.7486257978183812,1.5970517312826544
KYSE-70,24797083,1.8843278101436565,1.6044126068915796
LXF 289,65064,4.964411921317377,4.932794492883654
SNU-449,16736978,1.6431800441666105,1.6739490487613915
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289,4.113678381527091
CAL-51,3062316,-2.5625958708444205,1.8340789987949215
Panc 04.03,49793307,-2.352687994078586,-2.1408317506233683
MSTO-211H,10302451,2.2723798321327826,3.6433933198811537
A-673,54619267,3.9525164677601015,3.885176821288913
G-401,448949,1.8289326894340776,1.8643629980601852
SCC-9,15983966,-4.042628093805887,0.010045549480336148
CA46,3854666,0.2733202158609283,0.8840634176027862
SBC-5,42642645,2.1700569257248734,0.9452849370966893
FTC-133,6184667,4.171777093513536,3.090875096700139
A-673,3543504,4.433549859321033,3.840948586566013
CAL-51,409805,3.8515087112009656,4.99012296957414
SNU-61,5287620,-1.5621550618200195,-2.2207994460570286
BT-549,6610216,4.341228931549091,4.357364500084454
MDA-MB-453,44566777,-0.164341777615228,0.7658880302063015
CAL-51,219104,3.260140555917495,3.85246513870924
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187,-1.6704321902225745
A2780,65064,4.350950935999884,4.53623761973169
G-401,9803433,5.696660690430479,4.480725675609472
BT-549,11626560,2.6049019780447473,2.004453113018373
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214,4.26653823017173
A-673,107970,1.5652885370840817,2.2394644013506824
A-498,46199207,3.6222117747737057,3.2584759400516727
OPM-2,navitoclax-pluripotin (1-1 mol-mol),-2.4334437397089053,-1.814748497486908
BT-549,11364421,-5.683704390961643,-1.4935754188367196
G-401,25195348,3.8836243061511215,3.1560259801930886
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003,3.0253866658954593
LoVo,24901704,1.9806347162028537,3.42081227408579
NCI-H2009,11485656,2.228831542035607,2.570051436622267
NCI-H2171,1750826,-2.946975931831454,-2.6787704592429877
MSTO-211H,5738263,2.0448017247583996,3.6567363847214858
SBC-5,2729026,3.0750341046070933,2.631228085471109
A-673,60700,-2.9578260017137437,-1.1060895814463196
KMRC-1,216239,3.2937854483312172,2.2483350860105666
G-401,7251185,1.5631627066286176,2.0993596910180967
NCI-H522,568763,-0.6787143148403639,0.3277695470466447
MDA-MB-453,52912189,0.0253127265648339,2.3809690468334033
NCI-H1623,637858,3.185553411157662,2.1263471894866184
BxPC-3,65064,4.239552039257921,4.9341707894233835
BxPC-3,44202524,1.2355479078044973,2.4912793180700046
HCC1143,10231331,3.1675049490504943,2.3426262390903645
NCI-H727,4917,3.0740580007272125,2.8486008924371022
NCI-H522,46907787,0.5375692456309028,1.4110990524309233
G-401,4261,0.8301994759372666,1.3505933117727815
HSC-4,46398810,3.0881815243810897,2.642261220907071
NCI-H460,16722836,2.818869820371906,1.8631480440604746
CAL-51,107985,-4.126908547019261,-3.626990669314883
EFO-27,445643,4.157223404562412,4.115928155984141
NCI-H661,327653,3.5614910429728295,3.406055920921796
A2780,15547703,2.917961616739491,2.8542056782241456
Panc 04.03,11222830,1.7267772277517466,1.8145604463640839
NCI-H727,445455,6.030056890362138,4.592511509243058
A-673,72199292,0.9360047714765588,0.7203754035210816
DMS 273,2945648,3.171749675698132,2.5601843470826533
SCC-9,6917907,-5.592045136043938,-4.672407772836099
CAL-51,72193861,0.6423702350358801,1.6776352023320902
SBC-5,5281321,2.671163534426493,-0.6580454199273683
NCI-H2009,10231331,-1.9302715463885551,2.0967194832420826
SCC-9,3825829,4.24505295528646,4.195082330509672
NCI-H661,702558,4.861012061293982,5.278401103466665
SCC-9,piperlongumine-MST-312 (1-1 mol-mol),2.236566574852554,2.0992866901302953
MSTO-211H,451668,4.9569649646478515,4.418856935066892
A2780,9908783,4.382006664554736,4.747609000914566
EFO-27,44566777,0.6667958565864378,0.8170742297107806
SNU-449,11228183,3.721594588319689,2.4920654922995364
MSTO-211H,322968,3.0218271531726897,4.105613671789037
NCI-H522,135999136,4.552466214525868,3.1718625034139607
BxPC-3,375860,-1.018881063070817,-0.09601109503914833
FTC-133,46398810,3.783858454202458,2.6352885653278015
LXF 289,446155,3.7142968943868073,2.57849453739741
NCI-H146,54619267,2.4574193717136663,3.7989718212432644
JM-1,400769,-1.2746733592438322,-1.1975734062869143
BT-549,5328940,1.7912058861852873,1.9290053323139886
NCI-H460,15547703,4.965379127843483,3.277371222758519
JM-1,10026128,4.426440879951995,3.073893885323914
LoVo,327653,2.9108064375514604,3.2586232643483344
HSC-4,5329102,2.7247882686097458,2.2281353043531036
BxPC-3,5460769,-0.1362128387149436,2.905103297176686
SNU-449,148124,1.515559327544478,-1.0770336048003575
KYSE-70,24951314,1.3178292218062186,1.684923419754191
BT-549,11485656,2.9441987555380855,2.5200843995559254
CAL-51,9866186,1.45916914556855,0.649306830075862
NOMO-1,5278396,3.0205756000124775,3.0655857708148115
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257,1.2454247293952911
KMRC-1,42642645,1.142476115564406,1.0623034409546621
NCI-H460,100016,5.855223104671776,6.2793014640098
MDA-MB-157,25062766,0.4624374403471977,2.0424326952777476
MDA-MB-453,107970,2.0242856345207834,1.9852499092743594
DMS 273,16741245,5.579276049340643,3.6460435279056775
BxPC-3,3689413,-0.056748072256038,0.737193473718148
KYSE-70,25126798,3.963979956832577,3.861867705014625
A-673,54678924,2.025744293137832,1.7520796383970623
HCC1143,25062766,2.2830484377909492,2.1886637011044314
NCI-H2171,11625818,4.794880990749841,3.6407587601491485
MDA-MB-453,2729026,2.974469204821206,2.5535979116818712
G-401,9933475,0.0956350981602405,1.8313597136098485
NCI-H460,51039095,3.9314979002332535,2.7168682011619025
NCI-H522,219104,3.343081396349963,3.2085777509773163
NCI-H661,56946209,-3.6194559692185018,-4.00575459526112
SNU-81,568763,0.5116878508289208,0.3811675055372569
A-673,67291369,2.4007963238191854,1.8262973379421412
LoVo,3854666,1.417426416420887,2.2306502612899983
MSTO-211H,439501,-1.1644309958543906,-2.0961352861016898
SNU-449,285033,1.5882926770841097,-1.4285366767503063
CA46,6918878,-0.7300256707111569,0.3188553423593266
NCI-H146,71466445,0.6815814889300492,3.2018202290075704
SBC-5,10385095,2.1758850118167077,1.4047207166986144
A-498,637858,3.4757595298108974,2.2807054106754525
ONS-76,11964036,2.0748582848578865,1.3525583427827081
NCI-H727,16725315,4.353817237787042,4.2595763259097135
G-401,10427712,4.653472001336551,3.8607860156610263
CA46,10127622,5.462644164632326,3.2521994475781795
SNU-449,25161177,4.378304661297746,4.2664240781542055
MDA-MB-157,49766530,-2.405889714389838,-0.6045988500039741
FU-OV-1,23582824,0.4003812349581704,0.9970726146937976
FTC-133,24180719,5.041424864241871,3.3904320358841264
CA46,3689413,-3.563387503989764,-1.403859004036332
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012,1.970414097790484
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-0.9099218586937239
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947,3.966329459661151
NCI-H522,6918638,0.2628749411775776,0.28243037055565895
EFO-27,10127622,7.049186817655218,4.57978241299389
MDA-MB-157,400769,-0.9429856644264992,-0.6199983979585499
CAL-51,54618164,4.021329289838694,4.144697925987657
LOU-NH91,9935249,4.429052878520747,3.279047676152053
NCI-H727,49766530,1.5110740555461553,-0.07477858051586367
A-673,9926054,1.7717409858597033,1.8692808972725679
HCC1143,5351362,1.6023771560954885,1.5513078470246935
NOMO-1,54613361,-1.5441782746277026,-0.8737094089928839
JM-1,613000,2.2697515166000355,2.5641159385911942
CAL-51,49793307,-3.2015156477281193,-2.6746435485249807
NCI-H1623,1750826,-0.130863987039663,-0.588311639208478
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516,0.2279315621490811
NCI-H460,107970,2.752075604137296,2.386010110547596
SNU-81,JQ-1-vorinostat (2-1 mol-mol),0.90621526316067,0.44406215089904777
CAL-51,46199207,3.548155956826357,3.2033557591894914
NCI-H2171,10074640,2.5219754676966435,3.0638320186256283
A2780,selumetinib-navitoclax (8-1 mol-mol),1.1083480952702989,1.5386555574775818
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225,2.898352592314587
JM-1,11238147,1.2374439058156688,2.0663379322638127
SNU-449,54678924,2.162306121493456,2.095247158221115
NCI-H522,3854666,0.0482767863302698,1.5168825638165868
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561,1.0612232474703447
HSC-4,10427712,3.709601221495256,4.271476417968852
KMRC-1,10296883,4.079927671527966,3.822661793566861
A-673,46907787,1.1836850249017303,0.8868178765237447
NCI-H460,67156097,3.7191617083219097,-0.36494277799627883
Panc 04.03,11364421,2.200002813497647,-0.37200216327351476
A2780,57330099,3.934423580004946,4.11152352721824
KMRC-1,400769,0.144742351180573,-0.13847950809117615
LOU-NH91,25062766,1.8056251936091945,1.9579139426586938
NCI-H460,11175137,3.7005840280640374,2.8579755446440145
HSC-4,124202324,2.961748327308983,2.7673787080445873
DMS 273,46191454,0.2871755056280096,1.4042462102837638
LoVo,23582824,-0.7966748622900964,0.8306347523544726
FU-OV-1,24785538,3.56375796516153,1.7014564105763892
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883,2.7525930408235495
CAL-51,216345,2.9520334452605637,4.018411645654833
KYSE-70,11427553,3.0124804015996185,2.988414814158618
NCI-H2009,decitabine-navitoclax (2-1 mol-mol),4.93341873674704,2.5651442328714738
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898,2.017378568644391
A2780,54618164,3.641335469190071,4.053736196919436
SNU-61,2708,5.501133929338057,4.239426725718661
CAL-51,702558,3.5144984342436563,5.295671965805445
CAL-51,11175137,1.2330676481368064,2.6075980889082873
OPM-2,119607,4.667002181538018,4.548167167942299
BxPC-3,4096211,0.9773140949236826,2.0478998090999405
NCI-H146,2749,0.7789788955457625,1.5567722381326508
LXF 289,16725315,3.2486511295045677,4.395150700269129
HCC1143,4261,1.976797651434544,2.024855166520191
SNU-449,11152667,1.3844218204303944,-0.31930408510633634
CAL-51,52947716,-4.729660133739893,0.2101790501463938
SBC-5,4477,-0.6853772163114386,0.548159159910635
A4/Fukuda,44819697,-1.7397384839387715,-1.0107982555751067
NCI-H2009,54618771,-0.2233577251443086,1.266093794099815
LOU-NH91,2733487,6.3296049393179485,6.336993630499436
G-401,erlotinib-PLX-4032 (2-1 mol-mol),3.757739778609172,3.1044135759699776
NCI-H146,89928392,0.6603214053079605,1.1087956112816024
SW1463,10231331,-1.1566445252598772,1.813000141641069
MDA-MB-453,11977753,-1.828846421242697,-1.1007175139385004
HSC-4,445643,4.123722857917103,3.9334287381525415
EFO-27,42642645,1.7670896576814532,1.04291585899539
EFO-27,crizotinib-PLX-4032 (2-1 mol-mol),3.36614562688719,2.3279665018122975
BxPC-3,5311281,3.739267965753581,2.3406021120126312
SBC-5,44185566,3.097813648169307,2.5449780723117974
LOU-NH91,5351362,1.6461408289790205,1.817850628546519
EFO-27,50905018,5.404252445104634,4.570664515661134
MDA-MB-453,374536,3.68630764751743,1.1484889194910592
G-401,25262965,-3.9564581939856582,-1.7989645513352146
CA46,2749,1.009648399882346,1.0243062026908278
SW1463,387447,-4.88012723681038,-4.1198089235698605
A4/Fukuda,8515,2.244185004641864,3.391039939978305
NCI-H1623,24901704,3.7829050158791064,3.47569860039594
HCC1143,71680916,4.5741598898507565,4.903590613333483
YAPC,54143018,2.4773688492488892,0.4710704619906234
FU-OV-1,49793307,-0.2872221589202163,-2.1183641769058337
Panc 04.03,168312962,4.832441653848414,2.533955505427006
NCI-H292,11609586,2.9930145326420146,3.1102065442772204
NCI-H727,25150857,2.574637897952517,2.2567383719140746
NCI-H292,6438330,2.681078996624105,2.4792804621940348
OPM-2,12003241,-2.9738714531294232,-1.2043847457252854
MSTO-211H,BRD-A02303741-navitoclax (2-1 mol-mol),0.3230364092955163,2.5879631071708684
NCI-H522,151289,0.0217168787144745,1.0426025930550802
NCI-H146,docetaxel-tanespimycin (2-1 mol-mol),-0.2232334336717333,-3.6197690980187462
BT-549,11238147,3.2866911979765803,3.1199438046021855
OVISE,9866186,0.5630702781820192,1.0741533038309954
HSC-4,6918328,0.4827098957230251,0.101834114687478
NCI-H2009,135411,0.2253946709705592,0.7739016776503129
JM-1,10385095,0.4126425157623973,1.0460940687135414
CA46,45279963,3.66447519946476,2.653737906565775
A-673,44197249,4.247235211402652,3.1663754217556384
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069,0.9194614895633556
NCI-H661,135440466,2.665416885593315,2.412626599605672
G-401,168313016,4.483065775660181,4.4058147722403955
BxPC-3,168313047,2.402437406788064,2.5132475767347127
NCI-H661,2746,2.7828270451310786,3.153300664328248
FU-OV-1,11612883,1.8669069183790803,2.9774193860469653
DMS 273,53232,2.0931635545137266,2.6840054009908845
BxPC-3,9903786,2.126136875029704,2.6315574712127923
NCI-H661,11625818,4.41260734243293,4.629947205370964
NCI-H522,16659841,2.9113601324358287,3.3314450687707926
OVISE,53232,2.4849914286727426,3.219849462037719
EFO-27,135440466,3.806006891786582,2.4805903467427544
SNU-449,5746,3.348109332475853,1.714718695879868
CAL-51,969516,2.948027689121256,2.7160840628716336
FTC-133,11238147,4.273178384451577,2.9205399944384345
NCI-H522,24748573,1.6076101041751254,2.12762472328176
MDA-MB-453,46224516,2.0758190952131215,2.422312971214105
LXF 289,6918878,2.1668969721619833,3.0279686567868316
OPM-2,451668,-1.14063259637223,-0.36537153153866164
HCC1143,3689413,0.0716522323698814,0.11137987926225616
SBC-5,135398744,6.447254342428179,6.523414077725517
CAL-51,227681,3.694103991631346,3.5127496801575258
CAL-51,5287620,-2.338247824560234,-2.125074806530959
A2780,3062316,2.0817886994426704,1.5882605605104994
SNU-61,2858523,2.9582475566417195,3.186219892435616
SNU-61,54649381,3.9147762798202863,3.4066914563551354
A2780,10385095,0.5603604864283975,1.122380564359365
MDA-MB-157,11152667,0.7570225590856333,-0.25727328016184325
ONS-76,400769,-0.3525004301248006,-0.42052471217466203
A-673,409805,3.491559756034339,4.183833548629188
SBC-5,10184653,2.5351322042771356,1.2770273169728719
NCI-H727,66577038,2.8647542032772604,3.032660003269795
A-498,6505803,4.020571046679738,-0.1154324468057248
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045,-2.951393584979629
NCI-H522,2708,5.085998334781725,4.288838181364253
BT-549,45279963,4.047021813577569,3.9511450556751435
LOU-NH91,25183872,2.2713164299079627,-0.5395416913264739
FU-OV-1,24797083,1.8707999880079529,1.403028360819649
SNU-449,44607530,1.456313243054954,1.8648050925119821
MSTO-211H,1566236,2.167071233614174,2.523840162906393
JM-1,24951314,0.1302219808330525,0.11846255841877483
EFO-27,53392493,1.9151019076026368,2.884320868519531
FU-OV-1,16725315,4.930691545287574,4.36821923100427
NCI-H1623,12003241,-0.4868602659209724,-0.3261371251568951
SBC-5,148198,-1.371938553790338,-3.6857326565521795
BxPC-3,17755052,0.5794893802598977,1.8279754064651965
SNU-61,11485656,2.115016827038527,1.9976865866093152
LXF 289,2729026,2.289348740995074,2.689256246262276
MSTO-211H,654092,-1.1984807631004837,-0.36828057182591883
A-673,5291,3.269854942504113,3.4228515771403663
LOU-NH91,4705,2.8449970854381945,3.5751854429885377
SBC-5,24753719,5.823724927288436,4.441491605344047
SNU-61,675434,4.254516948181055,4.470041612994212
A2780,5278396,2.562980728115376,3.235741980544883
DMS 273,122327,5.509571347430681,4.135492548411864
A-673,9884685,0.1604809562987641,0.2668400570556405
NCI-H1623,16722836,1.0817030477122866,1.7411327311571485
NCI-H661,67291369,1.7470049727917394,3.0374420216721534
A4/Fukuda,135398516,0.099848878431286,1.494355572236955
A-673,568763,-0.0608974572236531,0.032100369959693564
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115,3.7340842901974436
SNU-81,11178236,-8.196337700198193,-2.656071668602584
OVISE,navitoclax-PLX-4032 (1-1 mol-mol),-1.1204888715090109,1.665354208143905
A4/Fukuda,46215462,1.453707580765341,1.3438475223112025
HSC-4,6252,1.1187983220422375,1.3152775953306972
HSC-4,3062316,-0.6194675763886993,0.680148900369305
NCI-H1623,57330099,4.486652982197453,4.346441731479292
BxPC-3,23635314,-1.513116034089344,-1.8645255448490026
OPM-2,46943432,-1.735277326796896,0.884021066538186
FTC-133,11175137,3.295108533345337,2.535881800249158
SNU-61,100016,6.106397388471953,5.754117141751847
MDA-MB-453,446155,5.408001660467943,2.6442118290033285
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194,2.4108845386047366
MSTO-211H,168313200,3.954855187852925,2.7887488034943626
LoVo,2729026,2.166128688763036,2.615511468795711
FU-OV-1,73707398,1.0047751906041116,1.5327355306472992
LOU-NH91,44241473,5.33179348194517,4.92528075998305
YAPC,135440466,2.1529261418392807,2.457151992475598
KMRC-1,568763,1.1483170277588293,0.7115634763451949
CAL-51,656346,0.8466306406200714,0.8390219797865207
MDA-MB-157,327653,1.3811083957143218,3.1740436249531974
NCI-H460,107985,-2.632533954936978,-3.020902596296494
NCI-H460,135875424,3.211754300989152,4.085559885285363
BT-549,119607,5.663531776682701,5.361105894354248
KYSE-70,4261,1.9447398866595849,1.393455664158315
CAL-51,44543605,3.919885801001582,4.064643951637172
SCC-9,44566777,0.4714703461280546,0.7526093865459955
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783,1.9714340419394236
EFO-27,10322450,4.618987367546035,4.103647266212949
LoVo,452548,-1.7762082467733018,0.387685680811339
G-401,24821094,2.5559581237528097,2.7593297071486145
Panc 04.03,docetaxel-tanespimycin (2-1 mol-mol),-0.4013709222669032,-2.13234282082067
KYSE-70,135999136,5.194226724950964,4.082980425707984
NCI-H146,6438330,-0.4558524131736901,1.9729332766010057
BxPC-3,31703,-0.5929664629875476,-0.7153258814270386
Panc 04.03,5470400,0.9135030177256964,-0.8118306526893988
KYSE-70,25150857,2.5963104301055258,2.5163917551509303
OVISE,selumetinib-piperlongumine (8-1 mol-mol),3.917327807535022,3.517817486525124
A4/Fukuda,439501,-3.252400391503616,-2.1816055812944075
SBC-5,107985,-2.339881885950972,-3.423734296210018
NCI-H146,25227462,0.2247724046939956,-0.4100296959781234
JM-1,44491742,3.590859136704876,3.822178255040458
YAPC,6505803,-0.1975849276423945,-0.6926733059367719
MDA-MB-453,10113978,3.193218839681212,3.076106302918266
A-673,16038120,-1.140194872712738,0.7289010428745655
FTC-133,675434,4.640800834602054,4.668833179579702
MDA-MB-157,439501,-3.062684000428755,-2.255745023603764
SBC-5,10074640,3.660613951501144,3.1488779015744033
DMS 273,3689413,-1.7704206659692223,-1.1751815941565926
SCC-9,36462,2.4622585602605493,2.420636421956632
NCI-H1623,46843906,3.212648418277938,3.0697405143462424
NCI-H2009,676352,1.803439035619831,2.3210273536123727
CAL-51,387447,-3.720200693098244,-4.342679993248004
SNU-61,navitoclax-pluripotin (1-1 mol-mol),0.1014096267424324,-0.7984692526456718
CAL-51,44632017,0.9975947899898204,1.3915325657260007
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122,-0.40945401333265735
DMS 273,9936388,3.4086707637717883,-3.591755195845331
NCI-H1623,24180125,3.727544824819635,3.130446657549884
NOMO-1,969516,2.327280884248625,2.3453872840252386
A4/Fukuda,1750826,-3.1003590099134284,-2.672225772396435
Panc 04.03,5281321,2.674318568781228,-1.040213431219259
FTC-133,176870,5.80195413779655,3.555475439680785
CAL-51,10113978,3.4506321601115397,3.216123650460828
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193,2.7006455543136774
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566,0.31831764117932737
A2780,3385,2.4446535707127537,3.373464573075252
DMS 273,45279963,3.8289869697511527,3.1863841830394093
OPM-2,11609586,2.7966274513563496,1.766137832343837
NCI-H1623,26596,-1.1542368606327895,-1.1499922183286255
SW1463,5479543,1.0422897086412093,2.9733688578162645
SNU-449,53392493,3.0071956547718113,2.950297389794508
Panc 04.03,11178236,-2.395899374087587,-2.919533453784993
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344,1.20377881921683
OVISE,BRD-A02303741-navitoclax (2-1 mol-mol),0.9537570528694392,2.6848576796412162
NCI-H460,9866186,0.4176494313944011,0.98118898828481
FTC-133,53232,1.7186310962422595,2.536470414258523
BxPC-3,216345,4.279216843902863,4.106489619407495
A-673,10296883,3.758044639987347,3.649306436922271
ONS-76,11178236,-3.26201925681368,-2.461875209173614
CAL-51,25062766,1.9168321284868295,2.1149518361330464
NCI-H522,6852167,2.4506568165817777,2.492103288578918
SNU-61,72193861,1.1230875557226898,0.9717298747551578
ONS-76,vorinostat-navitoclax (4-1 mol-mol),1.54700333580169,1.084541906894846
BxPC-3,3543504,4.240175882152398,4.4879594788104615
NCI-H661,73707438,4.487630336801632,4.0574256503273896
OVISE,638278,1.1296919637825429,3.489994912159081
A4/Fukuda,36314,4.126705075384559,-1.6778347119729384
SBC-5,10127622,7.037598772691409,4.061726801937349
MDA-MB-157,selumetinib-decitabine (4-1 mol-mol),4.44139235410904,3.9653165885181147
BxPC-3,49766530,0.5943123243750338,-0.2020658055315842
LoVo,54143018,-0.354466194309244,0.444559758210627
BT-549,44589607,2.161067974853105,3.367305843746528
LOU-NH91,3136844,4.41334270983783,4.51296299392343
OPM-2,5311,-0.071810443528602,0.7063361478769511
G-401,JQ-1-MK-0752 (1-1 mol-mol),0.1350272017197765,1.5931778104588386
HCC1143,676352,2.389016147507623,2.2064395725548858
Panc 04.03,11657048,4.4356176445581,4.279786408185277
NCI-H661,navitoclax-piperlongumine (1-1 mol-mol),2.7076431504633676,1.9268009377472515
DMS 273,doxorubicin-navitoclax (2-1 mol-mol),-0.5717172949913683,-1.4933776898261186
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807,2.142931796941685
NCI-H1623,374536,0.6337427379168257,2.015230969807158
SNU-61,3825829,4.102120147241808,3.7355802950804797
DMS 273,56649450,3.5073695444545288,3.1551861959735397
CAL-51,24785538,0.7720267524795773,1.7178065767532902
OVISE,16038120,2.1825815777023965,1.348058870853918
EFO-27,6918328,-0.3264411901724555,0.25359026840759014
FTC-133,3025944,4.352563236352026,4.384498096958052
A-673,89183176,3.363943107585485,3.661047875793497
KYSE-70,123631,1.697265417228948,2.164087724795512
MDA-MB-157,441298,1.9245422363016824,2.358559233752981
A-673,156422,4.078876073319714,3.5259545163993353
BxPC-3,676352,2.25430531813019,2.3407830673306558
HSC-4,25150857,3.233332545340528,2.5722667728378887
G-401,24856436,-0.0141865957174665,0.3194984834841826
MSTO-211H,49793307,-4.316049670445352,-1.9727519643699996
OPM-2,11485656,1.3184852346481954,1.6879849727000629
HSC-4,208908,1.4999275809756432,1.8403702910979063
MDA-MB-453,54613361,-2.035930507333412,0.012537867076469294
G-401,serdemetan-SCH-529074 (1-1 mol-mol),0.8425945982642317,1.8077812461891156
EFO-27,44589607,3.0601109795549295,3.087032680552808
SNU-61,44493528,4.287806417412906,4.232976916577516
G-401,11152667,0.9519757620011424,-0.9328430452820151
NCI-H2009,5287620,-2.745575302534365,-1.989846504611604
ONS-76,23725625,4.840348822045759,4.7873635141002335
CAL-51,44620216,5.469091994130916,3.7348512306099635
NCI-H460,9903786,4.057661845653794,2.5085390124311124
A-673,11214940,1.1675505170406824,1.4352401335874672
A-673,24964624,2.426022149354347,1.9293245154593655
BxPC-3,9866186,0.8001699279354296,0.6038875318150798
FTC-133,25062766,3.8237771334178903,2.310424099989947
HSC-4,42642645,1.8060847122685193,1.2606784019635249
HSC-4,11178236,-3.2670379451965164,-3.0281805919937024
HCC1143,JQ-1-vorinostat (2-1 mol-mol),1.5570491988867368,0.9298160449726907
NCI-H2009,selumetinib-UNC0638 (4-1 mol-mol),-1.7113919065901229,3.086331383249402
MDA-MB-157,selumetinib-MK-2206 (8-1 mol-mol),3.246099259686085,2.7001714519126043
NOMO-1,46843906,1.7610241193794407,1.187701255092843
NCI-H2171,6917907,-6.363958938419671,-4.9032357594472895
DMS 273,11707110,5.189560989731051,0.8752298892617607
LoVo,6918328,-0.3156299102516719,0.15526914650548315
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717,3.3406502360174812
NCI-H2009,44632017,1.0717713653211387,1.6427964511470494
DMS 273,11626560,1.283315066012986,1.3273075720585734
MDA-MB-157,11317348,1.0421206228140214,3.463611674915051
A2780,5311281,0.918852428114819,2.3630095582990602
DMS 273,2113511,5.781557942421417,5.369572699982737
LOU-NH91,10184653,1.5324310696398793,1.6944962770936731
BT-549,selumetinib-navitoclax (8-1 mol-mol),4.705621989339038,2.284327855955131
Panc 04.03,73707398,1.757833710000806,1.7573788578073342
JM-1,JQ-1-navitoclax (2-1 mol-mol),-2.0715419523140883,-0.47756498208176223
BxPC-3,11455910,2.77826122800999,1.3065730480285227
MDA-MB-453,11955716,-2.2213534191245303,-1.3440236177954359
A-673,navitoclax-MST-312 (1-1 mol-mol),0.824497586093143,0.6471199313348002
NCI-H661,3634881,2.923822089210327,3.3618415621233133
NCI-H460,5281672,4.99885948312363,4.497407375602683
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808,1.3561983271622244
KYSE-70,4259181,-4.187670573846372,0.40690426362236515
BxPC-3,2756,5.8394588105914105,4.161682218542512
HCC1143,24901704,3.259585605807663,3.3558463826037466
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374,2.109150071627523
CAL-51,5470400,4.528848471588079,-0.7899871782844433
JM-1,10296883,2.092198976716966,3.0788219069426077
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176,-0.2906027187242444
NCI-H146,46199207,1.7925573568525552,2.953065847192779
OPM-2,448949,1.278414281383,1.56959694588939
NCI-H146,216239,1.510222966819436,2.0591828732032362
HSC-4,9903786,4.262681016067309,2.930107558753767
ONS-76,57330099,4.261013423315652,4.228353166744373
NCI-H522,148124,-6.241132033807486,-2.707733130154771
SNU-449,156414,1.8120811787876097,1.8225608153024064
NCI-H2171,2746,1.1013983502046127,2.072417692143026
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268,-0.5038749054724984
LXF 289,135398744,6.087135496005038,6.191360288568083
SNU-449,3689413,-2.168376107627999,-0.4386975490795323
A4/Fukuda,5351362,0.320845740356061,1.076074877965175
A4/Fukuda,446155,1.0805751863544764,2.605753181372188
CA46,151289,0.6780663351050565,0.4712964537805195
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984,1.2344427938778058
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525,1.9767247291209626
NCI-H460,11625818,5.428588497019925,4.410139718793471
A2780,119182,-2.871948238792312,-1.553615633300518
ONS-76,10385095,1.1655527010487017,1.36790119387475
EFO-27,51037431,5.317639691280149,3.2029523748170896
A-673,72376,-3.645473298633041,-2.6648921049635588
MDA-MB-157,24748573,1.7707431454067368,2.1717724303578025
JM-1,6610355,3.6312795132079136,4.053247041722484
EFO-27,44819697,-1.290536172530674,-0.6248064789288541
A2780,5702613,3.197014181878355,2.869089692296047
A-498,25102847,3.3376740856950335,2.868371295256925
KMRC-1,3634881,3.321374403116886,3.149548720754632
OPM-2,3081361,1.5210485339307265,1.7611848158412204
LOU-NH91,3038522,4.554088179549466,3.1820510638995994
SNU-61,216239,1.9834133881004128,2.1876101392034806
FU-OV-1,124202324,1.4335087059128786,2.7420751903844867
NCI-H292,72193861,2.2952018559260363,1.9766371291202658
MDA-MB-453,53495165,1.832682106227088,0.7331169224572862
NCI-H2171,31703,-2.460746582121975,-1.507300011939018
NCI-H460,2729026,3.0609463870825926,2.789665630849969
SBC-5,9868037,1.591902673624677,3.269202782271617
LoVo,44632017,0.6073588127957028,1.2626436859625307
JM-1,25262965,-2.478831797463893,-2.2724319056854076
SCC-9,148198,-2.735497552895971,-2.9965847385359985
CA46,89928392,0.0283947615438792,0.09484655009134192
OVISE,5566,3.518034595538079,3.0474280692926943
HSC-4,5278396,3.3910828172613128,3.546483539613159
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388,0.3606709583399811
KYSE-70,4788,5.890959200463747,5.610606879826019
SNU-61,serdemetan-SCH-529074 (1-1 mol-mol),2.1746130433144386,1.9026479080248393
Panc 04.03,374536,2.376032280196277,2.531975034539832
NCI-H661,20959075,-3.3600823520668306,-2.336158810073839
LXF 289,3543504,4.042070583449167,4.624259152672679
SNU-449,5287620,0.008240040829162,-2.052232605601508
HCC1143,11719255,3.553533872223464,3.582214302979131
NOMO-1,54618164,3.731990472759892,3.7664546227709406
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889,1.1840257141405734
NCI-H1623,5311,1.5946462199665867,1.4711659002202049
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.3582602050637156
LOU-NH91,216468,5.562373540734892,3.612515887083723
JM-1,9915743,0.8499678141273637,0.31373183661702325
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426,2.1654959592971865
NOMO-1,107985,-4.118574275669005,-3.890446667980315
JM-1,135423438,1.5495237102322077,0.32106269143636373
A-673,24856436,-1.1403661815810562,0.2711265305714569
CAL-51,5282054,3.552468823116285,3.575798115007279
CAL-51,11178236,-3.674192911743539,-3.1643892907209556
G-401,6252,-0.6004387834343344,-0.7172109134157176
KMRC-1,4261,3.216149224144429,1.5899848101164507
MSTO-211H,54454,-0.190602208325988,2.5397467683916806
CAL-51,4917,3.122174268556499,3.020875802158081
HCC1143,54649381,3.828405406955801,3.8177980186840146
EFO-27,25262965,-3.442895730672298,-1.5835270118659794
NCI-H522,54626689,4.6269731577498066,4.482925892668232
KMRC-1,123631,2.4243478642730634,2.07497711037158
JM-1,JQ-1-vorinostat (2-1 mol-mol),-2.067527251050835,-0.5487844477606781
MSTO-211H,6438330,1.6419113469823416,2.120395794753557
CAL-51,446155,1.9002286289262065,2.6785267138737776
MSTO-211H,25126798,3.885175037199499,3.7798256813958124
KYSE-70,54626689,6.762622459467938,4.618712975689501
FTC-133,navitoclax-pluripotin (1-1 mol-mol),-1.324010652875928,-0.5560413788626886
CA46,4705,3.1649236354970154,2.825391682862783
LOU-NH91,36314,-6.12634068503974,-0.030661053783789846
OPM-2,49766530,-3.767684481967312,-1.729475464796938
NCI-H460,135411,0.3374737909082799,0.6086000121875925
NCI-H2009,6623618,3.0922058987418315,2.6346109094274914
KMRC-1,44185566,3.110367208302614,2.328074205344938
Panc 04.03,9933475,2.3468691227324965,2.2161756789333613
NCI-H146,25105715,3.2144396386290617,3.2941720593454344
SBC-5,25062766,3.305997596539037,1.98345867326687
G-401,11364421,-5.069536717957333,-3.2884152364065233
OPM-2,1285940,4.143301448340403,2.5532626579849964
NCI-H661,46843906,3.609730466041,3.0929158721792542
JM-1,selumetinib-piperlongumine (8-1 mol-mol),2.3811879474866093,2.314622649263932
NCI-H292,selumetinib-MK-2206 (8-1 mol-mol),0.2769010439937888,2.5472903775016587
ONS-76,656346,2.4725060186946974,0.9531089603870677
A-498,135421197,2.4500558267656873,2.2484168836675575
YAPC,5280436,4.973863444979394,3.8184626157608106
NCI-H522,53481919,3.906372094667401,3.6467877400281843
CAL-51,448949,2.479839067238928,2.0019457175539235
MSTO-211H,JQ-1-navitoclax (2-1 mol-mol),-0.1744059770900167,0.9872934803004368
NCI-H727,15953870,3.6175866373148713,3.563551562218708
A4/Fukuda,4378219,1.9024946719152895,1.870007738580147
ONS-76,374536,5.32668572402577,2.2912443363195623
HCC1143,387447,-2.8902460626215216,-3.928302718217057
A2780,navitoclax-piperlongumine (1-1 mol-mol),1.0612869409921282,1.1292536647189753
OPM-2,3543504,2.699241331915609,3.8321453115070034
G-401,54618305,4.431468655886698,4.411921057595796
A2780,54649381,3.634529154077109,3.612895332416333
LXF 289,5287620,-2.3080718171081385,-2.041301303282275
YAPC,637858,2.16601707981449,2.1453960882750995
NCI-H522,9915743,1.083108246388964,0.985883315278452
KYSE-70,25183872,-0.2407157689495178,-0.3711986613913198
NCI-H522,56649450,4.1349782138767655,3.078095877391894
OPM-2,52947716,0.8847701060718332,-3.456228708888455
SBC-5,124202324,2.6085939591802307,2.5110519280882473
DMS 273,2742550,3.72774264414297,3.4238386114207238
NCI-H522,BRD-A02303741-navitoclax (2-1 mol-mol),5.562601250875811,2.1280556335263503
NCI-H522,44491742,4.766943404170333,4.238338644022307
MSTO-211H,3503,2.7854032891391163,2.3869526949360913
FTC-133,10427712,4.710340548147587,4.501705929502046
SW1463,56946209,-2.6004240108086187,-4.188921631661739
KMRC-1,11178236,-3.5821993315226175,-3.1157141635066767
NCI-H146,5281672,3.80713040102785,4.2787595114160375
SBC-5,16038120,3.1431644252796835,1.2267541099462484
NCI-H522,421610,1.9391714098470076,3.052167836010144
DMS 273,9866186,1.1265446059819233,0.7933816370437854
SNU-61,11717001,3.914635952460324,3.8012473041639185
NCI-H522,JQ-1-MK-0752 (1-1 mol-mol),0.1872499419058635,2.0010221982235286
LOU-NH91,44137675,3.1585262513685612,3.818438334039255
JM-1,5335621,3.4974928376934766,3.889017180834886
CAL-51,444795,5.053001195278548,4.514149060136689
SNU-81,68056272,2.81466177200511,3.37451368569436
MDA-MB-157,23582824,1.002360199735323,0.5391346973424895
CAL-51,44185566,1.8630594392382311,2.708373037473598
MDA-MB-453,54618771,-0.4179555738274852,1.0999281390339923
MDA-MB-157,16038120,1.7351596622267822,1.268695159035504
OVISE,44589607,3.8530354372246394,3.101660824391993
LOU-NH91,navitoclax-MST-312 (1-1 mol-mol),-1.3828767553270485,0.9872481606681585
NCI-H460,400769,-0.4007490431715684,-0.46021858259349036
SCC-9,5460769,4.655053652221148,2.7331542679318583
MDA-MB-453,135398516,1.6443590350340722,1.9622945728853685
OPM-2,444795,4.04932788863876,3.202038930375194
MDA-MB-157,navitoclax-birinapant (1-1 mol-mol),-3.5674569438027977,1.736264372956369
OVISE,navitoclax-MST-312 (1-1 mol-mol),0.1298249702458385,1.157784277320081
HSC-4,11656518,1.5757846986297326,2.135629192763703
MDA-MB-453,navitoclax-pluripotin (1-1 mol-mol),-0.3400363144819007,-0.9734836796987562
G-401,3062316,1.3877203939609295,1.4949982708576377
SNU-61,16013152,3.3306050431250056,3.6261197130161356
NCI-H292,4259181,-0.3596950747779806,0.5283861634135127
G-401,6918638,0.0373379560261908,0.16323238093805909
NCI-H460,53232,3.485336782178725,2.78052976495337
NCI-H292,navitoclax-pluripotin (1-1 mol-mol),-0.7245377190748261,-0.6998540204967755
HSC-4,262093,2.780665409693215,3.1553944166999472
LoVo,100016,6.001395250082881,6.165755644948096
OVISE,2729026,3.0624747536258843,2.783707401350589
SNU-449,46174525,4.694645250518289,4.590887257874558
MDA-MB-453,25102847,3.185871702253412,2.3254627629296887
NCI-H661,selumetinib-piperlongumine (8-1 mol-mol),4.143402820216487,3.71012718445246
LoVo,208908,1.8298234127328137,1.9388763344507622
DMS 273,36462,2.158918041886743,1.6752613583109721
SCC-9,252682,6.244434841835944,6.557370131477949
CAL-51,3689413,0.5709426612715743,0.07778631032533428
ONS-76,5328940,1.5304760606777814,1.6896274835042735
KYSE-70,46199207,3.0458734214111436,3.29223244828086
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225,0.9510836426875693
NCI-H727,16720766,2.0944103672723577,0.8660576175725716
CAL-51,16741245,4.222373420591208,3.924501071717737
HSC-4,23939,4.494005895197972,3.8706963717457494
LoVo,60700,-0.3967380120150421,0.09689422446370251
MDA-MB-453,25262965,-0.03783703480807,-1.7984090931833248
A-498,374536,-1.3715174839162405,2.25901357196817
SNU-61,107970,2.0644711824277757,2.353159953685134
G-401,702558,4.958816468985481,4.573779105952443
MDA-MB-157,tanespimycin-gemcitabine (1-1 mol-mol),-1.0230607950179071,-0.6273949488784945
NOMO-1,16038120,-0.1786929053902652,0.16434980306767094
HSC-4,3543504,3.922868331711394,4.5673207113618535
NCI-H460,vorinostat-carboplatin (1-1 mol-mol),4.479996249659036,3.2350637933907773
SNU-61,10410894,3.2150759349666176,3.3448107586425935
JM-1,2746,0.8560843341026924,1.6845472407661517
NCI-H2009,15547703,2.9018345982556935,3.472446736397316
A2780,246676,4.314588687253318,4.26878314273563
CA46,135398738,2.145043320547598,2.1333313235114213
MDA-MB-157,55508,0.9028127001821934,3.2510383560382654
Panc 04.03,71304818,2.709197405012258,2.594620976256147
MDA-MB-453,53301938,4.664434739240087,2.561188210625194
A-673,46843906,1.5511639515888018,2.1985663024103967
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384,-0.4139932159392093
MDA-MB-453,3543504,4.170014094465671,3.900459765584622
NCI-H2171,5470400,-1.4637445210918176,-0.17979216941289405
NCI-H292,25062766,1.6798511870535655,2.1891116150687178
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.2516380350908356
A4/Fukuda,16736978,-0.5754825114210159,0.9849306394443983
JM-1,2749,0.0460059123026362,0.8163843331985646
SCC-9,46215462,2.815249887965138,2.1758638493734987
SNU-61,24821094,2.5022209832597757,3.0577719632200298
LXF 289,44493528,4.295099384269069,4.484216260173069
KYSE-70,54649381,4.140433754758901,3.7182985441127285
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603,-0.578544791424844
SNU-61,9826308,1.2155896819085543,0.24834227869596653
NCI-H522,49766530,-2.92412408259348,-0.814668813741883
HCC1143,44493528,4.485488370266477,4.420206683200025
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555,-0.06755190628708566
CAL-51,3081361,1.780158758130264,2.3493837111454003
DMS 273,2746,1.8465116882146249,2.185073878289641
HCC1143,5282054,3.2164949694146237,3.777746941519343
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594,-0.9541457441134706
SBC-5,644241,3.9213876276885458,2.1483875505939665
DMS 273,702558,5.649496210085508,4.284465996538277
NCI-H661,25183872,-0.013752841490686,-0.7642890869389052
NCI-H1623,71751553,5.091527890142487,4.477725539966207
SNU-61,10322450,3.828611192492266,3.4720798330065015
YAPC,44589607,1.444383642816813,3.163826899532938
FTC-133,426756,4.37678677221598,4.4255063292733094
DMS 273,25062766,2.819032107658894,1.8645589629452368
KYSE-70,375860,-0.042936769343065,0.13733738793894726
NCI-H292,6623618,2.2662127680014708,2.4131948227224074
A2780,3634881,2.2771511965432767,3.0016748502495894
FTC-133,11427553,5.52425857278767,2.7825217143855228
FTC-133,613753,3.41594619216373,3.17023642835374
DMS 273,5978,-4.4169630962529896,-2.5025204159137773
MDA-MB-453,135398738,3.241714649843938,4.165984104923864
G-401,252682,7.482268639703102,6.6020603853241004
CAL-51,126941,-2.448006630223804,-2.7909956332838863
KMRC-1,1716436,3.642710819139985,2.8860948959822053
KMRC-1,9967941,4.338887861114791,3.561596023356879
ONS-76,serdemetan-SCH-529074 (1-1 mol-mol),2.2978761416603812,1.9936159668127553
A-673,16725315,4.562355532440761,3.828244416651623
NCI-H661,54613361,-0.43407763491745,-0.07536914216940864
NCI-H727,17755052,2.165535951118127,1.9125234211833702
LOU-NH91,4521392,4.279385220000522,4.435920172555717
NCI-H661,448949,1.832526735111792,2.1519814071624723
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881,5.799079616580602
JM-1,24753719,1.6485500810507543,3.156419618916766
CA46,42642645,0.1424242949920916,-0.29802721177439473
A2780,122327,3.970459431332868,4.355510043043148
LoVo,11609586,1.9215259939554383,2.8970830335837974
NCI-H292,piperlongumine-MST-312 (1-1 mol-mol),3.188802005351175,2.0989752302509017
Panc 04.03,6918328,0.7116207668770654,0.4347175077935116
YAPC,10302451,3.503177254309001,3.0368570699799777
Panc 04.03,262093,3.918875507815306,3.1283291528376083
Panc 04.03,4261,1.8035720705799856,1.9946938455335748
HCC1143,11238147,3.6259374679037943,3.196501153861015
FU-OV-1,24951314,0.7779749033617789,1.5441971109392554
CA46,135440466,2.9995621349054007,1.7382428767463785
SNU-449,675434,6.334911868299287,4.616352244565665
G-401,568763,-0.8413074079434755,0.08082862648026484
A4/Fukuda,421610,2.9916322722523425,2.4902250961784547
NCI-H727,11964036,1.415853516680377,1.5271745423912504
SBC-5,53232,3.018737473370281,2.799792005798387
NCI-H1623,2746,3.1722069840164533,3.238278827021203
A-673,25102847,1.6240664882379,2.134018058009049
NCI-H146,71680916,3.9962882248297182,4.540302257822064
CA46,702558,3.0016875761250383,3.9135344658538687
HSC-4,3465537,2.7025414883497443,2.5653451746546865
SBC-5,15983966,-3.760719305706525,-1.5259086446393904
NCI-H661,10184653,-0.0970326303224196,1.652597960196498
KMRC-1,docetaxel-tanespimycin (2-1 mol-mol),-1.2179749713416546,-2.5064866402652304
MDA-MB-453,3634881,3.217596499324366,3.1925651524974876
KMRC-1,54596558,4.448003654736506,4.350016528723388
SBC-5,6438330,2.801398037891768,2.2730727464103917
DMS 273,11317348,1.436395200538785,1.9848957622180443
MDA-MB-453,241158,3.8848602363142697,3.7534184005080924
CA46,72376,-3.3789820311778764,-3.6169891181337523
EFO-27,1242560,3.615097330539702,3.7367765657987144
BxPC-3,51039095,2.7952547650191297,3.057147151320277
BxPC-3,71466380,5.524538311672043,4.470808140621689
A2780,49850262,3.28716577139928,3.3652502352226765
EFO-27,148124,2.931737870457193,-1.5536341500785469
DMS 273,65064,5.260786534928717,4.592076204681507
NCI-H727,5328940,1.5210077536616875,1.8686182848341928
SBC-5,20959075,-3.707780876124786,-2.633840974118203
LOU-NH91,5281321,-2.3527775967876097,-1.4099034130749775
OVISE,123631,2.580734449711204,2.4312301848798956
BT-549,navitoclax-piperlongumine (1-1 mol-mol),2.0033323756459325,1.930319071016686
OVISE,56946209,-1.506774361262591,-3.9319561727224266
DMS 273,5282054,2.793045570742954,2.931544271324286
SNU-449,11626560,2.613161578711923,2.03089002717292
HCC1143,vorinostat-carboplatin (1-1 mol-mol),2.950179443799285,3.4633589895150454
KYSE-70,11214940,1.7563649507227177,2.3476912111876924
Panc 04.03,15953870,4.151399322633975,3.6420515532917226
LXF 289,16736978,1.6084503302226174,1.593495530318213
MDA-MB-157,60700,-3.9633933148193066,-0.04379539222046922
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544,2.6118232287851657
NCI-H522,11152667,0.761836671652074,-0.7842716073107182
SCC-9,1750826,-1.358939777918893,-1.0537096075303252
CAL-51,3854666,1.1494535123186709,1.9339412003846315
CA46,11656518,1.817934601803022,0.4289362562435566
CA46,46843906,1.200591966763502,1.2205444236586016
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864,0.15621810791946783
CA46,24772860,-2.6679944090404035,-3.0058990557670686
G-401,24771867,0.701574094296253,0.7902404749174243
SBC-5,44202524,1.3408029920565403,2.4010161569716173
NCI-H2009,44507138,1.543580962147717,2.319213392476879
OPM-2,24748573,1.2641689672749945,1.7453191542115656
NCI-H661,3025986,-0.862198206140106,-0.6705183726483936
ONS-76,107970,2.339276188405755,2.600568276170894
BxPC-3,54619267,3.7277591748612866,4.15368753541765
ONS-76,4917,3.1821597264511863,2.798399563492587
NOMO-1,44493528,4.211717002525977,4.146188935376947
SNU-449,421610,4.477929285236737,3.592224801777206
NCI-H460,4259181,-0.2054535095090753,0.16511807058008213
G-401,327653,2.827166761380022,2.856394972651777
SNU-449,10302451,2.626140201612578,3.4516045201550383
OPM-2,24964624,1.0133948666397414,1.3679968291733084
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,4.285994613217798
SBC-5,441298,0.8643210359830038,2.50318050411742
NCI-H727,44489367,5.9503570299169875,4.520218374959125
HSC-4,123631,0.7882754974693414,2.297931264694035
ONS-76,24753719,3.8801096922841656,4.171568388416404
A2780,53495165,-2.5208465146636008,-0.8083257300783226
SCC-9,135411,1.0456929507985402,0.898040773403734
A2780,6918878,0.724096247903148,1.7710225156716326
A-498,45279963,3.865048616527305,3.9349582533649454
NCI-H522,51039095,-2.208127710853326,2.44272888932175
LoVo,5335621,4.644708398315867,4.5409575000892985
HSC-4,46199207,3.2853086951025197,3.2522568354013726
KMRC-1,45279963,3.811973271229391,3.788946734753368
LXF 289,56946209,-4.292268406284497,-3.640815050436631
OPM-2,24775005,3.1759511003243532,3.2926474346008403
MDA-MB-453,11609586,2.797782394552202,2.7657705054096464
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175,2.488614337027579
A2780,53481919,3.3933560170788355,3.511562579141282
G-401,25150857,1.6513368879801875,2.1024883130434886
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.2516380350908356
G-401,126941,-1.029913917257394,-2.8115364012642066
FTC-133,JQ-1-MK-0752 (1-1 mol-mol),4.281585420865333,1.4904232833966469
MDA-MB-453,BRD-K55473186,2.6877336742225424,3.940442545837739
MSTO-211H,5311281,0.6318902138586533,2.482225195032429
CAL-51,44589607,2.4963130908502107,3.055655298660481
KMRC-1,11234052,5.10610802043039,3.859691041448514
OPM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.4874212858880314,2.930767009639085
HSC-4,5291,4.568554891244716,3.693185382343099
KYSE-70,3543504,4.273044270546896,4.406527142500212
NCI-H522,54618164,3.979913879048498,4.001345431229872
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581,3.143157460892465
DMS 273,439501,-3.5888564067388633,-2.0658537458699886
MDA-MB-453,122327,4.8881767020652775,4.473111899342627
A2780,6918837,-3.827695834319955,-3.5550266838695626
A4/Fukuda,44489675,3.3968348796203003,3.6754177894052917
NCI-H522,25195348,4.252884841670477,3.183198086859404
SNU-449,11404337,-0.5921655065432572,-0.03024811586067178
MSTO-211H,12003241,-2.79016034960529,-1.3400575050220462
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287,3.5380738473236244
SNU-61,654092,-1.5451038120184588,-0.18268123785667328
NCI-H1623,4705,0.0935418442786881,2.917392917110799
NCI-H460,3543504,4.388423548450019,4.563113235201346
NCI-H522,23635314,-4.582316729083318,-1.9468183507031553
LXF 289,6918837,-2.0130943060067454,-2.242721770337777
LoVo,31703,-2.470313869470646,-0.6854200736446119
MSTO-211H,ISOX-bortezomib (250-1 mol-mol),-0.1802030513255949,0.7221444404045062
FU-OV-1,654092,-1.6613932676517214,-0.2827060351811567
OPM-2,60750,-2.943046758118922,-3.469753956515401
Panc 04.03,serdemetan-SCH-529074 (1-1 mol-mol),2.4838177280551057,2.302700102139298
A4/Fukuda,445643,2.2110077600401996,3.624420561746346
JM-1,25105715,3.1433974364296526,3.094757047427568
KYSE-70,9967941,5.193135802047497,3.425900933858931
Panc 04.03,24748573,2.946919213932378,2.5629744036073685
MDA-MB-453,6918878,0.409116855324534,2.5994724011750447
Panc 04.03,24901704,4.022965674422846,3.5556151446491118
CAL-51,16736978,0.375988055286384,1.808108577393011
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885,0.8744314399351255
NCI-H727,carboplatin-etoposide (40-17 mol-mol),5.344630715975986,3.1521328386116227
Panc 04.03,462382,1.207122186011881,0.6608574091508355
BxPC-3,568763,0.1839879990612418,0.531792726997119
A4/Fukuda,11640390,-1.5428779369431247,2.488522124067555
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102,3.0129699982456577
NCI-H522,216239,1.926799438191183,1.9308773333079736
G-401,53392493,1.8463111416757765,2.2866595214392897
KMRC-1,241158,4.823138037217212,3.9630574016535642
A-498,5566,2.910612965628124,3.2006751371740516
SNU-61,17755052,2.932810476371255,1.493558493036338
HSC-4,49793307,-1.7279713732228117,-2.401047144790223
SW1463,49793307,-1.9541064611693424,-2.9943043291782767
LXF 289,11964036,0.5627528071719251,1.5805173120948965
FU-OV-1,11228183,2.3859582400300683,2.442243064708354
EFO-27,5311,0.9089041307391243,1.7748896581893874
SNU-449,44819697,-1.6819344520854818,-0.29296292675691427
G-401,JQ-1-UNC0638 (2-1 mol-mol),-0.8221581174940659,1.0751027419613315
A-498,168313307,4.423397924448837,2.8465028945242223
NCI-H522,19582717,4.722348713472889,3.452176458113065
FU-OV-1,9903786,2.8592788804010936,3.14930779378827
DMS 273,444795,4.3404236236698495,3.310439086692426
A2780,56946209,-4.674045280410088,-4.359700590232253
A-498,tretinoin-navitoclax (4-1 mol-mol),1.5109888268131983,2.7049691095713007
A4/Fukuda,3503,1.0521499831923595,2.131647962238405
SBC-5,6918837,-2.402107568310104,-2.8464682999708204
YAPC,23582824,3.2647123156294855,0.8643397898129215
HSC-4,159324,3.192829599869501,3.3140200724524544
ONS-76,54619238,4.4304444652836805,4.9800405919084545
G-401,11228183,5.702662541402335,0.9318682246264409
JM-1,44819697,-3.7816867530650535,-1.719980078721993
SBC-5,54143018,-0.8844414516239579,0.7514606123544086
A4/Fukuda,44589607,1.1710928843495056,2.109863049004564
ONS-76,44543605,3.8219566402137457,3.6116838440832115
YAPC,15983966,2.0827072702810847,-0.8990053501033358
SBC-5,2749,1.818007095297154,1.982002626779164
FU-OV-1,44487872,4.488734888040304,4.5244367079567835
EFO-27,44197249,3.884486906001317,4.261706946187779
NCI-H2171,10385095,0.5588950968794439,1.036384641220941
LXF 289,5351362,2.37199640031851,1.8331600660037577
OPM-2,54618305,3.930022905522119,4.138498118904958
NCI-H146,327653,2.704686127708374,2.843634506850328
OVISE,11497983,4.4381003844097595,3.8268043255901274
NCI-H522,11977753,-0.2877362686640902,-1.9013512518466162
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.2650914241151237
NCI-H522,11707110,3.8955176091352857,1.0965428267013608
HSC-4,3676137,3.997252050059137,4.734680212244326
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095,0.7109685641075646
A2780,9840324,5.381878860524984,5.6127171020538995
BT-549,crizotinib-PLX-4032 (2-1 mol-mol),2.4648473849576384,2.1266927834024387
FU-OV-1,6917907,-4.405886494893828,-4.545252356810556
CAL-51,71304818,3.0248956992793565,2.5309647206231505
FU-OV-1,51039095,3.5191953123451096,3.000485219102467
SNU-449,5470400,0.6313893315276518,-0.21315736080908457
MDA-MB-157,6438330,1.1379279588809148,2.3842419331662814
NCI-H727,969516,3.103754409621015,2.965993846990835
LOU-NH91,439501,-1.197324809082114,-1.9217785770404672
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977,1.0733081337092403
FTC-133,148124,-3.926787463073679,-1.899702262251164
NCI-H146,24901704,3.4954665576646216,2.868877812188287
NCI-H146,6505803,-0.3489025917214021,-0.3052002645799934
BT-549,44819697,3.658602858416661,-0.2933366827358427
Panc 04.03,5278396,4.260606427966062,3.7571612774071683
G-401,11647372,0.0479330615057392,0.8907854519423576
EFO-27,71466445,6.412452895571818,4.45996134216029
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993,1.4042655046556
SNU-61,selumetinib-UNC0638 (4-1 mol-mol),1.9080621375720417,2.934787953052187
NOMO-1,1716436,2.6410194121109773,2.538290696958791
JM-1,navitoclax-pluripotin (1-1 mol-mol),-1.136595381126137,-2.0000146142108823
SNU-61,46199207,3.1956978461436014,3.2202385852304305
LXF 289,4261,1.4002862892534345,1.7632810426550287
DMS 273,46843906,2.9019571008738763,1.8749205880546345
SCC-9,25150857,2.532575506870741,2.5999747336879917
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,0.9977434580402044
NCI-H727,24785538,-1.326987163467981,1.7759872701992216
NCI-H661,11404337,-0.0954545894437525,-0.13527054371542988
MSTO-211H,66577038,3.302731292752764,2.770366784557566
OVISE,126941,-1.5326684035544371,-1.9298361558141535
BT-549,44566777,1.3521548270810906,0.9313194194691764
A2780,3025986,-2.2950808421603983,-1.021211895413979
NCI-H727,16736978,4.598640955798025,1.9154873348551333
JM-1,6610216,3.7780643735318615,3.940268352482951
MDA-MB-453,168312962,-1.3854623993271444,1.336162890462724
LoVo,2749,2.494181165729376,1.8118303517087342
OVISE,15547703,4.212246909591729,3.167471447361385
ONS-76,16736978,2.0849164003870877,1.7334910528117802
MDA-MB-453,1714884,2.9618056579194585,3.306601857960119
DMS 273,327653,3.1988672985426847,2.755891390992982
YAPC,2828334,6.193046978626199,6.142614972917426
CAL-51,10184653,1.4453250777347395,1.527202875434667
Panc 04.03,9936388,2.385451093408398,-0.03794828432420016
NCI-H2009,4477,0.2115452666376647,0.583989707238095
A2780,322968,2.566344426002007,3.120348247132477
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596,2.31547376022175
EFO-27,216345,4.384346641524126,4.364438990182801
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194,1.7855698635546744
LOU-NH91,9956119,4.571782850484356,3.8821921513451514
NCI-H661,1641662,2.9325574972427813,3.532133984119586
CA46,44493528,3.81061502276679,3.9850181614102462
OPM-2,navitoclax-PLX-4032 (1-1 mol-mol),2.9114134564638037,0.1709261140459778
A2780,11647372,-1.4335547211387447,0.7200602705887492
SCC-9,176870,2.779248818408345,3.1572688141084284
NCI-H2171,JQ-1-vorinostat (2-1 mol-mol),-0.591426926021434,0.4622676356695781
SCC-9,ISOX-bortezomib (250-1 mol-mol),0.3127664498221564,0.813308966492369
NCI-H2009,25183872,2.394233803753281,-0.5941648493793679
BxPC-3,selumetinib-piperlongumine (8-1 mol-mol),1.5279722865269718,3.275422375569197
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789,1.638486988683055
NCI-H727,11222830,1.7878002384813196,1.772413860133864
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319,-0.5161924333284003
SCC-9,9823820,5.247901285797655,4.113295965014057
FTC-133,44462760,4.267925011817446,3.700276211097497
EFO-27,salermide-PLX-4032 (12-1 mol-mol),5.523351402733512,5.096215212558565
DMS 273,54618164,3.989243888703328,3.9969786172734114
A-673,5470400,-1.9410984929514092,-0.2969182166800754
A4/Fukuda,56973724,1.7857996527787343,1.3982024713420684
NOMO-1,5311281,1.2143454060885572,1.9177694673462364
CA46,135423438,1.6657304721140649,0.949112956637342
HCC1143,5287620,-1.5012475814925117,-1.6834407760424568
EFO-27,107970,2.9901836608736883,2.4520215554696163
EFO-27,7251185,1.6138148752584345,2.8342158847302215
LoVo,11214940,1.900565531770479,1.8672003447931393
NCI-H2009,6450551,1.0382100121131883,2.9529308989644405
LoVo,3081361,0.9226789940369008,2.3774120753674004
SBC-5,BRD-A02303741-carboplatin (1-1 mol-mol),4.575375432825298,4.088403442632412
Panc 04.03,2113511,7.412620584739622,5.994869201112692
G-401,crizotinib-PLX-4032 (2-1 mol-mol),1.2254709557426715,1.7627263793820078
A2780,42642645,-1.071178701221225,0.40066419137002945
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051,1.9290788010756452
G-401,72376,-2.6056367900842745,-2.6719245704001344
NCI-H460,54618771,1.6853262233131374,1.0762154478162176
BT-549,selumetinib-piperlongumine (8-1 mol-mol),4.450190552332179,3.5805439912573576
NCI-H1623,60750,-5.650217340343659,-1.4976171785709709
BT-549,49766530,-1.005486623843658,-0.6870751192515602
NCI-H292,10184653,1.6188231902933972,1.5148348828344818
NCI-H727,5282054,3.939726324876112,3.9620108865866386
Panc 04.03,11485656,3.4698409381110435,2.4204637652129475
NCI-H522,24772860,-1.6489481573528793,-1.8650684542855347
NOMO-1,136227331,3.913043208951298,2.955823221495561
FU-OV-1,984333,0.3323688812243723,0.7210326679088181
LoVo,9911463,2.8816718818913176,3.877495107097482
NCI-H661,6917907,-5.078778116905793,-4.920525649621803
SNU-81,25102847,1.5499571993593506,2.4157461830651408
CAL-51,159324,3.1794720270506307,3.157340100739016
A-673,122327,3.9666709409894527,4.2973682697350135
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911,4.871574340432463
KMRC-1,2858523,3.233729541186922,3.056501556035645
LOU-NH91,9823820,5.384931157369051,4.348750374472621
NCI-H2171,5287969,-2.1635291246577286,-2.0992337256195204
A-673,426756,2.5032328390514365,3.9356226701676262
HSC-4,24964624,2.5086826728272538,2.473132698218801
NCI-H1623,176870,0.1873243677029567,3.132877935485479
KMRC-1,7251185,3.109058235493882,2.445617293852464
NCI-H727,6610216,4.563405769903236,4.226821113597643
BxPC-3,15983966,-3.8778410742282694,-0.3408822693495769
G-401,46843906,1.9398273455018735,2.04679093489702
NCI-H661,126941,-5.16742432120375,-3.0683825994587823
FU-OV-1,5746,2.910322472492285,1.1548619713966803
CAL-51,11609586,1.5077859423552509,2.9960927984284007
NCI-H292,navitoclax-birinapant (1-1 mol-mol),3.1013974556417825,1.564416170875559
NCI-H1623,23582824,0.0165284592292431,0.8603906249126012
SNU-449,31703,3.0847938162993707,-0.546507291058919
A2780,4788,4.492604658524488,5.250962686564651
Panc 04.03,25102847,3.783052108341051,2.7657563784211594
FTC-133,selumetinib-decitabine (4-1 mol-mol),6.596226241094775,3.5011967287855232
NCI-H522,5113032,5.82110442960573,4.728973292353693
KYSE-70,16038120,2.0286855638164054,1.1851812695295405
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544,3.2338285604380785
JM-1,2828334,5.9839290329767945,5.523467860507878
G-401,16736978,0.7492323653316314,1.4922381211517604
CAL-51,107970,2.299284460939792,2.3632678123891337
NCI-H522,carboplatin-etoposide (40-17 mol-mol),3.969229835066765,2.1032669014787966
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007,3.016598947043742
NCI-H460,51039095,3.9314979002332535,2.7168682011619025
MDA-MB-157,9903786,1.458865596348786,3.1604391058417205
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127,2.6944233919264464
Panc 04.03,54678924,3.3151598744761626,2.285847385722361
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012,-0.991860756854395
ONS-76,25195348,3.7356955751438754,3.367848270385419
MSTO-211H,71466578,5.31450298723974,4.654872260249165
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203,0.913952411753003
LOU-NH91,10385095,0.9698085069900604,1.6422580688300414
FTC-133,24856436,2.183528137346661,0.5825679607945743
A2780,54613361,-2.0737031658574043,-0.1692576094107331
CAL-51,5311,1.4183219405835503,1.21629677978584
NCI-H522,51037431,4.989409718658752,3.30368469410216
Panc 04.03,11647372,2.0191280123179824,1.5536662627081865
NCI-H727,327653,3.8552398443183193,3.0216967151183587
OPM-2,9884685,-0.7869928949425254,-0.6901176316586488
BT-549,676352,1.8104954024890367,2.226174070451417
CAL-51,46907787,3.297361866649883,2.2671022833199883
EFO-27,11494412,4.723849828867172,2.1824656243511034
A2780,60700,-2.20534635529039,-0.8487021739271791
A-673,5281321,-1.2857978730590742,-1.9247618141638703
NCI-H522,navitoclax-birinapant (1-1 mol-mol),2.79987001717094,0.5918418714692262
NCI-H661,6610216,4.875851858170822,4.217049614907202
NCI-H460,6917907,-4.956095121428261,-4.690435669884923
A4/Fukuda,5460769,3.0365194168079572,2.278079098710188
BxPC-3,3025944,3.477531707151509,4.324878238571485
CAL-51,16065773,2.8749329306977853,2.3693641465033752
SBC-5,navitoclax-piperlongumine (1-1 mol-mol),3.0140004933884796,1.812253917580203
EFO-27,2874250,5.869363689503336,4.794391646553503
A-673,702558,2.7000584853196936,4.426949902958203
HCC1143,107985,-3.4652614368177432,-3.497642833468908
SNU-81,navitoclax-piperlongumine (1-1 mol-mol),0.0853232254018234,1.280597623666346
NCI-H522,3025986,-1.0139106356663683,-0.8861485931630534
NCI-H2171,439501,-3.0635131055453924,-2.0938222258096397
NCI-H522,444795,5.191031194563041,3.983661234851042
NCI-H661,53392493,2.28152765608909,2.6748657636147213
Panc 04.03,445643,3.9306423242452673,4.182317460033519
NCI-H727,selumetinib-piperlongumine (8-1 mol-mol),-1.6426158910123243,2.908953240887322
NCI-H292,25150857,2.3048085705836563,2.600423892071412
NCI-H727,25126798,3.836281743476004,3.8945102335009767
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416,5.074977180300935
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187,-0.19403818961013589
ONS-76,9887053,4.335145594020597,4.04179627428579
OPM-2,675434,4.053836549963459,4.100130055383157
KMRC-1,16725315,5.238650021868635,3.925596079784609
SNU-449,piperlongumine-MST-312 (1-1 mol-mol),1.362794205944183,2.1189736154250283
A4/Fukuda,151289,0.1986917338936865,0.6327496699803503
SNU-449,ISOX-bortezomib (250-1 mol-mol),2.1712489431250437,0.9103118024253207
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291,0.944251588858527
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698,2.3697982044152424
MDA-MB-453,56963564,1.2952259038449256,0.863018782568387
NCI-H522,65064,5.303150406450188,4.593389018773115
NCI-H2171,24772860,-3.209318985857815,-1.9969184529792898
KMRC-1,104842,1.0931359128213904,-2.4612407241535035
NCI-H460,16741245,2.175171044948558,3.97910193576091
OVISE,4259181,0.909929291036465,0.6742338212768246
HSC-4,46191454,1.405754738797376,1.5490677310228411
KYSE-70,2749,2.2442090130660577,2.256135823886173
SNU-81,400769,-1.1944669265215293,-0.39318947194610415
NCI-H2009,6852167,1.9075911063810396,3.0829364413218787
SBC-5,241158,4.402731015442316,3.841137409704635
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236,1.107543161181182
HSC-4,44185566,3.0805483382503844,2.5242472875138944
FU-OV-1,17755052,0.0450390211671309,2.03387642471486
KMRC-1,53495165,5.726132279462146,0.29406985905796573
NCI-H146,6184667,1.5836777358218528,2.785972353452936
NCI-H1623,selumetinib-MK-2206 (8-1 mol-mol),1.9939850846524236,2.4178066592123906
HCC1143,55283,3.9101720152241226,2.74443515575009
OPM-2,71466445,2.165442844786418,2.2670050040816925
A2780,49867926,3.0666746223408157,3.5237837394307503
LOU-NH91,17755052,2.4120102833965844,2.2498110815483714
MDA-MB-453,49867926,4.180155964726801,4.073554933783623
Panc 04.03,25183872,0.1973991794911014,-0.4514094400061088
CAL-51,9967941,3.511576456928413,3.6969137483008785
SBC-5,6852167,3.965917526242172,3.0135774874770447
NCI-H292,navitoclax-gemcitabine (1-1 mol-mol),-2.2738254252186314,-0.48969615883690154
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294,3.117176238263022
NCI-H522,54596558,4.342696772784201,4.343926643829948
HSC-4,2733526,3.5101027459294425,3.6462378892456644
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981,5.254160465031734
OVISE,decitabine-navitoclax (2-1 mol-mol),0.3462958100091469,1.7363409415734659
MDA-MB-453,4477,-0.2020943624975227,0.3518080764302014
NCI-H2171,72193861,0.5955631718249997,0.46580918297332446
NCI-H292,2828334,6.458495810735601,6.338932263570179
ONS-76,7326481,1.79748139254514,2.975222838247486
A-673,44607531,1.457749077960986,1.6407142593706074
NOMO-1,73707438,4.2876330596581305,4.132220849539214
NCI-H460,60750,-0.8382921927225392,-1.894448785735395
NCI-H522,4259181,-0.2456063667287351,-0.1896290877021972
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366,1.5353558247080341
ONS-76,969516,2.910086136195903,2.7793906486129756
YAPC,49850262,3.6789282041181095,3.967674247310556
SNU-449,44491742,3.9284370838515903,4.3087834739796556
MDA-MB-453,11485656,1.765591398344026,2.210359184366215
NCI-H460,44607530,3.4043015144880444,1.8153678035097982
OPM-2,56949517,5.349058842742104,3.896902277892947
SBC-5,216239,1.5582588949606833,2.5719519626859206
NCI-H661,219104,3.9372744940630646,3.943506502564521
NCI-H460,44484440,3.757520830720006,3.371137117314213
MDA-MB-453,44462760,5.00879187339522,3.7691513347178263
ONS-76,5281321,-1.2480266745690851,-1.32828324218097
LOU-NH91,5566,3.288881685822646,3.1117424014594848
MSTO-211H,72193861,1.6065459514404858,2.039361095869673
NCI-H1623,16038120,-0.158474112921266,1.3320118021687566
BxPC-3,11238147,1.751681691561693,2.9256116980298867
YAPC,3025944,4.720838189364642,4.343379224054233
SNU-61,1239801,4.195034605110225,3.6101202970300204
NCI-H522,11640390,4.472705990017258,3.3062308356846364
OPM-2,11238147,3.2386204402735874,2.034954765137437
YAPC,16722836,1.8948218470527252,1.6833409378071063
MSTO-211H,4261,1.9115438043118669,1.991943701739353
BxPC-3,24901704,3.2492386456059266,3.4308883450874017
A2780,2742550,2.799223861459344,3.6145372991635707
LoVo,6918736,-4.296362304597629,-1.910503520235861
NCI-H292,3854666,3.3764205876154074,2.6179906134070268
G-401,11222830,1.5347756238466792,1.2226896850841134
CAL-51,44620216,5.469091994130916,3.7348512306099635
NCI-H146,6918328,-4.616864565737749,-0.700826074657032
SNU-449,100016,6.350050439021361,6.47147949038301
CAL-51,6438330,3.884194225982375,2.398807300680575
A4/Fukuda,451668,-0.3897468918932548,0.12213286352113832
NOMO-1,135875424,3.068632733482165,3.2491180493012495
OPM-2,selumetinib-UNC0638 (4-1 mol-mol),2.327180479574148,2.154700892458751
MDA-MB-453,9907093,5.353373126975176,4.033841964672442
SNU-81,11404337,-1.7380856142345846,-0.4367772081452287
BT-549,3634881,2.142843752657143,3.404250863111977
SW1463,6918837,-3.406571913442127,-2.922183020092008
HSC-4,6610216,4.241818899552939,4.343062065210629
G-401,135421197,1.4306754302223277,1.5148272910102003
MSTO-211H,400769,-2.118881346037636,-0.37106995063388415
OPM-2,56946209,-6.715247823396851,-4.637025453690206
OPM-2,156414,0.898749748032719,0.9083811637246726
SCC-9,2708,5.420316309291021,5.0033032012835905
BxPC-3,72376,-2.7426383250741786,-1.967331418173318
LXF 289,44607530,1.309750089611443,1.8909873567264766
A4/Fukuda,216468,0.7779788317268376,1.166679673697197
ONS-76,9936388,2.029236983033262,-0.8177854570332117
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383,0.44994111982762347
A4/Fukuda,15953870,2.701018205920996,3.0483189317541775
A4/Fukuda,3825829,2.918538307685252,3.348715264162536
NCI-H522,1716436,2.601362471636894,2.8890220458975158
NCI-H460,16725315,5.407057101640495,4.424731993261769
NCI-H661,969516,2.7370069869182996,2.854202896077515
SNU-449,9915743,1.6643053553641087,1.3758937250746297
NCI-H522,16219061,2.1788816492377054,2.9101882697496295
NCI-H1623,25126798,4.062693377799547,3.913439316498755
LoVo,46199207,2.62459096292295,3.2250994943366154
Panc 04.03,2126,5.406308275886939,4.920427709535576
NCI-H522,702558,5.065903257418961,4.634021862213535
NCI-H661,44489675,4.0470438340050086,4.004107594152345
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975,5.135780324637006
CAL-51,11175137,1.2330676481368064,2.6075980889082873
EFO-27,tanespimycin-gemcitabine (1-1 mol-mol),1.7387659506719169,-0.6965563873790366
A-498,119607,5.756544485429512,5.335323231185401
CAL-51,89183176,3.8950338695454088,4.496073200902532
FTC-133,2828334,5.859070513237425,6.453818011098839
KMRC-1,135440466,2.425894917183188,2.2178645090443876
NCI-H2009,36314,-5.253596358515139,-0.7214449347802753
G-401,11238147,2.0802759078276853,2.3746829508105445
NCI-H661,452548,0.003417557634082,0.2648818223310708
NCI-H292,5282054,4.085287507740134,4.061797219387449
HCC1143,10385095,1.0799280769088206,1.4974285145007278
A4/Fukuda,11626560,-1.03034976821798,0.9489407442559304
FTC-133,65064,5.375666939367713,4.8513289031231315
BT-549,753704,4.958873098850826,5.0865306885361585
KYSE-70,46224516,2.993089177283032,2.511503760471598
CA46,11707110,2.876405562319207,0.7328928775471644
LXF 289,11609586,2.9430338892136354,3.1041434855207517
KYSE-70,10296883,3.691258417269261,3.954342836524438
A2780,tanespimycin-gemcitabine (1-1 mol-mol),-1.0115297721833665,-1.4101507199030519
DMS 273,67156097,-2.1294955352549,-1.7456947803666614
NCI-H2171,11955716,-2.5749004703466976,-1.7321817418475292
LOU-NH91,124202324,3.0671378719618283,2.5542189753224878
A2780,135659046,3.385733838662662,3.6376627526909795
OPM-2,11427553,0.184758700497643,1.5465439280332103
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377,3.2973383846485156
OVISE,11427553,3.886061021243629,3.0513471369244876
A2780,24821094,2.7975033336102095,2.7979897279346755
LoVo,10410894,2.092646303934145,3.4192237261812313
CA46,327653,2.398308016277815,2.2555733932621402
NCI-H522,135440466,2.851321997265629,2.1926389716818946
NCI-H661,9903786,4.646166413465223,3.1244507029612505
ONS-76,docetaxel-tanespimycin (2-1 mol-mol),-1.0307664921769042,-2.5283537379804444
CA46,11427553,1.0834968953052575,1.1716422338431434
Panc 04.03,6450551,3.8538949310121353,3.2459811239543024
A2780,644241,1.9281614760038184,1.2817455556200037
A2780,3815108,2.053113262637462,2.5169368201198155
NOMO-1,71466380,3.4384411266907295,3.890286970502759
EFO-27,serdemetan-SCH-529074 (1-1 mol-mol),3.002804413616897,2.299206848564017
A4/Fukuda,24821094,2.016569070962388,2.5010581012771733
LoVo,3503,2.2987332704820016,2.568215116238079
LXF 289,46398810,1.8383298322371264,2.749461827332929
NCI-H146,42642645,1.3339409860624971,0.7625306158774302
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408,-1.9734024504548549
HCC1143,135984461,4.873829103860087,4.158747088712935
LoVo,23725625,5.102020281972671,5.115843105028389
NCI-H2171,4477,0.0540600744484099,0.42996720649114806
Panc 04.03,24964624,3.127575767188385,2.6662874133924954
CA46,676352,1.5563040092860552,1.682079217431742
ONS-76,135440466,2.234484066901876,2.457092688937195
EFO-27,31703,1.037291503873681,-0.5512874872742417
MDA-MB-157,208908,2.741119640746793,2.1189722807974762
G-401,46191454,0.141864729037356,1.1912679065075193
LoVo,439501,-1.7683171506776545,-2.1111813492301668
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813,3.330867229664113
A-498,36314,4.095863504824457,0.1641156214590894
G-401,ISOX-bortezomib (250-1 mol-mol),0.1394395041296586,0.5235024082170299
NCI-H727,9935249,3.73205967923935,3.0304765842264447
KYSE-70,53392493,3.454381994737171,2.7097087214350437
HCC1143,11234052,5.229903952882612,4.349254419955993
CAL-51,4705,2.903463840875761,3.248835283133463
MDA-MB-157,56946209,-3.6171244608990905,-3.725997239537764
LoVo,3689413,-0.0015328635235731,0.7462423049478137
NCI-H460,46199207,3.5033257005335163,3.175826682735016
BxPC-3,135411,0.8341107494370649,0.5889942463991736
NCI-H727,46191454,2.1799448668848105,1.7575653936749212
OPM-2,25195348,0.9238255530721258,2.715825213521378
SNU-61,JQ-1-UNC0638 (2-1 mol-mol),2.3060253857026343,1.1349256114319393
SNU-61,656346,0.8749051442535513,0.9714438711450749
JM-1,136227924,1.2038413750130548,2.11901197202131
SNU-449,49867930,4.864159132996777,4.514077520912769
A2780,2733526,2.8794725769531997,3.6050685557889786
OVISE,23725625,5.908959950408421,5.123237383874349
BxPC-3,60700,-0.122761385712052,0.04867442194822111
OPM-2,53495165,-4.146839218250571,-1.958117170538891
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497,0.8705409030072709
A-673,25227462,-5.829932006274449,0.26786302084158026
KMRC-1,6918328,0.9635513821249304,-0.1212725193716025
JM-1,89183176,3.1890961462334335,3.250284181853015
MSTO-211H,16038120,0.2471942161915729,1.2867136884099528
JM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.175928698896838,3.8504714346477518
ONS-76,6918878,5.0214366982824306,2.1972041614618867
CA46,60750,-0.9269398092944348,-4.02404006189514
HCC1143,42642645,1.0566197638440329,0.9633318129654879
OPM-2,3503,1.0860674816661569,1.8058257874356536
BxPC-3,11612883,2.2063280154469993,2.942986535007538
NCI-H522,16065773,1.5488087432962436,2.277876208553704
A-673,3634881,3.109333818891092,2.854196902349234
NCI-H2171,71466445,1.378191899492029,2.906973382994473
SNU-81,JQ-1-UNC0638 (2-1 mol-mol),0.4433096898383019,0.8129949785570533
NCI-H292,17755052,1.3393568867062529,2.014898085780106
NCI-H522,11427553,1.733163384028149,2.1031960673957624
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819,1.105449069190822
BT-549,24797083,1.6394182791354686,1.587233404597496
OVISE,6438330,2.2515103089504818,2.675604871967924
LXF 289,10410894,3.939992216810496,3.6511800621686974
EFO-27,60750,5.390319994108079,-2.105992200996401
BT-549,400769,-1.1296625579443007,-0.4485154929029847
SCC-9,2742550,4.1692460597635135,3.847232653051111
JM-1,5281321,-3.43257780081901,-2.8235978251549327
OVISE,24771867,1.656692666128474,2.6147644030812542
SBC-5,3384730,0.0954837515635063,2.8875509986351973
BT-549,navitoclax-sorafenib (1-1 mol-mol),3.9279804703061703,2.1381867119820317
A4/Fukuda,2749,1.141581020051295,1.2112081379746957
G-401,1716436,2.4290804430946547,2.8987737992615537
NCI-H2009,23635314,-2.363129056883172,-2.0458837924967095
SNU-449,3081361,2.056588488576824,2.6349800520432494
NCI-H522,969516,2.4900188230240485,2.7178141422121973
MDA-MB-157,11626560,3.460415978238755,1.6813712223761246
NCI-H292,selumetinib-UNC0638 (4-1 mol-mol),2.5678319047053244,3.110777362961244
HSC-4,11719255,4.924721636143113,3.657656588854037
KYSE-70,17755052,0.9465092626724514,1.6600387242426555
G-401,25062766,0.8725390828623283,1.8378857203456778
KMRC-1,4477,0.198014478122684,0.7922797856743036
SNU-81,44197249,-2.185783961489413,3.167396779745875
A-673,10410894,2.502904420433103,3.2251706736318404
ONS-76,6914657,-4.101072641720643,-3.9605182287367415
MDA-MB-157,53495165,-1.8622859982145463,0.9417382370051846
Panc 04.03,72734382,5.165438336919353,4.732202976554012
FU-OV-1,navitoclax-pluripotin (1-1 mol-mol),-0.2689466648852067,-0.7617314635856147
CA46,613000,1.1767209163070167,2.338991055703928
EFO-27,3503,2.721888959468924,2.5592652644309295
SNU-81,decitabine-navitoclax (2-1 mol-mol),0.903824446896739,1.021012239997249
MSTO-211H,6917907,-6.416473568686441,-4.60245229392417
CAL-51,675434,4.354107922133551,4.606884347796662
CA46,5278396,3.312720557512005,3.0152295290773243
FU-OV-1,9911463,4.1305925074662575,3.9907981087927333
DMS 273,5328940,1.9629216769229116,1.445666867163914
LXF 289,54454,1.7599180903835134,2.3983456169506105
A2780,446155,3.1527811730433366,2.591981392169611
CA46,11222830,0.90552754986452,1.087254221031664
MDA-MB-157,15547703,2.7177027433879912,3.192680871995812
A-673,9915743,0.6829950735134661,0.5644654813434413
Panc 04.03,50905018,4.96616490546014,4.472197614834702
NCI-H146,50905018,3.857703749758686,3.9330885089000365
OPM-2,carboplatin-etoposide (40-17 mol-mol),2.4358856749484596,0.4289588389799002
CA46,148198,-5.7845042531785,-4.2060168415474655
BxPC-3,11427553,2.964396595429347,3.0626890445326165
JM-1,17755052,1.8568486472237824,0.8961162145810445
MDA-MB-453,135875424,2.7753375231350104,3.9462652759560757
LoVo,52947716,-5.666189039665748,-0.1887455456831555
SNU-81,3543504,4.205084802754879,4.023641876472678
CAL-51,9887053,4.486783389261201,3.7890821729165647
YAPC,SNX-2112-bortezomib (250-1 mol-mol),0.1222425985645655,-0.9091198792834799
FTC-133,6852167,4.78859095347106,2.9175827863930226
SBC-5,46907787,3.799315463541784,2.218560570007387
SNU-449,6918638,1.2557717528626495,0.8337724087413884
NCI-H2171,6438330,1.125878118169246,1.8321861324885071
ONS-76,15953870,3.841628876209717,3.5448975955419804
KYSE-70,44493528,4.735176242945038,4.346336124786332
BT-549,71751553,4.2471267374516435,4.563158101131154
NCI-H2171,46943432,3.4065574915710735,1.5270562674492734
SNU-61,carboplatin-UNC0638 (2-1 mol-mol),3.8198655410363287,3.4287250679422216
A4/Fukuda,135875424,2.943838777845953,3.2944112420614404
SCC-9,25154868,5.2906536290113975,4.404045571587674
A4/Fukuda,11964036,-0.0142982917472374,0.6232125836319018
NCI-H292,10302451,3.577296661602114,3.1009910856810445
A2780,135999136,1.5930192405329104,3.262579615745604
NCI-H292,54618164,4.184972812062346,4.17683229048873
LXF 289,107985,-2.691798131563437,-2.9649177730458107
NCI-H522,44137675,3.8599044567005434,3.529727593857869
CAL-51,3503,3.2899889427654245,2.2983458751029286
A2780,409805,4.989244714218352,4.340665970542048
HSC-4,71466380,3.6804948915169784,4.5863379767035415
JM-1,6918638,-1.945896791217812,-0.7361896668385063
SNU-449,44566777,0.6479277578392284,0.9411630698304496
MSTO-211H,387447,-3.4382078488280063,-3.7826015612180526
DMS 273,9915743,1.912374780622189,1.0923522975142195
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022,1.010356445199547
NCI-H661,16736978,1.5408428303752983,1.8429834036486534
MSTO-211H,44241473,3.911097970359605,4.904446196087644
NCI-H460,60700,-0.2314807684970784,-0.2637997565087424
A2780,serdemetan-SCH-529074 (1-1 mol-mol),0.9740349619499052,1.8319513696487815
JM-1,227681,1.6891640861629382,2.491888960010819
G-401,JQ-1-navitoclax (2-1 mol-mol),-0.4060053682032895,0.18929994460691194
NCI-H661,656346,0.6919490200967222,1.0743464614971756
SW1463,5311,0.7635678260369684,1.2117954196355867
NCI-H460,387447,-2.436463262555682,-3.7005470568698855
MSTO-211H,navitoclax-MST-312 (1-1 mol-mol),-0.7166631771213113,0.9090436900024613
HSC-4,9825149,2.985341504866837,2.3244241438352558
NCI-H727,25262965,0.7692581364380534,-1.310716940346478
A2780,10077130,2.5506457702723786,3.032361510173553
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617,1.9680863241769027
NCI-H661,136227924,2.7818959309662183,3.3253291434139216
SCC-9,446155,1.3937663931747788,2.935616237390878
BT-549,73707398,1.468839183930599,1.3654042708501186
A-498,navitoclax-PLX-4032 (1-1 mol-mol),0.6341402769109122,1.8423083376829825
CAL-51,6623618,2.223133904662847,2.3781709327560634
LOU-NH91,327653,3.620861790086289,3.38502920795743
BT-549,67291369,4.3793706620025095,3.077308809326867
MSTO-211H,docetaxel-tanespimycin (2-1 mol-mol),-6.863228932141716,-2.806870810621203
NCI-H460,3025986,0.3909368316008428,-0.817656000819497
Panc 04.03,11228183,3.2874901590346934,2.603662834212981
LoVo,25262965,-3.8912736240644694,-1.3774415408403906
SBC-5,73707398,1.6541333685248465,1.3315193594176788
NCI-H661,89183176,4.289155461605826,4.369222535292988
G-401,44241473,4.28251451131172,4.472890638628888
BT-549,2746,3.8188337512891137,3.4901116490514075
YAPC,25062766,2.237282024435701,2.255683620525252
LXF 289,20959075,-2.4089188058085,-2.6422256173336183
SCC-9,53232,2.1606412524830017,2.9234241353289345
G-401,56649450,1.8227428945555348,3.1277633768225086
MSTO-211H,11222830,1.162959487763126,1.7640020988252116
JM-1,15953870,2.1778700018066144,2.8734476501780097
LoVo,15953870,2.9352023189332703,3.4494114811244816
DMS 273,15953870,3.8128904638275216,3.3436030572569955
G-401,JQ-1-vorinostat (2-1 mol-mol),-0.8769966942019048,0.5280741403190261
CAL-51,1750826,-0.4147302595408071,-0.8889021743761932
NCI-H522,9884685,0.1045560296672991,0.24514130720879845
HSC-4,327653,3.5197711195347434,3.2207899612844644
BxPC-3,6918328,-0.2318480121478282,0.23873401603953565
NCI-H661,10074640,2.974634579766932,3.013544439369772
FTC-133,11178236,-4.398882676695501,-3.260938921736857
CAL-51,6450551,1.9748462748620472,2.578855998268423
NCI-H522,SNX-2112-bortezomib (250-1 mol-mol),-2.0311318982301665,-1.4037429889886437
SCC-9,5978,-3.875351555062552,-1.076660445923403
LOU-NH91,5311,1.697115177859265,1.7165378446363613
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876,3.897122392845052
A4/Fukuda,49766530,-0.1813275565198268,-1.8354806984137708
CA46,5978,-7.34958411963843,-3.8497426392755862
JM-1,15547703,2.5122126082355227,2.449545327491686
HSC-4,3038522,3.958216901800584,3.418088566021972
MDA-MB-453,24901704,3.2296574944609735,3.191792017881479
SCC-9,23635314,-1.650613607792241,-1.2163361884072312
KMRC-1,11612883,3.608500084904783,2.7146336016652226
OVISE,24772860,-1.0102375693918164,-1.3820664616742113
A2780,11626560,0.43489025720173,1.56743825402432
MDA-MB-453,51037431,1.3361098813185686,3.2125177790549615
HSC-4,4705,3.95336427523857,2.95317813011997
A4/Fukuda,24748573,1.3032837048402657,1.7133044885843338
OPM-2,51039095,-2.6866952618976434,2.2200465888817966
KMRC-1,11609586,2.4412406506497155,2.6861827275736236
ONS-76,11609586,3.485979398565755,2.685662673449766
LoVo,12003241,-2.8621949377385465,-0.8439143388319847
DMS 273,241158,3.177272786345067,2.7932563697776143
KYSE-70,20959075,-2.927604227069557,-2.7675066786359235
SNU-61,16722836,1.3959733890222568,1.4025404691819572
SBC-5,89928392,2.3719311856170537,1.7141534183831049
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.7518116480602428
A-498,4261,1.667462132250413,1.8710786157246335
SNU-449,23725625,6.429990861305722,5.182771624506817
A2780,4259181,-1.27299012623329,-0.2721836212562229
ONS-76,10127622,-2.1347139098699706,3.7938827413253375
A2780,1641662,2.3828094640764412,3.2156806013525183
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891,2.0370860790602108
Panc 04.03,9549297,5.2530677537073975,2.5022353916641813
MDA-MB-453,53481919,3.1180191774885735,3.8690486068439
JM-1,56963564,0.0249959117693502,-0.4160322426338434
HSC-4,11234052,4.4583786214563865,4.296187763654205
A-498,SNX-2112-bortezomib (250-1 mol-mol),0.1538165542627618,-0.4337694849069644
BxPC-3,119607,5.22613990212802,5.434292599112862
BxPC-3,5278396,2.866816315326302,3.602592818068651
LOU-NH91,400769,-0.4518117512524929,-0.45642279695542987
A-673,doxorubicin-navitoclax (2-1 mol-mol),-4.20921708976932,-1.9191195834926162
FU-OV-1,16722836,-0.0099462763207794,1.7299659005748507
SNU-449,46907787,4.480861537403045,2.7601732779408126
NCI-H292,24748573,1.9235457900331792,2.2920258121047645
NCI-H460,2113511,6.407699041859446,5.757984748396601
HCC1143,selumetinib-UNC0638 (4-1 mol-mol),1.3639730576271398,3.445346469298218
NCI-H1623,46174525,4.205988468269685,4.606280981566074
NCI-H1623,6917907,-5.728045829659389,-4.932478178639934
MDA-MB-453,1641662,3.085427143962118,3.403459735379804
NOMO-1,3854666,1.0231806307237967,0.7955566091790781
SNU-449,24821094,1.9429996101140543,3.2823540457031872
SNU-449,crizotinib-PLX-4032 (2-1 mol-mol),2.114422576149497,2.0419025153672883
Panc 04.03,216345,4.594435961426402,4.180811870707266
DMS 273,2708,4.711982190259564,3.7895009627068426
NCI-H2009,navitoclax-MST-312 (1-1 mol-mol),0.6133760469311309,0.8938039710805157
A-673,11222830,1.3107049031534492,1.3506539130137138
SCC-9,219104,4.323236898621614,3.9306097685110704
KYSE-70,11455910,0.6771697782379181,1.707793714298134
MSTO-211H,9915743,-1.0722844498490078,1.352978567401024
HCC1143,3062316,0.306898118520016,0.8655406548415522
NCI-H460,11427553,3.3912724357702873,3.2081983403069914
NCI-H1623,675434,4.403585448845777,4.473533519643347
NCI-H1623,135928012,3.849713333151309,4.224699061800331
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473,1.550903269062433
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785,2.0350625683168047
KMRC-1,11222830,1.6210071273597368,1.8588326221988352
NCI-H661,44607530,1.6067743901515843,1.9208860029485135
HSC-4,24753719,5.996217074466553,4.420176136302803
NCI-H1623,44607530,0.6082825778474802,1.778290821029139
G-401,409805,3.720272745750916,4.151354461806068
MSTO-211H,24771867,-1.256499005348058,3.1398147477519665
LOU-NH91,100016,8.416108067142021,6.3957509999602715
LOU-NH91,navitoclax-gemcitabine (1-1 mol-mol),-1.5749911209291652,-0.9209976529598335
MDA-MB-453,9911830,2.483477791354312,2.5768011061403895
MSTO-211H,216345,2.6222222224733702,3.7346581927624487
A-673,5738263,2.33182798743241,3.0156777388013727
NCI-H292,navitoclax-MST-312 (1-1 mol-mol),1.1730740558558932,1.2469500081790732
CAL-51,16038120,-0.248771562775031,1.0846829538544833
SNU-449,11222830,1.6348775900621026,1.7916051892670497
SBC-5,11656518,1.8588197700646856,1.8491788962710514
LoVo,637858,1.5179613366947162,1.8717554222075876
OPM-2,16065773,1.0643824527623371,1.994736823758449
LoVo,17759555,2.3197484044750905,3.3818875879312227
LoVo,23635314,-2.3980395881052723,-1.4136143958621445
OVISE,241158,2.9923875981017134,4.1554070775741385
LXF 289,6918736,-2.4177135652368476,-1.5737226093179308
NCI-H727,24180125,3.0565666249941015,2.9158646839744806
HCC1143,72193861,2.4539335535877607,1.6729979211462984
LXF 289,17755052,1.3903450452706496,2.095526334872637
SNU-449,24797083,1.6612369643963127,1.5303178641302255
A-673,9903786,1.5948741514342302,2.4747565681245165
FU-OV-1,docetaxel-tanespimycin (2-1 mol-mol),1.25716738994227,-2.052724695182242
SCC-9,3552672,2.2159119862051355,2.781929938729362
G-401,9903786,2.8038927126182327,2.36522656305207
CAL-51,36314,1.3238047725901672,-1.7400413629926783
A2780,4917,2.608891014350475,2.9488102609620874
BT-549,446155,2.043062772915461,2.874858690898892
LOU-NH91,2828334,6.123728588021327,6.288359635334098
SCC-9,89928392,1.8759175792930969,1.6791280692642303
LXF 289,54613361,1.2100808209747431,0.29584922821299814
BT-549,navitoclax-pluripotin (1-1 mol-mol),-0.784652451279203,-0.6840881141321788
YAPC,4788,5.944205132488497,5.781876388791229
NCI-H661,11485656,2.0326011859644075,2.39651003228373
A4/Fukuda,56649450,0.8497740308893211,2.975554992338674
JM-1,151289,0.6364544108799082,0.5893500910202917
SNU-449,1566236,1.8764566240908545,2.2830114094820804
NCI-H522,11234052,4.642717967560772,3.5907638608738517
MDA-MB-453,262093,2.6969191096415113,2.679305959305625
SNU-449,36314,1.881882754123643,-0.29073990957196316
FTC-133,3552672,1.929463221662531,2.9372842684816174
DMS 273,44202524,0.9824733163321672,1.74602887842936
CAL-51,2708,4.939881356462198,5.0414250107407605
NCI-H661,doxorubicin-navitoclax (2-1 mol-mol),-1.1391297012173984,-1.2782039209559204
LOU-NH91,44507138,2.849532358816909,2.63236070239541
A4/Fukuda,24856436,-2.105951383298443,-0.13950849096181625
EFO-27,9967941,3.205966960393555,3.9363676773152014
NCI-H460,24964624,3.5490884182562565,2.6811705210524024
A2780,71304818,1.3100858151797232,2.21213400999856
LoVo,16065773,3.0239362353443195,2.4780433732714986
MDA-MB-157,19582717,3.2682056974125744,4.032054410911998
G-401,44607531,1.4405644617048554,1.4569078420924018
DMS 273,426756,5.171527401006451,4.086321823645153
A-673,selumetinib-MK-2206 (8-1 mol-mol),2.344238409661225,2.0220241580306424
A-673,3465537,3.0102553460613626,2.470893078616029
KYSE-70,135398744,6.338938630156892,6.432903410426717
NCI-H727,439501,-2.2848783314382133,-1.9723334741116707
EFO-27,1750826,-2.462449966677767,-0.9531835861977394
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236,1.0659365428101666
NCI-H2171,15547703,3.4091207334536717,2.804994255062254
BxPC-3,24753719,4.274594841538204,4.384848643510575
A2780,49846579,2.326369228321655,0.8213679381111437
KMRC-1,135398516,2.513650186922018,1.9861500397380019
LXF 289,12001922,1.5738020993239468,2.19255488450272
OVISE,107985,-3.603598955800668,-3.27865876915928
FTC-133,crizotinib-PLX-4032 (2-1 mol-mol),3.9800326864083506,1.7589790089131674
MSTO-211H,51039095,-0.728954813106199,2.7392415310548506
MDA-MB-453,24856436,0.153871218683687,0.5117856737666174
OVISE,12003241,-0.8183931153803442,-0.7716620272268228
JM-1,219104,1.4868441806857289,2.356477409678672
KMRC-1,24901704,3.4724240700357414,3.336473775352822
CAL-51,25105715,4.077363851334658,3.384836481939704
Panc 04.03,5284616,3.514498334257777,2.8879948752402225
NCI-H2009,446155,3.3217785993510884,2.9360610161563887
NCI-H1623,66577038,3.365380490578284,2.9647893956343205
NCI-H460,72193861,2.1658883750752844,1.6684028926603995
NCI-H522,17755052,3.243909986839396,1.5993649914395265
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655,4.4985597664060215
LoVo,9936388,-7.372990206557469,-0.95376226988406
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742,1.4710840791665745
A2780,46907787,0.387414270491788,1.23160520525227
A-673,25150857,0.7583223763798244,2.0532863665060326
KYSE-70,11175137,2.267736133904179,2.7265840188021917
KYSE-70,6852167,2.2981101713941814,2.605916308200705
SNU-61,3081361,2.723820700669796,2.0968954636844916
NCI-H661,6252,2.9131036022991728,1.2419767862584
NCI-H1623,9903786,3.0418604220511436,2.8695219355123895
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.34104707231282133
NCI-H2009,JQ-1-navitoclax (2-1 mol-mol),-0.3100400196592782,1.1315209881842463
SNU-449,10322450,2.7236273289045942,4.023078681643373
LXF 289,4096211,2.4023988219433337,2.213984576845357
SNU-81,10026128,-0.7780702377310673,3.646870240412206
KYSE-70,6610216,4.087252338732691,4.091984297070243
MDA-MB-453,44607530,0.880863900568506,1.3984713170576382
NCI-H522,24978538,3.1859390482195216,1.0368350544480034
SBC-5,107970,3.247043743319875,2.3825934800152098
DMS 273,969516,2.584462316279732,2.485969929541202
MDA-MB-453,5284616,0.7898078062241378,1.3392246994180725
A2780,16720766,0.7344228111589829,0.27821947235396055
OPM-2,25154868,3.783948059993976,4.06868916458491
DMS 273,44493528,4.2569430545307725,4.1146699062075385
MDA-MB-157,25022340,3.479219964634342,3.17541337040697
LOU-NH91,15547703,3.808438680736899,3.4167658660261715
CA46,426756,4.77193452473935,3.7873055073816646
DMS 273,2858523,3.0502279484440233,2.9575206352469277
EFO-27,3676137,4.310046032716647,4.7000229430263225
MDA-MB-157,3025986,-1.856662168016076,-0.909184313815275
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705,-0.1479901941837615
LOU-NH91,44607531,1.3180545967249335,1.6246702208780568
G-401,46215462,1.5390133747858452,1.774111477205492
OPM-2,7251185,0.5721351512480617,1.6588659246443767
CAL-51,15953870,3.220977372988981,3.5475412981519368
YAPC,11964036,3.221056153642411,1.2787796198923425
BxPC-3,208908,2.4547812946400502,1.8078550764019394
MDA-MB-157,44589607,1.2787513073565453,3.054799422016911
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868,0.011505350706759647
NCI-H727,72193861,2.684204612264405,1.399680502589826
MDA-MB-453,5287969,-1.436813958809434,-1.998728586364695
NCI-H727,15983966,2.109759483394555,-1.0669132172259084
KMRC-1,216468,4.973373200756221,3.11959784620552
SNU-449,52912189,4.380826008996873,2.350483540626613
SCC-9,46174525,4.3512864598075645,4.663218673297364
A2780,3011155,5.55303778809739,3.1534460352188307
SBC-5,135999136,5.333154079184271,3.8734706254644085
YAPC,322968,3.8135092450764656,3.9323668386624244
SNU-449,vorinostat-navitoclax (4-1 mol-mol),2.197410731070427,1.1164513646328458
NCI-H146,5328940,1.6811042727449883,1.6326694746156463
CAL-51,168313200,3.900876548563449,2.9474128487500484
DMS 273,1750826,-1.913269562568005,-2.487495286224755
A2780,54618305,3.781380565087532,4.40354840055927
NOMO-1,9936388,-6.523282887173488,-4.8147952042152875
NCI-H460,5282054,4.802373462225767,3.9358642626946687
SBC-5,82146,3.3774942308101785,3.9031198358322508
NCI-H727,56946209,-2.7175198163763232,-4.111936144275878
FTC-133,3062316,3.806169585149848,0.955991175163326
A2780,9967941,1.4564169862408056,3.441100120863727
DMS 273,5351362,1.0025978169272032,1.1583538270238287
SCC-9,16038120,1.877705535955449,1.3871685909402376
NCI-H522,6917907,-6.015261010654924,-4.802060015958315
CA46,4477,-0.2706834990523855,0.45667157228007854
NCI-H661,erlotinib-PLX-4032 (2-1 mol-mol),2.455448460706525,3.0736412647281997
SNU-449,11178236,-2.056078636199096,-3.2068181182027997
SBC-5,5278396,3.3013936373431996,3.5297876358110782
NCI-H1623,44493528,4.638812765070766,4.322616162290731
NOMO-1,16720766,-1.891739380903732,-0.4296591932545746
G-401,2729026,2.5705443446476828,2.5465830592085643
G-401,6917907,-5.905222634362146,-5.650262829761418
MDA-MB-453,2858523,2.664825786894245,2.999963990986665
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.6204480178389533
LoVo,11427553,2.604805449600099,3.017117802956429
G-401,11234052,3.7167035951130423,3.412458023075637
FU-OV-1,168312962,3.576057642182836,1.8394482456263896
JM-1,11228183,-0.9199972643114134,0.34651594963762766
ONS-76,65628,4.406189432641036,4.299153813266237
Panc 04.03,11964036,1.4501208375942458,1.6178532086634863
YAPC,17759555,4.434513834785858,3.4465277559200302
Panc 04.03,5311,1.931700632460216,1.569809814491724
NCI-H522,tretinoin-carboplatin (2-1 mol-mol),5.2025586729101185,4.181763821095748
NOMO-1,49793307,-3.1091933140229,-3.9742609779229854
MDA-MB-453,46174525,3.691895458218128,4.273066040769568
G-401,11977753,-3.640604480016117,-1.7355440613622497
A-673,16722836,0.9037523157925,1.380507066215965
MDA-MB-453,5494449,3.8003034085581993,2.3121202553803486
NCI-H522,25150857,1.47132219158847,2.0950448148872334
OPM-2,5311037,3.4844810711382936,2.70383869276756
LXF 289,11152667,-0.4789950074309144,-0.2618104719104778
CAL-51,9911830,2.6702149728757343,2.52544923635857
KMRC-1,4378219,2.060133570967863,3.062752381195226
SNU-61,navitoclax-sorafenib (1-1 mol-mol),1.8672566595023088,1.1097826019798582
CAL-51,156414,1.13799157004995,1.5450079084984625
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173,1.5773674376161855
NCI-H727,89928392,1.7873251449620886,1.7145788329708378
KYSE-70,6918837,-2.6267197721971582,-2.9689967649988036
JM-1,135928012,4.176764785732949,3.557108959475347
NCI-H522,10427712,4.202859541756615,4.047761334448591
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.9524555647636133
CA46,5470400,3.727677755196873,-0.27937877589935645
KMRC-1,navitoclax-pluripotin (1-1 mol-mol),-0.6870292633838142,-1.1839029231989506
EFO-27,9936388,3.039710224097925,-0.26943108050100767
NCI-H292,54618771,0.019803014891406,1.2290808234101371
KYSE-70,25262965,-2.1035778811550836,-1.3075438009693001
ONS-76,selumetinib-piperlongumine (8-1 mol-mol),-1.0642702210035522,2.9716849608547142
MDA-MB-453,11656518,1.9818038641727111,1.204299115222305
YAPC,5282054,4.005772938817316,3.9215483380214224
SNU-449,24180719,3.8016565421464072,3.6493773391400803
FU-OV-1,15983966,2.2280291717608947,-1.2001963511692788
SBC-5,11485656,2.2866280503579812,2.399249085374194
ONS-76,702558,5.821489397293988,4.988390258074516
SCC-9,9911463,4.4493328300482995,3.999030646860804
HSC-4,72193861,2.788231918333871,1.9687186503629224
DMS 273,2126,4.20633218634453,3.6474307430957644
OVISE,46199207,4.361349086507746,3.302026449586636
Panc 04.03,241158,4.444137488799797,4.117347242876438
NCI-H460,654092,0.4612941847378306,-0.24434378196612794
A4/Fukuda,45279963,1.9027034071047564,2.853692427297335
NCI-H292,44259,1.4427392496176257,1.1745943927842482
FU-OV-1,17759555,4.190415677120393,3.710137654916197
SNU-81,3634881,2.620060882721275,3.0183044611761414
NCI-H2009,107970,2.2954238398166344,2.43745385677057
LoVo,5278396,2.046108484267772,3.5473250431433314
NCI-H146,vorinostat-navitoclax (4-1 mol-mol),-3.3112811386444525,0.45622459213832445
HCC1143,12003241,-0.0421467164139253,-0.6676798943434535
Panc 04.03,46926350,-3.8788763459733473,-3.869777195038605
A4/Fukuda,4578,3.815086457915261,3.9255719200091606
CAL-51,9929138,6.421072450841616,5.539236757810976
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383,-0.9141488042872881
SNU-81,4259181,-0.3131255720640173,-0.1411362571193052
KYSE-70,675434,4.695192974207532,4.526902193363781
A2780,selumetinib-MK-2206 (8-1 mol-mol),0.1736531975308503,2.195847533246524
A-673,135659046,3.595490040408381,3.5915370726858242
NCI-H522,4578,4.727447650100284,4.204312058418953
DMS 273,54765302,4.301325739041371,4.123068178030696
A4/Fukuda,135440466,-0.9873079875011114,1.8261124539014657
LXF 289,24821094,2.4128137194258215,2.9309637794625307
NCI-H460,5746,0.0249012606464236,1.5258868805968198
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195,1.514035605799949
A-498,25062766,2.0793230877467166,2.369962996260602
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058,2.990222026539004
Panc 04.03,10127622,4.886231353649791,3.9564214224491194
G-401,57330099,4.350194890812272,4.192335413812761
NCI-H1623,168312962,4.13769742192025,2.225083676044831
SBC-5,5566,3.1825236444892124,3.0146367279244424
Panc 04.03,9825149,3.055289787116955,2.3839065042373093
BT-549,11507802,2.533090965918468,2.0740344051939195
OPM-2,5951923,4.162321290800766,3.3488415793088757
MDA-MB-453,salermide-PLX-4032 (12-1 mol-mol),3.8592412133005265,4.660565200918674
NOMO-1,9935249,2.770043096032674,1.2773651905136425
LOU-NH91,11640390,4.567382593568383,3.8679981685155895
MDA-MB-453,135440466,2.739035638886915,2.1173581262625993
HSC-4,644241,2.6183127396598262,2.4289071286098736
MSTO-211H,17755052,-0.0733710656781619,2.1907892841940577
A-498,crizotinib-PLX-4032 (2-1 mol-mol),2.697469324317316,2.2578694452234633
BxPC-3,5281321,-1.5422365883768068,-1.0578984216695746
MSTO-211H,9444,4.1850544738080915,4.193205771894743
LoVo,17755052,-0.1303127354802701,1.7726641573542452
KMRC-1,44137675,2.117874577310701,3.779859133622982
A4/Fukuda,9911463,2.417745886609146,3.2374076833567136
MSTO-211H,3101542,4.302130070317232,3.0171362115612936
NCI-H146,426756,4.36191990335561,3.9981501924063974
Panc 04.03,44589607,3.8783822611027454,3.2198659840928405
G-401,24901704,2.2796887972749307,2.932284263289408
MSTO-211H,285033,-3.2380358495287695,-1.5255365902781466
BxPC-3,452548,1.628130986083035,0.5445047158897158
SCC-9,9926054,1.898935947612019,2.112153125040112
MSTO-211H,1750826,-4.930051018535606,-1.2251578693125706
NCI-H2171,navitoclax-sorafenib (1-1 mol-mol),0.0359030592746101,0.39998724751438064
HSC-4,216345,4.5807127841732775,4.180878414239811
LOU-NH91,168312962,3.892175490150028,2.8231884840309784
MSTO-211H,53232,-0.5437095856797647,2.760321716324707
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576,0.36252573048934544
EFO-27,5335621,6.264647611417884,4.634207084621934
CAL-51,1716436,3.275997904874087,3.0319940420607163
NCI-H460,53232,3.485336782178725,2.78052976495337
MDA-MB-157,54454,1.950382699789776,2.2530172076573796
NCI-H292,44489367,4.492014578968512,4.790452174954157
KMRC-1,4521392,4.136909747869898,4.281992467331969
HCC1143,selumetinib-PLX-4032 (8-1 mol-mol),-0.2774552513051289,3.817543050613979
HSC-4,56649450,2.6853332826773144,3.290140507933776
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.6863240356254825
BT-549,9926054,1.9687680834705423,2.2266345768239155
SCC-9,9911830,2.3699428367857145,2.761433567358046
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,4.536117671255507
FU-OV-1,409805,4.026686349090877,4.929421422596567
BxPC-3,387447,-4.571753731996322,-3.9719987717278378
CA46,44486219,3.6158388001945463,3.6724736039651718
EFO-27,135659046,3.7618075322397297,3.6583480615594492
NCI-H661,104842,-3.978937701952532,-2.906097896231856
SBC-5,16741245,1.694771238369721,3.8150465664335718
FU-OV-1,676352,2.7826635655764473,2.0778174664419664
CA46,969516,2.1845952347247306,2.212065698800846
ONS-76,decitabine-navitoclax (2-1 mol-mol),2.571137533276933,2.2812853318715645
HCC1143,9825149,3.0211594258387486,2.293126381712222
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785,-0.34151100147261837
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935,1.5788635355161236
MDA-MB-453,selumetinib-UNC0638 (4-1 mol-mol),4.2655945403569815,2.463355275237434
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272,2.100805907097688
MDA-MB-453,676352,1.703646310562033,1.850300313110808
CAL-51,46191454,0.2698308836515951,1.5971404977294292
Panc 04.03,9823820,5.907522872650916,4.171680945417045
SNU-81,44259,0.6272555485824429,0.8294372710408523
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325,2.9020657733158783
EFO-27,445455,4.405247459654703,4.718268571985465
BT-549,11152667,-0.4620191787747055,-0.26996047066911494
HSC-4,23725625,4.12890848458229,5.308357987615276
BxPC-3,11640390,3.353927872983648,3.753438897664953
HCC1143,216468,1.9778651637296407,3.2567296240933037
Panc 04.03,49766530,1.2448845141630578,-0.19462184615965542
SCC-9,10427712,3.976850957625781,4.302566106734709
HCC1143,36462,4.303888689757339,2.390484961294939
NCI-H460,262093,3.3627537421549314,3.076725004216496
SNU-61,56963564,0.6866306287041547,0.4083152913029335
SNU-449,2858523,3.0307383113048676,3.129439208903617
KMRC-1,11214940,1.677559369833433,1.9082033264595477
A2780,216239,1.3949646663017006,2.24825778826473
MDA-MB-157,89183176,3.472749903375588,4.472165859008759
NCI-H146,11152667,-0.8780602169524299,-0.2124165463234906
NCI-H460,9956119,4.485375019847723,3.7497281596197922
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.2741999757407774
A2780,BRD-A02303741-carboplatin (1-1 mol-mol),3.111500594060002,4.313203309187572
DMS 273,6450551,2.589238729256945,1.7255171018107007
NCI-H2171,5311281,0.8399284053106422,2.4086707850829265
SNU-81,23635314,-3.737654632526069,-1.3996050982143975
FTC-133,119182,-0.5312905210850081,-0.3038907788809583
A2780,656346,0.4231070640442763,0.8995631173183566
HSC-4,441298,2.8371907900438535,2.8055297090111524
MDA-MB-157,285033,-2.194765851649468,-1.6501704873946732
JM-1,73707398,-0.8556338999048841,0.4740984365463049
JM-1,6852167,1.3157742507093588,1.5832956242681018
A2780,11364421,-5.7057574677584295,-3.2326147370040546
NCI-H522,54596490,4.410611853984333,4.345369025624874
NOMO-1,159324,1.6027654254866297,1.2773651905136425
A-673,107985,-4.827881226135439,-3.7867758586513083
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,2.0082597271752154
NCI-H661,5287620,-2.104840782561513,-1.9186116341107478
LOU-NH91,119182,4.180997641513534,-0.3309928366944689
SBC-5,10113978,4.162999994539472,3.267469588503223
A-673,252682,5.861850244558702,6.583096052076792
NCI-H2171,5281321,-4.274427204887198,-1.921657731491228
EFO-27,3854666,3.6632128701571194,2.7010481689992276
A-498,25154868,5.700321852894753,4.59221566966247
LOU-NH91,JQ-1-vorinostat (2-1 mol-mol),0.7101877793592652,1.3429389152578954
CAL-51,31703,-2.726607914110417,-1.144980121020215
KMRC-1,9840324,5.892638074147807,5.891529239469879
BxPC-3,49850262,4.227475038244019,4.089055408388991
JM-1,6450551,1.340572992486765,1.013842164308432
KMRC-1,148124,2.1112012667960656,-1.2611925254803322
MDA-MB-453,navitoclax-gemcitabine (1-1 mol-mol),-2.0425828682575684,-0.4187596532360354
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528,-0.0874318145185664
NCI-H522,7326481,4.603358487226629,2.9646546072711635
KMRC-1,3025944,4.220614757043024,4.245887040656108
EFO-27,9935249,3.352272124535396,3.2648279656375756
SNU-449,10296883,3.939630786750968,4.042872483584911
A-673,42611257,3.360985567795572,3.3521349853739815
MDA-MB-453,156422,3.699160121301749,4.063595523085953
A4/Fukuda,89928392,-0.3543848103605003,0.5141235189151839
SNU-449,10385095,1.0986031812390589,1.3946782382406206
HCC1143,6438330,1.6030228226948184,2.6449893872423234
MDA-MB-453,3854666,1.8999840682298523,2.0775048016215387
SCC-9,46191454,1.8170261878735936,1.7582591465721942
OPM-2,9825149,0.9763440152106764,1.6168702190191573
NCI-H661,vorinostat-carboplatin (1-1 mol-mol),2.835829919183064,3.183603410855948
BxPC-3,25150857,2.298115585090939,2.5767951718261526
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033,2.608340467689359
NCI-H2171,25227462,0.3993487036849301,-0.21045002517943018
JM-1,24748573,1.2692721555493711,1.4909560939615256
EFO-27,selumetinib-navitoclax (8-1 mol-mol),4.865349283387626,2.2578461992948236
JM-1,doxorubicin-navitoclax (2-1 mol-mol),-4.099692246271054,-2.6279772229698186
KYSE-70,5281321,-0.9979352327108848,-0.9677349207832342
NCI-H460,11507802,2.848054270429628,1.9613011397551912
SCC-9,4259181,1.940043087837339,0.49149151681375775
ONS-76,135421197,2.4329108516652775,2.022791408795583
CAL-51,52947716,-4.729660133739893,0.2101790501463938
JM-1,123631,2.636256127990424,2.0268752515949418
HCC1143,1641662,3.4150871228937563,3.5091182221656823
NCI-H292,8515,4.694095877434875,4.17217954343273
SNU-449,71304818,1.9790204353457292,2.731792672100944
A2780,5566,2.7251077604344696,2.9764008547769225
EFO-27,82146,5.16738023752069,3.944309851562233
NCI-H727,107985,-2.9799734550318204,-3.320461004391818
CAL-51,446155,1.9002286289262065,2.6785267138737776
SNU-61,4378219,2.193359587578685,2.3175446170075333
NCI-H522,1641662,3.4912081270508293,3.0410857243684135
FTC-133,44607530,3.0000417574370157,1.8030291304735286
A-673,448949,0.8158812974066569,1.5796297319308927
LOU-NH91,20959075,-3.4746906487579494,-2.656660818275786
SNU-449,5113032,5.017862259712187,4.978679716131412
NCI-H522,6450551,3.1458433056927295,1.6341038140187123
SNU-449,16659841,4.200866251374559,4.162878841915526
NCI-H460,409805,5.4278006548731295,5.277499097748116
MSTO-211H,46943432,4.749068259324704,3.110669071782253
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425,0.6354303766992403
ONS-76,navitoclax-MST-312 (1-1 mol-mol),0.8596431807362984,1.0128919429071104
SCC-9,11455910,1.869884665357408,1.676862368152669
Panc 04.03,613753,3.3040029053289772,3.4756212912427213
OPM-2,6918736,-1.006954953557461,-2.513580610961071
A2780,3854666,-0.0414990172822217,1.3802592987623077
FTC-133,25183872,2.254027462535002,-0.45858525874720757
MDA-MB-157,387447,-4.079240132125457,-3.943437797007005
SNU-449,54618771,0.9697829427454708,1.5154373194470685
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866,1.5728040692783518
MDA-MB-157,72376,-2.1484578807410553,-1.7364259426448692
SBC-5,5287620,-1.4097460130546278,-2.276837719270948
FU-OV-1,54649381,4.3760479468817675,3.979767775894392
NCI-H2009,26596,-1.5885219134108934,-0.7921076230324146
A-673,66577038,2.223533674143975,2.9420778544160737
SBC-5,6918878,2.928817535111611,3.00196375617609
OPM-2,11640390,0.8264429779628358,2.136462002061721
NCI-H460,3503,2.4668231300278154,2.5086224116525457
SBC-5,156422,4.2102641448485345,4.085894750184752
ONS-76,216345,3.2166812322741043,3.9109496542595803
BT-549,15983966,-4.218963036377602,-1.2378584580952512
A4/Fukuda,3038522,1.5780319148667876,2.927545294111283
BT-549,23582824,0.5256314804740283,0.904422744434035
NCI-H146,2871966,-2.058689249756004,0.5997947946138753
OVISE,17755052,3.2346427318945263,2.1122046029492627
OVISE,44819697,-1.8576377458936848,0.011988133874067554
SNU-449,46398810,3.267032406348896,2.6634065126983035
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727,3.0509327722101074
A2780,11228183,2.2113347222865123,1.1474328519799943
NCI-H1623,piperlongumine-MST-312 (1-1 mol-mol),2.715053183810439,1.9566781631127024
NCI-H661,tanespimycin-gemcitabine (1-1 mol-mol),-0.3480588357963589,-0.4252783991003952
SNU-81,46398810,0.3023493978041217,2.2202489486339103
KYSE-70,11152667,0.5949086715112851,-0.5286497445361782
LoVo,73707386,4.416344333605744,2.966604965084061
NCI-H522,5746,0.3558137383480795,0.6956936069095686
NCI-H460,135421197,3.2510260026522233,2.0572383177544746
MDA-MB-453,11507802,1.551744908234443,1.7696163578649884
A-673,4096211,1.8222389073608836,1.7786574645093105
NCI-H727,136227924,3.2179651731130585,3.059620471670466
NCI-H460,16065773,2.454458456288103,2.4840169308021105
SNU-61,24901704,3.3171528895384115,2.991288676689263
NCI-H292,11612883,2.84187428422206,2.897335096880376
NCI-H2171,9907093,4.086146580877247,3.929693919940754
NCI-H522,3634881,3.092168984490579,2.7801202034647603
G-401,9915743,0.7240748800691799,0.8259145121080961
SNU-61,46843906,2.645147040347038,2.511388318885116
SNU-81,73707386,1.6277005390789234,2.5191324116239233
NCI-H1623,4261,0.4244365105903193,1.6288858945898415
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687,2.6735956109456454
OVISE,1750826,-3.1689535405206715,-1.0099142076886505
OVISE,25183872,-0.2641805795712313,-0.2956320558575138
MDA-MB-157,753704,5.007751734334353,4.984369048153138
CAL-51,54618771,0.0049145289548569,1.393161726932799
NCI-H661,25195348,2.4001868352132445,3.1495233747493194
KMRC-1,3689413,-1.8207429228817171,-0.3079055959485264
HSC-4,650361,3.951915492066197,3.8092541573080387
KYSE-70,10427712,2.9549225300897977,4.37059193285492
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842,1.2762783066069314
OPM-2,11717001,3.8340096164502135,3.69218690074118
NCI-H727,11214940,2.165075102098245,1.832738743618161
KMRC-1,11404337,1.3121470144090095,-0.006807132992301752
MDA-MB-453,24951314,-0.4314694021522904,1.1858940282075465
SCC-9,135398516,3.38372398158662,2.3270048765880045
KMRC-1,11977753,-0.1874629547163491,-1.5802345848555581
NCI-H2009,25062766,1.439977805675878,2.1942404690082338
NCI-H2171,6918638,-1.5146784294865197,-0.46321204768395524
Panc 04.03,3081361,3.5741960453568464,2.5204112574344
BxPC-3,73707398,1.0061551215696194,1.3602373206872633
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361,-0.38858639618589613
BT-549,11404337,-0.1293922368150601,-0.08608722881505161
SCC-9,5281321,1.285660121438517,-1.2425730165865039
SNU-81,104842,-4.044454085478647,-2.6697039341937963
CAL-51,6610216,4.7761200098267365,4.360372894104453
JM-1,9933475,1.5625695981291614,1.4950788189204274
NCI-H727,11485656,2.2939690780404423,2.4354838945810178
A2780,426756,4.623757394028108,4.059385621332553
A2780,5311,0.5155233924036543,0.9900785916396333
NCI-H146,11707110,3.3128142773805176,-0.18960215349140938
MDA-MB-157,11977753,-1.6055696025393866,-1.012125331421515
A4/Fukuda,11494412,-1.359408079628026,0.42886431448594614
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097,1.3417403239958354
LoVo,11977753,-2.85765012298846,-1.1390649234208519
FU-OV-1,56963564,3.5833852081145836,0.7407457420814407
NOMO-1,375860,-0.5184264862355304,-0.4903487630907829
EFO-27,3136844,4.472321824110979,4.5171432983674285
MDA-MB-157,selumetinib-BRD-A02303741 (4-1 mol-mol),5.186273377251054,4.366048899936279
NCI-H292,168312962,3.5892294654935726,2.5726607428858386
CAL-51,44607530,2.3415901962162855,1.8430099372848048
EFO-27,2949965,3.1309950522818277,2.9354086085001843
DMS 273,carboplatin-UNC0638 (2-1 mol-mol),3.439220302346012,3.221232986688071
A4/Fukuda,12001922,1.2276815023009988,1.5735781748625723
CAL-51,24951314,1.3730048574034712,1.3076848361901947
A4/Fukuda,135928012,2.23734461349398,3.8439071767570665
SNU-81,10127622,-3.2164123245129095,3.167218913415813
MDA-MB-157,navitoclax-PLX-4032 (1-1 mol-mol),-2.380477221349832,1.7789307988720142
NCI-H2171,decitabine-navitoclax (2-1 mol-mol),-1.124671467486642,-0.09367524168462445
OPM-2,122327,3.690232587907526,3.8977605682587706
NCI-H522,5329102,1.9502496806074603,1.8462834956801124
NCI-H2171,9903786,1.7901794952315444,2.7667326810725528
HCC1143,SNX-2112-bortezomib (250-1 mol-mol),-0.3762551319629964,-0.7374363136576537
YAPC,676352,2.46422610000008,2.287187921374553
NCI-H292,44507138,1.692325111571909,2.6211705664178635
SNU-449,2945648,2.540265867455936,3.1825390956868436
MDA-MB-157,navitoclax-gemcitabine (1-1 mol-mol),-2.3120540291625766,-0.7376568877225529
A-673,3136844,3.9161258830055736,3.9728975898333685
OPM-2,151289,0.8971834485048114,0.5949673627878187
LoVo,219104,3.1119995266948237,3.9842192226638713
NCI-H1623,9936388,-4.968103162812744,-0.7458598925575557
DMS 273,11485656,2.8704893197930272,1.941593943719184
LoVo,73707398,0.5951327141059009,1.2710595320930582
NCI-H2009,135421197,1.5480281661357902,2.104345554544032
NCI-H1623,409805,3.8984511674912943,5.078398538964847
CAL-51,1750826,-0.4147302595408071,-0.8889021743761932
MDA-MB-453,54143018,-0.7571444922765344,0.8829819903380741
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203,-0.5658813781145106
HSC-4,54619267,4.093335991980471,4.219740035471483
BxPC-3,4378219,2.0321108717651426,2.4044456680709243
NCI-H292,5978,-1.7096488796134024,-1.2668084941843285
A2780,71466380,3.7792629508428783,4.365646136525112
MSTO-211H,44589607,1.2735087838172758,3.148107388106863
NOMO-1,54143018,-1.1216489579847602,-0.3125455387173099
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857,-0.5679739182201878
A-673,46174525,2.7075701285598375,3.805813736144391
NCI-H661,3854666,2.0669995151297633,2.07461332948307
NCI-H1623,322968,2.7878661836218863,3.816536230955728
Panc 04.03,52947716,3.0713971775620448,0.26931971358994
DMS 273,9840324,6.645778367521572,5.471638225135897
NCI-H460,15547703,4.965379127843483,3.277371222758519
FTC-133,11228183,0.2445093238012437,2.4483201379672357
NCI-H522,9935249,3.002706281912375,2.414842883093017
NOMO-1,6610216,4.0700997553747325,4.01610697257744
A4/Fukuda,46199207,1.9027513858957976,2.730932641284773
EFO-27,16659841,4.389988364450653,4.135072706623756
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278,2.837106328247219
CA46,11977753,-4.21997551918338,-2.5200705048736602
OPM-2,tretinoin-navitoclax (4-1 mol-mol),3.1299009016579253,0.3395021126442711
SBC-5,54613361,-1.7173374464522142,0.05821893952613861
MDA-MB-157,16065773,0.9216763205067852,2.765593011925335
NCI-H1623,selumetinib-BRD-A02303741 (4-1 mol-mol),6.385895152539582,3.4020203583299646
SNU-81,44137675,1.234825635215107,3.310936692215891
OVISE,9929138,5.66720682434708,5.394515296088517
Panc 04.03,16725315,5.278537246983346,4.646329776278415
A4/Fukuda,6438330,0.8804707138455458,1.5336989002673331
NCI-H292,984333,1.6058463338689488,1.173718815561043
NOMO-1,11396600,3.3888037624860674,2.8237136521686255
SNU-81,24964624,0.6434241987426411,1.841590118201035
BT-549,11964036,1.9997330886235436,1.5516221419308633
A-673,135411,0.3370419809316401,0.2511186911732452
NCI-H1623,10296883,4.489600285768525,4.129987566887074
NCI-H292,2733526,4.552154891253422,3.8371756714255407
YAPC,6914657,-3.2827547721856423,-3.886737623792072
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459,1.7752662406861515
NCI-H2009,327653,3.1880644035572825,3.4340424446593345
CAL-51,3384730,2.4775948365465905,2.9418421046730816
FTC-133,3689413,-0.3036251064519336,-0.08599781332610547
MDA-MB-453,11964036,0.3676608059270313,1.3059107587621321
NCI-H2009,5281321,-2.3281539094269843,-1.2528974217477187
FU-OV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.708642246881296,2.1558429952304405
LoVo,654092,0.3814222362545946,-0.14834729756499887
MDA-MB-453,50905018,4.488581944485688,4.175376237016474
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736,3.000203010749423
OPM-2,46215462,1.142494911690201,1.2083235724757917
SCC-9,navitoclax-PLX-4032 (1-1 mol-mol),4.098864709147574,2.1544376470308584
A4/Fukuda,5329102,0.822909221294871,1.559160763180121
A4/Fukuda,11228183,1.827405863351363,0.916299405144498
Panc 04.03,5460769,2.0457621674825224,2.7806625298468783
MDA-MB-157,9933475,1.5029335433067268,1.7028923611354483
A-673,12003241,-2.2168793422392103,-1.0359627690618902
NCI-H460,54618164,4.49670945938676,4.09100825868164
NCI-H292,11656518,2.099021496243428,2.200171497085316
SCC-9,51039095,3.242385267473305,3.1247625602943363
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685,4.377238996711824
SBC-5,3634881,3.763213110876527,3.1573039980553324
SCC-9,984333,1.3591962563360305,0.9950157935195248
CAL-51,72193861,0.6423702350358801,1.6776352023320902
SNU-449,6610216,3.892858260461962,4.319673062604835
HCC1143,6918837,-2.8885170378203995,-2.2075610129318117
DMS 273,10427712,3.7833762157010655,3.953747516297599
SBC-5,ISOX-bortezomib (250-1 mol-mol),0.5037473854516791,0.6127558071229399
LoVo,8515,2.0502092932288543,3.8924090872386343
ONS-76,5311281,3.0534152046102507,2.685676431819469
EFO-27,100016,6.711163327148508,6.313079402690963
A-498,6610216,4.284288503720797,4.4024643408707655
SNU-449,docetaxel-tanespimycin (2-1 mol-mol),0.921733403174168,-2.074715623078547
G-401,71466578,3.958692091033976,3.7422083457801767
A2780,2749,1.2168739363641357,1.4677577535966275
LXF 289,23635314,-2.0420734326640253,-1.971612495444771
LXF 289,24901704,2.332916050939017,3.4704731352070066
LoVo,9887053,2.8676927346989265,4.149968957203919
OPM-2,6918837,-6.102124609605729,-4.437000550695947
NOMO-1,72734382,3.160209893803666,3.61612463059272
A2780,44507138,1.3155442648841038,2.3044499586344007
NCI-H661,9915743,-0.8538809858854721,1.5549380526563754
SW1463,168313047,-3.1836020137929246,2.484023686958039
SNU-81,55283,4.080745185244615,1.9285906511022932
YAPC,159324,3.323857793241652,3.387785724313344
HCC1143,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9300366262923152,4.092349914216956
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194,2.7379977855905757
A-673,31703,-3.778183583095139,-1.8964915628607042
OPM-2,439501,-4.648238189793765,-2.2834619250330777
A2780,452548,-4.864509732913544,-1.0518275666932717
CA46,71304818,1.9606514180280712,1.7146117367986082
LoVo,25150857,3.1045912764862056,2.5593485277364287
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915,2.1909166803447446
OVISE,446155,3.256033609420766,3.063015418083128
SBC-5,54626689,4.608121703383126,4.7613638367348905
DMS 273,11497983,-3.3171386440582467,1.781053279592256
BT-549,46398810,3.037551805065761,2.735506691511599
KYSE-70,44819697,2.67312291481412,0.06557633601222124
DMS 273,10113978,3.3411401717417135,2.509672969430914
YAPC,11178236,-2.1853000629740342,-2.994237777150405
EFO-27,89928392,2.3405290602814586,1.6574656843079472
NCI-H727,3062316,3.1124899612632135,1.730173452505268
MSTO-211H,9825149,1.7087798179810727,2.4785776450781083
OPM-2,25062766,1.526966504091227,1.6475615092681537
LoVo,24797083,1.0858534416002044,1.5168806070659095
MDA-MB-157,11612883,1.9249665557248452,3.037719366491271
MDA-MB-453,24978538,2.762094535978925,0.8242634300367648
A-673,55283,2.8138583621562288,2.9538456344227138
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781,4.0894324709302685
OPM-2,11228183,2.227238978219669,0.4561191329121692
SNU-449,11640390,3.8548607423510384,3.8358823297398414
NCI-H522,5281321,-1.0736628447197911,-1.2528264075449678
NCI-H460,25126798,4.092385726400508,3.845009682377783
JM-1,9887053,1.8224498727300744,2.627660990827335
MDA-MB-453,3689413,0.605092083526794,0.25648785361485227
BT-549,322968,4.038930181616003,3.981959202136132
G-401,969516,2.4612878169829067,2.420321652554651
FU-OV-1,10127622,2.361983631252389,4.3073027319075585
G-401,5738263,2.503403034491448,2.9946037662789706
MDA-MB-453,5328940,1.6011356292327752,1.7574058128373966
HSC-4,25105715,3.6888708464756337,3.478854697201425
G-401,5291,3.6897209629580616,3.2955137959335015
SNU-81,148198,-1.0516438667772403,-3.221698497587023
FU-OV-1,25183872,1.8271723160300688,-0.1805396692505078
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,2.0486040255792117
JM-1,9935249,0.9666917954448688,1.2367612455400774
JM-1,44607531,1.0390724505323097,1.0343351642309264
BT-549,5566,3.2694223641451887,3.0755305937253117
LXF 289,637858,2.285720521187594,2.1575204838972133
SNU-81,56946209,-4.781557694686043,-4.061653637068421
FU-OV-1,89928392,1.4286122200262183,1.5663074448721346
MSTO-211H,doxorubicin-navitoclax (2-1 mol-mol),-1.8407653022035375,-0.7224715764581022
CAL-51,54618359,4.544084907505638,2.0008348630281096
LoVo,15983966,-3.091518031584947,-0.7636960674897292
CA46,5746,0.6077367646083516,-0.8700470685341309
CAL-51,2733487,8.211583338705053,6.20965945856865
NCI-H522,4705,3.8595388748644375,3.1208611053467648
A4/Fukuda,5284329,2.3119801528783244,2.6719219136534895
DMS 273,ISOX-bortezomib (250-1 mol-mol),0.050266361305609,0.3223676042398559
OPM-2,6505803,-0.5489645461029444,-0.7343388457650445
NCI-H146,11955716,-2.61946993472624,-1.6443000349399068
Panc 04.03,19582717,5.125237161512837,4.39816506764896
LXF 289,9926054,2.043368643335034,2.1290173424924785
BT-549,136227924,3.266068806496957,2.956869559201106
LOU-NH91,24901704,2.9181520482303585,3.5365390228029394
A2780,11167602,1.1290528312474395,2.251184837560491
HCC1143,15983966,0.2074313732487278,-1.3653832107279291
G-401,piperlongumine-MST-312 (1-1 mol-mol),1.0766364038162666,1.283788283800113
JM-1,2871966,-2.1290689366468354,-0.20676050455821118
FU-OV-1,6852167,2.292876265150526,2.847066835821675
MSTO-211H,31703,-2.679199045886266,-0.9224435246241474
BxPC-3,5335621,4.830409945539455,4.699859188627339
SNU-81,6438330,3.0600940001891863,2.169850824940771
CAL-51,6918878,3.0110486558166274,2.9482257017312423
LXF 289,6610355,4.558728947318035,4.884970997812529
KYSE-70,12001922,1.7900886800743383,1.9903729933539787
BxPC-3,60168763,4.708123265391542,3.007616444515157
CAL-51,44137675,3.485867182081199,3.567664138848647
SBC-5,carboplatin-UNC0638 (2-1 mol-mol),4.8107215741986105,3.258734806653465
NCI-H460,216345,3.827300936034388,3.898950537035964
NCI-H522,15953870,3.615553645162116,3.501315656808083
A-673,46199207,3.2534509529249176,2.99417056159878
SCC-9,10127622,7.404435857651999,3.751287935248967
Panc 04.03,11977753,1.829262770264154,-1.1365585609702087
HCC1143,168313047,3.0210205197435935,2.7011035202532487
EFO-27,3465537,3.52414234339403,2.911472419536524
A-498,462382,4.566729065673536,0.8426501700818281
FTC-133,45279963,4.126382655862848,4.010136264632056
G-401,71751553,4.092007605377758,4.114236701328811
MDA-MB-453,119607,3.891659451485504,5.171900544873977
MDA-MB-453,3384730,-0.7236289420344145,3.1385574632106006
SNU-61,6184667,2.8549853776409937,2.684767762526848
NOMO-1,23635314,-2.3321691272104697,-2.834823566282326
SNU-81,54618164,-0.3986435357924686,3.8723636482996424
NCI-H727,65064,3.1010913931031867,4.948483245927532
CAL-51,44607531,1.640429423812436,1.6443192605100305
CAL-51,72376,-2.938334648898351,-1.5067426273351157
NCI-H522,126941,-2.655181013676553,-2.848416870852841
ONS-76,3025944,4.431691617199171,4.304258731203328
NCI-H460,25154868,3.4600493825904564,4.1628925800114125
FTC-133,71304818,3.18789827914798,2.6457053662606653
CAL-51,151289,0.6583498849401344,1.2421257231567906
LXF 289,11238147,3.4273419568352006,3.0416369941159127
BT-549,BRD-A02303741-carboplatin (1-1 mol-mol),5.675509495895237,4.620549144958448
KYSE-70,702558,6.39879445367054,5.207126125686937
CAL-51,124202324,2.033990287468598,2.62310143727046
MSTO-211H,46907787,2.574686905184434,2.6849836642997507
MSTO-211H,4521392,4.029667841571139,4.285115340740795
EFO-27,ISOX-bortezomib (250-1 mol-mol),0.3269008359156463,0.6876352868663598
A2780,9549297,1.1491610880845489,2.0222161437328716
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277,-0.06222292817793105
NCI-H2009,2729026,1.97459320968498,2.843914753434945
HSC-4,5311,1.8002123285320597,1.5640742840128663
YAPC,135398738,5.4751822545753415,4.4114002693378245
Panc 04.03,285033,-1.1400173305697017,-1.4905508489088093
OPM-2,decitabine-carboplatin (1-1 mol-mol),3.56587263318402,0.49956874132261125
A4/Fukuda,71466578,0.6387062903604859,2.759568712782082
CAL-51,135398738,4.757337519270393,4.607799262285017
A2780,selumetinib-PLX-4032 (8-1 mol-mol),1.6060841409900903,3.9416230823621112
A-498,24785538,3.3641680302296564,1.9976414373750153
HSC-4,452548,-1.2537746146037845,0.40217645126631063
NOMO-1,6918837,-4.687337521865761,-4.280869977536468
A2780,6505803,-1.803583295606165,-0.8247298635005467
YAPC,387447,-2.999100837413036,-4.0909900947097215
NCI-H292,25183872,-0.4983801682636667,-0.13650884427029258
NCI-H1623,44137675,2.921297693984664,3.5425324191208944
LoVo,46843906,2.381362357237743,2.9339045210447567
MDA-MB-157,5281321,-2.46264909171439,-0.7439767015186272
NCI-H292,44137675,3.1459685562862707,3.8300233809623383
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106,0.8266996672610822
JM-1,5470400,3.917661049847631,-0.6505624412609384
NCI-H522,52912189,0.1662181985496506,1.6599291308384148
MDA-MB-157,15983966,-4.787780953616188,-0.8512798384237965
CAL-51,10322450,3.881825194853649,4.006373593634104
CAL-51,6918837,-3.0563476396929703,-2.8317537212743082
NCI-H661,54639126,4.507619035006863,3.7740121416839725
NCI-H661,5311281,4.526772174839299,2.9314920106300035
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.3237708929346166
LXF 289,3025986,-0.453776319374568,-0.3743024429714291
Panc 04.03,25262965,-1.014076783670677,-1.2606068415818634
MDA-MB-453,5746,3.800897853250581,0.4915670310215154
SBC-5,15953870,3.487984127844562,3.5948824116307194
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557,2.372195090758165
OVISE,3025986,-0.0395702470459638,-1.0421366178428777
FTC-133,5311,2.4215013743463647,1.7188333678839889
NCI-H2171,11485656,1.3701169509015756,1.7991417443188684
A4/Fukuda,5282054,2.418862118344995,2.8156108133161326
NCI-H1623,25102847,3.8675819706398418,2.594631461389962
OPM-2,984333,-0.0237710386013994,0.19132907578446598
FTC-133,387447,-3.6414317999651336,-3.746126267865752
BT-549,5311281,2.333978253730499,2.450863995973673
OVISE,16720766,3.986904391501256,0.8977692223468327
NOMO-1,11612883,1.4996443311921075,1.728668987909363
NCI-H146,5282054,2.6062567229872924,3.319900636576061
SBC-5,6917907,0.6114763356012877,-3.9877273653625194
NCI-H727,24951314,2.050368453430269,1.4688228282317295
MDA-MB-157,613753,2.6621381248494456,3.1780399841517597
JM-1,44486219,4.06629583721778,3.6746384088806368
CA46,285033,-4.358161131916293,-3.4924821329928215
A-673,9952709,2.6406542482442545,2.798262764435785
BxPC-3,124202324,2.2278087185314694,2.4320584808462757
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.34104707231282133
A-673,6852167,1.8255345198368305,2.127617555618288
NCI-H146,6610355,3.561762383324193,4.523198006693484
NOMO-1,46215462,1.6253213091786816,1.169074773769666
CA46,439501,-3.521132637790176,-2.5700922970525393
KMRC-1,5329102,1.6227643750477536,1.9716587700872217
MDA-MB-453,568763,0.1355288059345826,0.37347398128919623
NCI-H2009,15953870,4.632669867834425,3.7604157361955908
G-401,16725315,3.2068580834321048,3.7163375061375774
SNU-81,25154868,4.054299809836995,4.355438145715368
SNU-61,2742550,3.576212598776706,3.4792393880078833
BxPC-3,44589607,1.722183316619471,3.201760974007284
SNU-61,3025986,-0.1307165413786875,-0.9630641722516862
NCI-H1623,3062316,1.6941172744123574,1.643882726280983
ONS-76,16115403,-5.005393778847352,-3.6987010752743514
LXF 289,12003241,-2.348837864712453,-1.0052346114349575
DMS 273,168313016,5.378851860414917,4.061433620387391
CA46,54765302,3.694944477545822,3.648254952696173
MDA-MB-453,vorinostat-navitoclax (4-1 mol-mol),-0.1886705997266854,0.8441045437465288
A2780,10113978,1.7525717433500034,2.7609640362304537
OVISE,9911463,4.4041109725525525,3.6984758818044954
ONS-76,44589607,2.6985455021272573,2.7604282462114407
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965,4.043187337810893
FU-OV-1,JQ-1-vorinostat (2-1 mol-mol),0.8626774662663057,1.0796171150744527
NCI-H522,JQ-1-UNC0638 (2-1 mol-mol),-1.3225503189993402,1.0987147727558568
A2780,26596,-4.32263985415392,-1.738663439893509
SNU-449,53481919,3.639889931386733,4.127001918130534
A-673,135875424,2.9734448822107886,3.673296162571816
A-673,49867926,4.049605811998934,3.5429718968019355
MSTO-211H,16720766,-0.9979081980160748,0.46619140510037516
MDA-MB-157,24785538,1.324170410962965,1.9143333933454734
CAL-51,107970,2.299284460939792,2.3632678123891337
OVISE,11178236,-4.082767785475175,-2.9325205348447976
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941,2.3283597972610663
A4/Fukuda,25154868,2.544294393199085,4.2514856816572815
CAL-51,46191454,0.2698308836515951,1.5971404977294292
NOMO-1,136227924,2.5449106490851263,2.2129797509362623
KMRC-1,24821094,3.705597482955712,2.4698396987872173
A2780,5282054,2.567919090275208,3.0777213119546207
NCI-H2009,11404337,-0.0657811746758558,-0.10663126225004267
HSC-4,409805,5.399675964474335,5.031404057131912
LoVo,24772860,-3.380615847351667,-2.2068506615227745
MDA-MB-453,54626689,4.438407624810902,4.557268124263155
G-401,104842,-3.837747012299513,-3.9461406942102637
BT-549,135440466,3.2033555971359267,2.6052576534627754
MDA-MB-157,docetaxel-tanespimycin (2-1 mol-mol),-4.4000012039018594,-3.05319589911498
NCI-H460,5280436,4.847067650781305,3.6670368768544743
NCI-H727,10385095,1.3903964913374658,1.4414546699505002
NCI-H727,262093,2.950291125725139,2.9042752896857693
CA46,25227462,-5.088225796968986,-1.5432672074152085
HCC1143,439501,-0.7374061663212956,-1.7810146513298735
MSTO-211H,10113978,1.403014421240365,3.5409214360794152
SNU-449,72734382,5.7131640484247805,4.908734206027433
MSTO-211H,tanespimycin-gemcitabine (1-1 mol-mol),-0.5272277437526489,-0.4983266258852538
MSTO-211H,selumetinib-decitabine (4-1 mol-mol),3.004409574636068,4.142571593428055
BxPC-3,24772860,-3.1359973170310993,-1.7532323504005836
LoVo,5281321,-2.272723057934536,-0.9699560927564248
FU-OV-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9353082171221765,2.110305725577748
MDA-MB-453,10427712,3.2513664008238874,4.101971484507407
Panc 04.03,53495165,2.8699642151767746,1.064159348022921
FU-OV-1,54619267,4.302850520300199,4.181690771749935
MSTO-211H,24964624,0.1425074184859401,2.7191070057513413
G-401,135875424,3.147536590476696,3.402089589472759
ONS-76,selumetinib-tretinoin (2-1 mol-mol),-0.7324247564116871,3.194704592194011
A-673,selumetinib-UNC0638 (4-1 mol-mol),2.386430695912322,3.120533051342802
MDA-MB-157,9967941,1.858403940770751,3.749850566110784
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368,0.6873603850310501
NCI-H292,11497983,4.544493181272098,4.4047358234188545
HSC-4,3011155,4.427149856421904,4.295079181975124
NCI-H1623,17755052,0.7357373094762232,1.6290231160810518
SNU-61,navitoclax-piperlongumine (1-1 mol-mol),1.6755715296131175,1.0354110474440734
BxPC-3,5746,0.9856415477525818,1.2074776780607543
OPM-2,24901704,1.9220236520558196,2.2219441796729402
MSTO-211H,2858523,3.0747353868294627,3.123831312655422
BT-549,107970,2.9169966931039113,2.383168757021357
NCI-H292,135875424,4.14052752249008,4.159136072057959
LOU-NH91,107970,2.5070848864255093,2.376804955945598
MDA-MB-453,6918328,-2.060631340343386,-0.7770394293007169
KMRC-1,44566777,-0.0538941449270197,0.5345189156130618
HCC1143,17755052,1.15684078766818,2.188888329628726
Panc 04.03,9956119,4.202347043107845,3.808081801121989
G-401,54613361,-0.5160099475891917,-0.05870564071366111
NCI-H460,6918837,-0.9355989207233988,-2.4423858011401576
SCC-9,10302451,2.205114392498864,2.860760755093595
BT-549,24856436,0.2415814283223239,0.9081540049542111
Panc 04.03,25150857,3.139734816867742,2.699626329176863
A-498,9866186,-1.262750837313692,1.2785713238129004
SW1463,11497983,4.077621288565615,2.756979249059735
LoVo,124202324,1.6089295836770297,2.612018602131983
JM-1,46215462,1.389060279673689,1.2935341338335522
A-673,2729026,1.806074207860909,2.3287669166725142
MSTO-211H,241158,2.290519528489604,3.990750576625152
A4/Fukuda,6917907,-6.123586781218294,-5.288652355193842
NCI-H460,11485656,2.6212830818798065,2.420116402911575
A2780,135875424,2.703796648613349,3.5297317640003603
NCI-H292,10127622,7.746640801358069,3.8565541522921296
DMS 273,9887053,1.8082863610482875,3.120681076615296
EFO-27,426756,4.432789586131128,4.46967940226111
MDA-MB-453,2749,0.298775024907787,2.0941907680540703
NCI-H460,11222830,2.8861636193629323,1.7355260478642769
NCI-H460,119182,0.2489341964189734,-0.5420445216494391
MSTO-211H,676352,2.2606828184976955,2.1645146037800798
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816,1.3706283127506689
SNU-81,16736978,0.587276282018702,1.3872344551430138
BxPC-3,10113978,2.7603674185652536,3.780633658062863
SCC-9,6505803,-0.8932206272709824,-0.4856072269857388
HSC-4,122327,4.034102983304833,4.721299836505943
MDA-MB-157,107985,-3.8805729202788304,-3.4521528541552904
HCC1143,5566,3.096162587379626,3.045578550090091
BT-549,5738263,2.4683192628765753,3.521695230850542
A-498,3854666,2.914304878080617,2.7173344170928657
SNU-449,navitoclax-pluripotin (1-1 mol-mol),0.5416887924611083,-0.36778900867449993
ONS-76,73707398,1.7098056225756528,1.2835801289532833
A2780,10322450,2.9165978660974545,3.733058154586283
CA46,3062316,1.4079672687586804,0.2783375584373652
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664,2.554654771616121
BT-549,71466380,5.5332032048485065,4.611123115129161
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198,1.3040730397775042
KYSE-70,24180719,3.52071426185984,3.336694045285522
BT-549,10385095,1.777553004720717,1.4506219572128873
JM-1,4259181,-0.0762731042787348,-0.2772737119026163
BxPC-3,12003241,-1.7282705692868598,-0.9949402501210652
LXF 289,9840324,4.681234496405457,5.837295968059238
KYSE-70,17759555,3.816264723168541,3.5635856419850596
NCI-H292,9911830,2.887423578139022,2.6898154462267687
HSC-4,9840324,5.223554072523372,5.803589096684431
G-401,selumetinib-UNC0638 (4-1 mol-mol),3.413545127228383,3.4464730594037856
A2780,9915743,1.3754925129164983,1.0102752574819285
NCI-H2009,10302451,1.2105403110698565,3.3298140639352365
JM-1,tretinoin-navitoclax (4-1 mol-mol),0.3453404774126501,0.5388461926466862
ONS-76,9935249,3.5330143946083874,2.9107363013677165
BT-549,11427553,2.4752578658091524,2.953077772636843
G-401,148198,-4.717755806624399,-3.5666440219452493
NCI-H661,JQ-1-UNC0638 (2-1 mol-mol),3.1332466289853884,1.948226330070618
NCI-H460,5351362,3.0809857123464037,1.7282795122876677
BxPC-3,5978,-3.126756112961715,-1.3221047682114206
OPM-2,11396600,1.8817984525619431,2.879728833916792
A-673,5328940,0.9058407904985936,1.3905464465992248
LoVo,16720766,-0.1141862087465287,0.5630413763528833
LoVo,11404337,-0.8407014552816361,-0.38992554404739743
JM-1,11455910,-0.0097968256607179,0.5381253148266587
A2780,54686904,3.0280150906907206,3.444511430545034
G-401,selumetinib-decitabine (4-1 mol-mol),1.9675825066475652,2.6890510099000466
SNU-449,9956119,3.198924280342594,3.913766320148895
OPM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.9902018365290752,-2.5074948352503355
SNU-81,60700,-1.0304958014583914,-0.19237600065182486
SBC-5,navitoclax-PLX-4032 (1-1 mol-mol),2.6386672409141756,2.2169708187772934
Panc 04.03,216468,3.559067681626077,3.602628283773788
OVISE,46398810,3.0089868889673426,2.587111366484221
MDA-MB-453,11494412,1.83607541398336,1.4049053498980595
NOMO-1,409805,3.6617718212828874,3.861542228444448
BT-549,25062766,0.9643791751629904,2.1284709568698204
FTC-133,446155,0.3759987857405991,2.5650598366678974
KMRC-1,23635314,0.7760380281113136,-1.389882287600782
SW1463,15953870,3.283482316204368,3.436925487309787
LoVo,46943432,3.050109964187685,2.5689809721066648
HSC-4,46907787,5.727789952108257,2.5072598003412496
BT-549,navitoclax-MST-312 (1-1 mol-mol),1.130665765716481,1.1056116042890907
FTC-133,135440466,5.15132472260749,2.4085505238951708
SW1463,568763,0.7789022422759734,0.18352129718093269
JM-1,25150857,0.7748927856999902,1.6167585167979874
A4/Fukuda,71304818,1.5363144884487692,2.0147411107237407
HCC1143,tanespimycin-gemcitabine (1-1 mol-mol),0.1249858816054574,-0.21277073762936424
NCI-H661,24785538,4.2805678056942,1.7510785447335473
FTC-133,5282054,4.434007222498336,3.9357863344060515
A2780,613000,1.210736664046428,2.486649182774397
SNU-449,6852167,2.6501635563943977,3.2054611938577784
NCI-H1623,5280436,2.3425513929901043,3.5305039092822414
SNU-61,11625818,5.738401007397874,3.9729097038950165
NCI-H146,selumetinib-tretinoin (2-1 mol-mol),5.090146461709555,3.315638167454687
G-401,selumetinib-BRD-A02303741 (4-1 mol-mol),3.259716171612134,4.308270260757126
G-401,11396600,3.403558125152034,3.169232268243373
LoVo,11396600,2.965288622606591,3.806479731589059
YAPC,5311,2.641039705119952,1.6490550703646927
HSC-4,168313047,3.0036663016787015,2.4731340708353504
LXF 289,135440466,1.0541158239349229,2.260518148968308
FTC-133,navitoclax-PLX-4032 (1-1 mol-mol),5.2980010762745415,1.7002177885613705
SW1463,16720766,2.9834843450585193,0.8130932635216177
Panc 04.03,2708,5.3340089352485816,5.062337152608142
MSTO-211H,11612883,1.8196539401694043,3.0171689877763
G-401,219104,1.9483296496250493,2.9704763064659034
OVISE,3854666,4.260793298508907,2.616371813865626
JM-1,327653,2.4402793258430786,2.3784414010890274
SNU-449,984333,0.3609894515007521,0.7791399992620078
NCI-H146,40482356,6.02837292181762,3.7172456219252945
NCI-H2009,selumetinib-navitoclax (8-1 mol-mol),-2.134794996272836,2.426957768575373
HSC-4,9952709,2.643320259436509,3.1462102773992897
CA46,71680916,4.255070441315874,3.906216610368723
MSTO-211H,119182,-3.3068023354733156,-0.7155636981729474
HSC-4,4788,5.270141450772874,5.716323036610387
MDA-MB-453,11612883,2.003650622053601,2.5162034547402437
A-498,2729026,3.0720683032694827,2.843210838809959
CAL-51,135659046,3.6035863494873137,3.734900507068241
A-673,16736978,0.9204710311128564,1.5265900402437682
SNU-61,selumetinib-navitoclax (8-1 mol-mol),-0.634937533687344,1.708202749796595
G-401,5335621,4.041162639386401,4.14203264846499
NCI-H292,11647372,0.0082735983152987,1.5342040005600899
NCI-H661,46191454,1.844409109204796,1.9469346706634048
NCI-H460,439501,-2.362377537788676,-2.06973304670568
NCI-H146,BRD-A02303741-navitoclax (2-1 mol-mol),-1.9757799692204725,1.5695279380321159
JM-1,navitoclax-birinapant (1-1 mol-mol),0.1360362208330573,-0.11179372282618001
A4/Fukuda,5328940,-0.5379688872377596,1.2866639310434804
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125,4.327200134241569
LOU-NH91,25126798,3.943021506059378,3.9727669015316924
CAL-51,56963564,0.4281851677964957,0.5383084969234333
Panc 04.03,24785538,2.964340727211602,1.6032818100376096
SNU-449,56963564,1.9660320048352,0.7694990979549984
SBC-5,156414,2.5142262290401516,1.384492226586488
FU-OV-1,46398810,1.7086224401878771,2.6403424206130324
MDA-MB-157,426756,4.156862898324412,4.351545952981664
G-401,4521392,4.161493335374481,4.104864890728454
OVISE,36462,4.611657944155446,2.4760334709656844
SCC-9,serdemetan-SCH-529074 (1-1 mol-mol),2.940999186382139,2.0028230462986354
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918,-1.233110721108294
CAL-51,5351362,1.1872361858703535,1.5815871679066793
CAL-51,119182,-1.323881847361974,-0.6754428989860215
NCI-H522,24753719,5.009376195679754,3.9208457771273477
JM-1,tretinoin-carboplatin (2-1 mol-mol),2.443432654603248,3.6534605066036403
HCC1143,9915743,0.7364353129897024,1.005035672884799
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,2.0486040255792117
NCI-H522,24889392,3.251100273050004,3.858259044588357
LoVo,11178236,-1.6059359070935737,-2.8412776337404666
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212,4.152962778890514
CA46,23725625,5.582899861703026,3.1813337702980173
NCI-H460,25154868,3.4600493825904564,4.1628925800114125
CAL-51,36462,0.7338920585832341,2.1809889326471215
EFO-27,5281321,-1.9543223460886947,-1.114960611083087
LXF 289,11612883,1.9814919247106189,3.0817398826971782
HCC1143,2828334,6.454192166435682,6.314712532774184
A4/Fukuda,3854666,-0.0838776105349313,0.864731113630047
CA46,10322450,2.6264913036213606,2.993875289339853
NCI-H2009,51039095,1.8360035457780568,3.070187742684688
BxPC-3,10231331,0.6961573218104748,2.2494107827347762
LOU-NH91,56649450,2.5557041031897705,3.7149342501335054
G-401,216239,1.6826916037000108,2.180761190322043
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.3490920721729487
HCC1143,5281321,0.7613054606946723,-0.8856225108283214
EFO-27,72376,-1.8608022629783372,-1.2591513993950558
NCI-H2171,19582717,3.772812394316534,3.323820509134834
MDA-MB-453,10074640,2.421510718072182,2.8110940748658027
G-401,11317348,2.32763680059041,2.1018172080033155
FU-OV-1,selumetinib-tretinoin (2-1 mol-mol),-1.802800887870168,3.9389193353824687
NCI-H146,2729026,1.2131739481587438,2.659327811353476
OPM-2,46907787,-3.368300500627006,-0.2261151517366016
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154,1.9604512174244535
KYSE-70,15547703,3.259406085484829,3.3692019265278366
NCI-H522,107985,-4.282222583037789,-3.4188355584608807
A4/Fukuda,9933475,1.717973727652582,1.7908871723702786
CAL-51,6505803,-1.1525670311484852,-0.7805256728961361
HCC1143,5329102,2.41968992927328,2.0345962752799807
MDA-MB-453,46215462,2.7539180673476986,1.865961179020296
LoVo,151289,0.7390860710542093,0.9685318863339366
SCC-9,10296883,4.238304408621306,4.0582091128864946
LOU-NH91,54454,2.054793401572522,2.4590133283929188
A4/Fukuda,9884685,-2.10728676228506,-0.25993956295561127
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156,-3.349374901838664
JM-1,11317348,1.0457451678280252,1.2392205306652726
MDA-MB-157,5287620,-1.8230093056434509,-1.7403799992332474
FU-OV-1,24821094,1.823018038350918,2.952563552419752
Panc 04.03,15547703,3.067090198790942,3.6025601723173093
DMS 273,568763,0.8680081273298318,0.06040361531627186
KMRC-1,16038120,1.697027615564608,1.1218414076455399
A4/Fukuda,11214940,3.3298423014633585,1.4685898640541388
LoVo,168313016,4.599216339831628,4.7507005531090725
JM-1,3011155,4.445867330482826,2.4307214710644978
NOMO-1,135411,-0.3073928829727976,-0.08370137658508726
A2780,24772860,-3.463956246093966,-2.45882930531209
MSTO-211H,11625818,2.0984197145893853,4.363582473791677
FU-OV-1,219104,2.911303350256359,3.958809312687945
SBC-5,JQ-1-navitoclax (2-1 mol-mol),3.919217693519999,0.9608634041867083
SBC-5,49793307,2.0795512515040144,-2.8091340792675363
CA46,53232,2.437328600755792,2.637527271511628
EFO-27,24901704,4.244323432217726,3.5075025453952735
CA46,2746,0.9501634288999758,1.6669841052351624
Panc 04.03,selumetinib-navitoclax (8-1 mol-mol),2.4072445179954665,2.0854826717182124
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842,0.9148175449448479
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768,1.1251787650274052
NCI-H661,9956119,3.313685900900753,3.63199421502253
SW1463,44185566,1.4171512734588314,2.067507787605974
FU-OV-1,3384730,4.633609637548597,3.1442429402426546
SW1463,3384730,2.9539510373394458,2.620404969176195
MDA-MB-453,3825829,3.844348445708714,3.657036571590379
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937,0.773205876218579
Panc 04.03,400769,-0.067858138339059,-0.3896580483224104
CAL-51,445643,4.334473435217703,3.9076872319230493
EFO-27,156414,2.3785601677308215,1.7226459133735377
NCI-H2009,4259181,1.0344432117954978,0.6041916424417941
MSTO-211H,16722836,0.7655247341289007,1.868524406634736
SNU-81,11364421,-4.012430935720713,-1.9436819213934038
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.4173295137067647
A-673,2746,1.857945511282164,2.528448009613909
OVISE,navitoclax-sorafenib (1-1 mol-mol),0.9257424766739848,1.9266288375377647
NCI-H460,135398516,4.13019906717736,2.269437900400517
BT-549,25183872,-0.4430920052505824,-0.7331654756193317
JM-1,49846579,-3.8749150343559498,-0.7250764228163732
NCI-H522,10127622,6.598645867237379,3.664041335751073
OPM-2,446155,0.7744505725193765,2.409081417413533
G-401,10296883,3.7583450228982342,3.5929566519230036
DMS 273,1716436,3.74376938939547,2.6997077479695
SNU-449,serdemetan-SCH-529074 (1-1 mol-mol),2.2114452533334212,2.2932339591831066
NCI-H522,44566777,-0.9754694174653856,0.6490004102386395
MDA-MB-453,53393127,2.113910519669698,3.7669738442843057
FTC-133,49793307,1.1308238833509443,-2.212652671371652
OPM-2,carboplatin-UNC0638 (2-1 mol-mol),3.55532531474596,2.758958442037878
A-673,135928012,2.926877088120134,4.047797282275672
NCI-H661,5280436,4.871704282803626,3.6096476027071724
NCI-H661,docetaxel-tanespimycin (2-1 mol-mol),-5.324368950628822,-2.5396409577606978
JM-1,5282054,2.3244175489984573,2.4132214285390674
JM-1,9549297,1.5955396397117223,1.443515475082747
NCI-H460,11507802,2.848054270429628,1.9613011397551912
A-673,387447,-4.940230504934896,-4.6349043484433805
LoVo,89928392,0.5944678691764933,1.5480595952762746
SNU-449,navitoclax-MST-312 (1-1 mol-mol),1.1854227296029016,1.0412981786737676
BxPC-3,doxorubicin-navitoclax (2-1 mol-mol),-1.6348135682657186,-0.8313275975424268
NCI-H2171,67156097,-2.093355563734418,-1.4852735362116634
CAL-51,9929138,6.421072450841616,5.539236757810976
NCI-H522,11609586,2.3447481698139545,2.4654998367077847
JM-1,56946209,-6.537344033049601,-5.053006426567175
MSTO-211H,54649381,3.373909346349482,4.138937084832259
A-673,4261,1.089626824326701,1.058445682157786
SNU-61,56649450,4.501229591303133,3.0750362239535787
EFO-27,5738263,4.449588569174732,3.570906096768647
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515,-1.8187332500324909
EFO-27,462382,1.6036436678954449,0.3407945112788605
BT-549,24180719,4.750015939259711,4.025495519485116
HSC-4,73707398,0.9895931551524366,1.5453016027746753
LXF 289,52912189,-0.1394416798850269,2.7029483581374234
DMS 273,BRD-A02303741-navitoclax (2-1 mol-mol),4.151780169779293,1.8887903139196818
NCI-H2009,31703,-0.97323545782719,-0.592221014451436
NCI-H2009,219104,3.953506929532588,4.189010997759909
A2780,11626927,5.568414170846121,2.1340585978139854
NCI-H1623,navitoclax-pluripotin (1-1 mol-mol),-0.2970825131911801,-0.6029747721879102
Panc 04.03,4788,6.095957987809042,5.790065570600368
OPM-2,4259181,-0.0185783035827133,-0.3542868780203372
LOU-NH91,9915743,1.51930479588737,1.4583192159170044
G-401,2828334,5.836351566381613,5.836537927136841
LXF 289,3689413,0.4542816941401804,-0.35207386935848567
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467,1.365534813453757
SBC-5,119182,0.2964340092945935,-0.2673094480572237
JM-1,2729026,2.071801783442454,2.2403985060655716
SNU-81,11214940,1.7135053171337324,1.453021547581184
SBC-5,439501,-2.4874901722547977,-2.391305286428866
OPM-2,46174525,3.627220507837432,3.291420136823536
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402,-0.05287795404049453
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765,2.274255436303393
NCI-H2009,3062316,-2.678423554108453,1.7163720759837142
HSC-4,6438330,1.0116267584860468,2.3167932291728643
A2780,1317464,4.304763369285543,2.4255716827924916
G-401,3025944,3.816605103301755,4.071884051927205
NOMO-1,9915743,0.4758643096003905,-0.013070599257599262
CAL-51,9877608,5.917079709597661,3.2291365700962755
LoVo,71466380,3.017013363980257,4.44501900043386
HCC1143,53392493,2.60613854373917,2.526997933936793
A-673,6918837,-5.129930095166698,-3.8535607691529976
SNU-61,60700,1.2670278964841577,-0.3716859693333958
OVISE,6918837,-1.5846953199834826,-3.0351032108826517
NCI-H727,11609586,3.3120945172723917,2.870443004017381
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415,3.3581849946832807
NCI-H1623,5281672,4.562545083615407,4.686367523781787
NCI-H2009,6918328,-0.9509353973047906,0.2624936072829225
LOU-NH91,vorinostat-carboplatin (1-1 mol-mol),3.369896826709664,3.465213551452793
OVISE,16722836,2.434488476233433,1.8218802376283356
JM-1,10127622,5.153041805169496,3.7110500873540553
NCI-H1623,252682,6.46254793762087,6.651053064284975
JM-1,53392493,1.8440760854554048,1.7724621227201525
MDA-MB-157,168312962,1.1798186112423137,2.3793978438538765
YAPC,44819697,-1.3460219164430964,-0.008003983136411947
KMRC-1,44607531,1.585622780528836,1.5702342998037468
NCI-H2171,6918878,0.0284372668850805,1.7020726746661392
MDA-MB-453,44607531,1.359301388322155,1.1518924542362137
ONS-76,11485656,2.5953354109263262,2.3587078606218164
MDA-MB-157,135398516,1.565807276365399,2.0186461702423975
A2780,24753719,3.5545225878481745,3.8282802595459935
NCI-H661,6918328,-0.1140400883450083,0.1651926044640388
JM-1,4578,4.1991230056704785,3.683260399780979
A4/Fukuda,9903786,0.7546004224414102,2.089326875128392
CAL-51,11485656,2.6541256228973773,2.458893037624345
NCI-H292,24964624,2.911439833663599,2.708391141223038
NCI-H661,6918837,-3.3797686305940156,-2.606295779840732
EFO-27,71304818,3.2919872626583486,2.6550357440597736
MSTO-211H,4705,2.457156821386339,3.0814285526775915
DMS 273,107985,-4.548014092027974,-3.368529797059294
SNU-61,2729026,2.4451253635155106,2.655074766786005
JM-1,60700,-2.9904484465209036,-2.1327220661512194
SNU-449,JQ-1-MK-0752 (1-1 mol-mol),5.5892167281424285,2.2214324926402544
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257,3.6128452445124024
SNU-449,24856436,4.072390930567189,0.6770226848433765
NCI-H460,159324,4.0462841352482855,3.2750248520314362
NCI-H2009,11175137,2.49599907102206,2.9077020714497688
A-673,208908,1.851861192467165,2.221958516884122
BxPC-3,25183872,-1.12027566647844,-0.46753443242709053
EFO-27,5328940,2.731901822530229,1.983234335918484
HSC-4,135398516,2.2759469773851224,2.2294097605583163
HSC-4,11647372,1.1815136799972823,0.9120581480641167
CA46,16038120,1.1324791438314847,0.21558178757122587
MDA-MB-453,9868037,1.568237926564538,3.2917846612481134
A-673,446155,1.1478268834845686,2.5684862834682836
A2780,5479543,3.565203320915574,2.907320327453907
MDA-MB-157,10322450,5.067042624032479,4.052294540590697
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236,1.0279993141859596
MDA-MB-157,9915743,0.9957990206413116,1.0739180990098136
A4/Fukuda,219104,2.2512696330904447,2.435404004709141
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723,3.341756051499756
SBC-5,12001922,2.404615034975172,2.020805954075874
A-673,51037431,1.861905373589415,3.3344461707115896
A2780,637858,1.382423379201008,1.4708586236432617
NCI-H2171,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1592201049133759,0.669884402850993
A2780,9884685,-1.5939943621043984,0.18189676716971104
JM-1,5311,-0.0672732572458771,0.42666349114352586
CA46,15547703,2.518572103836232,2.3556938841958526
BxPC-3,54618164,4.016743819691475,4.246799787953014
BT-549,2749,3.5786970568950913,1.9815104131143415
SNU-81,73707398,1.1294477244846828,1.0787830428629188
SNU-61,docetaxel-tanespimycin (2-1 mol-mol),-4.617294417621486,-3.132904440544248
A-673,55508,3.3138750706926157,2.6016525686032144
SNU-449,carboplatin-etoposide (40-17 mol-mol),5.135900435909966,3.1017942408590438
MDA-MB-453,23725625,4.029710365908802,4.796090917442481
A4/Fukuda,4261,-0.9007526332595048,0.825283570881219
NCI-H727,446155,4.65589483782911,2.9485653366651574
NCI-H1623,44486219,4.206804435599472,4.279700343466959
MDA-MB-453,441298,1.8295928982069447,2.621789841608956
SNU-449,54454,2.520106415523585,2.661356659251891
A2780,387447,-4.368237522415053,-4.551903933218658
MSTO-211H,11152667,-3.5300772231011703,-0.26781310184497376
SNU-449,25195348,3.622170031481097,3.6017315286277607
MDA-MB-157,322968,2.1225136411127545,3.967313578958084
A2780,168313200,1.7543183926879495,3.1515638626891285
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625,1.4973167624996537
SNU-449,5329102,2.0099859216843075,2.192013547070055
NCI-H2009,322968,4.70725114827159,4.1782753972110545
KYSE-70,16722836,1.4327625680833322,1.6703117580171056
MDA-MB-157,11609586,1.0926317538630208,2.9792047885464257
FU-OV-1,10231331,3.398558944555642,2.2668736507215073
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172,3.114769064633057
NCI-H292,docetaxel-tanespimycin (2-1 mol-mol),-3.440758677710888,-2.0517454224383287
LOU-NH91,11238147,4.007302405058718,3.1307261442137446
LOU-NH91,49766530,0.361985362717411,-0.5217285778933682
YAPC,9444,4.346283036692295,4.071521328224169
NCI-H522,15547703,3.471643136947843,3.0004765307622243
NCI-H522,375860,-0.630771500248647,-0.416415037214465
CA46,119182,-4.388833865288787,-2.5502371251043945
OPM-2,10410894,2.9147321100270593,3.084535917847555
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,3.2042320541372673
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803,1.3729390850146037
OPM-2,docetaxel-tanespimycin (2-1 mol-mol),-6.145766231617617,-4.501147854414825
NCI-H2171,4261,0.9024779156039784,1.0044770871037534
NCI-H1623,25262965,-3.228781743363827,-1.296107299244217
NCI-H2171,navitoclax-gemcitabine (1-1 mol-mol),-4.23755685830139,-1.4798656262403103
MSTO-211H,10427712,4.183883954719584,4.416358720932844
EFO-27,navitoclax-birinapant (1-1 mol-mol),3.2392186746278244,1.3477912085867956
A-498,9967941,4.3277437867326025,3.684765445114844
HCC1143,25183872,-1.001460572121427,-0.2629853583408561
NCI-H522,crizotinib-PLX-4032 (2-1 mol-mol),2.133335771815486,1.6343506394139127
CAL-51,17755052,0.5283491907817935,1.4867179201871417
SW1463,44137675,3.7114847318755806,3.57584390125199
BT-549,5278396,3.375604766419473,3.5524108162938375
NCI-H292,3025986,-0.8794264876923694,-1.1060463022818414
NCI-H2171,3825829,3.727904622873516,3.5086050010308973
EFO-27,327653,2.4330037956805133,3.268862670964663
NCI-H460,637858,3.384702960830197,2.349692623330605
G-401,5746,-1.2143401521495898,0.6245127950039729
A2780,5281321,-0.7497434400684011,-1.714506245069776
NCI-H460,409805,5.4278006548731295,5.277499097748116
MSTO-211H,alisertib-navitoclax (2-1 mol-mol),-1.8568151112874771,0.7524340191259629
SNU-81,11964036,-0.3940350311201446,1.1743590387742373
OPM-2,53232,1.210133300080481,2.720056067583818
A-498,216468,3.41587450505901,3.820506124632865
LoVo,6852167,1.8421975016001388,2.855664069523874
SNU-449,53325874,4.456238471946744,4.662279973855107
FU-OV-1,10296883,4.259179003182187,4.088504853646649
LoVo,3136844,3.7568853791466608,4.35778445974147
HSC-4,637858,2.398043952194309,2.2240011205737193
NCI-H522,9927531,4.749051096908956,4.592615238396002
MSTO-211H,53392493,1.8202473930982712,3.045077521105693
Panc 04.03,11626560,2.20525660125161,2.082956310187956
EFO-27,11178236,-5.208504296414087,-3.223251870387825
SBC-5,3503,1.24841833111282,2.3798046285348526
G-401,11640390,2.8162749001609417,3.26583766774943
NCI-H727,selumetinib-UNC0638 (4-1 mol-mol),-1.3488333019368446,2.9069090515375926
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158,3.0576266408083974
FTC-133,54454,1.7579296666098376,2.795464975970024
MSTO-211H,54613361,-0.4311183648022992,0.2885132359226918
G-401,5282054,2.6200467258422235,2.99934811373293
NCI-H727,135440466,0.3181577925646752,2.1850919244806217
SCC-9,6852167,2.7106856908699255,2.880966512511358
NCI-H2009,124202324,1.390796248932456,2.635852231636858
SCC-9,54618771,0.4910288003516506,1.5746298102616885
A-673,9826308,0.1905391916215918,0.09242719741619712
KYSE-70,446155,3.830415114438346,2.7590720215077265
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.2646970850158121
CA46,10296883,3.259152671675197,2.9127292124478483
NCI-H661,159324,2.633762936698375,3.2227831835935423
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827,1.6988394823145418
LXF 289,5328940,2.0490491787199687,1.713516505770005
KYSE-70,400769,-0.6610715268602807,-0.48218379591894994
BxPC-3,9911463,3.950256717526944,3.843456382004519
MDA-MB-157,119607,5.813382396653367,5.171938368447506
NCI-H727,168312962,2.354698653601169,1.9424463189084715
G-401,67156097,-1.3508759360204068,-1.3774487291076094
HSC-4,53232,3.536415160688875,2.8071847741061817
BT-549,9866186,1.9395157417186848,1.2151364630289896
A2780,46174525,3.809782337657401,3.769094807192812
NCI-H661,24797083,0.8737198077858661,1.5142352137651238
OPM-2,107970,1.3408908225452507,2.0189177351684764
HCC1143,3038522,3.729990546362485,3.3417746034404625
JM-1,5746,-1.3315669786621744,-0.8267813474219037
OPM-2,9935249,1.874633336412032,1.3948801246587883
A4/Fukuda,10302451,3.353566161735505,2.9627936674636453
SBC-5,1641662,2.7360117188732684,3.4644344676718184
CAL-51,25183872,-0.1080661998677032,-0.4873055026360533
HCC1143,72734382,3.642829686089203,4.64217532432865
SCC-9,67156097,-0.5297515363076177,-0.7153276712261107
LOU-NH91,17759555,3.0310153631552295,3.760212188980715
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249,1.6599538989078717
FTC-133,6252,3.0791801983523297,1.2365893290825272
NCI-H146,10026128,3.971012402354388,3.701503908656966
HCC1143,327653,2.9245812810780745,3.3089145362817978
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335,2.01336119496334
BxPC-3,docetaxel-tanespimycin (2-1 mol-mol),-4.5492420076102045,-3.138512769755814
SNU-449,SNX-2112-bortezomib (250-1 mol-mol),0.2827290486356496,-0.7752269178445254
A2780,71466445,2.121500658196736,3.3017807530361654
FTC-133,11640390,4.129780643497309,3.8566279568366553
NCI-H661,66577038,3.3791675548307225,3.1254025734809545
A4/Fukuda,89183176,1.286008536767452,3.0807250519732294
KYSE-70,49793307,-3.275020883815728,-2.998983218118354
NCI-H2171,36314,-6.271125424872196,-1.6470476702957084
G-401,5351362,1.1066788885055705,1.1125099753311267
NOMO-1,44507138,0.557170216692965,1.9744399145028373
CAL-51,56649450,1.7310987503885624,3.2823870595262075
MDA-MB-453,100016,6.0730906594859215,5.960427634265779
NCI-H1623,6852167,1.7873387390250663,2.912170987439062
A-673,16659841,2.6132078541729404,3.193992401295773
OPM-2,67291369,1.773293288142809,0.8589659853398303
OVISE,374536,3.768512931442208,1.6701067512231524
CAL-51,11238147,2.100409816322544,2.894390504801417
YAPC,11175137,3.2313352651289327,2.9505641201163457
NCI-H522,ISOX-bortezomib (250-1 mol-mol),0.0474854277983787,0.5085110668807951
OVISE,10427712,4.5158462716299415,4.366016963159113
EFO-27,5351362,1.1790960486008195,1.5659994976971328
NCI-H292,6505803,0.1482155149138876,-0.4659703968938085
SNU-61,vorinostat-carboplatin (1-1 mol-mol),3.629887150631109,2.377202232158156
DMS 273,71680916,4.789726238699708,3.936661546826178
CA46,10184653,1.13668363671425,0.7617785037146722
SBC-5,49867926,4.30527508614513,4.347557098989715
LoVo,11238147,1.4038592423826672,2.98686771649486
MDA-MB-157,11427553,2.127814795485051,2.8065976705678097
SNU-61,11178236,-3.475859478717308,-2.7902002183854107
SBC-5,piperlongumine-MST-312 (1-1 mol-mol),2.5701291604117045,1.9272477506243382
FU-OV-1,11214940,1.6800576649286882,2.029865797773098
LoVo,9903786,0.6551100591729495,2.680451900960693
NCI-H1623,135411,0.3784026464220375,0.8305486509160187
LoVo,3062316,-2.119304437973892,1.6833108616353394
NCI-H661,46174525,4.042428757819544,4.595498303374235
SBC-5,51037431,0.5420283127367359,3.15367382676114
A-498,3689413,-0.327867250415736,-0.057387119005645394
DMS 273,selumetinib-UNC0638 (4-1 mol-mol),4.157627757757485,2.9179459155708485
CAL-51,54649381,3.902782783768603,3.9092183467954316
A4/Fukuda,16038120,-3.113498344638628,0.398000674971611
A-673,135398516,1.4288802928040978,2.066040038522411
NOMO-1,135398744,6.340708200805823,4.741638685256389
KYSE-70,216468,2.031191966418552,3.3183244697306646
A2780,67291369,1.1130592599106983,1.7184127481341593
NCI-H2009,654092,0.0283248260105453,-0.18845748059557071
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535,2.038461884862323
NCI-H146,navitoclax-PLX-4032 (1-1 mol-mol),-2.8852479543284617,0.9126090245687807
SNU-61,11612883,3.050953505253589,2.5010249890569183
SNU-61,5746,1.3298489283886064,0.8536311248432411
KYSE-70,124202324,2.186627813347476,2.3196291696756486
SNU-449,carboplatin-UNC0638 (2-1 mol-mol),4.161475175536438,3.309498998108134
BxPC-3,409805,3.7922849099240734,4.924968600015866
A4/Fukuda,3552672,1.9607713184754867,2.5148942234374125
KYSE-70,9907093,3.6347338213446454,4.243654321927154
SNU-61,12003241,0.1572719330395487,-0.6809849769602502
HSC-4,322968,4.636798889333657,4.035963737487261
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673,2.6585946123915294
CAL-51,16115403,-4.643171700082743,-4.437684143323292
LOU-NH91,2746,5.002248002286792,3.6105070856426846
A2780,3543504,4.147653095225295,4.201882537207891
NCI-H661,25126798,3.9237728184770946,3.697616367335351
DMS 273,4521392,4.235410021964807,4.1186700843641475
BxPC-3,49836020,-2.380895293574403,3.4770988795082842
NCI-H146,JQ-1-vorinostat (2-1 mol-mol),-0.8208901447975969,0.612458724678708
OPM-2,3689413,-4.501811354570108,-0.9946510074928535
Panc 04.03,selumetinib-piperlongumine (8-1 mol-mol),4.132461761791421,3.3814149594892804
NCI-H727,navitoclax-gemcitabine (1-1 mol-mol),1.335724896470854,-0.6184676885053231
NCI-H460,5328940,3.322075361136407,1.76892689360341
ONS-76,25126798,4.148768722347094,3.873728685860241
OPM-2,57519531,1.419627244644159,1.5473233149616652
BxPC-3,20959075,-3.864209289368053,-2.5817164670918125
OVISE,54618164,4.29678583267412,4.1286824958921216
YAPC,10074640,3.068654585130056,3.1937632265240414
BxPC-3,5287620,-2.837282092833542,-2.0135801569210985
SNU-81,24785538,-0.3807988804027284,0.42389203250834
NCI-H292,5287620,-2.1513248285430997,-2.209083298849273
NCI-H146,104842,-5.965892600420639,-3.742682666094582
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236,2.544641178551972
KMRC-1,17755052,1.9475900469511016,1.9045026147107558
NCI-H2171,24856436,-0.4096039036242957,0.2767847729724408
NCI-H2009,11364421,-4.013811791110126,-1.1591593336586212
MDA-MB-157,5470400,0.4579153499304774,0.5061415715108475
HCC1143,51039095,3.6749130279746938,2.840379664376842
G-401,11964036,0.0453230579510409,1.251650110857669
NOMO-1,1641662,3.174576963224712,2.954210471932767
MSTO-211H,25102847,1.842661618149511,2.4430196954508023
A-673,9908783,4.713034696547774,4.576426060899419
BT-549,71680916,6.0821013857398745,4.964690583172014
JM-1,11719255,1.4438675590466743,2.341489377626555
HSC-4,2874250,5.810325396532396,4.777197783059499
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553,0.7671911577982516
NCI-H460,654092,0.4612941847378306,-0.24434378196612794
OPM-2,5328940,0.8145180628284293,1.2389620790133926
A4/Fukuda,44202524,1.0259860145116777,1.5745137144106627
G-401,11213558,0.7886605378704363,1.2819477770631662
OVISE,135984461,1.6429740508824469,3.8295156664415897
NOMO-1,11964036,-1.1045639043109698,0.29393372504031867
CA46,6184667,1.8666466805539537,2.4083496537396236
NCI-H460,9903786,4.057661845653794,2.5085390124311124
BxPC-3,25102847,2.0998558206838913,2.7457159226195382
SCC-9,5470400,0.9401931564199802,0.03066085880581793
ONS-76,5284329,2.36276815665719,3.601144352003229
DMS 273,25227462,-3.883072621079263,-0.07880519569218322
A-673,42642645,-0.8052568071576633,0.23994420734185373
A4/Fukuda,9549297,1.6255879909683784,1.9139746908914126
FU-OV-1,11427553,3.01783779671809,3.087435679893842
SNU-61,5328940,1.147707594205283,1.5674642430839436
HSC-4,5281321,1.7816899121848235,-1.2115920471074815
KYSE-70,656346,0.9492660515895844,1.472739305948547
NCI-H1623,72734382,4.853935764849827,4.820249227821375
MSTO-211H,67156097,-3.635314822435898,-0.2466736796978733
MDA-MB-453,637858,1.2138352699902215,1.9327207811446256
CAL-51,56963564,0.4281851677964957,0.5383084969234333
A-673,10113978,2.507382463710335,2.8227653841302556
YAPC,2946601,6.339465197306548,3.6705423332902685
NCI-H2171,ISOX-bortezomib (250-1 mol-mol),-0.1667670458768617,0.1656270859034304
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872,3.1664995359538306
HSC-4,65628,3.12205826618997,4.5159558265039035
HCC1143,227681,3.1373347590378335,3.7384361813008917
A-673,53301938,4.3782771731899555,1.498468581988533
G-401,66577038,2.320880294749871,2.8579522382519302
NCI-H661,9884685,0.1767392095869446,0.5992042568371485
SNU-449,6184667,3.7989058233577566,3.29855887383397
OPM-2,24951314,0.2222837933942169,0.27084978431479867
LXF 289,56963564,0.2991276479966406,0.36191521245882663
HCC1143,11364421,-2.85203888888326,-1.360010781208046
NCI-H292,9936388,-1.1579069678838152,0.037708830855585615
G-401,10231331,2.894718734978725,1.7345686634919912
CAL-51,89928392,1.068329558331595,1.4329528540836798
NCI-H2171,53392493,1.8740494203136608,1.9963699763257747
A-673,136227331,4.241984110268528,3.4455623970743012
NCI-H727,11717001,2.7053596974758594,3.8528925192300285
A2780,16219061,2.814782356526162,2.867228332757327
SCC-9,54454,3.1137155512464596,2.732176813376262
YAPC,12003241,-0.7644111057992425,-1.055683715700849
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.6863240356254825
SNU-81,5335621,4.181800470543683,4.087847703949396
CAL-51,5329102,2.0492492410301484,2.058861923288895
NCI-H146,10385095,0.6869778017915235,1.1901837331029308
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165,2.719363623413092
SCC-9,2113511,6.3303497429476625,5.61503467424223
ONS-76,2708,5.792421817961339,4.818440332143951
SNU-449,11485656,3.58452534173841,2.6680984159930032
A-673,46215462,1.2771489946566346,1.6909410616757055
FTC-133,285033,-1.2963608176743802,-1.411697666615712
SCC-9,6184667,3.279451062583292,3.044263855670298
NCI-H146,16722836,0.0677462505380894,1.5113223469548638
NCI-H661,44137675,3.7576040576240257,3.7498233846608247
NCI-H1623,11612883,1.5649574760969076,2.761587900266831
LOU-NH91,3825829,4.327670981782257,4.298848087412104
SCC-9,5287969,-2.1272191034883874,-1.6355920681074907
Panc 04.03,10410894,3.886544188244091,3.564154006442391
NCI-H146,135398516,1.5035346569298091,2.089216671858857
A-498,4096211,4.004902569915099,2.452076242527062
OVISE,104842,-0.680714151991963,-2.0918811282531617
SCC-9,135440466,2.439160969941936,2.217962142012621
ONS-76,10322450,3.321198163736043,3.915010203824157
SNU-449,81146,6.119223793669881,4.844098055285365
JM-1,148124,-7.840698833354439,-4.425822022555799
BT-549,5460769,6.35928800843138,2.9683888387707027
MDA-MB-157,969516,1.7670354115722269,2.883110491489254
LXF 289,5278396,2.6487510770020104,3.7036437426655286
ONS-76,100016,6.019166856387977,6.021800184261548
A4/Fukuda,11707110,-3.666992219196893,0.8942179296816399
JM-1,6438330,0.1685207017328377,0.949914988766588
SBC-5,navitoclax-sorafenib (1-1 mol-mol),1.4051935643931297,1.9982420310092166
BT-549,10074640,3.6929061121608577,3.2709750255605843
A4/Fukuda,46926350,-6.021657358635238,-4.464029228301344
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384,0.6852130016640418
SNU-81,4917,2.3748179961814375,3.014733639833437
A4/Fukuda,119607,3.918640768426122,4.47584055786144
HSC-4,613753,3.3632883902358715,3.193738105690471
DMS 273,135411,0.7219297948054574,0.34285193594238833
KMRC-1,46907787,3.729545872280723,1.965499940998347
LXF 289,44489675,4.904101073680104,3.8828543524093373
BxPC-3,6918736,-1.9181543280529496,-1.5506095106501672
KYSE-70,65064,5.1318583658275205,4.759180421628411
HSC-4,25062766,1.8609848482730849,2.1002143074821524
SW1463,15983966,1.3055923116721375,-2.3432422432747733
HCC1143,11396600,3.529486359294858,4.0018199607020595
SCC-9,45279963,4.124125049817703,3.8538625369642143
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289,-2.06606654420931
NCI-H661,5113032,4.99918939361245,4.791941262867979
LXF 289,17759555,2.434653643868842,3.8169225648219705
DMS 273,46926350,-4.333780789364997,-4.211807009200583
OPM-2,46224516,2.1207785622277373,2.098541039481598
A4/Fukuda,9908783,4.281950187885367,4.55963669804344
A4/Fukuda,1716436,2.785785051354721,2.7532416196290495
KMRC-1,54454,2.958009627513852,2.700119351537062
HSC-4,73707371,4.771220465805862,5.019385553667946
KYSE-70,9911830,3.1951659700149886,2.725340771128556
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346,-0.7643781836580572
HSC-4,16720766,-1.6245250648624636,0.8457635880006553
OPM-2,11964036,0.2409704368173301,0.38306529148080737
LXF 289,3038522,4.104388560491244,3.215537091741309
A2780,49793307,-3.5064247630527494,-3.599754215763001
MDA-MB-157,12003241,-1.4339892472843776,-0.7037626384207613
MSTO-211H,53495165,-2.281905985837366,0.8608845710254818
MDA-MB-453,24797083,1.319210590833939,1.1714238613365473
HSC-4,25126798,3.2488654911973196,3.8238991161466096
BxPC-3,3854666,3.4835595653471167,2.311248073306855
HSC-4,176870,2.813832788377266,3.144436490357524
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128,-0.12686878323885806
MDA-MB-157,alisertib-navitoclax (2-1 mol-mol),-2.615500389933575,0.3772516440945639
YAPC,135398744,6.484368053683043,6.102169484475269
MDA-MB-453,51039095,2.709903892694302,2.664664586400268
CAL-51,24821094,3.2618915388877023,2.8964297491441493
NCI-H522,1239801,3.903810420887451,3.600023852135821
KYSE-70,7251185,4.369311092923008,2.598772018548772
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.2989391762439864
G-401,60750,-4.380742093252711,-2.912203680293233
YAPC,11404337,0.4717703732171429,-0.03360965728639105
MDA-MB-157,9826308,-1.0851482905673768,0.9799045857290389
MDA-MB-157,25262965,0.470934001928582,-1.2094484692684955
FU-OV-1,10427712,2.3896052276409887,4.492048921509609
CAL-51,285033,-2.914004430070481,-2.0095467791013752
CA46,246676,4.699933053014099,3.6895584846578497
A-498,9926054,1.5026788619071982,2.3307690036719446
LXF 289,44632017,2.313535350982782,1.7318884655492375
NCI-H727,3689413,0.3749801507161196,0.25455492772294763
SNU-449,1716436,3.0856052265463023,3.1120146066735983
LOU-NH91,24951314,1.380037957351277,1.5839063449954125
SNU-81,46191454,-1.5874627182763832,1.366202106630974
KMRC-1,119182,-0.1449504353389931,-0.6847252896598374
NCI-H522,9823820,3.261618834820585,3.2887460392682852
NCI-H460,11178236,-2.300904923417752,-3.1045512723683
A2780,5738263,3.096886997462696,3.0362022774179964
NCI-H661,carboplatin-etoposide (40-17 mol-mol),2.8210696568936786,2.7577823593603865
BT-549,5287969,-2.055370090828861,-1.817081951941063
BT-549,11609586,2.735581966533724,3.154223917092815
OPM-2,1317464,3.5924971065959244,2.6995952354475117
NCI-H146,54639701,4.038686865533554,2.8682779492392223
LOU-NH91,3384730,3.7773271912609623,3.4021630762737494
YAPC,11152667,0.3482753398657929,-0.30720672653659864
SNU-449,702558,5.257858019653286,5.330172969517678
MDA-MB-157,selumetinib-tretinoin (2-1 mol-mol),1.8981533797930392,3.940396560326065
FTC-133,6438330,2.249518605035186,2.3620737285702003
NCI-H727,12001922,1.7281936629666887,1.8416208792359585
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685,3.0658523672725453
HSC-4,60750,-5.118377280037083,-1.6148423369414227
SNU-61,1566236,1.9599867850180668,2.128511976087887
NCI-H460,5282054,4.802373462225767,3.9358642626946687
DMS 273,6610216,4.172124776089646,4.207832695250196
NCI-H727,6852167,3.356078560596427,2.930818053834423
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.493679797699447
SNU-61,445455,4.539446073708065,4.342671597295725
DMS 273,3062316,3.60345807305724,1.740005048244742
MDA-MB-157,9956119,2.310937024804907,3.637372926326251
OPM-2,135423438,0.9866001177758746,0.9437664131915744
Panc 04.03,16722836,2.845252730089092,1.8233331600618363
MDA-MB-453,9936388,0.6028011486270662,-1.7014771130481774
A-673,68056272,3.7833857366006094,3.401698248784491
HCC1143,16722836,1.2433455264432278,1.5765226304297215
DMS 273,72193861,0.4647891664131632,0.593103887167229
DMS 273,navitoclax-birinapant (1-1 mol-mol),3.616691876772055,0.7613564155256907
Panc 04.03,11396600,3.73844061007523,3.8920677193913082
NCI-H522,6505803,-3.5272214952237344,-0.3862456156665787
CA46,56963564,-0.0544830399645368,-0.39182604828114004
A-673,9825149,0.7138432506885886,1.666005887199623
NCI-H1623,2871966,1.4286416314522286,0.772160181596552
SNU-449,4096211,1.9400565485658428,2.34080163170748
CAL-51,44137675,3.485867182081199,3.567664138848647
MDA-MB-157,375860,0.0174110406826079,-0.12151891601264728
MSTO-211H,327653,2.467891014920142,3.1956669567929183
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371,0.13599858244438975
CA46,11178236,-6.883102305003874,-3.826506528113197
NCI-H661,5291,3.8370923902638063,3.60031522365267
FTC-133,25262965,1.6757685209235111,-1.052865776229393
SNU-449,24771867,3.0453458349703793,2.8683412182798547
HCC1143,9911830,2.6182666070844447,2.7028425698739302
SNU-61,44185566,2.430559307269213,1.9099890287742034
SNU-449,445091,4.4459202939225815,4.519013676537907
LXF 289,123631,1.612545473594554,2.753411109528048
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453,4.398010859107156
SNU-61,637858,1.6436621136217924,1.7704597650720877
MSTO-211H,3025944,3.596075182431598,4.3624382881561035
SNU-81,11612883,1.8877401103471,2.367684265089768
A-673,52912189,-0.9448854486243604,1.204451260801346
NCI-H727,613753,3.184500780825273,3.4881194597680936
BxPC-3,24856436,-0.8809901773698104,0.8000958336923645
SNU-61,3038522,3.6960216122526943,3.3642850031183476
KMRC-1,374536,2.325099751463231,2.09688790222555
CAL-51,54613361,0.2180057854442524,-0.013666177443219159
CAL-51,10385095,1.0305027810027567,1.2979013992130535
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945,4.199191681759218
LXF 289,5281321,-2.4870532876216487,-1.1300480932696197
SNU-449,10184653,1.7910926490151993,1.8230632699229332
SNU-81,9887053,2.281153151762533,3.287575099986684
KYSE-70,11485656,2.2230455690794404,2.612932564511434
CAL-51,439501,-2.444412450902406,-2.306884189317507
A4/Fukuda,72967,3.695839205584607,2.3685246112117664
NCI-H1623,navitoclax-MST-312 (1-1 mol-mol),2.6356568038196175,1.0141687493869305
BT-549,57519531,1.7866000969199525,2.809369620150018
YAPC,9911830,4.0093640169179325,2.697091079985526
KYSE-70,54143018,-0.2928055682999507,0.8272077189573496
ONS-76,6852167,3.4771955261396252,2.7598608949248815
CA46,216468,1.7849524837603168,0.9299132460180481
KYSE-70,71304818,1.8226881659751617,2.5071694028200544
SNU-449,10427712,4.716616821408685,4.535551579224025
KYSE-70,11364421,-0.2598881855214042,-0.9728022171972648
SCC-9,46199207,3.715699147831311,3.299896372903799
OVISE,tretinoin-navitoclax (4-1 mol-mol),1.2267801901076945,2.822483057990921
SNU-81,selumetinib-navitoclax (8-1 mol-mol),-4.808792251277437,1.6331411737940176
NCI-H522,45279963,2.975445810656792,3.3524467320360674
NCI-H727,44137675,3.902640688581202,3.7700814792488746
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.2948188113994552
CAL-51,3854666,1.1494535123186709,1.9339412003846315
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446,2.639107763619295
NCI-H2009,81146,6.16166931928307,4.880608630393134
LoVo,135440466,2.5900307411888357,2.3713478790898477
G-401,445455,4.8654155018395535,4.327158507659329
NCI-H1623,15547703,3.108106821400364,3.2320186576445513
SCC-9,322968,4.6886309532040435,4.112479010168581
MDA-MB-157,23635314,-3.347178711973772,-1.6881896749671785
CA46,49793307,-4.01311922110524,-4.37966011613359
CAL-51,53495165,0.3298774405260949,0.6014425912693441
SNU-449,54618164,4.194291334344069,4.118554400110937
LOU-NH91,11178236,-2.353397629942184,-3.1979345224296436
A2780,5284616,-6.357248921927095,1.6287633836088116
OVISE,11404337,1.793635825025173,0.049553683998973766
HSC-4,216239,1.6239220207771676,2.47781838092963
NCI-H1623,208908,0.8939149685214822,1.9382738782376436
NCI-H146,25161177,3.485806465133522,3.4737798867740763
YAPC,6918328,1.93910137978286,0.216731857461996
EFO-27,3038522,3.6669358154068097,3.2815998763420486
DMS 273,25262965,-3.6359475061731534,-1.5882948140808875
SNU-81,9803433,4.184314019267332,4.5815208567765175
SBC-5,5351362,3.2358684618056164,1.6659138403740477
NCI-H661,9826308,-0.3578866099027624,0.4634609479498409
CA46,462382,0.6475442737717811,0.31450870729533686
SNU-449,168313200,1.9091128501610053,2.8950795152137836
SBC-5,613753,3.3291324843640497,3.3402691561685645
HCC1143,24797083,1.671403596818138,1.596968028114179
NCI-H522,11625818,5.118334572164132,4.06502976922014
Panc 04.03,446155,2.4976903608369994,3.360342818473544
NOMO-1,2733487,3.664178503465112,4.840598947275231
CA46,11494412,-0.1540181126177876,0.5561187829631552
KMRC-1,168313200,3.9547474801247455,3.134702019124597
BT-549,12003241,-0.9663956127583828,-1.2481784666977205
MDA-MB-453,53232,4.528141583720988,2.937294723134245
Panc 04.03,BRD-A02303741-carboplatin (1-1 mol-mol),4.551523048928573,4.091489768127795
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604,2.1630697072348597
BT-549,7251185,2.7032329014559555,2.634185007108778
YAPC,72734382,4.459010686131963,4.661077893186744
NCI-H2171,navitoclax-birinapant (1-1 mol-mol),-1.0975266283205345,0.14272003685977222
LoVo,10113978,1.9718639606113115,3.4191690352125166
G-401,9884685,-1.463173781220529,0.2318754228707052
NCI-H460,969516,4.1763077592827225,3.0294235280821566
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.7480089011023954
NCI-H522,10302451,3.5044820085806645,3.3312023600198097
SNU-61,10127622,0.6703048084308344,3.0304306435523336
DMS 273,216239,1.7826696655906364,2.0116960400227772
NCI-H2171,24785538,-0.9958553447114444,0.4008285786176937
OPM-2,2945648,2.5610378238786367,2.4761503655461627
JM-1,5278396,3.0111139094733987,3.056746420978736
A-673,11625818,4.166556040788123,3.9856056519366536
MSTO-211H,23582824,0.616921606097025,0.6033517853671928
CAL-51,11977753,-3.094424679361229,-1.2558376352079714
OPM-2,55283,2.954343465689474,2.413233780916822
SCC-9,445091,4.9115801471194365,4.537610206461777
FTC-133,11609586,3.5175505098064113,3.1435682987095905
DMS 273,16065773,2.5819171284899873,2.279847828208913
NCI-H661,16725315,3.2574493912109315,4.309395717656735
ONS-76,3825829,4.014711164490238,3.9490121499359394
NCI-H2009,613753,3.3208706433892483,3.296981589018518
OVISE,72376,-0.0680425204905225,-1.6380248013591865
Panc 04.03,1566236,3.6247050899799698,2.554948379747437
KMRC-1,10385095,1.0697515150450725,1.463707801858289
MDA-MB-157,6918638,0.523436976846598,0.41993864731349434
SNU-61,10231331,-0.1396530061474971,1.4594394678799132
SBC-5,67156097,-2.1260485275267684,-0.6083033885814103
HCC1143,16720766,1.508740109375584,0.8443521731121183
SNU-449,5311281,1.2425771495660034,2.3384733825121686
EFO-27,15547703,3.36481674718985,3.3169307982655774
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683,4.423613286025098
HCC1143,71466445,2.406598865609875,4.096847170186354
HCC1143,11625818,4.1599423197543395,4.417825154226437
LoVo,67156097,-2.753278115102512,-0.44248506772249635
NOMO-1,3385,1.8227638422939128,2.6135225318236697
JM-1,11494412,0.2153546786296628,0.28900186942122225
SNU-449,3384730,4.130527031297823,3.2576525248547115
KMRC-1,2871966,0.6996568641549454,0.7040870347910497
MDA-MB-157,2126,3.382661447598077,4.693558822508112
SBC-5,444795,4.741830288065925,4.8499217078134045
CAL-51,135398516,1.449392214756173,2.4209185524587475
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.4634230067947267
FTC-133,11626560,4.477282693511418,1.7173611104081257
NCI-H2171,135411,0.036573209368321,0.2755730024735361
NCI-H522,5479543,3.719555600198391,3.0272228396046774
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547,1.5949688534906366
SNU-81,44494148,1.061827805146114,3.482991792091003
OVISE,119607,5.735286818250817,5.224134566473865
CA46,4578,4.451375135730711,3.5335240010987734
FU-OV-1,navitoclax-piperlongumine (1-1 mol-mol),2.023653307095543,1.996120077931189
MDA-MB-453,148198,-6.384072425395857,-3.8602987221281717
CAL-51,44491742,5.152478206660974,4.369745877431878
G-401,6438330,1.230579919692557,1.9223529748774095
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266,2.2108473986215778
KMRC-1,2746,4.901784458568857,3.311165001322511
SW1463,3025986,0.7137013515595916,-1.2172175220943078
NCI-H727,54618164,4.079418853402711,4.048268891005483
CA46,9907093,3.753589195065423,3.366834371623058
CA46,1750826,-4.755590130007624,-2.933190785986497
G-401,135411,0.5966957307940325,0.2884094140071426
NCI-H727,9825149,0.533141934304371,2.2264586588483373
NCI-H2009,168312962,3.455210391348572,2.372324083197414
NCI-H522,25154868,4.970187113391964,4.2328361835574
HSC-4,3503,2.6271988960037502,2.3994094118554496
SNU-449,54619267,4.584813130836932,4.102960291326631
CAL-51,44507138,2.6477043136390637,2.528431998686777
CAL-51,24753719,3.9981702522006257,4.332633565267225
SBC-5,16725315,4.9617798252058165,4.288204953253926
CAL-51,123631,2.4616591372530605,2.315068327320603
A2780,56963564,-1.0587892817911606,0.1362120716374911
LoVo,119182,-3.2827225124554804,-0.7696427596429678
A-498,3503,2.8872062971439436,2.458097955842152
ONS-76,navitoclax-sorafenib (1-1 mol-mol),1.6529923050445217,1.928646760650494
FU-OV-1,9915743,0.5010130642537969,1.5258416980078444
LOU-NH91,6917907,-5.4115573726076125,-4.767253971605892
A4/Fukuda,322968,1.909418940393303,2.215107585000973
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936,2.424960187034787
HSC-4,54618164,4.183236352259565,4.207785971052227
SNU-81,navitoclax-MST-312 (1-1 mol-mol),0.1255158725803597,0.9220095272273028
MSTO-211H,89928392,0.2675284607275224,1.6435657845002445
MSTO-211H,16741245,3.31564558456852,3.4994499068230476
FU-OV-1,969516,2.7898134338200093,3.0905315765738415
FTC-133,9840324,5.72186430729165,5.944140076509766
FU-OV-1,2828334,6.23308188240882,6.185726391788353
JM-1,docetaxel-tanespimycin (2-1 mol-mol),-7.819980451052631,-5.091839800964232
NCI-H146,25062766,0.9164062509537028,2.1095150318291105
MDA-MB-453,44197249,5.538441394278097,3.8537015726230464
NCI-H292,25126798,3.8121795120859865,3.9243876217723166
NCI-H2009,49793307,-2.1832388254663746,-2.2281164407428298
ONS-76,446155,1.9434822335598465,2.7778312650236625
NCI-H460,613753,5.368273372553464,3.2815403418100213
NCI-H1623,375860,-0.2497324332058591,-0.10050618999415638
NCI-H292,135440466,1.1809367948500966,2.3053984396837848
DMS 273,24821094,3.2786522000090974,2.7852105448718785
CA46,1566236,0.9666867201201066,1.4532036828417965
LXF 289,6914657,-2.1957863105134474,-3.5988290095861037
BxPC-3,68056272,4.30573170491611,3.8346313209553062
CA46,24856436,-0.7056093623802927,-0.6468785658264463
SCC-9,136227924,3.721677265331546,3.113070105454481
BT-549,5281672,6.431065394953252,4.640468579362482
KMRC-1,136227924,2.9529226708788734,2.7822163329779994
A2780,46224516,3.0956757820489966,2.3217638188387064
OPM-2,2871966,-0.6940984937409527,0.13807236583339397
NCI-H522,44607530,1.256897748575463,1.687055482180505
YAPC,135421197,1.6415717791988456,1.8108806181243489
Panc 04.03,11609586,3.1950022878003375,3.1040728345782975
YAPC,285033,-1.734058118132599,-1.2839643864330177
EFO-27,25161177,4.775691091389994,4.535361634349588
MDA-MB-453,285033,-3.584093663874095,-1.6646428464482073
YAPC,135398516,2.168624804585352,2.24882485745798
BT-549,10184653,2.4120945582019098,1.726111964305998
SNU-61,322968,3.1681402320576924,3.073622048820697
CAL-51,9911463,4.251278022142156,4.046635011524657
NCI-H661,119607,4.8407678671423975,5.255486138058061
Panc 04.03,navitoclax-pluripotin (1-1 mol-mol),0.6568791219760653,-0.5096793657677537
CA46,16720766,0.453567173389679,-0.823502769528048
CAL-51,11404337,-1.4033364127444676,-0.2294034213515112
SBC-5,9911463,4.310936662946409,3.898422547497944
NCI-H727,2828334,5.890997909388885,6.139639610804512
JM-1,104842,-7.303088314363844,-4.7721191443587525
NCI-H460,5335621,5.645903220513178,4.470136891123392
MDA-MB-157,ISOX-bortezomib (250-1 mol-mol),0.8277419655011916,0.5178044868446953
HSC-4,12003241,-0.0373048915881231,-1.1213022370196557
MDA-MB-157,53301938,4.15898814375023,2.4719479907591744
MDA-MB-453,25150857,2.1104930677980964,2.1969224125835076
HSC-4,25183872,-0.8460464512297751,-0.2954342170975336
CA46,46907787,-0.8110179268567884,-0.2570785597915261
LXF 289,5311,1.216776445363927,1.5500315985154922
NOMO-1,6610355,3.932739350210071,4.027046141226894
CAL-51,11222830,1.6762547521470548,1.6817809701352378
HSC-4,9915743,0.765957034876682,0.6411373982142301
SBC-5,72193861,-0.1091418694351138,1.8450700872943477
NCI-H460,60700,-0.2314807684970784,-0.2637997565087424
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585,-0.16896422414449513
SNU-449,2729026,2.998695944617882,2.7828238353094847
A-673,6914657,-9.096845778146204,-4.821019763218479
EFO-27,64971,3.389505323176025,3.080881546298605
MDA-MB-157,44137675,2.4962707088889524,3.632155119887047
A-673,374536,-2.1767869041067462,1.3387621830586176
NCI-H522,24951314,1.0216385721244754,0.7906437275617227
JM-1,16038120,-0.8379540118722992,0.012775747003252734
SNU-449,25126798,3.9846076439311258,3.991172033072654
JM-1,9444,3.0857992205099616,3.5966707150397115
NCI-H2009,selumetinib-MK-2206 (8-1 mol-mol),-2.109665042041408,2.380980983066801
A-673,327653,2.521292352419487,2.718330286582222
MDA-MB-453,5470400,0.9814504444661803,-0.38669315902057105
KMRC-1,71751553,4.436686890494674,4.336479462909501
FU-OV-1,52947716,3.0881190342895626,-0.06954227482613756
A2780,selumetinib-piperlongumine (8-1 mol-mol),1.4682842142884078,2.895147351062292
JM-1,3825829,3.3725964609251005,3.1961845537301157
G-401,6918328,-1.3062418496747916,-0.5661833109468083
OPM-2,136227331,3.7431952210756014,2.8682007234701006
OVISE,5281321,-1.443802792924895,-1.2939001939664456
CAL-51,6450551,1.9748462748620472,2.578855998268423
DMS 273,387447,-5.016212668564022,-4.4438811072474405
OPM-2,5278396,3.463635489570463,3.2318943016473374
ONS-76,445643,3.769289821936489,3.974230603308261
OVISE,676352,3.019558255819343,2.2304144497987255
OPM-2,126941,-4.73900193491969,-2.8217076445354237
MDA-MB-453,11404337,-0.3002498088297632,-0.45653825486313176
NOMO-1,24797083,1.0415171353084307,1.1266929284457319
NCI-H522,374536,3.894183139895475,1.9411714068265058
A-673,6252,-1.7615808961584718,-0.30080290794889275
LXF 289,9915743,1.5678711489122208,1.1208868113532082
DMS 273,72734382,4.203397510599988,3.7355004883888387
NCI-H522,selumetinib-tretinoin (2-1 mol-mol),5.363366003063694,3.612578145352366
A4/Fukuda,BRD-K55473186,4.020373973875239,3.8207467362085623
FU-OV-1,6505803,0.8019489696335256,0.204600508366498
NCI-H292,10074640,3.1247192788252134,3.375941424345299
A-673,3854666,0.8608139997201792,1.2944726435465115
EFO-27,637858,1.802850970746332,2.2135919717473156
MSTO-211H,123631,1.7071024302486195,2.4337144443237317
OPM-2,54619267,3.38914180731132,3.6851644991828807
SCC-9,11612883,3.4111633177056992,2.8823462262693487
MSTO-211H,BRD-K55473186,4.0690738661382175,4.393126217865924
CA46,25154868,4.248651634430963,3.971927450535554
LOU-NH91,6918837,-1.6936529516603684,-2.2740812307448035
OPM-2,9911830,2.101419447334853,1.9514758275068846
BT-549,6438330,1.5528656655176645,2.4935565014130012
EFO-27,11647372,2.575313315468432,1.5854354808802313
SNU-61,568763,-0.2886838000487807,0.07084695441970217
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462,2.625477395079628
Panc 04.03,5282054,4.5317440773242925,4.084191222246946
YAPC,53232,3.166937959197618,3.045650808535939
SCC-9,44486219,3.972056382599232,4.31035592613977
NCI-H460,104842,-2.7771726159534773,-2.536413737618879
BxPC-3,4788,5.831531206482249,5.722179069531657
KMRC-1,753704,4.9867166993089365,4.976730728980376
MDA-MB-157,71729975,1.9097389430207852,1.9765743684689587
MDA-MB-157,46398810,3.5828771462995666,2.6624948260525896
ONS-76,42642645,1.3507577274785498,1.0155134336132874
EFO-27,9956119,4.364890218263242,3.792940128416417
SNU-61,49850262,3.504538311157692,3.1949042753359422
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322,4.189831018269501
MDA-MB-453,9967941,2.180105496017499,3.1873441622173266
OPM-2,409805,3.1459770002319023,3.998164496348896
BxPC-3,11214940,1.4945762019529478,2.160611191872042
CAL-51,71466445,4.7818956768695715,4.143320516514349
YAPC,44137675,4.160217990140765,3.631593869598854
A2780,3465537,2.6217509140821247,2.394384153620615
SNU-449,135398744,6.632733291537939,6.3148961117984586
A4/Fukuda,676352,1.592410759121419,1.9683204417439761
NCI-H522,5566,3.055916396278747,2.9525969852542344
SBC-5,6252,1.1660150864515155,1.0330519640184246
NCI-H460,65064,5.803776096144955,5.091411660162254
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678,0.8281377584524674
KMRC-1,60700,1.5998244644110848,-0.43955774743195797
MDA-MB-453,72734382,3.580352840578633,4.383949509807818
FTC-133,BRD-K55473186,4.331616686106064,4.252883419807104
NCI-H661,3062316,-1.6378145648450078,1.58792759869861
NCI-H661,11977753,-1.2976183269776842,-1.1182404609078707
KYSE-70,4477,1.3887255745641551,0.7457824784562216
A2780,15953870,2.2934332620703457,3.3576337278505877
SBC-5,44589607,3.2873586375678627,2.860872900729265
NCI-H2009,3634881,3.6058977960867233,3.3507037919129488
A2780,5951923,4.306994873236267,3.634605518412698
HSC-4,11152667,-1.532358108136572,-0.9260294965251349
OVISE,3543504,4.513312782724499,4.355553248524449
CAL-51,676352,2.3367523995253454,2.159669685323189
LXF 289,100016,7.121965810949268,6.086367247873219
OVISE,JQ-1-vorinostat (2-1 mol-mol),2.753881285057562,1.0606290876460132
KMRC-1,4096211,2.4789291220770053,2.081559797940349
NCI-H522,2949965,1.5154466163896825,2.5298548459776793
G-401,613000,2.0341288465268397,2.4750149657259928
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745,3.3708009741033425
FU-OV-1,46907787,-0.0188806347407138,2.3466144335530563
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331,1.329625916933249
NCI-H522,9926054,1.815484319665427,1.9054935367470534
EFO-27,9866186,1.214213380462077,1.2117722062404797
DMS 273,446155,1.3230843960440628,2.6483670963512513
EFO-27,136227924,3.515702384882397,3.2623085421749067
NCI-H522,25161177,5.347457629837048,3.7640795942780834
BT-549,107985,-4.157404914346088,-3.3144673581969433
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344,1.8926495561524412
CAL-51,984333,0.1261860025273146,0.7614162346991123
NCI-H2009,60700,0.1880080174398503,0.06436848340392534
CAL-51,135421197,1.6266864976107616,1.8359869411099594
MDA-MB-453,54619267,4.30313846005301,3.9208447565579405
NCI-H727,72376,-1.9917966726836325,-1.6506672536435325
A4/Fukuda,54618771,0.259551202975953,0.5733101213047453
HCC1143,5280436,2.2824596389444567,3.678168785966284
FTC-133,168313200,3.883948141330694,3.0263804932236082
LOU-NH91,11427553,1.5999683226177923,2.9258193772027203
LoVo,5287620,-2.196691557023958,-2.155095815382444
LOU-NH91,11222830,1.619786635706389,1.8206233447360938
SNU-81,ISOX-bortezomib (250-1 mol-mol),0.4477556870323437,0.48886309133929273
ONS-76,44507138,2.3475098717107685,2.639319521954339
EFO-27,12001922,2.6878207164132517,2.1010078792227116
HSC-4,25102847,2.881629074853979,2.6997571815623838
A-673,4477,0.9527863024115504,0.33345840471607346
YAPC,119607,5.457421403002251,5.268155501436982
SNU-449,11364421,1.172419453845969,-1.3693874583695607
FTC-133,1566236,2.958331107997485,2.5211992498398077
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068,3.1682129119650773
A2780,9956119,3.341179703016576,3.4612532310179827
A2780,421610,3.3194399172740296,2.888882636077103
MSTO-211H,11656518,-2.9147381038014095,1.9070344621229764
YAPC,carboplatin-etoposide (40-17 mol-mol),3.290819811015708,3.290377488487366
ONS-76,5282054,3.726244399490591,3.6226279809420396
BT-549,JQ-1-vorinostat (2-1 mol-mol),2.606631722875188,1.252492793722209
SNU-449,1750826,-2.5268598200751504,-0.9611135284468755
HSC-4,56949517,4.34052816497715,4.292408345647454
BxPC-3,alisertib-navitoclax (2-1 mol-mol),-2.4786410081497223,0.5981964849409511
LXF 289,11175137,1.607203821415342,2.7260157755328716
LoVo,400769,-0.9988261077541156,-0.34247987225987486
SNU-449,9823820,4.446865909721317,4.095015172326767
A2780,23582824,-1.3073183780043152,0.7355513078880719
LOU-NH91,24821094,3.1074025746804854,3.3317736341980844
NCI-H2171,1566236,1.862945078393334,1.762296496909629
SBC-5,alisertib-navitoclax (2-1 mol-mol),-0.5027212648938616,0.14146211443922035
SNU-81,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.6771468011681286,2.9832590828639143
LXF 289,3815108,3.5075214319549683,3.050986064848945
SCC-9,6918638,0.4192666549800527,0.8393451101844692
LoVo,54626689,4.759845357486115,4.538297767560428
HSC-4,9956119,3.775946121479013,3.59456013944675
Panc 04.03,carboplatin-UNC0638 (2-1 mol-mol),4.7376936577432405,3.4500620136519156
JM-1,2708,2.6994993672471774,3.3306154507534362
A2780,151289,-0.0035192392559562,0.7773692019026346
JM-1,135440466,2.1821804764998785,1.8849901038355494
SNU-449,JQ-1-vorinostat (2-1 mol-mol),1.642225062280099,1.166356799838296
SCC-9,100016,6.423023301160456,6.367459864475348
MDA-MB-453,24180125,2.9500133631526477,2.815280873969799
MDA-MB-157,6610216,4.481014218943506,4.250101830822959
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758,-0.5711975262846202
MDA-MB-157,216239,2.048111671637324,2.796539509298567
ONS-76,72376,-2.745447792813742,-1.9571410428498681
YAPC,56946209,-4.683971162846982,-3.9878170911961752
LXF 289,11977753,-2.1467130480879217,-1.377740371416467
A-673,46926350,-6.171938943197618,-4.365742330298702
SNU-81,44490293,1.2258782245734428,2.9577446756273917
A-673,3384730,1.4382839107098095,2.0668999912767183
HSC-4,5328940,0.4436918358674775,1.6939965527182732
MDA-MB-453,15953870,2.92470748098227,3.201656833325219
ONS-76,44487061,4.494085272908884,3.4044528208581193
MSTO-211H,656346,1.1626228980727835,1.097105356955131
NCI-H522,72376,-2.490005030905514,-2.141573107983356
A2780,2945648,2.954770875487345,2.6391409694741825
OPM-2,49867926,3.883283056469906,3.4100607359545427
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078,-1.4433817083297404
FU-OV-1,2729026,1.7636424043101242,2.8040475295755396
A-673,5351362,0.6290025594893434,1.0148788303958112
NCI-H727,crizotinib-PLX-4032 (2-1 mol-mol),1.979940863489789,1.9863931520710647
NOMO-1,3384730,0.781590014898287,1.2758609327741537
A2780,753704,5.064252843259393,4.68625379372952
LOU-NH91,104842,-1.007764649763801,-1.9847267496177572
SCC-9,selumetinib-PLX-4032 (8-1 mol-mol),4.645114234652884,3.19856050635106
NCI-H661,135398738,5.197398941249139,4.599495425528779
OPM-2,11213558,0.5330056992590615,1.3546529347778877
SCC-9,216345,4.596520649168519,4.027183724902863
LXF 289,73707398,1.5723760999376108,1.4883904579690932
KYSE-70,148198,-2.193158047226166,-3.1204581894211754
LoVo,5281672,4.34355838965171,4.758018406027057
NCI-H292,3081361,1.6323755734101046,2.4535103168718844
NCI-H292,969516,2.7034021602074207,2.994683144477108
BxPC-3,carboplatin-UNC0638 (2-1 mol-mol),3.4079462645676815,3.310457166040199
DMS 273,56963564,0.2331753873879126,-0.22423434597020075
CAL-51,168313047,1.9592520089902103,2.4207900657822408
CA46,2949965,2.263314804434843,1.9442075799756073
G-401,135423438,1.541142645334712,1.6642047904150559
OVISE,16741245,2.37455837119256,3.927872865251245
CA46,3634881,2.7183374991781903,2.647831650973266
HSC-4,11427553,3.1625220487182193,3.1279260396751716
BT-549,selumetinib-UNC0638 (4-1 mol-mol),5.0457009484631365,4.046429822833469
G-401,168313200,3.793890782777564,2.854701319337786
A-673,3689413,-2.493408888485536,-1.0615022507142604
OVISE,JQ-1-navitoclax (2-1 mol-mol),0.6695486858757606,0.8231741545004924
A-673,3062316,1.882423163055416,1.0911064424828911
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045,2.580899990593615
FU-OV-1,49766530,-1.0180111021842635,-0.570980943309084
NCI-H1623,4259181,0.7011384719609343,0.4808244873796266
NOMO-1,11427553,1.1686106553832942,1.01690793808186
JM-1,25102847,1.7356230100982195,1.914406839360076
A2780,219104,2.8403974518726938,3.0590000356514304
SBC-5,2113511,4.3346082595960045,5.637345691012249
BxPC-3,navitoclax-birinapant (1-1 mol-mol),-2.5138239615221907,1.6493839771343761
A-498,JQ-1-vorinostat (2-1 mol-mol),1.7562292819472516,1.3159992101600102
BT-549,44607530,1.0072782741331217,2.1414955003605622
FTC-133,56946209,-2.082875590070058,-3.532834454281013
SBC-5,49766530,2.674414744921775,-0.7797338389399299
NCI-H727,1750826,-0.0055354600789778,-0.7225020781119662
SNU-449,2749,2.680740017346485,2.1605113659636577
YAPC,46843906,3.8406256643083214,3.1593195071484677
OVISE,3503,3.051689922997692,2.572231496571162
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903,-0.680975951348155
A4/Fukuda,24901704,2.035809268681581,2.621461906194503
SNU-449,2949965,2.551789087127138,2.9088934432650695
MSTO-211H,65064,5.509158922836103,4.858172948583952
NCI-H460,753704,5.635234970240753,4.946079479547954
BT-549,9907093,5.687861442777729,4.44418603829781
SNU-449,89928392,1.7008506784074908,1.7385388461060405
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506,1.9519039660955877
LOU-NH91,675434,4.5447066201437325,4.737083011664274
CA46,5351362,0.7524287969492447,0.9049271379955265
BT-549,3025944,4.080638158593822,4.446749217717818
SW1463,57330099,3.693611547578868,4.278629741955206
HSC-4,16722836,1.7684769334825834,1.7283728807633407
G-401,4096211,1.4243357241965535,1.6713128924036196
Panc 04.03,6610216,4.328711123736605,4.386370649964518
KMRC-1,5287620,-2.779883294896464,-1.8158931466900434
BxPC-3,119182,-1.1309049402050737,-0.37657777750096083
G-401,135999136,2.1711954992798987,3.053098655780186
KYSE-70,285033,-2.195981319752621,-1.3775515188934124
NCI-H1623,selumetinib-decitabine (4-1 mol-mol),5.307511276565798,3.4028306764349536
KYSE-70,44607531,3.0404164934883733,1.5326294115653918
SCC-9,6918878,3.402250236896725,3.1583384481035055
MDA-MB-453,5282054,2.7696083041072237,3.6426816065195133
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563,2.752852370177731
BxPC-3,57519531,2.3630144255947045,2.685498925969632
NCI-H2171,56949517,4.289308734480345,3.850039856307422
Panc 04.03,54619267,4.1321899610425215,4.290341095802569
G-401,11485656,1.708547873036538,1.977728197463119
A-673,6917907,-5.646852280462545,-5.370726470446571
NOMO-1,71304818,2.372593058500035,1.9031618561441326
MSTO-211H,11214940,0.3292815706978371,2.3304799110819228
HSC-4,1750826,0.4564084690350189,-0.8063484859827967
HSC-4,426756,6.131320111521982,4.39294472472808
SCC-9,12001922,2.463166865850559,1.9454569444278105
CAL-51,656346,0.8466306406200714,0.8390219797865207
NCI-H661,49793307,-1.6947898398784864,-2.7626527423318894
MSTO-211H,6450551,1.5186693992042568,2.791411258091773
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005,1.867202343566398
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277,1.093751486273295
NCI-H460,73707398,3.251551904382877,1.6182383744291298
CAL-51,168313016,5.819136604546001,4.880953733592949
NCI-H292,119607,5.8072644572840915,5.464317957114055
SNU-81,31703,-2.2099083949209715,-0.6173224530679181
A-673,11719255,3.0296971336672627,2.648876789935319
HSC-4,9911830,2.7717739782698563,2.646422519049101
CAL-51,44589607,2.4963130908502107,3.055655298660481
FU-OV-1,24180125,2.037807307003979,2.97910325862337
EFO-27,3634881,3.530057446917586,3.3697834266788624
MSTO-211H,25262965,-3.426128826799908,-1.3110210707574113
LOU-NH91,3543504,4.266458043071255,4.528422634267127
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961,0.5994426061231808
NCI-H2171,23582824,0.048802245172864,0.852121228530006
SCC-9,11507802,1.3688807961315366,2.1758313698555183
MDA-MB-453,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9656310639147305,2.80774404408312
CAL-51,65628,4.560195683913681,4.449686046966946
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256,3.234025630913595
CA46,6505803,0.7805822725654986,-0.9152370555036992
KYSE-70,327653,3.7336437717951103,3.0669365789046186
NCI-H2171,11494412,-0.1110474347644453,0.8580737691876987
LXF 289,6918328,-0.239589445073231,0.209205358439935
CAL-51,24951314,1.3730048574034712,1.3076848361901947
OPM-2,tretinoin-carboplatin (2-1 mol-mol),4.37691141446878,3.229522278625218
A4/Fukuda,2858523,2.415383768636832,2.8329234062959485
NCI-H522,753704,4.098243268802601,4.637037637731013
A4/Fukuda,11625818,2.700159842549232,3.4265487974506517
MDA-MB-157,2949965,2.5406478696331587,2.9134147448864187
ONS-76,409805,3.962852167855045,4.79239297796763
NCI-H146,439501,-3.5641402563292393,-2.2406398943528996
CAL-51,24856436,-0.3083697359271743,0.4250523610514684
SBC-5,31703,-1.5086983052531706,-0.720131296270137
NCI-H522,10184653,0.5663226513641079,1.1857323329442615
NCI-H522,135421197,1.9700795220087195,1.7706809582125593
A-673,alisertib-navitoclax (2-1 mol-mol),-1.8576644604152912,-1.0590447027609264
NCI-H1623,46398810,3.5623335184860196,2.648987583767984
A-673,216468,-1.1121166448103192,1.9755126685780242
BxPC-3,2708,4.650566781622339,5.031510619931375
SNU-81,6184667,-0.6614889419446587,2.5498934160413125
NOMO-1,168312962,2.6221164331885003,0.996762057544563
MDA-MB-453,16720766,-0.5495005772629474,0.5047972203032922
NCI-H522,9956119,4.024745164263863,3.33884769883545
NCI-H1623,135440466,0.8012621152288821,2.4521860617096083
CA46,3025944,4.264528242833472,3.6105566555900657
CAL-51,71466380,3.802692276073616,4.580138357929485
Panc 04.03,11656518,3.295682085422899,1.9969840605768843
SNU-61,JQ-1-MK-0752 (1-1 mol-mol),2.077081766151821,1.32913168713337
LOU-NH91,16720766,0.888730139062919,0.545226803992642
HCC1143,selumetinib-MK-2206 (8-1 mol-mol),0.0669797287296957,2.2322974522486017
JM-1,57519531,1.1574190263295916,1.6824026675738575
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.2646970850158121
MSTO-211H,148198,-2.180219295506665,-3.1116543996913903
SCC-9,4521392,4.43257578464979,4.3480512930521735
FTC-133,2746,3.487652314498242,3.472591208873569
LoVo,44819697,3.398153390084315,-0.35821098624696224
Panc 04.03,122327,5.490637645011104,4.835446394008155
BxPC-3,25154868,5.007679584209566,4.455700970681407
NCI-H661,3503,2.324538290067321,2.442734862628118
NCI-H727,54618771,2.7901712320729333,1.5021259663026272
A2780,10302451,4.067201499125142,3.2497622809232407
A4/Fukuda,5281321,-4.090150251628595,-2.083811055952425
Panc 04.03,24771867,4.398084543376112,3.0097807136401338
CA46,241158,1.6221144264981358,2.3229918545014097
SBC-5,26596,-2.1907470722084414,-0.9074146307793753
A-498,11625818,3.6553151033235904,4.692915808300151
G-401,9911830,0.6760173642929876,2.2247073239969684
CA46,123631,1.9024335998312112,1.9561621564694778
LoVo,104842,-3.39586805089817,-2.8376210716141266
OPM-2,5479543,3.226492982806864,2.4310584454242843
HCC1143,6623618,3.4930934009716226,2.6362687182926026
NCI-H2009,46199207,3.041674504763304,3.1921381515088205
NCI-H661,49766530,1.1318827683023138,-0.4822034260323998
CAL-51,1641662,3.5457804017420744,3.434737621675179
ONS-76,44819697,-0.7397391051726983,-0.24112268788881258
BxPC-3,57330099,4.21152658046839,4.431178948495294
MSTO-211H,3038522,3.865174160499475,3.0396340574776626
LXF 289,71466380,3.888647536265504,4.680916565987738
CA46,5479543,2.004846411807367,2.3129249278069737
OPM-2,9907093,3.786753386665246,3.5914879392907655
NCI-H522,54613361,-1.014694822148615,-0.24183214253835916
NCI-H2171,25195348,2.4042641753284872,3.2222677116813396
LOU-NH91,9911463,4.226439837654448,4.1089362819032065
JM-1,6918736,-2.112176013423493,-2.4742183382708056
OPM-2,89183176,2.1177805080987633,2.5537789932371693
OPM-2,135875424,2.796643273298537,3.202428485141647
HCC1143,24964624,2.836653438175677,2.425807252531255
DMS 273,44566777,1.254196350489733,0.544425368239605
NCI-H522,49867926,4.17523654199276,3.7387594765263983
LoVo,72193861,-0.0557430791680942,1.5079972519259743
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856,1.6198184281550478
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008,1.7326163002370196
SNU-61,374536,-1.8297483787291275,1.4291896192883482
CA46,44566777,-1.0409480025289963,-0.36313113855017326
JM-1,54613361,-0.7111924625528845,-0.7630174153312617
LoVo,25154868,3.829103546750207,4.335568140846717
A4/Fukuda,15547703,2.4441609561923547,2.561588767171504
KMRC-1,10074640,3.6694615069556886,3.1887214177802097
NCI-H2171,2729026,2.1337054337121466,2.392645561938801
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768,-0.44517930202867406
HCC1143,68056272,4.744387863321378,3.38763233042798
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,0.9761248284949606
NCI-H2009,44607531,0.9822487023795796,1.660054427799608
KYSE-70,89183176,4.766828638924323,4.131896293107192
SBC-5,25154868,3.0138435145006155,4.419886605722428
A-498,11719255,3.5352993104723245,3.8042370645770167
SCC-9,208908,2.838235608451249,2.076778264704513
SW1463,2126,3.781949624288532,4.189417211091804
SBC-5,5311,0.7694897344457827,1.56899643640364
BxPC-3,11609586,2.766108761160721,2.9098592015883495
CA46,71466380,3.212448709653588,3.7947927875053233
FTC-133,25126798,4.495223588633032,3.8356207426683295
JM-1,44632017,0.8586744690995054,0.6932494792077017
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598,0.8946019937322802
SNU-449,4917,3.4001304631059965,3.199567952512116
JM-1,135984461,1.552881480804892,2.698112444291334
NCI-H2009,969516,2.7623608328977314,3.0260421749056134
SCC-9,104842,-1.437225086828998,-2.6703717946488457
CAL-51,73707398,0.7053044464230985,1.1242142896845264
KMRC-1,67156097,2.0694443843024173,-0.619626464349777
SNU-449,135411,1.1071215925884743,0.901013560274668
A4/Fukuda,72376,-3.4342601152101473,-3.401051357124036
CAL-51,54619238,5.308906879487735,4.7710209052824775
SBC-5,5282054,4.370273963099393,3.7625781463964163
SNU-81,vorinostat-carboplatin (1-1 mol-mol),3.3031492334396977,2.6909676520449897
OVISE,5328940,2.3935755372069676,1.8880648675418397
SNU-449,BRD-A02303741-carboplatin (1-1 mol-mol),6.10453045453208,4.275706865422289
A2780,24779724,4.3340331177123765,3.6121780217038224
A-673,400769,-0.9976419565742564,-0.6771409003109138
MDA-MB-453,3081361,2.1431734647577496,2.2757477653502
A4/Fukuda,123631,1.573225246333458,2.1240564853604065
A-498,46224516,5.193995490382977,2.6413830240950644
CA46,5738263,2.2696720462337456,2.408164041816201
DMS 273,16722836,2.1308156944151833,1.3613397318963605
KYSE-70,119607,5.065055719995064,5.244713621285613
MDA-MB-157,637858,0.0650158223638603,2.128030027779286
KMRC-1,24180125,3.3952911821821052,2.904805473905741
A4/Fukuda,9935249,-4.132944592984893,1.6544581074933995
A4/Fukuda,9915743,-0.3554458205966057,0.929599641731339
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143,-4.037706824976013
FU-OV-1,11222830,1.8946229471337992,1.826977573731265
SNU-81,BRD-K27188169-navitoclax (2-1 mol-mol),2.560233422856499,1.9584220453844707
NCI-H522,24775005,3.057250054087749,3.4571256560458483
NCI-H522,15983966,4.053677978120726,-2.163096810497143
DMS 273,25102847,1.54508352242066,2.442695275395034
A4/Fukuda,44543605,3.1271044447490235,3.633371177785413
CAL-51,44507138,2.6477043136390637,2.528431998686777
SNU-61,16725315,5.215969195263621,4.269412936190259
EFO-27,448949,1.7491267397814168,2.089133288095307
A-673,5280436,1.8974559090481808,2.869323201693935
MDA-MB-453,24779724,5.606505141806212,4.30644368633648
SCC-9,carboplatin-etoposide (40-17 mol-mol),3.166154009244092,3.192783643869861
G-401,alisertib-navitoclax (2-1 mol-mol),-1.5256164798687666,-0.8879642694764666
NCI-H522,216345,3.499198551341706,3.501314451929957
BT-549,25022340,3.398199457605664,2.9617931235819683
SCC-9,23725625,6.300420686237622,5.251761711692535
MSTO-211H,54619267,2.133098694540018,4.1541826753409286
NCI-H146,JQ-1-UNC0638 (2-1 mol-mol),-1.369706115362065,0.7775872732088862
A-498,148198,-1.0809020747576437,-2.818614141561505
SNU-449,10127622,5.039458046327855,4.477719011349356
CAL-51,1641662,3.5457804017420744,3.434737621675179
MDA-MB-453,5291,3.622613892398656,3.4155984773642256
A-673,168312962,-0.712468254461992,1.3749200736075544
SNU-61,52912189,0.4386789975034979,1.3112978026521853
LXF 289,2828334,5.402872149224608,6.305979041157625
BxPC-3,374536,3.0351492595764347,2.213507955041582
EFO-27,9825149,3.71226874457915,2.369564290781408
NCI-H727,216345,4.166745514794161,4.034063918314583
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.95516867139764
A2780,156414,1.0391092981452308,1.3654829259236314
BxPC-3,11647372,-0.5523773269560157,1.5263917408524454
NOMO-1,10296883,3.647443685498321,3.1579079565528274
LOU-NH91,60750,2.5426597160889823,-2.3970911589831347
NCI-H460,16038120,2.547350732010626,1.181772355442608
ONS-76,123631,2.7486777230854176,2.2157593793299055
OVISE,9903786,4.69480560533159,3.150076742582103
HSC-4,168312962,-1.5337410071263893,1.9640280081699577
NOMO-1,421610,4.35383474826381,2.745141786170565
NCI-H661,4917,2.840246866325883,2.9934950848265145
LXF 289,3634881,3.11935208210029,3.2748403810322317
EFO-27,9911830,3.273850069923984,2.577128572229623
A2780,46215462,1.4920420325768875,1.6003020226661244
MSTO-211H,11234052,3.0252233847843515,4.1734759887057225
NCI-H522,2842253,4.095670069869479,4.151926715324806
A-673,3385,3.2869772752619033,3.686031600239857
MSTO-211H,46398810,1.7478948810000858,2.864298933533886
ONS-76,49850262,3.849158291733923,3.6506795420995597
MDA-MB-157,11507802,-0.5781039838427031,1.956225651419546
A2780,24978538,0.9309197302054482,0.8459701963743683
BxPC-3,24180719,3.164671730334926,3.2428348713542086
NCI-H146,676352,1.7139908333138,1.960852232162996
A-673,82146,3.820966427179324,3.3740942867751453
NCI-H2009,46174525,3.5250507211438107,4.351802382436974
EFO-27,10302451,6.465018307145316,3.486273072769556
A-673,135984461,3.9402009784769745,3.3298796421493777
HCC1143,4521392,4.180219407268625,4.443893409961157
A2780,5351362,1.3372825777001471,1.2540951276434147
EFO-27,10296883,4.235346466258499,4.063639099065732
SNU-61,25150857,2.1451887473522295,2.1697150054118124
LXF 289,25150857,2.4132050810476,2.6907370149056664
KYSE-70,135440466,2.892957215680813,2.1730248655161173
MDA-MB-453,11222830,1.1155100991132725,1.54188397498534
A2780,6918289,-5.622064624678881,1.7505357364398313
OPM-2,445455,3.93427157933256,3.771560078833918
EFO-27,15953870,3.8448280803188233,3.638787780990736
A4/Fukuda,4917,1.915641979161103,2.855791448106328
YAPC,44185566,2.6271326170179248,2.6017705005398106
SNU-449,3634881,3.3285371967859128,3.2359545444636324
OPM-2,44566777,-0.9514063433103236,-0.01751872660632949
NCI-H2171,docetaxel-tanespimycin (2-1 mol-mol),-7.650275881256593,-3.809804150130401
MDA-MB-157,4259181,-0.4671059045276012,0.33156485642710204
SNU-81,11656518,-0.0512259493867009,1.4790702120209573
NCI-H522,11494412,-0.7022253688217924,1.2302766443463968
A2780,selumetinib-decitabine (4-1 mol-mol),1.5025491201295178,2.6061580509985607
CA46,24180719,4.114109141176105,3.1504061829141623
MDA-MB-157,82146,3.0360891700929984,3.827282336888869
G-401,23635314,-3.865618451368766,-2.0331169186938722
LoVo,42642645,0.0146125142547242,0.9938334347622306
HSC-4,9826308,3.3704185574061456,0.6364166431446617
NCI-H292,176870,4.643600229240446,3.510630116025169
ONS-76,44202524,1.6130278410730936,2.4595598963609127
KYSE-70,9911463,3.4914249269651307,3.925822177612991
NCI-H146,24779724,4.32606530761132,4.017839527735169
LoVo,44493528,4.114958638118981,4.317881845117301
CAL-51,44486219,4.943814728636009,4.281915782605802
HCC1143,serdemetan-SCH-529074 (1-1 mol-mol),1.8750312876622353,1.997068211555108
MDA-MB-453,8515,4.14044832994183,3.550863522829798
A-498,tanespimycin-gemcitabine (1-1 mol-mol),3.605685519475067,0.10408898625898491
FTC-133,56963564,0.7376209226585526,0.46782344323238023
MDA-MB-157,11494412,-1.4760508995443156,1.5755726169120885
SNU-449,4261,2.5462586921108197,1.8605699507591769
MSTO-211H,984333,0.926178476056404,0.8180372859613572
SCC-9,1641662,3.777884166860496,3.6257535242573202
HSC-4,2949965,3.8536489984175097,3.0041814860064617
NCI-H2009,5566,2.98031688083636,3.0802020251501676
HCC1143,16741245,3.781249389530293,3.7945942610083843
CA46,67156097,-2.616833441535583,-2.297114977473802
SNU-449,vorinostat-carboplatin (1-1 mol-mol),4.005391500954191,3.4739900724969393
G-401,55283,4.120501166008349,2.555224095515349
A-673,11977753,-4.8378783477247875,-2.358335030313497
BT-549,637858,2.0216713295762614,2.236919598255179
MDA-MB-453,5287620,-1.4808110009700917,-2.216787584383035
BxPC-3,46907787,0.03250860780982,2.35757474901435
NCI-H661,44819697,-3.610310878099198,-0.6255127650121393
Panc 04.03,vorinostat-carboplatin (1-1 mol-mol),3.8664916709741792,3.487230730151113
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492,2.877297043948877
BxPC-3,46191454,0.7426288337003383,1.8645219240546282
MDA-MB-453,322968,3.088283756332906,3.618248363724524
NCI-H1623,16736978,1.234327001570643,1.6411304640743536
KYSE-70,1641662,3.490090790744947,3.521128408124322
A2780,5470400,5.365026906170319,0.10901395932134278
NCI-H522,23582824,0.9084599252004664,0.7704227474420102
OPM-2,BRD-A02303741-carboplatin (1-1 mol-mol),5.621987253531824,3.8701505371033824
MDA-MB-157,23725625,0.2462467633250468,5.17036574553338
SNU-61,44632017,1.0979359106396418,1.1320599038601586
ONS-76,8515,4.109060881613791,3.862487148654803
BT-549,erlotinib-PLX-4032 (2-1 mol-mol),4.9890831311831665,3.3898084135940043
HSC-4,54626689,4.284935050666877,4.654481374343804
SCC-9,42642645,1.380036396261508,1.1530465223913031
LOU-NH91,9866186,2.5706791809917258,1.237315927332417
MDA-MB-453,3552672,1.8646445353613752,2.7086765653774507
LXF 289,11507802,1.7765111516543377,1.9383074184042264
KYSE-70,107985,-3.298359335305578,-3.439180199099884
G-401,53325874,4.831157164763357,4.057423594321872
NCI-H460,5746,0.0249012606464236,1.5258868805968198
MSTO-211H,11213558,-0.8326933060339966,1.6414803773790694
KYSE-70,56963564,0.3897414986371327,1.0438639939661072
FU-OV-1,11485656,3.4521578130267336,2.472037379445666
A4/Fukuda,56963564,-0.5107551488404702,-0.2595322002640557
A-498,51039095,3.6847311434926535,2.763141731619602
BxPC-3,44486219,3.8860987116797703,4.361432671705734
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696,0.5228909962159052
OPM-2,piperlongumine-MST-312 (1-1 mol-mol),0.9476168525414524,1.1640087845994866
HSC-4,44819697,-1.3561318696958864,-0.0520276468063844
LOU-NH91,selumetinib-PLX-4032 (8-1 mol-mol),3.969843428334973,3.6693430508666443
A2780,148198,-4.120801514793353,-3.8715946101677634
YAPC,36462,2.246335150310725,2.7373564674342146
NCI-H460,10184653,3.574651577310896,1.5286841586520148
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.4899341734023577
LOU-NH91,54678924,3.1162234647683205,2.140724286566634
ONS-76,11214940,1.2536021206371053,1.746471045986686
SCC-9,9907093,4.490912734248418,4.1855427445765265
NCI-H661,11964036,1.3116184134954847,1.5984459133242606
CAL-51,135411,0.595745817277345,0.6940980221797717
EFO-27,613753,3.260816470325069,3.3286923911111335
A-673,73707398,-0.4228078892765429,0.670022710777725
YAPC,25262965,-0.9761970914901598,-1.0295587996331472
LXF 289,31703,0.1888440469000175,-0.8944831901569644
A-673,44486219,3.969252294689724,4.154392677570256
HCC1143,135875424,3.1375636080090925,3.9663884584427205
NCI-H661,241158,4.406370209729512,3.885640551424514
A-673,17755052,1.3895683648511998,1.008073328112587
LXF 289,4788,5.213081732847737,5.7233423657102245
NCI-H522,5738263,2.340773324031017,3.1192382153611073
SCC-9,4788,5.928282303581182,5.67211122414631
JM-1,46843906,0.1108259550663182,1.308881694281128
CAL-51,9967941,3.511576456928413,3.6969137483008785
Panc 04.03,5746,1.7282227653726634,1.5570139962264122
JM-1,444795,2.4559914793227597,2.79183067260131
A2780,25183872,-0.9660294253312856,-1.0632210567367772
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.9633687162437988
A-498,12001922,2.3665933531109564,2.122426932122155
NCI-H522,selumetinib-decitabine (4-1 mol-mol),5.680021227414058,2.3891153219191756
NCI-H460,3384730,3.247736649900264,3.0354074053448086
NCI-H292,9884685,1.805947993429832,0.7393849516275119
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456,4.142913001157221
NCI-H2009,25126798,3.423512143516965,3.7953379466952253
A-673,67156097,-2.6530750558799268,-1.372860145146675
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538,0.9022872256668484
NCI-H1623,11364421,1.5638784569997608,0.08613297730111434
OVISE,65064,5.3042455172619345,5.195763341388463
CAL-51,11485656,2.6541256228973773,2.458893037624345
EFO-27,navitoclax-MST-312 (1-1 mol-mol),1.1101378003165483,1.007371789250233
G-401,135984461,4.271777659576195,3.246296510580905
A2780,11960529,3.87105656281655,3.531354344409502
OVISE,168312962,-1.1497759256084987,2.2866578194615603
SNU-449,25062766,2.0173338536366776,2.1624990668013298
CA46,44462760,4.878030903037556,2.6136010693131295
SNU-449,126941,-4.267074342641938,-2.6758740006104107
BxPC-3,55283,0.3092833280624811,2.72474381556722
MDA-MB-453,2708,5.180783048838842,4.838491679981089
EFO-27,441298,3.357031616162376,2.5636006026095437
A-673,25195348,4.457358631051988,3.0867901253147028
OPM-2,285033,-4.309653599496783,-3.159540874588089
FTC-133,156414,2.701071854154092,1.177056143083393
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065,0.6036818959474567
A-673,vorinostat-navitoclax (4-1 mol-mol),0.758498532756487,0.6189508552460652
SNU-449,219104,4.193064059209751,3.9819492615899303
SNU-61,387447,-3.847354855280633,-4.457398304573704
ONS-76,89928392,2.125505613903981,1.6110844650581546
DMS 273,10296883,4.130929131041443,3.4071418102069195
SCC-9,71466380,4.753733846444339,4.5004752427742485
CAL-51,11234052,5.18044926966805,4.093032872727531
FTC-133,135875424,4.265925786122884,4.267600011240756
NCI-H292,135398738,5.91070825601545,4.647738557099116
NCI-H2009,24785538,-2.0037312151285462,1.6149324320323075
KMRC-1,5281321,-2.040334048066586,-1.3826668873306864
OPM-2,9926054,1.8132463747821628,1.5204662029561025
NOMO-1,44607530,2.1799605259844914,1.5357832815297088
BxPC-3,104842,-2.6661298782325265,-2.5063533173349195
JM-1,decitabine-carboplatin (1-1 mol-mol),-2.2469818975584004,0.31462654296866566
A-498,1716436,3.6890609174990057,3.2745202092391903
NCI-H522,252682,6.061888172888063,6.5036693872123825
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908,4.042895034314686
CAL-51,409805,3.8515087112009656,4.99012296957414
SNU-449,676352,1.7938896042567478,2.1868835673626004
NOMO-1,72193861,0.7304873005319745,0.32590493955923167
FU-OV-1,5566,3.32118213388136,2.950974768397756
YAPC,piperlongumine-MST-312 (1-1 mol-mol),2.5050103055031356,1.9541111203985073
CAL-51,5291,4.8235616489491635,3.6114359935924347
NCI-H1623,73707398,1.8898657972875643,1.4397476610847901
G-401,navitoclax-PLX-4032 (1-1 mol-mol),3.453832495837289,0.9260066668000266
A2780,54619267,2.083839750794981,3.965301361214261
A4/Fukuda,25150857,1.0832866246256998,1.8682293333998052
SCC-9,25195348,3.9019221273063858,3.4352697179291107
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705,4.292776595770641
NCI-H2009,20959075,-3.4439076637996076,-2.691641708870552
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907,1.7585441231822705
YAPC,135875424,4.215334227700636,3.9252208519693856
NCI-H522,vorinostat-carboplatin (1-1 mol-mol),3.5371010286521827,2.7248137503108
LOU-NH91,2708,7.798658787946165,5.054767306555727
MDA-MB-157,54613361,-1.9100924648361528,-0.011113029170573574
YAPC,613753,3.436227254149273,3.265838864865719
G-401,26596,-1.5666727843222663,-1.691732951612321
A2780,124202324,1.685811695923782,1.8797464771742738
BT-549,52912189,4.655826026030035,2.5963662262112335
OPM-2,6438330,0.5735051923287856,1.6000436995461929
ONS-76,49766530,-0.8397126534273769,-0.8440269956675672
A-673,24180719,3.918829940752815,3.5243887175880655
A-673,72734382,3.862779655203366,4.196358432573073
JM-1,46926350,-6.131969810114727,-4.4459556986652125
A-498,216239,2.9738940537308203,2.5805943858324154
NOMO-1,54618771,-0.7336388686704796,0.6229452600766117
A4/Fukuda,25126798,3.529395374343333,3.5718610036853273
NCI-H522,16013152,4.870026952980287,3.5340093304500484
NCI-H1623,JQ-1-vorinostat (2-1 mol-mol),1.274501215342979,1.0161440600379075
ONS-76,6918328,0.1573953751573411,0.237905903086244
LOU-NH91,1566236,3.241690914019502,2.5876597527175966
HCC1143,2858523,3.0390361797055276,3.115619331203024
BT-549,71304818,3.5849392152335713,2.519148746559712
MDA-MB-453,49867930,4.991198207309722,4.313510847793662
LOU-NH91,4261,2.7247094190978007,1.9942379090278868
NCI-H522,52947716,2.6251827866590385,-1.121640787598938
NCI-H661,6852167,3.3441449371697205,3.036855319962722
NCI-H292,16736978,2.16203795839555,1.8689857806483305
SNU-449,637858,2.172600125936458,2.3938470934064635
SBC-5,16720766,-1.9276845300945755,0.4905883084095485
ONS-76,piperlongumine-MST-312 (1-1 mol-mol),1.8657254357935973,1.879709504211474
NCI-H661,2828334,5.966055284777512,6.1760953865207355
EFO-27,9884685,1.4230112837032636,0.9084040358085467
OPM-2,25227462,-6.0467342682230445,-1.783621063057132
A-673,3038522,2.0400506341720237,3.0027613314333115
HSC-4,54686904,4.85379149564711,3.5482791998926455
A4/Fukuda,969516,2.117405484631732,2.3667382321132715
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573,1.8578217889530135
LOU-NH91,6610216,4.701575628194421,4.299535746684717
NCI-H661,24856436,-1.6135015308236011,0.4987543663424983
LoVo,6252,1.008875569338637,1.0152199692835728
CAL-51,5281672,3.9430830045045857,4.559469014124767
YAPC,25183872,-0.4840811687838853,-0.5393980540704603
NCI-H2171,11222830,1.3474519729527985,1.2576088082120838
SBC-5,16722836,3.112579400078665,1.7671371695791813
FU-OV-1,3689413,-2.180005064661593,-0.3052869420468624
JM-1,6914657,-7.803103466538306,-5.329590568062597
A4/Fukuda,11222830,1.361211164053787,1.3613784780001772
OPM-2,24180719,3.7347961717129383,3.3480486766502042
A2780,50905018,3.503420862443992,3.8000966139828516
LXF 289,168313016,5.746715572468322,4.762986980729712
MDA-MB-453,2874250,4.390759253530558,4.425427032663765
NCI-H146,3543504,3.2112662755133616,3.9488857171076
MSTO-211H,9956119,3.2798548332341246,3.614484381387623
NOMO-1,11152667,-1.8753376491976492,-2.0201122012181485
NCI-H292,241158,3.585722962787503,4.087085676469434
SCC-9,52912189,3.371588298050412,2.7589604241688517
A-673,15983966,-8.138595470092604,-2.8896935772689702
OPM-2,JQ-1-navitoclax (2-1 mol-mol),-3.008224254673695,-0.7031358570379475
NCI-H146,5287969,-2.632266530811145,-1.9076726193082445
A4/Fukuda,44632017,0.3391160528514481,0.9962372030903985
CA46,1242560,2.637858421223904,3.032763210450749
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.150534278436751
NCI-H727,10184653,0.8809089143232124,1.5145396723020963
MSTO-211H,6918736,-4.031815262851263,-1.4929162269087335
Panc 04.03,54454,4.748257983656133,2.9567070448685935
BxPC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.8536024337573052,-0.7428444188624439
SNU-449,6918328,2.053547134624907,0.39991127921609887
A4/Fukuda,262093,3.0357368226896178,1.8049772508845723
ONS-76,6918837,-2.636307015456442,-2.482679126429363
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525,-2.5238600007830705
ONS-76,107985,-3.307412021608342,-3.3649029790423417
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383,2.9556394073173435
OPM-2,42642645,-0.4905470491794313,-0.031826854938079505
FTC-133,16722836,3.262117509304611,1.9706824451311737
SNU-449,123631,2.9179285945779183,2.723191665428518
OPM-2,644241,1.6900050339542656,0.26377584055616515
HSC-4,1242560,3.572222416741055,3.6519014281623985
NCI-H292,123631,3.5457837677726833,2.4127562585178493
HSC-4,2842253,4.76622062087716,5.539484881597286
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908,3.7402847437852977
Panc 04.03,3689413,0.3957464459941977,0.7270661941241399
NCI-H460,135398516,4.13019906717736,2.269437900400517
NCI-H460,5311,2.161812802665503,1.5549532859834247
SNU-61,11238147,3.2212717665721375,2.61789081965558
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242,0.9867380765509186
HCC1143,44607531,1.4024247683472026,1.5989038249658065
NCI-H727,5351362,1.1476230363651536,1.5260629792993217
KMRC-1,6852167,3.0099217565414693,2.8202487609002787
MDA-MB-157,5311,0.9088479539093504,1.727056088158877
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117,3.95768771244097
HCC1143,crizotinib-PLX-4032 (2-1 mol-mol),1.506008388614785,2.139884996511454
SNU-449,3025944,4.153676005178765,4.342830610996268
A-673,23635314,-4.460908555858267,-2.113412462409785
JM-1,5351362,0.3312371174067021,0.9827695232584445
DMS 273,24901704,3.9468378622372264,2.5929438093665125
MDA-MB-453,9911463,3.8683390626627454,3.8245551992458484
OVISE,60700,1.357326318980797,0.15620868213055183
FTC-133,448949,3.317946341403347,2.136924316664898
LoVo,5566,2.507145044552918,3.0242769709706705
DMS 273,9967941,3.979035067958665,3.086450759065138
LOU-NH91,16038120,-0.2213795856096394,1.3008081123013775
NCI-H1623,11977753,-1.4500330036408269,-0.9750243368634477
NCI-H522,JQ-1-navitoclax (2-1 mol-mol),0.228465095222191,0.7887809200248127
NCI-H460,31703,-0.6563705559837907,-0.7416860287974464
A-673,9866186,-0.4052980916556575,0.2259108735461116
OVISE,31703,0.0982732174518241,-0.5035653481433127
HCC1143,124202324,1.6321362493528402,2.85833668001126
G-401,4705,3.1032512954578415,3.0882138963612236
NOMO-1,3025986,-1.4139862297409005,-1.7179666549093873
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.7930912883472209
NOMO-1,148198,-5.33573798573566,-3.7355351222814623
A2780,9907093,2.8643649893432106,3.784030192539212
HSC-4,44607531,1.5153971496977892,1.3408548293707299
LXF 289,2746,3.190299829163617,3.563742028498357
MDA-MB-453,4261,0.3032353935433951,1.1654996024539472
BxPC-3,656346,-0.1234429100103727,0.8020957685434881
Panc 04.03,BRD-K55473186,5.259619810258457,4.02209117819578
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966,0.9643317611274508
CAL-51,3385,3.064238699960593,4.27290738198279
BT-549,675434,4.287026263227802,4.6529497195941465
LOU-NH91,9868037,3.6278868560603574,3.4746710756394985
G-401,400769,-0.955062013548762,-0.5729629031702773
SNU-449,44185566,2.80206906512974,2.86329838245058
DMS 273,613753,3.2268993277161524,2.896832359445039
FTC-133,9911830,2.8814152307979946,2.7988643739387764
KMRC-1,selumetinib-navitoclax (8-1 mol-mol),3.760872598946533,2.1027952438296653
FTC-133,462382,1.2436445575195818,0.476085961485243
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276,2.74755454321052
NOMO-1,9884685,0.4754269892492985,-0.25619429950840605
FU-OV-1,44589607,2.6910555486326397,3.160517989127146
CA46,11228183,3.2150932794291975,0.5588973171317432
G-401,24797083,1.4378353960151609,1.2356712839804973
OPM-2,4705,3.10353547990691,3.1558775606847824
SCC-9,49766530,0.4117706354329887,-0.393737948401715
DMS 273,44819697,-0.9932488797546292,-0.8819708448305321
NCI-H661,56963564,-1.1338494929069671,0.6219297795667306
NCI-H727,25154868,4.680199730171404,4.389594862817094
MDA-MB-453,56649450,1.3470223737131497,2.809579616290295
CAL-51,54678924,3.225490994604415,1.8423608031644683
NCI-H292,vorinostat-navitoclax (4-1 mol-mol),3.14329221790471,1.4186485097476973
NCI-H522,56963564,-0.3134921987801757,0.37174948500228294
JM-1,10322450,2.576608882705072,3.327846369736975
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433,0.33962704856256437
A-673,24748573,1.962021648564739,2.0184774407838106
LoVo,24785538,0.3940436885335026,1.7952320035189933
NCI-H292,135421197,1.1571557888211337,2.1839135475559583
SCC-9,19582717,4.601399638975327,4.207380869273453
NCI-H2009,5311281,-0.1357038590739554,2.738486349350081
BT-549,24951314,1.7605147679012945,1.6737735660568867
CAL-51,10302451,1.350542324147247,3.5587588436484947
HCC1143,10127622,3.54698748679943,4.2562804924936986
NCI-H460,44589607,4.73035444754351,3.172026922800504
LXF 289,10113978,1.6721223719755247,3.5302962278841385
YAPC,5566,3.1204203259985044,3.105023192198081
NCI-H522,135423438,2.202740699610144,1.4958129849415698
MDA-MB-453,5280436,1.8692407341233208,3.2438452916164446
BxPC-3,400769,-1.094495387384235,-0.47451102610771473
MDA-MB-453,57330099,4.336922942952946,4.128676548449219
DMS 273,24964624,-0.4885915334424611,1.64796378155038
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546,1.680401817491503
A2780,11964036,-0.2399638951327319,1.153405473672943
BxPC-3,56963564,-0.5407215297938537,0.621937611296968
A-673,9907093,4.212541297476806,3.855252362040828
EFO-27,11427553,3.591439679350591,3.116190335793046
MDA-MB-453,439501,-3.002845657836036,-1.9814767274988931
LOU-NH91,11485656,3.2972382499502935,2.6897478273579565
MDA-MB-453,25161177,4.057301598200359,4.015283096691095
NCI-H460,54143018,2.5592633032091956,0.7558708283465174
MDA-MB-453,53325874,4.468628295310174,4.461105281761248
CAL-51,71466380,3.802692276073616,4.580138357929485
NCI-H1623,4788,5.98570816019398,5.579642536495103
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446,2.189104096124412
Panc 04.03,11707110,4.882480457753906,0.018190926889604858
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181,2.9086270176981697
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196,1.8910466281545906
SNU-61,285033,-2.2323165928541746,-1.674160306835962
A2780,25150857,2.724824774969284,2.1038660908562625
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825,-0.48963750637567943
SW1463,36314,3.0951531870893523,-0.07839900393524203
A2780,2858523,2.134868506415456,2.9378832036864777
NCI-H460,3825829,4.446795399525052,3.9191691120912884
A2780,1750826,-0.9954774428329844,-2.188747185789203
NCI-H661,carboplatin-UNC0638 (2-1 mol-mol),4.544203960519617,3.063255092067907
MSTO-211H,selumetinib-MK-2206 (8-1 mol-mol),1.2523786732506748,2.5445523019543588
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606,1.228884693085486
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552,0.05222121196413859
MSTO-211H,107985,-3.699787970340743,-3.3168003477783357
SNU-81,navitoclax-birinapant (1-1 mol-mol),-3.02925999333472,1.1394294545453776
DMS 273,10302451,4.121656528900648,3.3350149631413335
CAL-51,262093,2.862241975448649,3.1027023917864796
DMS 273,4261,-0.2104746005525494,1.1967840868739281
MDA-MB-453,148124,-4.8335014079709975,-1.934658086901557
G-401,11178236,-6.653209761704985,-3.0504557149473994
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312,2.558659469418629
MDA-MB-157,262093,2.565616950913742,2.95448277164075
MSTO-211H,9868037,1.9157833543052896,3.4703008226550405
HSC-4,5280436,3.1415705358429884,3.63688826058025
MSTO-211H,10231331,1.7809441814393978,2.166746261498143
NCI-H2171,969516,2.758162928931276,2.288113251039417
HCC1143,10184653,0.277782870066905,1.4685454980420014
A-673,4788,5.851137286094999,5.152123054756455
OVISE,11364421,1.999223974612241,-0.9745009126657025
NCI-H661,44202524,1.2385989199848235,2.3614142749574434
NCI-H460,3062316,3.704520183651484,1.6471722565028029
NCI-H1623,44607531,0.8047036576600745,1.6744415246370212
OPM-2,9956119,3.674575368535915,3.0114878054607743
OVISE,carboplatin-UNC0638 (2-1 mol-mol),3.0965224412296743,3.5140029592033097
NCI-H146,54618305,4.054654997899016,4.3742906246515085
OPM-2,11507802,0.0988268127526858,0.7501449160000405
CAL-51,10385095,1.0305027810027567,1.2979013992130535
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.912109061505323
A-673,71466380,3.8107210551169577,4.240757158984539
A-673,10427712,3.6867963290416346,3.8862606430996975
DMS 273,56946209,-5.704769625352934,-4.388306059894216
A2780,53301938,-5.924783673466769,1.71507771965659
MDA-MB-453,3025944,3.940846865776467,4.284407752462354
NCI-H146,9840324,5.546223512080725,5.629281238673382
HCC1143,3815108,2.289037887638348,3.0322099483021883
NCI-H460,11625818,5.428588497019925,4.410139718793471
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886,4.886134143528026
SNU-61,123631,1.7897165257078365,2.048828140036333
HCC1143,73707398,0.6963565440176983,1.3713906245387242
FU-OV-1,24964624,0.6948307959675745,2.628084058339922
BxPC-3,89928392,1.339609071089843,1.8574805489645172
MSTO-211H,carboplatin-etoposide (40-17 mol-mol),1.373265530821681,2.9346690345739916
NCI-H661,46398810,2.545394900571619,2.6319037143993347
NCI-H661,17755052,1.4228000150725233,1.8891200356727216
CAL-51,10427712,4.2973287072996085,4.203901082387926
NCI-H661,208908,1.9265593878348335,2.1038523762913286
LXF 289,71466578,4.726723075051965,4.812494223985631
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549,2.3753528303850437
KMRC-1,46224516,3.1277122869876064,2.5144871465907666
JM-1,2113511,3.632981632735763,4.803792557726032
LOU-NH91,2113511,6.175446639496144,5.7088148943011605
A4/Fukuda,6918837,-6.1208599704470865,-3.790915891568862
FU-OV-1,11640390,5.4167064390474335,3.690413175759037
SBC-5,44607531,2.697205944866836,1.53184139730314
OVISE,71304818,3.3064642565645572,2.572808581158315
OPM-2,11152667,-1.3080541002664456,-1.768623537626492
NCI-H146,3552672,1.604439194031644,2.644502771896135
CAL-51,12001922,2.008779489179369,2.028107701928291
SBC-5,969516,3.68635139774897,2.848985982252141
KMRC-1,alisertib-navitoclax (2-1 mol-mol),1.4545717666785216,0.42052364136653103
CA46,53495165,-3.0280125025934495,-1.935641283948112
SW1463,60750,0.1610513612263897,-1.511415441949274
FU-OV-1,46215462,1.830231092617303,2.078174792553808
ONS-76,49793307,-2.5280436252167733,-2.5790632454157025
NOMO-1,11404337,-0.1001889231988697,-1.0095532084174754
SW1463,123631,0.5150504925697384,2.269487810512498
A2780,44819697,-3.3662473846109333,-0.9614016042242283
A-673,44491742,3.844993574977925,4.075244232185813
NOMO-1,5280436,3.413613220161409,2.8118486903335134
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034,3.9605884166844687
BxPC-3,2858523,2.8297817429760945,2.994557307175892
A2780,445091,3.798794327077476,4.069980224002011
OPM-2,11647372,1.2733466761832082,0.3846683034558176
CA46,71751553,4.222934016329145,3.75327724596008
G-401,44486219,4.1772416968228505,4.126519474726502
NCI-H522,9826308,0.3930789830124517,0.43556289113822205
CAL-51,5566,3.271951139375183,2.96244783468576
G-401,89183176,4.003742825914683,3.6310536463820866
NOMO-1,12003241,-0.5951695723430065,-1.2362189833909116
MDA-MB-157,2708,2.34132544783096,4.818057395057065
YAPC,10410894,3.466680540940763,3.4616578202775976
HCC1143,65064,3.71051637258464,4.775163002757725
EFO-27,2746,3.149760082978987,3.563499524675083
LoVo,216468,2.992200557668688,3.093959324775037
DMS 273,3025944,4.590997145359233,4.0806920020115625
NCI-H661,15983966,-5.492856258402122,-1.2247712488281408
BxPC-3,selumetinib-tretinoin (2-1 mol-mol),-1.7965498046170116,2.9607365889751964
CAL-51,2708,4.939881356462198,5.0414250107407605
HCC1143,11175137,3.393081010308343,2.7095994051877046
CA46,42611257,2.680269393096826,3.0999096651753475
ONS-76,68056272,2.9147642388168675,3.215495359850751
Panc 04.03,2871966,2.8539977368648275,0.8077221361048867
CAL-51,25062766,1.9168321284868295,2.1149518361330464
FU-OV-1,52912189,0.1271866873311006,2.402230713877167
EFO-27,73707371,4.965139584704115,5.361130481912387
SNU-449,24951314,2.758293516562198,1.5583151884354138
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691,0.3836050633342556
A4/Fukuda,135999136,4.178898868342667,2.696113719035931
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716,1.2843393978558664
HSC-4,119182,0.0150561689419209,-0.40131283198166207
LXF 289,68056272,4.660756431297166,3.490316325229293
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265,1.734573457334651
SNU-61,31703,0.3335579072308824,-0.6508107356778027
SCC-9,9915743,1.0040050158500469,0.9041594931974497
NCI-H460,446155,3.79922347841428,2.7910882673367086
MSTO-211H,51037431,1.7350128995421004,2.983217874327658
OPM-2,73707438,4.146852269482474,4.1576379418169624
MDA-MB-453,9926054,1.6596725660557576,1.9064852032117405
FU-OV-1,selumetinib-decitabine (4-1 mol-mol),7.280025082931535,4.142296613964238
MDA-MB-157,126941,-4.13859012935224,-2.5624344860918806
NCI-H522,doxorubicin-navitoclax (2-1 mol-mol),-0.6296252861358815,-1.32912205862852
MDA-MB-453,24785538,3.5897722779252383,1.7057857896693092
JM-1,24978538,0.0218307924501431,-0.48820311298579283
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434,4.095524099312976
DMS 273,3503,1.4004718919159695,2.2635090241776483
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.2650914241151237
NCI-H2009,9926054,2.181635437582939,2.084638855953922
KYSE-70,23725625,6.518030965677853,5.080539091111497
CA46,2729026,2.6315261399645755,2.183575839538701
OPM-2,135398516,1.2750707316498222,1.4752185555320079
SNU-449,42642645,1.3579889941817174,1.1611552192981573
HCC1143,25126798,4.15297730422149,3.9467976917712155
KMRC-1,9933475,1.7755712843428362,1.7269047920130884
G-401,12003241,-2.103305079214356,-1.0027396717644663
A-498,5113032,5.384850868352965,4.874726439236459
NCI-H2009,6918736,-2.2815319513344896,-1.8287832154370036
NCI-H292,11455910,1.285235050416197,1.2897152862732961
NOMO-1,24889392,4.281820029392572,3.0288316281423846
HSC-4,4259181,1.301377168384764,0.3489304447842448
NCI-H2171,73707371,5.940029655461802,3.720260129299234
A-498,5329102,2.2449182254359843,2.3004848436919803
JM-1,51037431,4.238886241129638,2.888726986783686
A-673,56973724,1.675633920325915,2.3274691963804592
MDA-MB-157,BRD9876-MK-1775 (4-1 mol-mol),0.1874852527806031,0.6900520593103032
MDA-MB-157,136227331,3.870321503168366,4.104947094395709
A-673,navitoclax-gemcitabine (1-1 mol-mol),-4.77481524796036,-1.6381913238334866
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128,1.5263743735949524
OPM-2,7326481,2.643641332780412,2.7143089731089662
NCI-H146,135423438,2.8528911509997137,2.134536322870523
BT-549,36314,1.6954100357352504,-0.2915562950851529
A2780,11717001,3.193837101204412,4.180484274023213
NCI-H2171,136227924,2.167829841056951,2.6027946710518415
NCI-H292,selumetinib-navitoclax (8-1 mol-mol),1.0361315723218127,2.265061175079325
NCI-H460,11152667,1.2005763717636435,-0.43365707639615997
JM-1,462382,-0.3688196944858197,0.269071751962227
SNU-61,262093,2.836545473910542,2.461286568227137
FU-OV-1,10385095,1.480245925499038,1.2818871813541335
SCC-9,72193861,2.3270498811162508,2.045114348416096
NCI-H661,1242560,4.217168015363727,3.633236901952586
CAL-51,984333,0.1261860025273146,0.7614162346991123
NCI-H522,navitoclax-pluripotin (1-1 mol-mol),-0.4896519907045426,-0.7089237849175192
MDA-MB-157,SNX-2112-bortezomib (250-1 mol-mol),-2.8250293733048615,-0.9435741274505841
BT-549,374536,3.1184462544943363,2.593537080913296
NCI-H1623,11640390,0.1271923003977441,3.6690142035481084
HSC-4,387447,-4.060952426407354,-3.731515346145991
MDA-MB-157,5311037,2.9595373739718087,3.7866420989472265
MDA-MB-453,navitoclax-sorafenib (1-1 mol-mol),1.523284542572191,1.3778554306924615
YAPC,3543504,4.3832051547821855,4.557149677156587
SNU-449,tanespimycin-gemcitabine (1-1 mol-mol),2.625273627898756,-0.17006132224633755
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006,1.7643332228687743
NCI-H1623,9866186,-0.0100221274837169,0.9296051298734015
SNU-449,4788,5.842775682236554,5.778110281858468
Panc 04.03,5287620,-2.39349186702993,-1.876563280745852
MDA-MB-157,11717001,3.389932991765854,4.033992467038249
NCI-H2009,216468,1.7077485468094884,3.4600298471172097
HSC-4,24821094,3.2038955653523713,2.836225921980823
A-673,4578,4.214026417190043,4.017183717718418
KMRC-1,135875424,5.075329697898493,4.043906263447141
G-401,11612883,1.6387860096052431,2.36989681942765
HSC-4,156422,5.249929789072156,4.059310236489065
NCI-H522,2742550,2.7952007563166203,3.4060592273537873
NCI-H522,400769,-0.9806645547005408,-0.666954093196935
NCI-H2009,selumetinib-PLX-4032 (8-1 mol-mol),-1.4525193887521055,3.4698062362495374
NCI-H661,46199207,2.8133245189521054,3.120791143555936
A2780,10184653,1.3482388837291208,1.3322992586210212
SCC-9,24856436,1.519847806890015,0.9173382921435034
NCI-H460,2729026,3.0609463870825926,2.789665630849969
LXF 289,11222830,2.2114905387790755,1.7624571290702107
KMRC-1,46215462,1.6205494448376236,1.9526812065827719
SCC-9,tanespimycin-gemcitabine (1-1 mol-mol),-0.581626900680549,-0.6153158169639528
OPM-2,421610,2.2409150931042072,2.4784606624602916
KMRC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.70640431324625,1.6992991687005259
CAL-51,119607,5.291790266428237,5.186570902065158
CAL-51,24753719,3.9981702522006257,4.332633565267225
KMRC-1,25154868,5.3943697684741805,4.485532739881157
Panc 04.03,89928392,1.6805018731496522,2.188886221372319
SNU-61,25126798,4.129245799651812,3.616511965814199
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854,0.9484539175973886
HSC-4,11977753,4.574500022269399,-0.868855517891749
NCI-H727,4477,0.5438785176620984,0.511849007672845
CA46,5335621,3.676802077981384,3.929595425397582
JM-1,322968,1.8634300837521185,2.1009894497728845
CAL-51,46907787,3.297361866649883,2.2671022833199883
OVISE,doxorubicin-navitoclax (2-1 mol-mol),-1.2556065332393784,-0.8260966155760423
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629,4.781615631679949
NCI-H522,53495165,-1.820766752755188,-0.5065190087035921
MSTO-211H,11626560,1.3885064506517848,2.007709289995869
SBC-5,262093,2.1741934315953726,2.8721383375241403
MSTO-211H,52912189,3.1066961080068123,2.273603575704003
HSC-4,568763,1.3764913265299208,0.7213063143011529
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626,0.8976781419307991
DMS 273,25195348,3.734209419300899,3.340439316950775
Panc 04.03,5951923,4.37213064077745,4.758898999749881
FU-OV-1,439501,-0.5556149973103641,-1.8855534974252293
A2780,BRD-A02303741-navitoclax (2-1 mol-mol),1.977156193717172,1.6918730669080222
LXF 289,168313047,4.113002678801054,2.413608929901038
SCC-9,67291369,5.015060977849177,2.7921710508265227
OPM-2,5351362,0.2459388559982981,1.0928343344833393
FTC-133,11485656,4.087051585535102,2.615775239902987
HSC-4,46843906,4.814917111969106,3.1767926702489926
CA46,51039095,1.651262767418978,2.170517500968928
NCI-H522,2945648,3.0823392214986343,2.717442003663785
MDA-MB-453,selumetinib-piperlongumine (8-1 mol-mol),3.1080333616625713,2.6873424116962825
YAPC,9911463,3.901904463732921,3.991460250173251
DMS 273,11977753,-2.475673354763999,-1.77239698944592
SNU-449,46191454,5.774811831739998,1.9840699450345631
NCI-H661,25062766,2.1967321973268294,2.1944564808290554
A-498,53301938,4.241910990361246,2.694723756959303
Panc 04.03,10302451,3.874200048588579,2.9605472167442715
A-673,16065773,1.4559751864460968,2.227113864065685
NCI-H1623,135398516,1.607867961646436,2.1200389157869224
FTC-133,60700,-2.7194012548196,0.2648371788421537
NCI-H661,3384730,1.2254103498827775,2.9392118983412754
SCC-9,168313200,4.072126418899639,3.100349986067619
OPM-2,25150857,1.3601106429565517,1.6892441164203604
NCI-H292,3385,4.509781783210997,4.361394014785891
NOMO-1,227681,3.177880686522457,2.737472426549041
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947,2.9705455319257474
OPM-2,46191454,-0.9534482392265864,0.1892641319840755
NCI-H522,3081361,1.6470006965888542,2.2009890686346565
CA46,374536,0.6029387131655304,0.8153356383054272
SCC-9,selumetinib-UNC0638 (4-1 mol-mol),3.717663096766538,3.436626168116792
DMS 273,4705,3.496116762813734,3.273387301696413
A4/Fukuda,17755052,-0.6813796549781841,1.2933022554378437
SNU-81,24180125,-1.7131691030529954,2.3563741611888798
Panc 04.03,969516,3.706271998961216,3.0111937058142
CAL-51,15547703,3.503799403292956,3.2294340630621026
NCI-H460,24951314,1.96669984187411,1.447084917565941
SBC-5,446155,1.3486611419477716,2.8351276671559167
Panc 04.03,6184667,3.768891848670565,3.1371225824766196
MDA-MB-157,4096211,2.1957324566584715,2.1911539401593982
CAL-51,15983966,-4.387912760170627,-1.9010665818217682
NCI-H2171,49793307,-5.547674326636965,-3.8443820659315326
MDA-MB-453,31703,-1.1483878700266144,-1.084499578010047
KMRC-1,24785538,2.687509195601708,1.9097133437778928
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615,1.2469497253500486
FU-OV-1,54618164,4.603510021761196,4.205496919267247
YAPC,5287620,-1.8729921135671632,-1.6472572221203254
NCI-H661,16065773,2.6852778174065435,2.4223982162019264
CA46,5329102,1.3169898780971163,1.388460284259668
OVISE,66577038,3.7859124338920065,3.0132438891134545
LOU-NH91,57519531,4.764819520424852,2.7644619264878814
LOU-NH91,448949,2.461672905148464,2.239798813104309
LXF 289,10427712,4.0701965709145504,4.572145193576281
CAL-51,9915743,1.1260994347217144,1.0598864598799178
NCI-H2009,11609586,4.059888202416809,3.20023026475951
SBC-5,60700,-1.8327808511007615,-0.28171082033417694
NCI-H2009,SNX-2112-bortezomib (250-1 mol-mol),-2.754596306388576,-0.9346694667385123
OVISE,24951314,2.5954730551837386,1.5572157139770726
KMRC-1,66577038,2.9827052655036206,2.8276404667596062
LXF 289,36314,1.2391029615263165,-0.6430406862120686
NCI-H292,44607531,0.4181911293940362,1.5234252992014405
KYSE-70,219104,3.9271840577372705,3.8634156811085334
NCI-H460,71304818,2.359856693071434,2.577583549855534
SNU-81,4477,1.0310003158688126,0.5574817441477061
A2780,1716436,1.933630716197044,2.923273179871611
LOU-NH91,11964036,1.2476019563081622,1.761151520704987
SBC-5,9936388,-5.234314033557506,-0.8294427120955659
KMRC-1,24964624,2.351358467802262,2.40033196601802
MSTO-211H,73707438,4.334782721865043,3.664395766397515
MDA-MB-453,73707438,3.778137609083601,3.6521890339446994
EFO-27,49793307,-1.9052761294403429,-2.272322709795137
G-401,71680916,4.434691555895244,4.2437748875518455
MSTO-211H,3634881,2.531877742135044,3.488024585339298
NCI-H292,42642645,0.8145779285410705,1.1788864816781932
OPM-2,168313200,1.8002020874491595,2.61560001666599
NCI-H2009,53232,2.115043522086945,2.9408093612575663
SNU-449,9825149,2.659052538489635,2.1120404981219876
CAL-51,25105715,4.077363851334658,3.384836481939704
MDA-MB-157,53232,1.9030895496471385,2.4736714234117465
NCI-H727,2708,6.607150814967448,4.956484826308365
A-673,carboplatin-etoposide (40-17 mol-mol),0.9497431982903584,1.4238779695971102
NCI-H1623,44632017,1.5464636141196502,1.581947361243411
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478,0.883510467999825
FTC-133,selumetinib-tretinoin (2-1 mol-mol),5.415389433541197,3.6503019038449316
SCC-9,3689413,-0.5284639903905319,0.5871366452776005
NCI-H460,23725625,5.666756485817308,5.065081850933385
NCI-H460,100016,5.855223104671776,6.2793014640098
NCI-H2009,24771867,-1.6305331500245923,2.8446394699468556
SBC-5,9952709,3.0525329755213466,3.293979656396906
SNU-449,5566,3.0151612646695822,3.1338895382572165
NOMO-1,9926054,1.6113291347040215,1.561745756580725
EFO-27,11404337,1.0583908830182924,-0.14825632130091418
A2780,54626689,3.943205764450006,4.510179808554542
A4/Fukuda,168313200,2.9572494196719723,2.917743041023933
LoVo,5460769,-2.1468642890382412,2.5291658796775094
NCI-H661,25102847,2.378632231655901,2.523201644115014
A4/Fukuda,9866186,-0.2462641713744652,0.397439094508008
MSTO-211H,selumetinib-piperlongumine (8-1 mol-mol),2.1949656994292455,3.1396418988481702
KYSE-70,36314,1.2189527676950276,-0.46974605087320626
BT-549,2828334,6.061535937537666,6.121111562959344
NOMO-1,25262965,-2.043358942198166,-2.2252855253617283
LXF 289,25195348,5.284501520866742,3.469105989228604
CA46,451668,2.285623139838705,-0.5587003159492152
SNU-61,24856436,-0.371488374536367,0.7130725572290337
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,2.032056433023199
SCC-9,44137675,3.491154886377157,3.665319165850028
BT-549,151289,0.9825598768305964,1.464343945684135
JM-1,49836020,4.6064946369246025,3.0175445957310685
YAPC,54618771,0.5686030675412354,1.33655683104974
SCC-9,24772860,-2.0717241396099473,-1.9112934628633689
A-673,10385095,1.0544598585596625,1.1422718408304406
SNU-449,216468,4.54901774756382,3.460665327631141
SNU-61,67291369,4.2845115751683736,2.13975649076745
FU-OV-1,5291,4.051520848138153,3.7128486228413347
LoVo,12001922,1.64420677630862,1.877011325074179
NCI-H661,3815108,3.885074716587427,2.9534010369493897
JM-1,374536,-1.2279479926310035,0.983561906941945
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119,4.956818406470138
NOMO-1,4788,5.067002306940809,5.277068587504565
SNU-61,24748573,1.6967337473161408,2.037393760037738
BxPC-3,16720766,0.4925277259578197,0.9123135790294087
EFO-27,46215462,2.714023108610326,1.9787439070608648
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564,0.7739874603737291
SCC-9,31703,-1.2436349312067534,-0.7568574701693472
A2780,5335621,4.014990109441054,3.9079758248114755
EFO-27,4917,3.7917867214450096,3.166099653657002
A2780,9926054,1.5482217772077662,1.797798136944285
A4/Fukuda,3689413,-1.7998697854540155,-0.9939499338715184
OPM-2,6610216,3.8953919440086575,3.9911001231574676
NCI-H522,6918328,0.2751454024017333,-0.12271437675895079
LoVo,60750,-4.161283305326802,-2.404248046525859
LXF 289,15547703,4.3915240757493565,3.2600554964337665
HSC-4,55283,3.529343210540244,2.7710637116765797
MDA-MB-453,6436223,-6.0469700747965325,-4.252031664006883
OVISE,54619267,4.300185321056238,4.154668938808455
CA46,12001922,1.4868064190708767,1.4159530613291256
SNU-61,53392493,2.2959575452819543,2.4597687073694354
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632,-1.1882607046148161
G-401,44137675,2.141460704144857,3.459669644526494
NOMO-1,9825149,1.4944850939332062,1.7778615462550151
CAL-51,4788,6.061217822513647,5.519850354093561
HSC-4,119607,3.948608575005578,5.342839015379055
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645,0.08549696840704585
LXF 289,4477,1.125394938272502,0.4859739913259349
JM-1,11657048,4.676495506604394,2.8057557151346035
G-401,10302451,3.1015289114526774,3.408077423647117
HCC1143,31703,-0.2055424786168501,-0.5610492888225955
HCC1143,374536,1.384467639208202,2.5459114859713083
Panc 04.03,10184653,2.983159460505767,1.58489713607047
NCI-H2009,crizotinib-PLX-4032 (2-1 mol-mol),1.3104929839779844,2.002402842147175
MDA-MB-453,9915743,0.2126089191242519,-0.8460723054496506
HCC1143,4477,1.746819852748151,1.0650104491533297
LoVo,44486219,3.9526381308541025,4.13345852347342
ONS-76,135875424,3.856833286433643,3.8560718837382946
SCC-9,24797083,1.144476664186746,1.6078279336746277
OPM-2,4096211,1.0315429789467454,1.193983444922274
OPM-2,selumetinib-piperlongumine (8-1 mol-mol),2.005304394078306,2.1989478855248565
SNU-81,25262965,-1.8265758424412304,-1.2447765854710484
KYSE-70,44137675,3.4677446622108925,3.760766421408215
NCI-H1623,3854666,1.505587442259218,2.531962050146078
HSC-4,10385095,0.4573663196580717,1.551989840419958
EFO-27,107985,-2.474640150808475,-3.251066663519852
NCI-H2009,6610216,3.953101400309774,4.396444703679125
SNU-61,135421197,1.1046098427392648,1.9093885019283534
HCC1143,4259181,-0.4991941409006941,-0.044609755340357486
BxPC-3,16038120,0.5924635925282854,1.1295973309858314
NCI-H661,135875424,2.4725937826628006,3.820980762574698
SCC-9,9866186,1.319539660579235,1.2661713681783733
LXF 289,24964624,1.3940062455599875,2.507368357559889
HCC1143,vorinostat-navitoclax (4-1 mol-mol),1.2828606463085703,1.2530688354816422
HCC1143,6610216,3.638345017281011,4.4716699882123905
G-401,2949965,1.5385484234582818,2.3649474902968204
BxPC-3,49793307,-3.2953922214008697,-2.4139410239164754
A4/Fukuda,5287969,-2.571307610380136,-2.139791772749996
A-673,6184667,1.935989865778159,2.795091188260084
NCI-H2171,24821094,2.9775477594317743,2.742520511478854
NCI-H2009,67156097,-1.7347724318553324,-0.6823461601397541
A4/Fukuda,409805,3.596796639089143,3.707290625202922
JM-1,5738263,2.278112606764228,2.5488271521287102
SBC-5,2828334,5.980106592077389,6.215480039987323
BxPC-3,107985,-2.51349631829315,-3.2628643492596607
G-401,11427553,1.555705840809683,1.9504617634474735
G-401,10113978,1.710663554595952,2.77205082638826
NCI-H661,16013152,4.678017706607999,4.168877796886338
A4/Fukuda,11497983,-1.0595923666648657,0.9155379767158859
NCI-H522,10296883,3.751667506317718,3.733546171760624
HCC1143,6610355,4.569348514461763,4.604368614801074
SCC-9,56946209,-4.978704692275232,-3.954077271474976
LOU-NH91,54613361,0.2217026048603205,0.3132239517024555
Panc 04.03,ISOX-bortezomib (250-1 mol-mol),0.266400908707645,0.8516425301322467
G-401,42642645,-0.5846467586678221,0.25207610627361693
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289,1.8315723257462924
NCI-H727,5287620,-1.579053209750056,-1.897799522672276
FTC-133,16038120,2.9212616737408896,1.2273312072772498
SCC-9,11626560,2.4253223939520976,2.024979734509824
Panc 04.03,2742550,4.347188786942969,4.017471089654945
OPM-2,15547703,2.634316496996711,2.6146627721578932
NCI-H522,10074640,3.1231046963753686,2.8808276233668515
HSC-4,2945648,2.59041604505869,2.9225352837541525
NCI-H661,vorinostat-navitoclax (4-1 mol-mol),1.2789358142207048,1.4886890477566126
MSTO-211H,10127622,2.776094640706434,3.8815348105654435
FTC-133,serdemetan-SCH-529074 (1-1 mol-mol),3.1500157786176777,2.1659405004788486
NCI-H661,2858523,3.1395656938248124,2.8706689273539467
A-673,56946209,-5.889509916794497,-4.5086009045948385
CAL-51,44185566,1.8630594392382311,2.708373037473598
YAPC,51039095,2.046611375354791,2.9232649579397587
OPM-2,4261,-0.9911458583810344,0.37834494291176746
BT-549,969516,2.601131538014171,2.962424133161645
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637,2.9030874378939937
A-498,55508,4.21947279006693,3.2267310738572372
SNU-449,71466380,4.63195087543953,4.750132818384005
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363,3.8613888576825377
A-673,11707110,3.906892758790242,1.5595419925340732
NCI-H460,54649381,4.173104904963283,3.801948168872834
KYSE-70,5282054,4.279196842795529,3.9298582328403167
G-401,119607,4.5837417334889885,4.778672700014881
YAPC,24856436,1.898811352025064,0.7307293614176176
CAL-51,5460769,1.3780575552768597,2.512605637388526
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787,-2.3166436438382756
CA46,400769,-1.5476292313826252,-1.4152367833743333
SNU-449,19582717,4.423938746946012,4.512285436296708
KMRC-1,46191454,1.86757619496812,1.5186317056241807
MDA-MB-453,45279963,3.011106079512325,3.504941013835284
BT-549,25150857,2.011062957026122,2.523021880479882
BxPC-3,navitoclax-pluripotin (1-1 mol-mol),-1.3920803089523777,-0.865659822921859
NCI-H2009,135999136,4.285465393980956,4.078801739251169
LXF 289,984333,0.880488465949386,1.1649623832306948
NCI-H146,11238147,0.964491846183422,2.773159465199007
Panc 04.03,5287969,-1.8253556910298991,-1.8481539742519177
NCI-H292,654092,0.1209701484650686,-0.14787037612778234
MDA-MB-453,9927531,3.885109165752666,4.4434454413928925
NCI-H522,44819697,-2.38793523497331,-0.8520524736618692
LOU-NH91,11364421,-1.522672653311712,-0.8980733580580873
NOMO-1,4477,1.0767445259598296,0.3781776430523574
LoVo,148198,-1.1147075342847712,-3.361781379548018
SBC-5,54619267,3.782844847718682,4.026128070691782
BxPC-3,vorinostat-carboplatin (1-1 mol-mol),1.8300641490410745,3.3601335569883006
NCI-H2171,46224516,1.006764214935909,2.191277034267976
SNU-61,55283,2.411692675664504,2.4383467390428213
ONS-76,navitoclax-birinapant (1-1 mol-mol),1.131765862858429,1.642614663381903
BxPC-3,vorinostat-navitoclax (4-1 mol-mol),1.2956332154746788,1.2357620128906759
G-401,135398738,4.751845538055463,3.053094094626534
A2780,24889392,2.5877097444926265,3.881523931254246
CAL-51,3081361,1.780158758130264,2.3493837111454003
MSTO-211H,3025986,-0.6925850648320051,-0.6435993764692166
NCI-H1623,10231331,4.737119210946733,2.133670987692464
LXF 289,60750,-4.482846219959503,-2.6041425299828997
JM-1,19582717,1.6871405928140415,2.995810325769625
MDA-MB-453,24775005,1.4926368241852035,3.5898276379738308
JM-1,10074640,2.5195149680920657,2.380682070218196
A-673,2749,0.4791921848862392,1.5473258797434806
ONS-76,9911463,3.87028315643254,3.849463349043605
A2780,3136844,3.626688956130205,4.059004354140288
LOU-NH91,2945648,3.130856585594597,3.234290894447194
NCI-H146,52912189,0.5266703058361273,1.7650399327758735
A2780,156422,3.602973007130472,3.5011538840555243
LXF 289,969516,2.6399649875984355,3.0665747903590743
NCI-H146,25154868,-1.0719819424572428,4.227100402769626
YAPC,1641662,3.645861677961698,3.606222816383929
LOU-NH91,136227331,3.865245001267085,4.196632898495796
YAPC,46224516,2.408657893134071,2.471214166780787
JM-1,46199207,1.915427322474508,2.621746667598178
G-401,54618164,3.8592700204433807,4.026852429092056
A-673,53232,1.7702469915903785,2.582042637799722
SBC-5,6918289,2.991753308414544,2.4916352396531942
MDA-MB-453,selumetinib-MK-2206 (8-1 mol-mol),2.1996282854374303,2.1976552078544804
NCI-H522,24797083,1.396487413816628,1.3744264476894852
YAPC,11238147,2.574935183805209,2.9239024788940866
BT-549,9444,3.939814284899288,4.3415216641032375
NCI-H460,11364421,0.3566052665939138,-1.4952340731287623
LXF 289,23582824,0.8647594683412683,0.9788175265648466
FTC-133,89928392,1.8077600838169707,1.8714505593197504
NCI-H661,15547703,3.600649740500543,3.4633340576611324
JM-1,8515,3.19981027650634,3.1624303288118147
LXF 289,25102847,1.656353256373218,2.4949843014493958
NCI-H1623,11626560,2.1087636260711333,1.9762918080611032
NOMO-1,2729026,1.9247353379999697,2.4728601077980046
A2780,carboplatin-etoposide (40-17 mol-mol),-0.855870041276873,1.9643184135814025
OPM-2,60700,-1.448416790812607,-1.5787356874934657
NCI-H292,9825149,1.7347241761388297,2.4406765470895455
KMRC-1,6918878,5.2070030404450485,2.1858925667951885
SBC-5,4259181,0.3536055110585087,0.07856095651352774
KMRC-1,71466578,5.804397104747809,3.6581881798644234
JM-1,selumetinib-MK-2206 (8-1 mol-mol),3.384959636780238,1.5416010333447516
SCC-9,54596490,5.620994411748341,4.6189324808473975
MSTO-211H,42642645,-0.4763575861779333,0.9879085455088209
DMS 273,4378219,3.0463884183789336,2.079875758823119
FTC-133,SNX-2112-bortezomib (250-1 mol-mol),2.186622613691835,-0.9064677621159081
MDA-MB-453,11626560,2.2881538301476696,2.159691638949497
BT-549,46215462,1.7261150757919093,2.296946560901858
SNU-449,45279963,4.011305658965759,3.962198181477246
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935,4.058180548312066
MSTO-211H,serdemetan-SCH-529074 (1-1 mol-mol),1.7679544322052605,2.2138490745638792
A-673,10302451,3.0176041071951345,3.1780509648274786
CAL-51,5280436,3.749440064194485,3.401614309868112
OPM-2,23582824,0.3145394278485406,0.8642428717261488
JM-1,5287620,-0.1298713463901946,-2.1495997006674274
MDA-MB-157,3503,1.1658051797362206,2.3691108695755814
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757,1.9781549424086533
SNU-61,16741245,4.568608723382813,3.722441568517778
SNU-449,54626689,4.585589968636992,4.738516841289042
G-401,49867930,6.047675909857249,4.058414149392465
HCC1143,46199207,3.122692827276537,2.9891070526649774
OPM-2,445643,3.4082912819673536,3.639693600457676
DMS 273,54618771,0.8675837195237585,1.0055464002281063
NCI-H1623,71304818,2.8160491805212615,2.602167170536146
MDA-MB-157,16659841,3.727147143419768,3.7991595947429424
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146,0.9032312278395755
MDA-MB-453,1750826,0.6003684780059517,-1.3448355462899095
NCI-H1623,5281321,-0.5392861044239732,-0.9936043298031002
MDA-MB-453,613753,2.5060803116052357,2.845092891550781
MDA-MB-453,2871966,-0.7610622755396385,0.5456312727559133
MSTO-211H,5281321,-2.386258436411726,-1.188646974745367
KMRC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.854846859119752,2.8717439255679964
FU-OV-1,44137675,3.1043101525841377,3.751093215418631
NCI-H2171,285033,-3.2427052076981693,-2.74944459731603
FTC-133,alisertib-navitoclax (2-1 mol-mol),-1.780189218062184,0.37468937436731986
NCI-H727,5311,2.2708816030438816,1.4486970611670267
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859,-0.8355552090731305
A2780,5746,0.8697095475366516,0.8005628398314205
NCI-H2171,53232,2.7429596689347875,2.9831683896798324
EFO-27,5291,4.106816055599409,3.6870407113175876
MDA-MB-453,9933475,1.6213532539721074,1.9543429966590782
OPM-2,5281321,-3.721370442971226,-2.4205270974133684
SBC-5,25183872,-1.21590268467039,-0.4829893383027062
SBC-5,452548,-1.978558467437607,0.26547976198249473
NCI-H522,5351362,1.1598735323390523,1.3038279730036293
MSTO-211H,3552672,1.7334798735784387,2.5193553616673925
A2780,10427712,3.0744297357135557,4.027431111321793
LOU-NH91,409805,5.248055334811583,4.993412208500914
JM-1,5460769,0.6255065324989537,1.7362180559987122
NCI-H292,9967941,4.033073764451828,3.922666146046488
NCI-H727,16038120,-0.1646423801756905,1.0830755777667493
NCI-H460,16038120,2.547350732010626,1.181772355442608
LXF 289,241158,4.717778097263283,3.818645446028938
OPM-2,46398810,1.9487214127979129,1.90332733239551
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038,1.474211047942206
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738,2.5212912034980848
CAL-51,9884685,-0.2528326244590672,0.4070285218409662
LoVo,44607531,1.302221694572025,1.4280009041133612
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.5959114486240115
MSTO-211H,56963564,1.234327129960966,0.5240010146573041
MDA-MB-453,73707398,1.1537227860078607,1.3491815301773795
BxPC-3,5329102,1.9407746673909456,2.24493173235294
HSC-4,5287620,-1.917371788332746,-1.5861497728472265
FTC-133,11152667,-0.4786534736280033,-0.18643599825453067
NCI-H146,9935249,1.0600603569941576,2.2593432506802547
YAPC,2729026,2.7496252904978293,2.7636178339506716
SNU-449,71751553,4.402646349497825,4.675832945401626
HCC1143,9926054,1.808099247882512,2.164424392271464
Panc 04.03,448949,2.534760210414342,2.182321905801761
NCI-H661,5566,3.151274839096282,3.0613996799557825
FTC-133,6610355,5.440540243356366,4.776888153421401
JM-1,16741245,4.187666128361383,3.60957391898844
SBC-5,navitoclax-birinapant (1-1 mol-mol),2.2573957245834246,1.4085773274504763
LXF 289,107970,2.2922723928752307,2.456266419904316
Panc 04.03,54626689,4.659724899973851,4.759039083831879
MSTO-211H,16736978,0.1439838744803616,1.9114714301514368
MDA-MB-453,151289,1.613318506724072,1.12531112319492
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.912109061505323
CA46,6918638,-2.155597959241919,-0.8625138556324307
ONS-76,selumetinib-UNC0638 (4-1 mol-mol),0.4414887098860544,3.20597159699992
A4/Fukuda,53495165,-3.058270414187161,-1.6513551473048507
DMS 273,135984461,4.327877942465965,3.4720594238027225
OPM-2,89928392,0.3187576395153793,0.480274966547238
NCI-H1623,10385095,1.1256497169747182,1.4565558801437937
ONS-76,11717001,3.327449083785458,3.9024892183728457
LoVo,6610216,4.332472846182503,4.179855261146679
NCI-H292,16722836,1.3558361632896196,1.8932951714966302
MSTO-211H,135440466,1.110539790918092,2.444593518925057
BxPC-3,9868037,2.7194108471732243,3.453103010696696
CA46,2874250,4.668483912698598,4.135299632982378
MSTO-211H,11238147,2.1702387480753393,3.0282361872186727
JM-1,44607530,1.0639194271383936,1.3972866873553615
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,2.2374665573695283
ONS-76,2749,5.1102698724547375,1.9529505926418
CAL-51,36462,0.7338920585832341,2.1809889326471215
CAL-51,6610216,4.7761200098267365,4.360372894104453
KYSE-70,3062316,0.8461927752800795,1.3103417775553836
LOU-NH91,285033,0.7293222441785373,-1.3662261723392022
A2780,11485656,1.5628347007454235,1.9263199857837867
A-673,26596,-3.820628112159822,-1.86094618528049
KYSE-70,44632017,1.4611535882953923,1.1504304728183454
NCI-H2171,702558,3.801125308495619,4.2861184216437715
MSTO-211H,23635314,-1.96294908215212,-1.9307924458815862
SNU-81,5746,1.2061469752663514,0.7252851316344401
KMRC-1,4788,5.9167994505540475,5.68518215161811
CAL-51,15983966,-4.387912760170627,-1.9010665818217682
CA46,49867930,4.292641096024632,3.4022981018210676
HSC-4,11455910,0.337268703123225,1.3718537463404537
YAPC,5281672,4.680001258160183,4.648781883245946
SBC-5,5978,-3.632907311761228,-1.3827843083252644
NCI-H460,3825829,4.446795399525052,3.9191691120912884
MDA-MB-157,9444,2.0478202605503206,4.183766632856765
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207,0.37515453000205745
SBC-5,46191454,2.9096163569547,1.8074225238976849
CA46,644241,2.374325583681648,0.19636113598705357
EFO-27,erlotinib-PLX-4032 (2-1 mol-mol),3.67875442693599,3.3470768552381363
FTC-133,252682,6.679184103041344,6.545533608911966
SCC-9,56649450,2.7319907342568275,3.217346693256076
CA46,5311,-0.1889513685103653,0.47926986815563183
OVISE,9967941,3.747669270164806,3.6736241784882835
KMRC-1,5328940,2.3844062156656256,1.7722266970078482
NCI-H146,9825149,1.1795040286889695,1.968525746769623
SNU-81,445091,-0.9408785363266468,4.05175459872137
FU-OV-1,6610216,4.742914927321441,4.3785871074814935
A2780,56949517,4.37203598237815,4.2459888566052735
EFO-27,119607,5.664089470896734,5.303040413562095
ONS-76,57519531,2.0495811593793105,2.6863082247431005
MDA-MB-157,42642645,0.4106458170856017,1.0353797125918347
CA46,135421197,1.13174100448049,1.1493105061870852
LOU-NH91,11719255,2.9529273796726394,3.7483199017096576
A-673,9967941,2.0264988474191377,3.3927118422853586
A-673,23582824,0.2073680927392712,0.6717269099229679
CAL-51,374536,3.1977545561189347,2.118465868590985
SNU-449,5311,2.373513113952619,1.5271206353442355
SCC-9,11178236,-3.8920346249942264,-2.7547763544595507
SNU-61,71680916,4.248107596602719,4.264501108424092
BT-549,4578,4.840393866327907,4.564473398921009
JM-1,56973724,1.572059771180543,1.6983971557411692
BT-549,6184667,4.320802676068414,3.1284962976222466
OPM-2,6918878,0.2719026340750923,0.7921163517823803
HSC-4,9967941,3.0274642479334215,3.5407996192102393
G-401,6610355,3.5029306645068696,4.319736903283381
Panc 04.03,1750826,0.308709425359425,-0.5987695909863073
KYSE-70,6610355,4.961596413135767,4.455633803256598
A-673,24775005,3.310963685757038,3.6739134298589793
SNU-81,208908,2.232815974371363,1.8210348931309632
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772,0.9140961268219957
NCI-H727,3543504,4.299187359877464,4.51205553910041
SCC-9,11152667,-0.1233430086603879,-0.13565623095884416
A2780,208908,2.5004436475537974,2.235808799866169
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678,-0.9592433823704921
A4/Fukuda,44607531,1.1783204907000706,1.4863270372160104
ONS-76,54649381,4.0197495944656465,3.8950051705868685
A4/Fukuda,31703,-2.1013190360416147,-2.210219827186921
EFO-27,46398810,2.9967281863964867,2.69178857909892
JM-1,119182,-5.01139227406357,-2.9695452799978703
NCI-H2171,25183872,-2.065345244597309,-0.975398434446792
SCC-9,53392493,3.3396857977581917,2.7429470337728628
ONS-76,44259,0.6373390659589321,1.1711710825201112
NCI-H661,72376,-3.040643961037913,-1.4035559932291963
KYSE-70,11609586,2.827625452517046,3.0201296604646184
NCI-H727,3025944,4.64192894764355,4.309241248661739
NCI-H460,262093,3.3627537421549314,3.076725004216496
MDA-MB-157,tretinoin-navitoclax (4-1 mol-mol),4.215736518135254,2.576533877444338
NCI-H292,11396600,3.7365966834404225,3.9890049492598947
OPM-2,11626560,0.8852338363333486,0.5603304792426584
MDA-MB-453,24772860,-3.354356853525474,-1.2935145641332002
BxPC-3,168312962,2.7485538585474547,2.2193003652887873
KMRC-1,46199207,3.449143967158838,3.0272879647631687
MDA-MB-157,2729026,3.2437974205657816,2.6505431191412265
LoVo,4259181,0.2045859597859785,0.5388151827411278
KYSE-70,5329102,1.9375891375175784,2.068667725780756
EFO-27,3025944,4.337116030950391,4.257715410675397
EFO-27,2742550,4.50908635993052,3.932504182266434
A2780,6610216,3.3472253004646593,4.092212589903913
LOU-NH91,docetaxel-tanespimycin (2-1 mol-mol),-3.5084138300894625,-1.741005173681541
EFO-27,24856436,4.205894943099943,0.6738141374221668
Panc 04.03,9444,4.565679465533194,4.2618468191943855
ONS-76,72193861,2.0006819721723197,1.6577960609341265
MSTO-211H,445643,1.8400808237063873,3.9398708037935233
CAL-51,8515,3.5852991976047863,3.851243396844396
OVISE,25150857,3.4132003431569524,2.614679880629763
KMRC-1,tanespimycin-gemcitabine (1-1 mol-mol),2.381825597611343,-0.7841197259304244
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442,-0.11630775803893088
OVISE,5746,2.6308159153246047,1.303185149025943
A4/Fukuda,168313016,2.0147776130358253,3.8855381042979475
LOU-NH91,54686904,4.160622905506427,3.704125622446686
LOU-NH91,8515,5.2113767400480775,4.185358396915927
NCI-H727,73707398,1.5620380856857303,1.4622340094405468
OPM-2,16722836,0.349034656527362,0.8535829497370432
NCI-H2009,119607,5.663513162505294,5.4217901773914505
G-401,11707110,-1.5866495763270043,1.4608808246118317
SCC-9,439501,-2.6581193485563737,-1.9932143890793776
NCI-H2171,4259181,0.2390230285316857,0.10566270050937861
MDA-MB-157,45279963,1.9862312593637983,3.771947148702534
LXF 289,6610216,3.700752852024682,4.265871561837706
NCI-H2009,9936388,-6.076047204085024,-0.5178206480222981
ONS-76,11612883,3.1090836160489417,2.7541174445702445
SNU-61,969516,2.346236032939849,2.616567199820291
HCC1143,3025986,-1.3091092061734078,-0.9228460768749684
NCI-H146,46398810,1.4219775291726766,2.1764283020819044
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953,2.5380637254064453
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336,-1.6646544556874008
HSC-4,9887053,4.087399127765092,4.176075353581457
JM-1,11178236,-8.647638887964375,-4.00021684676808
LOU-NH91,24856436,2.045063798311017,0.8783105504122318
JM-1,4477,0.6485766089343484,0.3891152287661262
MDA-MB-157,31703,-2.5361356877609142,-0.9047027763027677
NCI-H1623,carboplatin-UNC0638 (2-1 mol-mol),3.4805064241678627,3.4065553249636995
NCI-H661,54619267,3.8937949591354486,4.177725180198395
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452,0.978310872727197
CAL-51,135398516,1.449392214756173,2.4209185524587475
CA46,4917,3.2539126844885757,2.5584800410248394
A-673,4705,3.2416788332737454,3.1024124290048043
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746,2.623407283960356
NCI-H661,107985,-3.0533673433660393,-3.3247174920774967
G-401,navitoclax-gemcitabine (1-1 mol-mol),-3.419368467159671,-1.5225406671627661
NCI-H727,322968,3.201201930682186,3.7311723943778885
MDA-MB-453,9823820,3.844639760703811,4.09893102995471
CAL-51,44202524,1.5528850010053556,2.0620296383640158
MDA-MB-157,BRD-A02303741-navitoclax (2-1 mol-mol),-1.256832531766744,2.3312536394589567
NCI-H522,216468,3.814024876197808,1.9630133453500176
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244,1.7533584080898006
FTC-133,46191454,4.521976640758756,1.75913767861805
A-673,tanespimycin-gemcitabine (1-1 mol-mol),-3.600781620367816,-1.3333447624178236
NCI-H460,3385,3.2657114863965573,4.286393212360572
SBC-5,4917,3.6947166304022465,2.990616887016852
SNU-449,241158,4.010766929552104,4.000958073396764
SBC-5,676352,1.191452976157089,2.185356857364995
FU-OV-1,11626560,1.6217924510760422,2.086531406974065
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608,2.117310751322367
JM-1,23635314,-4.012358401321602,-2.87709469462595
MSTO-211H,24978538,-1.489482683206989,1.7178869296641401
A-673,6438330,1.8412388803722883,1.8352635906097308
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088,2.8074522074539243
SNU-449,11719255,4.899085715446655,3.743023753689174
SBC-5,3025986,0.415316224839701,-1.3532434868772287
YAPC,439501,-1.3344819600707327,-1.8251567430414817
NCI-H292,25262965,-1.3774761624707286,-1.1043360185426083
OVISE,4261,2.633875372862392,1.5686841044586657
SCC-9,24951314,2.365472705935838,1.6221243054795047
CAL-51,57519531,1.893237876741888,2.4444560018750066
SNU-449,4521392,4.287622659497221,4.3098194229168225
SNU-61,136227924,2.341371828887226,2.6048795281825643
HCC1143,24772860,-1.4749293698634824,-1.267911226823233
BT-549,11178236,-2.7962989267365828,-3.449778767796735
G-401,322968,2.2957138552590264,3.072581287024266
DMS 273,322968,3.714238246037839,2.9285042500678298
NCI-H460,135875424,3.211754300989152,4.085559885285363
SNU-449,8515,3.796953450261519,4.0261308293365285
EFO-27,3689413,-2.375877948841856,-0.009550397457314386
SBC-5,46224516,4.445568719663603,2.28544806017805
SCC-9,285033,-1.0227924755741569,-1.3547507767355045
MDA-MB-157,vorinostat-navitoclax (4-1 mol-mol),-2.302516692171374,1.0938140861990189
YAPC,6610216,4.2275333940091215,4.327445865472701
DMS 273,26596,-2.1961333269229173,-2.1633123425221235
NCI-H460,15953870,5.00315267734786,3.541959506837261
JM-1,16065773,2.0826903108024646,1.9849032376199562
CA46,5280436,1.6785665289286047,2.681997613710818
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884,0.8029161870397971
JM-1,navitoclax-piperlongumine (1-1 mol-mol),-0.2702753374722612,0.08583090514213751
NCI-H522,40482356,5.076444098213918,3.2068232730843187
SNU-449,72193861,2.670314458690751,2.1827475999766732
A-673,44185566,1.862123250313604,2.150717392074929
MSTO-211H,6623618,1.8328237574963773,2.38476991585233
NCI-H661,9868037,2.6835007144938032,3.4825866703790886
NCI-H522,9903786,3.9217135447784783,2.486874216947092
A2780,2828334,5.5086207374667175,5.875603788639309
FTC-133,9887053,4.335569761437092,4.067508936844206
Panc 04.03,3503,2.292907505320521,2.5818579695190964
A-498,126941,-2.1438583463370495,-2.14369509763465
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268,0.5393577632656056
OPM-2,2130404,2.9720984033823896,1.8827623549556527
HCC1143,10427712,3.6655746579836497,4.3953918833431125
EFO-27,148198,-4.612142049540045,-3.079303739586197
MSTO-211H,25195348,2.7607409792089186,3.3801803944326254
NCI-H460,11455910,1.4134750909778395,1.0960077748428918
LOU-NH91,selumetinib-piperlongumine (8-1 mol-mol),4.488619060244233,3.827303234619422
NCI-H727,11640390,0.8742840152576016,3.214990315583737
EFO-27,51039095,3.8168650627357903,2.918863559493864
OPM-2,148198,-4.827513159673032,-3.8976119081257115
CAL-51,10113978,3.4506321601115397,3.216123650460828
NCI-H2009,71304818,2.93523377765095,2.65584486165025
A4/Fukuda,24772860,-3.4983689572797307,-2.6069150025767054
NCI-H460,6918837,-0.9355989207233988,-2.4423858011401576
MDA-MB-453,3503,1.4691071846699333,1.8642933298005462
EFO-27,135398516,1.6834680726831996,2.433346253005968
A2780,19582717,2.5113952618702102,3.449240176565533
SNU-61,6918289,4.130324820008196,2.3531741032003386
SNU-81,navitoclax-pluripotin (1-1 mol-mol),-1.399520137964588,-0.8577055679064225
MDA-MB-157,448949,1.9498713128669924,2.0747715492792724
NCI-H727,675434,4.719754403481023,4.731199553719458
KMRC-1,11152667,-0.0604913513883814,-0.18975790961969952
ONS-76,9926054,2.5108803232151304,2.0416071126838826
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566,-0.6202638535659158
CAL-51,44491742,5.152478206660974,4.369745877431878
NCI-H1623,5278396,3.5068270087169022,3.7207284109506547
DMS 273,3634881,3.2856933751991844,2.8716923524546085
NCI-H146,23582824,-0.1302486758765051,0.9069581112714651
NCI-H522,salermide-PLX-4032 (12-1 mol-mol),5.39637133830604,4.6664573624435075
A-673,11175137,1.5552265537901524,2.2486901102592682
A-673,4378219,1.9880690032317576,2.2876623056850756
NCI-H661,5460769,1.0320957244219937,2.690854589142175
NCI-H522,selumetinib-BRD-A02303741 (4-1 mol-mol),6.687730464329683,3.786910454156729
NCI-H146,2746,0.8652413173737366,2.475296389467586
NCI-H1623,11955716,5.690110889982477,-1.2453583031103934
JM-1,46224516,0.3128269384104456,1.9559717796925278
NCI-H2009,docetaxel-tanespimycin (2-1 mol-mol),-5.612671071914989,-2.8249481172076
A2780,11317348,0.9115498056774632,2.2366691501425886
NCI-H661,9911830,2.711917815790479,2.54699550532696
CAL-51,44202524,1.5528850010053556,2.0620296383640158
BT-549,4096211,1.216432091282546,2.1602795888459014
FTC-133,6918328,0.7944971797491694,0.22240560015806898
CAL-51,9911830,2.6702149728757343,2.52544923635857
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482,1.3279036137275535
NCI-H146,BRD-K55473186,3.591565624419444,3.7166344144959607
ONS-76,doxorubicin-navitoclax (2-1 mol-mol),-1.5086467428383314,-0.7569099381875769
SNU-81,16720766,0.0913844680975832,0.5761889171524492
LOU-NH91,46215462,2.06389335978863,2.0360849210307914
MDA-MB-453,navitoclax-PLX-4032 (1-1 mol-mol),2.982075726164247,1.4346407065441105
CAL-51,5978,-2.6819752982341463,-2.1363769047950103
CAL-51,5278396,3.885366261927898,3.532368350998634
HSC-4,4477,1.1301199037714704,0.5668871850164412
HSC-4,25195348,4.125902627491381,3.2817973768765074
NCI-H661,227681,4.255095664751994,3.512387764531844
NCI-H292,24951314,1.8411912809473163,1.5836812063085515
NCI-H522,3543504,4.389197316233122,3.9851386091853427
NCI-H460,452548,0.6919333948360032,0.35176172962171043
SNU-61,25105715,3.603411279706935,3.226055903256976
NCI-H727,navitoclax-pluripotin (1-1 mol-mol),-0.0549082702470221,-0.6992542739738755
SW1463,11175137,3.4916395483032256,2.593007127162715
SBC-5,6914657,-3.351925471283153,-3.36160322204403
JM-1,65064,5.210865559450395,3.6682148613784493
OPM-2,9967941,3.958466181768741,3.1961945512821512
KMRC-1,969516,2.336566526495707,2.9330059113429394
MSTO-211H,15983966,-3.5322347663594016,-1.3809417158197843
OPM-2,9952709,2.422518614873216,2.7912917687630814
NOMO-1,16741245,4.369418152152245,3.4271317273654422
DMS 273,16659841,4.479005871158747,3.100973154817113
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.866534732202092
JM-1,46398810,2.06860116520361,1.900235576765951
NCI-H661,12003241,-1.8871798966926587,-0.9420375303325278
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748,-5.571806622776982
FU-OV-1,10184653,3.943218547538411,1.4430662173778008
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402,3.8911405724237356
OPM-2,156422,3.8836640353636382,2.811438949446832
BxPC-3,JQ-1-vorinostat (2-1 mol-mol),0.8253599744929256,1.041577693713259
SNU-449,56649450,3.812927022122559,3.615133727217032
CAL-51,119607,5.291790266428237,5.186570902065158
LOU-NH91,selumetinib-UNC0638 (4-1 mol-mol),4.70852852885549,3.3977241045368247
BT-549,148124,3.591112191677911,-2.3083714668240205
A2780,216468,0.3493873836888674,2.099457372075039
MDA-MB-453,176870,4.531738011413092,3.3129233518435446
FTC-133,docetaxel-tanespimycin (2-1 mol-mol),-1.4229742664151317,-2.266319492571579
LXF 289,24180125,2.8590757937383517,3.089033096426513
G-401,4259181,0.5796012369716917,-0.2075703282227684
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044,4.55037386469628
SNU-81,alisertib-navitoclax (2-1 mol-mol),-2.6757706059542445,0.19558134102244248
JM-1,54618305,4.117087010604098,3.728930721946508
NCI-H522,16736978,1.523319728114192,1.3885645155179025
NCI-H522,36462,3.1215227661343925,1.3897897410289377
HSC-4,400769,-0.948607557046086,-0.5954133209264263
FU-OV-1,piperlongumine-MST-312 (1-1 mol-mol),2.3913949476666243,2.0294913860589356
YAPC,20959075,1.1991758721406616,-2.5209500840651247
A-498,5328940,1.8314953095149151,2.008145993566009
YAPC,9915743,1.8269757962027744,1.1142567690729352
SNU-81,54613361,-2.01246069716893,-0.15692954541725762
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224,-2.2516085810957516
OPM-2,1716436,2.6292767753294437,2.562350404786575
Panc 04.03,3025986,-1.5275729109481309,-0.964941024482822
NCI-H661,25150857,2.764254958619497,2.43883208143507
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544,2.644325758019767
LOU-NH91,5746,1.403252091596802,1.6290329439238627
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391,1.9456608306684482
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698,2.745267971652359
NCI-H146,135398738,5.0513404057578155,3.8786367990017214
MDA-MB-453,25227462,0.3575965628816619,-0.24337225296034048
NCI-H460,2858523,3.1665522277325575,3.1266838669911077
SNU-449,9866186,1.4050575476777012,1.08898346734899
CAL-51,54686904,4.850424917483252,3.294784718477884
LoVo,53392493,2.4765619401689154,2.599743403346232
LXF 289,24951314,1.0119406639366386,1.5664407049217701
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992,2.571464913720039
NCI-H1623,5329102,1.790138577011996,2.1796050874300974
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017,2.449500172844457
NCI-H292,3815108,3.432884993584308,3.0921670214456984
OPM-2,400769,-3.2268127368380215,-1.198726079528093
MDA-MB-157,9823820,1.002295209558588,4.0674536213888555
MDA-MB-453,vorinostat-carboplatin (1-1 mol-mol),1.132828187068375,2.999823866492987
YAPC,135999136,4.461108174764027,4.015614738123957
A-498,71680916,6.416494665581045,4.8908529173473445
BT-549,252682,5.865498031558929,6.6286142766449
NCI-H522,2130404,2.4549438882602463,2.5863003345359767
BT-549,60750,3.345812478570961,-2.4121031589828164
A2780,55508,1.942124594025635,2.9811675954144645
BT-549,3136844,5.53345832245052,4.418792076401088
A-673,SNX-2112-bortezomib (250-1 mol-mol),-3.639662214518592,-1.591657825806374
NCI-H522,135398516,2.766899162932887,2.0256090434328917
Panc 04.03,45279963,4.427260741974604,3.8262509271362326
MDA-MB-157,107970,2.1200224507121868,2.480551514254542
DMS 273,24180719,3.915275581303962,3.4417842285978515
Panc 04.03,71680916,5.172010716636655,4.894869301527641
DMS 273,44632017,0.8019003224742934,0.9169609649860678
NCI-H292,5311281,4.174884455345005,2.515958636336967
NCI-H2171,9549297,1.2348443580878434,2.1148926367805374
NCI-H661,135398516,2.0112722508641525,2.4632625234655046
A4/Fukuda,6918328,-3.9252329494253586,-1.053375098636392
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603,2.541160189223884
A-673,5284616,-2.8220877865693996,1.1610578186401161
A-498,11222830,1.898532346529896,1.9139723370486594
SNU-81,44589607,-1.0723208776906596,2.4997734151017372
SCC-9,54596558,4.378159430294897,4.402164019755621
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617,-0.32479116078603426
OPM-2,56649450,1.6365959554779024,2.477332463991757
JM-1,2945648,1.8231052373320176,2.3739972640204474
Panc 04.03,6852167,3.6951209581653743,3.214139423803922
OPM-2,5311281,1.024044758253736,1.9608029120938035
SCC-9,9967941,4.677287493278682,3.7839762269405894
CAL-51,11609586,1.5077859423552509,2.9960927984284007
SNU-61,9911463,3.407728451470452,3.5892324218494966
LOU-NH91,BRD-A02303741-navitoclax (2-1 mol-mol),0.4254312881757893,2.51328362348066
KMRC-1,72193861,2.923138623905541,1.8408869560692438
SCC-9,168313016,4.940700460648117,4.891098640593121
NCI-H1623,46215462,1.70222177248337,2.091815443807215
MDA-MB-157,6505803,-0.678815881739905,-0.42583544754631963
A-673,25062766,1.5933001652207863,2.104400729769905
NCI-H522,148198,-5.538025476960186,-3.4380516733512296
KMRC-1,11625818,4.222506706272698,4.504805944450516
LoVo,10074640,2.9851259451828476,3.2247510575939144
NCI-H1623,12001922,2.89915315578861,1.804440211794578
NCI-H460,107970,2.752075604137296,2.386010110547596
HSC-4,10322450,4.749470049467763,4.094184463595497
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982,-0.03809213065553411
CAL-51,65628,4.560195683913681,4.449686046966946
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797,3.1211209859279916
SCC-9,2746,3.644005246156997,3.331043796358271
JM-1,107985,-4.195149425063274,-3.3769176884441925
NCI-H146,119607,3.9951566487227823,4.810426595087229
JM-1,44566777,-1.1129943275867182,-0.4016917749214505
SBC-5,11167602,1.6319389998554443,2.692685137644959
LOU-NH91,9936388,-6.294191236399446,0.3199660825242534
SNU-61,135875424,3.609444893060012,3.611190188167742
NCI-H292,6917907,-6.008612763335491,-4.876794317478616
G-401,19582717,3.4233639988307623,3.3755697673621112
LXF 289,46174525,4.3838011857350585,4.5929457831376155
SW1463,10184653,-0.9517511422842978,1.2606202738755536
SCC-9,7251185,3.4755501931610486,2.685077681940439
OPM-2,4788,3.799883557086963,5.072426923132551
MSTO-211H,selumetinib-UNC0638 (4-1 mol-mol),2.638630251212758,3.6080359908511666
OPM-2,selumetinib-navitoclax (8-1 mol-mol),2.2674041559669917,0.6875416918955863
DMS 273,JQ-1-navitoclax (2-1 mol-mol),1.419130204387569,0.26322817301237583
NCI-H460,387447,-2.436463262555682,-3.7005470568698855
NCI-H522,3465537,1.2201304719285595,2.3310023376123628
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637,2.409825233024346
OVISE,11228183,1.089434907795814,2.4112343661746594
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958,1.1372353796666548
NOMO-1,10410894,2.884775843935945,2.9826778018566102
NCI-H522,3062316,1.3416096793720445,1.5703337659633458
NCI-H522,5328940,1.3898569828081493,1.664399620607263
OVISE,6917907,-2.8614664806523975,-3.819704036317769
DMS 273,53392493,1.951320459884087,2.0110595855791984
BxPC-3,44259,0.1590720374324279,1.1527123708848643
CAL-51,17755052,0.5283491907817935,1.4867179201871417
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112,2.2747413314267977
NCI-H661,676352,2.2217693895783115,2.053895672590895
LXF 289,452548,0.2436004430663324,0.22618513791574912
LoVo,6438330,1.2087527750724023,2.5960879689683525
OPM-2,16736978,1.1906517256258733,0.9528430443025999
DMS 273,89928392,1.202164769006387,0.8008825136791241
CA46,3543504,2.8823298921776717,3.3624913844716713
SBC-5,11427553,4.187017651849035,2.7558769042969833
CAL-51,67156097,-2.385254348530768,-1.073315313825371
FTC-133,23725625,5.526585624025884,5.170645946456423
BT-549,25227462,1.1552638438270102,1.0810651676503573
SNU-81,374536,-2.2172994025671877,1.4970601845332778
MSTO-211H,navitoclax-pluripotin (1-1 mol-mol),-2.948162650279317,-0.8100369719096551
BT-549,65064,5.372588334008338,4.908393266774832
NOMO-1,135398738,0.7085728369009435,2.132297869056552
A-673,44566777,0.6818018070798556,0.7076157731587955
OVISE,42642645,1.7980918591344808,1.255535389713294
CA46,637858,0.8997823848237061,1.0070400861344004
NCI-H292,9877608,5.923265260718527,3.495389231628376
DMS 273,11964036,0.5570994002779035,1.092710668862996
FTC-133,44137675,6.176024086140045,3.4838322329012703
BxPC-3,9926054,1.7603137158224154,1.8280153094532665
DMS 273,5311,0.3077166337368,0.9084634949505069
SNU-61,36314,2.631499046696298,-0.8872976888014512
EFO-27,6917907,-5.745836009999857,-4.815280329200614
OPM-2,11455910,0.7503761469114726,0.43189168596224353
NCI-H1623,24785538,-1.341558176424811,1.98844153382653
SNU-449,462382,1.3667681892704822,0.6130404447702427
G-401,8515,3.316277000480566,3.479570109500577
SNU-449,25102847,2.813788740655036,2.6467991789870995
BT-549,JQ-1-UNC0638 (2-1 mol-mol),2.8120688111855845,2.046340475830533
ONS-76,11404337,-0.4259392266769182,-0.11277717979376892
KMRC-1,49766530,-0.1675164065777726,-1.1890162757403813
HSC-4,24785538,3.772420906085344,1.9743339941977096
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447,5.307624223371528
KYSE-70,73707398,2.029692143461395,1.6110432359514868
NCI-H1623,2729026,3.210868522276231,2.659424607435202
ONS-76,selumetinib-MK-2206 (8-1 mol-mol),-0.5692436577416031,2.35549925792799
FTC-133,56649450,4.4227260509908275,3.41652779926876
NCI-H727,3815108,3.498449156165097,3.0945650828082343
FU-OV-1,448949,2.8154029654914137,2.164372638461692
FU-OV-1,168313200,1.721890351327649,3.041196928875665
HSC-4,107985,-2.2656284906222144,-3.248014758506971
NCI-H2009,44241473,6.22803294537171,4.956794539325853
CAL-51,46843906,2.776329873296567,3.139408817680585
NCI-H1623,56946209,-3.1229213094171895,-3.8634237571639782
FU-OV-1,3825829,3.720797122696784,4.245337058433751
LXF 289,10385095,0.5776298837700374,1.439407118157966
KMRC-1,4259181,1.968851453570829,0.20334824965143053
G-401,11494412,0.2825252149996007,0.9953083592434464
KYSE-70,6918878,2.8589087884624673,2.9731748489577283
CA46,44185566,1.786162700750641,1.563702127190246
LoVo,54618164,3.038824107117225,4.136857875619708
NOMO-1,16722836,0.125485002235246,1.0581639681947537
A4/Fukuda,44486219,1.5854911698245977,3.913435502552433
LOU-NH91,10127622,4.686411868973226,4.2929836135137265
KMRC-1,387447,-4.945508167403058,-3.3395923131886507
NCI-H146,54618164,3.6762408834701423,3.87840134119765
KMRC-1,5351362,3.133883590343709,1.5334161740766552
NCI-H2171,54765302,2.983840848305476,3.8094007886031274
KMRC-1,16013152,4.7431155582488325,4.046681928913241
SNU-61,71304818,2.3861681407496125,2.222144798891017
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046,1.7378628055761671
SW1463,2708,3.597321448088185,4.3134806062971025
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546,-0.13698177766252043
FTC-133,piperlongumine-MST-312 (1-1 mol-mol),3.9575841468826383,1.9823255136882156
SBC-5,445643,4.051401497201939,3.952922491050299
A4/Fukuda,241158,1.407426277414268,2.3980174039903503
NOMO-1,6852167,1.234836949550939,1.7105784179504675
A-673,9887053,2.3565868011684956,3.0197913875131475
SNU-61,6450551,3.0035817833604783,2.0954075111818518
OPM-2,24771867,-0.0082042750480303,-0.9441796191003117
NOMO-1,11507802,1.1250810428603863,0.7783746687928434
CAL-51,2828334,6.190580852669228,6.174606786516281
OPM-2,selumetinib-PLX-4032 (8-1 mol-mol),2.3146569091496847,3.294904484855826
KMRC-1,44489675,3.6404436921550607,3.825862057273988
FU-OV-1,23725625,5.156277829802871,5.239623798996901
NCI-H1623,navitoclax-gemcitabine (1-1 mol-mol),-5.01790230865627,-0.3315017659485697
OVISE,439501,-2.343202219776273,-1.7348795157739159
CAL-51,5281321,-0.4656602142962174,-1.0441090734173448
DMS 273,151289,0.7083247440682101,0.6486310799119509
MSTO-211H,9903786,1.212702371904443,2.96924275418433
LXF 289,135421197,2.6553019911408056,2.190454606418486
NCI-H146,24771867,1.252264036368602,0.9196354789817827
CAL-51,136227924,2.079284078064279,2.9370902431113524
NCI-H522,3689413,-4.273368850016072,-0.5958857543612277
NCI-H460,46907787,4.3372157131836255,2.614525096555309
NCI-H146,25183872,-1.3449770735764903,-1.1979496846894688
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.370622321562245
CAL-51,9887053,4.486783389261201,3.7890821729165647
NCI-H460,107985,-2.632533954936978,-3.020902596296494
YAPC,65064,4.247853222703643,5.011161047895948
SCC-9,9884685,0.522968392230544,0.6157589367142413
SNU-61,6852167,3.859693430343892,2.608886543054515
NCI-H292,400769,-0.4441855968341354,-0.4426104120987876
EFO-27,24748573,3.2354879524418347,2.4212267633925877
CA46,65628,4.372814936384242,3.235780421142925
NOMO-1,1750826,-5.797741098147838,-2.850434153594179
LOU-NH91,135440466,0.9387697781897782,2.3241430331713415
MSTO-211H,11427553,1.7459714847796464,2.9216362043553987
SNU-61,9903786,2.1391845181717373,2.4823633070039937
JM-1,9952709,2.333856130884211,2.1761669405990274
YAPC,44507138,4.423761616669373,2.398131195964163
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152,1.7490211325664708
NCI-H727,10231331,-2.105430518957453,1.7089299266232236
NCI-H661,navitoclax-gemcitabine (1-1 mol-mol),-0.9367360763965996,-0.7511399859034819
LoVo,6610355,3.962139785065475,4.4106901928322495
LOU-NH91,16065773,1.5129164046929433,2.603606946353129
NCI-H292,51039095,2.62578521626359,2.977802791065043
NCI-H2009,135398516,3.792403018557381,2.329685367449789
Panc 04.03,44566777,0.5187219827219705,0.7621153716507959
NOMO-1,285033,-2.4289999699368923,-3.166725867152422
LOU-NH91,doxorubicin-navitoclax (2-1 mol-mol),-1.426641258307621,-0.5843401950055276
KYSE-70,51039095,3.5490987853947247,2.8301095419112396
NCI-H460,36462,3.103581216464206,2.1014189879246516
MDA-MB-157,216345,3.882260039310166,3.8370183629601518
NCI-H522,104842,-1.8805759610000512,-3.5315727789273854
FU-OV-1,72376,-3.2802123060842283,-1.2004162311639879
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302,1.7291259743692424
NCI-H661,5978,-4.21717720873681,-1.4793871646616756
A-498,54619267,3.764771843303345,4.273957172110689
SCC-9,53495165,0.7472636588137463,0.6325434388829474
MSTO-211H,9823820,1.3460489687603958,4.083523403134561
EFO-27,11222830,1.8018026478898377,1.862647144168045
JM-1,11612883,1.345048153552996,1.9047862226268972
NCI-H146,carboplatin-etoposide (40-17 mol-mol),0.3222331814864832,2.1272926095197766
EFO-27,12003241,-1.7336155023360622,-0.858977461320947
SNU-449,969516,2.7263398794742972,2.925854946532758
NCI-H146,4259181,0.4591034911128469,-0.07255125166891771
NOMO-1,24901704,1.738276567126731,2.0126008120942953
BxPC-3,54619238,5.160880582862859,5.1351018283151575
SBC-5,654092,0.9915803206550192,-0.15217052734034997
MDA-MB-453,71751553,4.5545018888168185,4.426194310673709
MDA-MB-157,5978,-4.802538048228265,-1.230453777761396
CAL-51,24964624,1.6704816041215405,2.544284462992278
LOU-NH91,5280436,5.173335280456015,3.6517475004485704
EFO-27,53481919,4.175905541374054,4.147568244099758
ONS-76,6610216,4.821554065133985,4.147386398324892
JM-1,53495165,-3.850144918627292,-1.9575731267527794
YAPC,16065773,2.864044457230109,2.5188886752327417
SNU-449,51039095,3.650396552732121,2.8657187520912117
NCI-H661,71466445,2.1620252686029646,4.216971236877028
A4/Fukuda,984333,-0.4165614363108865,0.014222649214765619
JM-1,4096211,0.9764948319580444,1.229452382315795
SNU-449,44197249,4.950419501644914,4.086922535873089
NCI-H460,11178236,-2.300904923417752,-3.1045512723683
MDA-MB-453,12001922,1.470906003655458,1.691228501976008
NCI-H460,44620216,3.8133491956675902,3.711329999711361
A-673,119182,-1.0392852637873304,-1.319651127032827
NCI-H727,11178236,-2.542459533585497,-2.7840024019955765
NCI-H1623,erlotinib-PLX-4032 (2-1 mol-mol),-0.1422885712238643,2.7661244478641684
A4/Fukuda,753704,3.7176461109746897,4.292429170572938
SW1463,168312962,2.678519281942756,1.6972554314590251
KMRC-1,SNX-2112-bortezomib (250-1 mol-mol),0.0767950067042666,-1.7128201611059608
OPM-2,227681,1.827584998281281,2.73893159355522
HCC1143,3081361,2.3254724072420316,2.489488864316985
CAL-51,44607531,1.640429423812436,1.6443192605100305
HCC1143,322968,3.187805633465504,3.9108127559309995
FTC-133,9911463,4.36756965003986,3.9969946783797434
SNU-61,159324,1.5880493113453718,2.4480150531250597
NCI-H2171,5738263,2.6832104272478188,2.75010372246697
CA46,49867926,4.142181337076857,3.1797881670650607
SNU-81,BRD-A02303741-navitoclax (2-1 mol-mol),0.8522567387086551,1.7341269791789942
HSC-4,44589607,3.345116081225748,3.057286119857457
EFO-27,11485656,3.240498776862908,2.523903270199298
SNU-81,23725625,1.2739024793065858,4.0502957200107526
A4/Fukuda,9911830,0.8865121451383732,2.227578158491344
NCI-H1623,JQ-1-UNC0638 (2-1 mol-mol),2.6843347454635604,1.5338860271325787
NCI-H292,9866186,0.3072921576740348,0.9119169471770325
NCI-H460,54143018,2.5592633032091956,0.7558708283465174
A2780,4378219,4.7769256594107254,2.3123721783494506
NCI-H1623,44566777,3.7111231324950102,0.7931387801343389
CAL-51,10074640,3.192334769578339,3.110016601255972
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452,4.6618358496426575
CAL-51,60700,-0.6497243984818711,-0.35714431435289584
HCC1143,12001922,1.8011931254041345,1.9836096053067387
NCI-H727,638278,3.5555642892396744,3.199433374282655
LOU-NH91,72376,-0.6247816475402558,-1.5076844786755346
EFO-27,4578,4.426476303141277,4.472221148055244
HCC1143,119607,4.074424413991316,5.254419071912013
JM-1,selumetinib-decitabine (4-1 mol-mol),-2.432451496880968,1.1432054282655597
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878,0.6701332877261756
NCI-H727,159324,3.364651085509472,3.0304765842264447
NCI-H1623,5287620,-2.020641279124402,-2.187722343464244
CAL-51,4261,2.4552246887350417,1.7755726184905294
JM-1,3543504,2.821603823672808,3.4821371708555198
SNU-81,11497983,2.4691665919847514,1.916216056044381
G-401,5113032,4.898905985161468,4.424521173171965
MDA-MB-157,52912189,4.238554807379722,2.3958950716137144
G-401,selumetinib-navitoclax (8-1 mol-mol),2.1097176548583407,1.5253506565072457
KYSE-70,10410894,6.372300696648814,3.3275060653283437
LXF 289,54618164,3.0378434141224617,4.242201457474544
SNU-61,11214940,-0.337645985307237,1.8952297016967834
ONS-76,11364421,-0.3098764345335473,-1.2105323337291387
KYSE-70,5978,-0.772629381148284,-1.4022692337964284
Panc 04.03,53232,3.444660782403792,3.2233667192994004
FTC-133,46926350,-4.117104249862265,-4.02993958982824
